trait,description
BXD_10001,"Central nervous system, morphology: Cerebellum weight, whole, bilateral in adults of both sexes [mg]"
BXD_10002,"Central nervous system, morphology: Cerebellum weight after adjustment for covariance with brain size [mg]"
BXD_10003,"Central nervous system, morphology: Brain weight, male and female adult average, unadjusted for body weight, age, sex [mg]"
BXD_10004,"Central nervous system, morphology: Cerebellum volume [mm3]"
BXD_10005,"Central nervous system, morphology: Cerebellum volume, adjusted for covariance with brain size [mm3]"
BXD_10006,"Central nervous system, morphology: Cerebellum internal granule layer (IGL) volume without adjustment [mm3]"
BXD_10007,"Central nervous system, morphology: Internal granule layer (IGL) of the cerebellum volume, adjusted for sex, age, body and brain weight [mm3]"
BXD_10008,"Central nervous system, pharmacology, behavior: Phencyclidine response (7.5 mg/kg ip), locomotor response, difference in activity (PCP minus saline) between 1 hr test periods [cm]"
BXD_10009,"Central nervous system, pharmacology, behavior: Phencyclidine response (7.5 mg/kg ip), locomotor activity from 0-60 min after PCP injection [cm]"
BXD_10010,"Central nervous system, behavior: Saline control response (0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of phencyclidine) [cm]"
BXD_10011,"Central nervous system, pharmacology, behavior: Amphetamine response (5 mg/kg ip), locomotor response, difference in activity (amphetamine minus saline) between 1 hr test periods [cm]"
BXD_10012,"Central nervous system, pharmacology, behavior: Amphetamine response (5 mg/kg ip), locomotor activity from 0-60 min after injection [cm]"
BXD_10013,"Central nervous system, behavior: Saline control response (0.9% ip), locomotor activity from 0-60 min after injection (just prior to injection of 5 mg/kg amphetamine) [cm]"
BXD_10014,"Central nervous system, pharmacology, protein: Calcium (Ca2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes  (monogenic trait mapping to Entpd8) [umolPi /mg protein/hr]"
BXD_10015,"Central nervous system, pharmacology, protein: Magnesium (Mg2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes (monogenic trait mapping to Entpd8) [umolPi /mg protein/hr]"
BXD_10016,"Central nervous system, pharmacology, metabolism: Morphine response (variable doses, ip), induced hypothermia [slope of drug-response curve]"
BXD_10017,"Central nervous system, pharmacology, behavior: Morphine response (variable doses ip), analgesia, slope of the drug response curve [slope]"
BXD_10018,"Central nervous system, pharmacology: Morphine response (variable doses ip), Straub tail test response, slope of the dose response  curve [slope]"
BXD_10019,"Metabolism: Body temperature following saline injection, control for morphine response [degree C]"
BXD_10020,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, hot plate latency after saline control injection [seconds]"
BXD_10021,"Central nervous system, behavior: Saline control response (vehicle ip), open field activity after injection (unpublished data from Belknap and Crabbe, 1992) [units]"
BXD_10022,"Central nervous system, behavior, gustation: Saccharin sweet taste response, saccharin preference versus water ratio [%]"
BXD_10023,"Central nervous system, behavior, gustation: Saccharin sweet taste water consumption (BXD5 value of 1228 units winsorized to 700 units) [mg/kg/day]"
BXD_10024,"Central nervous system, behavior, epilepsy: Handling-induced convulsions (HIC) baseline scores [units]"
BXD_10025,"Central nervous system, pharmacology, epilepsy: Nitrous oxide response, withdrawal severity measured by handling-induced convulsion (HIC) area under the curve [units]"
BXD_10026,"Central nervous system, pharmacology, epilepsy: Nitrous oxide response, withdrawal severity measured by handling-induced convulsion (HIC), corrected peak level [units]"
BXD_10027,"Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal severity measured by handling-induced convulsion (HIC), difference between treated and baseline untreated [units]"
BXD_10028,"Central nervous system, pharmacology, behavior: Ethanol response, withdrawal severity measured as the difference in handling-induced convulsion (HIC) scores from a saline control group (unpublished supplementary data) [units]"
BXD_10029,"Central nervous system, pharmacology, nociception: Morphine response (16 mg/kg), analgesia relative to maximum possible effect [%]"
BXD_10030,"Central nervous system, pharmacology, nociception: Naloxone ([3H]-naloxone) Bmax concentration (binding maximum) [pM/mg]"
BXD_10031,Morphology: Body weight of adult males [g]
BXD_10032,"Central nervous system, morphology: Brain weight in young adult males [mg]"
BXD_10033,"Central nervous system, morphology: Brain to body weight ratio [ratio]"
BXD_10034,"Infectious disease, immune system: Salmonella typhimurium bacterial strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3, filled circles) [log10 CFU]"
BXD_10035,"Infectious disease, immune system: Salmonella typhimurium bacterial strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3 open circles) [log10 CFU]"
BXD_10036,"Infectious disease, immune system: Salmonella typhimurium bacterial strain SR-11, net growth in livers and spleens 6 days after inoculation with 10^2 CFU (figure 5, triangles, Itk/Nramp1/Slc11a1-associated) [log10 CFU]"
BXD_10037,"Central nervous system, behavior: Locomotor activity in a novel environment (Day 1) in young adult males over a 5 min trial (Digiscan 16-beam automated activity monitor) [cm]"
BXD_10038,"Central nervous system, behavior: Habituation measured as difference in locomotor activity between day 1 and day 3 in young adult males over a 5 min test trial (Digiscan 16-beam automated activity monitor) [cm]"
BXD_10040,"Central nervous system, pharmacology, behavior: Ethanol response, blood ethanol concentration (BEC) at recovery of righting reflex (retro-orbital sinus sample) [mg/ml]"
BXD_10041,"Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), duration of loss of righting reflex [minutes]"
BXD_10042,"Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as the latency to fall, saline response minus ethanol response [seconds]"
BXD_10043,"Infectious disease, immune system: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]"
BXD_10044,"Infectious disease, immune system: Ectromelia virus-induced mortality [3 = resistant,  1 = both intermediate and  susceptible, ordinal scale]"
BXD_10045,Metabolism: Body temperature (baseline control for quinpirole study) [degrees C]
BXD_10046,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia 60 min after injection on day 1 measured as change from baseline temperature [degrees C]"
BXD_10047,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 2 compared to day 1 [degrees C]"
BXD_10048,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 3 compared to day 1 [degrees C]"
BXD_10049,"Central nervous system, behavior: Saline response (ip injection), locomotor activation (control for quinpirole study) [cm]"
BXD_10050,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), locomotion change relative to baseline [cm]"
BXD_10051,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), locomotion change relative to baseline [cm]"
BXD_10052,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]"
BXD_10053,"Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks]"
BXD_10054,"Central nervous system, behavior: Saline baseline response (ip, control for quinpirole study), vertical activity (rears, beam breaks) after injection [n]"
BXD_10055,"Central nervous system, pharmacology, behavior: Ethanol withdrawal handling induced convulsions (HIC), 2-12 hours after 4 g/kg 20% v/v ethanol injection (ip), area under curve  [HIC AUC]"
BXD_10056,"Immune system, development: Hematopoietic stem cell pool size, cobblestone area-forming cells per 100,000 bone marrow cells [n]"
BXD_10057,"Immune system: T-cell anergy induced by Bacillus Calmetteâ€“GuÃ©rin tuberculosis vaccine (BCG), delayed type hypersensitivity in footpad increments [mm]"
BXD_10058,"Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of B cells [B220 %]"
BXD_10059,"Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD4+ T cells [%]"
BXD_10060,"Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD8+ T cells [%]"
BXD_10061,"Immune system,  pulmonary system: Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)]"
BXD_10062,"Immune system,  pulmonary system: Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml]"
BXD_10063,"Central nervous system, pharmacology, behavior: Ethanol response, withdrawal-associated handling-induced convulsions (HIC) after a 72 hr exposure to ethanol vapor (with Pyrazole injections to inhibit EtOH metabolism) (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [seizure severity score area-under-25-hr curve]"
BXD_10064,"Central nervous system, pharmacology, behavior: Ethanol response, area under the 25-hr curve for withdrawal following 72 hr exposure to air. Pyrazole injections were given daily to inhibit EtOH metabolism. Handling-induced convulsions (HIC) were scored hourly for 10 hr and again at hrs 24 and 25 [seizure severity]"
BXD_10065,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip loading dose and 68.1 mg/kg pyrazole), chronic withdrawal, handling-induced convulsion score (HIC) corrected for response to pyrazole alone (difference between strain mean values for AREA25 and PYRAREA25) (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only)  [seizure severity]"
BXD_10066,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg), blood ethanol concentration (BEC) normalization data set (BEC was stabilized to ~1.5 mg EtOH/ml blood using daily pyrazole injections) [mg/ml]"
BXD_10067,"Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]"
BXD_10068,"Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]"
BXD_10069,"Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C]"
BXD_10070,"Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg ip), hypothermia after injection [degrees C]"
BXD_10071,"Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia after injection [degrees C]"
BXD_10072,"Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia after injection [degrees C]"
BXD_10073,"Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake relative to previous water intake in 20-24 week-old males [ratio]"
BXD_10074,"Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake in 20-24 week-old males [g/kg]"
BXD_10075,"Central nervous system, pharmacology, behavior: Saline response (saline injection ip), open field activity in 20-24 week-old males (control for ethanol trait 10077) [beam crossings]"
BXD_10076,"Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), distance run in the grid test, 10-12 min after injection in 20-24 week-old males [n beam crossings]"
BXD_10077,"Central nervous system, pharmacology, behavior: Ethanol response (1.33 g/kg ip), open field activity in 20-24 week-old males tested under dim light, 10-13 min after injection of saline (day 1) and ethanol (day 2), difference in number of beam crossings relative to saline control injection [n]"
BXD_10078,"Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), ataxia on grid test, 10 to 12 min after injection in 24-28 week-old males, foot fall errors/distance run in the apparatus [n/distance]"
BXD_10079,"Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day), handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, first experimental replication (Table 4) [HIC area under curve]"
BXD_10080,"Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day), handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, second experimental replication (Table 4) [HIC area under curve]"
BXD_10081,"Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day), handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, third experimental replication (Table 4) [HIC area under curve]"
BXD_10082,"Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]"
BXD_10083,"Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]"
BXD_10084,"Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C]"
BXD_10085,"Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]"
BXD_10086,"Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]"
BXD_10087,"Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C]"
BXD_10088,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute difference in locomotion between experimental ethanol-condidtioned and saline control group of males [activity counts/min]"
BXD_10089,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males, difference between activity after fourth ethanol trial and first trial [cm]"
BXD_10090,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in males in the experimental group over a 30 min trial test [% time]"
BXD_10091,"Central nervous system, pharmacology, behavior: Saline control response (vehicle ip) of ethanol-treated (2 mg/kg ip) males, locomotion 1-5 min after saline injection, trial 4 (experimental group, prior ethanol exposure) [activity counts per min]"
BXD_10092,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 1 in males [activity counts per min]"
BXD_10093,"Central nervous system, behavior: Floor preference baseline, time on grid textured floor for experimental group of males [sec/min]"
BXD_10094,"Central nervous system, pharmacology, behavior: Locomotion from 1-5 min after a single saline i.p. injection for the control group of males [activity/min]"
BXD_10095,"Central nervous system, pharmacology, behavior: Saline control response (vehicle, ip), locomotion of control group from 1-5 min after injection on trial 1 [activity/min]"
BXD_10096,"Central nervous system, pharmacology, behavior: Locomotion from 1-5 min after a saline injection for the control group of males on trial 4 [activity/min]"
BXD_10097,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [s/min]"
BXD_10098,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired hole floor in experimental group males [s/min]"
BXD_10099,"Central nervous system, behavior: Saline control response (vehicle ip), habituation, locomotion from 1-5 min after a single saline injection for the experimental group of males [activity/min]"
BXD_10100,"Central nervous system, pharmacology, behavior: Locomotion from 1-5 min after a single saline ip injection of saline vehicle for the experimental group on trial 1 [activity counts per min]"
BXD_10101,"Central nervous system, behavior: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]"
BXD_10102,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min]"
BXD_10103,"Central nervous system, behavior: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min]"
BXD_10104,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control group on fourth conditioning day [activity counts/min]"
BXD_10105,"Central nervous system, pharmacology, behavior: Saline control response (0.9% ip), activity habituation in males [4th saline injection trial activity minus first saline activity trial activity]"
BXD_10106,"Central nervous system, morphology: Striatum cholinergic neurons, section 11 [n/section]"
BXD_10107,"Central nervous system, morphology: Striatum cholinergic neurons section 14 [n/section]"
BXD_10108,"Central nervous system, morphology: Striatum cholinergic neurons in section 17 [n/section]"
BXD_10109,"Central nervous system, morphology: Striatum cholinergic neurons section 20 [n/section]"
BXD_10110,"Central nervous system, morphology: Striatum cholinergic neurons section 22 [n/section]"
BXD_10111,"Central nervous system, morphology: Striatum cholinergic neurons section 24 [n/section]"
BXD_10112,"Aging: Lifespan, longevity of females (RWW winsorized outliers BXD2, BXD14, and DBA2J from 400, 500, and 175 days, respectively, data originally from Gelman et al. 1988, except parental strains) [days]"
BXD_10113,"Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent stem cells in aged mice, cobblestone area forming cells (CAFC) at day 35 in culture, frequency in bone marrow [CAFC per 10e5 bone marrow cells]"
BXD_10114,"Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells]"
BXD_10115,"Immune system, aging: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC]"
BXD_10116,"Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change [% CAFC]"
BXD_10117,"Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC]"
BXD_10118,"Immune system, aging: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 10e5 bone marrow cells]"
BXD_10119,"Immune system, aging: Proliferative activity of hematopoietic stem cells on day 7 in culture [% CAFC]"
BXD_10120,"Central nervous system, pharmacology, behavior: Chlordiazepoxide response (10 mg/kg ip), acute locomotor activation, distance traveled 0 to 5 min after injection [cm]"
BXD_10121,"Central nervous system, pharmacology, behavior: Chlordiazepoxide response (10 mg/kg ip), acute locomotor activation, distance traveled 5 to 10 min after injection [cm]"
BXD_10122,"Central nervous system, pharmacology, behavior: Chlordiazepoxide response (10 mg/kg ip), acute locomotor activation, distance traveled 10 to 15 min after injection [cm]"
BXD_10123,"Central nervous system, pharmacology, behavior: Chlordiazepoxide response (10 mg/kg ip), acute locomotor activation, distance traveled 15 to 20 min after injection [cm]"
BXD_10124,"Central nervous system, pharmacology, behavior: Chlordiazepoxide response (10 mg/kg ip), acute locomotor activation, distance traveled 5 to 20 min after injection [cm]"
BXD_10125,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 mg/kg ip), acute locomotor activation, distance traveled 0 to 5 min after injection [cm]"
BXD_10126,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 mg/kg ip), acute locomotor activation, distance traveled 5 to 10 min after injection [cm]"
BXD_10127,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 mg/kg ip), acute locomotor activation, distance traveled 10 to 15 min after injection [cm]"
BXD_10128,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 mg/kg ip), acute locomotor activation, distance traveled 15-20 min after injection [cm]"
BXD_10129,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 mg/kg ip), acute locomotor activation, distance traveled 5 to 20 min after injection (C15orf52 is strong candidate gene with nonsense mutation in D) [cm]"
BXD_10130,"Central nervous system, behavior: Saline control response (ip injection), locomotor activity, distance traveled 0 to 5 min after injection [cm]"
BXD_10131,"Central nervous system, behavior: Saline control response (ip injection), locomotor activity, distance traveled 5 to 10 min after injection [cm]"
BXD_10132,"Central nervous system, behavior: Saline control response (ip injection), locomotor activity, distance traveled 10 to 15 min after injection [cm]"
BXD_10133,"Central nervous system, behavior: Saline control response (ip injection), locomotor activity, distance traveled 15 to 20 min after injection [cm]"
BXD_10134,"Central nervous system, behavior: Saline control response (ip injection), locomotor activity, distance traveled 5 to 20 min after injection [cm]"
BXD_10135,"Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation), raw mean consumption of adult males (same data as  Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight]"
BXD_10136,"Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation) by young adult females (74-91 days, same data as in Rodriguez et al., 1994 with outliers removed and two strains added) [g/kg]"
BXD_10137,"Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation) by young adult males (53-67 days, residual values and same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10138,"Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation) by young adult females (74-91 day, residuals and same data as in Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10139,"Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption using two-bottle choice in young adult males (53-67 days, same data as  Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10140,"Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption using two-bottle choice in young adult females (74-91 days, and same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10141,"Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption using two-bottle choice in young adult males (53-67 days, residuals and same data as  Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10142,"Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption using two-bottle choice in young adult females (74-91 days, residuals over a two week test period and same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg]"
BXD_10143,"Central nervous system, circadian rhythm: Sleep need, slow wave sleep delta EEG power after 6 hrs sleep deprivation, 4-6 males per strain at 92 days of age [%]"
BXD_10144,"Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), initial sensitivity measured as the ataxia onset threshold following first of five injections [mg/kg]"
BXD_10145,"Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), maximal threshold to ethanol induced ataxia [mg/ml]"
BXD_10146,"Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), tolerance, difference between ethanol induced ataxia (maximal threshold blood ethanol concentration BEC) minus onset threshold [mg/ml]"
BXD_10147,"Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), tolerance measured as the fold-increase of blood ethanol concentration (BEC) to ethanol-induced ataxia [ratio of tolerance BEC over initial BEC ataxia]"
BXD_10148,"Aging: Lifespan, longevity of females (mean age) at the Dana-Faber Cancer Institute (Redstone Animal Facility, Boston MA) from Jackson Laboratory between Nov 1982 and Mar 1983 on Purina chow (all data reinstated, authors initially excluded BXD13 due to seizures and BXD31 and BXD32 due to poor marker coverage, BXD13 winsorised to 439) [days]"
BXD_10149,"Liver, metabolism: Hepatic lipid peroxidation (LPO) levels in 2-month-old males [malondialdehyde (MDA)/mg]"
BXD_10150,Immune system: Thymic T-cell proliferative unresponsiveness (anergy) to anti-CD3-induced proliferation (chemokine-associated) [units]
BXD_10151,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), total fluid intake during 4-day forced 10% ethanol exposure period [ml/day]"
BXD_10152,"Central nervous system, pharmacology, behavior: Fluid intake (total) during free choice ethanol period [ml/day]"
BXD_10153,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), preference during 3-week free choice period using two-bottle choice test for males [fraction]"
BXD_10154,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference during free choice period for females using two-bottle choice test [ratio]"
BXD_10155,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during 3-week free choice period using two-bottle choice test for males [gm/kg/day]"
BXD_10156,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during free choice period for females using two-bottle choice test [gm/kg/day]"
BXD_10157,Morphology: Body weight [g]
BXD_10158,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), ethanol preference ratio using a two-bottle choice test [ratio]"
BXD_10159,"Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), voluntary consumption ratio using a two-bottle choice test [gm/kg]"
BXD_10160,"Liver, protein: Catalase activity in liver [uMol]"
BXD_10161,"Central nervous system, protein: Catalase activity in brain [nMol]"
BXD_10162,"Liver, protein: Aldehyde dehydrogenase (ALDH) activity in liver [nMol NADH/min/mg]"
BXD_10163,"Central nervous system, protein: Aldehyde dehydrogenase (ALDH) activity in brain [nMol NADH/min/mg protein]"
BXD_10164,"Central nervous system, behavior: Home cage activity level 10-14 week old males after saline injection [quadrant crossings/min]"
BXD_10165,"Central nervous system, behavior, pharmacology: Methamphetamine response (4 mg/kg ip), locomotor activity difference from saline in 10-14 week males [quadrant crossings/min]"
BXD_10166,"Central nervous system, behavior, pharmacology: Methamphetamine response (8 mg/kg ip), locomotor activity difference from saline in 10-14 week males [quadrant crossings/min]"
BXD_10167,"Central nervous system, behavior, pharmacology: Methamphetamine response  (16 mg/kg ip), locomotor activity difference from saline control in 10-14 week males [quadrant crossings/min]"
BXD_10168,"Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg ip), frequency of sterotyped chewing events 33 min after injection in 10-14 week males [quadrant crossings/min]"
BXD_10169,"Central nervous system, pharmacology, metabolism: Methamphetamine response (4 mg/kg ip), body temperature change 48 min after injection in 10-14 week males [degree C]"
BXD_10170,"Central nervous system, metabolism, pharmacology: Methamphetamine response (8 mg/kg ip), body temperature change 48 min after injection in 10-14 week males [degree C]"
BXD_10171,"Central nervous system, pharmacology, metabolism: Methamphetamine response (16 mg/kg ip), body temperature change 48 min after injection in 10-14 week males [degree C]"
BXD_10172,"Central nervous system, pharmacology: Methamphetamine response (8 mg/kg ip), brain concentration in brain after injection in 10-14 week males [ug/gm]"
BXD_10173,"Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg ip), climbing scores of 10-14 week females 1 hr period after injection, 0=on floor, 1=two paws up; 3=climbing [index]"
BXD_10174,"Central nervous system, pharmacology: Methamphetamine response (4 mg/kg ip), brain concentration after injection in 10-14 week males [ug/gm]"
BXD_10175,"Pharmacology, metabolism: Ethanol response (2 g/kg ip), rate of ethanol clearance [mg/ml/hr]"
BXD_10176,"Pharmacology, metabolism: Ethanol response (3 g/kg ip), rate of clearance, beta [mg/ml/hr]"
BXD_10177,"Pharmacology. metabolism: Ethanol response (2 g/kg ip), blood ethanol concentration (BEC) 60 min after injection [mg/ml]"
BXD_10178,"Pharmacology, metabolism: Ethanol response (3 g/kg ip), blood ethanol concentration (BEC) 60 min after injection [mg/ml]"
BXD_10179,"Cancer biology: Metastasis of implanted breast tumor in lymph node, cases with tumor metastasis [n]"
BXD_10180,"Cancer biology: Metastasis of implanted breast tumor in pancreas, cases with tumor metastasis [n]"
BXD_10181,Cancer biology: Necrosis of implanted breast tumor [n]
BXD_10182,"Cancer biology: Syngeneic breast tumor growth, number of cases with tumor metastasis [n]"
BXD_10183,"Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm3]"
BXD_10184,Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3]
BXD_10185,Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3]
BXD_10186,"Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm3]"
BXD_10187,Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3]
BXD_10188,Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm3]
BXD_10189,"Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm3]"
BXD_10190,Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3]
BXD_10191,Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3]
BXD_10192,Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3]
BXD_10193,Cancer biology: Leukocyte infiltration in metastatic breast tumor on day 5 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and  4 means most severe destruction) [index]
BXD_10194,Cancer biology: Leukocyte infiltration in metastatic breast tumor on day 12 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and  4 means most severe destruction) [index]
BXD_10195,Cancer biology:Leukocyte infiltration in metastatic breast tumor on day 30 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]
BXD_10196,"Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 5 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]"
BXD_10197,"Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 1 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]"
BXD_10198,"Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells on day 30 (0 means no leukocyte infiltration and no destruction of implanted tumor cells and 4 means most severe destruction) [index]"
BXD_10199,Cancer biology: Apoptosis of breast tumor cells on day 12 (0 means no apoptosis infiltration and no destruction of implanted tumor cell and 4 means most severe) [index]
BXD_10200,Cancer biology: Apoptosis of breast tumor cells on day 30 (0 means no apoptosis infiltration and no destruction of implanted tumor cell and 4 means most severe) [index]
BXD_10201,Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated]
BXD_10202,"Central nervous system, pharmacology, behavior: Cocaine response (variable dose, iv), dosage required to induce tonic seizure infused via tail vein [mg/kg]"
BXD_10203,"Central nervous system, pharmacology, behavior: Cocaine response (variable dose iv via tail vein), dose required to induce clonic seizure [mg/kg]"
BXD_10204,Immune system: TRBV4+ T cell levels among CD8+ T cells in spleen [%]
BXD_10205,Immune system: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%]
BXD_10206,Immune system: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul]
BXD_10207,"Immune system, hematopoesis, aging: Hematopoietic stem cell and progenitor cell proliferative capacity (Lin-Sca1++ cells from femur bone marrow), in vitro assay of cells from 2-3 month old females in response to KL, flt3L, and TPO (Figure 3A of paper) [n cells]"
BXD_10208,"Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells, numbers of Lin-Sca1++ cells at 2 months of age in females (Figure 3B of paper) [n]"
BXD_10209,"Immune system, hematopoesis, aging: Relative fraction of hematopoietic stem cells and progenitor cells (Lin-Sca1++) from bone marrow in 2-3 month old females (Figure 3C of paper) [%]"
BXD_10210,"Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells in femur bone marrow, percentage of c-kit-postiive cells to c-kit-ngative cells among Lin-Sca1++ cells in 2-month old femaies (Figure 3d of paper) [%]"
BXD_10211,"Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (Fig 2A of paper) [n per well]"
BXD_10212,"Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells in femur bone marrow (lin-Sca1++ c-kit+) at 18 months of age (Figure 2B of paper) [%]"
BXD_10213,"Immune system, aging: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age in response to KL, flt3L and TPO (figure 2C of paper) [n cells]"
BXD_10214,"Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (additional data not included in paper) [n cells total]"
BXD_10215,"Immune system, aging: Hematopoietic stem cell and progenitor cell number (lin-Sca1++ c-kit+ cells) from femur bone marrow of females a 18 months (confirm) (unpublished additional data) [n cells]"
BXD_10216,"Immune system, aging: Proliferative capacity, number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.01 ng/ml) at 18 months of age (confirm) (unpublished additional data) [% increase]"
BXD_10217,"Immune system, aging: Proliferative capacity, effect of TGF-beta2 stimulation (0.1 ng/ml) on numbers of lin-Sca1++ c-kit+ cells (unpublished additional data) [% increase]"
BXD_10218,"Immune system, aging: Proliferative capacity change, difference between old (18 months) and young (2 months) on number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.1 nl/ml) (unpublished additional data) [cells per well]"
BXD_10219,"Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow  [%]"
BXD_10220,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of young adult males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10221,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the nucleus accumbens core of young adult males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10222,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the nucleus accumbens shell of young adult males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10223,"Central nervous system, morphology: Tyrosine hydroxylase dopaminergic neurons in ventral tegmental area in young adult males [n/section]"
BXD_10224,"Central nervous system, morphology: Tyrosine hydroxylase dopaminergic neurons in substantia nigra compacta in young adult males [n/section]"
BXD_10225,"Immune system, aging: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4)[unit]"
BXD_10226,"Immune system, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells in thymus [%]"
BXD_10227,"Immune system, aging: Age-related T-cell decline, percent of CD4-CD8 double positive cells in thymus [%]"
BXD_10228,"Immune system, aging: T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells in thymus at 22 months [%]"
BXD_10229,"Immune system, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells in thymus [%]"
BXD_10230,"Immune system, aging: Age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%]"
BXD_10231,"Immune system, morphology, aging: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4)"
BXD_10232,"Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0]"
BXD_10233,"Immune system, morphology, aging: Thymocyte count, projected at 60 days [units]"
BXD_10234,"Central nervous system, pharmacology, protein expression: Dopamine transporter (DAT, SLC6A3, Chr 13 at 73.6 Mb) protein density in the dorsal striatum (caudate putamen) [Bmax, pmol/mg]"
BXD_10235,"Immune system: Proliferation of T cell clone (JTL-G12 clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]"
BXD_10236,"Immune system: Proliferation of T cell clone (JTL-G12 clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]"
BXD_10237,"Immune system: Proliferation of T cell clone (JTL-G12.8 clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) (unknown variant on Chr 1 between 177 and 182 Mb) [cpm]"
BXD_10238,"Immune system: Proliferation of T cell clone (JTL-G12.8 clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm]"
BXD_10239,"Central nervous system, metabolism: Iron level in medial prefrontal cortex of males [ug/g]"
BXD_10240,"Central nervous system, metabolism: Iron level in medial prefrontal cortex of females [ug/g]"
BXD_10241,"Central nervous system, metabolism: Iron level in dorsal striatum (caudate putamen) of males [ug/g]"
BXD_10242,"Central nervous system, metabolism: Iron level in dorsal striatum (caudate putamen) of females [ug/g]"
BXD_10243,"Central nervous system, metabolism: Iron level in nucleus accumbens of males [ug/g]"
BXD_10244,"Central nervous system, metabolism: Iron level in nucleus accumbens of females [ug/g]"
BXD_10245,"Central nervous system, metabolism: Iron level in ventral midbrain of males [ug/g]"
BXD_10246,"Central nervous system, metabolism: Iron level in ventral midbrain of females [ug/g]"
BXD_10247,"Liver, metabolism: Iron level in liver of males [ug/g]"
BXD_10248,"Liver, metabolism: Iron level in liver of females [ug/g]"
BXD_10249,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10250,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10251,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10252,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10253,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10254,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10255,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10256,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10257,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10258,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10259,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10260,"Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight]"
BXD_10261,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10262,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10263,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males and females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10264,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10265,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10266,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10267,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10268,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10269,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10270,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10271,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10272,"Central nervous system, pharmacology, protein expression: Dopamine receptor 2 and 3 (DRD2/DRD3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (125I-epidepride ligand) [fmol/mg wet weight]"
BXD_10273,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10274,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10275,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10276,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10277,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10278,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]
"
BXD_10279,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10280,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10281,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10282,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10283,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10284,"Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight]"
BXD_10285,"Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males and females [cm]"
BXD_10286,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males [n difference]"
BXD_10287,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in females [n difference]"
BXD_10288,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males and females [n difference]"
BXD_10289,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males [cm difference]"
BXD_10290,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion measured as difference from saline control in females [cm difference]"
BXD_10291,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males and females [cm difference]"
BXD_10292,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males [n]"
BXD_10293,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in females [n difference"
BXD_10294,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males and females [n difference]"
BXD_10295,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), cocaine stereotypy, number of movements as difference from saline control injection in males [n]"
BXD_10296,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), stereotypy evaluated as the number of movements (difference from saline control) in adult females [n]"
BXD_10297,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), stereotypy evaluated as the number of movements (difference from saline control) in adult males and females [n]"
BXD_10298,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), locomotion in an open field, total distance measured as difference from saline control in males [cm]"
BXD_10299,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field activity, total distance, difference from saline control in females [cm]"
BXD_10300,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/k ip), open field locomotor activity, total distance relative to saline control in males and females [cm]"
BXD_10301,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]"
BXD_10302,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]"
BXD_10303,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]"
BXD_10304,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection for males [n]"
BXD_10305,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/k ip) stereotypy, increase in numbers of movements relative to saline controls in females [n]"
BXD_10306,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female combined [n]"
BXD_10307,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/k ip), open field locomotor activity, total distance relative to saline control in males [cm]"
BXD_10308,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/k ip), open field locomotor activity, total distance relative to saline control in females [cm]"
BXD_10309,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/k ip), open field locomotor activity, total distance relative to saline control in males and females [cm]"
BXD_10310,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]"
BXD_10311,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]"
BXD_10312,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]"
BXD_10313,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip) stereotypy, increase in numbers of movements relative to saline controls in males [n]"
BXD_10314,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip) stereotypy, increase in numbers of movements relative to saline controls in females [n]"
BXD_10315,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip) stereotypy, increase in numbers of movements relative to saline controls in males and females [n]"
BXD_10316,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field locomotor activity, total distance relative to saline control in males [cm]"
BXD_10317,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field locomotor activity, total distance relative to saline control in females [cm]"
BXD_10318,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field locomotor activity, total distance relative to saline control in males and females [cm]"
BXD_10319,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference]"
BXD_10320,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference]"
BXD_10321,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference]"
BXD_10322,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/k ip), open field locomotor activity relative to saline control (area under the curve with saline covariate) [cm x min]"
BXD_10323,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/k ip), open field locomotor activity relative to saline control (area under the curve with saline covariate) [cm x min]"
BXD_10324,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/k ip), open field locomotor activity relative to saline control (area under the curve with saline covariate) [cm x min]"
BXD_10325,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field locomotor activity relative to saline control (area under the curve with saline covariate) [cm x min]"
BXD_10326,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, difference in time spent in the field center relative saline injection for females [sec]"
BXD_10327,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg), open field behavior, center time (difference from saline) in males [sec]"
BXD_10328,"Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), open field behavior, center time difference from saline control in females [sec]"
BXD_10329,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field center time relative to saline control in males [sec]"
BXD_10330,"Central nervous system, pharmacology, behavior: Cocaine response (45 mg/k ip), open field center time relative to saline control in females [sec]"
BXD_10331,"Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males [cm]"
BXD_10332,"Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for females [cm]"
BXD_10333,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg, ip), anxiety assay, center time in an open field test, difference from saline control in males [sec]"
BXD_10334,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg), anxiety assay, center time in an open field test, difference from saline control in females [sec]"
BXD_10335,"Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, time in the field center (difference from saline control) in males [sec]"
BXD_10336,"Central nervous system, pharmacology, behavior, epilepsy: Haloperidol response, induced catalepsy at ED50 [mg/kg]"
BXD_10337,"Central nervous system, morphology: Hippocampus granule cell number [n total per side]"
BXD_10338,"Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, day 1 after last BrdU injection [n cells]"
BXD_10339,"Central nervous system, adult neurogenesis: Survival of BrdU-labeled cells in the hippocampal dentate gyrus subgranular zone 4 weeks after last injection [n cells]"
BXD_10340,"Central nervous system, adult neurogenesis: New neuron percentage in hippocampal dentate gyrus 4 weeks after last BrdU injection [%]"
BXD_10341,"Central nervous system, adult neurogenesis: Astrocyte cell number percentage 4 weeks after last cell labeling (BrdU) injection [%]"
BXD_10342,"Central nervous systems, adult neurogenesis: Newly generated neurons in the dentate gyrus 4 weeks after last BrdU injection [n BrdU cells X ratio of NeuN / BrdU labeled cells]"
BXD_10343,"Central nervous system, adult neurogenesis: New astrocytes, 4 weeks after last BrdU injection [n BrdU cells X ratio of S100 beta/BrdU labeled cells]"
BXD_10344,"Central nervous system, behavior, learning and memory: Learning measured by the time spent in target quadrant on day 5 (probe trial) using the Morris water maze [%]"
BXD_10345,"Central nervous system, behavior, learning and memory: Learning and memory function, Morris water maze, swim time for the probe trial on day 5 [%]"
BXD_10347,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a dowel test (BEC time 0) [mg % ethanol]"
BXD_10348,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), acute functional tolerance (AFT) measured as the difference in blood alcohol concentration (BEC, retrobulbar bleed) following the second recovery of balance and the first recovery of balance using a dowel test (BEC2 minus BEC1) [mg %]"
BXD_10349,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of balance using a dowel test (Loss corresponds to BEC time 0) [min]"
BXD_10350,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), duration of ataxia following the first ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1) [min]"
BXD_10351,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), duration of ataxia following the second ethanol injection using a dowel test (Regain Test 2 corresponds to BEC2) [min]"
BXD_10352,"Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, basal level measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]"
BXD_10353,"Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimuated with forskolin (10 uM) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]"
BXD_10354,"Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimulated with isoproterenol (1 um) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP]
"
BXD_10355,"Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3]"
BXD_10356,"Immune system, pulmonary system, environmental toxicology: Airway inflammatory response  to ozone (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3]"
BXD_10357,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) measured by DXA in 12-week-old females for whole body [mg/cm2]"
BXD_10358,"Musculoskeletal system, morphology: Body weight [g]"
BXD_10359,"Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in males [mm^2]"
BXD_10360,"Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in females [mm^2]"
BXD_10361,"Immune system, aging: Progenitor cell proliferation in young mice (2 months of age), effect of TGFB2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells relative to control without TGFB2 [%]"
BXD_10362,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total [units]"
BXD_10363,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, CA4 (dentate gyrus) component [volume units]"
BXD_10364,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal component (SPMF) [units]"
BXD_10365,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, intra- and infrapyramidal component (IIPMF) [units]"
BXD_10366,"Central nervous system, morphology: Hippocampus mossy fiber pathway, ratio of volume of CA4 to total MF [%]"
BXD_10367,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of suprapyramidal component relative to total volume [%]"
BXD_10368,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of IIPMT relative to total volume [%]"
BXD_10369,"Genetics, development, epigenetics: Androgenetic blastocysts (embryos) percentage induced by sperm-mediated egg cytoplasmic epigenetic imprinting effects [%]"
BXD_10370,"Cancer biology, liver, toxicology: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n]"
BXD_10371,"Liver, biochemistry, protein: Cytosolic aryl-hydrocarbon receptor (AHR) protein levels in liver (fmol/mg cytosolic protein)"
BXD_10372,"Immune system, metabolism: Tumor necrosis factor (TNF)-induced hypothermia [degree C]"
BXD_10373,"Immune system: Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml]"
BXD_10374,Immune system: Tumor necrosis factor (TNF) lethality after injection [%]
BXD_10375,"Central nervous system, morphology: Hippocampus weight, bilateral, fixed and hand-dissected tissue, unadjusted for differences in age, sex, or body weight [mg]"
BXD_10376,"Central nervous system, morphology: Hippocampus bilateral weight with adjustment only for age and sex (no adjustment for brain weight) [mg]"
BXD_10377,"Central nervous system, morphology: Hippocampus granule cell density [n x10^3]"
BXD_10378,"Central nervous system, morphology: Hippocampus granule cell number, unilateral [n x10^3]"
BXD_10379,"Central nervous system, morphology: Brain weight [mg]"
BXD_10380,"Liver, protein: B-mannosidase activity in liver of females, p-nitrophenl liberated per tissue wet weight per hour at 37 deg C (Manba gene on Chr 3 at 135 Mb) [mg/gm/hr]"
BXD_10381,"Urogenital system, kidney, protein: B-mannosidase activity in kidney of females measured as the release of p-nitrophenl per gram tissue wet weight per hour at 37 deg C [mg/g/hr]"
BXD_10382,"Central nervous system, behavior, gustation: Raffinose bitter taste response (raffinose undecaacetate 0.4 mM in water), consumption [%]"
BXD_10383,"Central nervous system, behavior, gustation: Lactose sweet taste response (0.3 mM beta-lactose acetate in water), consumption [%]"
BXD_10384,"Central nervous system, behavior, gustation: Saccharin sweet taste response (3.2 mM in water), consumption [%]"
BXD_10385,"Central nervous system, behavior, gustation: Acesulfame sweet taste response (3.2 mM in water), consumption [%]"
BXD_10386,"Central nervous system, behavior, gustatory: Glycine (sweet) taste response (10 mM in water), consumption [%]"
BXD_10387,"Central nervous system, behavior: Seizure threshold pressure at compression rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) [atm]"
BXD_10388,"Central nervous system, behavior: Seizure threshold pressure at compression rate of 1000 atm hr-1 (1000iPc) (also see McCall, 2011, 21384758) [atm]"
BXD_10389,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to 5 kHz white-noise bursts at 100 dB SPL [force]"
BXD_10390,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to 10 kHz white noise bursts at 100 dB [force]"
BXD_10391,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to 15 kHz white-noise bursts at 100 dB SPL [force]"
BXD_10392,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to 20 kHz white-noise bursts at 100 dB [g]"
BXD_10393,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to 25 kHz white noise bursts at 100 dB SPL [force]"
BXD_10394,"Central nervous system, behavior, auditory system: Acoustic startle response to a 110 dB SPL, 10 kHz tone without prepulse stimulus [force]"
BXD_10395,"Central nervous system, behavior, auditory system: High frequency hearing loss, acoustic startle response to white-noise bursts at 110 dB SPL [force]"
BXD_10396,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 5 kHz, 80 dB prepulse stimulus [%]"
BXD_10397,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 10 kHz, 80 dB prepulse stimulus [%]"
BXD_10398,"Central nervous system, behavior: Prepulse inhibiition of the acoustic startle response to 110 dB SPL white-noise bursts, 15 kHz, 80 dB prepulse stimulus [%]"
BXD_10399,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 20 kHz, 80 dB prepulse stimulus [%]"
BXD_10400,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 56 db SPL white-noise prepulse stimulus [%]"
BXD_10401,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL 10 kHz tone, following a 68 db SPL white noise prepulse stimulus [%]"
BXD_10402,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 80 db SPL white-noise prepulse stimulus [%]"
BXD_10403,"Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV) spinal cored demyelination susceptibility (excludes strains with B allele at H2 locus) [% affected]"
BXD_10404,"Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV, dermal injection), delayed-type hypersensitivity (DTH) response measured as ear swelling [inch x 1E-3]"
BXD_10405,Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm]
BXD_10406,Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm]
BXD_10407,Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [thymidine uptake cpm]
BXD_10408,"Immune system: Graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm]"
BXD_10409,Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [thymidine uptake cpm]
BXD_10410,"Immune system: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake, cpm]"
BXD_10411,Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm]
BXD_10412,Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10  [thymidine uptake cpm]
BXD_10413,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Llat1 Table 1), males and females combined [log sec]"
BXD_10414,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Llat2 Table 1), males and females combined [log sec]"
BXD_10415,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Llat3 Table 1), males and females combined [log sec]"
BXD_10416,"Central nervous system, behavior: Locomotion, distance traveled in 30 min in open field, baseline [cm]"
BXD_10417,"Central nervous system, pharmacology, behavior: Cocaine response (dose), locomotor activation after injection, distance in 30 min test [cm]"
BXD_10418,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for males and females [sec]"
BXD_10419,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for females [sec]"
BXD_10420,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies baseline (before 3 min forced swim in 15 degree C water), male [sec]"
BXD_10421,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latencies post-swim, male and female average [sec]"
BXD_10422,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies post-swim in female [seconds]"
BXD_10423,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies post-swim in male [sec]"
BXD_10424,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males and females  [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] "
BXD_10425,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]"
BXD_10426,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males [%MPE=(postswim-baseline)/(cut-off-baseline)*100)]"
BXD_10427,"Infectious disease, immune system: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells measured as mean fluorescence value (sum of products of each channel number times n cells in that channel divided by n cells counted) [units]"
BXD_10428,Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level measured as mean fluorescence value (sum of products of each channel number times the number of spleen cells in that channel divided by the number of cells counted [units]
BXD_10429,"Blood chemistry: Serum amyloid P component level (APCS protein, endogenous SAP maps to Chr 1 at 174,8 Mb)  [ug/ml]"
BXD_10430,"Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm3]"
BXD_10431,Cancer biology: Tumor growth 3 weeks post-implantation [mm3]
BXD_10432,Cancer biology: Tumor growth 7 weeks post-implantation [mm3]
BXD_10433,"Immune system, urogenital system: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits]"
BXD_10434,"Central nervous system, behavior, epilepsy: Audiogenic seizure incidence [% cases]"
BXD_10435,"Central nervous system, behavior, epilepsy: Audiogenic seizure severity [score]"
BXD_10436,"Central nervous system, morphology: Cerebellum fissure number (vermis, midsagittal section, intraculminate fissure variation) [n]"
BXD_10437,"Central nervous system, epilepsy: Audiogenic seizure, severity score in response to pure tone [score]"
BXD_10438,"Central nervous system, epilepsy: Audiogeneic seizure, relative frequency [%]"
BXD_10439,"Lung, immune system: Airway bronchial constrictor response after exposure to atracurium, airway pressure time index [cmH2O/s]"
BXD_10440,"Blood, cardiovascular system: Red blood cell osmotic fragility, following treatment with 0.425% NaCl [% lysis]"
BXD_10441,"Immune system: Anti-F antigen (liver protein) titer, experiment 1, log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen [log binding]"
BXD_10442,"Immune system: Anti-F antigen (liver protein) titer, experiment 2, log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen [log binding]"
BXD_10443,"Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in males corrected for whole body weight (Fig 3, top) [mg/cm2]"
BXD_10444,"Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in females corrected for whole body weight (Fig 3, bottom) [mg/cm2]"
BXD_10445,"Central nervous system, behavior: Fear response control (unconditioned auditory stimulus stimulus, US) in a contextualized fear conditioning paradigm [% freezing]"
BXD_10446,"Central nervous system, behavior: Fear response to context [% freezing]"
BXD_10447,"Central nervous system, behavior: Fear response to preconditioned (altered) context stimulus [% freezing]"
BXD_10448,"Central nervous system, protein: ATPase activity (total activity) for whole brain homogenate [umol Pi/h/mg protein]"
BXD_10449,"Central nervous system, protein: ATPase activity (Mg2+ ATPase, magnesium ATPase, Mg-ATPase) for whole brain homogenate [umol Pi/h/mg protein]"
BXD_10450,"Central nervous system, protein: ATPase activity (Na+/K+-ATPase, sodium-potassium ATPase, sodium-potassium pump) for whole brain homogenate [umol Pi/h/mg protein]"
BXD_10451,"Central nervous system, neurophysiology, epilepsy: Seizure susceptibility, audiogenic seizure severity [scale]"
BXD_10452,"Central nervous system, neurophysiology, epilepsy: Seizure susceptibility, clonic-tonic audiogenic seizure incidence [%]"
BXD_10453,"Central nervous system, behavior: Control response (20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion between day 3 (third vehicle injection) and day 2 (vehicle baseline) using Accuscan activity monitors [cm/30 min]"
BXD_10454,"Central nervous system, pharmacology, endocrinology, behavior: Allopregnanolone response (10 mg/kg 3a-hydroxy-5a-pregnan-20-one, THP, in 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion between day 3 (first injection) and day 2 (vehicle baseline) using Accuscan activity monitors [cm/30 min]"
BXD_10455,"Central nervous system, pharmacology, endocrinology, behavior: Allopregnanolone response (17 mg/kg 3a-hydroxy-5a-pregnan-20-one in 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion between day 3 (first injection) and day 2 (vehicle baseline) using Accuscan activity monitor [cm/30 min]"
BXD_10456,"Central nervous system, morphology: Hippocampus volume, total [mm^3]"
BXD_10457,"Central nervous system, morphology: Hippocampus proper volume [mm^3]"
BXD_10458,"Central nervous system, morphology: Hippocampus pyramidal cell layer volume, unilateral [mm^3]"
BXD_10459,"Central nervous system, morphology: Hippocampus dentate gyrus granule cell layer volume, unilateral [mm^3]"
BXD_10460,"Central nervous system, morphology: Hippocampus dentate gyrus volume [mm^3]"
BXD_10461,"Morphology: Body weight, average males and females [g]"
BXD_10462,"Central nervous system, morphology: Brain weight [mg]"
BXD_10463,"Immune system, morphology: Thymus to body size ratio [x10^3]"
BXD_10464,"Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 positive T cells) [%]"
BXD_10465,"Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 positive T cells) [%]"
BXD_10466,"Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 negative T cells) from Fig 4 y-axis [%]"
BXD_10467,"Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 negative T cells) from Fig 4 x-axis [%]"
BXD_10469,"Central nervous system, pharmacology, behavior: Morphine response (0.3 to 0.7 mg/ml in water), consumption using two-bottle choice test [ml/test period]"
BXD_10470,"Central nervous system, behavior, gustation: Quinine response, consumption using two-bottle choice test (quinine at 0.1 to 0.4 mg/ml) [ml/test period]"
BXD_10471,"Central nervous system, behavior, gustation: Saccharin response, consumption using two-bottle choice test (concentration) [ml/test period]"
BXD_10472,"Central nervous system, behavior, gustation: Saccharin response, preference using two-bottle choice test [ratio]"
BXD_10473,"Central nervous system, behavior, gustation: Saccharin response, consumption using a two-bottle choice test (0.2%, mg/kg) vs. tap water, mean of day 2 and day 4 over a 4-day 24-hr access period [g/kg/day]"
BXD_10474,"Central nervous system, pharmacology, behavior: Ethanol response (3%, g/kg in tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]"
BXD_10475,"Central nervous system, pharmacology, behavior: Ethanol response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]"
BXD_10476,"Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]"
BXD_10477,"Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day]"
BXD_10478,"Central nervous system, pharmacology, behavior: Ethanol response, withdrawal severity, handling-induced convulsion (HIC) score, corrected area under the HIC curve after voluntary ethanol consumption [HIC AUC]"
BXD_10479,"Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), preference using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [ratio]"
BXD_10480,"Central nervous system, pharmacology, behavior: Water response, consumption using a two-bottle choice test offered vs. 10% ethanol [ml]"
BXD_10481,"Central nervous system, pharmacology, behavior: Water response, consumption using a two-bottle choice test offered vs. 0.2% saccharin [ml]"
BXD_10482,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injections, difference between day 2 saline control and day 11 ethanol injection (first and only ethanol injection) in young adult control saline (CS) females (ACCS) [cm]"
BXD_10483,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol, difference in locomotor activity between saline control group (CS) and ethanol treated group (CD) to final acute ethanol test on day 11 (deltaBG) [cm]"
BXD_10484,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol (CD group), difference in locomotor activity between fifth ethanol treatment (day 11) and first ethanol treatment (day 3), 1- 5 min after injections in young adult females (Figure 2 of paper, deltaCD) [cm]"
BXD_10485,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injection, difference between day 2 saline injection response and day 3 ethanol injection in young adult females (Figure 1 of paper, ACCD) [cm]"
BXD_10486,"Central nervous system, behavior: Acute locomotor baseline activity response (horizontal distance), 1-5 min after saline injection on day 2 in young adult females (BASACT in the CD group) [cm]"
BXD_10487,"Central nervous system, behavior: Saline control response (vehicle ip), locomotion (baseline) on day 2 using Accuscan activity monitors, mean all cases [cm/15 min test]"
BXD_10488,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]"
BXD_10489,"Central nervous system, pharmacology, behavior: Cocaine response (40 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]"
BXD_10490,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]"
BXD_10491,"Central nervous system, pharmacology, behavior: Cocaine response (40 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]"
BXD_10492,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min]"
BXD_10493,"Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min]"
BXD_10494,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) following ethanol injection, day 3 (first treatment) minus day 2 (saline baseline) in the chronic ethanol group  [beam breaks/10 min test] "
BXD_10495,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n beam breaks/10 min test]"
BXD_10496,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol measured as the difference in locomotion using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [beam breaks/10 min test]"
BXD_10497,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic drug group [n grid test errors/10 min test]"
BXD_10498,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute ataxia measured using using grid test (Accuscan activity monitor), difference between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n errors/activity counts/10 min test]"
BXD_10499,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), intoxication and adaptation measured as difference in missteps using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [n/10 min test]"
BXD_10500,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between acute ethanol on day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic ethanol group  [n errors/activity counts/10 min test]"
BXD_10501,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between injection on day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [errors/activity counts/10 min test]"
BXD_10502,"Central nervous system, pharmacology, behavior: Ethanol response, change in ataxic effects of 2 g/kg (ip) after repeated treatment, difference between day 11 (fifth treatment) minus day 3 (first treatment) in the chronic drug (CD) group, 10 min test [grid test inside accuscan activity monitors]"
BXD_10503,"Central nervous system, behavior: Saline response (vehicle ip control), baseline locomotor activity using grid test on day 2 after injection [n beam breaks/10 min test]"
BXD_10504,"Central nervous system, behavior, epilepsy: Audiogenic seizure susceptibility and severity at 21 days [score]"
BXD_10505,"Central nervous system, behavior: Open-field activity following saline injection [number of crossings during 3 min]"
BXD_10506,"Central nervous system, behavior, epilepsy: Seizure susceptibility, seizure initiation atmospheric pressure at 100 atmospheres  (14.7 PSI per atm) [atm]"
BXD_10507,"Central nervous system, behavior, epilepsy: Seizure susceptibility atmospheric pressure to high atmospheric pressure at 1000 atmospheres  (14.7 PSI per atm) [atm]"
BXD_10508,Immune system: V beta 3+ T cells in lymph nodes [%]
BXD_10509,"Central nervous system, peripheral nervous system, behavior, nocicieption: Antinociceptive responsive (pain analgesia), nitrous oxide antinociception in the acetic acid writhing (abdominal constriction) test [%]"
BXD_10510,"Pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in males [degrees C]"
BXD_10511,"Blood chemistry, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in females [mg/dl]"
BXD_10512,"Blood chemistry, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in males [mg/dl]"
BXD_10513,"Blood chemistry, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in females [mg/dl]"
BXD_10514,"Blood chemistry, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in males [mg/dl]"
BXD_10515,"Blood chemistry, metabolism: Blood glucose levels before saline ip control injection in females [mg/dl]"
BXD_10516,"Blood chemistry, metabolism: Blood glucose levels before saline ip control injection in males [mg/dl]"
BXD_10517,Blood chemistry: Blood glucose levels 120 min after saline control injection in females [mg/dl]
BXD_10518,Blood chemistry: Blood glucose levels 120 min after saline control injection in males [mg/dl]
BXD_10519,Metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in females [degrees C]
BXD_10520,Metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in males [degrees C]
BXD_10521,"Pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in females [degrees C]"
BXD_10522,Metabolism: Body temperature baseline control before saline injection in females [degrees C]
BXD_10563,"Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 16-20 min after injection [activity counts/min]"
BXD_10564,"Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 16-20 min after injection [activity counts/min]"
BXD_10565,"Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 21-25 min after injection [activity counts/min]"
BXD_10566,"Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 21-25 min after injection [activity counts/min]"
BXD_10567,"Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 26-30 min after injection [activity counts/min]"
BXD_10568,"Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 26-30 min after injection [activity counts/min]"
BXD_10569,"Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 0-15 min after injection [activity counts/min]"
BXD_10570,"Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 0-15 min after injection [activity counts/min]"
BXD_10571,"Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 15-30 min after injection  [activity counts/min]"
BXD_10572,"Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 15-30 min after injection [activity counts/min]"
BXD_10573,"Endocrinology, pharmacology, blood chemistry: Ethanol response (4/g/kg ip), plasma corticosterone concentration 1 hr after injection  [ug/dl]"
BXD_10574,"Endocrinology, pharmacology, blood chemistry: Corticosterone plasma concentration 1 hr after saline injection [ug/dl]"
BXD_10575,"Endocrinology, pharmacology, blood chemistry: Ethanol response (4 g/kg ip), plasma corticosterone concentration 6 hr after injection [ug/dl]"
BXD_10576,"Endocrinology, pharmacology, blood chemistry: Plasma corticosterone concentration 6 hr after saline control injection (ip) [ug/dl]"
BXD_10577,"Endocrinology, pharmacology, blood chemistry: Ethanol response (4 g/kg ip), corticosterone plasma level 7 hr after injection [ug/dl]"
BXD_10578,"Central nervous system, pharmacology, behavior: Ethanol response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection [score]"
BXD_10579,"Endocrinology, pharmacology, blood chemistry: Ethanol response (4 g/kg ip), corticosterone plasma level 6 hr after injection in females (unpublished means from Roberts et al. 1995, Behav Neurosci 109:1199) [ug/dl]"
BXD_10580,"Endocrinology, pharmacology, blood chemistry: Ethanol response [4/g/kg ip], plasma corticosterone concentration 6 hr after injection in males (unpublished data from Roberts, Phillips, Belknap, Finn, Keith 1995, Behavioral Neurosci 109:1199-1208) [ug/dl] "
BXD_10581,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg]"
BXD_10582,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for males [g/kg]"
BXD_10583,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference for alcohol for females [g/kg]"
BXD_10584,"Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), preference of females using 2-bottle choice [g/kg]"
BXD_10585,"Central nervous system, pharmacology, behavior: Ethanol response (variable dose ip), hypnotic dose sensitivity (HDS), sleep time for females [min]"
BXD_10586,"Central nervous system, pharmacology, behavior: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex of males [min]"
BXD_10587,"Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake [g/kg]"
BXD_10588,"Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference and consumption of 10% ethanol vs. water over 15 days [g/kg]"
BXD_10589,"Central nervous system, pharmacology, behavior: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex [min]"
BXD_10590,Cardiovascular system: Vascular endothelial growth factor (VEGF)-induced angiogenesis measured using corneal micropocket neovascularization assay [mm2]
BXD_10591,"Infectious disease, immune system: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU (KLRA complex) [log10 burden]"
BXD_10592,"Infectious disease, immune system: Anergy measured by footpad thickness resulting from BCG injection [mm]"
BXD_10593,"Central nervous system, pharmacology, metabolism: Amphetamine response (20 mg/kg ip d amphetamine), core body temperature change after injection [degree C]"
BXD_10594,"Central nervous system, morphology: Brain weight [mg]"
BXD_10595,"Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) volume, unilateral, corrected for shrinkage [mm^3]"
BXD_10596,"Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) total cell number, unilateral [n x10^3]"
BXD_10597,"Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) neuron number, unilateral  [n x10^3]"
BXD_10598,"Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) glial cell number, unilateral [n x10^3]"
BXD_10599,"Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) endothelial cell number, unilateral [n x10^3]"
BXD_10600,"Central nervous system, morphology, eye, visual system: Retinal ganglion cell axon number in the optic nerve in young adults (both sexes), unilateral estimates from transmission EM [N x 1000]"
BXD_10601,"Central nervous system, morphology, eye, visual system: Retinal ganglion cells (RGC) to lateral geniculate nucleus (LGN) principal neuron number ratio [ratio]"
BXD_10602,"Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml]"
BXD_10603,"Endocrinology, metabolism: Serum thyroxine (T4) content (free) [ug/100ml]"
BXD_10604,"Central nervous system, neurophysiology, epilepsy: Seizure susceptibility (audiogenic), severity [score]"
BXD_10605,"Central nervous system, neurophysiology, epilepsy: Seizure susceptibility (audiogenic), clonic tonic percentage [%]"
BXD_10606,"Central nervous system, pharmacology, protein: High affinity choline uptake (concentration of 0.5 10xE-6 M) in frontal cortex [pmole/4min/mg protein]"
BXD_10607,"Central nervous system, pharmacology, protein: High affinity choline uptake (concentration of 0.5*10^-6M) in hippocampus [pmole/4min/mg protein]"
BXD_10608,"Central nervous system, pharmacology, protein: High affinity choline uptake (concentration of 0.5*10^-6M) in striatum [pmole/4min/mg protein]"
BXD_10609,"Central nervous system, pharmacology, behavior: Cocaine response (32 mg/kg ip), locomotion from 0-60 min after injections in an activity chamber [n beam breaks]"
BXD_10610,"Central nervous system, pharmacology, behavior: Cocaine response (32 mg/kg ip), sensitization of locomotor response [% initial response]"
BXD_10611,"Central nervous system, pharmacology, behavior: Cocaine response (32 mg/kg ip, daily), stereotypical behavior frequency after consecutive daily injections on day 8 [units]"
BXD_10612,"Genetics, cancer, infectious disease: Endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, primiparous lactating female [% total RNA]"
BXD_10613,"Genetics, cancer, infectious disease: Endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, multiparous lactating female [% total RNA]"
BXD_10614,"Central nervous system, pharmacology, behavior: Pentylenetetrazol (PTZ, a GABA antagonists) response, dosage level (threshold) required to induce seizure [mg/kg]"
BXD_10615,Immune system: Proliferation of T cell clone (A9.4 subclone) without 50 ug/ml KLH experiment 1 [cpm]
BXD_10616,"Immune system: Proliferation of T cell clone (A9.4 subclone) with 50 ug/ml KLH experiment 1, 5X10E5 stimulator cells [cpm]"
BXD_10617,Immune system: Proliferation of T cell clone (A9.4 subclone) without 50 ug/ml KLH experiment 2 [cpm]
BXD_10618,"Immune system: Proliferation of T cell clone (A9.4 subclone) with 50 ug/ml KLH experiment 2, 1X10E6 stimulator cells [cpm]"
BXD_10619,"Central nervous system, behavior, learning and memory: Learning and memory performance measured using Morris water maze, site preference computed as crosses over trained site minus crosses over alternative sites [n]"
BXD_10620,"Central nervous system, behavior, learning and memory: Morris water maze search-time preference, amount of time spent in the trained quadrant of the pool minus mean time in the alternative quadrants [seconds]"
BXD_10621,"Central nervous system, protein: Protein kinase C (PKC) activity in hippocampus [pmol/min/mg protein total hippocampus]"
BXD_10622,"Central nervous system, protein: Protein kinase C (PKC) activity for hippocampus particulate fraction [pmol/min/mg protein]"
BXD_10623,"Central nervous system, protein: Protein kinase C (PKC) activity in hippocampus cytosol [pmol/min/mg protein]"
BXD_10624,"Central nervous system, protein: Protein kinase C (PKC) activity for neocortex (total sample) [pmol/min/mg protein]"
BXD_10625,"Central nervous system, protein: Protein kinase C (PKC) activity for cortex particulate fraction [pmol/min/mg protein]"
BXD_10626,"Central nervous system, protein: Protein kinase C (PKC) activity in cortex cytosol [pmol/min/mg protein]"
BXD_10627,"Immune system: T-cell response, cytotoxic T lymphocytes,  51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [units]"
BXD_10628,"Immune system: T-cell response, cytotoxic T lymphocytes, Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [units]"
BXD_10629,"Immune system: T-cell response, antibody-dependent cell-mediated cytotoxicity, 51Cr release at 5:1 E:T after spleen cells primed and boosted in mixed lymphocyte culture (MLC) in pool of five responders [units]"
BXD_10630,"Immune system: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]"
BXD_10631,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]"
BXD_10632,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units]"
BXD_10633,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2 [units]"
BXD_10634,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units]"
BXD_10635,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2 [units]"
BXD_10636,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]"
BXD_10637,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]"
BXD_10638,"Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [units]"
BXD_10639,"Central nervous system, morphology: Hindbrain medulla weight (unadjusted) [mg] "
BXD_10640,"Central nervous system, morphology: Hindbrain weight, unadjusted [mg]"
BXD_10642,"Central nervous system, morphology: Olfactory bulb weight, bilateral, without any statistical corrections (raw) [mg]"
BXD_10643,"Central nervous system, morphology: Olfactory bulb weight, adjusted by age, sex, body weight, and brain minus olfactory bulb weight (Hager et al. 2012) [mg]"
BXD_10645,"Central nervous system, morphology, olfaction: Olfactory bulb weight, bilateral, fixed tissue, hand-dissected, unadjusted [mg]"
BXD_10646,"Central nervous system, morphology: Brain weight [mg]"
BXD_10647,"Morphology: Body weight, adult sex average [g]"
BXD_10648,"Central nervous system, morphology: Brain weight [mg]"
BXD_10649,"Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [n x10^3]"
BXD_10650,"Central nervous system, morphology, eye, visual system: Retinal ganglion cell number residuals, unilateral, corrected for variation in brain and body size, sex, and age [residual n x10^3]"
BXD_10651,"Central nervous system, morphology, auditory system: Spiral ganglion cell density in the hook in 1-year-old males (corrected Mar2022) [cells per 10000 um2]"
BXD_10652,"Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-base in 1-year old males (corrected Mar2022) [cells per 10000 um2]"
BXD_10653,"Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-apical in 1-year old males (corrected Mar2022)  [cells per 10000 um2]"
BXD_10654,"Central nervous system, morphology, auditory system: Spiral ganglion cell density in the apex in 1-year-old males (corrected Mar2022)  [cells per 10000 um2]"
BXD_10655,"Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density total in 1-year old males, average of 15 cases per strain based on Table 1 of Willott et al, units (corrected Mar2022 for error in Table 1 of Willot regarding BXD24) [cells per 10000 um2]"
BXD_10656,"Infectious disease, immune system: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]"
BXD_10657,"Infectious disease, immune system: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]"
BXD_10658,"Infectious disease, immune system: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]"
BXD_10659,"Infectious disease, immune system: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4]"
BXD_10660,"Infectious disease, immune system: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%]"
BXD_10661,"Infectious disease, immune system: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%]"
BXD_10662,"Infectious disease, immune system: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%]"
BXD_10663,"Infectious disease, immune system: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%]"
BXD_10664,"Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/]"
BXD_10665,"Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml]
"
BXD_10666,"Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml]"
BXD_10667,"Eye, morphology, visual system: Eye weight corrected for age, sex, body and brain weight (BXD38 added) [mg]"
BXD_10668,"Eye, morphology, visual system: Lens weight, corrected for variance associated with sex and age (normalized to values of 75-day-old 22 gm female mouse, lens data for subset of 122 cases) [mg]"
BXD_10669,"Central nervous system, morphology, eye, visual system: Retinal area, adults of both sexes [mm2]"
BXD_10670,"Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x1000]"
BXD_10671,"Eye, morphology, visual system: Eye weight, regression corrected for age, sex, body and brain weight [mg]"
BXD_10672,"Central nervous system, morphology: Brain weight [mg]"
BXD_10673,"Urogenital system, morphology: Testis weight [g]"
BXD_10674,"Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral, shrinkage corrected from serial histological sections  [mm^3] "
BXD_10675,"Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral shrinkage corrected and adjusted for variation in body weight and plane of section from serial histological sections [mm^3]"
BXD_10676,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral [n/mm^3]"
BXD_10677,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral without adjustment [n]"
BXD_10678,"Skin, pigmentation: Hair coat color, ordinal scale version 1 black=4, brown=3, grey=2, dba dilute=1 [color intensity]"
BXD_10679,"Central nervous system, adult neurogenesis: New neurons in dentate gyrus [density index]"
BXD_10680,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral, adjusted for data-collector as a predictor [n]"
BXD_10681,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral without adjustment [n]"
BXD_10682,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]"
BXD_10683,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral [n]"
BXD_10684,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral and adjusted for data-collector as a predictor [n]"
BXD_10685,"Central nervous system, aging: Polyglucosan bodies in the hippocampus of 18-month-old females (unpublished companion data to 2000 paper by Jucker) [density]"
BXD_10686,"Central nervous system, aging: Polyglucosan bodies in the hippocampus of 18-month-old females, number of aggregates per series of sections through entire hippocampus (unpublished companion data to 2000 paper by Jucker, also see AXB/BXA data) [log10 n]"
BXD_10687,"Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU), fraction dead 21 days after infection [ratio]"
BXD_10688,"Infectious disease, immune system: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions [burden]"
BXD_10689,"Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate [units]"
BXD_10690,"Infectious disease, immune system, pulmonary system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia"
BXD_10691,"Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia"
BXD_10692,"Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units]"
BXD_10693,"Central nervous system, pharmacology, protein: Morphine metabolism, morphine UDP-glucuronyltransferase activity [units]"
BXD_10694,"Central nervous system, pharmacology, protein: Morphine UDP-glucouronytransferease activity (B3GAT genes) [units]"
BXD_10695,"Infectious disease, immune system,  pulmonary system: Lung inflammatory response, pulmonary granulomatous inflammation induced by Bacillus Calmetteâ€“GuÃ©rin tuberculosis vaccine (BCG) [units]"
BXD_10696,"Immune system, morphology: Spleen weight, splenomegaly induced by Bacillus Calmetteâ€“GuÃ©rin tuberculosis vaccine (iv injection in oil and saline) (BCG) [mg]"
BXD_10697,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0 set to 0]"
BXD_10698,"Infectious disease, immune system: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4)"
BXD_10702,"Central nervous system, gene expression: Cocaine and amphetamine-regulated transcript (CART) expression in hypothalamus [rtPCR cycles]"
BXD_10709,"Central nervous system, adult neurogenesis: New astrocytes in the dentate gyrus [n per gyrus]"
BXD_10710,"Central nervous system, morphology: Striatum volume, dorsal striatum of young adults, bilateral and shrinkage corrected [mm^3] "
BXD_10711,Immune system: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype)[units]
BXD_10712,"Toxicology, cancer biology: Skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate (TPA) (last column, Table 2) [n tumors/case]"
BXD_10713,"Toxicology, development: Hydronephrosis induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]"
BXD_10714,"Toxicology, development: Cleft palate frequency induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%]"
BXD_10715,"Infectious disease, immune system: Sendai virus lethality with 1.0 TCID50 [% mortality]"
BXD_10716,"Immune system, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%]"
BXD_10717,"Cancer, toxicology, skin: Epidermal ornithine decarboxylase (ODC) activity induced by topical administration of  12-O-tetradecanoylphorbol-13-acetate (TPA) [units]"
BXD_10718,"Infectious disease, immune system: Leishmania L. mexicana lesion diameter after subcutaneous injection in males (this entry is missing data) [mm]"
BXD_10719,"Infectious disease, immune system: Leishmania L. mexicana skin lesion diameter in females [mm]"
BXD_10720,"Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of males [nmol/g]"
BXD_10721,"Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of females [nmol/g]"
BXD_10722,"Central nervous system, metabolism, nutrition: Zinc levels in nucleus accumbens of males [nmol/g]"
BXD_10723,"Central nervous system, metabolism, nutrition: Zinc level in nucleus accumbens of females [nmol/g]"
BXD_10724,"Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of males [nmol/g]"
BXD_10725,"Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of females [nmol/g]"
BXD_10726,"Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of males [nmol/g]"
BXD_10727,"Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of females [nmol/g]"
BXD_10728,"Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of males [nmol/g]"
BXD_10729,"Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of females [nmol/g] "
BXD_10730,"Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of males [nmol/g]"
BXD_10731,"Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of females [nmol/g]"
BXD_10732,"Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of males [nmol/g]"
BXD_10733,"Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of females [nmol/g]"
BXD_10734,"Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of males [nmol/g]"
BXD_10735,"Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of females [nmol/g]"
BXD_10736,"Toxicology, cancer biology: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate (column 2, Table 2) [% mice]"
BXD_10737,"Central nervous system, morphology: Cerebral cortex grey matter volume residuals after adjustment for age [mm^3 residuals]"
BXD_10738,"Central nervous system, morphology: Dorsal thalamus volume of young adults, shrinkage corrected [mm^3]"
BXD_10739,"Musculoskeletal system, morphology: Soleus muscle weight of 200-day-old males [mg]"
BXD_10740,"Musculoskeletal system, morphology: Soleus weight of 200-day-old females [mg]"
BXD_10741,"Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 200-day-old males [mg]"
BXD_10742,"Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight of 200-day-old females [mg]"
BXD_10743,"Musculoskeletal system, morphology: Tibialis anterior (TA) muscle mass of 200-day-old males [mg]"
BXD_10744,"Musculoskeletal system, morphology: Tibialis anterior (TA) weight of 200-day-old females [mg]"
BXD_10745,"Musculoskeletal system, morphology: Gastrocnemius muscle mass of 200-day-old males [mg]"
BXD_10746,"Musculoskeletal system, morphology: Gastrocnemius muscle weight of 200-day-old females [mg]"
BXD_10747,"Central nervous system, behavior: Polydipsia, drinking slope (contact G Mittleman, g.mittleman@mail.psyc.memphis.edu)"
BXD_10748,"Cardiovascular system, metabolism: Aortic atherosclerotic lesions following 16-week atherogenic diet in 16-month females [n]"
BXD_10749,"Blood chemistry, metabolism: High-density lipoprotein (HDL)  cholesterol level following 16-week high-fat diet [mg/dL]"
BXD_10750,"Blood chemistry, metabolism: High-density lipoprotein (HDL)  cholesterol levels following 16-week chow diet (control group) [mg/dL]"
BXD_10751,"Blood chemistry, metabolism: Low-density lipoprotein (LDL)  cholesterol levels following 16-week chow diet (control group) [mg/dL]"
BXD_10752,"Blood chemistry, metabolism: Cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]"
BXD_10753,"Blood chemistry, metabolism: Low-density lipoprotein (LDL)  cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels]"
BXD_10754,"Central nervous system, morphology: Cortical grey matter volume, residual volume adjusting for volume of thalamus [mm3]"
BXD_10755,"Central nervous system, morphology: Hippocampus, dorsal hippocampus volume, age-adjusted residuals [mm3]"
BXD_10756,"Central nervous system, morphology: Hippocampus, ventral hippocampus volume, age-adjusted residuals (V2 Table 2A) [mm3]"
BXD_10757,"Central nervous system, morphology: Hippocampus, ventral hippocampus volume residuals, adjusted for differences in age and brain weight (from V3 Table 2A) [mm3]"
BXD_10758,"Musculoskeletal system, morphology: Soleus muscle weight of males at 500 days [mg]"
BXD_10759,"Musculoskeletal system, morphology: Soleus muscle weight of females at 500-days-of-age [mg]"
BXD_10760,"Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 500-day-old males [mg]"
BXD_10761,"Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 500-day-old females [mg]"
BXD_10762,"Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old males [mg]"
BXD_10763,"Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old females [mg]"
BXD_10764,"Musculoskeletal system, morphology: Gastrocnemius muscle mass of 500-day-old males [mg]"
BXD_10765,"Musculoskeletal system, morphology: Gastrocnemius muscle mass in 500-day-old females [mg]"
BXD_10766,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10767,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10768,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10769,"Infectious disease, immune system: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10770,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10771,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10772,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10773,"Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)]"
BXD_10774,"Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450]"
BXD_10775,Immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450]
BXD_10776,"Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450]"
BXD_10777,"Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450]"
BXD_10778,"Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450]"
BXD_10779,"Infectious disease, immune system: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)]"
BXD_10780,"Immune function: Antibody IgG1 response  following iv injection of canine coagulation factor IX (cF.IX, 3E11 vg/mouse) [ng/ml]"
BXD_10781,"Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to only plain-flavored food [percent of baseline diet]"
BXD_10782,"Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to cinnamon-flavored food [percentage of total diet]"
BXD_10783,"Central nervous system, behavior, gustation: Novel food preference for cinnamon-flavored food [difference score, percentage total diet without pre-exposure minus percentage total diet with pre-exposure to cinnamon]"
BXD_10784,"Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)]"
BXD_10785,"Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)]"
BXD_10786,"Central nervous system, gene expression: Corticotropin-releasing factor (CRF) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]"
BXD_10787,"Central nervous system, gene expression: Corticotropin releasing factor receptor 1 (Crf-R1, CRF1, CRHR1) mRNA transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]"
BXD_10788,"Central nervous system, gene expression: Corticotropin-releasing factor binding protein (CRFBP, CRHBP) mRNA expression level in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]"
BXD_10789,"Central nervous system, gene expression: Arginine vasopressin (AVP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)]"
BXD_10790,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 0 to 5 min interval (updated data PMID 9880575) [cm]"
BXD_10791,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 5 to 10 min interval (updated data PMID 9880575) [cm]"
BXD_10792,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 10 to 15 min interval (updated data PMID 9880575) [cm]"
BXD_10793,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 15 to 20 min interval (updated data PMID 9880575) [cm]"
BXD_10794,"Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), adaptation to ethanol defined as 15-20 min interval locomotion minus 0-5 min interval locomotion [cm]"
BXD_10795,"Central nervous system, adult neurogenesis: Cell proliferation in the adult dentate gyrus, Ki67-positive cells [residuals]"
BXD_10796,"Central nervous system, adult neurogenesis: Survival of new cells in the adult dentate gyrus, BrdU-positive cells [residual n]"
BXD_10797,"Central nervous system, adult neurogenesis: New neurons in the adult dentate gyrus [BrdU/NeuN; residuals]"
BXD_10798,"Central nervous system, adult neurogenesis: New astrocyte production level based on ratio of total BrdU cells to S100b+BrdU labeled cells [residuals of the ratio]"
BXD_10799,"Eye, visual system, morphology: Eye weight, fresh unfixed, corrected for age [mg]"
BXD_10801,"Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (Fig 1A, residuals after correction for age, sex, body weight and log inoculum, with added strains BXD76 and BXD80) [-1 = high susceptible, +1 is resistant]"
BXD_10803,"Cardiovascular system, morphology: Heart weight without statistical adjustment (C57BL/6J data looks anomalous) [mg]"
BXD_10805,"Central nervous system, adult neurogenesis: Rostral migratory stream (RMS) BrdU-labeled cells in adults [number per mm]"
BXD_10806,"Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival]"
BXD_10807,"Central nervous system, behavior, learning and memory: Memory performance measured as fraction of swim distance spent in the learned target quadrant [%]"
BXD_10808,"Central nervous system, behavior, learning and memory: Learning performance measured as the latency to reach the platform during acquisition of Morris water maze task [s]"
BXD_10809,"Blood chemistry: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of males and females [ug/dL]"
BXD_10810,"Central nervous system, behavior, learning and memory: Average path length to reach the platform during acquisition of task using Morris water maze [cm] "
BXD_10811,"Immune system, metabolism: Iron level in spleen of males and females [ug/g]"
BXD_10812,"Liver, metabolism: Iron level in liver of males [ug/g]"
BXD_10813,"Immune system, metabolism: Iron level in spleen of females [ug/g] "
BXD_10814,"Central nervous system, behavior: Swimming speed during acquisition of task using Morris water maze [cm/s] "
BXD_10815,"Central nervous system, behavior, learning and memory: Learning performance measured as the difference in swim path to reach the platform between days 1 and 4 of training using Morris water maze [cm] 

"
BXD_10816,"Central nervous system, behavior, learning and memory: Learning measured by the difference in time (latency) to reach the platform between day 1 and day 4 of training using Morris water maze [s] "
BXD_10817,"Blood chemistry, metabolism: Iron level in plasma of males [ug/dL]"
BXD_10818,"Immune system, metabolism: Iron level in spleen of males [ug/g]"
BXD_10819,"Central nervous system, behavior: Open field behavior, locomotion from 0-45 min [n beam breaks] "
BXD_10820,"Blood chemistry: Hematocrit (packed cell volume, erythrocyte volume fraction) in males and females [%]"
BXD_10821,"Liver, metabolism: Iron level in liver of males and females [ug/g]"
BXD_10822,"Blood chemistry, metabolism: Transferrin saturation of males [%]"
BXD_10823,"Blood chemistry, metabolism: Transferrin saturation of males and females [%]"
BXD_10824,"Central nervous system, behavior: Locomotor performance, duration on an accelerating rotarod, mean of three trials [s]"
BXD_10825,"Blood chemistry, cardiovascular system: Hemoglobin in males [g/dL]"
BXD_10826,"Blood chemistry, cardiovascular system: Hemoglobin in males and females [g/dL]"
BXD_10827,"Blood chemistry, metabolism: Iron binding capacity (systemic, total iron-binding capacity, TIBC, transferrin level) of males [ug/dL]"
BXD_10828,"Blood chemistry, metabolism: Iron level in plasma of females [g/dL]"
BXD_10829,"Blood chemistry, metabolism: Iron level in plasma of males and females [ug/dL]"
BXD_10830,"Blood chemistry, metabolism: Transferrin saturation of females [%]"
BXD_10831,"Blood chemistry, metabolism: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of females [ug/dL]"
BXD_10832,"Blood chemistry, cardiovascular system: Hemoglobin in females [g/dL]"
BXD_10833,"Blood chemistry, cardiovascular system: Hematocrit (packed cell volume, erythrocyte volume fraction) in males [%]"
BXD_10834,"Blood chemistry, cardiovascular system: Hematocrit (packed cell volume, erythrocyte volume fraction) in females [%]"
BXD_10835,"Liver, metabolism: Iron level in liver of females [ug/g]"
BXD_10836,"Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (differs from Fig 1A slightly, residuals after correction for age, sex, body weight and log inoculum, with added strain BXD80) where -1 means highly susceptible and +1 means resistant [index]"
BXD_10855,"Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio]"
BXD_10856,"Urogenital system, kidney, morphology: Kidney weight, males and females (unilateral, uncorrected, 2006) [mg]"
BXD_10858,"Urogenital system, kidney, morphology: Kidney weight (unilateral, regressed to eliminate variance due to age, body weight, and sex in 2006) [mg]"
BXD_10859,"Urogenital system, kidney, morphology: Kidney weight of adult females, unilateral, without any adjustments [mg]"
BXD_10861,"Urogenital system, kidney, morphology: Kidney weight of females (unilateral, corrected for age and body weight)[mg]"
BXD_10862,"Urogenital system, kidney, morphology: Kidney weight of males (unilateral) [mg]"
BXD_10863,"Urogenital system, kidney, morphology: Kidney weight of males (unilateral, adjusted for age and body size) [mg]"
BXD_10865,"Infectious disease, immune system: H5N1 influenza A virus mortality rate 30 days after infection (10^4 EID-50 of HK213 virus in 30 microliters saline) [% death]"
BXD_10866,"Infectious disease, immune system: H5N1 influenza A virus survival time (10^4 EID-50 of HK213 virus in 30 microliters saline) [days, max to 30]"
BXD_10867,"Infection disease, immune function: Cox-Hasty trait 1"
BXD_10870,"Endocrinology, blood chemistry: Corticosterone in plasma, level after a 10 min forced Porsolt swim test (blood taken 30 min after stressor) [ng/ml]"
BXD_10873,"Endocrinology, blood chemistry: Corticosterone in plasma, baseline control level [ng/ml]"
BXD_10877,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral without adjustment (revised) [n]"
BXD_10878,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron cell density [n/mm^3]"
BXD_10879,"Central nervous system, morphology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell density [n/mm^3]"
BXD_10887,"Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield area without statistical adjustments [mm2]"
BXD_10888,"Central nervous system, morphology: Brain weight, fixed tissue without statistical adjustments [mg]"
BXD_10890,"Immune system, aging: Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published) [n]"
BXD_10891,"Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD32 excluded due to retinal degeneration, 201980+/-30851) [cells/mm^3]"
BXD_10893,"Central nervous system, morphology: Septal nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10894,"Central nervous system, morphology: Striatum (caudate-putamen), bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10895,"Central nervous system, morphology: Hippocampus volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10896,"Central nervous system, behavior: Anxiety assay, closed arm entries in an elevated plus maze test [n]"
BXD_10897,"Central nervous system, behavior: Pain response, thermal nociception, latency to paw withdrawal and licking response using a hot plate test [sec]"
BXD_10898,"Central nervous system, behavior: Anxiety assay, open arm entries in an elevated plus maze test [n]"
BXD_10899,"Central nervous system, behavior, learning and memory: Fear conditioning, baseline preconditioning freezing during a 2 min acclimation period prior to first pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]"
BXD_10900,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing during consolidation period after final pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%]"
BXD_10901,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing in response to context exposure 48 hr after conditioning [%]"
BXD_10902,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing during conditioned stimulus exposure, 24 hr after conditioning [%]"
BXD_10903,"Central nervous system, behavior: Depression assay, immobility from 2-10 min in a 10 min Porsolt forced swim test [%]"
BXD_10904,"Central nervous system, behavior: Anxiety assay, locomotion in the light compartment relative to total in a light-dark test [%]"
BXD_10905,"Central nervous system, behavior: Anxiety assay, time in the center of an elevated plus maze [sec]"
BXD_10906,"Central nervous system, behavior: Novel open field behavior, time in the field center [sec]"
BXD_10907,"Central nervous system, behavior: Anxiety assay, percentage of time in light compartment of a light-dark test [%]"
BXD_10908,"Central nervous system, behavior: Anxiety assay, percentage of time in open arms of an elevated plus maze [%]"
BXD_10909,"Central nervous system, behavior: Anxiety assay, arm entries (total) in an elevated plus maze [n]"
BXD_10910,"Central nervous system, behavior: Novel open field behavior, locomotion from 0-30 min [cm]"
BXD_10911,"Central nervous system, behavior: Novel open field behavior, locomotion from 0-5 min [cm]"
BXD_10912,"Central nervous system, behavior: Novel open field behavior, locomotion from 10-15 min [cm]"
BXD_10913,"Central nervous system, behavior: Novel open field behavior, locomotion from 15-20 min [cm]"
BXD_10914,"Central nervous system, behavior: Novel open field behavior, locomotion from 20-25 min [cm]"
BXD_10915,"Central nervous system, behavior: Novel open field behavior, locomotion from 25-30 min [cm]"
BXD_10916,"Central nervous system, behavior: Novel open field behavior, locomotion from 5-10 min [cm]"
BXD_10917,"Central nervous system, behavior: Anxiety assay, transitions between light and dark compartments in light/dark test [n]"
BXD_10918,"Central nervous system, peripheral nervous system, behavior: Pain response, chemical nociception, acetic acid writhing test [writhes]"
BXD_10919,"Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield, statistically adjusted for variation in brain weight [mm2]"
BXD_10921,"Central nervous system, morphology: Cerebellum volume,  in situ postmortem from high field MRI [bilateral mm^3]"
BXD_10922,"Central nervous system, morphology: Cerebral cortex volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10923,"Central nervous system, morphology: Olfactory bulb volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10924,"Central nervous system, morphology: Amygdala volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10925,"Central nervous system, morphology: Hypothalamus volume, bliateral, in situ postmortem from high field MRI [mm^3]"
BXD_10926,"Central nervous system, morphology: Superior colliculus volume, bilateral, from in situ postmortem high field MRI) [mm^3]"
BXD_10927,"Central nervous system, morphology: Inferior colliculus volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10928,"Central nervous system, morphology: Brain volume, in situ postmortem from high field MRI [mm^3]"
BXD_10929,"Central nervous system, morphology: Brain ventricle volume (bilateral, all ventricles, in situ postmortem from high field MRI [mm^3]"
BXD_10930,"Central nervous system, morphology: Corpus callosum volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10931,"Central nervous system, morphology: Trigeminal tract volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10932,"Central nervous system, morphology, visual system: Optic tract volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10933,"Central nervous system, morphology, visual system: Anterior pretectal nucleus volume, bilateral, from in situ postmortem high field MRI [mm^3]"
BXD_10934,"Central nervous system, morphology, visual system: Geniculate nuclei volume of thalamus (MGN and LGN combined, bilateral, in situ postmortem from high field MRI) [mm^3]"
BXD_10935,"Central nervous system, morphology: Laterodorsal nucleus of thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10936,"Central nervous system, morphology: Deep mesencephalic nuclei (MRN, RN, right and left combined) volume in situ from high field MRI [mm3]"
BXD_10937,"Central nervous system, morphology: Globus pallidus volume, in situ postmortem from high field MRI [bilateral mm^3]"
BXD_10938,"Central nervous system, morphology, auditory system: Cochlear nuclei volume (right and left combined), in situ postmortem from high field MRI [mm3]"
BXD_10939,"Central nervous system, morphology: Interpeduncular nucleus volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10940,"Central nervous system, morphology: Cerebral peduncle volume, bilateral, from in situ postmortem high field MRI [mm^3]"
BXD_10941,"Central nervous system, morphology: Substantia nigra, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10942,"Central nervous system, morphology: Pontine nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10943,"Central nervous system, morphology: Nucleus accumbens volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10944,"Central nervous system, morphology: Anterior commissure volume, bilateral, from in situ postmortem high field MRI [mm^3]"
BXD_10945,"Central nervous system, morphology: Ventral thalamic nuclei volume, bilateral from in situ postmortem from high field MRI (includes the VPL, VPM, VP, and VA) [mm^3]"
BXD_10946,"Central nervous system, morphology: Fimbria volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10948,"Central nervous system, morphology: Periaqueductal gray volume, bilateral, in situ postmortem from high field MRI [mm^3] "
BXD_10949,"Central nervous system, morphology: Lateral lemniscus (right and left combined), in situ postmortem from high field MRI [mm3]"
BXD_10950,"Central nervous system, morphology: Thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3]"
BXD_10951,"Central nervous system, morphology: Midbrain partial volume, bilateral (excludes individually segmented nuclei) in situ postmortem from high field MRI [mm^3]"
BXD_10952,"Central nervous system, morphology: Brainstem partial volume, bilateral including DpMe, APT, pons, but excluding other individually segmented nuclei, in situ postmortem from high field MRI [mm^3]"
BXD_10953,"Central nervous system, morphology: Brain volume minus cerebellum volume, in situ postmortem value from high field MRI [mm^3]"
BXD_10954,"Cancer biology, liver, toxicology: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n]"
BXD_10955,"Central nervous system, behavior: Anxiety assay (S5_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side using a light-dark box in 8-12 week-old males during 5 min session [%]"
BXD_10957,"Central nervous system, behavior: Anxiety assay (S5_TLA) following restraint stress (15 min) and a saline injection (0.018 mL/g ip), distance traveled in light-dark box by 8-12 week-old males during a 5 min session [cm]"
BXD_10960,"Central nervous system, behavior: Anxiety assay (S5_NT) following restraint stress (15 min) and a saline injection  (0.018 mL/g ip), entries into light side of light-dark box by 8-12 week-old males during a 5 min session [n]"
BXD_10961,"Central nervous system, behavior: Anxiety assay (S5_NR) following restraint stress (15 min) and a saline injection (0.018 mL/g ip), rearing events in the light side using a light-dark box in 8-12 week-old males during a 5 min session [n]"
BXD_10964,"Central nervous system, pharmacology, behavior: Anxiety assay (E5_PDT) after restraint stress (15 min) and ethanol injection (1.8 g/kg ip), percent distance traveled in light side using a light-dark box by 8-12 week-old males during a 5 min session [%]"
BXD_10966,"Central nervous system, pharmacology, behavior: Anxiety assay (E5_TLA) following restraint stress (15 min) and ethanol injection (1.8 g/kg ip), locomotor activity in light-dark box by 8-12 week-old males during a 5 min session [cm]"
BXD_10969,"Central nervous system, pharmacology, behavior: Anxiety level following restraint stress (15 min) and ethanol treatment (1.8 g/kg i.p., E5 NT group) measured as the number of entries into light side of light-dark box in 8-12 week-old males (5 min session) [n]"
BXD_10970,"Central nervous system, pharmacology, behavior: Anxiety assay following restraint stress (15 min) and ethanol injection (1.8 g/kg ip), rearing events in the light side using a light-dark box by 8-12 week-old males during a 5 min session [n]"
BXD_10973,"Central nervous system, behavior, pharmacology: Anxiety assay following restraint stress (15 min) and saline injection (0.018 ml/g ip), percent distance in light side using a light-dark box by 8-12 week-old males during 10 min session [%]"
BXD_10975,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_TLA), restraint stress (15 min) and saline treated (0.018 ml/g ip), distance traveled in light-dark box, 8-12 week-old males during a 10 min session [cm]"
BXD_10978,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_NT), entries into light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during a 10 min test [n]"
BXD_10979,"Central nervous system, behavior, pharmacology: Anxiety assay after restraint stress (15 min) and a saline injection (0.018 ml/g ip), rearing events in the light side using a light-dark box by 8-12 week-old males during a 10 min session [n]"
BXD_10982,"Central nervous system, behavior, pharmacology: Anxiety assay (E10_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [%]"
BXD_10984,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [cm]"
BXD_10987,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_NT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during a 10 min session [n]"
BXD_10988,"Central nervous system, pharmacology, behavior: Anxiety assay after restraint stress (15 min) and an ethanol injection (1.8 g/kg ip), rearing events in the light side using a light-dark box by 8-12 week-old males during a 10 min session [n]"
BXD_10991,"Urogenital system, kidney, morphology: Kidney weight (unilateral) in adult males and females without statistical adjustments [mg]"
BXD_10992,"Central nervous system, morphology: Cerebral cortex volume, shrinkage corrected [mm^3]"
BXD_10993,"Central nervous system, morphology: Cerebral cortex volume, regression adjusted for age and body weight, shrinkage corrected [mm^3]"
BXD_10994,"Urogenital system, kidney, morphology: Kidney weight (unilateral, corrected for age, sex, and body weight) [mg]"
BXD_10995,"Central nervous system, morphology: Cerebral cortex volume, bilateral, shrinkage corrected [mm^3]"
BXD_10997,"Central nervous system, morphology: Cerebral cortex volume, adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch) [mm^3]"
BXD_10998,"Central nervous system, morphology: Striatum volume, dorsal striatum, bilateral and adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch (mm^3)"
BXD_11001,"Infectious disease, immune system: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml]"
BXD_11002,"Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia (supplementary data to Brigman et al.) [deg C]"
BXD_11003,"Central nervous system, pharmacology, behavior: Ethanol response (3 g/kg ip), loss of righting reflex (LORR) sleep time (supplementary data to Brigman et al.) [min]"
BXD_11004,"Central nervous system, behavior: Rotarod performance, baseline control (supplementary data to Brigman et al.) [sec]"
BXD_11005,"Central nervous system, behavior, learning: Motor performance, improvement in rotarod training measured as change in time on rod [sec]"
BXD_11006,"Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance, difference from saline baseline (supplementary data to Brigman et al.)"
BXD_11007,"Central nervous system, behavior, auditory system: Startle response to loud acoustic stimulus [force]"
BXD_11008,"Central nervous system, behavior: Prepulse inhibition of the acoustic startle response [%]"
BXD_11009,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 48 hours [%]"
BXD_11010,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 24 hours [%]"
BXD_11011,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing response to context after 48 hours [%]"
BXD_11012,"Central nervous system, behavior: Anxiety assay, time in open arm of elevated plus maze in young adult males and females [sec]"
BXD_11013,"Central nervous system, behavior: Anxiety assay, number of closed arm entries using elevated plus maze [n]"
BXD_11014,"Central nervous system, behavior: Locomotor activity, distance, open field behavior [cm]"
BXD_11015,"Central nervous system, behavior: Anxiety assay, open field behavior, duration in center of field [sec]"
BXD_11016,"Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, litter size, and parity [mg]"
BXD_11018,"Central nervous system, morphology: Forebrain weight, adjusted by age, sex, body weight and BXD epoch [mg]"
BXD_11020,"Urogenital system, kidney, morphology: Wilms tumor 1 negative (WT1-neg) cells per glomerular cross section in males (8 - 20 weeks of age) [n/section]"
BXD_11021,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) dissemination to spleens, 24 h post-infection (Fig 1C) [CFU/ml]"
BXD_11022,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection corrected for age, sex, body weight, log inoculum (Fig 1B) [corrected log CFU/ml]"
BXD_11023,"Central nervous system, development, morphology: CxEct_Rosen_Mar2011"
BXD_11024,"Central nervous system, eye, visual system, morphology: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD32 excluded due to retinal degeneration (3.46+/-0.096 million) [n x10^6]"
BXD_11025,"Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males (subset of cases) [log ng of DNA] "
BXD_11026,"Infectious disease, immune system, morphology: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm]"
BXD_11027,"Central nervous system, metabolism: Iron level in hippocampus of males [ug/g]"
BXD_11028,"Central nervous system, metabolism: Iron level in hippocampus of females [ug/g]"
BXD_11029,"Central nervous system, metabolism: Copper level in hippocampus of males [ug/g wet tissue]"
BXD_11030,"Central nervous system, metabolism: Copper level in hippocampus of females [ug/g wet weight]"
BXD_11031,"Central nervous system, metabolism: Zinc level in hippocampus of males [ug/g]"
BXD_11032,"Central nervous system, metabolism: Zinc level in hippocampus of females [ug/g]"
BXD_11033,"Musculoskeletal system, morphology: Soleus-femoral muscle attachment anomaly [frequency]"
BXD_11262,"Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for females [um]
"
BXD_11263,"Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for males [um]
"
BXD_11266,"Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for males [um]
"
BXD_11267,"Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for females [um]
"
BXD_11268,"Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for males [um]"
BXD_11269,"Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for females [um]
"
BXD_11270,"Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width in young adult males [um]
"
BXD_11271,"Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width for females [um]
"
BXD_11272,"Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for males [um]"
BXD_11273,"Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for females [um]
"
BXD_11280,"Skin, pigmentation: Hair coat color, ordinal scale version 2 where black=4, grey=3, brown=2, dba dilute=1 (updated 2016) [color intensity]"
BXD_11281,"Central nervous system, visual system: Ocular dominance index (imaged ocular dominance index of undeprived mice at P35 given by (control_OD_contra - control_OD_ipsi) / (control_OD_contra+control_OD_ipsi) [ratio]"
BXD_11282,"Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of contralateral eye [intensity]"
BXD_11283,"Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of ipsilateral eye [intensity]"
BXD_11284,"Central nervous system, visual system: Ocular dominance index shift after monocular deprivation of the contralateral eye from P28 to P35"
BXD_11285,"Central nervous system, visual system: Contralateral visual cortex (V1) shift in intrinsic response to contralateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35"
BXD_11286,"Central nervous system, visual system: Visual cortex (V1) activity, ipsilateral shift in intrinsic response to ipsilateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35"
BXD_11288,"Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for females [um]
"
BXD_11291,"Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for females [um]
"
BXD_11293,"Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for males [um]
"
BXD_11295,"Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for males [um]
"
BXD_11296,"Central nervous system, peripheral nervous system: mechanical sensitivity, Von Frey hair test threshold [units] "
BXD_11297,"Central nervous system, pharmacology, behavior: Ethanol response (10% w/v in water), consumption using a two-bottle choice for males and females, average days 5-11 [g/kg/24h]"
BXD_11298,"Endocrinology, neuroendocrine system, morphology: Adrenal total weight for females [mg]
"
BXD_11299,"Endocrinology, neuroendocrine system, morphology: Adrenal total weight for males [mg]
"
BXD_11300,"Metabolism, genetics: Mitochondrion genotype at rs8281487 in mtNd3 (maternal mitochondrial strain origin) corrected Oct 2018 using sequence data (-1 = C57BL/6J and 1 = DBA/2J) [genotype]"
BXD_11302,"Central nervous system, behavior, somatosensory system: Pain sensitivity, vocalization threshold to mild foot shock for males [mA]"
BXD_11303,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males [sec]

"
BXD_11304,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males [sec]"
BXD_11305,"Central nervous system, behavior: Motor coordination, time on dowel over a 2 min baseline test period for males [sec]"
BXD_11306,"Central nervous system, behavior: Depression assay, Porsolt behavioral despair test, time immobile for males [sec]"
BXD_11307,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception using Hargreaves' test for males [units]"
BXD_11308,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate test, average of two trials for males [sec]"
BXD_11309,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, mechanical nociception, tail clip latency for males [sec]"
BXD_11310,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, tail withdrawal latency for males [sec]"
BXD_11311,"Central nervous system, peripheral nervous system, behavior: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males [Force in mg]"
BXD_11312,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males [n beam breaks]"
BXD_11313,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males [n beam breaks]"
BXD_11314,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males [n beam breaks]"
BXD_11315,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males [n beam breaks]"
BXD_11316,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males [n beam breaks]"
BXD_11317,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males [n beam breaks]"
BXD_11318,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males [n beam breaks]"
BXD_11319,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males [n beam breaks]"
BXD_11320,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males [n beam breaks]"
BXD_11321,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males [n beam breaks]"
BXD_11322,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males [n beam breaks]"
BXD_11323,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males [cm]"
BXD_11324,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males [cm]"
BXD_11325,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males [cm]"
BXD_11326,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males [cm]"
BXD_11327,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for males [cm]"
BXD_11328,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males [cm]"
BXD_11329,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males [cm]"
BXD_11330,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males [cm]"
BXD_11331,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males [cm]"
BXD_11332,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males [cm]"
BXD_11333,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males [cm]"
BXD_11334,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males [ordinal scale, 0=no effect, 3=max]"
BXD_11335,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males [n fecal boli]"
BXD_11336,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males [n/15 min test]"
BXD_11337,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min after injection (total open field activity over 3 hour test) for males [n beam breaks]"
BXD_11338,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males [cm]"
BXD_11339,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]"
BXD_11340,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min after injection (total vertical activity over 3 hour test) for males [n beam breaks]"
BXD_11341,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [n beam breaks]"
BXD_11342,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the morphine test battery [n beam breaks]"
BXD_11343,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [n beam breaks]"
BXD_11344,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [n beam breaks]"
BXD_11345,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [cm]"
BXD_11346,"Central nervous system, behavior: Novel open field behavior, locomotion locomotion in the periphery from 15-30 min for males in the morphine test battery [cm]"
BXD_11347,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [cm]"
BXD_11348,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [cm]"
BXD_11349,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min for males [n beam breaks]"
BXD_11350,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males [n beam breaks]"
BXD_11351,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for males [n beam breaks]"
BXD_11352,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males [n beam breaks]"
BXD_11353,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]"
BXD_11354,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm]"
BXD_11355,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males [n beam breaks]"
BXD_11356,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males [n beam breaks]"
BXD_11357,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males [cm]"
BXD_11358,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip) and naloxone response (30 mg/kg ip), naloxone-induced withdrawal after morphine, vertical activity (rears) from 0-15 min for males [n beam breaks]"
BXD_11359,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males [ordinal scale, 0=no effect, 3=max]"
BXD_11360,"Central nervous system, pharmacology: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males [ordinal scale, 0=no effect, 3=max]"
BXD_11361,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males (BXD38 winsorized from1.833 to 0.850 by RWW) [ordinal scale, 0=control level, 3=max]"
BXD_11362,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]"
BXD_11363,"Central nervous system, urogenital system, behavior: Novel open field behavior, urinations for males [n/test period]"
BXD_11364,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males [n beam breaks]"
BXD_11365,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males [n beam breaks]"
BXD_11366,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males [n beam breaks]"
BXD_11367,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males [n beam breaks]"
BXD_11368,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males [n beam breaks]"
BXD_11369,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males [n beam breaks]"
BXD_11370,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males [n beam breaks]"
BXD_11371,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males [n beam breaks]"
BXD_11372,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males [n beam breaks]"
BXD_11373,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males [n beam breaks]"
BXD_11374,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males [n beam breaks]"
BXD_11375,"Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males [cm/90 min test]"
BXD_11376,"Central nervous system, behavior: Locomotor activity after first saline injection (day 1) for males (MDMA control) [cm/ test period]"
BXD_11377,"Central nervous system, behavior: Saline control response, locomotor activity after second injection for males (control for MDMA response experiment) [cm/test period]"
BXD_11378,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males [explain the score]"
BXD_11379,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsions (HIC) 6 hrs after injections for males (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11380,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males [units]"
BXD_11381,"Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11382,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11383,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate latency for males [sec]"
BXD_11384,"Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for males [cm]"
BXD_11385,"Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males [sec]"
BXD_11386,"Central nervous system, behavior: Locomotion in both compartments of a light-dark box for males [cm]"
BXD_11387,"Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males [cm]"
BXD_11388,"Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males [sec]"
BXD_11389,"Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males [%]"
BXD_11390,"Central nervous system, behavior: Anxiety assay, percentage of time in light side of a light-dark box for males [%]"
BXD_11391,"Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males [n]"
BXD_11392,"Central nervous system, behavior: Fear conditioning response, activity in altered context for males [units]"
BXD_11393,"Central nervous system, behavior: Fear conditioning behavior, baseline activity in apparatus for males [units]"
BXD_11394,"Central nervous system, behavior: Fear conditioning response, contextual activity for males [units]"
BXD_11395,"Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for males [n beam breaks]"
BXD_11396,"Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males [units]"
BXD_11397,"Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males [units]"
BXD_11398,"Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males [units]"
BXD_11399,"Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males [units]"
BXD_11400,"Central nervous system, behavior: Fear conditioning response, activity after first tone shock pairing for males [n beam breaks/30 sec test]"
BXD_11401,"Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males [n beam breaks/30 sec test]"
BXD_11402,"Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males [n beam breaks/30 sec test] "
BXD_11403,"Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males [units]"
BXD_11404,"Central nervous system, behavior: Open field behavior, percentage of distance in the center for males [%]"
BXD_11405,"Central nervous system, behavior: Open field behavior, percentage of time in center for males [%]"
BXD_11406,"Central nervous system, behavior: Open field behavior, time in corners for males [min]"
BXD_11407,"Central nervous system, behavior: Open field behavior, locomotion from 0-5 min for males [cm]"
BXD_11408,"Central nervous system, behavior: Open field behavior, locomotion from 10-15 min for males [cm]"
BXD_11409,"Central nervous system, behavior: Open field behavior, locomotion from 15-20 min for males [cm]"
BXD_11410,"Central nervous system, behavior: Open field behavior, locomotion from 5-10 min for males [cm]"
BXD_11411,"Central nervous system, behavior: Open field activity, habituation ratio for males (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]"
BXD_11412,"Central nervous system, behavior: Open field behavior, percentage time in perimeter minus time in corners  for males [%]"
BXD_11413,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-20 min for males [n beam breaks]"
BXD_11414,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-5 min for males [n beam breaks]"
BXD_11415,"Central nervous system, behavior: Open field behavior, vertical activity (rears) 10-15 min for males [n beam breaks]"
BXD_11416,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 15-20 min for males [n beam breaks]"
BXD_11417,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 5-10 min for males [n beam breaks]"
BXD_11418,"Central nervous system, behavior: Open field behavior, locomotion for entire test period for males [cm]"
BXD_11419,"Central nervous system, behavior: Open field behavior, percentage of distance in the perimeter for males [%]"
BXD_11420,"Central nervous system, behavior: Open field behavior, percentage of time in perimeter for males [%]"
BXD_11421,"Central nervous system, behavior: Startle response, baseline level for males (BXD65b winsorized from 0.741+/- 0.361 to 0.271) [units]"
BXD_11422,"Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11423,"Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11424,"Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11425,"Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11426,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11427,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11428,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11432,"Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males [sec below threshold movement level]"
BXD_11433,"Central nervous system, behavior: Locomotion in zero maze for males [n beam breaks]"
BXD_11434,"Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males (higher values associated with higher anxiety)[n]"
BXD_11435,"Central nervous system, behavior: Anxiety assay, entries in open quadrants of a zero maze for males [n]"
BXD_11436,"Central nervous system, behavior: Zero maze, latency to enter an open quadrant for males [sec]"
BXD_11437,"Central nervous system, behavior: Anxiety assay, percentage of time in open quadrants of a zero maze for males [%]"
BXD_11438,"Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males [sec]"
BXD_11439,"Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males [sec]

"
BXD_11440,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males [cm]"
BXD_11441,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males [cm]"
BXD_11442,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males [cm]"
BXD_11443,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males [cm]"
BXD_11444,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males [cm]"
BXD_11445,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males [cm]"
BXD_11446,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males [cm]"
BXD_11447,"Central nervous system, behavior:  Saline control response (10 ml/kg ip) for cocaine, locomotion from 15-20 min after injection for males [cm]"
BXD_11448,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males [cm]
"
BXD_11449,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males [cm]"
BXD_11450,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males [cm]"
BXD_11451,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males [cm]"
BXD_11452,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males [cm]"
BXD_11453,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males [mg/dl XX min after injection]"
BXD_11454,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males [n]"
BXD_11455,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males [n]"
BXD_11456,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males [%]"
BXD_11457,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males [%]"
BXD_11458,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males [%]"
BXD_11459,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for males [%]"
BXD_11460,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec]"
BXD_11461,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males [sec]"
BXD_11462,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec]"
BXD_11463,"Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males [sec]"
BXD_11464,"Central nervous system, behavior: Motor coordination effect of saline control injection (ip), difference in time on rotarod between training session and saline for males [sec]"
BXD_11465,"Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for males [sec]"
BXD_11466,"Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males [sec]"
BXD_11467,"Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males [sec]"
BXD_11468,"Central nervous system, behavior: Anxiety assay, time in open arms of a plus maze for males [sec]"
BXD_11469,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [n beam breaks]"
BXD_11470,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [n beam breaks]"
BXD_11471,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [n beam breaks]"
BXD_11472,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [n beam breaks]"
BXD_11473,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [cm]"
BXD_11474,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [cm]"
BXD_11475,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [cm]"
BXD_11476,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [cm]"
BXD_11477,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males [n beam breaks]"
BXD_11478,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males [n beam breaks]"
BXD_11479,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males [n beam breaks]"
BXD_11480,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males [n beam breaks]"
BXD_11481,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11482,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11483,"Central nervous system, behavior, pharmacology: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11484,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males [n beam breaks] "
BXD_11485,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males [cm]"
BXD_11486,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males [cm]"
BXD_11487,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males [cm]"
BXD_11488,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males [cm]"
BXD_11489,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11490,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11491,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11492,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males [n beam breaks]"
BXD_11493,"Central nervous system, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males [sec]"
BXD_11494,"Central nervous system, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males [sec]"
BXD_11495,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males [sec]	"
BXD_11496,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males [sec]"
BXD_11497,"Central nervous system, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males [%]"
BXD_11498,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [sec]"
BXD_11499,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage of time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [% change]"
BXD_11500,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks]"
BXD_11501,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm]"
BXD_11502,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males [n beam breaks]"
BXD_11503,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males [n beam breaks]"
BXD_11504,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males [cm]"
BXD_11505,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for males [n beam breaks]"
BXD_11506,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [n beam breaks]"
BXD_11507,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males [n beam breaks]"
BXD_11508,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males [n beam breaks] "
BXD_11509,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [n beam breaks]"
BXD_11510,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [cm]"
BXD_11511,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males [cm]"
BXD_11512,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males [cm]"
BXD_11513,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [cm]"
BXD_11514,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males [n beam breaks]"
BXD_11515,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males [n beam breaks]"
BXD_11516,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males [n beam breaks]"
BXD_11517,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males [n beam breaks]"
BXD_11518,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the cocaine test battery [n beam breaks]"
BXD_11519,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the cocaine test battery [n beam breaks]"
BXD_11520,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the cocaine test battery [n beam breaks]"
BXD_11521,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the cocaine test battery [n beam breaks]"
BXD_11522,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males in the cocaine test battery [cm]"
BXD_11523,"Central nervous system, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for males in the cocaine test battery [cm]"
BXD_11524,"Central nervous system, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery  for males in the cocaine test battery [cm]"
BXD_11525,"Central nervous system, behavior: Novel open field behavior, locomotion from 45-60 min in the periphery for males in the cocaine test battery [cm]"
BXD_11526,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males [n beam breaks]"
BXD_11527,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males [n beam breaks]"
BXD_11528,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males [n beam breaks]"
BXD_11529,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males [n beam breaks]"
BXD_11530,"Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males [%]"
BXD_11531,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males [n beam breaks]"
BXD_11532,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males [cm]"
BXD_11533,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males [n beam breaks]"
BXD_11534,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [n beam breaks]"
BXD_11535,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [cm]"
BXD_11536,"Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males [n beam breaks/60 min]"
BXD_11537,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males [difference in cm/1 hr test, positive values indicate sensitization]"
BXD_11538,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [n beam breaks, positive values indicate sensitization]"
BXD_11539,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [cm, positive values indicate sensitization]"
BXD_11540,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males between first and second injections [difference in n/1 hr test, positive values indicate sensitization]"
BXD_11541,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [n beam breaks/15 min]"
BXD_11542,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [n beam breaks/15 min]"
BXD_11543,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [n beam breaks/15 min]"
BXD_11544,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [n beam breaks/15 min]"
BXD_11545,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [cm]"
BXD_11546,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [cm]"
BXD_11547,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [cm]"
BXD_11548,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [cm]"
BXD_11549,"Central nervous system, pharmacology, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males [n beam breaks/15 min]"
BXD_11550,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males [n beam breaks/15 min]"
BXD_11551,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males [n beam breaks/15 min]"
BXD_11552,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males [n beam breaks/15 min]"
BXD_11553,"Central nervous system, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]"
BXD_11554,"Central nervous system, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [cm]"
BXD_11555,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks]"
BXD_11556,"Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males [density]"
BXD_11557,"Endocrinology, morphology: Adrenal weight (left) of males [mg]"
BXD_11558,"Endocrinology, morphology: Adrenal weight (right) of males [mg]"
BXD_11559,"Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for females [mA]"
BXD_11560,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for females [sec]"
BXD_11561,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for females [sec]"
BXD_11562,"Central nervous system, behavior: Motor coordination, time on dowel over a 2 min baseline test period for females [sec]"
BXD_11563,"Central nervous system, behavior: Depression assay, Porsolt behavioral despair test, time immobile for females [sec]"
BXD_11564,"Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, Hargreaves' test for females [units]"
BXD_11565,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate test, average of two trials for females [sec]"
BXD_11566,"Central nervous system, peripheral nervous system, behavior: Pain response, mechanical nociception, tail clip latency for females [sec]"
BXD_11567,"Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, tail withdrawal latency for females [sec]"
BXD_11568,"Central nervous system, peripheral nervous system, somatosensory system: Mechanical sensitivity using Von Frey test, threshold for females [force in mg]"
BXD_11569,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for females [n beam breaks]"
BXD_11570,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for females [n beam breaks]"
BXD_11571,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for females [n beam breaks]"
BXD_11572,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for females [n beam breaks]"
BXD_11573,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for females [n beam breaks]"
BXD_11574,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for females [n beam breaks]"
BXD_11575,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for females [n beam breaks]"
BXD_11576,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for females [n beam breaks]"
BXD_11577,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for females [n beam breaks]"
BXD_11578,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for females [n beam breaks]"
BXD_11579,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for females [n beam breaks]"
BXD_11580,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for females [cm]"
BXD_11581,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for females [cm]"
BXD_11582,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for females [cm]"
BXD_11583,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for females [cm]"
BXD_11584,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for females [cm]"
BXD_11585,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for females [cm]"
BXD_11586,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for females [cm]"
BXD_11587,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for females [cm]"
BXD_11588,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for females [cm]"
BXD_11589,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for females [cm]"
BXD_11590,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for females [cm]"
BXD_11591,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for females [ordinal scale, 0=no effect, 3=max]"
BXD_11592,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for females [n fecal boli]"
BXD_11593,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for females [n/15 min test]"
BXD_11594,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]"
BXD_11595,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [cm]"
BXD_11596,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]"
BXD_11597,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks]"
BXD_11598,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [n beam breaks]"
BXD_11599,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [n beam breaks]"
BXD_11600,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [n beam breaks]"
BXD_11601,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [n beam breaks]"
BXD_11602,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [cm]"
BXD_11603,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [cm]"
BXD_11604,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [cm]"
BXD_11605,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [cm]"
BXD_11606,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 for females [n beam breaks]"
BXD_11607,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for females [n beam breaks]"
BXD_11608,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for females [n beam breaks]"
BXD_11609,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for females [n beam breaks]"
BXD_11610,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]"
BXD_11611,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for females [cm]"
BXD_11612,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for females [n beam breaks]"
BXD_11613,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for females [n beam breaks]"
BXD_11614,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for females [cm]"
BXD_11615,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for females [n beam breaks]"
BXD_11616,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for females [ordinal scale, 0=no effect, 3=max]"
BXD_11617,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for females [ordinal scale, 0=no effect, 3=max]"
BXD_11618,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for females [ordinal scale, 0=control level, 3=max]"
BXD_11619,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for females [ordinal scale, 0=no effect, 3=max]"
BXD_11620,"Central nervous system, behavior: Novel open field behavior, urinations for females [n/test period]"
BXD_11621,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for females [n beam breaks]"
BXD_11622,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for females [n beam breaks]"
BXD_11623,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for females [n beam breaks]"
BXD_11624,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for females [n beam breaks]"
BXD_11625,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) 150-165 min after injection in an activity chamber for females [n beam breaks]"
BXD_11626,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for females [n beam breaks]"
BXD_11627,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for females [n beam breaks]"
BXD_11628,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for females [n beam breaks]"
BXD_11629,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for females [n beam breaks]"
BXD_11630,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for females [n beam breaks]"
BXD_11631,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for females [n beam breaks]"
BXD_11632,"Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for females [cm/90 min test]"
BXD_11633,"Central nervous system, behavior: Locomotor activity after first saline injection (day 1) for females (MDMA control) [cm/ test period] "
BXD_11634,"Central nervous system, pharmacology, behavior: Saline control response, locomotor activity after second injection for females (control for MDMA response experiment) [cm/test period]"
BXD_11635,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for females (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) (BXD44 winterized from 1.125+/-0.479 to 0.5) [score]"
BXD_11636,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsions (HIC) 6 hrs after injections for females (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11637,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for females [units]"
BXD_11638,"Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for females (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11639,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for females (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11640,"Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, hot plate latency for females [sec]"
BXD_11641,"Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for females [cm]"
BXD_11642,"Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for females [sec]"
BXD_11643,"Central nervous system, behavior: Locomotion in both compartments of a light-dark box for females [cm]"
BXD_11644,"Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for females [cm]"
BXD_11645,"Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for females [sec]"
BXD_11646,"Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for females [%]"
BXD_11647,"Central nervous system, behavior: Anxiety assay, percentage of time in the light side of a light-dark box for females [%]"
BXD_11648,"Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for females [n]"
BXD_11649,"Central nervous system, behavior: Fear conditioning response, activity in altered context for females [units]"
BXD_11650,"Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for females [units]"
BXD_11651,"Central nervous system, behavior: Fear conditioning response, contextual activity for females [units]"
BXD_11652,"Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for females [units]"
BXD_11653,"Central nervous system, behavior: Fear conditioning response, suppression of activity in altered context for females [units]"
BXD_11654,"Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for females [units]"
BXD_11655,"Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for females [units]"
BXD_11656,"Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for females [units]"
BXD_11657,"Central nervous system, behavior: Fear conditioning response, activity after first tone-shock pairing for females [n beam breaks/30 sec test]"
BXD_11658,"Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for females [n beam breaks/30 sec test] 
"
BXD_11659,"Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for females [n beam breaks/30 sec test] "
BXD_11660,"Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for females [units]"
BXD_11661,"Central nervous system, behavior: Open field behavior,  percentage of distance in the center for females [%]"
BXD_11662,"Central nervous system, behavior: Open field behavior, percentage of time in center for females [%]"
BXD_11663,"Central nervous system, behavior: Open field behavior, time in corners for females [min]"
BXD_11664,"Central nervous system, behavior: Open field behavior, locomotion from 0-5 min for females [cm]"
BXD_11665,"Central nervous system, behavior: Open field behavior, locomotion from 10-15 min for females [cm]"
BXD_11666,"Central nervous system, behavior: Open field behavior, locomotion from 15-20 min for females [cm]"
BXD_11667,"Central nervous system, behavior: Open field behavior locomotion from 5-10 min for females [cm]"
BXD_11668,"Central nervous system, behavior: Open field activity, habituation ratio for females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]"
BXD_11669,"Central nervous system, behavior: Open field behavior, percentage time in perimeter minus time in corners  for females [%]"
BXD_11670,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-20 min for females [n beam breaks]"
BXD_11671,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-5 min for females [n beam breaks]"
BXD_11672,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 10-15 min for females [n beam breaks]"
BXD_11673,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 15-20 min for females [n beam breaks]"
BXD_11674,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 5-10 min for females [n beam breaks]"
BXD_11675,"Central nervous system, behavior: Open field behavior, locomotion for entire test period for females [cm]"
BXD_11676,"Central nervous system, behavior: Open field behavior, percentage distance in the perimeter for females [%]"
BXD_11677,"Central nervous system, behavior: Open field behavior, percentage of time in perimeter for females [%]"
BXD_11678,"Central nervous system, behavior: Startle response, baseline level for females [amplitude]"
BXD_11679,"Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11680,"Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11681,"Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11682,"Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11683,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11684,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11685,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]
"
BXD_11689,"Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for females [sec below threshold movement level]"
BXD_11690,"Central nervous system, behavior: Activity level, locomotion in zero maze for females [n beam breaks]"
BXD_11691,"Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for females [n]"
BXD_11692,"Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for females [n]"
BXD_11693,"Original post publication description: Latency to enter an open quadrant (anxiety assay) using a zero maze, for females [sec]"
BXD_11694,"Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for females [%]"
BXD_11695,"Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for females [sec]"
BXD_11696,"Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for females [sec]"
BXD_11697,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for females [cm]"
BXD_11698,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for females [cm]"
BXD_11699,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for females [cm]"
BXD_11700,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for females [cm]
"
BXD_11701,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for females [cm]"
BXD_11702,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for females [cm]"
BXD_11703,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for females [cm]"
BXD_11704,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for females [cm]"
BXD_11705,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for females [cm]"
BXD_11706,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for females [cm]"
BXD_11707,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for females [cm]"
BXD_11708,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for females [cm]"
BXD_11709,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for females [cm]"
BXD_11710,"Pharmacology, metabolism: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for females [mg/dl XX min after injection]"
BXD_11711,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for females [n]"
BXD_11712,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for females [n]"
BXD_11713,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for females [%]"
BXD_11714,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for females [%]"
BXD_11715,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for females [%]"
BXD_11716,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for females [%]"
BXD_11717,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for females [sec]"
BXD_11718,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for females [sec]"
BXD_11719,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for females [sec]"
BXD_11720,"Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for females [sec]"
BXD_11721,"Central nervous system, behavior: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for females [sec]"
BXD_11722,"Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for females [sec]"
BXD_11723,"Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for females [sec]"
BXD_11724,"Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for females [sec]"
BXD_11725,"Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for females [sec]"
BXD_11726,"Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [n beam breaks]"
BXD_11727,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [n beam breaks]"
BXD_11728,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [n beam breaks]"
BXD_11729,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [n beam breaks]"
BXD_11730,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [cm]"
BXD_11731,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [cm]"
BXD_11732,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [cm]"
BXD_11733,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [cm]"
BXD_11734,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for females [n beam breaks]"
BXD_11735,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for females [n beam breaks]"
BXD_11736,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for females [n beam breaks]"
BXD_11737,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for females [n beam breaks]"
BXD_11738,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11739,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11740,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11741,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11742,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for females [cm]"
BXD_11743,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for females [cm]"
BXD_11744,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for females [cm]"
BXD_11745,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for females [cm]"
BXD_11746,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11747,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11748,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11749,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for females [n beam breaks]"
BXD_11750,"Central nervous system, pharmacology, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for females [sec]"
BXD_11751,"Central nervous system, pharmacology, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for females [sec]"
BXD_11752,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for females [sec]"
BXD_11753,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for females [sec]"
BXD_11754,"Central nervous system, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for females [%]"
BXD_11755,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [sec]"
BXD_11756,"Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [% change]"
BXD_11757,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks]"
BXD_11758,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for females [cm]"
BXD_11759,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for females [n beam breaks]"
BXD_11760,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for females [n beam breaks]"
BXD_11761,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for females [cm]"
BXD_11762,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for females [n beam breaks]"
BXD_11763,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for females [n beam breaks]"
BXD_11764,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for females [n beam breaks]"
BXD_11765,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [n beam breaks]"
BXD_11766,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [n beam breaks]"
BXD_11767,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for females [cm]"
BXD_11768,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for females [cm]"
BXD_11769,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [cm]"
BXD_11770,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [cm]"
BXD_11771,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for females [n beam breaks]"
BXD_11772,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from15-30 min in the center for females [n beam breaks]"
BXD_11773,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for females [n beam breaks]"
BXD_11774,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for females [n beam breaks]"
BXD_11775,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the cocaine test battery [n beam breaks]"
BXD_11776,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the cocaine test battery [n beam breaks]"
BXD_11777,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the cocaine test battery [n beam breaks]"
BXD_11778,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the cocaine test battery [n beam breaks]"
BXD_11779,"Central nervous system, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for females in the cocaine test battery [cm]"
BXD_11780,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for females in the cocaine test battery [cm]"
BXD_11781,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for females in the cocaine test battery [cm]"
BXD_11782,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 45-60 min in the periphery  for females in the cocaine test battery [cm]"
BXD_11783,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for females [n beam breaks]"
BXD_11784,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for females [n beam breaks]"
BXD_11785,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for females [n beam breaks]"
BXD_11786,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for females [n beam breaks]"
BXD_11787,"Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for females [%]"
BXD_11788,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [n beam breaks]"
BXD_11789,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [cm]"
BXD_11790,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for females [n beam breaks]"
BXD_11791,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [n beam breaks]"
BXD_11792,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [cm]"
BXD_11793,"Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for females [n beam breaks/60 min]"
BXD_11794,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for females [difference in cm/1 hr test, positive values indicate sensitization]"
BXD_11795,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [n beam breaks, positive values indicate sensitization]"
BXD_11796,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [cm, positive values indicate sensitization]"
BXD_11797,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]"
BXD_11798,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [n beam breaks/15 min]"
BXD_11799,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [n beam breaks/15 min]"
BXD_11800,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [n beam breaks/15 min]"
BXD_11801,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [n beam breaks/15 min]"
BXD_11802,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [cm]"
BXD_11803,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [cm]"
BXD_11804,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [cm]"
BXD_11805,"Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [cm]"
BXD_11806,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for females [n beam breaks/15 min]"
BXD_11807,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for females [n beam breaks/15 min]"
BXD_11808,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for females [n beam breaks/15 min]"
BXD_11809,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for females [n beam breaks/15 min]"
BXD_11810,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]"
BXD_11811,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [cm]"
BXD_11812,"Central nervous system, pharmacology, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks]"
BXD_11813,"Central nervous systems, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult females [density]"
BXD_11814,Endocrinology: Adrenal weight (left) of females [mg]
BXD_11815,"Endocrinology, morphology: Adrenal weight (right) of females [mg]"
BXD_11816,"Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for males and females [mA]"
BXD_11817,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males and females [sec]"
BXD_11818,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males and females [sec]"
BXD_11819,"Central nervous system, behavior: Motor coordination, time on dowel over a 2 min baseline test period for males and females [sec]
"
BXD_11820,"Central nervous system, behavior: Depression assay, Porsolt behavioral despair test, time immobile for males and females [sec]"
BXD_11821,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, Hargreaves' test for males and females"
BXD_11822,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate test, average of two trials for males and females [sec]"
BXD_11823,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, mechanical nociception, tail clip latency for males and females [sec]"
BXD_11824,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, tail withdrawal latency for males and females [sec]"
BXD_11825,"Central nervous system, peripheral nervous system, skin, behavior: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males and females [force in mg]"
BXD_11826,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11827,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11828,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11829,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11830,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11831,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11832,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11833,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11834,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11835,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11836,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11837,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males and females [cm]"
BXD_11838,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males and females [cm]"
BXD_11839,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males and females [cm]"
BXD_11840,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males and females [cm]"
BXD_11841,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injections in an activity chamber for males and females [cm]"
BXD_11842,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males and females [cm]"
BXD_11843,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males and females [cm]"
BXD_11844,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males and females [cm]"
BXD_11845,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males and females [cm]"
BXD_11846,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males and females [cm]"
BXD_11847,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males and females [cm]"
BXD_11848,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males and females [ordinal scale, 0=no effect, 3=max]"
BXD_11849,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males and females [n fecal boli]"
BXD_11850,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males and females [n/15 min test]"
BXD_11851,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]"
BXD_11852,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [cm]"
BXD_11853,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males and females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference]"
BXD_11854,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks]"
BXD_11855,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [n beam breaks]"
BXD_11856,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the morphine test battery [n beam breaks]"
BXD_11857,"Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [n beam breaks]"
BXD_11858,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [n beam breaks]"
BXD_11859,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [cm]"
BXD_11860,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion locomotion in the periphery from 15-30 for males and females in the morphine test battery [cm]"
BXD_11861,"Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [cm]"
BXD_11862,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [cm]"
BXD_11863,"Central nervous system, behavior: Novel open field behavior,vertical activity (rears) from 0-15 min for males and females [n beam breaks]"
BXD_11864,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males and females [n beam breaks]"
BXD_11865,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from min 30-45 for males and females [n beam breaks]"
BXD_11866,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males and females [n beam breaks]"
BXD_11867,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]"
BXD_11868,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]"
BXD_11869,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males and females [n beam breaks]"
BXD_11870,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males and females [n beam breaks]"
BXD_11871,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males and females [cm]"
BXD_11872,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for males and females [n beam breaks]"
BXD_11873,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males and females [ordinal scale, 0=no effect, 3=max]"
BXD_11874,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males and females [ordinal scale, 0=no effect, 3=max]"
BXD_11875,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males and females [ordinal scale, 0=control level, 3=max]"
BXD_11876,"Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max]"
BXD_11877,"Central nervous system, behavior: Novel open field behavior, urinations for males and females [n/test period]"
BXD_11878,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11879,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11880,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11881,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11882,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11883,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11884,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11885,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11886,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11887,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11888,"Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males and females [n beam breaks]"
BXD_11889,"Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males and females [cm/90 min test]"
BXD_11890,"Central nervous system, behavior: Locomotor activity after first saline injection (day 1) for males and females (MDMA control) [cm/ test period]"
BXD_11891,"Central nervous system, behavior: Saline control response, locomotor activity after second injection for males and females (control for MDMA response experiment) [cm/test period]"
BXD_11892,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males and females [ordinal scale]"
BXD_11893,"Central nervous system, behavior, pharmacology: Ethanol response (4.0 g/kg i.p.), handling-induced convulsions (HIC) 6 hrs after injections for males and females [units]"
BXD_11894,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males and females [ordinal scale]"
BXD_11895,"Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males and females (0=no effect, 1=facial grimace during tail spin, 2=tonic convulsion during spin, 3=tonic-clonic convulsion during spin, 4= tonic convulsion on lift only, 5=tonic-clonic on lift only) [score]"
BXD_11896,"Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males and females [ordinal scale]"
BXD_11897,"Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate latency for males and females [sec]"
BXD_11898,"Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for males and females [cm]"
BXD_11899,"Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males and females [sec]"
BXD_11900,"Central nervous system, behavior: Locomotion in both compartments of a light-dark box for males and females [cm]"
BXD_11901,"Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males and females [cm]"
BXD_11902,"Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males and females [sec]"
BXD_11903,"Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males and females [%]"
BXD_11904,"Central nervous system, behavior: Anxiety assay, percentage time in light side of a light-dark box for males and females [%]"
BXD_11905,"Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males and females [n]"
BXD_11906,"Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context for males and females [units]"
BXD_11907,"Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for males and females [units]"
BXD_11908,"Central nervous system, behavior: Fear conditioning response, contextual activity for males and females [units]"
BXD_11909,"Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context during presentation of cue for males and females [units]"
BXD_11910,"Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males and females [units]"
BXD_11911,"Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males and females [units]"
BXD_11912,"Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males and females [units]"
BXD_11913,"Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males and females [units]"
BXD_11914,"Central nervous system, behavior, learning and memory: Fear conditioning response, activity after first tone-shock pairing for males and females [n beam breaks/30 sec test]"
BXD_11915,"Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males and females [n beam breaks/30 sec test]
"
BXD_11916,"Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males and females [n beam breaks/30 sec test] "
BXD_11917,"Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males and females [units]"
BXD_11918,"Central nervous system, behavior: Open field behavior, percentage of distance in the center for males and females [%]"
BXD_11919,"Central nervous system, behavior: Open field behavior, percentage of time in center for males and females [%]"
BXD_11920,"Central nervous system, behavior: Open field behavior, time in corners for males and females [min]"
BXD_11921,"Central nervous system, behavior: Open field behavior, locomotion from 0-5 min for males and females [cm]"
BXD_11922,"Central nervous system, behavior: Open field behavior, locomotion from 10-15 min for males and females [cm]"
BXD_11923,"Central nervous system, behavior: Open field behavior, locomotion from 15-20 min for males and females [cm]"
BXD_11924,"Central nervous system, behavior: Open field behavior, locomotion from 5-10 min for males and females [cm]"
BXD_11925,"Central nervous system, behavior: Open field activity, habituation ratio for males and females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks]"
BXD_11926,"Central nervous system, behavior: Open field behavior, percentage of time in perimeter minus time in corners for males and females [%]"
BXD_11927,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-20 min for males and females [n beam breaks]"
BXD_11928,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 0-5 min for males and females [n beam breaks]"
BXD_11929,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 10-15 min for males and females [n beam breaks]"
BXD_11930,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 15-20 min for males and females [n beam breaks]"
BXD_11931,"Central nervous system, behavior: Open field behavior, vertical activity (rears) from 5-10 min for males and females [n beam breaks]"
BXD_11932,"Central nervous system, behavior: Open field behavior, locomotion for entire test period for males and females [cm]"
BXD_11933,"Central nervous system, behavior: Open field behavior, percentage of distance in the perimeter for males and females [%]"
BXD_11934,"Central nervous system, behavior: Open field behavior, percentage of time in perimeter for males and females [%]"
BXD_11935,"Central nervous system, behavior: Startle response, baseline level for males and females [amplitude]"
BXD_11936,"Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11937,"Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11938,"Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11939,"Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force]"
BXD_11940,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11941,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11942,"Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition]"
BXD_11946,"Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males and females [sec below threshold movement level]"
BXD_11947,"Central nervous system, behavior: Locomotion in zero maze for males and females [n beam breaks]"
BXD_11948,"Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males and females [n]"
BXD_11949,"Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for males and females [n]"
BXD_11950,"Central nervous system, behavior: Anxiety assay, latency to enter an open quadrant of a zero maze for males and females [sec]"
BXD_11951,"Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for males and females [%]"
BXD_11952,"Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males and females [sec]"
BXD_11953,"Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males and females [sec]"
BXD_11954,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]"
BXD_11955,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males and females [cm]"
BXD_11956,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males and females [cm]"
BXD_11957,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males and females [cm]"
BXD_11958,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]"
BXD_11959,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males and females [cm]"
BXD_11960,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males and females [cm]"
BXD_11961,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males and females [cm]  "
BXD_11962,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males and females [cm]"
BXD_11963,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males and females [cm]"
BXD_11964,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males and females [cm]"
BXD_11965,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males and females [cm]"
BXD_11966,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males and females [cm]"
BXD_11967,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males and females [mg/dl XX min after injection]"
BXD_11968,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males and females [n]"
BXD_11969,"Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males and females [n]"
BXD_11970,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males and females [%]"
BXD_11971,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males and females [%]"
BXD_11972,"Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males and females [%]"
BXD_11973,"Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of plus maze for males and females [%]"
BXD_11974,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males females [sec]"
BXD_11975,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males and females [sec]"
BXD_11976,"Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec]"
BXD_11977,"Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males and females [sec]"
BXD_11978,"Central nervous system, behavior: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males and females [sec]"
BXD_11979,"Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for males and females [sec]"
BXD_11980,"Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males and females [sec]"
BXD_11981,"Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males and females [sec]"
BXD_11982,"Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for males and females [sec]"
BXD_11983,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [n beam breaks]"
BXD_11984,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [n beam breaks]"
BXD_11985,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [n beam breaks]"
BXD_11986,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [n beam breaks]"
BXD_11987,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [cm]"
BXD_11988,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [cm]"
BXD_11989,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [cm]"
BXD_11990,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [cm]"
BXD_11991,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males and females [n beam breaks]"
BXD_11992,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males and females [n beam breaks]"
BXD_11993,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males and females [n beam breaks]"
BXD_11994,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males and females [n beam breaks]"
BXD_11995,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_11996,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_11997,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_11998,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_11999,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males and females [cm]"
BXD_12000,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males and females [cm]"
BXD_12001,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males and females [cm]"
BXD_12002,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males and females [cm]"
BXD_12003,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_12004,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_12005,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_12006,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males and females [n beam breaks]"
BXD_12007,"Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males and females [sec]"
BXD_12008,"Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males and females [sec]"
BXD_12009,"Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on day 5 for males and females [sec]"
BXD_12010,"Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on day 5 for males and females [sec]"
BXD_12011,"Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males and females [%]"
BXD_12012,"Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [sec]"
BXD_12013,"Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [% change]"
BXD_12014,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks]"
BXD_12015,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm]"
BXD_12016,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males and females [n beam breaks]"
BXD_12017,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males and females [n beam breaks]"
BXD_12018,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males and females [cm]"
BXD_12019,"Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in the open field from 0-60 min after first cocaine injection for males and females [n beam breaks] "
BXD_12020,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [n beam breaks]"
BXD_12021,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [n beam breaks]"
BXD_12022,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [n beam breaks]"
BXD_12023,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [n beam breaks]"
BXD_12024,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [cm]"
BXD_12025,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [cm]"
BXD_12026,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [cm]"
BXD_12027,"Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [cm]"
BXD_12028,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males and females [n beam breaks]"
BXD_12029,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males and females [n beam breaks]"
BXD_12030,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males and females [n beam breaks]"
BXD_12031,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males and females [n beam breaks]"
BXD_12032,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12033,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12034,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12035,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12036,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males and females in the cocaine test battery [cm]"
BXD_12037,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for males and females in the cocaine test battery [cm]"
BXD_12038,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for males and females in the cocaine test battery [cm]"
BXD_12039,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 45-60 min in the periphery for males and females in the cocaine test battery [cm]"
BXD_12040,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males and females [n beam breaks]"
BXD_12041,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males and females [n beam breaks]"
BXD_12042,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males and females [n beam breaks]"
BXD_12043,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males and females [n beam breaks]"
BXD_12044,"Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males and females [%]"
BXD_12045,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [n beam breaks]"
BXD_12046,"Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [cm]"
BXD_12047,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males and females [n beam breaks]"
BXD_12048,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [n beam breaks]"
BXD_12049,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [cm]"
BXD_12050,"Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males and females [n beam breaks/60 min]"
BXD_12051,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males and females [difference in cm/1 hr test, positive values indicate sensitization]"
BXD_12052,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [n beam breaks, positive values indicate sensitization]"
BXD_12053,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [cm, positive values indicate sensitization]"
BXD_12054,"Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males and females between first and second injections [difference in n/1 hr test, positive values indicate sensitization]"
BXD_12055,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [n beam breaks/15 min]"
BXD_12056,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [n beam breaks/15 min]"
BXD_12057,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [n beam breaks/15 min]"
BXD_12058,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [n beam breaks/15 min]"
BXD_12059,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [cm]"
BXD_12060,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [cm]"
BXD_12061,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [cm]"
BXD_12062,"Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [cm]"
BXD_12063,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males and females [n beam breaks/15 min]"
BXD_12064,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males and females [n beam breaks/15 min]"
BXD_12065,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males and females [n beam breaks/15 min]"
BXD_12066,"Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males and females [n beam breaks/15 min]"
BXD_12067,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12068,"Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [cm]"
BXD_12069,"Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks]"
BXD_12070,"Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males and females [density]"
BXD_12071,"Endocrinology, morphology: Adrenal weight (left) of males and females [mg]"
BXD_12072,"Endocrinology, morphology: Adrenal weight (right) of males and females [mg]"
BXD_12073,"Metabolism, blood chemistry: Albumin-to-creatinine ratio  (ABR) baseline control in males at 10-12 weeks of age [ratio of ug/mg]"
BXD_12226,"Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cell density in glomerular sections in males (8-20 wks of age) [WT1-positive cell number per 1000 um2 glomerular area]"
BXD_12227,"Urogenital system, kidney, morphology: Podocytes per glomerulus in males (8-20 wks) [number per glomerulus in cross sectioned material]"
BXD_12228,"Urogenital system, kidney, morphology: Glomerular section area (GSA) in glomeruli of males (8-20 wks of age) [um^2]"
BXD_12229,"Urogenital system, kidney, morphology: Kidney weight of males at 8-20 wk [mg] "
BXD_12230,"Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cells per glomerular section in males (8-20 wks of age) [WT1-positive cells/glomerular section]"
BXD_12231,"Urogenital system, kidney, morphology: Kidney weight/body weight ratio in males (8 - 20 wks) [mg/g]"
BXD_12232,"Urogenital system, kidney, morphology: Glomerular cells per glomerular section in males (8 to 20 weeks of age) [cell density]"
BXD_12296,"Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for 0.1 M sucrose over 20 min (Davis MS160 lickometer), male and female adults [mSec]"
BXD_12297,"Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for water over 20 min (Davis MS160 lickometer), male and female adults [mSec]"
BXD_12300,"Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg]"
BXD_12303,"Eye, visual system, physiology: Intraocular pressure (IOP), 3 to 5 months old, both sexes, average of left and right eyes [mmHg]"
BXD_12306,"Eye, visual system, physiology: Intraocular pressure (IOP), 6 to 9 months old, both sexes, average of left and right eyes [mmHg]"
BXD_12309,"Eye, visual system, physiology: Intraocular pressure (IOP), 10 to 13 months old, both sexes, average of left and right eyes [mmHg]"
BXD_12312,"Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes [mmHg]"
BXD_12315,"Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes [mmHg]"
BXD_12318,"Eye, visual system: Iris pigmentation at 1-2 months in males and females  [ordinal scale, 0=full pigmentation, 4=light]"
BXD_12321,"Eye, visual system: Iris pigmentation at 3-5 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed]"
BXD_12324,"Eye, visual system: Iris pigmentation at 6-9 months, males and females [ordinal score, 0=normal, 4=light, dispersed]"
BXD_12327,"Eye, visual system: Iris pigmentation score at 10-13 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed]"
BXD_12330,"Eye, visual system, aging: Iris pigmentation score in old males and females (>13 months) [ordinal scale, 0=full pigmentation, 4=light, dispersed]"
BXD_12333,"Eye, visual system: Iris pigmentation (all ages) [ordinal scale, 0=pigmented, 4=light, dispersed]"
BXD_12334,"Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width in males [um]
"
BXD_12335,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]"
BXD_12336,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]"
BXD_12337,"Central nervous system, pharmacology, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]"
BXD_12338,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]"
BXD_12339,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]"
BXD_12340,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]"
BXD_12341,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]"
BXD_12342,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]"
BXD_12343,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]"
BXD_12344,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]"
BXD_12345,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]"
BXD_12346,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]"
BXD_12347,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]"
BXD_12348,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]"
BXD_12349,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]"
BXD_12350,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]"
BXD_12351,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]"
BXD_12352,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]"
BXD_12353,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]"
BXD_12354,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]"
BXD_12355,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]"
BXD_12356,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]"
BXD_12357,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]"
BXD_12358,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]"
BXD_12359,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]"
BXD_12360,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]"
BXD_12361,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]"
BXD_12362,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]"
BXD_12363,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]"
BXD_12364,"Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]"
BXD_12365,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]"
BXD_12366,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during first 5 min [% time]"
BXD_12367,"Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [% time]"
BXD_12368,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during whole 10 min test [% time]"
BXD_12369,"Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]"
BXD_12370,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]"
BXD_12371,"Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]"
BXD_12372,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]"
BXD_12373,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]"
BXD_12374,"Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated (1.8 g/kg ip) (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]"
BXD_12375,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]"
BXD_12376,"Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time]"
BXD_12377,"Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time]"
BXD_12378,"Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time]"
BXD_12379,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]"
BXD_12380,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]"
BXD_12381,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]"
BXD_12382,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]"
BXD_12383,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min (winsorized DBA/2J, BXD65b, BXD89 BXD102 from 12.7, 25.3, 53.1, and 76.7) [beam breaks/sec]"
BXD_12384,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]"
BXD_12385,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]"
BXD_12386,"Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]"
BXD_12387,"Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time]"
BXD_12388,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]"
BXD_12389,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]"
BXD_12390,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]"
BXD_12391,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]"
BXD_12392,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]"
BXD_12393,"Central nervous system, pharmacology, behavior: Ethanol response (1.8 g/kg ip), anxiety assay in ethanol-treated (NOE) group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks/sec]"
BXD_12394,"Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min (BXD102 winterized from 21.008 +-19.93 to 3.0 and BXD89 from 5.397 +-3.844 to 2.9)  [beam breaks/sec]"
BXD_12395,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]"
BXD_12396,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]"
BXD_12397,"Central nervous system, behavior: Anxiety assay, saline treated (0.18 ml/kg ip, NOS group), time in open quadrants only during last 5 min of test using an elevated zero maze for 60- to 120-day-old females [%]"
BXD_12398,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]"
BXD_12399,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]"
BXD_12400,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]"
BXD_12401,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]"
BXD_12402,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]"
BXD_12403,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]"
BXD_12404,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]"
BXD_12405,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]"
BXD_12406,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]"
BXD_12407,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]"
BXD_12408,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]"
BXD_12409,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]"
BXD_12410,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]"
BXD_12411,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]"
BXD_12412,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]"
BXD_12413,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]"
BXD_12414,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]"
BXD_12415,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]"
BXD_12416,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]"
BXD_12417,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]"
BXD_12418,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]"
BXD_12419,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]"
BXD_12420,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]"
BXD_12421,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]"
BXD_12422,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]"
BXD_12423,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]"
BXD_12424,"Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]"
BXD_12425,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]"
BXD_12426,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [% time]"
BXD_12427,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [% time]"
BXD_12428,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]"
BXD_12429,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]"
BXD_12430,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]"
BXD_12431,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]"
BXD_12432,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip)(RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks/sec]"
BXD_12433,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]"
BXD_12434,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg ip] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females over 10 min [beam breaks/sec]"
BXD_12435,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]"
BXD_12436,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time]"
BXD_12437,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time]"
BXD_12438,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time]"
BXD_12439,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]"
BXD_12440,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]"
BXD_12441,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]"
BXD_12442,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks/sec]"
BXD_12443,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min (data for BXD77 (4.463 +/- 3.288) deleted by RWW) [beam breaks/sec]"
BXD_12444,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]"
BXD_12445,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]"
BXD_12446,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [% time]"
BXD_12447,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time]"
BXD_12448,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [% time]"
BXD_12449,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]"
BXD_12450,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]"
BXD_12451,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]"
BXD_12452,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]"
BXD_12453,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]"
BXD_12454,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min  (BXD11 (16.419 ) and BXD77 (46.897)  data deleted by RWW) [beam breaks/sec]"
BXD_12455,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec]"
BXD_12456,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time]"
BXD_12457,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time]"
BXD_12458,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time]"
BXD_12459,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks]"
BXD_12460,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks]"
BXD_12461,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks]"
BXD_12462,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec]"
BXD_12463,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [0.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec]"
BXD_12464,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec]"
BXD_12465,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec]"
BXD_12466,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time]"
BXD_12467,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time]"
BXD_12468,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time]"
BXD_12469,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) for RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks]"
BXD_12470,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks]"
BXD_12471,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks]"
BXD_12472,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec]"
BXD_12473,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec]"
BXD_12474,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec]"
BXD_12475,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec]"
BXD_12476,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time]"
BXD_12477,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time]"
BXD_12478,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time]"
BXD_12479,"Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) in the RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks]"
BXD_12480,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks]"
BXD_12481,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks]"
BXD_12482,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec]"
BXD_12483,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec]"
BXD_12484,"Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec]"
BXD_12485,"Central nervous system, morphology: Cerebellar Purkinje cell number, with Abercrombie correction, for male and females between 30 and 150-days-of-age [n x1000]
"
BXD_12486,"Central nervous system, pharmacology, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 3 ppm Fe diet [Âµg/g]"
BXD_12487,"Central nervous system, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 3 ppm Fe diet [Âµg/g]"
BXD_12488,"Immune system, morphology, nutrition: Spleen weight of 120-day-old females fed 3 ppm Fe diet [g]"
BXD_12489,"Immune system, morphology, nutrition: Iron level in spleen of 120-day-old females fed 3 ppm Fe diet  [Âµg/g]"
BXD_12490,"Liver, morphology, nutrition: Iron level of liver of 120-day-old females fed 3 ppm Fe diet  [Âµg/g]"
BXD_12491,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 3 ppm iron (Fe) diet [ug/dl]"
BXD_12492,"Blood chemistry, cardiovascular system, nutrition: Hematocrit of 120-day-old females fed 3 parts per million iron (ppm Fe) diet  [% packed red blood cells]"
BXD_12493,"Morphology, nutrition: Body weight of 120-day-old females fed 3 ppm Fe diet [g]"
BXD_12494,"Central nervous system, metabolism, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 3 ppm Fe diet [Âµg/g]"
BXD_12495,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in males fed 3 ppm Fe diet [Âµg/g]"
BXD_12496,"Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 3 ppm Fe diet [g]"
BXD_12497,"Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males fed 3 ppm Fe diet [Âµg/g]"
BXD_12498,"Liver, metabolism, nutrition: Iron level of liver of 120-day-old males fed 3 ppm Fe diet [Âµg/g]"
BXD_12499,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males fed 3 ppm Fe diet  [Âµg/dl]"
BXD_12500,"Blood chemistry, cardiovascular system, nutrition: Hematocrit of 120-day-old males fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells]"
BXD_12501,"Morphology, nutrition: Body weight of 120-day-old males fed 3 ppm Fe diet [g]"
BXD_12502,"Central nervous system, metabolism, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 270 ppm Fe diet [Âµg/g]"
BXD_12503,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 270 ppm Fe diet [Âµg/g]"
BXD_12504,"Immune system, morphology, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g]"
BXD_12505,"Immune system, morphology, nutrition: Iron level in spleen of 120-day-old females fed 270 ppm Fe diet  [Âµg/g]"
BXD_12506,"Liver, metabolism, nutrition: Iron level in liver of 120-day-old females fed 270 ppm Fe diet [Âµg/g]"
BXD_12507,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 270 ppm Fe diet  [Âµg/dl]"
BXD_12508,"Blood chemistry, cardiovascular system, nutrition: Hematocrit of 120-day-old females fed 270 parts per million iron (ppm Fe) diet  [% packed red blood cells]"
BXD_12509,"Morphology, nutrition: Body weight of 120-day-old females fed 270 ppm Fe diet [g]"
BXD_12510,"Central nervous system, metabolism, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 270 ppm Fe diet [Âµg/g]"
BXD_12511,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in males fed 270 ppm Fe diet [Âµg/g]"
BXD_12512,"Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g]"
BXD_12513,"Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males fed 270 ppm Fe diet [Âµg/g]"
BXD_12514,"Liver, metabolism, nutrition: Iron level of liver of 120-day-old males fed 270 ppm Fe diet  [Âµg/g]"
BXD_12515,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males fed 270 ppm Fe diet  [Âµg/dl]"
BXD_12516,"Blood chemistry, cardiovascular system, nutrition: Hematocrit of 120-day-old males fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells]"
BXD_12517,Body weight of 120-day-old males fed 270 ppm Fe diet [g]
BXD_12518,"Central nervous system, metabolism, nutrition: Iron level in caudate-putamen of 120-day-old males and females fed 3 ppm Fe diet [Âµg/g]"
BXD_12519,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old males and females fed 3 ppm Fe diet [Âµg/g]"
BXD_12520,"Immune system, morphology, nutrition: Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g]"
BXD_12521,"Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [Âµg/g]"
BXD_12522,"Liver, metabolism, nutrition: Iron level of liver of 120-day-old males and females fed 3 ppm Fe diet  [Âµg/g]"
BXD_12523,"Blood chemistry, nutrition: Transferrin saturation in plasma of 120-day-old males and females fed 3 ppm Fe diet [%]"
BXD_12524,"Blood chemistry, nutrition: Iron binding capacity (total) in plasma of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]"
BXD_12525,"Blood chemistry, nutrition: Iron level of plasma of 120-day-old males and females fed 3 ppm Fe diet [Âµg/dl]"
BXD_12526,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 3 ppm Fe diet [ug/dl]"
BXD_12527,"Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet  [% packed red blood cells]"
BXD_12528,"Morphology, nutrition: Body weight of 120-day-old males and females fed 3 ppm Fe diet [g]"
BXD_12529,"Central nervous system, metabolism, nutrition: Iron level in caudate-putamen of 120-day-old males and females fed 270 ppm Fe diet [Âµg/g]"
BXD_12530,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in males and females fed 270 ppm Fe diet [Âµg/g]"
BXD_12531,"Immune system, morphology, nutrition: Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g]"
BXD_12532,"Immune system, metabolism, nutrition: Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [Âµg/g]"
BXD_12533,"Liver, metabolism, nutrition: Iron level of liver of 120-day-old males and females fed 270 ppm Fe diet  [Âµg/g]"
BXD_12534,"Blood chemistry, metabolism, nutrition: Transferrin saturation in plasma of 120-day-old males and females fed 270 ppm Fe diet [%]"
BXD_12535,"Blood chemistry, metabolism, nutrition: Iron binding capacity (total) in plasma of 120-day-old males and females fed 270 ppm Fe diet [ug/dl]"
BXD_12536,"Blood chemistry, metabolism, nutrition: Iron level of plasma of 120-day-old males and females fed 270 ppm Fe diet [Âµg/dl]"
BXD_12537,"Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 270 ppm Fe diet  [Âµg/dl]"
BXD_12538,"Blood chemistry, cardiovascular system, nutrition: Hematocrit of 120-day-old males and females fed 270 parts per million iron (ppm Fe) diet  [% packed red blood cells]"
BXD_12539,"Morphology, nutrition: Body weight of 120-day-old males and females fed 270 ppm Fe diet [g]"
BXD_12540,"Blood chemistry, metabolism, nutrition: Transferrin saturation  of 120-day-old females fed 3 ppm iron diet [%]"
BXD_12541,"Blood chemistry, cardiovascular system, nutrition: Iron binding capacity in plasma of 120-day-old females fed 3 ppm iron diet [Âµg/dL]"
BXD_12542,"Blood chemistry, nutrition: Iron level of plasma of 120-day-old females fed 3 ppm Fe diet [ug/dL]"
BXD_12543,"Blood chemistry, metabolism, nutrition: Transferrin saturation  of 120-day-old males fed 3 ppm iron diet [%]"
BXD_12544,"Blood chemistry, metabolism, nutrition: Iron binding capacity in plasma of 120-day-old males fed 3 ppm iron diet [Âµg/dL]"
BXD_12545,"Blood chemistry, metabolism, nutrition: Plasma iron of 120-day-old males fed 3 ppm iron (Fe) diet [ug/dL]"
BXD_12546,"Blood chemistry, metabolism, nutrition: Transferrin saturation  of 120-day-old females fed 270 ppm iron diet [%]"
BXD_12547,"Blood chemistry, metabolism, nutrition: Iron binding capacity in plasma of 120-day-old females fed 270 ppm iron diet [Âµg/dL]"
BXD_12548,"Blood chemistry, metabolism, nutrition: Plasma iron of 120-day-old females fed 270 ppm iron diet [ug/dL]"
BXD_12549,"Blood chemistry, metabolism, nutrition: Transferrin saturation  of 120-day-old males fed 270 ppm iron diet [%]"
BXD_12550,"Blood chemistry, nutrition: Iron binding capacity in plasma of 120-day-old males fed 270 ppm iron diet [Âµg/dL]"
BXD_12551,"Blood chemistry, metabolism, nutrition: Plasma iron of 120-day-old males fed 270 ppm iron diet [ug/dL]"
BXD_12553,"Central nervous system, gene expression: Cart gene mRNA expression level in hypothalamus [relative concentration by qt RT-PCR cycle count]"
BXD_12554,"Central nervous system, behavior: Depression assay, duration of immobility during trial 1 of a tail suspension test (TST) using a 20% mobility threshold over a 5 min test for males [sec]"
BXD_12555,"Endocrinology, neuroendocrine system, morphology: Adrenal medulla width [um]"
BXD_12556,"Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width [um]"
BXD_12557,"Central nervous system, gene expression: Neurexin 1 (Nrxn1) expression in hippocampus, first principal component generated using all coding exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]"
BXD_12558,"Musculoskeletal system, morphology: Diaphysis bone density of tibia of females at 4 months measured by micro computed tomography (microCT) (ImTek MicroCAT II, 2005) [mg/cc]"
BXD_12560,"Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [percent]"
BXD_12561,"Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [slope]"
BXD_12562,"Infectious disease, immune system: Survival after Francisella tularensis live vaccine strain (FTLVS) intratracheal [coefficient]"
BXD_12563,"Aging: Lifespan, longevity of males on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=116 days and BXD31=434 days are deleted outliers)"
BXD_12564,"Aging: Lifespan, longevity of females on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=158 days and BXD31=264 days are deleted outliers)"
BXD_12565,"Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily preference ratio, two-bottle choice in males and females [EtOH/water ratio]"
BXD_12566,"Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]
"
BXD_12567,"Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after saline control injection (ip) in adult males [ng/g]"
BXD_12568,"Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after saline control injection (ip) in adult males [ng/g]"
BXD_12569,"Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g]"
BXD_12574,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 6th week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12575,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 5th week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12576,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 4th week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12577,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 3rd week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12578,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 2nd week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12579,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 1st week average, young adult male or female (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12580,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol using a two-bottle choice systems (ethanol vs water), 2 h access, principal component 1 eigentrait (similar to residuals) based on weeks 1 through 6 data (Dec 2009 Cohort 1) [log g/kg/2h] "
BXD_12584,"Endocrinology: Thyroxine (T4), free level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ng/dL]
"
BXD_12585,"Endocrinology: Thyroxine (T4), total level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ug/dL]"
BXD_12586,"Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily consumption, two-bottle choice, males and females [g/kg]"
BXD_12587,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total without IMF (hilus + SMF) [mm^3]"
BXD_12588,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, infrapyramidal (IMF) [mm^3]"
BXD_12589,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal (SMF) [mm^3]"
BXD_12590,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, hilus [mm^3]"
BXD_12591,"Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total (hilus + IMF + SMF) [mm^3]"
BXD_12592,"Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per unit glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]"
BXD_12593,"Urogenital system, kidney, morphology: Kidney morphology, total glomerular cell count per glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2]"
BXD_12594,"Urogenital system, kidney, morphology: Kidney morphology, podocyte (WT1-positive cells) count per glomerular section following longterm diabetes (streptozotocin treatment) [n]"
BXD_12595,"Urogenital system, kidney, morphology: Kidney morphology, glomerular surface area following longterm diabetes (streptozotocin treatment) [1000 um2]"
BXD_12596,"Urogenital system, kidney, morphology: WT1-negative cell count per glomerular section following longterm diabetes (streptozotocin treatment)  [units]"
BXD_12597,"Urogenital system, kidney, morphology: Kidney, total glomerular cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units]"
BXD_12598,"Urogenital system, kidney, morphology: Wilm's tumor 1 (WT1) -negative cells per glomerular surface area in longterm diabetes [n/1000 um2]"
BXD_12599,"Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per 1000 um2 [units]"
BXD_12600,"Urogenital system, kidney, morphology: Kidney morphology, podocytes (WT1-positive cells) per glomerular section, 6 months after induction of type I diabetes by streptozotocin treatment [n/section] "
BXD_12601,"Central nervous system, behavior: Central motor pattern generator, lick count for water over 20 minutes (MS160 lickometer), male and female adults [n/20 min]"
BXD_12602,"Central nervous system, behavior: Central motor pattern generation, lick count for 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [n/20 min]"
BXD_12603,"Immune system, cardiovascular system: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio]"
BXD_12604,"Central nervous system, behavior: Central motor pattern generation (CPG), volume per lick, water over 20 min (MS160 lickometer), male and female adults [ul]"
BXD_12605,"Central nervous system, behavior: Central motor pattern generation, volume per lick, 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [ul]"
BXD_12621,"Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, last two coding exons and entire 3' UTR, whole brain [normalized RNA-seq counts] "
BXD_12622,"Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, distal 3' UTR, whole brain [normalized RNA-seq counts] "
BXD_12623,"Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water) average daily consumption, two bottle choice [g/kg], males"
BXD_12624,"Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water), average daily consumption using two-bottle choice method in females [g/kg]"
BXD_12631,"Central nervous system, behavior, pharmacology: Anxiety assay (E5_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]"
BXD_12632,"Central nervous system, pharmacology, behavior: Anxiety assay (E5_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [%]"
BXD_12633,"Central nervous system, behavior, pharmacology: Anxiety assay (E5_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]."
BXD_12634,"Central nervous system, pharmacology, behavior: Anxiety assay (E5_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [sec]"
BXD_12635,"Central nervous system, pharmacology, behavior: Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]."
BXD_12636,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [%]"
BXD_12637,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]"
BXD_12638,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]"
BXD_12639,"Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %]"
BXD_12640,"Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]."
BXD_12641,"Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %]."
BXD_12642,"Central nervous system, behavior, pharmacology: Anxiety assay (S5_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]."
BXD_12643,"Central nervous system, behavior, pharmacology: Anxiety assay (S5_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec]."
BXD_12644,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTR), percent time spent without locomotion in the light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during 10 min test [n %]"
BXD_12645,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %]."
BXD_12646,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]"
BXD_12647,"Central nervous system, pharmacology, behavior: Anxiety assay (S10_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]."
BXD_12659,"Central nervous system, morphology: Brain weight, corrected only for dissection error (modified Feb2015 with new data for BXD79, from 374.017 to 432.7+/-10 ) [mg]  "
BXD_12660,"Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, corrected only for initial dissection errors [mg]"
BXD_12661,"Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight and for dissection error (Hager et al., 2012) [mg]

Brain weight data (Trait Data and N per straine and SE) for 18 strains (BXD113 and above) added March 2019 by Casey Chapman using data collected from the BXD CITG colony at UTHSC from 2016-2017. "
BXD_12662,"Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, and dissection error [mg]"
BXD_12663,"Gastrointestinal system, morphology: Small intestine length, statistically adjusted for variation in sex and age [cm]"
BXD_12664,"Gastrointestinal system, morphology: small intestine length, without statistical adjustment [cm]"
BXD_12667,"Infectious disease, immune system: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit]"
BXD_12668,"Infectious disease, immune system: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.8 is all animals present with lesions]"
BXD_12669,"Infectious disease, immune system: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid unpredictable death]"
BXD_12670,"Infectious disease, immune system: Ectromelia virus measure of disease onset, day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.83 is early onset (before day 8) and 0.9 is late onset (<11 days)[residual days]"
BXD_12671,"Infectious disease, immune system: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.93 is unaffected animal to 0.65 is severe disease]"
BXD_12672,"Infectious disease, immune system: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit]"
BXD_12673,"Infectious disease, immune system: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.3 is where no lesions present on animals and 0.7 is where all animals present with lesions]"
BXD_12674,"Infectious disease, immune system: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -1.1 is unaffected animal to 1.2 is severe disease]"
BXD_12675,"Infectious disease, immune system: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body [scaled days where -1.1 is >8 days and 0.96 is <11 days]"
BXD_12676,"Infectious disease, immune system: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit]"
BXD_12677,"Infectious disease, immune system: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body  [ordinal scale where -0.5 = relatively unaffected and +0.5 is most severe disease] "
BXD_12678,"Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.40 is early onset (6 days) and +0.5 is late onset (>10 days)]"
BXD_12679,"Infectious disease, immune system: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >34.5 and 0.5 is <38]"
BXD_12680,"Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.6 is >5 days and 0.6 is <10 days]"
BXD_12681,"Infectious disease, immune system: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % loss where -0.6 = minimal weight loss of 3% and +0.7 is maximal weight loss of 34%]"
BXD_12682,"Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days in which -0.8 is >5 days and 1.7 is <13 days]
"
BXD_12683,"Infectious disease, immune system: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale]"
BXD_12684,Radiation biology: Rad6.5 (contact Ryan Yates at cyates4@uthsc.edu)
BXD_12685,"Morphology: Body weight, statistically adjusted for variation in sex and age, and corrected for pregnancy (Hager et al., 2012) [g]"
BXD_12686,Morphology: Body weight (no statistical adjustment) [g]
BXD_12687,"Infectious disease, immune system: Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days]"
BXD_12688,"Genetics, statistics, cofactors: BXD epoch or phase of production trait 1 [-1 = Taylor BXD series BXD1 to 32, 0 = Taylor series BXD33 to 42, 1 = UTHSC BXD series BXD43 and higher]"
BXD_12689,"Genetics, statistics, cofactors: BXD epoch or phase of production trait 2 [-1 = Taylor BXD series BXD1 to 42, 1 = UTHSC BXD series BXD43 and higher]"
BXD_12690,"Genetics, statistics, cofactors: BXD epoch or phase of production trait 3 [-1 = Taylor BXD series BXD1 to 32, 1 = Taylor series BXD33 to 42 and all UTHSC BXD series BXD43 and higher]"
BXD_12702,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control]"
BXD_12703,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), parasite burden in feet 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12704,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12705,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), granulocyte colony-stimulating factor (G-CSF, CSF3, Chr 11 at 98.6 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control]"
BXD_12706,"Infectious disease, immune system: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [% of C57BL/6 control]"
BXD_12707,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12708,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), interleukin-1 beta level (IL1B, Chr 2 at 129 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control]"
BXD_12709,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12710,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12711,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12712,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12713,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12714,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12715,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12716,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12717,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12718,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12719,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), chemokine (C-X-C motif) ligand 1 level (CXCL1, KC, Chr 5 at 91 Mb) from draining lymph node 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12720,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12721,"Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), monocyte chemoattractant protein-1 (MCP1) level from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]"
BXD_12723,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12724,"Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), macrophage inflammatory protein-1 beta (MIP1B) from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control]"
BXD_12725,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12726,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12727,"Infectious disease, immune system, protein: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), tumor necrosis factor alpha level (TNFA, Chr 17 at 35 Mb) from draining lymph node 3 weeks post infection in females using Luminex assay [% of C57BL/6 control]"
BXD_12728,"Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), vascular endothelial growth factor (VEGF) level from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control]"
BXD_12730,"Central nervous system, behavior, learning and memory: Learning speed, initial acquisition of task, trials to criterion in naive 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]"
BXD_12731,"Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, trials to criterion after acquisition in 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n]"
BXD_12732,"Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, residual trials to criterion after acquisition in 4-month adult males corrected for variation in acquisition learning (Med Associates nose poke chamber) [residual n]"
BXD_12733,"Central nervous system, pharmacology, behavior: Ethanol response (10% v/v ethanol), average daily consumption at 2 hr, males and females combined [g/kg]"
BXD_12735,"Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP, allopregnanolone) level in the olfactory bulb and tubercle 6 hrs after saline injection, afternoon sample collection (control for dexamethasone injection) [pg/g] "
BXD_12736,"Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP) level in the olfactory bulb and tubercle 1 hrs after saline injection, morning sample collection (control for ethanol experiments) [pg/g] "
BXD_12737,"Central nervous system, pharmacology, endocrinology: 3a,5a-pregnane-3a,21-diol-20-one (THDOC) level in the olfactory bulb and tubercle 1 hour after saline injection, morning sample collection (control for dexamethasone injection) in young adult males [pg/g]"
BXD_12738,"Endocrinology: Pregnenolone levels X hrs after saline injection, XX sample collection (preliminary) [pg/g] "
BXD_12741,"Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 4th cycle of ethanol vapor chamber treatment, young adult male or female (Dec 2009 Cohort 1) [% change from baseline]"
BXD_12742,"Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 3rd cycle of ethanol vapor chamber treatment, young adult male or female (Dec 2009 Cohort 1) [% change from baseline]"
BXD_12743,"Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 2nd cycle of ethanol vapor chamber treatment, young adult male or female  (Dec 2009 Cohort 1) [% change from baseline]"
BXD_12744,"Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 1st cycle of ethanol vapor chamber treatment, young adult male or female (Dec 2009 Cohort 1) [% change from baseline]"
BXD_12745,"Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), baseline consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 before any ethanol vapor chamber treatments (control consumption), young adult male or female (Dec 2009 Cohort 1) [g/kg]"
BXD_12747,"Reproduction, urogenital system, morphology: Uterus and ovary  weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]"
BXD_12748,"Reproduction, urogenital system, morphology: Uterus weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg]"
BXD_12749,"Reproduction, urogenital system, morphology: Uterus horn length at maturity (average of right and left sides), unadjusted for body weight, age, or parity [mg]"
BXD_12750,"Reproduction, urogenital system, morphology: Uterus body length, unadjusted for body weight, age, or parity [cm]"
BXD_12751,"Reproduction, urogenital system, morphology: Uterus body width at maturity, unadjusted for body weight, age, or parity [cm]"
BXD_12752,"Reproduction, urogenital system, morphology: Ovary weight at maturity, unilateral (average of right and left), unadjusted for body weight, age, or parity [mg]"
BXD_12753,"Central nervous system, behavior: Distance in open field in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male and female wildtype cases [cm]"
BXD_12754,"Central nervous system, behavior: Distance in open field  in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male and female R6/2 cases [cm]"
BXD_12755,"Central nervous system, behavior: Locomotion, difference in distance traveled, R6/2 versus wildtype (WT), in an open field test in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington [% WT]"
BXD_12756,"Central nervous system, behavior: Rearing in open field in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, wildtype cases [n vertical beam breaks]"
BXD_12757,"Central nervous system, behavior: Rearing in open field in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male and female R6/2 cases [n vertical beam breaks]"
BXD_12758,"Central nervous system, behavior: Rearing difference in an open field test between 8-week-old R6/2 and wildtype cases (males and females) [% WT]"
BXD_12759,"Central nervous system, behavior: Rotarod time on Day 2 in 8-week-old wildtype males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [sec]"
BXD_12760,"Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in an open field test in 8-week old males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington), wildtype cases [ratio]"
BXD_12761,"Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in an open field test in 8-week-old males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington), R6/2 cases only [ratio]"
BXD_12762,"Central nervous system, behavior: Anxiety difference between R6/2 and wildtype as measured by center-distance ratio in an open field test in 8-week-old males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [% of WT]"
BXD_12763,"Central nervous system, behavior: Rotarod time on Day 2 in 8-week-old males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington), R6/2 cases [sec]"
BXD_12764,"Central nervous system, behavior: Rotarod time difference on Day 2 between R6/2 and wildtype in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington [% WT]"
BXD_12765,"Central nervous system, behavior: Body weight in 8-week-old male and female wildtype (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [gm]"
BXD_12766,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, R6/2 cases only [gm]"
BXD_12767,"Central nervous system, behavior: Body weight difference in 8-week R6/2 versus wildtype males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [% wildtype]"
BXD_12768,"Central nervous system, behavior: Acoustic startle response (ASR) in 8-week-old wildtype cases (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [ordinal intensity]"
BXD_12769,"Central nervous system, behavior: Acoustic startle response (ASR) in 8-week-old R6/2 males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [ordinal intensity]"
BXD_12770,"Central nervous system, behavior: Acoustic startle response (ASR) difference between R6/2 and wildtype 8-week-old males and females (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [% of WT]"
BXD_12771,"Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition at 4, 8, and 12 dB above background in 8 week old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male and female wildtype (WT) [%]"
BXD_12772,"Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition at 4, 8, and 12 dB above background in 8-week-old male R6/2 heterozygous carriers (F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington) [%]"
BXD_12773,"Central nervous system, behavior: Prepulse inhibition (PPI) reduction in R6/2 compared to wildtype (WT) control, averaged at 4, 8, and 12 dB above background, in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington [%]"
BXD_12774,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]"
BXD_12775,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]"
BXD_12776,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]"
BXD_12777,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]"
BXD_12778,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]"
BXD_12779,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec]"
BXD_12780,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid (DOPAC) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] "
BXD_12781,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine (NE) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] "
BXD_12782,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), dopamine (DA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] "
BXD_12783,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12784,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] "
BXD_12785,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] "
BXD_12786,"Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12787,"Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12788,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid (5-HIAA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12789,"Central nervous system, pharmacology: Control for ethanol response, homovanilic acid (HVA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12790,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12791,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine levels (NE) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12792,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid levels (DOPAC) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12793,Sep_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136
BXD_12794,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxyindoleacetic acid levels (5-HIAA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12795,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12796,Sep_E_5HT [ng/mg]
BXD_12797,"Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12798,"Central nervous system, pharmacology: Ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC, a dopamine metabolite) in the medial septal nucleus 72 h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 15 to 17 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12799,"Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12800,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in the medial septal nucleus 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12801,"Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12802,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12803,"Central nervous system, pharmacology: Ethanol response (chronic intermittent vapor exposure CIE), norepinephrine (NE) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12804,BrS_E_Dopac [ng/mg]
BXD_12805,"Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), dopamine level in hindbrain tissue 72h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12806,"Central nervous system, pharmacology: Ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12807,"Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), homovanillic (HVA) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12808,"Central nervous system, pharmacology: Ethanol response, 5-hydroxytrptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12809,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12810,"Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12811,"Central nervous system, pharmacology: Control for ethanol response, dopamine levels (DA) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12812,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12813,"Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA, a dopamine metabolite) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12814,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12815,"Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg]"
BXD_12816,"Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access, 3 days after 1st cycle of ethanol vapor chamber treatment, young adult male or female (Dec 2009 Cohort 1) [% from baseline]"
BXD_12817,"Central nervous system, pharmacology, behavior: Ethanol response, ethanol consumption using a 2-bottle choice with 2 h access/day from day 3 to day 8 after the fourth cycle of treatment in a chronic intermittent ethanol vapor chamber (CIE) [g/kg/2h/day]"
BXD_12819,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-weeK-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]"
BXD_12820,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]"
BXD_12821,Blood chemistry: Alpha-amylase of 14-week old females [U/l]
BXD_12822,"Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old females [U/L]"
BXD_12823,Blood chemistry: Albumin of 14-week old females [g/l]
BXD_12824,"Blood chemistry: Alkaline phosphatase of 14-week old females,  (ALPL gene product) [U/l]"
BXD_12825,Blood chemistry: Aspartate transaminase of 14-week old females [U/l]
BXD_12826,"Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old females [mg/dl]"
BXD_12827,"Morphology, metabolism: Brown adipose tissue mass of 20-week old females [g]"
BXD_12828,"Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g]"
BXD_12829,"Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g/cm2]"
BXD_12830,"Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [cm2]"
BXD_12831,Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old females [mmHg]
BXD_12832,"Musculoskeletal system, morphology: Body weight of 13-week old females [g]"
BXD_12833,"Musculoskeletal system, morphology: Body weight of 14-week old females [g]"
BXD_12834,"Musculoskeletal system, morphology: Body weight of 15-week old females [g]"
BXD_12835,"Musculoskeletal system, morphology: Body weight of 16-week old females [g]"
BXD_12836,"Musculoskeletal system, morphology: Body weight of 17-week old females [g]"
BXD_12837,"Morphology, cardiovascular system: Body weight at echocardiography of 17-week old females [g]"
BXD_12838,"Musculoskeletal system, morphology: Body weight of 18-week old females [g]"
BXD_12839,"Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old females [g]"
BXD_12840,"Musculoskeletal system, morphology: Body weight of 19-week old females [g]"
BXD_12841,"Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old females [g]"
BXD_12842,"Musculoskeletal system, morphology: Body weight of 20-week old females [g]"
BXD_12843,"Musculoskeletal system, morphology: Body weight of 20-week old females at necropsy  [g]"
BXD_12844,Blood chemistry: Calcium of 14-week old females [mM]
BXD_12845,Blood chemistry: Chloride of 14-week old females [mM]
BXD_12846,Blood chemistry: Creatinine of 14-week old females [uM]
BXD_12847,Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old females [mm]
BXD_12848,Cardiovascular system: End-systolic diameter by echocardiography of 17-week old females [mm]
BXD_12849,"Morphology, metabolism: Body fat mass percentage of 19-week old females [%]"
BXD_12850,"Morphology, metabolism: Body fat mass of 19-week old females [g]"
BXD_12851,Cardiovascular system: Ejection fraction by echocardiography of 17-week old females [%]
BXD_12852,"Central nervous system, metabolism, behavior: Food intake of 13-week old females [g/mouse]"
BXD_12853,Cardiovascular system: Shortening fraction by echocardiography of 17-week old females [%]
BXD_12854,"Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old females [g]"
BXD_12855,"Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old females [mMl]"
BXD_12856,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old females [mg/dl]
BXD_12857,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old females [mg/dl]
BXD_12858,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old females [mg/dl]
BXD_12859,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old females [mg/dl]
BXD_12860,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old females [mg/dl]
BXD_12861,"Blood chemistry, cardiovascular system: Hematocrit of 14-week old females [%]"
BXD_12862,"Blood chemistry, cardiovascular system: Hemoglobin of 14-week old females [g/dl]"
BXD_12863,"Cardiovascular system, physiology: Heart rate during echocardiography of 17-week old females [beat/min]"
BXD_12864,Blood chemistry: Potassium of 14-week old females [mM]
BXD_12865,"Morphology, metabolism: Body lean mass of 19-week old females [g]"
BXD_12866,"Morphology, metabolism: Body lean mass percentage of 19-week old females [%]"
BXD_12867,"Liver, morphology, gastrointestinal system: Liver mass of 20-week old females [g]"
BXD_12868,Cardiovascular system: Left ventricular mass by echocardiography of 17-week old females [mg]
BXD_12869,Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old females [ratio]
BXD_12870,"Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old females [pg]"
BXD_12871,"Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old females [g/dl]"
BXD_12872,"Blood chemistry, cardiovascular system: Mean red blood cell volume (MCV of standard complete blood count) of 14-week old females [fL]"
BXD_12873,Blood chemistry: Sodium of 14-week old females [mM]
BXD_12874,Blood chemistry: Phosphorus of 14-week old females [mM]
BXD_12875,"Blood chemistry, cardiovascular system: Platelet count of 14-week old females [x10^3/ul]"
BXD_12876,Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old females [mm]
BXD_12877,"Blood chemistry, cardiovascular system: Red blood cell count of 14-week old females [x10^6/ul]"
BXD_12878,"Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old females [ratio]"
BXD_12879,Metabolism: Body temperature (rectal) of 13-week old females [deg C]
BXD_12880,Cardiovascular system: Septum thickness by echocardiography of 17-week old females [mm]
BXD_12881,Blood chemistry: Cholesterol (total) of 14-week old females [mM]
BXD_12882,Blood chemistry: Triglyceride of 14-week old females [mM]
BXD_12883,Blood chemistry: Blood proteins (total) of 14-week old females [g/l]
BXD_12884,Blood chemistry: Urea of 14-week old females [mM]
BXD_12885,"Respiratory system, metabolism: Volume of CO2 production of 13-week old females [ml/kg/h]"
BXD_12886,"Respiratory system, metabolism: Volume oxygen consumption of 13-week old females [ml/kg/h]"
BXD_12887,"Morphology, metabolism: White adipose tissue mass of 20-week old females [g]"
BXD_12888,"Blood chemistry, cardiovascular system: White blood cell count of 14-week old females [x10^3/ul]"
BXD_12889,"Central nervous system, metabolism, behavior: Water intake of 13-week old females [ml/mouse/unit time]"
BXD_12890,"Central nervous system, metabolism, behavior: Activity of 13-week old females, total counts of fine movements and ambulatory activity [counts/unit time]"
BXD_12891,Blood chemistry: Alpha-amylase of 14-week old males [U/l]
BXD_12892,"Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old males [U/L]"
BXD_12893,Blood chemistry: Albumin of 14-week old males [g/l]
BXD_12894,Blood chemistry: Alkaline phosphatase of 14-week old males (ALPL gene product) [U/l]
BXD_12895,Blood chemistry: Aspartate transaminase of 14-week old males [U/l]
BXD_12896,"Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old males [mg/dl]"
BXD_12897,"Morphology, metabolism: Brown adipose tissue mass of 20-week old males [g]"
BXD_12898,"Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g]"
BXD_12899,"Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g/cm2]"
BXD_12900,"Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [cm2]"
BXD_12901,Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old males [mmHg]
BXD_12902,"Musculoskeletal system, morphology: Body weight of 13-week old males [g]"
BXD_12903,"Musculoskeletal system, morphology: Body weight of 14-week old males [g]"
BXD_12904,"Musculoskeletal system, morphology: Body weight of 15-week old males [g]"
BXD_12905,"Musculoskeletal system, morphology: Body weight of 16-week old males [g]"
BXD_12906,"Musculoskeletal system, morphology: Body weight of 17-week old males [g]"
BXD_12907,"Morphology, cardiovascular system: Body weight at echocardiography of 17-week old males [g]"
BXD_12908,"Musculoskeletal system, morphology: Body weight of 18-week old males [g]"
BXD_12909,"Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old males [g]"
BXD_12910,"Musculoskeletal system, morphology: Body weight of 19-week old males [g]"
BXD_12911,"Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old males [g]"
BXD_12912,"Musculoskeletal system, morphology: Body weight of 20-week old males [g]"
BXD_12913,"Musculoskeletal system, morphology: Body weight of 20-week old males at necropsy  [g]"
BXD_12914,Blood chemistry: Calcium of 14-week old males [mM]
BXD_12915,Blood chemistry: Chloride of 14-week old males [mM]
BXD_12916,Blood chemistry: Creatinine of 14-week old males [uM]
BXD_12917,Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old males [mm]
BXD_12918,Cardiovascular system: End-systolic diameter by echocardiography of 17-week old males [mm]
BXD_12919,"Morphology, metabolism: Body fat mass percentage of 19-week old males [%]"
BXD_12920,"Morphology, metabolism: Body fat mass of 19-week old males [g]"
BXD_12921,Cardiovascular system: Ejection fraction by echocardiography of 17-week old males [%]
BXD_12922,"Central nervous system, metabolism, behavior: Food intake of 13-week old males [g/mouse]"
BXD_12923,Cardiovascular system: Shortening fraction by echocardiography of 17-week old males [%]
BXD_12924,"Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old males [g]"
BXD_12925,"Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old males [mMl]"
BXD_12926,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old males [mg/dl]
BXD_12927,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old males [mg/dl]
BXD_12928,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old males [mg/dl]
BXD_12929,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old males [mg/dl]
BXD_12930,Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old males [mg/dl]
BXD_12931,"Blood chemistry, cardiovascular system: Hematocrit of 14-week old males [%]"
BXD_12932,"Blood chemistry, cardiovascular system: Hemoglobin of 14-week old males [g/dl]"
BXD_12933,"Cardiovascular system, physiology: Heart rate during echocardiography of 17-week old males [beat/min]"
BXD_12934,Blood chemistry: Potassium of 14-week old males [mM]
BXD_12935,"Morphology, metabolism: Body lean mass of 19-week old males [g]"
BXD_12936,"Morphology, metabolism: Body lean mass percentage of 19-week old males [%]"
BXD_12937,"Liver, morphology, gastrointestinal system: Liver mass of 20-week old males [g]"
BXD_12938,Cardiovascular system: Left ventricular mass by echocardiography of 17-week old males [mg]
BXD_12939,Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old males [ratio]
BXD_12940,"Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old males [pg]"
BXD_12941,"Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old males [g/dl]"
BXD_12942,"Blood chemistry, cardiovascular system: Mean cell volume (red blood  cells) of 14-week old males (mean corpuscular volume, MCV) [fl]"
BXD_12943,Blood chemistry: Sodium of 14-week old males [mM]
BXD_12944,Blood chemistry: Phosphorus of 14-week old males [mM]
BXD_12945,"Blood chemistry, cardiovascular system: Platelet count of 14-week old males [x10^3/ul]"
BXD_12946,Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old males [mm]
BXD_12947,"Blood chemistry, cardiovascular system: Red blood cell count of 14-week old males [x10^6/ul]"
BXD_12948,"Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old males [ratio]"
BXD_12949,Metabolism: Body temperature (rectal) of 13-week old males [deg C]
BXD_12950,Cardiovascular system: Septum thickness by echocardiography of 17-week old males [mm]
BXD_12951,"Blood chemistry, metabolism: Cholesterol (total) in serum of 14-week old males [mM]"
BXD_12952,Blood chemistry: Triglyceride of 14-week old males [mM]
BXD_12953,Blood chemistry: Blood proteins (total) of 14-week old males [g/l]
BXD_12954,Blood chemistry: Urea of 14-week old males [mM]
BXD_12955,"Respiratory system, metabolism: Volume of CO2 production of 13-week old males [ml/kg/h]"
BXD_12956,"Respiratory system, metabolism: Volume oxygen consumption of 13-week old males [ml/kg/h]"
BXD_12957,"Morphology, metabolism: White adipose tissue mass of 20-week old males [g]"
BXD_12958,"Blood chemistry, cardiovascular system: White blood cell count of 14-week old males [x10^3/ul]"
BXD_12959,"Central nervous system, metabolism, behavior: Water intake of 13-week old males [ml/mouse/unit time]"
BXD_12960,"Central nervous system, metabolism, behavior: Activity of 13-week old males, total counts of fine movements and ambulatory activity [counts/unit time]"
BXD_12961,"Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2h access after cycle 4 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake [g/kg/2h]"
BXD_12962,"Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h]"
BXD_12963,"Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 h access after the second cycle of air exposure (control for CIE) in vapor chamber (average of 5 days ethanol intake, young adult males or females [g/kg/2h]"
BXD_12964,"Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 hr access after cycle 1 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake, 16 to 18 weeks males or females  [g/kg/2h]"
BXD_12965,"Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after first cycle of exposure, intake over 5 days [g/kg/2h]"
BXD_12966,"Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 2 of ethanol exposure in vapor chamber, average of 5 days ethanol intake [g/kg/2h]    "
BXD_12967,"Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after third cycle of exposure, intake over 5 days [g/kg/2h]"
BXD_12968,"Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]"
BXD_12969,"Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives]"
BXD_12970,"Endocrinology, pharmacology: 3a,5a-THP_CIE Ethanol vapor, from plasma entered at February/03/2011"
BXD_12971,"Infectious disease, immune system: TNFa cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]"
BXD_12972,"Infectious disease, immune system: MCP1 cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]"
BXD_12973,"Infectious disease, immune system: Interferon alpha (IFNa) cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL]"
BXD_12974,"Central nervous system, morphology, protein expression: Hippocampus dentate gyrus cells positive for calretinin protein (CALB2) by immunohistochemistry [n total, unilateral]"
BXD_12975,"Central nervous system, behavior, neurogenesis: Hippocampus dentate gyrus cells positive for doublecortin protein (DCX) by immunohistochemistry [n total, unilateral]"
BXD_12977,"Pharmacology, toxicology: Alcohol response (6 mg/kg in saline,  gastric gavage), blood alcohol concentration (BAC) 1-3 hr after gavage of young adult males and females (strain average associated with GenEx EtOH liver gene expression) [mg/dl]"
BXD_12978,"Pharmacology, toxicology: Alcohol response (6 mg/kg in saline,  gastric gavage), blood alcohol concentration (BAC) 24 hr after gavage of young adult males and females (strain average associated with GenEx EtOH liver gene expression) [mg/dl]"
BXD_12979,"Blood chemistry, pharmacology, toxicology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours after gavage in young adult males and females ( DBA/2J winsorized from 89.37 +/- 10.96 to 84, BXD69 from 91.05 +/- 5.12 to 85, and BXD16 from 107.49 +/- 24.41 to 86) (strain average associated with GenEx EtOH liver gene expression) [U/L]"
BXD_12980,"Pharmacology, toxicology: Alcohol response (6 mg/kg in saline,  gastric gavage), blood alcohol concentration (BAC) 1-3 hr after gavage of young adult males (associated with GenEx EtOH liver gene expression) [mg/dl]"
BXD_12981,"Pharmacology, toxicology: Alcohol response (6 mg/kg in saline,  gastric gavage), blood alcohol concentration (BAC) 1-3 hr after gavage of young adult females (associated with GenEx EtOH liver gene expression) [mg/dl]"
BXD_12983,"Pharmacology, toxicology: Alcohol response (6 mg/kg in saline,  gastric gavage), blood alcohol concentration (BAC) 24 hr after gavage of young adult females (associated with GenEx EtOH liver gene expression) [mg/dl]"
BXD_12984,"Blood chemistry, pharmacology, toxicology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours after gavage in young adult females (associated with GenEx EtOH liver gene expression) [U/L]"
BXD_12985,"Blood chemistry, pharmacology, toxicology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours after gavage in young adult males (BXD16 winsorized from 158 +/- 32 to 92 and DBA/2J from 107 +/- 26 to 91) (associated with GenEx EtOH liver gene expression) [U/L]"
BXD_12994,"Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction]"
BXD_12995,"Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction]"
BXD_12996,"Infectious disease, immune function: Time to death (mean) after infection  with H1N1 (PR8) influenza A virus (2x10E3 FFU) in 9-14 week-old females [days]"
BXD_13000,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%]"
BXD_13001,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%]"
BXD_13002,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%]"
BXD_13003,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%]"
BXD_13004,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%]"
BXD_13005,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%]"
BXD_13006,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%]"
BXD_13007,"Infectious disease, immune function: Body weight change three days post infection (3 dpi) with H1N1 (PR8) influenza A virus (2x10E3 FFU) in 9-14 week old females (different cases that those in Xu et al. 2020) [%]"
BXD_13008,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%]"
BXD_13009,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%]"
BXD_13010,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%]"
BXD_13011,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%]"
BXD_13012,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%]"
BXD_13013,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%]"
BXD_13014,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%]"
BXD_13015,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%]"
BXD_13016,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%]"
BXD_13017,"Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%]"
BXD_13018,"Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, all three experiments averaged (not in Table 4) [area under curve]"
BXD_13019,"Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]"
BXD_13020,"Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]"
BXD_13021,"Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g]"
BXD_13022,"Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-androsterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]"
BXD_13023,"Endocrinology, blood chemistry: Ethanol response (CIE), corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor chamber treatment [ng/g]  "
BXD_13024,"Endocrinology, blood chemistry: Control for ethanol response, corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [ng/g]"
BXD_13025,"Endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydroprogesterone (THP, allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old males or females (Dec 2009 Cohort 1) [pg/g]"
BXD_13026,"Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]"
BXD_13027,"Endocrinology, blood chemistry: Ethanol response control, 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (CIE air control) [pg/g]"
BXD_13028,"Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g]"
BXD_13029,"Endocrinology, blood chemistry: Air control response, 3a,5a-androsterone in blood plasma 72 h after 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [pg/g]"
BXD_13030,"Liver, metabolism, toxicology: Vials of hepatocyte obtained per strain from first run of spring 2011 by Piedmont and Varigenix, one vial of approximately 1 million cells (the error term is 2 times the percentage of non-viable cells) [n]"
BXD_13031,"Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment for age, sex, body weight, and brain minus hippocampus weight."
BXD_13032,"Gastrointestinal system, biochemistry: electrophoretic band variant of Lap-1 protein (ANPEP) that maps to proximal Chr 9 (this is not the Anpep locus, but is a possible trans-effect) [-1 band present, 1 band absent]"
BXD_13033,"Genetics, statistics, cofactors: BXD epoch or phase of production trait 4 [-1 = Taylor BXD series BXD1 to 30, 0 = BXD31 and higher]"
BXD_13034,"Hematology: Transthyretin protein serum band (prealbumin, Pre locus) detected by acylamide electrophoresis in adult males [a-genotype of DBA/2J with band is coded as 1, o-genotype without band is coded as -1]"
BXD_13035,"Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus Cdm (Slc39a8) [-1= resistant, 1 = susceptible]"
BXD_13036,"Reproductive system, toxicology: Cadmium toxicity (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm (Slc39a8) [-1= resistant, 1 = susceptible]"
BXD_13037,"Liver, metabolism, toxicology: Hepatocyte phase I (CYP1A) metabolic activity measured by 7-ethoxycoumarin-o-deethylase (ECOD, 7EC) consumption at 0 and 30 minutes (25 uM/sample) using cryorederived hepatocytes from young adult male liver  (BXD31 winsorized from 1394 to 1250) [ECOD pmol/million cells/min]"
BXD_13038,"Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity (7HC, glucuronidation and sulfation) measured by production of 7-hydroxycoumarin glucouronide at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver (BXD15 and BXD13 winsorized from 4125 and 4485 to 3300 and 3500) [7-HCG pmol/million cells/min]"
BXD_13040,"Liver, metabolism, toxicology: Hepatocyte viability, fraction of viable cells after rederivation relative to viable cells immediately after isolation in suspension (data from first run of Spring 2011 by Piedmont/CRL and Varigenix) [ratio]"
BXD_13042,"Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity measured by 7-hydrozycoumarin sulfate (7-HCS) sulfation assay at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [pmol/million cells/min]"
BXD_13043,"Infectious disease, immune system,  pulmonary system: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) in 7 to 12-week-old females, 10 per strain [log10 median CFU per lung 15 days after infection]"
BXD_13044,"Central nervous system, behavior, metabolism: Body weight in 3-4 month old test naive females [g]"
BXD_13045,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) of the femur of males adjusted for age differences (dual energy X-ray absorptiometry PIXImus) [mg/cm2]"
BXD_13046,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) of the tibia of adult males adjusted for age differences (dual energy X-ray absorptiometry DEXA using PIXIimus) [mg/cm2]"
BXD_13047,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) of femurs of females adjusted for age differences (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]"
BXD_13048,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) of the tibia of females adjusted for age differences (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2]"
BXD_13049,"Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA PIXImus) [g hydroxyapatite]"
BXD_13050,"Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]"
BXD_13051,"Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old females (dual energy X-ray absorptiometry PIXImus) [mg]"
BXD_13052,"Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite]"
BXD_13053,"Musculoskeletal system, morphology: Surface area of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]"
BXD_13054,"Musculoskeletal system, morphology: Surface area of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]"
BXD_13055,"Musculoskeletal system, morphology: Surface area of femur of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]"
BXD_13056,"Musculoskeletal system, morphology: Surface area of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2]"
BXD_13057,"Urogenital system, kidney, morphology: Kidney weight of females (raw data) [mg]"
BXD_13058,"Urogenital system, kidney, morphology: Kidney weight of males (unilateral, raw data, unadjusted) [mg]"
BXD_13060,"Central nervous system, morphology: Neuron number in cerebral neocortex of adults, bilateral (direct 3D counting disector method) [millions] "
BXD_13061,"Central nervous system, morphology: Non-neuronal cell number in cerebral neocortex of adults, bilateral (direct 3D counting disector method) [millions] "
BXD_13062,"Central nervous system, morphology: Total cell number in cerebral neocortex of adults (neurons, glial cells, endothelial cells), bilateral (direct 3D counting disector method) [millions] "
BXD_13346,"Central nervous system, behavior: Acoustic startle response for males, 100 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13347,"Central nervous system, behavior: Acoustic startle response for males, 105 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13348,"Central nervous system, behavior: Acoustic startle response for males, 110 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13349,"Central nervous system, behavior: Acoustic startle response for males, 115 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13350,"Central nervous system, behavior: Acoustic startle response for males, 120 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13351,"Central nervous system, behavior: Acoustic startle response for males, 65 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13352,"Central nervous system, behavior: Acoustic startle response for males, 70 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13353,"Central nervous system, behavior: Acoustic startle response for males, 75 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13354,"Central nervous system, behavior: Acoustic startle response for males, 80 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13355,"Central nervous system, behavior: Acoustic startle response for males, 85 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13356,"Central nervous system, behavior: Acoustic startle response for males, 90 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13357,"Central nervous system, behavior: Acoustic startle response for males, 95 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force]"
BXD_13358,"Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 10 dB below startle threshold, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]"
BXD_13359,"Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 65 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]"
BXD_13360,"Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 70 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]"
BXD_13361,"Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 75 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]"
BXD_13362,"Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 80 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%]"
BXD_13363,"Central nervous system, behavior, cognition: Response accuracy, measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]"
BXD_13364,"Central nervous system, behavior, cognition: Errors of omission, measure of attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]"
BXD_13365,"Central nervous system, behavior, cognition: Mean correct response latency, measure of attention/motivation/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s]"
BXD_13366,"Central nervous system, behavior, cognition: Correct response latencies (modal value), a measure of processing speed and speed of motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, where low values are faster and better performance [s]"
BXD_13367,"Central nervous system, behavior, cognition: Standard deviation of correct response latencies, measure of lapses in attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = better performance [s]"
BXD_13368,"Central nervous system, behavior, cognition: Mean latency to retrieve food pellet, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = low motivation [s]"
BXD_13369,"Central nervous system, behavior, cognition: Number of completed trials in a 25 min session, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = low motivation [n]"
BXD_13370,"Central nervous system, behavior, cognition: Response accuracy during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%]"
BXD_13371,"Central nervous system, behavior, cognition: Errors of omission during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%]"
BXD_13372,"Central nervous system, behavior: Acoustic startle threshold for males, lowest sound pressure level at which startle response can be detected [dB]"
BXD_13384,"Central nervous system, morphology: Lateral septum volume, adult both sexes (MBL samples), morphometric point counting estimate from serial sections (without corrections) [mm3]"
BXD_13385,"Central nervous system, morphology: Midsagittal area of the corpus callosum, corrected for shrinkage, age, sex, brain weight, epoch [mm2]"
BXD_13399,"Central nervous system, morphology: Septum volume corrected for shrinkage, age, sex, plane of section, brain weight, and epoch [mm3]"
BXD_13441,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [sec]"
BXD_13442,"Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only"
BXD_13443,"Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only"
BXD_13444,"Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only]"
BXD_13446,"Central nervous system, behavior: Rotarod, time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec]"
BXD_13447,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]"
BXD_13448,"Central nervous system, behavior, motor: Rotarod test improvement between day 1 and 2 in 8-week-old F1s transgene carriers of both sexes (progeny of BXD males crossed to  C57BL/6J-R6/2 Huntington's disease females) [% gain]"
BXD_13449,"Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec]"
BXD_13450,"Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec]"
BXD_13451,"Central nervous system, behavior: Rotarod improvement from Day 1 to Day 2 in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, wildtype [%]"
BXD_13452,"Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement]"
BXD_13453,"Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1]"
BXD_13454,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm]"
BXD_13455,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm]"
BXD_13456,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm]"
BXD_13457,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm]"
BXD_13458,"Central nervous system, behavior: Open field activity (OFA), total distance by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [% of wildtype control]"
BXD_13459,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT]"
BXD_13460,"Central nervous system, behavior: Rearing in open field test by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [n beam breaks]"
BXD_13461,"Central nervous system, behavior: Rearing in open-field arena (OFA) in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male R6/2 cases only [n vertical beam breaks]	"
BXD_13462,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks]	"
BXD_13463,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks]	"
BXD_13464,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	"
BXD_13465,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	"
BXD_13466,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm]"
BXD_13467,"Central nervous system, behavior: Body weight of 8-week F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male R6/2 [gm]"
BXD_13468,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype]"
BXD_13469,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype]"
BXD_13470,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm]"
BXD_13471,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male wildtype [gm]"
BXD_13472,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec]"
BXD_13473,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]	"
BXD_13474,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec]	"
BXD_13475,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec]	"
BXD_13476,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	"
BXD_13477,"Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	"
BXD_13478,"Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT]	"
BXD_13479,"Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT]	"
BXD_13480,"Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec]"
BXD_13481,"Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec]"
BXD_13482,"Central nervous system, behavior: Rotarod, time on Day 2 in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, female wildtype cases only [sec]"
BXD_13483,"Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec]"
BXD_13484,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)] "
BXD_13485,"Central nervous system, behavior: Prepulse inhibition (PPI), averaged at 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, female R6/2 cases [%]"
BXD_13486,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]"
BXD_13487,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak amplitude, both sexes at 2 weeks-of-age [ln(uV)]"
BXD_13488,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak frequency, both sexes at 2 weeks-of-age [Hz]"
BXD_13489,"Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition at 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, male R6/2 [%]"
BXD_13490,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)]"
BXD_13491,"Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)]"
BXD_13492,"Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%]"
BXD_13493,"Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%]"
BXD_13494,"Central nervous system, behavior: Prepulse inhibition, average difference in inhibition compared to wildtype for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXDs and C57BL/6J-R6/2 Huntington model females only [% of WT]"
BXD_13495,"Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%]"
BXD_13507,"Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive]"
BXD_13511,"Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg]"
BXD_13512,"Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg]"
BXD_13513,"Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT]"
BXD_13514,"Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight]"
BXD_13515,"Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight]"
BXD_13516,"Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight]"
BXD_13518,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm]"
BXD_13519,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington, corrected, female R6/2 [gm]"
BXD_13520,"Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]"
BXD_13521,"Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm]"
BXD_13522,"Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec]"
BXD_13523,"Central nervous system, behavior: Motor performance measured by the rotarod test on Day 1 (first test) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model (corrected female R6/2 cases only) [sec]"
BXD_13524,"Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec]"
BXD_13525,"Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec]"
BXD_13526,"Central nervous system, behavior: Motor performance, accelerating rotarod test, day 2 in 8-week F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, corrected, male R6/2 [sec]"
BXD_13527,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm]"
BXD_13528,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm]"
BXD_13529,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks]"
BXD_13530,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks]"
BXD_13531,"Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%]"
BXD_13532,"Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%]"
BXD_13533,"Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only"
BXD_13534,"Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm]"
BXD_13535,"Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks]"
BXD_13536,"Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio]"
BXD_13537,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]"
BXD_13538,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, corrected, R6/2 cases [sec]"
BXD_13539,"Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec]"
BXD_13540,"Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units]"
BXD_13541,"Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%]"
BXD_13542,"Liver, metabolism, toxicology: Hepatocyte general viability at 0 hr post-thaw in suspension, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well]"
BXD_13543,"Liver, metabolism, toxicology: Hepatocyte general viability at 4 hr post-thaw on plates, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well]"
BXD_13545,"Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in young adult rostral migratory stream (RMS), unadjusted data [N per mm of RMS length]"
BXD_13546,"Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (newer data extension linked to Airey et al.) [residual mg]"
BXD_13548,"Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] "
BXD_13549,"Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, body weight (Hager et al., 2012, data from Mozhui et al. 2007) [residual mm^3] "
BXD_13550,"Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] "
BXD_13551,"Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]"
BXD_13552,"Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells corrected for DNA content 31.5 hr after seeding with 20,000 cells, young adult male liver (BXD15 winsorized from 223 to 160) [ratio LDH/DNA]"
BXD_13553,"Liver, metabolism, toxicology: Hepatocyte plating efficiency, cells per control wells (DNA assay) 31.5 hr after seeding with 20,000 cells/well, young adult male liver [ng/ml]"
BXD_13554,"Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells (uncorrected for viable cell number) 33 hours after seeding with 20,000 cells, young adult male liver (BXD29 and BXD15 winsorized from 10821 and 11658 to 8500 and 9000) [LDH units]"
BXD_13555,"Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD31 winsorized from 243 to 200) [LDH/DNA ratio]"
BXD_13556,"Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1223 to 900) [LDH/DNA ratio]"
BXD_13557,"Liver, metabolism, toxicology: Maximal hepatocyte cytotoxicity response 9 hr after treatment with lysis buffer, lactate dehydrogenase (LDH) release assay, young adult male liver [LDH]"
BXD_13558,"Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad control LDH, BXD31 winsorized from 169.8 to 100) to  [LDH/DNA ratio difference]"
BXD_13559,"Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1131 to 800) [LDH/DNA ratio difference]"
BXD_13560,"Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay (relative fluorescent units), young adult male liver [RFU]"
BXD_13561,"Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), ratio of ethanol-induced release to maximal (lysis) lactate dehydrogenase (LDH) release, young adult male liver (BXD15 deleted due to bad LDH control, BXD29 winsorized from 1.57 to 1.20) [ratio]"
BXD_13562,Endocrine system: Corticosterone in serum 15 min following 15 min restraint in females (6-8 months) for normally housed control group for chronic mild stress (CMS)  [ng/ml]
BXD_13563,Endocrine system: Corticosterone in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS) [ng/ml]
BXD_13564,"Endocrine system: Corticosterone difference in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS), CMS group minus control [ng/ml]"
BXD_13565,"Central nervous system, pharmacology, behavior: Ethanol response  (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in normally housed group, control for chronic mild stress (CMS) group (Phase 1) [g/kg]"
BXD_13566,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in chronic mild (CMS) stress group 1 week before start of 7 weeks of CMS (Phase 1) [g/kg]"
BXD_13567,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, first DID) in females, difference between chronic mild stress (CMS) and control groups one week before the start of 7 weeks of CMS (Phase 1) [g/kg]"
BXD_13568,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID phase)  in females, control group for chronic mild stress (CMS) group (Phase 2) [g/kg]"
BXD_13569,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, chronic mild stress (CMS) group (Phase 2) [g/kg]"
BXD_13570,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, difference between chronic mild stress (CMS) group and control group (Phase 2) [g/kg]"
BXD_13571,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID)in females, in the control group for the chronic mild stress (CMS) group (Phase 3) [g/kg]"
BXD_13572,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, chronic mild stress (CMS) group following CMS (Phase 3) [g/kg]"
BXD_13573,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, difference between chronic mild stress (CMS) group and control group following CMS (Phase 3) [g/kg]"
BXD_13574,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the control group [g/kg] 

"
BXD_13575,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the chronic mild stress (CMS) group [g/kg]"
BXD_13576,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) in the control group for chronic mild stress (CMS) group [g/kg]"
BXD_13577,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) for the chronic mild stress (CMS) group [g/kg]"
BXD_13578,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the control group for chronic mild stress (CMS) [g/kg]"
BXD_13579,"Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the chronic mild stress (CMS) group [g/kg]"
BXD_13580,"Endocrinology, neuroendocrine system, morphology: Adrenal gland weight in normally housed females (6â€“8 months) [mg x 10]"
BXD_13581,"Endocrinology, neuroendocrine system, morphology: Adrenal gland weights in chronic mild stress (CMS) cases following CMS in adult females (6-8 months) [mg x 10]"
BXD_13582,"Endocrinology, neuroendocrine system, morphology: Adrenal weight difference in adult females (6-8 months) between chronic mild stress group (CMS for 7 weeks) and control group [mg x 10]"
BXD_13583,"Endocrine system, immune system: Thymus weight in normally housed adult female controls (6â€“8 months) for chronic mild stress (CMS) [mg x 10]"
BXD_13584,"Endocrine system, immune system: Thymus weight in adult females (6â€“8 months) following 7 weeks of chronic mild stress (CMS) [mg x 10]"
BXD_13585,"Endocrine system: Thymus gland weight difference in adult females (6-8 months), chronic mild stress (CMS) group minus control group [mg x 10]"
BXD_13586,"Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age effects [N cells per mm of RMS length]"
BXD_13587,"Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg]"
BXD_13588,"Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3]"
BXD_13965,"Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]"
BXD_13966,"Central nervous system, protein expression: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio]"
BXD_14308,"Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum]"
BXD_14309,"Infectious disease, immune function: Serum glucose (unfasted) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [mg/dL serum)"
BXD_14310,"Infectious disease, immune system, central nervous system: Candida albicans titer in brain at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]"
BXD_14311,"Infectious disease, immune system, urogenital system: Candida albicans titer, renal, at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [CFU x 10^4 per gram tissue weight]"
BXD_14312,"Infectious disease, immune system, urogenital system: Candida albicans titer in kidney (log) at 72 h after inoculation with 1 x 10^6 cfu (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue]"
BXD_14313,"Blood chemistry, infectious disease, immune system: White blood cell (WBC) count 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [number per ul of whole blood]"
BXD_14314,"Infectious disease, immune system: Ratio of number of neutrophil to lymphocyte ratio at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [neutrophil to lymphocyte ratio, whole blood]"
BXD_14315,"Infectious disease, immune system: Hematocrit 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [proportional packed cell volume of RBCs in whole blood]"
BXD_14316,"Infectious disease, immune system: lipocalin-2 (LCN-2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]"
BXD_14317,"Infectious disease, immune system: Interleukin-6 (IL-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein]"
BXD_14318,"Infectious disease, immune system: G-CSF (granulocyte colony stimulating factor) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]"
BXD_14319,"Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, kidney] "
BXD_14320,"Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]"
BXD_14321,"Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]"
BXD_14322,"Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney]"
BXD_14323,"Infectious disease, immune system, urogenital system: TNF-a at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] "
BXD_14324,"Infectious disease, immune function: temperature during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C)"
BXD_14325,"Infectious disease, immune function: Temperature during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C) "
BXD_14326,"Infectious disease, immune function: Temperature during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]"
BXD_14327,"Infectious disease, immune function: Temperature during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus  immediately after light onset [difference from baseline, C]"
BXD_14328,"Infectious disease, immune function: Temperature during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C]"
BXD_14329,"Infectious disease, immune function: Temperature during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus ; immediately after light onset [difference from baseline, C]"
BXD_14330,"Infectious disease, immune function: locomotor activity during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]"
BXD_14331,"Infectious disease, immune function: locomotor activity during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline]"
BXD_14332,"Infectious disease, immune function: locomotor activity during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]"
BXD_14333,"Infectious disease, immune function: locomotor activity during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]"
BXD_14334,"Infectious disease, immune function: locomotor activity during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]"
BXD_14335,"Infectious disease, immune system: Locomotor activity 60-72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline]"
BXD_14336,"Infectious disease, immune system, central nervous system: Candida albicans titer in brain (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue weight]"
BXD_14337,"Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum, log]"
BXD_14338,"Infectious disease, immune function: G-CSF (granulocyte colony stimulating factor) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]"
BXD_14339,"Infectious disease, immune system: IL-6 (interleukin-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]"
BXD_14340,"Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]"
BXD_14341,"Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, log, kidney] "
BXD_14342,"Infectious disease, immune system, protein expression: Lipocalin-2 (LCN-2) level in kidney 72 h after inoculation with 1 x 10^6 CFU Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein]"
BXD_14343,"Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]"
BXD_14344,"Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney]"
BXD_14345,"Infectious disease, immune system, urogenital system: TNF-a (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] "
BXD_14348,"Infectious disease, immune function: locomotor activity (log) during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline, log]"
BXD_14349,"Infectious disease, immune function: locomotor activity (log) during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline. log]"
BXD_14350,"Infectious disease, immune function: locomotor activity (log) during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]"
BXD_14351,"Infectious disease, immune function: locomotor activity (log) during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]"
BXD_14352,"Infectious disease, immune function: locomotor activity (log) during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]"
BXD_14353,"Infectious disease, immune system: Locomotor activity (log) during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log]"
BXD_14355,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data trimmed [ug hydroxyproline/g liver]"
BXD_14356,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver]"
BXD_14357,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, trimmed [ug hydroxyproline/g liver]"
BXD_14358,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver]"
BXD_14359,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data, trimmed [ug hydroxyproline/g liver]"
BXD_14360,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen data, trimmed [ug hydroxyproline/g liver]"
BXD_14361,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, trimmed [g] "
BXD_14362,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data trimmed [g] "
BXD_14363,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g]"
BXD_14364,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio, data trimmed [g]"
BXD_14365,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g]"
BXD_14366,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data  trimmed [g]"
BXD_14367,"Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14368,"Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l] "
BXD_14369,"Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14370,"Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l] "
BXD_14371,"Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14372,"Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14373,"Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14374,"Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) aktivity, trimmed [U/l] "
BXD_14375,"Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) activity, trimmed [U/l]"
BXD_14376,"Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) activity, trimmed [U/l] "
BXD_14377,"Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14378,"Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median  alanine aminotransferase (ALT) aktivity, trimmed [U/l]"
BXD_14379,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]"
BXD_14380,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]"
BXD_14381,"Liver, toxicology: Fibrosis susceptibility in males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]"
BXD_14382,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]"
BXD_14383,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity]"
BXD_14384,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severety]"
BXD_14385,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14386,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14387,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14388,"Liver, toxicology: Fibrosis susceptibility in females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14389,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14390,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%]"
BXD_14391,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory at Homburg), data trimmed [%]"
BXD_14392,"Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, Homburg Laboratory), trimmed [%]"
BXD_14393,"Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%]"
BXD_14394,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] "
BXD_14395,"Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] "
BXD_14396,"Liver, toxicology: fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] "
BXD_14397,"Eye, visual system: Corneal neovascular response to FGF2 (10 ng in corneal micro pocket assay), vessel length five days postoperatively measured by slit lamp (from Fig 1) [mm]"
BXD_14398,"Eye, visual system: Corneal neovascular response to FGF2 (10 ng, corneal micro pocket assay), vessel area five days postoperatively measured by slit lamp (from Fig 2) [mm2]"
BXD_14399,"Eye, visual system: Eldon Geisert trait, contact <egeisert@uthsc.edu>"
BXD_14401,"Infectious disease, immune system, pulmonary system: Immune function infectious disease: MA Miller Trait 1"
BXD_14402,"Immune function infectious disease, pulmonary system: MA Miller Trait 1"
BXD_14781,"Reproduction: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good]"
BXD_14783,"Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe] "
BXD_14785,"Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease] 
"
BXD_14786,"Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, unadjusted data [n cells]"
BXD_14787,"Central nervous system, behavior: Soluble/aggregate protein ratio by fluorescence resonance energy transfer (FRET) in 8 week old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington, 2B7/4C9 R6/2 cases [ratio]"
BXD_14788,"Central nervous system, morphology: MSACC corrected for shrinkage [mm2]"
BXD_14789,"Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]"
BXD_14791,"Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]"
BXD_14792,"Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]"
BXD_14793,"Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio]"
BXD_14794,"Central nervous system, behavior, sleep: Bruce 1, Contact Bruce O'Hara "
BXD_14796,"Liver, metabolism, toxicology: Acetaminophen (APAP) hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control]"
BXD_14797,Musculoskeletal system: Hip cartilage aggrecan 1 (Acan)
BXD_14798,"Musculoskeletal system: Hip cartilage collagen, type II alpha 1 (Col2a1)"
BXD_14799,"Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp), Chr8: 72.905142"
BXD_14800,Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1)
BXD_14801,Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13)
BXD_14802,"Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in females on 60% high fat diet [% cases]"
BXD_14803,"Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males (upper panel, Fig 1, dark bars) [sec]"
BXD_14804,"Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, conditioned place preference (CPP) on day 5 in 7-8-week old males (upper panel, Fig 1, light bars) [sec]"
BXD_14805,"Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, sc, twice a day on days 2-4), post-conditioning scores on day 5 in 7-8-week old males (supplementary data) [sec]"
BXD_14806,"Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, post-conditioning score on day 5 of CPP  in 7-8-week old males (supplementary data) [score]"
BXD_14807,"Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in blood 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)]"
BXD_14808,"Infectious disease, immune system, urogenital system, kidney:Bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de)"
BXD_14809,"bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), liver"
BXD_14810,"bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), heart"
BXD_14811,"bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), death"
BXD_14812,"Infectious disease, immune function: Susceptibility to Staphylococcus aureus, survival 10 days after infection with 10E5 colony forming units (CFU) in 10 to 14 day-old females [%]"
BXD_14813,"bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), suvival 4d"
BXD_14814,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d"
BXD_14815,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d"
BXD_14816,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 21d"
BXD_14817,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 90d"
BXD_14818,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 21d"
BXD_14819,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 90d"
BXD_14820,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 21d"
BXD_14821,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 90d"
BXD_14822,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 21d"
BXD_14823,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 90d"
BXD_14824,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), survival"
BXD_14825,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d, log10"
BXD_14826,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d, log10"
BXD_14827,"Infectious disease, immune function: Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized CFU lung 90d, log10"
BXD_14828,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), histology lung 90d"
BXD_14829,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), body weight 13 weeks pi, 1000 CFU"
BXD_14830,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund body weight 1000 CFU"
BXD_14831,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), temperature 13 week pi 1000 CFU"
BXD_14832,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund temperature 1000 CFU"
BXD_14833,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized median survival"
BXD_14834,"Bacterial infection, Ehlers (sehlers@fz-borstel.de), median survival"
BXD_14835,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, females"
BXD_14836,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, females"
BXD_14837,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, females"
BXD_14838,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, females"
BXD_14839,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, females"
BXD_14840,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, females"
BXD_14841,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, females"
BXD_14842,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, females"
BXD_14843,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, females"
BXD_14844,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, females"
BXD_14845,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, females"
BXD_14846,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, females"
BXD_14847,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, females"
BXD_14848,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, females"
BXD_14849,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, females"
BXD_14850,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, females"
BXD_14851,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, females"
BXD_14852,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, females"
BXD_14853,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, females"
BXD_14854,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, females"
BXD_14855,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, females"
BXD_14856,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, females"
BXD_14857,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, females"
BXD_14858,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, females"
BXD_14859,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, females"
BXD_14860,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, females"
BXD_14861,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, females"
BXD_14862,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, females"
BXD_14863,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, females"
BXD_14864,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, females"
BXD_14865,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, females"
BXD_14866,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, females"
BXD_14867,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, females"
BXD_14868,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, females"
BXD_14869,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, females"
BXD_14870,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, females"
BXD_14871,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, females"
BXD_14872,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, females"
BXD_14873,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, females"
BXD_14874,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, females"
BXD_14875,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, females"
BXD_14876,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, females"
BXD_14877,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, females"
BXD_14878,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, females"
BXD_14879,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, females"
BXD_14880,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, females"
BXD_14881,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, females"
BXD_14882,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, females"
BXD_14883,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, females"
BXD_14884,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, females"
BXD_14885,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, females"
BXD_14886,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, females"
BXD_14887,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, females"
BXD_14888,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, females"
BXD_14889,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, females"
BXD_14890,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, females"
BXD_14891,"Morphology, metabolism: Brain weight at 20 weeks in females fed a high fat diet (45% energy from fat) from weaning (4 weeks) [g]"
BXD_14892,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, females"
BXD_14893,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, females"
BXD_14894,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, females"
BXD_14895,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, females"
BXD_14896,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, females"
BXD_14897,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, females"
BXD_14898,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, females"
BXD_14899,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, females"
BXD_14900,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, females"
BXD_14901,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, females"
BXD_14902,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, females"
BXD_14903,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, females"
BXD_14904,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, females"
BXD_14905,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, females"
BXD_14906,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, females"
BXD_14907,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, females"
BXD_14908,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, females"
BXD_14909,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, females"
BXD_14910,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, females"
BXD_14911,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, females"
BXD_14912,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, females"
BXD_14913,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, females"
BXD_14914,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42 in females + males"
BXD_14915,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56 in females + males"
BXD_14916,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70 in females + males"
BXD_14917,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84 in females + males"
BXD_14918,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112 in females + males"
BXD_14919,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140 in females + males"
BXD_14920,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10 in females + males"
BXD_14921,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20 in females + males"
BXD_14922,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42 in females + males"
BXD_14923,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56 in females + males"
BXD_14924,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70 in females + males"
BXD_14925,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84 in females + males"
BXD_14926,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112 in females + males"
BXD_14927,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140 in females + males"
BXD_14928,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10 in females + males"
BXD_14929,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20 in females + males"
BXD_14930,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4 in females + males"
BXD_14931,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5 in females + males"
BXD_14932,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6 in females + males"
BXD_14933,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7 in females + males"
BXD_14934,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8 in females + males"
BXD_14935,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9 in females + males"
BXD_14936,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10 in females + males"
BXD_14937,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11 in females + males"
BXD_14938,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12 in females + males"
BXD_14939,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13 in females + males"
BXD_14940,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14 in females + males"
BXD_14941,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15 in females + males"
BXD_14942,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16 in females + males"
BXD_14943,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17 in females + males"
BXD_14944,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18 in females + males"
BXD_14945,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19 in females + males"
BXD_14946,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20 in females + males"
BXD_14947,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5 in females + males"
BXD_14948,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6 in females + males"
BXD_14949,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7 in females + males"
BXD_14950,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8 in females + males"
BXD_14951,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9 in females + males"
BXD_14952,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10 in females + males"
BXD_14953,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11 in females + males"
BXD_14954,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12 in females + males"
BXD_14955,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13 in females + males"
BXD_14956,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14 in females + males"
BXD_14957,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15 in females + males"
BXD_14958,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16 in females + males"
BXD_14959,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17 in females + males"
BXD_14960,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18 in females + males"
BXD_14961,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19 in females + males"
BXD_14962,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20 in females + males"
BXD_14963,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6 in females + males"
BXD_14964,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10 in females + males"
BXD_14965,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20 in females + males"
BXD_14966,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10 in females + males"
BXD_14967,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20 in females + males"
BXD_14968,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10 in females + males"
BXD_14969,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20 in females + males"
BXD_14970,"Morphology, metabolism: Brain weight at 20 weeks animals (males and females combined) fed a high fat diet (45% energy from fat) from weaning (4 weeks) [g]
"
BXD_14971,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver in females + males"
BXD_14972,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney in females + males"
BXD_14973,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen in females + males"
BXD_14974,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart in females + males"
BXD_14975,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung in females + males"
BXD_14976,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas in females + males"
BXD_14977,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis in females + males"
BXD_14978,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi in females + males"
BXD_14979,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF in females + males"
BXD_14980,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF in females + males"
BXD_14981,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF in females + males"
BXD_14982,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF in females + males"
BXD_14983,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF in females + males"
BXD_14984,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF in females + males"
BXD_14985,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF in females + males"
BXD_14986,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF in females + males"
BXD_14987,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT in females + males"
BXD_14988,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT in females + males"
BXD_14989,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass in females + males"
BXD_14990,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF in females + males"
BXD_14991,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF in females + males"
BXD_14992,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF in females + males"
BXD_14993,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, males"
BXD_14994,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, males"
BXD_14995,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, males"
BXD_14996,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, males"
BXD_14997,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, males"
BXD_14998,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, males"
BXD_14999,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, males"
BXD_15000,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, males"
BXD_15001,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, males"
BXD_15002,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, males"
BXD_15003,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, males"
BXD_15004,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, males"
BXD_15005,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, males"
BXD_15006,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, males"
BXD_15007,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, males"
BXD_15008,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, males"
BXD_15009,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, males"
BXD_15010,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, males"
BXD_15011,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, males"
BXD_15012,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, males"
BXD_15013,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, males"
BXD_15014,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, males"
BXD_15015,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, males"
BXD_15016,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, males"
BXD_15017,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, males"
BXD_15018,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, males"
BXD_15019,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, males"
BXD_15020,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, males"
BXD_15021,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, males"
BXD_15022,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, males"
BXD_15023,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, males"
BXD_15024,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, males"
BXD_15025,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, males"
BXD_15026,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, males"
BXD_15027,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, males"
BXD_15028,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, males"
BXD_15029,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, males"
BXD_15030,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, males"
BXD_15031,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, males"
BXD_15032,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, males"
BXD_15033,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, males"
BXD_15034,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, males"
BXD_15035,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, males"
BXD_15036,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, males"
BXD_15037,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, males"
BXD_15038,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, males"
BXD_15039,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, males"
BXD_15040,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, males"
BXD_15041,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, males"
BXD_15042,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, males"
BXD_15043,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, males"
BXD_15044,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, males"
BXD_15045,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, males"
BXD_15046,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, males"
BXD_15047,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, males"
BXD_15048,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, males"
BXD_15049,"Morphology, metabolism: Brain weight at 20 weeks in males fed a high fat diet (45% energy from fat) from weaning (4 weeks) [g]"
BXD_15050,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, males"
BXD_15051,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, males"
BXD_15052,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, males"
BXD_15053,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, males"
BXD_15054,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, males"
BXD_15055,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, males"
BXD_15056,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Testis, males"
BXD_15057,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, males"
BXD_15058,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, males"
BXD_15059,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, males"
BXD_15060,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, males"
BXD_15061,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, males"
BXD_15062,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, males"
BXD_15063,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, males"
BXD_15064,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, males"
BXD_15065,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, males"
BXD_15066,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, males"
BXD_15067,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, males"
BXD_15068,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, males"
BXD_15069,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, males"
BXD_15070,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Resistin, males"
BXD_15071,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Insulin, males"
BXD_15072,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Leptin, males"
BXD_15073,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL1B, males"
BXD_15074,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL6, males"
BXD_15075,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL10, males"
BXD_15076,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL17, males"
BXD_15077,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_MCP1, males"
BXD_15078,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_TNFa, males"
BXD_15079,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, males"
BXD_15080,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, males"
BXD_15081,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, males"
BXD_15082,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_UnsaturatedFat, males"
BXD_15083,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_SaturatedFat, males"
BXD_15084,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_TotalFat, males"
BXD_15085,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_acylchainlength, males"
BXD_15086,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_SaturatedFat.UnsaturatedFat, males"
BXD_15087,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_lipid.prot, males"
BXD_15088,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_TotalLipid.TotalProtein, males"
BXD_15089,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_collagen, males"
BXD_15090,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_AdiposeTissue_collagenintegrity, males"
BXD_15091,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de),  FTIR_liver_SatF, males"
BXD_15092,"Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_TotF, males"
BXD_15093,"Morphology, biochemistry: FTIR_liver_acylchainlength, males (contact Gudrun Brockmann at gudrun.brockmann@agrar.hu-berlin.de) "
BXD_15094,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de),  FTIR_liver_lipid.prot, males"
BXD_15095,"Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_Tot_lipid.Tot_prot, males"
BXD_15096,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagen, males"
BXD_15097,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagenintegrity, males"
BXD_15098,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_glycogen, males"
BXD_15099,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_SatF, males"
BXD_15100,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_TotF, males"
BXD_15101,"Morphology, metabolism: Acyl chain length measured by Fourier transform infrared spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit]"
BXD_15102,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_lipid.prot, males"
BXD_15103,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_Tot_lipid.Tot_prot, males"
BXD_15104,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagen, males"
BXD_15105,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagenintegrity, males"
BXD_15106,"Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_glycogen, males"
BXD_15107,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+ frequency of CD3+"
BXD_15108,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+ frequency of CD3+ CD4+ "
BXD_15109,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de),  CD45+ frequency of CD3+ CD8a+ "
BXD_15110,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD4+ frequency of CD25+"
BXD_15111,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+ frequency of CD3+ gamma/delta TCR+ "
BXD_15112,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD4+ frequency of Ly6C+"
BXD_15113,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de),CD3+CD4+ frequency of CD62L+"
BXD_15114,Immune function: CD44+ effector-memory T cells as a percentage of CD3+ CD4+ T cells in peripheral blood measured by fluorescence activated cell sorting (this trait maps to the CD44 locus of Chr 2) (FACS) [%]
BXD_15115,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de),CD3+ CD4+ frequency of CD44+CD62L-"
BXD_15116,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD4+ frequency of CD62L+CD44-"
BXD_15117,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD8+, frequency of Ly6C+ "
BXD_15118,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD8+, frequency of CD62L+"
BXD_15119,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD8+ frequency of CD44+ "
BXD_15120,Immune function: CD44+ Ly6C+ cells as a percentage of CD3+ CD8+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%]
BXD_15121,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de),CD3+CD8+ frequency of CD44+62L-"
BXD_15122,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+CD8+ frequency of CD44-62L+  "
BXD_15123,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+ cells, frequency of GR-1+ CD11b+, "
BXD_15124,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+, frequency of Gr-1-NKp46- CD11b+ "
BXD_15125,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de),CD45+, frequency of CD5-NKp46+cells "
BXD_15126,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD45+, frequency of B (=CD19+OR(B220+AND IgD+), "
BXD_15127,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), B cells frequency of CD5+ "
BXD_15128,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), B cells frequency of IgD+ cells "
BXD_15129,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), MHC class II (I/A-E)+, frequency Of B cells"
BXD_15130,"Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD5-cell frequency of CD11b+ NKp46+ "
BXD_15131,Cardiovascular system: Systolic blood pressure of adult males raised in Memphis measured using a tail cuff system (originally known as GN Trait 11017) [mm Hg]
BXD_15132,Cardiovascular system: Systolic blood pressure of adult females raised in Memphis measured using a tail cuff system (originally known as GN Trait 12076) [mm Hg]
BXD_15133,"Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = resistant, 1 = susceptible) [fraction of cohort that survives]"
BXD_15134,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_15135,"Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]"
BXD_15136,"Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) concentration in males 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_15137,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_15138,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_15139,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_15140,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_15141,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_15142,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in males 48h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_15143,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 3-methoxytyramine (3-MT, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_15144,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_15145,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_15146,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_15147,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]"
BXD_15148,"Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_15149,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_15150,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_15151,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg, sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline minus MPTP group) [ug/mg wet weight]"
BXD_15152,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]"
BXD_15153,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), 5-HT concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g wet weight] "
BXD_15154,"Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), serotonin (5-HT) concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_15155,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight]"
BXD_15156,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on 5-HIAA (5-HT metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein]"
BXD_15157,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_15158,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]"
BXD_15159,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum)  in males 48 h after injection (MPTP group) [ug/g total protein] "
BXD_15160,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum)  in males 48 h after injection (MPTP-Saline group) [ug/g total protein] "
BXD_15161,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein]"
BXD_15162,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g total protein] "
BXD_15163,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum)  in males 48 h after injection (saline-MPTP group) [ug/g total protein] "
BXD_15164,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_15165,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_15166,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response difference (12.5 mg/kg sc vs saline), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection [difference ug/mg]"
BXD_15167,"Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, females between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.6 is all animals present with lesions]"
BXD_15168,"Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.7 is all animals present with lesions]"
BXD_15169,"Central nervous system, behavior, learning and memory: Spatial navigation, crossing events over location of trained platform in Morris water maze, final probe trial, males and females combined [n annulus crossings]"
BXD_15170,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec]"
BXD_15171,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec]"
BXD_15172,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec]"
BXD_15173,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Lat3 Table 1), males and females combined [sec]"
BXD_15174,"Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec]"
BXD_15175,"Reproduction, development: Somatic cell nuclear transfer (SCNT) success measured as the percentage of SCNT (clones) embryos developing to the 2-cell stage (Table 1) [fraction]"
BXD_15176,"Reproduction, development: Somatic cell nuclear transfer (SCNT) embryos (cloned) that successfully develop from the 2-cell to 4-cell stage (Table 1) [%]"
BXD_15177,"Reproduction, development: Trait 3, SCNT Blastocysts/2 cell; lathamk1@msu.edu. Fraction (%) of somatic cell nuclear transfer (clone) embryos developing from the 2 cell to blastocyst stage (Table 1)."
BXD_15178,"Reproduction, development: Blastocysts development, fraction of somatic cell nuclear transfer (SCNT) embryos developing from 4-cell stage to blastocyst stage (Table 1, Trait 4)[fraction]"
BXD_15179,"Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in adults of both sexes [frequency scale: 3 = common, 2 = occasional, 1 = rare, 0 =none] "
BXD_15180,"Infectious disease, immune system: UTHSC RBL Trait 1"
BXD_15181,"Central nervous system, gene expression, learning and memory: Kcnq5 mRNA expression in hippocampus (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [relative residual concentration]"
BXD_15183,"Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Pdyn probe sets and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15184,"Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, substance P, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Tac1 probe sets and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15185,"Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15186,"Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd2 probe sets and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15552,"Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron developmental expression signature) mRNA expression in adult striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15553,"Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using six Affymetrix exon-level Dock1 probe sets (exon 45 to 50) and Striatum_Exon_0209 data [relative residual concentration]"
BXD_15554,"Central nervous system, gene expression: Dopamine-associated trait (rwilliams@uthsc.edu)"
BXD_15555,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI1"
BXD_15556,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI3"
BXD_15557,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI2"
BXD_15558,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI4"
BXD_15559,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI5"
BXD_15560,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI6"
BXD_15561,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI7"
BXD_15562,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI8"
BXD_15563,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI9"
BXD_15564,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI10"
BXD_15565,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI11"
BXD_15566,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI12"
BXD_15568,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues, TAFI13"
BXD_15569,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI14"
BXD_15570,"Infectious disease, immune system: Kramer RM, Lamkin T, and colleagues TAFI15"
BXD_15571,"Skin, pigmentation: Hair coat color, ordinal scale version 3 where grey=1, black=2, brown=3, dba dilute=4 [color intensity]"
BXD_15572,"Central nervous system, pharmacology, behavior: Withdrawal anxiety assay, 7-day nicotine-treated (24 mg/kg/day, s.c. minipump)  + day 8 mecamylamine (2.0 mg/kg, s.c.), number of somatic signs observed in 8- to 12-week-old males during 20 min  session [n]. Data update 091116 MFM."
BXD_15573,"Central nervous system, pharmacology, behavior: withdrawal anxiety assay (Nic_Sal_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump)  + day 8 saline (0.01mL/g, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number]. "
BXD_15574,"Nic (24mg/kg/day) + Mec (2mg/kg), percent time in open arms of the EPM [%] (revised 12/12/22, MFM)"
BXD_15575,"Nicotine (24 mg/kg/day) + Saline, percent time in open arms of the EPM [%] (updated by M. Miles,12/15/22)"
BXD_15698,"Metabolism, behavior: Activty (ambulations) at night, metabolic cage, chow diet, males [AUC]"
BXD_15699,"Metabolism, behavior: Activty (ambulations)  at night, metabolic cage, high fat diet, males [AUC]"
BXD_15733,"Metabolism: Body temperature after 6 hours in 4 deg C chamber, high fat diet / chow diet, males [ratio]"
BXD_15773,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, chow diet, males [mg/mL/min]"
BXD_15774,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, chow diet, males [mg/mL/min]"
BXD_15776,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, high fat diet, males [mg/mL/min]"
BXD_15777,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, high fat diet, males [mg/mL/min]"
BXD_15792,"Blood chemistry, metabolism: Bile acids, fasted state, chow diet, males [umol/L]"
BXD_15798,"Blood chemistry, metabolism: Bilirubin, fasted state, chow diet, males [umol/L]"
BXD_15810,"Blood chemistry, metabolism: Bile acids, fasted state, high fat diet, males [umol/L]"
BXD_15816,Trait_255_AUW-BXD
BXD_15868,"Hematology: Nucleated red blood cells, chow diet, males [%]"
BXD_15875,"Hematology: Nucleated red blood cells, chow diet, males [10^3/uL]"
BXD_15912,"Hematology: Nucleated red blood cells, high fat diet, males [%]"
BXD_15919,"Hematology: Nucleated red blood cells, high fat diet, males [10^3/uL]"
BXD_15948,"Central nervous system, development: Cell death in brainstem following exposure to ethanol at E9, TUNEL-positive cells [n/mm2)"
BXD_15949,Central nervous system; embryonic neurogenesis; Cell death in the forebrain following ethanol exposure at E9 (TUNEL+ cells/mm2)
BXD_15950,"Reproduction, development: Trait 5, Parthenote 2 cell/constructs; lathamk1@msu.edu. Fraction (%) of parthenogenetic embryos developing to the 2 cell stage (Table 1)."
BXD_15951,"Reproduction, development: Trait 6, Parthenote 4cell/2cell; lathamk1@msu.edu. Fraction (%) of parthenogenetic embryos developing from the 2 cell to 4 cell stage (Table 1)."
BXD_15952,"Reproduction, development: Trait 7, Parthenote Blastocyst/2cell; lathamk1@msu.edu. Fraction (%) of parthenogenetic embryos developing from the 2 cell to blastocyst stage (Table 1)."
BXD_15953,"Reproduction, development: Trait 8, Parthenote Blastocyst/4cell; lathamk1@msu.edu. Fraction (%) of parthenogenetic embryos developing from the 4 cell to blastocyst stage (Table 1)."
BXD_15954,"Reproduction, development: Trait 9, SCNT:Parthenote 2 cell/constructs; lathamk1@msu.edu. Ratio of the fraction (%) of somatic cell nuclear transfer (clone) embryos : fraction (%) of parthenogenetic embryos for development to the 2 cell stage (Table 1)."
BXD_15955,"Reproduction, development: Ratio of the fraction (%) of somatic cell nuclear transfer (clone) embryos to fraction (%) of parthenogenetic embryos for development from the 2-cell to 4-cell stage (Table 1) [%]"
BXD_15956,"Reproduction, development: Trait 11, SCNT:Parthenote Blastocyst/2cell; lathamk1@msu.edu. Ratio of the fraction (%) of somatic cell nuclear transfer (clone) embryos : fraction (%) of parthenogenetic embryos for development from the 2 cell to blastocyst stage (Table 1)."
BXD_15957,"Reproduction, development: Somatic cell nuclear transfer (clone) embryo percentage divided by parthenogenetic embryo percentage for development from 4-cell stage to blastocyst stage (see Table 1)"
BXD_15958,"Metabolism, pancreas, visual system: Lucki 1"
BXD_15959,"Central nervous system, toxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu)"
BXD_15960,Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2)
BXD_15961,Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to ethanol at E9 (TUNEL+ cells/mm2)
BXD_15962,"Infectious disease, immune system: Sassetti, Christopher, Trait 1"
BXD_15963,"Infectious disease, immune system: Sassetti, Christopher, Trait 2"
BXD_15964,"Infectious disease, immune system: Rona J Mogil and colleagues (contact rona.mogil@stjude.org)"
BXD_15965,"Central nervous system, gene expression: Vasopressin receptor expression gene family mapping to Avpr1a using Hypothalamus data set (BXD84 winsorized from 6.26 to 3.7)"
BXD_15966,"Development, morphology: Somite count at E9.5 (D. Goldowitz laboratory) [n]"
BXD_15967,"Musculoskeletal system: Bone mineral density (BMD) of femur, adjusted for sex and age difference, measured by dual energy X-ray absorptiometry (DEXA) [mg/cm2]"
BXD_15968,"Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) of the tibia in young adults corrected for sex and age [units]"
BXD_15969,"Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age, sex, body weight, and strain epoch effects [N cells per mm of RMS length]"
BXD_15970,Gustation: Filiform papillae number [adjusted n]
BXD_15971,"Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes"
BXD_15972,"Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes"
BXD_15973,"Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes"
BXD_15974,"Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes"
BXD_15975,"Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes"
BXD_15976,"Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes"
BXD_16177,"Central nervous system, development: Apoptosis in hippocampus CA1"
BXD_16178,Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)
BXD_16179,Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2)
BXD_16180,"Pharmacology, toxicology: Alcohol response (4 mg/kg in saline,  IP), blood alcohol concentration (BAC) 1 hr after injection of young adult males and females (strain average associated with GenEx EtOH cerebellum gene expression) [mg/dl]"
BXD_16181,Trait_2_GENEX_CB_BXD
BXD_16182,Trait_3_GENEX_CB_BXD
BXD_16183,Trait_4_GENEX_CB_BXD
BXD_16184,"Pharmacology, toxicology: Alcohol response (4 mg/kg in saline,  IP), blood alcohol concentration (BAC) maximum after injection of young adult males and females (strain average associated with GenEx EtOH cerebellum gene expression) [mg/dl]"
BXD_16185,"Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality]"
BXD_16186,"Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions]"
BXD_16187,"Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age effects [n cells]"
BXD_16188,"Central nervous system, behavior: Soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXDs and female C57BL/6J-R6/2 Huntington, 2B7/left hemisphere wt R6/2 cases only [FRET fluorescence ratio]"
BXD_16189,"Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]"
BXD_16190,"Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio]"
BXD_16191,"Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g]"
BXD_16192,"Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g]"
BXD_16193,"Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g]"
BXD_16194,"Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %]"
BXD_16195,"Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %]"
BXD_16196,"Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %]"
BXD_16197,"Central nervous system, pharmacology, behavior: Difference in nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4) and saline response (0.9%, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males (lower panel, Fig 1) [s]"
BXD_16198,Central nervous system; embryonic neurogenesis; Cell death in untreated brainstem at E9 (TUNEL+ cells/mm2)
BXD_16199,Central nervous system; embryonic neurogenesis; Cell death in untreated forebrain at E9 (TUNEL+ cells/mm2)
BXD_16202,"Central nervous system, behavior, learning and memory: Visual discrimination using a touchscreen assay, sessions required to reach the learning criterion during pre-training phase 2 (touch phase, animals must learn to nose-poke the screen) where low value = fast to learn (see Figure 4A) in 3-month-old males [n]
"
BXD_16203,"Central nervous system, behavior, learning and memory: Visual discrimination using a touchscreen assay, sessions required to reach the learning criterion during pre-training phase 3 (punish phase, animals must learn to nose-poke only random shaped visual stimuli) where low value = fast to learn (see Figure 4A) in 3-month-old males [n]"
BXD_16204,"Central nervous system, behavior, learning and memory: Visual discrimination learning using a touchscreen assay, sessions to discriminate between rewarded and unrewarded stimuli (low value = fast to learn, see Figure 4B blue bars) in 3-month-old males [n]"
BXD_16205,"Central nervous system, behavior, learning and memory: Reversal learning using a touchscreen assay, number of sessions to reverse previously learned stimulus-reward pairings (low value = fast to reverse responding, see Figure 4B red bars of Graybeal et al, 2014) in 3-month-old males [n]"
BXD_16206,"Central nervous system, behavior, learning and memory: Extinction learning, sessions to extinguish a well learned instrumental response using a touchscreen assay (low value = fast to extinguish unrewarded response, see Figure 4B yellow bars) in 3-month-old males [n]"
BXD_16207,"Central nervous system, behavior, learning and memory: Discrimination test correct responses using a touchscreen assay in 3-month-old males (supplementary trait data not in paper) [n]"
BXD_16208,"Central nervous system, behavior, learning and memory: Visual discrimination learning using a touchscreen assay, total mean number of errors during discrimination learning (see Figure 4C) in 3-month-old males [n]"
BXD_16209,"Central nervous system, behavior, learning and memory: Visual discrimination learning using a touchscreen assay, total mean number of corrections errors (incorrect responses following an initial error) during discrimination learning (see Figure 4D) in 3-month-old males [n]"
BXD_16210,"Central nervous system, behavior, learning and memory: Visual discrimination learning using a touchscreen assay, mean reaction time to nose-poke the stimulus across all discrimination learning sessions (see Figure S4A) in 3-month-old males [sec]"
BXD_16211,"Central nervous system, behavior, learning and memory: Visual discrimination learning using a touchscreen assay, mean magazine latency (time to retrieve reward) across all discrimination learning sessions (see Figure S4B) in 3-month-old males [sec]
"
BXD_16212,"Central nervous system, behavior: Reversal learning correct responses using a touchscreen assay in 3-month-old males (supplementary trait data not in paper) [n]"
BXD_16213,"Central nervous system, behavior: Reversal learning correct responses <50% using a touchscreen assay in 3-month-old males (supplementary trait data not in paper) [n]"
BXD_16214,"Central nervous system, behavior: Reversal learning correct responses >50% using a touchscreen assay in 3-month-old males (supplementary trait data not in paper, BXD95 winsorized from 878.5 to 662)  [n]
"
BXD_16215,"Central nervous system, behavior, learning and memory: Reversal learning errors using a touchscreen assay across all reversal learning sessions (see Figure 5A) in 3-month-old males [n]"
BXD_16216,"Central nervous system, behavior, learning and memory: Reversal learning using a touchscreen assay, number of errors during early reversal learning when performance was at or below 50% accuracy (see Figure 5C) in 3-month-old males [n]"
BXD_16217,"Central nervous system, behavior, learning and memory: Reversal learning errors using a touchscreen assay during the late reversal learning phase when performance was above 50% accuracy (Figure 5E) in 3-month-old males [n]"
BXD_16218,"Central nervous system, behavior, learning and memory: Reversal learning correction errors using a touchscreen assay, means across all reversal learning trials (Figure 5B ) in 3-month-old males [n]"
BXD_16219,"Central nervous system, behavior, learning and memory: Reversal learning correction errors using a touchscreen assay during the early phase trials when performance was at or below 50% accuracy (Figure 5D) in 3-month-old males [n]"
BXD_16220,"Central nervous system, behavior, learning and memory: Reversal learning correction errors using a touchscreen assay during the late phase trials when performance was above 50% accuracy (Figure 5F) in 3-month-old males [n]"
BXD_16221,"Central nervous system, behavior, learning and memory: Reversal learning reaction time to nose-poke stimuli using a touchscreen assay averaged across all reversal learning trials (Figure S4C) in 3-month-old males [sec]"
BXD_16222,"Central nervous system, behavior, learning and memory: Reversal learning magazine latency using a touchscreen assay (time to retrieve food reward) averaged across all reversal learning trials (Figure S4D) in 3-month-old males [sec]"
BXD_16223,"Central nervous system, behavior, learning and memory: Extinction learning, correct responses during extinction of a well learned instrumental response using a touchscreen assay (low value = fast to extinguish unrewarded response, supplementary trait data not in paper but related to Figure S5) in 3-month-old males [n]"
BXD_16224,"Central nervous system, behavior, learning and memory: Extinction learning using a touchscreen assay, error responses during extinction training of a well learned instrumental response (low value = fast to extinguish unrewarded response, Figure S5A of Graybeal et al, 2014) in 3-month-old males (added n/strain, Dec 1, 2016) [n]"
BXD_16225,"Central nervous system, behavior, learning and memory: Extinction learning correction errors using a touchscreen assay (low value = fast to extinguish unrewarded response, Figure S5B) in 3-month-old males [n]"
BXD_16226,"Central nervous system, behavior, learning and memory: Extinction learning reaction time using a touchscreen assay during extinction of a well learned instrumental response (Figure S5C) in 3-month-old males [sec]"
BXD_16227,"Central nervous system, behavior, learning and memory: Extinction of a learned stimulus using a touchscreen assay, food pellet magazine latency for a non-rewarded but well learned instrumental response in 3-month-old males (supplementary trait data not in paper)[sec]"
BXD_16228,"Infectious disease, immune system: Richard Thompson and Nancy Sawtell trait "
BXD_16229,"Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH]"
BXD_16230,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol, median in males and females [% LDH increase]"
BXD_16231,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta median in males and females [% LDH increase]"
BXD_16232,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol, median in males and females [% LDH increase]"
BXD_16233,"Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males [% LDH supernatant of total LDH]"
BXD_16234,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males [% LDH increase]"
BXD_16235,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta, median in males [% LDH increase]"
BXD_16236,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol, median in males [% LDH increase]"
BXD_16237,"Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment), median in females [% LDH supernatant of total LDH]"
BXD_16238,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol, median in females [% LDH increase]"
BXD_16239,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta, median in females [% LDH increase]"
BXD_16240,"Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells]"
BXD_16241,"Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]"
BXD_16242,"Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)]"
BXD_16243,"Metadata, cofactor: Age at death (average) of hippocampal samples (use only with UTHSC BXD Aged Hippocampus Affy expression data sets) [days]"
BXD_16244,"Cardiovascular system, morphology: Heart weight, young adult males and females, unadjusted (BXD19 winsorized from 101.4 to 118) [mg]"
BXD_16245,"Cardiovascular system, morphology: Heart weight, young adult males and females, adjusted by age, sex, and body weight (BXD19 winsorized from 80.7 to 118) [mg]"
BXD_16246,"Central nervous system, postnatal neurogenesis: contact Dan Goldowitz (dang@cmmt.ubc.ca)"
BXD_16247,"Metagenome, gastrointestinal system: Microbiome, Actinobacteria (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16248,"Metagenome, gastrointestinal system: Microbiome, Actinobacteria (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16249,"Metagenome, gastrointestinal system: Microbiome, Actinobacteridae (subclass) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16250,"Metagenome, gastrointestinal system: Microbiome, Actinomycetales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16251,"Metagenome, gastrointestinal system: Microbiome, Aerococcaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16252,"Metagenome, gastrointestinal system: Microbiome, Aerococcus (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16253,"Metagenome, gastrointestinal system: Microbiome, Alistipes (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16254,"Metagenome, gastrointestinal system: Microbiome, Bacilli (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16255,"Metagenome, gastrointestinal system: Microbiome, Bacteroidales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16256,"Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16257,"Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16258,"Metagenome, gastrointestinal system: Microbiome, Clostridia (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16259,"Metagenome, gastrointestinal system: Microbiome, Clostridiales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16260,"Metagenome, gastrointestinal system: Microbiome, Coriobacteriaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16261,"Metagenome, gastrointestinal system: Microbiome, Coriobacteriales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16262,"Metagenome, gastrointestinal system: Microbiome, Coriobacteridaesub (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16263,"Metagenome, gastrointestinal system: Microbiome, Coriobacterineae (suborder) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16264,"Metagenome, gastrointestinal system: Microbiome, Corynebacteriaceae (family) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16265,"Metagenome, gastrointestinal system: Microbiome, Corynebacterineae (suborder) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16266,"Metagenome, gastrointestinal system: Microbiome, Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16267,"Metagenome, gastrointestinal system: Microbiome, Erysipelotrichaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16268,"Metagenome, gastrointestinal system: Microbiome, Erysipelotrichales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16269,"Metagenome, gastrointestinal system: Microbiome, Erysipelotrichi (class) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16270,"Metagenome, gastrointestinal system: Microbiome, Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16271,"Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae Incertae Sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16272,"Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16273,"Metagenome, gastrointestinal system: Microbiome, Lactobacillaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16274,"Metagenome, gastrointestinal system: Microbiome, Lactobacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16275,"Metagenome, gastrointestinal system: Microbiome, Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16276,"Metagenome, gastrointestinal system: Microbiome, Marinilabilia (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16277,"Metagenome, gastrointestinal system: Microbiome, Prevotellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16278,"Metagenome, gastrointestinal system: Microbiome, Rikenellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16279,"Metagenome, gastrointestinal system: Microbiome, Ruminococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16280,"Metagenome, gastrointestinal system: Microbiome, TM7 genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16281,"Metagenome, gastrointestinal system: Microbiome, TM7 (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16282,"Metagenome, gastrointestinal system: Microbiome, Turicibacter (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16283,"Metagenome, gastrointestinal system: Microbiome, Bacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16284,"Metagenome, gastrointestinal system: Microbiome, Staphylococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16285,"Metagenome, gastrointestinal system: Microbiome, Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16286,"Metagenome, gastrointestinal system: Microbiome, Jeotgalicoccus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16287,"Metagenome, gastrointestinal system: Microbiome, Bacteroidaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16288,"Metagenome, gastrointestinal system: Microbiome, Bacteroides (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16289,"Metagenome, gastrointestinal system: Microbiome, Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16290,"Metagenome, gastrointestinal system: Microbiome, Lactobacillus johnsonii (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16291,"Metagenome, gastrointestinal system: Microbiome, Lactobacillus murinus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16292,"Metagenome, gastrointestinal system: Microbiome, Lactobacillus intestinalis (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16293,"Metagenome, gastrointestinal system: Microbiome, Staphylococcus xylosus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16294,"Metagenome, gastrointestinal system: Microbiome, Staphylococcus lentus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16295,"Metagenome, gastrointestinal system: Microbiome, Barnsiella (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction]"
BXD_16297,"Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged) [cells/mm^3]"
BXD_16298,"Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged, BXD32 is a photoreceptor mutant and should be removed before most analyses) [n x10^6]"
BXD_16300,"Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones), unilateral per retina in young adults of both sexes [cells/mm^3]"
BXD_16301,"Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes [n x10^6]"
BXD_16302,"Central nervous system, behavior: Depression assay, tail suspension test (TST) control levels of immobility before drug treatment (data of Dr. Gang Chen) [sec]"
BXD_16303,"Central nervous system: Apoptosis in cortex L5, percentage of caspase-3-positive immunolabeled cells [%]"
BXD_16304,"Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit]"
BXD_16305,"Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit]"
BXD_16307,"Central nervous system, morphology: Intra- and infrapyramidal mossy fiber (IIPMF) volume as  a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_16309,"Central nervous system, morphology: New neurons in the dentate gyrus of the young adult hippocampus corrected for number of proliferating precursors (data derived from Record IDs 10797 and 10795) [z score]"
BXD_16310,"Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration]"
BXD_16311,"Central nervous system, behavior, cognition: Impulsivity measured as motor impulsivity in the 5-choice serial reaction time task (5CSRT), premature responses before stimulus presentation (Med Associates 5-hole operant chambers) in males (high value = high impulsivity = poor performance, from Figure 1A, but BXD16 and BXD68 winsorised from 31.9%  and 21.5%  to 18.1% and 18.0%, respectively) [%]"
BXD_16312,"Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time]"
BXD_16313,"Morphology, cofactor : Body weight of young adult females before immunization with TSHR A-subunit (human) adenovirus (see Traits 16314-16323 by McLachlan and colleagues) [g]"
BXD_16314,"Immune system: TBI-0x, pre-immunization serum inhibition of TSH binding to the TSHR [% inhibition] "
BXD_16315,"Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition]"
BXD_16316,"Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females (controlled by MHC region of Chr 17) [% inhibition]"
BXD_16317,"Endocrine system, thyroid: T4-0x, serum thyroxine (T4) before immunization with TSHR A-subunit adenovirus [micrograms/dL]"
BXD_16318,"Endocrine system, thyroid: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus [micrograms/dL]"
BXD_16319,"Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL]"
BXD_16320,"Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm]"
BXD_16321,"Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm]"
BXD_16322,"Endocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL]"
BXD_16323,"Endocrine system, thyroid: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] "
BXD_16330,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive]
"
BXD_16331,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, day of death [days]"
BXD_16332,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight]

"
BXD_16333,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight]"
BXD_16334,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight]"
BXD_16335,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight]"
BXD_16336,Metabolism: Thorens Trait 1 (demo only)
BXD_16337,"Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes. Merged."
BXD_16338,"Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes. Merged."
BXD_16339,"Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes. Merged."
BXD_16340,"Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes (BXD48 and BXD48a are merged, BXD65 and BXD65a are merged, BXD73, BXD73a and BXD73b are merged) [mmHg]"
BXD_16341,"Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes. Merged."
BXD_16342,"Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes. Merged."
BXD_16343,"Infectious disease, immune function: Body weight change THREE days post infection (3 dpi) with H1N1 (PR8) influenza A virus (2x10E3 FFU) in 9-14 week old females (same cases used in BXD Lung RNAseq data set: HZI Lung Flu Infected BXD (Nov16), GN807) [%]"
BXD_16346,"Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit]"
BXD_16350,"Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight]"
BXD_16355,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16356,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16357,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16358,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16359,"Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 7, mixed sexes from 2 to 5 litters [kHz] (Data winsorized, BXD86 from 55.419 to 56.192)"
BXD_16360,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16361,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16362,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16363,"Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg]"
BXD_16364,"Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg]"
BXD_16365,"Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]"
BXD_16366,"Reproduction, urogenital system, morphology: uterine body width at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm]"
BXD_16367,"Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm]"
BXD_16368,CPV map 2
BXD_16369,"Infectious disease, immune system: CPV map 4"
BXD_16370,"Infectious disease, immune system: Cowpox virus disease (CPV) mapping 4 <amandad.rice@gmail.com>"
BXD_16371,CPV map 10
BXD_16372,"Infectious disease, immune system: CPV map 9 (Amanda Rice, Dick Moyer and colleagues 2013)"
BXD_16373,"Infectious disease, immune system: CPV map 8 (Amanda Rice and colleagues)"
BXD_16374,"Infectious disease, immune system: CPV map 7"
BXD_16375,"Central nervous system, pharmacology: Ethanol response, blood ethanol concentration (BEC) during 4th cycle of ethanol exposure in vapor chamber (not associated with voluntary consumption) for male or female (Dec 2009 Cohort 1) [mg%]"
BXD_16376,"Infectious disease, immune function:  Parameter 2"
BXD_16377,"Infectious disease, immune system: EOMES coefficient (Malak Kotb and colleagues 2014)"
BXD_16381,"Immune function, infectious disease: CPV map 6 (Charity Brannen (charity.brannen@bchs.edu), Amanda Rice, Richard W. Moyer, and Malak Kotb (mkotbster@gmail.com)"
BXD_16382,"Infectious disease, immune system: CPV map 5 (Amanda Rice and colleagues)"
BXD_16383,"Infectious disease, immune system: CPV map 3 (Amanda Rice and colleagues)"
BXD_16384,CPV mapping Amanda Data map 1
BXD_16385,"Central nervous system, cardiovascular system: Thad Nowak Trait 1 (contact tnowak@uthsc.edu)"
BXD_16386,"Central nervous system, cardiovascular system: Thad Nowak Trait 2 (contact tnowak@uthsc.edu)"
BXD_16387,"Central nervous system, cardiovascular system: Thad Nowak Trait 3 (contact tnowak@uthsc.edu)"
BXD_16388,"Central nervous system, cardiovascular system: Thad Nowak Trait 4 (contact tnowak@uthsc.edu)"
BXD_16389,"Central nervous system, cardiovascular system: Thad Nowak Trait 5 (contact tnowak@uthsc.edu)"
BXD_16600,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16601,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16602,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16603,"Central nervous system, behavior, development, communication: Infant vocalization, Roy1"
BXD_16604,"Toxicology, liver, pharmacology: Induction of CYP1B1 mRNA after treatment with beta-Naphthoflavone (BNF, 15 uM for 24 h), measured by rtPCR in cryorederived primary hepatocytes (Varigenix CRL Panel, three technical replicates/strain/treatment) [fold-increase relative DMSO control]"
BXD_16605,"Toxicology, liver, pharmacology: Basal CYP1B1 mRNA expression measured by rtPCR in cryorederived primary hepatocytes in DMSO (Varigenix CRL Panel, three technical replicates/strain/treatment, higher numbers = lower endogenous expression, the Cyp1b1 gene is located on Chr 17 at 80 Mb) [cycles]"
BXD_16606,"Central nervous system, phenotypes, behavior: ds1"
BXD_16607,"Infectious disease, immune system: D3_colo_Russo "
BXD_16608,"Infectious disease, immune system: Please put in a full description of the phenotype here with sex, age, innoculum, dose, route and at the end in square brackets the [units]"
BXD_16609,"Central nervous system, gene expression: Trpc3 mRNA expression in hippocampus (transient receptor potential cation channel, subfamily C, member 3), first principal component generated using exon probe sets and with high expression (<8.5, covaries well with exon 1, 2, 6, 7, 8, and 3' UTR probe set, r = +0.85, potential hybridization artifact) [relative residual concentration]"
BXD_16610,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16611,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16612,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16613,"Central nervous system, behavior, social interaction: Mounting of an unfamiliar juvenile male partner during a 6-min direct social interaction session in adult males [%].  "
BXD_16614,"Central nervous system, behavior, social interaction: Aggression toward an unfamiliar juvenile male partner during a 6-min direct social interaction session in adult males [%]."
BXD_16615,"Central nervous system, behavior, social interaction: Self-grooming during a 6-min direct social interaction session in adult males [%]"
BXD_16616,"Central nervous system, behavior, social interaction: Time spent in the center chamber during the 10-min social approach session in the 3-chamber social interaction task in adult males [%]."
BXD_16617,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16618,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16619,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16620,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16621,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 1"
BXD_16622,"Blood chemistry, metabolism, metabolite: AMC Trait 001 contact <sander.houten@mssm.edu>"
BXD_16623,"Blood chemistry, metabolism, metabolite: AMC Trait 002 contact <sander.houten@mssm.edu>"
BXD_16624,"Blood chemistry, metabolism, metabolite: AMC Trait 003 contact <sander.houten@mssm.edu>"
BXD_16625,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate levels measured by LC-MS/MS in pooled plasma after overnight fasting in males at 29 weeks of age (combined data for chow and high fat diets) [nmol/ml]"
BXD_16626,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate levels measured by LC-MS/MS in pooled plasma after overnight fasting in males at 29 weeks of age on a high fat diet (Harlan 06414, 60% kCal/fat) for 20 weeks [nmol/ml]"
BXD_16627,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate levels measured by LC-MS/MS in pooled plasma after overnight fasting in males at 29 weeks of age on a normal chow diet (Harlan 2918, 6% kCal/fat) [nmol/ml]"
BXD_16628,"Blood chemistry, metabolism, metabolite: AMC Trait 007 contact <sander.houten@mssm.edu>"
BXD_16629,"Blood chemistry, metabolism, metabolite: AMC Trait 008 contact <sander.houten@mssm.edu>"
BXD_16630,"Blood chemistry, metabolism, metabolite: AMC Trait 009 contact <sander.houten@mssm.edu>"
BXD_16631,"Blood chemistry, metabolism, metabolite: AMC Trait 010 contact <sander.houten@mssm.edu>"
BXD_16632,"Blood chemistry, metabolism, metabolite: AMC Trait 011 contact <sander.houten@mssm.edu>"
BXD_16633,"Blood chemistry, metabolism, metabolite: AMC Trait 012 contact <sander.houten@mssm.edu>"
BXD_16634,"Blood chemistry, metabolism, metabolite: AMC Trait 019 contact <sander.houten@mssm.edu>"
BXD_16635,"Blood chemistry, metabolism, metabolite: AMC Trait 020 contact <sander.houten@mssm.edu>"
BXD_16636,"Blood chemistry, metabolism, metabolite: AMC Trait 021 contact <sander.houten@mssm.edu>"
BXD_16637,"Blood chemistry, metabolism, metabolite: AMC Trait 022 contact <sander.houten@mssm.edu>"
BXD_16638,"Blood chemistry, metabolism, metabolite: AMC Trait 023 contact <sander.houten@mssm.edu>"
BXD_16639,"Blood chemistry, metabolism, metabolite: AMC Trait 024 contact <sander.houten@mssm.edu>"
BXD_16640,"Blood chemistry, metabolism, metabolite: AMC Trait 028 contact <sander.houten@mssm.edu>"
BXD_16641,"Blood chemistry, metabolism, metabolite: AMC Trait 029 contact <sander.houten@mssm.edu>"
BXD_16642,"Blood chemistry, metabolism, metabolite: AMC Trait 030 contact <sander.houten@mssm.edu>"
BXD_16643,"Blood chemistry, metabolism, metabolite: AMC Trait 031 contact <sander.houten@mssm.edu>"
BXD_16644,"Blood chemistry, metabolism, metabolite: AMC Trait 032 contact <sander.houten@mssm.edu>"
BXD_16645,"Blood chemistry, metabolism, metabolite: AMC Trait 033 contact <sander.houten@mssm.edu>"
BXD_16646,"Blood chemistry, metabolism, metabolite: AMC Trait 034 contact <sander.houten@mssm.edu>"
BXD_16647,"Blood chemistry, metabolism, metabolite: AMC Trait 035 contact <sander.houten@mssm.edu>"
BXD_16648,"Blood chemistry, metabolism, metabolite: AMC Trait 036 contact <sander.houten@mssm.edu>"
BXD_16649,"Blood chemistry, metabolism, metabolite: AMC Trait 037 contact <sander.houten@mssm.edu>"
BXD_16650,"Blood chemistry, metabolism, metabolite: AMC Trait 038 contact <sander.houten@mssm.edu>"
BXD_16651,"Blood chemistry, metabolism, metabolite: AMC Trait 039 contact <sander.houten@mssm.edu>"
BXD_16652,"Blood chemistry, metabolism, metabolite: AMC Trait 040 contact <sander.houten@mssm.edu>"
BXD_16653,"Blood chemistry, metabolism, metabolite: AMC Trait 041 contact <sander.houten@mssm.edu>"
BXD_16654,"Blood chemistry, metabolism, metabolite: AMC Trait 042 contact <sander.houten@mssm.edu>"
BXD_16655,"Blood chemistry, metabolism, metabolite: AMC Trait 043 contact <sander.houten@mssm.edu>"
BXD_16656,"Blood chemistry, metabolism, metabolite: AMC Trait 044 contact <sander.houten@mssm.edu>"
BXD_16657,"Blood chemistry, metabolism, metabolite: AMC Trait 045 contact <sander.houten@mssm.edu>"
BXD_16658,"Blood chemistry, metabolism, metabolite: AMC Trait 049 contact <sander.houten@mssm.edu>"
BXD_16659,"Blood chemistry, metabolism, metabolite: AMC Trait 050 contact <sander.houten@mssm.edu>"
BXD_16660,"Blood chemistry, metabolism, metabolite: AMC Trait 051 contact <sander.houten@mssm.edu>"
BXD_16661,"Blood chemistry, metabolism, metabolite: AMC Trait 052 contact <sander.houten@mssm.edu>"
BXD_16662,"Blood chemistry, metabolism, metabolite: AMC Trait 053 contact <sander.houten@mssm.edu>"
BXD_16663,"Blood chemistry, metabolism, metabolite: AMC Trait 054 contact <sander.houten@mssm.edu>"
BXD_16664,"Blood chemistry, metabolism, metabolite: AMC Trait 055 contact <sander.houten@mssm.edu>"
BXD_16665,"Blood chemistry, metabolism, metabolite: AMC Trait 056 contact <sander.houten@mssm.edu>"
BXD_16666,"Blood chemistry, metabolism, metabolite: AMC Trait 057 contact <sander.houten@mssm.edu>"
BXD_16667,"Blood chemistry, metabolism, metabolite: AMC Trait 058 contact <sander.houten@mssm.edu>"
BXD_16668,"Blood chemistry, metabolism, metabolite: AMC Trait 059 contact <sander.houten@mssm.edu>"
BXD_16669,"Blood chemistry, metabolism, metabolite: AMC Trait 060 contact <sander.houten@mssm.edu>"
BXD_16670,"Blood chemistry, metabolism, metabolite: AMC Trait 061 contact <sander.houten@mssm.edu>"
BXD_16671,"Blood chemistry, metabolism, metabolite: AMC Trait 062 contact <sander.houten@mssm.edu>"
BXD_16672,"Blood chemistry, metabolism, metabolite: AMC Trait 063 contact <sander.houten@mssm.edu>"
BXD_16673,"Blood chemistry, metabolism, metabolite: AMC Trait 064 contact <sander.houten@mssm.edu>"
BXD_16674,"Blood chemistry, metabolism, metabolite: AMC Trait 065 contact <sander.houten@mssm.edu>"
BXD_16675,"Blood chemistry, metabolism, metabolite: AMC Trait 066 contact <sander.houten@mssm.edu>"
BXD_16676,"Blood chemistry, metabolism, metabolite: AMC Trait 067 contact <sander.houten@mssm.edu>"
BXD_16677,"Blood chemistry, metabolism, metabolite: AMC Trait 068 contact <sander.houten@mssm.edu>"
BXD_16678,"Blood chemistry, metabolism, metabolite: AMC Trait 069 contact <sander.houten@mssm.edu>"
BXD_16679,"Blood chemistry, metabolism, metabolite: AMC Trait 070 contact <sander.houten@mssm.edu>"
BXD_16680,"Blood chemistry, metabolism, metabolite: AMC Trait 071 contact <sander.houten@mssm.edu>"
BXD_16681,"Blood chemistry, metabolism, metabolite: AMC Trait 072 contact <sander.houten@mssm.edu>"
BXD_16682,"Blood chemistry, metabolism, metabolite: AMC Trait 076 contact <sander.houten@mssm.edu>"
BXD_16683,"Blood chemistry, metabolism, metabolite: AMC Trait 077 contact <sander.houten@mssm.edu>"
BXD_16684,"Blood chemistry, metabolism, metabolite: AMC Trait 078 contact <sander.houten@mssm.edu>"
BXD_16685,"Blood chemistry, metabolism, metabolite: AMC Trait 082 contact <sander.houten@mssm.edu>"
BXD_16686,"Blood chemistry, metabolism, metabolite: AMC Trait 083 contact <sander.houten@mssm.edu>"
BXD_16687,"Blood chemistry, metabolism, metabolite: AMC Trait 084 contact <sander.houten@mssm.edu>"
BXD_16688,"Blood chemistry, metabolism, metabolite: AMC Trait 088 contact <sander.houten@mssm.edu>"
BXD_16689,"Blood chemistry, metabolism, metabolite: AMC Trait 089 contact <sander.houten@mssm.edu>"
BXD_16690,"Blood chemistry, metabolism, metabolite: AMC Trait 090 contact <sander.houten@mssm.edu>"
BXD_16691,"Blood chemistry, metabolism, metabolite: C5 dicarboxylylcarnitine levels measured by MS/MS in pooled plasma after overnight fasting in males at 29 weeks of age (combined data for chow and high fat diets) [nmol/ml]"
BXD_16692,"Blood chemistry, metabolism, metabolite: AMC Trait 092 contact <sander.houten@mssm.edu>"
BXD_16693,"Blood chemistry, metabolism, metabolite: C5 dicarboxylylcarnitine levels measured by MS/MS in pooled plasma after overnight fasting in males at 29 weeks of age on a normal chow diet (Harlan 2918, 6% kCal/fat) [nmol/ml]"
BXD_16694,"Blood chemistry, metabolism, metabolite: AMC Trait 100 contact <sander.houten@mssm.edu>"
BXD_16695,"Blood chemistry, metabolism, metabolite: AMC Trait 101 contact <sander.houten@mssm.edu>"
BXD_16696,"Blood chemistry, metabolism, metabolite: AMC Trait 102 contact <sander.houten@mssm.edu>"
BXD_16697,"Blood chemistry, metabolism, metabolite: AMC Trait 106 contact <sander.houten@mssm.edu>"
BXD_16698,"Blood chemistry, metabolism, metabolite: AMC Trait 107 contact <sander.houten@mssm.edu>"
BXD_16699,"Blood chemistry, metabolism, metabolite: AMC Trait 108 contact <sander.houten@mssm.edu>"
BXD_16700,"Blood chemistry, metabolism, metabolite: AMC Trait 109 contact <carmen.argmann@mssm.edu>"
BXD_16701,"Blood chemistry, metabolism, metabolite: AMC Trait 110 contact <carmen.argmann@mssm.edu>"
BXD_16702,"Blood chemistry, metabolism, metabolite: AMC Trait 111 contact <carmen.argmann@mssm.edu>"
BXD_16703,"Blood chemistry, metabolism, metabolite: AMC Trait 112 contact <sander.houten@mssm.edu>"
BXD_16704,"Blood chemistry, metabolism, metabolite: AMC Trait 113 contact <sander.houten@mssm.edu>"
BXD_16705,"Blood chemistry, metabolism, metabolite: AMC Trait 114 contact <sander.houten@mssm.edu>"
BXD_16706,"Blood chemistry, metabolism, metabolite: AMC Trait 127 contact <carmen.argmann@mssm.edu>"
BXD_16707,"Blood chemistry, metabolism, metabolite: AMC Trait 128 contact <carmen.argmann@mssm.edu>"
BXD_16708,"Blood chemistry, metabolism, metabolite: AMC Trait 129 contact <carmen.argmann@mssm.edu>"
BXD_16709,"Blood chemistry, metabolism, metabolite: AMC Trait 130 contact <carmen.argmann@mssm.edu>"
BXD_16710,"Blood chemistry, metabolism, metabolite: AMC Trait 131 contact <carmen.argmann@mssm.edu>"
BXD_16711,"Blood chemistry, metabolism, metabolite: AMC Trait 132 contact <carmen.argmann@mssm.edu>"
BXD_16712,"Blood chemistry, metabolism, metabolite: AMC Trait 133 contact <sander.houten@mssm.edu>"
BXD_16713,"Blood chemistry, metabolism, metabolite: AMC Trait 134 contact <sander.houten@mssm.edu>"
BXD_16714,"Blood chemistry, metabolism, metabolite: AMC Trait 135 contact <sander.houten@mssm.edu>"
BXD_16715,"Blood chemistry, metabolism, metabolite: AMC Trait 136 contact <sander.houten@mssm.edu>"
BXD_16716,"Blood chemistry, metabolism, metabolite: AMC Trait 137 contact <sander.houten@mssm.edu>"
BXD_16717,"Blood chemistry, metabolism, metabolite: AMC Trait 138 contact <sander.houten@mssm.edu>"
BXD_16718,"Blood chemistry, metabolism, metabolite: AMC Trait 139 contact <sander.houten@mssm.edu>"
BXD_16719,"Blood chemistry, metabolism, metabolite: AMC Trait 140 contact <sander.houten@mssm.edu>"
BXD_16720,"Blood chemistry, metabolism, metabolite: AMC Trait 141 contact <sander.houten@mssm.edu>"
BXD_16721,"Blood chemistry, metabolism, metabolite: AMC Trait 142 contact <sander.houten@mssm.edu>"
BXD_16722,"Blood chemistry, metabolism, metabolite: AMC Trait 143 contact <sander.houten@mssm.edu>"
BXD_16723,"Blood chemistry, metabolism, metabolite: AMC Trait 144 contact <sander.houten@mssm.edu>"
BXD_16724,"Blood chemistry, metabolism, metabolite: AMC Trait 145 contact <sander.houten@mssm.edu>"
BXD_16725,"Blood chemistry, metabolism, metabolite: AMC Trait 146 contact <sander.houten@mssm.edu>"
BXD_16726,"Blood chemistry, metabolism, metabolite: AMC Trait 147 contact <sander.houten@mssm.edu>"
BXD_16727,"Blood chemistry, metabolism, metabolite: AMC Trait 148 contact <sander.houten@mssm.edu>"
BXD_16728,"Blood chemistry, metabolism, metabolite: AMC Trait 149 contact <sander.houten@mssm.edu>"
BXD_16729,"Blood chemistry, metabolism, metabolite: AMC Trait 150 contact <sander.houten@mssm.edu>"
BXD_16730,"Blood chemistry, metabolism, metabolite: AMC Trait 151 contact <sander.houten@mssm.edu>"
BXD_16731,"Blood chemistry, metabolism, metabolite: AMC Trait 152 contact <sander.houten@mssm.edu>"
BXD_16732,"Blood chemistry, metabolism, metabolite: AMC Trait 153 contact <sander.houten@mssm.edu>"
BXD_16733,"Blood chemistry, metabolism, metabolite: AMC Trait 154 contact <sander.houten@mssm.edu>"
BXD_16734,"Blood chemistry, metabolism, metabolite: AMC Trait 155 contact <sander.houten@mssm.edu>"
BXD_16735,"Blood chemistry, metabolism, metabolite: AMC Trait 156 contact <sander.houten@mssm.edu>"
BXD_16736,"Blood chemistry, metabolism, metabolite: AMC Trait 157 contact <sander.houten@mssm.edu>"
BXD_16737,"Blood chemistry, metabolism, metabolite: AMC Trait 158 contact <sander.houten@mssm.edu>"
BXD_16738,"Blood chemistry, metabolism, metabolite: AMC Trait 159 contact <sander.houten@mssm.edu>"
BXD_16739,"Blood chemistry, metabolism, metabolite: AMC Trait 160 contact <sander.houten@mssm.edu>"
BXD_16740,"Blood chemistry, metabolism, metabolite: AMC Trait 161 contact <sander.houten@mssm.edu>"
BXD_16741,"Blood chemistry, metabolism, metabolite: AMC Trait 162 contact <sander.houten@mssm.edu>"
BXD_16742,"Blood chemistry, metabolism, metabolite: AMC Trait 163 contact <sander.houten@mssm.edu>"
BXD_16743,"Blood chemistry, metabolism, metabolite: AMC Trait 164 contact <sander.houten@mssm.edu>"
BXD_16744,"Blood chemistry, metabolism, metabolite: AMC Trait 165 contact <sander.houten@mssm.edu>"
BXD_16745,"Blood chemistry, metabolism, metabolite: AMC Trait 166 contact <sander.houten@mssm.edu>"
BXD_16746,"Blood chemistry, metabolism, metabolite: AMC Trait 167 contact <sander.houten@mssm.edu>"
BXD_16747,"Blood chemistry, metabolism, metabolite: AMC Trait 168 contact <sander.houten@mssm.edu>"
BXD_16748,"Blood chemistry, metabolism, metabolite: AMC Trait 169 contact <sander.houten@mssm.edu>"
BXD_16749,"Blood chemistry, metabolism, metabolite: AMC Trait 170 contact <sander.houten@mssm.edu>"
BXD_16750,"Blood chemistry, metabolism, metabolite: AMC Trait 171 contact <sander.houten@mssm.edu>"
BXD_16751,"Blood chemistry, metabolism, metabolite: AMC Trait 172 contact <sander.houten@mssm.edu>"
BXD_16752,"Blood chemistry, metabolism, metabolite: AMC Trait 173 contact <sander.houten@mssm.edu>"
BXD_16753,"Blood chemistry, metabolism, metabolite: AMC Trait 174 contact <sander.houten@mssm.edu>"
BXD_16754,"Blood chemistry, metabolism, metabolite: AMC Trait 175 contact <carmen.argmann@mssm.edu>"
BXD_16755,"Blood chemistry, metabolism, metabolite: AMC Trait 176 contact <carmen.argmann@mssm.edu>"
BXD_16756,"Blood chemistry, metabolism, metabolite: AMC Trait 177 contact <carmen.argmann@mssm.edu>"
BXD_16757,"Blood chemistry, metabolism, metabolite: AMC Trait 178 contact <carmen.argmann@mssm.edu>"
BXD_16758,"Blood chemistry, metabolism, metabolite: AMC Trait 179 contact <carmen.argmann@mssm.edu>"
BXD_16759,"Blood chemistry, metabolism, metabolite: AMC Trait 180 contact <carmen.argmann@mssm.edu>"
BXD_16760,"Blood chemistry, metabolism, metabolite: AMC Trait 181 contact <sander.houten@mssm.edu>"
BXD_16761,"Blood chemistry, metabolism, metabolite: AMC Trait 182 contact <sander.houten@mssm.edu>"
BXD_16762,"Blood chemistry, metabolism, metabolite: AMC Trait 183 contact <sander.houten@mssm.edu>"
BXD_16763,"Blood chemistry, metabolism, metabolite: AMC Trait 184 contact <sander.houten@mssm.edu>"
BXD_16764,"Blood chemistry, metabolism, metabolite: AMC Trait 185 contact <sander.houten@mssm.edu>"
BXD_16765,"Blood chemistry, metabolism, metabolite: AMC Trait 186 contact <sander.houten@mssm.edu>"
BXD_16766,"Blood chemistry, metabolism, metabolite: AMC Trait 187 contact <sander.houten@mssm.edu>"
BXD_16767,"Blood chemistry, metabolism, metabolite: AMC Trait 188 contact <sander.houten@mssm.edu>"
BXD_16768,"Blood chemistry, metabolism, metabolite: AMC Trait 189 contact <sander.houten@mssm.edu>"
BXD_16769,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate to lysine ratio in plasma after overnight fasting in males at 29 weeks of age (combined data for chow and high fat diets) [ratio]"
BXD_16770,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate to lysine ratio in plasma after overnight fasting in males at 29 weeks of age on a high fat diet (Harlan 06414, 60% kCal/fat) for 20 weeks [ratio]"
BXD_16771,"Blood chemistry, metabolism, metabolite: Alpha-aminoadipate to lysine ratio in plasma after overnight fasting in males at 29 weeks of age on a normal chow diet (Harlan 2918, 6% kCal/fat) [ratio]"
BXD_16772,"Blood chemistry, metabolism, metabolite: AMC Trait 193 contact <sander.houten@mssm.edu>"
BXD_16773,"Blood chemistry, metabolism, metabolite: AMC Trait 194 contact <sander.houten@mssm.edu>"
BXD_16774,"Blood chemistry, metabolism, metabolite: AMC Trait 195 contact <sander.houten@mssm.edu>"
BXD_16775,"Blood chemistry, metabolism, metabolite: AMC Trait 196 contact <sander.houten@mssm.edu>"
BXD_16776,"Blood chemistry, metabolism, metabolite: AMC Trait 197 contact <sander.houten@mssm.edu>"
BXD_16777,"Blood chemistry, metabolism, metabolite: AMC Trait 198 contact <sander.houten@mssm.edu>"
BXD_16778,"Blood chemistry, metabolism, metabolite: AMC Trait 199 contact <sander.houten@mssm.edu>"
BXD_16779,"Blood chemistry, metabolism, metabolite: AMC Trait 200 contact <sander.houten@mssm.edu>"
BXD_16780,"Blood chemistry, metabolism, metabolite: AMC Trait 201 contact <sander.houten@mssm.edu>"
BXD_16781,"Blood chemistry, metabolism, metabolite: AMC Trait 202 contact <sander.houten@mssm.edu>"
BXD_16782,"Blood chemistry, metabolism, metabolite: AMC Trait 203 contact <sander.houten@mssm.edu>"
BXD_16783,"Blood chemistry, metabolism, metabolite: AMC Trait 204 contact <sander.houten@mssm.edu>"
BXD_16784,"Blood chemistry, metabolism, metabolite: AMC Trait 205 contact <sander.houten@mssm.edu>"
BXD_16785,"Blood chemistry, metabolism, metabolite: AMC Trait 206 contact <sander.houten@mssm.edu>"
BXD_16786,"Blood chemistry, metabolism, metabolite: AMC Trait 207 contact <sander.houten@mssm.edu>"
BXD_16787,"Blood chemistry, metabolism, metabolite: AMC Trait 208 contact <sander.houten@mssm.edu>"
BXD_16788,"Blood chemistry, metabolism, metabolite: AMC Trait 209 contact <sander.houten@mssm.edu>"
BXD_16789,"Blood chemistry, metabolism, metabolite: AMC Trait 210 contact <sander.houten@mssm.edu>"
BXD_16790,"Blood chemistry, metabolism, metabolite: AMC Trait 211 contact <sander.houten@mssm.edu>"
BXD_16791,"Blood chemistry, metabolism, metabolite: AMC Trait 212 contact <sander.houten@mssm.edu>"
BXD_16792,"Blood chemistry, metabolism, metabolite: AMC Trait 213 contact <sander.houten@mssm.edu>"
BXD_16793,"Blood chemistry, metabolism, metabolite: AMC Trait 214 contact <sander.houten@mssm.edu>"
BXD_16794,"Blood chemistry, metabolism, metabolite: AMC Trait 215 contact <sander.houten@mssm.edu>"
BXD_16795,"Blood chemistry, metabolism, metabolite: AMC Trait 216 contact <sander.houten@mssm.edu>"
BXD_16796,"Blood chemistry, metabolism, metabolite: AMC Trait 217 contact <sander.houten@mssm.edu>"
BXD_16797,"Blood chemistry, metabolism, metabolite: AMC Trait 218 contact <sander.houten@mssm.edu>"
BXD_16798,"Blood chemistry, metabolism, metabolite: AMC Trait 219 contact <sander.houten@mssm.edu>"
BXD_16799,"Blood chemistry, metabolism, metabolite: AMC Trait 220 contact <sander.houten@mssm.edu>"
BXD_16800,"Blood chemistry, metabolism, metabolite: AMC Trait 221 contact <sander.houten@mssm.edu>"
BXD_16801,"Blood chemistry, metabolism, metabolite: AMC Trait 222 contact <sander.houten@mssm.edu>"
BXD_16802,"Blood chemistry, metabolism, metabolite: AMC Trait 223 contact <sander.houten@mssm.edu>"
BXD_16803,"Blood chemistry, metabolism, metabolite: AMC Trait 224 contact <sander.houten@mssm.edu>"
BXD_16804,"Blood chemistry, metabolism, metabolite: AMC Trait 225 contact <sander.houten@mssm.edu>"
BXD_16805,"Blood chemistry, metabolism, metabolite: AMC Trait 226 contact <sander.houten@mssm.edu>"
BXD_16806,"Blood chemistry, metabolism, metabolite: AMC Trait 227 contact <sander.houten@mssm.edu>"
BXD_16807,"Blood chemistry, metabolism, metabolite: AMC Trait 228 contact <sander.houten@mssm.edu>"
BXD_16808,"Blood chemistry, metabolism, metabolite: AMC Trait 229 contact <carmen.argmann@mssm.edu>"
BXD_16809,"Blood chemistry, metabolism, metabolite: AMC Trait 230 contact <carmen.argmann@mssm.edu>"
BXD_16810,"Blood chemistry, metabolism, metabolite: AMC Trait 231 contact <carmen.argmann@mssm.edu>"
BXD_16811,"Blood chemistry, metabolism, metabolite: AMC Trait 232 contact <carmen.argmann@mssm.edu>"
BXD_16812,"Blood chemistry, metabolism, metabolite: AMC Trait 233 contact <carmen.argmann@mssm.edu>"
BXD_16813,"Blood chemistry, metabolism, metabolite: AMC Trait 234 contact <carmen.argmann@mssm.edu>"
BXD_16814,"Blood chemistry, metabolism, metabolite: AMC Trait 235 contact <carmen.argmann@mssm.edu>"
BXD_16815,"Blood chemistry, metabolism, metabolite: AMC Trait 236 contact <carmen.argmann@mssm.edu>"
BXD_16816,"Blood chemistry, metabolism, metabolite: AMC Trait 237 contact <carmen.argmann@mssm.edu>"
BXD_16817,"Blood chemistry, metabolism, metabolite: AMC Trait 238 contact <sander.houten@mssm.edu>"
BXD_16818,"Blood chemistry, metabolism, metabolite: AMC Trait 239 contact <sander.houten@mssm.edu>"
BXD_16819,"Blood chemistry, metabolism, metabolite: AMC Trait 240 contact <sander.houten@mssm.edu>"
BXD_16820,"Blood chemistry, metabolism, metabolite: AMC Trait 241 contact <sander.houten@mssm.edu>"
BXD_16821,"Blood chemistry, metabolism, metabolite: AMC Trait 242 contact <sander.houten@mssm.edu>"
BXD_16822,"Blood chemistry, metabolism, metabolite: AMC Trait 243 contact <sander.houten@mssm.edu>"
BXD_16823,"Blood chemistry, metabolism, metabolite: AMC Trait 244 contact <carmen.argmann@mssm.edu>"
BXD_16824,"Blood chemistry, metabolism, metabolite: AMC Trait 245 contact <carmen.argmann@mssm.edu>"
BXD_16825,"Blood chemistry, metabolism, metabolite: AMC Trait 246 contact <carmen.argmann@mssm.edu>"
BXD_16826,"Blood chemistry, metabolism, metabolite: AMC Trait 247 contact <carmen.argmann@mssm.edu>"
BXD_16827,"Blood chemistry, metabolism, metabolite: AMC Trait 248 contact <carmen.argmann@mssm.edu>"
BXD_16828,"Blood chemistry, metabolism, metabolite: AMC Trait 249 contact <carmen.argmann@mssm.edu>"
BXD_16829,"Blood chemistry, metabolism, metabolite: AMC Trait 250 contact <sander.houten@mssm.edu>"
BXD_16830,"Blood chemistry, metabolism, metabolite: AMC Trait 251 contact <sander.houten@mssm.edu>"
BXD_16831,"Blood chemistry, metabolism, metabolite: AMC Trait 252 contact <sander.houten@mssm.edu>"
BXD_16832,"Blood chemistry, metabolism, metabolite: AMC Trait 253 contact <sander.houten@mssm.edu>"
BXD_16833,"Blood chemistry, metabolism, metabolite: AMC Trait 254 contact <sander.houten@mssm.edu>"
BXD_16834,"Blood chemistry, metabolism, metabolite: AMC Trait 255 contact <sander.houten@mssm.edu>"
BXD_16835,"Blood chemistry, metabolism, metabolite: AMC Trait 256 contact <sander.houten@mssm.edu>"
BXD_16836,"Blood chemistry, metabolism, metabolite: AMC Trait 257 contact <sander.houten@mssm.edu>"
BXD_16837,"Blood chemistry, metabolism, metabolite: AMC Trait 258 contact <sander.houten@mssm.edu>"
BXD_16838,"Blood chemistry, metabolism, metabolite: AMC Trait 259 contact <sander.houten@mssm.edu>"
BXD_16839,"Blood chemistry, metabolism, metabolite: AMC Trait 260 contact <sander.houten@mssm.edu>"
BXD_16840,"Blood chemistry, metabolism, metabolite: AMC Trait 261 contact <sander.houten@mssm.edu>"
BXD_16841,"Blood chemistry, metabolism, metabolite: AMC Trait 262 contact <carmen.argmann@mssm.edu>"
BXD_16842,"Blood chemistry, metabolism, metabolite: AMC Trait 263 contact <carmen.argmann@mssm.edu>"
BXD_16843,"Blood chemistry, metabolism, metabolite: AMC Trait 264 contact <carmen.argmann@mssm.edu>"
BXD_16844,"Blood chemistry, metabolism, metabolite: AMC Trait 265 contact <sander.houten@mssm.edu>"
BXD_16845,"Blood chemistry, metabolism, metabolite: AMC Trait 266 contact <sander.houten@mssm.edu>"
BXD_16846,"Blood chemistry, metabolism, metabolite: AMC Trait 267 contact <sander.houten@mssm.edu>"
BXD_16847,"Blood chemistry, metabolism, metabolite: AMC Trait 268 contact <sander.houten@mssm.edu>"
BXD_16848,"Blood chemistry, metabolism, metabolite: AMC Trait 269 contact <sander.houten@mssm.edu>"
BXD_16849,"Blood chemistry, metabolism, metabolite: AMC Trait 270 contact <sander.houten@mssm.edu>"
BXD_16850,"Blood chemistry, metabolism, metabolite: AMC Trait 271 contact <carmen.argmann@mssm.edu>"
BXD_16851,"Blood chemistry, metabolism, metabolite: AMC Trait 272 contact <carmen.argmann@mssm.edu>"
BXD_16852,"Blood chemistry, metabolism, metabolite: AMC Trait 273 contact <carmen.argmann@mssm.edu>"
BXD_16853,"Blood chemistry, metabolism, metabolite: AMC Trait 274 contact <carmen.argmann@mssm.edu>"
BXD_16854,"Blood chemistry, metabolism, metabolite: AMC Trait 275 contact <carmen.argmann@mssm.edu>"
BXD_16855,"Blood chemistry, metabolism, metabolite: AMC Trait 276 contact <carmen.argmann@mssm.edu>"
BXD_16856,"Blood chemistry, metabolism, metabolite: AMC Trait 277 contact <carmen.argmann@mssm.edu>"
BXD_16857,"Blood chemistry, metabolism, metabolite: AMC Trait 278 contact <carmen.argmann@mssm.edu>"
BXD_16858,"Blood chemistry, metabolism, metabolite: AMC Trait 279 contact <carmen.argmann@mssm.edu>"
BXD_16859,"Blood chemistry, metabolism, metabolite: AMC Trait 280 contact <carmen.argmann@mssm.edu>"
BXD_16860,"Blood chemistry, metabolism, metabolite: AMC Trait 281 contact <carmen.argmann@mssm.edu>"
BXD_16861,"Blood chemistry, metabolism, metabolite: AMC Trait 282 contact <carmen.argmann@mssm.edu>"
BXD_16862,"Blood chemistry, metabolism, metabolite: AMC Trait 283 contact <carmen.argmann@mssm.edu>"
BXD_16863,"Blood chemistry, metabolism, metabolite: AMC Trait 284 contact <carmen.argmann@mssm.edu>"
BXD_16864,"Blood chemistry, metabolism, metabolite: AMC Trait 285 contact <carmen.argmann@mssm.edu>"
BXD_16865,"Blood chemistry, metabolism, metabolite: AMC Trait 286 contact <sander.houten@mssm.edu>"
BXD_16866,"Blood chemistry, metabolism, metabolite: AMC Trait 287 contact <sander.houten@mssm.edu>"
BXD_16867,"Blood chemistry, metabolism, metabolite: AMC Trait 288 contact <sander.houten@mssm.edu>"
BXD_16868,"Blood chemistry, metabolism, metabolite: AMC Trait 289 contact <sander.houten@mssm.edu>"
BXD_16869,"Blood chemistry, metabolism, metabolite: AMC Trait 290 contact <sander.houten@mssm.edu>"
BXD_16870,"Blood chemistry, metabolism, metabolite: AMC Trait 291 contact <sander.houten@mssm.edu>"
BXD_16871,"Blood chemistry, metabolism, metabolite: AMC Trait 292 contact <sander.houten@mssm.edu>"
BXD_16872,"Blood chemistry, metabolism, metabolite: AMC Trait 293 contact <sander.houten@mssm.edu>"
BXD_16873,"Blood chemistry, metabolism, metabolite: AMC Trait 294 contact <sander.houten@mssm.edu>"
BXD_16874,"Liver, metabolism, metabolite: AMC Trait 295 contact <carmen.argmann@mssm.edu>"
BXD_16875,"Liver, metabolism, metabolite: AMC Trait 296 contact <carmen.argmann@mssm.edu>"
BXD_16876,"Liver, metabolism, metabolite: AMC Trait 297 contact <carmen.argmann@mssm.edu>"
BXD_16877,"Blood chemistry, metabolism, metabolite: AMC Trait 298 contact <sander.houten@mssm.edu>"
BXD_16878,"Blood chemistry, metabolism, metabolite: AMC Trait 299 contact <sander.houten@mssm.edu>"
BXD_16879,"Blood chemistry, metabolism, metabolite: AMC Trait 300 contact <sander.houten@mssm.edu>"
BXD_16880,"Blood chemistry, metabolism, metabolite: AMC Trait 301 contact <sander.houten@mssm.edu>"
BXD_16881,"Blood chemistry, metabolism, metabolite: AMC Trait 302 contact <sander.houten@mssm.edu>"
BXD_16882,"Blood chemistry, metabolism, metabolite: AMC Trait 303 contact <sander.houten@mssm.edu>"
BXD_16883,"Blood chemistry, metabolism, metabolite: AMC Trait 304 contact <carmen.argmann@mssm.edu>"
BXD_16884,"Blood chemistry, metabolism, metabolite: AMC Trait 305 contact <carmen.argmann@mssm.edu>"
BXD_16885,"Blood chemistry, metabolism, metabolite: AMC Trait 306 contact <carmen.argmann@mssm.edu>"
BXD_16886,"Blood chemistry, metabolism, metabolite: AMC Trait 313 contact <sander.houten@mssm.edu>"
BXD_16887,"Blood chemistry, metabolism, metabolite: AMC Trait 314 contact <sander.houten@mssm.edu>"
BXD_16888,"Blood chemistry, metabolism, metabolite: AMC Trait 315 contact <sander.houten@mssm.edu>"
BXD_16889,"Blood chemistry, metabolism, metabolite: AMC Trait 316 contact <carmen.argmann@mssm.edu>"
BXD_16890,"Blood chemistry, metabolism, metabolite: AMC Trait 317 contact <carmen.argmann@mssm.edu>"
BXD_16891,"Blood chemistry, metabolism, metabolite: AMC Trait 318 contact <carmen.argmann@mssm.edu>"
BXD_16892,"Blood chemistry, metabolism, metabolite: AMC Trait 319 contact <carmen.argmann@mssm.edu>"
BXD_16893,"Blood chemistry, metabolism, metabolite: AMC Trait 320 contact <carmen.argmann@mssm.edu>"
BXD_16894,"Blood chemistry, metabolism, metabolite: AMC Trait 321 contact <carmen.argmann@mssm.edu>"
BXD_16895,"Blood chemistry, metabolism, metabolite: AMC Trait 322 contact <carmen.argmann@mssm.edu>"
BXD_16896,"Blood chemistry, metabolism, metabolite: AMC Trait 323 contact <carmen.argmann@mssm.edu>"
BXD_16897,"Blood chemistry, metabolism, metabolite: AMC Trait 324 contact <carmen.argmann@mssm.edu>"
BXD_16898,"Blood chemistry, metabolism, metabolite: AMC Trait 325 contact <carmen.argmann@mssm.edu>"
BXD_16899,"Blood chemistry, metabolism, metabolite: AMC Trait 326 contact <carmen.argmann@mssm.edu>"
BXD_16900,"Blood chemistry, metabolism, metabolite: AMC Trait 327 contact <carmen.argmann@mssm.edu>"
BXD_16901,"Blood chemistry, metabolism, metabolite: AMC Trait 328 contact <carmen.argmann@mssm.edu>"
BXD_16902,"Blood chemistry, metabolism, metabolite: AMC Trait 329 contact <carmen.argmann@mssm.edu>"
BXD_16903,"Blood chemistry, metabolism, metabolite: AMC Trait 330 contact <carmen.argmann@mssm.edu>"
BXD_16904,"Blood chemistry, metabolism, metabolite: AMC Trait 331 contact <carmen.argmann@mssm.edu>"
BXD_16905,"Liver, metabolism, metabolite: AMC Trait 1001 contact <carmen.argmann@mssm.edu>"
BXD_16906,"Liver, metabolism, metabolite: AMC Trait 1002 contact <carmen.argmann@mssm.edu>"
BXD_16907,"Liver, metabolism, metabolite: AMC Trait 1003 contact <carmen.argmann@mssm.edu>"
BXD_16908,"Liver, metabolism, metabolite: AMC Trait 1004 contact <carmen.argmann@mssm.edu>"
BXD_16909,"Liver, metabolism, metabolite: AMC Trait 1005 contact <carmen.argmann@mssm.edu>"
BXD_16910,"Liver, metabolism, metabolite: AMC Trait 1006 contact <carmen.argmann@mssm.edu>"
BXD_16911,"Liver, metabolism, metabolite: AMC Trait 1007 contact <carmen.argmann@mssm.edu>"
BXD_16912,"Liver, metabolism, metabolite: AMC Trait 1008 contact <carmen.argmann@mssm.edu>"
BXD_16913,"Liver, metabolism, metabolite: AMC Trait 1009 contact <carmen.argmann@mssm.edu>"
BXD_16914,"Liver, metabolism, metabolite: AMC Trait 1010 contact <carmen.argmann@mssm.edu>"
BXD_16915,"Liver, metabolism, metabolite: AMC Trait 1011 contact <carmen.argmann@mssm.edu>"
BXD_16916,"Liver, metabolism, metabolite: AMC Trait 1012 contact <carmen.argmann@mssm.edu>"
BXD_16917,"Liver, metabolism, metabolite: AMC Trait 1013 contact <carmen.argmann@mssm.edu>"
BXD_16918,"Liver, metabolism, metabolite: AMC Trait 1014 contact <carmen.argmann@mssm.edu>"
BXD_16919,"Liver, metabolism, metabolite: AMC Trait 1015 contact <carmen.argmann@mssm.edu>"
BXD_16920,"Liver, metabolism, metabolite: AMC Trait 1016 contact <carmen.argmann@mssm.edu>"
BXD_16921,"Liver, metabolism, metabolite: AMC Trait 1017 contact <carmen.argmann@mssm.edu>"
BXD_16922,"Liver, metabolism, metabolite: AMC Trait 1018 contact <carmen.argmann@mssm.edu>"
BXD_16923,"Liver, metabolism, metabolite: AMC Trait 1019 contact <carmen.argmann@mssm.edu>"
BXD_16924,"Liver, metabolism, metabolite: AMC Trait 1020 contact <carmen.argmann@mssm.edu>"
BXD_16925,"Liver, metabolism, metabolite: AMC Trait 1021 contact <carmen.argmann@mssm.edu>"
BXD_16926,"Liver, metabolism, metabolite: AMC Trait 1022 contact <carmen.argmann@mssm.edu>"
BXD_16927,"Liver, metabolism, metabolite: AMC Trait 1023 contact <carmen.argmann@mssm.edu>"
BXD_16928,"Liver, metabolism, metabolite: AMC Trait 1024 contact <carmen.argmann@mssm.edu>"
BXD_16929,"Liver, metabolism, metabolite: AMC Trait 1025 contact <carmen.argmann@mssm.edu>"
BXD_16930,"Liver, metabolism, metabolite: AMC Trait 1026 contact <carmen.argmann@mssm.edu>"
BXD_16931,"Liver, metabolism, metabolite: AMC Trait 1027 contact <carmen.argmann@mssm.edu>"
BXD_16932,"Liver, metabolism, metabolite: AMC Trait 1028 contact <carmen.argmann@mssm.edu>"
BXD_16933,"Liver, metabolism, metabolite: AMC Trait 1029 contact <carmen.argmann@mssm.edu>"
BXD_16934,"Liver, metabolism, metabolite: AMC Trait 1030 contact <carmen.argmann@mssm.edu>"
BXD_16935,"Liver, metabolism, metabolite: AMC Trait 1031 contact <carmen.argmann@mssm.edu>"
BXD_16936,"Liver, metabolism, metabolite: AMC Trait 1032 contact <carmen.argmann@mssm.edu>"
BXD_16937,"Liver, metabolism, metabolite: AMC Trait 1033 contact <carmen.argmann@mssm.edu>"
BXD_16938,"Liver, metabolism, metabolite: AMC Trait 1034 contact <carmen.argmann@mssm.edu>"
BXD_16939,"Liver, metabolism, metabolite: AMC Trait 1035 contact <carmen.argmann@mssm.edu>"
BXD_16940,"Liver, metabolism, metabolite: AMC Trait 1036 contact <carmen.argmann@mssm.edu>"
BXD_16941,"Liver, metabolism, metabolite: AMC Trait 1037 contact <carmen.argmann@mssm.edu>"
BXD_16942,"Liver, metabolism, metabolite: AMC Trait 1038 contact <carmen.argmann@mssm.edu>"
BXD_16943,"Liver, metabolism, metabolite: AMC Trait 1039 contact <carmen.argmann@mssm.edu>"
BXD_16944,"Liver, metabolism, metabolite: AMC Trait 1040 contact <carmen.argmann@mssm.edu>"
BXD_16945,"Liver, metabolism, metabolite: AMC Trait 1041 contact <carmen.argmann@mssm.edu>"
BXD_16946,"Liver, metabolism, metabolite: AMC Trait 1042 contact <carmen.argmann@mssm.edu>"
BXD_16947,"Liver, metabolism, metabolite: AMC Trait 1043 contact <carmen.argmann@mssm.edu>"
BXD_16948,"Liver, metabolism, metabolite: AMC Trait 1044 contact <carmen.argmann@mssm.edu>"
BXD_16949,"Liver, metabolism, metabolite: AMC Trait 1045 contact <carmen.argmann@mssm.edu>"
BXD_16950,"Liver, metabolism, metabolite: AMC Trait 1046 contact <carmen.argmann@mssm.edu>"
BXD_16951,"Liver, metabolism, metabolite: AMC Trait 1047 contact <carmen.argmann@mssm.edu>"
BXD_16952,"Liver, metabolism, metabolite: AMC Trait 1048 contact <carmen.argmann@mssm.edu>"
BXD_16953,"Liver, metabolism, metabolite: AMC Trait 1049 contact <carmen.argmann@mssm.edu>"
BXD_16954,"Liver, metabolism, metabolite: AMC Trait 1050 contact <carmen.argmann@mssm.edu>"
BXD_16955,"Liver, metabolism, metabolite: AMC Trait 1051 contact <carmen.argmann@mssm.edu>"
BXD_16956,"Liver, metabolism, metabolite: AMC Trait 1052 contact <carmen.argmann@mssm.edu>"
BXD_16957,"Liver, metabolism, metabolite: AMC Trait 1053 contact <carmen.argmann@mssm.edu>"
BXD_16958,"Liver, metabolism, metabolite: AMC Trait 1054 contact <carmen.argmann@mssm.edu>"
BXD_16959,"Liver, metabolism, metabolite: AMC Trait 1055 contact <carmen.argmann@mssm.edu>"
BXD_16960,"Liver, metabolism, metabolite: AMC Trait 1056 contact <carmen.argmann@mssm.edu>"
BXD_16961,"Liver, metabolism, metabolite: AMC Trait 1057 contact <carmen.argmann@mssm.edu>"
BXD_16962,"Liver, metabolism, metabolite: AMC Trait 1058 contact <carmen.argmann@mssm.edu>"
BXD_16963,"Liver, metabolism, metabolite: AMC Trait 1059 contact <carmen.argmann@mssm.edu>"
BXD_16964,"Liver, metabolism, metabolite: AMC Trait 1060 contact <carmen.argmann@mssm.edu>"
BXD_16965,"Central nervous system, gene expression: Eigentrait for Trpc3 expression in hippocampus generated using exon 1, exon 1 or 5' UTR, 3' UTR, exon 6, and exon 8 [PC score]"
BXD_16966,"Central nervous system, gene expression: Trpc3 mRNA expression in hippocampus (transient receptor potential cation channel, subfamily C, member 3), first principal component generated using exon probe sets 5115892 (exon 6), 4650080 (exon 5), 4674708 (exon 9), 4727807 (exon 4), 4897386 (3' UTR), 4932602 (exon 8), 5158157 (exon 1), and 5418467 (exon 10) from UMUTAffyExon_0209 Data Set (all probe sets SNP-free in BXDs) [PC score]"
BXD_16967,"Central nervous system, gene expression: Mep1b eigentrait generated using probe sets 4972258 (exon 7), 4627542 (exon 9), 4977437 (5' UTR), 5091054 (exon 10), 4557674 (exon 11), all verified to be SNP-free and with expression greater than 7 unit using UMUTAffy_0209_ hippocampus mRNA data [PC score]"
BXD_16968,Central nervous system; embryonic neurogenesis: Cell death in otic vesicles following exposure to ethanol at E9 [TUNEL+ cells/mm2]
BXD_16969,"Central nervous system, embryonic neurogenesis: Cell death trait (Dan Goldowitz)"
BXD_16970,Central nervous system; embryonic neurogenesis; Cell death in otic vesicles following exposure to ethanol at E9 (TUNEL+ cells/mm2)
BXD_17019,LYW1
BXD_17020,"Metabolism, kidney, morphology: Diabetes model, response to alloxan (80 mg/kg iv to induce diabetes by killing pancretic beta cells), kidney weight 7 days after treatment as a percentage of body weight in adult males and females without statistical adjustments [%]"
BXD_17021,LYW3
BXD_17022,LYW4
BXD_17023,"Metabolism, visual system, eye, morphology: Trait LYW5 (contact Grant Morahan and colleagues)"
BXD_17024,"Urogenital system, musculoskeletal system, reproduction, morphology: Baculum shape factor 1 (principal component) [PC score]"
BXD_17025,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17026,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17027,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) concentration in caudate-putamen (striatum) in females 48h after injection (Saline-MPTP group) [ug/mg wet weight]"
BXD_17028,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17029,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17030,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in females 48 h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_17031,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17032,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17033,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in females 48h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_17034,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg of wet weight]"
BXD_17035,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), serotonin (5-HT) concentration in caudate-putamen (striatum) in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17036,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old females 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_17037,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17038,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen in females 48h after injection (MPTP group) [ug/mg wet weight]"
BXD_17039,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in females 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_17040,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg total protein]"
BXD_17041,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum)  in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17042,"Central nervous system, pharmacology, toxicology: MPTP-Saline group (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum)  in females 48 h after injection (MPTP-Saline group) [ug/mg wet weight]"
BXD_17043,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old females 48 h after saline injection (sc) [ug/mg total protein]"
BXD_17044,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in females 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17045,"Central nervous system, pharmacology, toxicology: Saline-MPTP group (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum)  in females 48 h after injection (Saline -MPTP) [ug/mg wet weight]"
BXD_17046,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old females, 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17047,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP group) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen in 2-4 month old females, 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17048,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen in 2-4 month old females, 48 h after saline injection (sc) [ratio of ug/mg]combined,  48h after injection (Saline-MPTP group) [ug/mg wet weight]"
BXD_17049,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old females, 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17050,"Central nervous system, pharmacology, toxicology: MPTP group (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month old females, 48 h after MPTP injection (sc) [ratio of ug/mg]"
BXD_17051,"Central nervous system, pharmacology, toxicology: Saline-MPTP group (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg, sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month old females (Saline minus MPTP)"
BXD_17052,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17053,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in mice, sexes combined, 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17054,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) concentration in caudate-putamen (striatum) in mice, sexes combined, 48h after injection (Saline-MPTP group) [ug/mg wet weight]"
BXD_17055,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17056,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in mice, sexes combined, 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17057,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in mice, sexes combined, 48 h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_17058,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ug/mg wet weight]"
BXD_17059,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in mice, sexes combined, 48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17060,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in mice, sexes combined, 48h after injection (saline-MPTP group) [ug/mg wet weight]"
BXD_17061,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ug/mg of wet weight]"
BXD_17062,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the concentration of serotonin (5-HT) in the striatum (caudate-putamen) in 2-4 month old mice, sexes combined, 48h after injection (MPTP group) [ug/mg wet weight]"
BXD_17063,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HT Concentration in Caudate-putamen in2-4 month old mice, sexes combined, 48h after injection (Saline-MPTP group) [ug/mg wet weight]"
BXD_17064,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old mice, sexed combined, 48 h after saline injection (sc) [ug/mg of wet weight]"
BXD_17065,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HIAA (5-HT metabolite) concentration in caudate-putamen in 2-4 month old mice, sexes combined, 48h after injection (MPTP group) [ug/mg wet weight]"
BXD_17066,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in 2-4 month old mice, sexes combined. 48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_17067,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ug/mg total protein]"
BXD_17068,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen in 2-4 month old mice, sexes combined, 48h after injection (MPTP group) [ug/mg wet weight]"
BXD_17069,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP minus saline group) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen in 2-4 month old mice, sexes combined,  48h after injection (MPTP minus saline group) [ug/mg total protein]"
BXD_17070,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined,  48 h after saline injection (sc) [ug/mg total protein]"
BXD_17071,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Tyrosine Hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) Concentration in Caudate-putamen in 2-4 month old mice, sexes combined, 48h after injection (MPTP group) ([g/mg total protein]"
BXD_17072,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) concentration in caudate-putamen (striatum) in 2-4 onth old mice, sexes combined,  48 h after injection (saline-MPTP group) [ug/mg total protein]"
BXD_17073,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined, 48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17074,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen in 2-4 month old mice, sexes combined,  48h after injection (MPTP group) [ug/mg wet weight]"
BXD_17075,"Central nervous system, pharmacology, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen in 2-4 month old mice, sexes combined,  48h after injection (Saline-MPTP group) [ug/mg wet weight]"
BXD_17076,"Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old mice, sexes combined,  48 h after saline injection (sc) [ratio of ug/mg]"
BXD_17077,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month old mice, sexes combined,  48 h after injection (MPTP group) [ug/mg wet weight]"
BXD_17078,"Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg, sc), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month old mice, sexes combined, 48 h after injection (saline minus MPTP group) [ug/mg wet weight]"
BXD_17079,"Central nervous system, behavior, social interaction: Time spent in the center chamber during the 10-min social novelty session in the 3-chamber social interaction task in adult males [%]."
BXD_17080,"Immunology, infectious disease: Kobt Lab trait 0001"
BXD_17081,"Infectious disease, immune system: Kobt Lab trait 0001"
BXD_17082,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 1 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17083,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 2 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17084,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 3 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17085,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 4 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17086,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 5 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17087,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 6 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17088,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 7 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17089,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 8 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17090,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 9 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17091,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 10 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17092,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 11 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17093,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 12 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17094,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 13 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17095,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 14 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17096,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 15 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17097,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 16 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17098,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 17 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17099,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 18 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17100,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 19 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17101,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 20 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17102,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 21 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17103,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 22 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17104,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 23 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17105,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 24 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17106,"Central nervous system, respiratory system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations with the respiratory rhythm, coherence at 25 Hz between local field potentials (LFP) in L2/3 of the primary whisker motor cortex and respiration in awake 6 to 12 month-old males and females  [coherence]"
BXD_17107,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 1 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17108,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 2 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17109,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 3 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17110,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 4 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17111,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 5 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17112,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 6 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17113,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 7 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17114,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 8 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17115,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 9 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17116,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 10 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17117,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 11 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17118,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 12 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17119,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 13 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17120,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 14 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17121,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 15 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17122,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 16 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17123,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 17 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17124,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 18 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17125,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 19 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17126,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 20 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17127,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 21 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17128,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 22 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17129,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 23 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17130,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 24 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17131,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 25 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17132,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 26 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17133,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 27 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17134,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 28 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17135,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 29 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17136,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 30 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17137,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 31 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17138,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 32 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17139,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 33 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17140,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 34 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17141,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 35 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17142,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 36 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17143,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 37 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17144,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 38 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17145,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 39 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17146,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 40 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17147,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 41 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17148,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 42 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17149,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 43 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17150,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 44 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17151,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 45 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17152,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 46 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17153,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 47 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17154,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 48 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17155,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 49 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17156,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 50 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17157,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 51 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17158,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 52 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17159,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 53 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17160,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 54 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17161,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 55 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17162,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 56 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17163,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 57 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (DBA/2J and BXD73 winsorized from 0.296 and 0.275 to 0.200 and 0.195, respectively) [coherence]"
BXD_17164,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 58 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17165,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 59 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.253 to 0.146) [coherence]"
BXD_17166,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 60 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17167,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 61 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17168,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 62 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17169,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 63 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17170,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 64 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17171,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 65 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.247 to 0.110) [coherence]"
BXD_17172,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 66 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.223 to 0.130) [coherence]"
BXD_17173,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 67 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17174,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 68 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.230 to 0.115) [coherence]"
BXD_17175,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 69 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.232 to 0.105) [coherence]"
BXD_17176,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 70 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.224 to 0.124) [coherence]"
BXD_17177,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 71 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 and DBA/2J winsorized from 0.231 and 0.179 to 0.110 and 0.100, respectively) [coherence]"
BXD_17178,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 72 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17179,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 73 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17180,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 74 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17181,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 75 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17182,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 76 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17183,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 77 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17184,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 78 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17185,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 79 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17186,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 80 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17187,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 81 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17188,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 82 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17189,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 83 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17190,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 84 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17191,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 85 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17192,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 86 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17193,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 87 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17194,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 88 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17195,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 89 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17196,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 90 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17197,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 91 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17198,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 92 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17199,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 93 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17200,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 94 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17201,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 95 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17202,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 96 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17203,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 97 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17204,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 98 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17205,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 99 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17206,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 100 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17207,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 101 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17208,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 102 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17209,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 103 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17210,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 104 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17211,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 105 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17212,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 106 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17213,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 107 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17214,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 108 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17215,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 109 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17216,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 110 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17217,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 111 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.131 to 0.055) [coherence]"
BXD_17218,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 112 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17219,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 113 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17220,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 114 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17221,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 115 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17222,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 116 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17223,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 117 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17224,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 118 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17225,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 119 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorised from 0.0109 to 0.043 by RWW) [coherence]"
BXD_17226,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 120 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorised from 0.110 to 0.041 by RWW) [coherence]"
BXD_17227,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 121 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized fom 0.107 to 0.035) [coherence]"
BXD_17228,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 122 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorised from 0.103 to 0.041 by RWW) [coherence]"
BXD_17229,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 123 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorised from 0.102 to 0.045 by RWW) [coherence]"
BXD_17230,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 124 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.092 to 0.045)[coherence]"
BXD_17231,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 125 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17232,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 126 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.091 to 0.042) [coherence]"
BXD_17233,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 127 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17234,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 128 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17235,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 129 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17236,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 130 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17237,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 131 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17238,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 132 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorized from 0.077 to 0.040) [coherence]"
BXD_17239,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 133 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17240,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 134 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17241,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 135 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17242,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 136 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females (BXD73 winsorised from 0.063 to 0.031 by RWW) [coherence]"
BXD_17243,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 137 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17244,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 138 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17245,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 139 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17246,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 140 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17247,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 141 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17248,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 142 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17249,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 143 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17250,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 144 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17251,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 145 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17252,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 146 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17253,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 147 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17254,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 148 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17255,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 149 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17256,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 150 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17257,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 151 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17258,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 152 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17259,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 153 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17260,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 154 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17261,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 155 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17262,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 156 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17263,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 157 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17264,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 158 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17265,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 159 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17266,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 160 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17267,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 161 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17268,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 162 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17269,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 163 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17270,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 164 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17271,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 165 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17272,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 166 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17273,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 167 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17274,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 168 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17275,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 169 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17276,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 170 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17277,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 171 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17278,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 172 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17279,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 173 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17280,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 174 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17281,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 175 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17282,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 176 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17283,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 177 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17284,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 178 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17285,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 179 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17286,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 180 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17287,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 181 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17288,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 182 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17289,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 183 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17290,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 184 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17291,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 185 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17292,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 186 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17293,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 187 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17294,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 188 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17295,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 189 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17296,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 190 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17297,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 191 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17298,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 192 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17299,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 193 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17300,"Central nervous system, electrophysiology, behavior: Brain activity and coherence of electrical field oscillations, coherence at 194 Hz between local field potentials (LFP) at two sites (0.3 mm apart) in L2/3 of the primary whisker motor cortex in awake 6 to 12 month-old males and females  [coherence]"
BXD_17301,"Central nervous system, gene expression: PCA trait 1 that maps to Chr 1 in the Qrr1 interval (used for statistical control) [PC value]"
BXD_17302,"Central nervous system, adult neurogenesis: Kempermann et al 2014 "
BXD_17303,"Central nervous system, adult neurogenesis: Kempermann and colleagues"
BXD_17304,"Central nervous system, adult neurogenesis: Kempermann and colleagues "
BXD_17305,"Central nervous system, endocrinology, blood chemistry: Porcu and Morrow trait 1"
BXD_17306,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydroprogesterone (3a,5a-THP or allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males and/or females (2010-2014-2015 data combined) [pg/ml]"
BXD_17309,"Metadata, cofactor: Batch processing lot number for treatment and lung expression experiments, where batch 1 processed by J Ziebarth, batch 2 and 3 processed by A Pandey (HZI PR8M-Infected Lungs Females RNAseq (Oct14) RPKM Log2) [lot n]"
BXD_17329,"Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 1) for nicotine experiment, basal movement on day 1 in CPP box in 7-8-week old males"
BXD_17330,"Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, locomotor activity on day 5 in CPP box in 7-8-week old males"
BXD_17331,"Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, change in movement (post - basal movement) on day 5 of CPP in 7-8-week old males"
BXD_17332,"Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg, s.c., b.i.d., on day 1), locomotor activity prior to conditioning (pre-drug paired side) in CPP box in 7-8-week old males [s]"
BXD_17333,"Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg, s.c., b.i.d., on days 2-4), locomotor activity on test day (day 5) in CPP boxes in 7-8-week old males"
BXD_17334,"Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg, s.c., b.i.d., on days 2-4), change in movement (predrug minus post drug on paired side) on day 5 of conditioned place preference (CPP) in 7-8-week old males"
BXD_17335,MID7
BXD_17336,MID8
BXD_17337,MID9
BXD_17338,MID10
BXD_17339,"Central nervous system, pharmacology, behavior: MID11"
BXD_17340,MID12
BXD_17341,"Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg, s.c., b.i.d., on days 1), locomotor difference in CPP box (saline - nicotine over 15 min test period) in 7-8-week old males [cm over 15 min]"
BXD_17342,MID14
BXD_17343,"Metadata, cofactor, visual system: Glaucoma, morphological optic nerve severity score to be used only with BXD Eye expression data (Howell et al. 2011, DBA/2J Glaucoma M430 2.0 (Sep11) RMA database). Not BXD data but DBA/2J data at different stages of disease where 0=control optic nerve, 1=no evident disease NOE, 2=moderate degeneration, 3=severe degeneration [index]"
BXD_17344,"Central nervous system, gene expression: Eigentrait for Cadm1 expression generated from probes that are SNP-free across BXDs using BXD Aged Hippocampus rev3 Affy Mouse Gene 1.0 ST (Sep12) RMA [PC Score]"
BXD_17347,"Central nervous system, adult neurogenesis: Cell proliferation in culture, percentage of cells incorporating BrdU [%]"
BXD_17348,"Central nervous system, adult neurogenesis: Neuron differentiation in culture, percentage of cells staining for Map2 [%]"
BXD_17349,"Central nervous system, adult neurogenesis: Astrocyte differentiation in culture, percentage of cells staining for GFAP [%]"
BXD_17350,"Reproduction: Breeding performance at the Jackson Laboratory between 2008 and 2014 scored as a qualitative trait, where a score of 1 indicates that a strain may require special maintenance, exhibit reduced productivity, and/or experience some incidence of non-productive matings, and where a score of 2 indicates that a strain regularly produces 3 to 7 pups per litter and is reliably productive for 7 or more months   [0 = extinct, 1 = challenging, 2 = good]"
BXD_17351,"Reproduction: Breeding performance at UTHSC between 2008 and 2014 scored as a qualitative trait, where a score of 1 indicates that a strain may require special maintenance, exhibit reduced productivity, and/or experience some incidence of non-productive matings and where a score of 2 indicates regularly produces 3 to 7 pups per litter and reliably productive for 7 or more months   [0 = extinct, 1=poor, 2=below average, 3=fair to good, 4=good, 5=very good]"
BXD_17352,"Central nervous system, behavior, learning and memory: Synome Trait 1 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17353,"Central nervous system, behavior, learning and memory: Synome Trait 2 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17354,"Central nervous system, behavior, learning and memory: Synome Trait 3 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17355,"Central nervous system, behavior, learning and memory: Synome Trait 4 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17357,"Central nervous system, gene expression: Gabra1 mRNA expression (Chr 11 at 42 Mb), first principal component from whole brain RNA-seq of 28 strains [PC1 value]"
BXD_17387,"Central nervous system, behavior, learning and memory: Synome Trait 5 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17388,"Central nervous system, behavior, learning and memory: Synome Trait 6 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17389,"Central nervous system, behavior, learning and memory: Synome Trait 7 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17390,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trial 1 before first saline control injection (Group 0 g/kg) in 60 to 130-day-old males (from Table 1, upper left panel, left column) [ml]"
BXD_17391,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after saline control injections (Group 0 g/kg) in 60 to 130-day-old males (from Table 1, upper left panel, middle column) [ml]"
BXD_17393,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after saline control injections expressed as a residual (regression of mean intake score on trail 1 intakes) (Group 0 g/kg) in 60 to 130-day-old males (from Table 1, upper left panel, right column) [residual ml]"
BXD_17395,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trial 1 before first 2 g/kg ethanol injection (Group 2 g/kg) in 60 to 130-day-old males (from Table 1, lower left panel, left column) [ml]"
BXD_17396,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after 2 g/kg ethanol injections (Group 2 g/kg) in 60 to 130-day-old males (from Table 1, lower left panel, middle column)[ml]"
BXD_17397,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after 2 g/kg ethanol injections expressed as a residual (regression of mean intake scores on trial 1 intakes) (Group 2 g/kg) in 60 to 130-day-old males (from Table 1, lower left panel, right column) [ml]"
BXD_17398,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trial 1 before first 4 g/kg ethanol injection (Group 4 g/kg) in 60 to 130-day-old males (from Table 1, upper right panel, left column) [ml]"
BXD_17399,"Original post publication description: Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after 4 g/kg ethanol injections (Group 4 g/kg) in 60 to 130-day-old males (from Table 1, upper right panel, middle column) [ml]"
BXD_17402,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after 4 g/kg ethanol injections expressed as a residual (regression of mean intake scores on trial 1 intakes)(Group 4 g/kg) in 60 to 130-day-old males (from Table 1, upper right panel, right column) [ml]"
BXD_17403,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trial 1 before first unpaired 4 g/kg ethanol injections (Group UP) in 60 to 130-day-old males (from Table 1, lower right panel, left column) [ml]"
BXD_17405,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after unpaired 4 g/kg ethanol injections (Group UP) in 60 to 130-day-old males (from Table 1, lower right panel, middle column) [ml]"
BXD_17407,"Central nervous system, behavior: Ethanol-induced conditioned taste aversion, saccharin intake during trials 2-4 after unpaired 4 g/kg ethanol injections expressed as a residual (regression of mean intake scores on trial 2 intakes) (Group UP) in 60 to 130-day-old males (from Table 1, lower right panel, right column)[ml]"
BXD_17409,"Central nervous system, morphology: Striatum (caudate putamen) neuron number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17410,"Central nervous system, morphology: Striatum (caudate putamen) non-neuronal number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17411,"Central nervous system, morphology: Striatum (caudate putamen) total cell number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17412,"Central nervous system, morphology: Striatum (caudate putamen) volume, shrinkage corrected, bilateral, both sexes between 50 and 300 days, using the Cavalieri probe [mm3]"
BXD_17413,"Central nervous system, morphology: Striatum (caudate putamen) neuron cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17414,"Central nervous system, morphology: Striatum (caudate putamen) non-neuronal cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17415,"Central nervous system, morphology: Striatum (caudate putamen) total cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17416,"Central nervous system, morphology: Striatum (caudate putamen) neuron number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17417,"Central nervous system, morphology: Striatum (caudate putamen) non-neuronal number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17418,"Central nervous system, morphology: Striatum (caudate putamen) total cell number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17419,"Central nervous system, morphology: Striatum (caudate putamen) volume, shrinkage corrected and corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using Cavalieri probes [mm3]"
BXD_17420,"Central nervous system, morphology: Striatum (caudate putamen) neuron cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17421,"Central nervous system, morphology: Striatum (caudate putamen) non-neuronal cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days,  using the optical disector [cells/mm3 x 10^3]"
BXD_17422,"Central nervous system, morphology: Striatum (caudate putamen) total cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17423,"Central nervous system, morphology: Neocortex neuron number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17424,"Central nervous system, morphology: Neocortex non-neuron number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17425,"Central nervous system, morphology: Neocortex total cell number, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17426,"Central nervous system, morphology: Neocortex volume, shrinkage corrected, bilateral, both sexes between 50 and 300 days, using the Cavalieri probe [mm3]"
BXD_17427,"Central nervous system, morphology: Neocortex neuron cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17428,"Central nervous system, morphology: Neocortex non-neuronal cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17429,"Central nervous system, morphology: Neocortex total cell packing density, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17430,"Central nervous system, morphology: Neocortex neuron number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17431,"Central nervous system, morphology: Neocortex non-neuronal number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17432,"Central nervous system, morphology: Neocortex total cell number corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [n x 10^6]"
BXD_17433,"Central nervous system, morphology: Neocortex volume (shrinkage corrected) corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days,  using the Cavalieri probe [mm3]"
BXD_17434,"Central nervous system, morphology: Neocortex neuron cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17435,"Central nervous system, morphology: Neocortex non-neuronal cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days,  using the optical disector [cells/mm3 x 10^3]"
BXD_17436,"Central nervous system, morphology: Neocortex total cell packing density corrected for age, sex, plane of section, and brain weight, bilateral, both sexes between 50 and 300 days, using the optical disector [cells/mm3 x 10^3]"
BXD_17437,"Metadata, cofactor, visual system: Glaucoma, optic nerve molecular PCA  severity score used only with BXD Eye expression data (Howell et al. 2011, DBA/2J Glaucoma M430 2.0 (Sep11) RMA database). Not BXD data but DBA/2J at different stages of disease from Figure S2 of paper, where 0=control optic nerve head, 1=Stage 1 NOE optic nerve head, 2=stage 2 NOE moderate ONH damage signature, 2 to 4= stronger PCA ONH damage signatures, 5=stage 5 servere ONH damage [index]"
BXD_17438,"Metadata, cofactor, visual system: Glaucoma, retina molecular severity score to be used only with BXD Eye expression data (Howell et al. 2011, DBA/2J Glaucoma M430 2.0 (Sep11) RMA databases). Not BXD data but DBA/2J data at different stages of disease where 0=control retina, 1=earliest signatures of retina stress (based on expression rather than group), 2 and 3=intermediate stages, 4=severe stage [index]"
BXD_17439,"Immune system, infectious disease: Rickettsiu tsutsugamushi susceptibility (strain Gilliam, ip 100 50% mouse infectious doses, two treatments) of both sexes at 6-12 weeks-of-age (ordinal scale 0 = resistant, 1=susceptible, also see BXH RI set), maps to Gbp6 gene, see PMID 21551061) [mortality]"
BXD_17440,"Reproduction: Breeding performance, litters per year per breeding trio (two females, one male) at the EPFL in Lausanne Switzerland between 2012 and 2015 [n litters/yr]"
BXD_17441,"Reproduction: Breeding performance, pups per year per breeding trio (two females, one male) at the EPFL in Lausanne Switzerland between 2012 and 2015 (excluding trios that never produced offspring) [n pups/yr]"
BXD_17442,"Reproduction: Breeding performance, productive trio matings (ratio of productive to non-productive trio cages) at the EPFL in Lausanne Switzerland between 2012 and 2015 (excludes trios with less than 6 weeks of cohabitation) [ratio]"
BXD_17443,"Reproduction: Breeding performance, litter size at birth (within 24 hrs) at the Jackson Laboratory (BXD29-Tlr4 not entered but value is 4.25+/-0.639 n=8), Mouse Phenome Database traits MDP:42302, 423033, and 44403 (TyJ in standard barrier room, RwwJ set in SPF maximum barrier room) [n]"
BXD_17444,"Reproduction: Breeding performance, litter size at weaning (circa 20 days) at the Jackson Laboratory (BXD29-Tlr4 not entered but value is 3.11+/-0.1.16 with n=8), Mouse Phenome Database traits MDP:42303, 42304, and 44404 (minimum SE for n<4 set to 1.0) [n]"
BXD_17445,"Reproduction: Breeding performance, interval between litters at the Jackson Laboratory (BXD29-Tlr4 not entered but value is 4.96 +/- 0.58 n=7), Mouse Phenome Database traits MDP:44301 and 42302 (TyJ in standard barrier room, RwwJ set in SPF maximum barrier room) [weeks]"
BXD_17446,"Reproduction: Breeding performance, litter size within 24 hrs of birth at UTHSC (2000 to 2010)"
BXD_17447,"Reproduction: Breeding performance, litter size at birth for breeding trio at the EPFL in Lausanne Switzerland between 2012 and 2015 [n]"
BXD_17448,"Central nervous system, endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydroprogesterone (3a,5a-THP or allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17449,"Central nervous system, endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydroprogesterone (3a,5a-THP or allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17450,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydroprogesterone (3a,5a-THP or allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17451,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydroprogesterone (3a,5a-THP or allopregnanolone) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17452,"Central nervous system, endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old males and/or females (2010-2014-2015 data combined) [pg/ml]"
BXD_17453,"Central nervous system, endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17454,"Central nervous system, endocrinology, blood chemistry: Air control response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17455,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males and/or females (2010-2014-2015 data combined) [pg/ml]"
BXD_17456,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17457,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, 3a,5a-tetrahydrodeoxycorticosterone (3a,5a-THDOC) in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17458,"Central nervous system, endocrinology, blood chemistry: Air control response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old males and/or females (2010-2014-2015 data combined) [pg/ml]"
BXD_17459,"Central nervous system, endocrinology, blood chemistry: Air control response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17460,"Central nervous system, endocrinology, blood chemistry: Air control response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent air control in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17461,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males and/or females (2010-2014-2015 data combined) [pg/ml]"
BXD_17462,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old males (2010-2014-2015 data combined) [pg/ml]"
BXD_17463,"Central nervous system, endocrinology, blood chemistry: chronic intermittent ethanol response, Pregnenolone in plasma 72 h after the 5th cycle of chronic intermittent ethanol in 16 to 18 week-old females (2010-2014-2015 data combined) [pg/ml]"
BXD_17464,"Genetics, cofactor: GABRA2 receptor expression status where 1 = normal high expression and 0 = low expression as seen in C57BL/6J after 1990 [level]"
BXD_17465,"Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injection, difference between day 2 saline injection response and day 3 ethanol injection in young adult females, replication study of 2014â€“2016 (see original data from 1995, BXD trait 10485) [cm]"
BXD_17466,"Aging, metabolism: DEPRECATED 2015 data set, Lifespan, longevity of females (mean age) at UTHSC, Memphis TN, on standard low fat diet (Harlan Teklad 2018 chow diet, 18.6% protein, 6.2% fat, 3.1 kcal/g of which 18% are from fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding) [days] "
BXD_17467,"Infectious disease, immune system: Log D1_Colonization
"
BXD_17468,"Aging, metabolism: DEPRECATED 2015 data set, Lifespan, longevity of females (mean age) at UTHSC, Memphis TN, on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding) [days]"
BXD_17469,"Aging, metabolism: DEPRECATED, Lifespan, longevity difference (low fat minus high fat) of females at UTHSC on either a normal low fat chow diet or a high fat diet (60% calories from fat), 12 hr light cycle (only computed if more than 4 cases per diet) [difference, days] "
BXD_17470,"Central nervous system, behavior, learning and memory: Synome Trait 8 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17471,"Central nervous system, behavior, learning and memory: Synome Trait 9 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17472,"Central nervous system, behavior, learning and memory: Synome Trait 10 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17473,"Central nervous system, behavior, learning and memory: Synome Trait 11 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17475,"Aging: Lifespan, longevity of females (median age) at the Dana-Faber Cancer Institute (Redstone Animal Facility, Boston MA) from Jackson Laboratory between Nov 1982 and Mar 1983 on Purina chow (all data reinstated, authors initially excluded BXD13 due to seizures and BXD31 and BXD32 due to poor marker coverage, BXD13 winsorised from 173 to 450 days and BXD32 from 419 to 451 days) [days]"
BXD_17476,"Central nervous system, morphology: Intra- and infrapyramidal mossy fiber (IIPMF) volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17477,"Central nervous system, morphology: Hilus volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17478,"Central nervous system, morphology: Suprapyramidal mossy fibers volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17479,"Central nervous system, morphology: Stratum pyramidale volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17480,"Central nervous system, morphology: Stratum oriens volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17481,"Central nervous system, morphology: Stratum radiatum volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17482,"Central nervous system, morphology: Stratum lacunosum volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in females at 12 to 14 weeks of age [percent]"
BXD_17483,"Central nervous system, morphology: Hilus volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17484,"Central nervous system, morphology: Suprapyramidal mossy fibers volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17485,"Central nervous system, morphology: Stratum pyramidale volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17486,"Central nervous system, morphology: Stratum oriens volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17487,"Central nervous system, morphology: Stratum radiatum volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17488,"Central nervous system, morphology: Stratum lacunosum volume as a percentage of total size of CA3 plus CA4 regions of hippocampus in males at 12 to 14 weeks of age [percent]"
BXD_17489,Morphology: Body weight of males at 12 to 14 weeks of age [g]
BXD_17490,"Central nervous system, morphology: brain weight of males at 12 to 14 weeks of age [g]"
BXD_17491,"Central nervous system, morphology: brain to body weight ratio in males at 12 to 14 weeks of age [percent]"
BXD_17492,Morphology: Body weight of females at 12 to 14 weeks of age [g]
BXD_17493,"Central nervous system, morphology: brain weight of females at 12 to 14 weeks of age [g] "
BXD_17494,"Central nervous system, morphology: brain to body weight ratio  in females at 12 to 14 weeks of age [percent]"
BXD_17495,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 3 in males at 11 to 13 weeks of age [n]"
BXD_17496,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 4 in males at 11 to 13 weeks of age [n]"
BXD_17497,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 5 in males at 11 to 13 weeks of age [n]"
BXD_17498,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on days 3 to 5 in males at 11 to 13 weeks of age [n]"
BXD_17499,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 3 in males at 11 to 13 weeks of age [n]"
BXD_17500,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 4 in males at 11 to 13 weeks of age [n]"
BXD_17501,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 5 in males at 11 to 13 weeks of age [n]"
BXD_17502,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on days 3 to 5 in males at 11 to 13 weeks of age [n]"
BXD_17503,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 3 in males at 11 to 13 weeks of age [sec]"
BXD_17504,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 4 in males at 11 to 13 weeks of age [sec]"
BXD_17505,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 5 in males at 11 to 13 weeks of age [sec]

"
BXD_17506,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on days 3 to 5 in males at 11 to 13 weeks of age [sec]"
BXD_17507,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 3 in females at 11 to 13 weeks of age [n]"
BXD_17508,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 4 in females at 11 to 13 weeks of age [n]"
BXD_17509,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on day 5 in females at 11 to 13 weeks of age [n]"
BXD_17510,"Central nervous system, behavior, learning and memory: number of errors made during an 8-arm radial maze test on days 3 to 5 in females at 11 to 13 weeks of age [n]"
BXD_17511,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 3 in females at 11 to 13 weeks of age [n]"
BXD_17512,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 4 in females at 11 to 13 weeks of age [n]"
BXD_17513,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on day 5 in females at 11 to 13 weeks of age [n]"
BXD_17514,"Central nervous system, behavior, learning and memory: number of new entries during the first 8-arm choices minus 5.3 in an 8-arm radial maze test on days 3 to 5 in females at 11 to 13 weeks of age [n]

"
BXD_17515,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 3 in females at 11 to 13 weeks of age [sec]"
BXD_17516,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 4 in females at 11 to 13 weeks of age [sec]"
BXD_17517,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on day 5 in females at 11 to 13 weeks of age [sec]"
BXD_17518,"Central nervous system, behavior, learning and memory: arm visit time during an 8-arm radial maze test on days 3 to 5 in females at 11 to 13 weeks of age [sec]"
BXD_17519,"Central nervous system, behavior, learning and memory: Synome Trait 12 (contact Dr. Alexa Horner (alexa@synome.eu))"
BXD_17520,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 4 [%]"
BXD_17521,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 3 [%]"
BXD_17522,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 2 [%]"
BXD_17523,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight, day 1 [%]"
BXD_17524,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections survival after infection corrected for strain, sex, age and body weight given as corrected relative survival value (-1.5 = highly susceptible, +1.5 = highly resistant) [index]"
BXD_17525,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), necrotizing soft tissue infection lesion size corrected for strain, sex, age and body weight given as the maximum lesion area [mm2]"
BXD_17527,"Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection), Necrotizing soft tissue infections body weight change after infection corrected for strain, sex, age and body weight given as principal component 1 of day 1 to day 4 [%]"
BXD_17528,"Central Nervous System, behavior, open field activity:  locomotion, total distance traveled from 0 to 20 min for males at 11 weeks of age [cm]"
BXD_17529,"Central Nervous System, behavior, open field activity: thigmotaxis, distance traveled at the periphery (relative to total distance) from 0 to 20 min for males at 11 weeks of age [percent]"
BXD_17530,"Central Nervous System, behavior, open field activity: thigmotaxis, time spent at the periphery (relative to total time) from 0 to 20 min for males at 11 weeks of age [percent]"
BXD_17531,"Central Nervous System, behavior, open field activity: number of leans observed from 0 to 20 min for males at 11 weeks of age [n]"
BXD_17532,"Central Nervous System, behavior, open field activity: number of rears observed from 0 to 20 min for males at 11 weeks of age [n]"
BXD_17533,"Central Nervous System, behavior, open field activity: grooming frequency from 0 to 20 min for males at 11 weeks of age [n]"
BXD_17534,"Central Nervous System, behavior, open field activity: grooming duration observed from 0 to 20 min for males at 11 weeks of age [sec]"
BXD_17535,"Central Nervous System, behavior, open field activity: grooming bout (grooming duration divided by grooming frequency) observed from 0 to 20 min for males at 11 weeks of age [sec]"
BXD_17536,"Central Nervous System, behavior, open field activity: number of jumps observed from 0 to 20 min for males at 11 weeks of age [n]"
BXD_17537,"Central Nervous System, behavior, open field activity: number of fecal boli observed from 0 to 20 min for males at 11 weeks of age [n]"
BXD_17538,"Central nervous system, behavior: locomotion in an open field, total distance traveled from 0 to 20 min for females at 11 weeks of age [cm]"
BXD_17539,"Central Nervous System, behavior, open field activity: thigmotaxis, distance traveled at the periphery (relative to total distance) from 0 to 20 min for females at 11 weeks of age [percent]"
BXD_17540,"Central Nervous System, behavior, open field activity: thigmotaxis, time spent at the periphery (relative to total time) from 0 to 20 min for females at 11 weeks of age [percent]"
BXD_17541,"Central Nervous System, behavior, open field activity: number of leans observed from 0 to 20 min for females at 11 weeks of age [n]"
BXD_17542,"Central Nervous System, behavior: number of rears in an open field from 0 to 20 min for females at 11 weeks of age [n]"
BXD_17543,"Central Nervous System, behavior, open field activity: grooming frequency from 0 to 20 min for females at 11 weeks of age [n]"
BXD_17544,"Central Nervous System, behavior: grooming duration in an open field from 0 to 20 min for females at 11 weeks of age [sec]"
BXD_17545,"Central Nervous System, behavior, open field activity: grooming bout (grooming duration divided by grooming frequency) observed from 0 to 20 min for females at 11 weeks of age [sec]"
BXD_17546,"Central Nervous System, behavior, open field activity: number of jumps observed from 0 to 20 min for females at 11 weeks of age [n]"
BXD_17547,"Central Nervous System, behavior: number of fecal boli observed in an open field from 0 to 20 min for females at 11 weeks of age [n]"
BXD_17548,"Liver, gene expression: Lrp6 mRNA expression in whole liver after carbon tetrachloride treatment, first principal component with correct polarity generated using SNP-free exon probe sets (exons 14, 17 and 18) and SUH_Liv_RMAEx_0611 data [relative residual concentration]"
BXD_17549,"Liver, gene expression: Lrp6 mRNA expression in untreated rederived hepatocytes, first principal component eigengene (loads heavily on almost all central exons, from exon 4 to exon 21, 40% of variance) with correct polarity generated using 18 SNP-free exon probe sets and UT-VGX_HEL1014 data [relative residual concentration]"
BXD_17550,"Liver, gene expression: Lrp6 mRNA expression in untreated rederived hepatocytes, second principal component eigengene (loads mainly on most proximal and most distal exons, exon 1, 22 and 23, 17% of total variance) with correct polarity generated using 18 SNP-free exon probe sets and UT-VGX_HEL1014 data [relative residual concentration]"
BXD_17551,"Metabolism, blood chemistry: Diabetes model, Streptozotocin-induced albumin-to-creatinine ratio (ABR, Streptozocin, STZ, Zanosar), in males at 10-12 weeks of age (BXD32 winsorised from 5047 to 1100) [ratio of ug/mg]"
BXD_17552,"Metabolism, blood chemistry: Diabetes model, Streptozotocin-induced albumin-to-creatinine log ratio (ABR, Streptozocin, STZ, Zanosar), in males at 10-12 weeks of age (BXD32 winsorised to log1100) [log ratio of ug/mg]"
BXD_17553,"Metadata: Cohort study order, chow diet (6% kCal/fat Harlan.2918), males [rank] (EPFL LISP3 Cohort)"
BXD_17554,"Metadata: Cohort study order, high fat diet (60% kCal/fat HarlanTD.06414), males [rank] (EPFL LISP3 Cohort)"
BXD_17555,"Metadata: Cohort study order, chow diet (6% kCal/fat Harlan.2918), males [weeks] (EPFL LISP3 Cohort)"
BXD_17556,"Metadata: Cohort study order, high fat diet (60% kCal/fat HarlanTD.06414), males [weeks] (EPFL LISP3 Cohort)"
BXD_17557,"Metabolism, morphology: Body weight at 8 weeks, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17558,"Metabolism, morphology: Body weight at 8 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17559,"Metabolism, morphology: Body weight at 16 weeks, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17560,"Metabolism, morphology: Body weight at 16 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17561,"Metabolism, morphology: Body weight at 28 weeks, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17562,"Metabolism, morphology: Body weight at 28 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17563,"Metabolism, morphology: Body weight at sacrifice, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17564,"Metabolism, morphology: Body weight at sacrifice, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17565,"Metabolism, morphology: Body weight at blood pressure measurement, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17566,"Metabolism, morphology: Body weight at blood pressure measurement, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17567,"Metabolism, morphology: Body weight during metabolic cage experiment, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17568,"Metabolism, morphology: Body weight during metabolic cage experiment, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17569,"Metabolism, morphology: Fat mass during metabolic cage experiment, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17570,"Metabolism, morphology: Fat mass during metabolic cage experiment, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17571,"Metabolism, morphology: Fat mass as percentage of body weight during metabolic cage experiment, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17572,"Metabolism, morphology: Fat mass as percentage of body weight during metabolic cage experiment, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17573,"Metabolism, morphology: Lean mass during metabolic cage experiment, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17574,"Metabolism, morphology: Lean mass during metabolic cage experiment, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17575,"Metabolism, morphology: Lean mass as percentage of body weight during metabolic cage experiment, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17576,"Metabolism, morphology: Lean mass as percentage of body weight during metabolic cage experiment, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17577,"Metabolism, morphology: Body weight before activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17578,"Metabolism, morphology: Body weight before activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17579,"Metabolism, morphology: Fat mass before activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17580,"Metabolism, morphology: Fat mass before activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17581,"Metabolism, morphology: Fat mass as percentage of body weight before activity wheel, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17582,"Metabolism, morphology: Fat mass as percentage of body weight before activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17583,"Metabolism, morphology: Lean mass before activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17584,"Metabolism, morphology: Lean mass before activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17585,"Metabolism, morphology: Lean mass as percentage of body weight before activity wheel, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17586,"Metabolism, morphology: Lean mass as percentage of body weight before activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17587,"Metabolism, morphology: Body weight after activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17588,"Metabolism, morphology: Body weight after activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17589,"Metabolism, morphology: Fat mass after activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17590,"Metabolism, morphology: Fat mass after activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17591,"Metabolism, morphology: Fat mass as percentage of body weight after activity wheel, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17592,"Metabolism, morphology: Fat mass as percentage of body weight after activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17593,"Metabolism, morphology: Lean mass after activity wheel, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17594,"Metabolism, morphology: Lean mass after activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17595,"Metabolism, morphology: Lean mass as percentage of body weight after activity wheel, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17596,"Metabolism, morphology: Lean mass as percentage of body weight after activity wheel, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17597,"Metabolism, morphology: Body weight gain 8-16 weeks, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17598,"Metabolism, morphology: Body weight gain 8-16 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17599,"Metabolism, morphology: Body weight percentage gain 8-16 weeks, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17600,"Metabolism, morphology: Body weight percentage gain 8-16 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17601,"Metabolism, morphology: Body weight gain 8-28 weeks, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17602,"Metabolism, morphology: Body weight gain 8-28 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17603,"Metabolism, morphology: Body weight percentage gain 8-28 weeks, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17604,"Metabolism, morphology: Body weight percentage gain 8-28 weeks, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17605,"Metabolism, morphology: Body weight loss percentage after exercise, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17606,"Metabolism, morphology: Body weight loss percentage after exercise, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17607,"Metabolism, morphology: Body weight fat mass loss percentage after exercise, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17608,"Metabolism, morphology: Body weight fat mass loss percentage after exercise, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17609,"Metabolism, morphology: Body weight loss pre-sacrifice, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17610,"Metabolism, morphology: Body weight loss pre-sacrifice, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17611,"Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day) at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17612,"Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day) at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17613,"Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night) at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17614,"Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night) at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17615,"Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17616,"Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17617,"Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17618,"Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17619,"Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17620,"Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17621,"Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17622,"Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17623,"Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17624,"Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17625,"Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17626,"Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17627,"Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17628,"Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17629,"Metabolism, behavior: Activity (movement) at dark phase (night) at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [AUC] (EPFL LISP3 Cohort)"
BXD_17630,"Metabolism, behavior: Activity (movement) at dark phase (night) at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [AUC] (EPFL LISP3 Cohort)"
BXD_17631,"Metabolism, behavior: Activty (rearing) at night at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [AUC] (EPFL LISP3 Cohort)"
BXD_17632,"Metabolism, behavior: Activty (rearing) at night at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [AUC] (EPFL LISP3 Cohort)"
BXD_17633,"Central nervous system, metabolism, behavior: Food intake in 24 h at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17634,"Central nervous system, metabolism, behavior: Food intake in 24 h at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17635,"Central nervous system, metabolism, behavior: Food intake in 24 h at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [kCal] (EPFL LISP3 Cohort)"
BXD_17636,"Central nervous system, metabolism, behavior: Food intake in 24 h at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [kCal] (EPFL LISP3 Cohort)"
BXD_17637,"Central nervous system, metabolism, behavior: Water intake in 24 h at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL] (EPFL LISP3 Cohort)"
BXD_17638,"Central nervous system, metabolism, behavior: Water intake in 24 h at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL] (EPFL LISP3 Cohort)"
BXD_17639,"Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17640,"Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17641,"Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected at 16 weeks of age, metabolic cage, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17642,"Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected at 16 weeks of age, metabolic cage, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/h] (EPFL LISP3 Cohort)"
BXD_17643,"Metabolism: Glycemia after overnight fast, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17644,"Metabolism: Glycemia after overnight fast, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17645,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17646,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17647,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17648,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17649,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17650,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17651,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17652,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17653,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17654,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17655,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17656,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17657,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17658,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17659,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17660,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mg/mL] (EPFL LISP3 Cohort)"
BXD_17661,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), overall, chow diet (6% kCal/fat Harlan.2918), males [AUC] (EPFL LISP3 Cohort)"
BXD_17662,"Metabolism: Glycemia during oral glucose tolerance test (OGTT), overall, high fat diet (60% kCal/fat HarlanTD.06414), males [AUC] (EPFL LISP3 Cohort)"
BXD_17663,"Metabolism: Insulin response from oral glucose tolerance test (OGTT), at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [AUC] (EPFL LISP3 Cohort)"
BXD_17664,"Metabolism: Insulin response from oral glucose tolerance test (OGTT), at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [AUC] (EPFL LISP3 Cohort)"
BXD_17665,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 0min, at 17 weeks of age, (after overnight fast), chow diet (6% kCal/fat Harlan.2918), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17666,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 0min, at 17 weeks of age, (after overnight fast), high fat diet (60% kCal/fat HarlanTD.06414), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17667,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17668,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17669,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17670,"Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ug/mL] (EPFL LISP3 Cohort)"
BXD_17671,"Metabolism: Glucose / insulin ratio in plasma after overnight fast, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17672,"Metabolism: Glucose / insulin ratio in plasma after overnight fast, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17673,"Metabolism: Glucose / insulin ratio in plasma 15 minutes after start of oral glucose tolerance test (OGTT), at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17674,"Metabolism: Glucose / insulin ratio in plasma 15 minutes after start of oral glucose tolerance test (OGTT), at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17675,"Metabolism: Glucose / insulin ratio in plasma 30 minutes after start of oral glucose tolerance test (OGTT), at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17676,"Metabolism: Glucose / insulin ratio in plasma 30 minutes after start of oral glucose tolerance test (OGTT), at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17677,"Metabolism: Glucose * insulin in plasma after overnight fast, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [(ug*mg)/(mL*mL)] (EPFL LISP3 Cohort)"
BXD_17678,"Metabolism: Glucose * insulin in plasma after overnight fast, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [(ug*mg)/(mL*mL)] (EPFL LISP3 Cohort)"
BXD_17679,"Metabolism: McAuley fasted insulin ratio in plasma after overnight fast, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males (EPFL LISP3 Cohort) [ratio]"
BXD_17680,Metabolism: Insulin ratio in plasma (McAuley method) after overnight fast in males at 17 weeks of age on a high fat diet (60% kCal/fat HarlanTD.06414)(EPFL LISP3 Cohort)[ratio]
BXD_17681,"Metabolism: HOMA-IR after overnight fast, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [index] (EPFL LISP3 Cohort)"
BXD_17682,"Metabolism: HOMA-IR after overnight fast, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [index] (EPFL LISP3 Cohort)"
BXD_17683,"Metabolism: HOMA-B after overnight fast, at 17 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [index] (EPFL LISP3 Cohort)"
BXD_17684,"Metabolism: HOMA-B after overnight fast, at 17 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [index] (EPFL LISP3 Cohort)"
BXD_17685,"Cardiovascular system, physiology: Diastolic blood pressure measured using a tail cuff system at 19 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmHg] (EPFL LISP3 Cohort)"
BXD_17686,"Cardiovascular system, physiology: Diastolic blood pressure measured using a tail cuff system at 19 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmHg] (EPFL LISP3 Cohort)"
BXD_17687,"Cardiovascular system, physiology: Systolic blood pressure measured using a tail cuff system at 19 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmHg] (EPFL LISP3 Cohort)"
BXD_17688,"Cardiovascular system, physiology: Systolic blood pressure measured using a tail cuff system at 19 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmHg] (EPFL LISP3 Cohort)"
BXD_17689,"Cardiovascular system, physiology: Heart rate measured using a tail cuff system at 19 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [bpm] (EPFL LISP3 Cohort)"
BXD_17690,"Cardiovascular system, physiology: Heart rate measured using a tail cuff system at 19 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [bpm] (EPFL LISP3 Cohort)"
BXD_17691,"Metabolism: Body temperature, basal, at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [Celsius] (EPFL LISP3 Cohort)"
BXD_17692,"Metabolism: Body temperature, basal, at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17693,"Metabolism: Body temperature after 1 hour in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17694,"Metabolism: Body temperature after 1 hour in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17695,"Metabolism: Body temperature after 2 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17696,"Metabolism: Body temperature after 2 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17697,"Metabolism: Body temperature after 3 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17698,"Metabolism: Body temperature after 3 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17699,"Metabolism: Body temperature after 4 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17700,"Metabolism: Body temperature after 4 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17701,"Metabolism: Body temperature after 5 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17702,"Metabolism: Body temperature after 5 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17703,"Metabolism: Body temperature after 6 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [deg C] (EPFL LISP3 Cohort)"
BXD_17704,"Metabolism: Body temperature after 6 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [deg C] (EPFL LISP3 Cohort)"
BXD_17705,"Metabolism: Body temperature loss after 3 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17706,"Metabolism: Body temperature loss after 3 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17707,"Metabolism: Body temperature loss after 6 hours in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17708,"Metabolism: Body temperature loss after 6 hours in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17709,"Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber at 21 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17710,"Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17711,"Metabolism: Body temperature, basal, diet ratio, at 21 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414) / chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17712,"Metabolism: Body temperature, after 6 hours in 4 deg C chamber at 21 weeks of age, diet ratio, high fat diet (60% kCal/fat HarlanTD.06414) / chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17713,"Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17714,"Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17715,"Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17716,"Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17717,"Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17718,"Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17719,"Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17720,"Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17721,"Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17722,"Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17723,"Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night), in standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17724,"Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night) in standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [counts/hour] (EPFL LISP3 Cohort)"
BXD_17725,"Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17726,"Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17727,"Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [kCal] (EPFL LISP3 Cohort)"
BXD_17728,"Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [kCal] (EPFL LISP3 Cohort)"
BXD_17729,"Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/g] (EPFL LISP3 Cohort)"
BXD_17730,"Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/g] (EPFL LISP3 Cohort)"
BXD_17731,"Morphology, metabolism: Body weight in home cage, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17732,"Morphology, metabolism: Body weight in home cage, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17733,"Cardiovascular system, behavior: Run distance untrained, treadmill at 10 degree incline at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [m] (EPFL LISP3 Cohort)"
BXD_17734,"Cardiovascular system, behavior: Run distance untrained, treadmill at 0 degree incline at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [m] (EPFL LISP3 Cohort)"
BXD_17735,"Cardiovascular system, behavior: Run distance trained, treadmill at 10 degree incline at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [m] (EPFL LISP3 Cohort)"
BXD_17736,"Cardiovascular system, behavior: Run distance trained, treadmill at 0 degree incline at 25 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [m] (EPFL LISP3 Cohort)"
BXD_17737,"Cardiovascular system, behavior: Run distance improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet (6% kCal/fat Harlan.2918), males [m] (EPFL LISP3 Cohort)"
BXD_17738,"Cardiovascular system, behavior: Run distance improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet (60% kCal/fat HarlanTD.06414), males [m] (EPFL LISP3 Cohort)"
BXD_17739,"Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 10 degree incline at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17740,"Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 0 degree incline at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17741,"Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 10 degree incline at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17742,"Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 0 degree incline at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17743,"Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 10 degree incline at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17744,"Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 0 degree incline at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17745,"Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 10 degree incline at 23 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17746,"Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 0 degree incline at 23 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17747,"Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 10 degree incline at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17748,"Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 0 degree incline at 25 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17749,"Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 10 degree incline at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17750,"Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 0 degree incline at 25 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17751,"Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 10 degree incline at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17752,"Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 0 degree incline at 25 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17753,"Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 10 degree incline at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17754,"Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 0 degree incline at 25 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17755,"Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17756,"Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17757,"Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet (6% kCal/fat Harlan.2918), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17758,"Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet (60% kCal/fat HarlanTD.06414), males [mL/kg/min] (EPFL LISP3 Cohort)"
BXD_17759,"Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet (6% kCal/fat Harlan.2918), males [ratio] (EPFL LISP3 Cohort)"
BXD_17760,"Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet (60% kCal/fat HarlanTD.06414), males [ratio] (EPFL LISP3 Cohort)"
BXD_17761,"Central nervous system, metabolism, behavior: Locomotor activity, light phase (day) running distance, activity wheel at 25 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [km] (EPFL LISP3 Cohort)"
BXD_17762,"Central nervous system, metabolism, behavior: Locomotor activity, light phase (day) running distance, activity wheel at 25 weeks of age, high fat diet HFD (60% kCal/fat HarlanTD.06414), males (EPFL LISP3 Cohort) [km/day]"
BXD_17763,"Central nervous system, metabolism, behavior: Locomotor activity, dark phase (night) running distance, activity wheel at 25 weeks of age, chow diet CD (6% kCal/fat Harlan.2918), males  (EPFL LISP3 Cohort) [km/night]"
BXD_17764,"Central nervous system, metabolism, behavior: Locomotor activity, dark phase (night) running distance, activity wheel at 25 weeks of age, high fat diet HFD (60% kCal/fat HarlanTD.06414), males (EPFL LISP3 Cohort) [km/night]"
BXD_17765,"Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel at 25 weeks of age, chow diet CD (6% kCal/fat Harlan.2918), males (EPFL LISP3 Cohort) [km/night] "
BXD_17766,"Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel at 25 weeks of age, high fat diet HFD (60% kCal/fat HarlanTD.06414), males (EPFL LISP3 Cohort) [km/24h] "
BXD_17767,"Gastrointestinal system, liver, morphology, metabolism: Liver mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17768,"Gastrointestinal system, liver, morphology, metabolism: Liver mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17769,"Cardiovascular system, morphology: Heart mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17770,"Cardiovascular system, morphology: Heart mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17771,"Morphology: Subcutaneous white adipose mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17772,"Morphology: Subcutaneous white adipose mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17773,"Morphology: Perirenal white adipose mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17774,"Morphology: Perirenal white adipose mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17775,"Urogenital system, morphology: Kidney mass at 29 weeks of age (bilateral), chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17776,"Urogenital system, morphology: Kidney mass at 29 weeks of age (bilateral), high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17777,"Morphology: Epididymal white adipose mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17778,"Morphology: Epididymal white adipose mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17779,"Musculoskeletal system, morphology: Gastrocnemius muscle mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17780,"Musculoskeletal system, morphology: Gastrocnemius muscle mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17781,"Musculoskeletal system, morphology: Soleus muscle mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g] (EPFL LISP3 Cohort)"
BXD_17782,"Musculoskeletal system, morphology: Soleus muscle mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g] (EPFL LISP3 Cohort)"
BXD_17783,"Gastrointestinal system, morphology: Liver mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17784,"Gastrointestinal system, morphology: Liver mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17785,"Cardiovascular systen, morphology: Heart mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17786,"Cardiovascular systen, morphology: Heart mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17787,"Morphology: Subcutaneous white adipose mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17788,"Morphology: Subcutaneous white adipose mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17789,"Morphology: Perirenal white adipose mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17790,"Morphology: Perirenal white adipose mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17791,"Urogenital system, morphology: Kidney mass at 29 weeks of age (bilateral), as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17792,"Urogenital system, morphology: Kidney mass at 29 weeks of age (bilateral), as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17793,"Morphology: Epididymal white adipose mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17794,"Morphology: Epididymal white adipose mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17795,"Musculoskeletal system, Musculoskeletal system, morphology: Gastrocnemius muscle mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17796,"Musculoskeletal system, morphology: Gastrocnemius muscle mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17797,"Musculoskeletal system, morphology: Soleus muscle mass at 29 weeks of age, as percentage of body weight, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17798,"Musculoskeletal system, morphology: Soleus muscle mass at 29 weeks of age, as percentage of body weight, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17799,"Blood chemistry, metabolism: Basal glucose in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17800,"Blood chemistry, metabolism: Basal glucose in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17801,"Blood chemistry, metabolism: Cholesterol in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17802,"Blood chemistry, metabolism: Cholesterol in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17803,"Blood chemistry, metabolism: High-density lipoprotein (HDL) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17804,"Blood chemistry, metabolism: High-density lipoprotein (HDL) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17805,"Blood chemistry, metabolism: High-density lipoprotein (HDL) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [batch-corrected z-score]"
BXD_17806,"Blood chemistry, metabolism: High-density lipoprotein (HDL) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [batch-corrected z-score]"
BXD_17807,"Blood chemistry, metabolism: Low-density lipoprotein (LDL) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17808,"Blood chemistry, metabolism: Low-density lipoprotein (LDL) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17809,"Blood chemistry, metabolism: Triglycerides in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17810,"Blood chemistry, metabolism: Triglycerides in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17811,"Blood chemistry, metabolism: Free fatty acids (FFA) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17812,"Blood chemistry, metabolism: Free fatty acids (FFA) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17813,"Blood chemistry, metabolism: Free fatty acids (FFA) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [batch-corrected z-score]"
BXD_17814,"Blood chemistry, metabolism: Free fatty acids (FFA) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [batch-corrected z-score]"
BXD_17815,"Blood chemistry, metabolism: Lactic acid in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17816,"Blood chemistry, metabolism: Lactic acid in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [mmol/L] (EPFL LISP3 Cohort)"
BXD_17817,"Blood chemistry, metabolism: Total protein in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/L] (EPFL LISP3 Cohort)"
BXD_17818,"Blood chemistry, metabolism: Total protein in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/L] (EPFL LISP3 Cohort)"
BXD_17819,"Blood chemistry, metabolism: Alanine transaminase (ALAT) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17820,"Blood chemistry, metabolism: Alanine transaminase (ALAT) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17821,"Blood chemistry, metabolism: Aspartate transaminase (ASAT) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17822,"Blood chemistry, metabolism: Aspartate transaminase (ASAT) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17823,"Blood chemistry, metabolism: Aspartate transaminase (ASAT) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [batch-corrected z-score]"
BXD_17824,"Blood chemistry, metabolism: Aspartate transaminase (ASAT) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [batch-corrected z-score]"
BXD_17825,"Blood chemistry, metabolism: Lactate dehydrogenase (LDH) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17826,"Blood chemistry, metabolism: Lactate dehydrogenase (LDH) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17827,"Blood chemistry, metabolism: Lactate dehydrogenase (LDH) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [batch-corrected z-score]"
BXD_17828,"Blood chemistry, metabolism: Lactate dehydrogenase (LDH) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [batch-corrected z-score]"
BXD_17829,"Blood chemistry, metabolism: Alkaline phosphatase (ALPL) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17830,"Blood chemistry, metabolism: Alkaline phosphatase (ALPL) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17831,"Blood chemistry, metabolism: Amylase in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17832,"Blood chemistry, metabolism: Amylase in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17833,"Blood chemistry, metabolism: Creatine kinase (CPK) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [U/L] (EPFL LISP3 Cohort)"
BXD_17834,"Blood chemistry, metabolism: Creatine kinase (CPK) in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [U/L] (EPFL LISP3 Cohort)"
BXD_17835,"Blood chemistry, metabolism: Creatinine in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [umol/L] (EPFL LISP3 Cohort)"
BXD_17836,"Blood chemistry, metabolism: Creatinine in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [umol/L] (EPFL LISP3 Cohort)"
BXD_17837,"Blood chemistry, metabolism: Creatinine in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [batch-corrected z-score]"
BXD_17838,"Blood chemistry, metabolism: Creatinine in plasma, fasted state at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [batch-corrected z-score]"
BXD_17839,"Blood chemistry, metabolism: Iron (Fe) in plasma, fasted state at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [umol/L] (EPFL LISP3 Cohort)"
BXD_17840,"Blood chemistry, metabolism: Iron (Fe) in plasma of fasted males at 29 weeks of age on a high fat diet (60% kCal/fat HarlanTD.06414) (BXD81 winsorized from 60.50+/-0.87 to 45.0+/-5.0) [umol/L] (EPFL LISP3 Cohort)"
BXD_17841,"Blood chemistry, metabolism: Interferon-gamma (IFN-g) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17842,"Blood chemistry, metabolism: Tumor necrosis factor-alpha (TNF, cachexin) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17843,"Blood chemistry, metabolism: Interleukin 15 (IL15) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17844,"Blood chemistry, metabolism: Monocyte chemotactic protein 1 (MCP1, CCL2) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17845,"Blood chemistry, metabolism: Interleukin 10 (IL10) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17846,"Blood chemistry, metabolism: Macrophage inflammatory protein 1-beta (MIP1B, CCL4) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17847,"Blood chemistry, metabolism: Macrophage inflammatory protein 1-alpha (MIP1A, CCL3) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17848,"Blood chemistry, metabolism: Interleukin 6 (IL6) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17849,"Blood chemistry, metabolism: Interleukin 18 (IL18) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17850,"Blood chemistry, metabolism: Regulated and normal T cell expressed and secreted (RANTES, CCL5) cytokine level in plasma after 12 h fast at 29 weeks of age, Luminex assay, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/mL] (EPFL LISP3 Cohort)"
BXD_17851,"Hematology: Red blood cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^6/uL] (EPFL LISP3 Cohort)"
BXD_17852,"Hematology: Red blood cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^6/uL] (EPFL LISP3 Cohort)"
BXD_17853,"Hematology: Mature red blood cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17854,"Hematology: Mature red blood cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17855,"Hematology: Mature red blood cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17856,"Hematology: Mature red blood cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17857,"Hematology: Hemoglobin at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17858,"Hematology: Hemoglobin at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17859,"Hematology: Hematocrit at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17860,"Hematology: Hematocrit at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17861,"Hematology: Mean corpuscular volume (MCV) at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [fL/RBC] (EPFL LISP3 Cohort)"
BXD_17862,"Hematology: Mean corpuscular volume (MCV) at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [fL/RBC] (EPFL LISP3 Cohort)"
BXD_17863,"Hematology: Mean corpuscular hemoglobin (MCH) at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [pg/RBC] (EPFL LISP3 Cohort)"
BXD_17864,"Hematology: Mean corpuscular hemoglobin (MCH) at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/RBC] (EPFL LISP3 Cohort)"
BXD_17865,"Hematology: Mean corpuscular hemoglobin concentration (MCHC) at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17866,"Hematology: Mean corpuscular hemoglobin concentration (MCHC) at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17867,"Hematology: Red blood cell hemoglobin content at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [pg/RBC] (EPFL LISP3 Cohort)"
BXD_17868,"Hematology: Red blood cell hemoglobin content at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/RBC] (EPFL LISP3 Cohort)"
BXD_17869,"Hematology: Red blood cell distribution width at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17870,"Hematology: Red blood cell distribution width at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17871,"Hematology: Hemoglobin concentration distribution width at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17872,"Hematology: Hemoglobin concentration distribution width at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17873,"Hematology: Reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17874,"Hematology: Reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17875,"Hematology: Reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17876,"Hematology: Reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17877,"Hematology: Mean corpuscular volume reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [fL/RTC] (EPFL LISP3 Cohort)"
BXD_17878,"Hematology: Mean corpuscular volume reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [fL/RTC] (EPFL LISP3 Cohort)"
BXD_17879,"Hematology: Mean corpuscular hemoglobin concentration reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17880,"Hematology: Mean corpuscular hemoglobin concentration reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17881,"Hematology: Red cell hemoglobin content reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [pg/RTC] (EPFL LISP3 Cohort)"
BXD_17882,"Hematology: Red cell hemoglobin content reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/RTC] (EPFL LISP3 Cohort)"
BXD_17883,"Hematology: Mature reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17884,"Hematology: Mature reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17885,"Hematology: Mature reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17886,"Hematology: Mature reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17887,"Hematology: Medium maturity reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17888,"Hematology: Medium maturity reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17889,"Hematology: Medium maturity reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17890,"Hematology: Medium maturity reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17891,"Hematology: Immature reticulocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17892,"Hematology: Immature reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17893,Hematology: Immature reticulocytes of males at 29 weeks of age on a standard chow diet (6% kCal/fat Harlan.2918) (EPFL LISP3 Cohort)[10^9/L] 
BXD_17894,"Hematology: Immature reticulocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^9/L] (EPFL LISP3 Cohort)"
BXD_17895,"Hematology: Platelets at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17896,"Hematology: Platelets at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17897,"Hematology: Mean platelet volume at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [fL/PLT] (EPFL LISP3 Cohort)"
BXD_17898,"Hematology: Platelet volume at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [fL/PLT] (EPFL LISP3 Cohort)"
BXD_17899,"Hematology: Platelet distribution width at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17900,"Hematology: Platelet distribution width at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17901,"Hematology: Plateletcrit at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17902,"Hematology: Plateletcrit at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17903,"Hematology: Platelet component concentration at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17904,"Hematology: Platelet component concentration at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17905,"Hematology: Platelet component distribution width at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17906,"Hematology: Platelet component distribution width at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [g/dL] (EPFL LISP3 Cohort)"
BXD_17907,"Hematology: Platelet mass at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [pg/PLT] (EPFL LISP3 Cohort)"
BXD_17908,"Hematology: Mean platelet mass at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [pg/PLT] (EPFL LISP3 Cohort)"
BXD_17909,"Hematology: White blood cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17910,"Hematology: White blood cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17911,"Hematology: Neutrophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17912,"Hematology: Neutrophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17913,"Hematology: Lymphocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17914,"Hematology: Lymphocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17915,"Hematology: Monocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17916,"Hematology: Monocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17917,"Hematology: Eosinophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17918,"Hematology: Eosinophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17919,"Hematology: Basophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17920,"Hematology: Basophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17921,"Hematology: Large unknown cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [%] (EPFL LISP3 Cohort)"
BXD_17922,"Hematology: Large unknown cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [%] (EPFL LISP3 Cohort)"
BXD_17923,"Hematology: Neutrophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17924,"Hematology: Neutrophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17925,"Hematology: Lymphocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17926,"Hematology: Lymphocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17927,"Hematology: Monocytes at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17928,"Hematology: Monocytes at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17929,"Hematology: Eosinophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17930,"Hematology: Eosinophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17931,"Hematology: Basophils at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17932,"Hematology: Basophils at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17933,"Hematology: Large unknown cells at 29 weeks of age, chow diet (6% kCal/fat Harlan.2918), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17934,"Hematology: Large unknown cells at 29 weeks of age, high fat diet (60% kCal/fat HarlanTD.06414), males [10^3/uL] (EPFL LISP3 Cohort)"
BXD_17935,"Central nervous system, behavior, learning and memory: Synome Trait 1 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17936,"Central nervous system, behavior, learning and memory: Synome Trait 2 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17937,"Central nervous system, behavior, learning and memory: Synome Trait 3 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17938,"Central nervous system, behavior, learning and memory: Synome Trait 4 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17939,"Central nervous system, behavior, learning and memory: Synome Trait 5 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17940,"Central nervous system, behavior, learning and memory: Synome Trait 6 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17941,"Central nervous system, behavior, learning and memory: Synome Trait 7 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17942,"Central nervous system, behavior, learning and memory: Synome Trait 8 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17943,"Central nervous system, behavior, learning and memory: Synome Trait 9 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17944,"Central nervous system, behavior, learning and memory: Synome Trait 10 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17945,"Central nervous system, behavior, learning and memory: Synome Trait 11 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17946,"Central nervous system, behavior, learning and memory: Synome Trait 12 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17947,"Central nervous system, behavior, learning and memory: Synome Trait 13 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17948,"Central nervous system, behavior, learning and memory: Synome Trait 14 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17949,"Central nervous system, behavior, learning and memory: Synome Trait 15 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17950,"Central nervous system, behavior, learning and memory: Synome Trait 16 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17951,"Central nervous system, behavior, learning and memory: Synome Trait 17 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17952,"Central nervous system, behavior, learning and memory: Synome Trait 18 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17953,"Central nervous system, behavior, learning and memory: Synome Trait 19 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17954,"Central nervous system, behavior, learning and memory: Synome Trait 20 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17955,"Central nervous system, behavior, learning and memory: Synome Trait 21 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17956,"Central nervous system, behavior, learning and memory: Synome Trait 22 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17957,"Central nervous system, behavior, learning and memory: Synome Trait 23 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17958,"Central nervous system, behavior, learning and memory: Synome Trait 24 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17959,"Central nervous system, behavior, learning and memory: Synome Trait 25 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17960,"Central nervous system, behavior, learning and memory: Synome Trait 26 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17961,"Central nervous system, behavior, learning and memory: Synome Trait 27 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17962,"Central nervous system, behavior, learning and memory: Synome Trait 28 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17963,"Central nervous system, behavior, learning and memory: Synome Trait 29 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17964,"Central nervous system, behavior, learning and memory: Synome Trait 30 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17965,"Central nervous system, behavior, learning and memory: Synome Trait 31 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17966,"Central nervous system, behavior, learning and memory: Synome Trait 32 (contact Dr. Alexa Horner, alexa@synome.eu)"
BXD_17967,"Blood chemistry: Blood 5-hydroxytryptamine (5-HT, serotonin) level in adult males [pg/ul]"
BXD_17968,Blood chemistry: Blood 5-hydroxyindoleacetic acid (5-HIAA) level in adult males [pg/ul]
BXD_17969,Blood chemistry: Blood 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult males [units]
BXD_17970,"Blood chemistry: Blood 5-hydroxytryptamine (5-HT, serotonin) level in adult females [pg/ul]"
BXD_17971,Blood chemistry: Blood 5-hydroxyindoleacetic acid (5-HIAA) level in adult females [pg/ul]
BXD_17972,Blood chemistry: Blood 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult females [units]
BXD_17973,"Blood chemistry: Blood 5-hydroxytryptamine (5-HT, serotonin) level in adult males and females [pg/ul]"
BXD_17974,Blood chemistry: Blood 5-hydroxyindoleacetic acid (5-HIAA) level in adult males and females [pg/ul]
BXD_17975,Blood chemistry: Blood 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult males and females [units]
BXD_17976,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine (5-HT, serotonin) level in adult males [ng/mg protein]"
BXD_17977,"Central nervous system, neurochemistry: Diencephalon 5-hydroxyindoleacetic acid (5-HIAA) level in adult males [ng/mg protein]"
BXD_17978,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult males [units]"
BXD_17979,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine (5-HT, serotonin) level in adult females [ng/mg protein]"
BXD_17980,"Central nervous system, neurochemistry: Diencephalon 5-hydroxyindoleacetic acid (5-HIAA) level in adult females [ng/mg protein]"
BXD_17981,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult females [units]"
BXD_17982,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine (5-HT, serotonin) level in adult males and females [ng/mg protein]"
BXD_17983,"Central nervous system, neurochemistry: Diencephalon 5-hydroxyindoleacetic acid (5-HIAA) level in adult males and females [ng/mg protein]"
BXD_17984,"Central nervous system, neurochemistry: Diencephalon 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult males and females [units]"
BXD_17985,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine (5-HT, serotonin) level in adult males [ng/mg protein]"
BXD_17986,"Central nervous system, neurochemistry: Midbrain 5-hydroxyindoleacetic acid (5-HIAA) level in adult males [ng/mg protein]"
BXD_17987,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult males [units]"
BXD_17988,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine (5-HT, serotonin) level in adult females [ng/mg protein]"
BXD_17989,"Central nervous system, neurochemistry: Midbrain 5-hydroxyindoleacetic acid (5-HIAA) level in adult females [ng/mg protein]"
BXD_17990,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine turnover rates (5-HIAA/5-HT) in adult females [units]"
BXD_17991,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine (5-HT, serotonin) level in adult males and females [ng/mg protein]"
BXD_17992,"Central nervous system, neurochemistry: Midbrain 5-hydroxyindoleacetic acid (5-HIAA) level in adult males and females [ng/mg protein]"
BXD_17993,"Central nervous system, neurochemistry: Midbrain 5-hydroxytryptamine turnover rate (5-HIAA/5-HT) in adult males and females [units]"
BXD_17994,"Central nervous system, protein expression: Midbrain serotonin transporter (SERT) expression level quantified by Western blotting in adult males [intensity score]"
BXD_17995,"Central nervous system, protein expression: Midbrain serotonin transporter (SERT) expression level quantified by Western blotting in adult females [intensity score]"
BXD_17996,"Central nervous system, protein expression: Midbrain serotonin transporter (SERT) expression level quantified by Western blotting in adult males and females [intensity score]"
BXD_17997,"Central nervous system, protein expression: Diencephalon serotonin transporter (SERT) expression level quantified by Western blotting in adult males [intensity score]"
BXD_17998,"Central nervous system, protein expression: Diencephalon serotonin transporter (SERT) expression level quantified by Western blotting in adult females [intensity score]"
BXD_17999,"Central nervous system, protein expression: Diencephalon serotonin transporter (SERT) expression level quantified by Western blotting in adult males and females [intensity score]"
BXD_18000,"Central nervous system, neurochemistry: Midbrain cysteic acid level in adult females [ug/mg protein]"
BXD_18001,"Central nervous system, neurochemistry: Midbrain homocysteic acid level in adult females [ug/mg protein]"
BXD_18002,"Central nervous system, neurochemistry: Midbrain aspartic acid level in adult females [ug/mg protein]"
BXD_18003,"Central nervous system, neurochemistry: Midbrain serine level in adult females [ug/mg protein]"
BXD_18004,"Central nervous system, neurochemistry: Midbrain glutamic acid level in adult females [ug/mg protein]"
BXD_18005,"Central nervous system, neurochemistry: Midbrain glycine level in adult females [ug/mg protein]"
BXD_18006,"Central nervous system, neurochemistry: Midbrain histidine level in adult females [ug/mg protein]"
BXD_18007,"Central nervous system, neurochemistry: Midbrain taurine level in adult females [ug/mg protein]"
BXD_18008,"Central nervous system, neurochemistry: Midbrain arginine level in adult females [ug/mg protein]"
BXD_18009,"Central nervous system, neurochemistry: Midbrain threonine level in adult females [ug/mg protein]"
BXD_18010,"Central nervous system, neurochemistry: Midbrain alanine level in adult females [ug/mg protein]"
BXD_18011,"Central nervous system, neurochemistry: Midbrain proline level in adult females [ug/mg protein]"
BXD_18012,"Central nervous system, neurochemistry: Midbrain GABA level in adult females [ug/mg protein]"
BXD_18013,"Central nervous system, neurochemistry: Midbrain cystine level in adult females [ug/mg protein]"
BXD_18014,"Central nervous system, neurochemistry: Midbrain tyrosine level in adult females [ug/mg protein]"
BXD_18015,"Central nervous system, neurochemistry: Midbrain valine level in adult females [ug/mg protein]"
BXD_18016,"Central nervous system, neurochemistry: Midbrain methionine level in adult females [ug/mg protein]"
BXD_18017,"Central nervous system, neurochemistry: Midbrain lysine level in adult females [ug/mg protein]"
BXD_18018,"Central nervous system, neurochemistry: Midbrain isoleucine level in adult females [ug/mg protein]"
BXD_18019,"Central nervous system, neurochemistry: Midbrain leucine level in adult females [ug/mg protein]"
BXD_18020,"Central nervous system, neurochemistry: Midbrain phenylalanine level in adult females [ug/mg protein]"
BXD_18021,"Central nervous system, neurochemistry: Midbrain Glu/GABA ratios in adult females [ratio]"
BXD_18022,"Central nervous system, neurochemistry: Midbrain cysteic acid level in adult males [pmol/ug protein]"
BXD_18023,"Central nervous system, neurochemistry: Midbrain homocysteic acid level in adult males [pmol/ug protein]"
BXD_18024,"Central nervous system, neurochemistry: Midbrain aspartic acid level in adult males [pmol/ug protein]"
BXD_18025,"Central nervous system, neurochemistry: Midbrain serine level in adult males [pmol/ug protein]"
BXD_18026,"Central nervous system, neurochemistry: Midbrain glutamic acid level in adult males [pmol/ug protein]"
BXD_18027,"Central nervous system, neurochemistry: Midbrain glycine level in adult males [pmol/ug protein]"
BXD_18028,"Central nervous system, neurochemistry: Midbrain histidine level in adult males [pmol/ug protein]"
BXD_18029,"Central nervous system, neurochemistry: Midbrain taurine level in adult males [pmol/ug protein]"
BXD_18030,"Central nervous system, neurochemistry: Midbrain arginine level in adult males [pmol/ug protein]"
BXD_18031,"Central nervous system, neurochemistry: Midbrain threonine level in adult males [pmol/ug protein]"
BXD_18032,"Central nervous system, neurochemistry: Midbrain alanine level in adult males [pmol/ug protein]"
BXD_18033,"Central nervous system, neurochemistry: Midbrain proline level in adult males [ug/mg protein]"
BXD_18034,"Central nervous system, neurochemistry: Midbrain GABA level in adult males [ug/mg protein]"
BXD_18035,"Central nervous system, neurochemistry: Midbrain cystine level in adult males [ug/mg protein]"
BXD_18036,"Central nervous system, neurochemistry: Midbrain tyrosine level in adult males [ug/mg protein]"
BXD_18037,"Central nervous system, neurochemistry: Midbrain valine level in adult males [ug/mg protein]"
BXD_18038,"Central nervous system, neurochemistry: Midbrain methionine level in adult males [ug/mg protein]"
BXD_18039,"Central nervous system, neurochemistry: Midbrain lysine level in adult males [ug/mg protein]"
BXD_18040,"Central nervous system, neurochemistry: Midbrain isoleucine level in adult males [ug/mg protein]"
BXD_18041,"Central nervous system, neurochemistry: Midbrain leucine level in adult males [ug/mg protein]"
BXD_18042,"Central nervous system, neurochemistry: Midbrain phenylalanine level in adult males [ug/mg protein]"
BXD_18043,"Central nervous system, neurochemistry: Midbrain Glu/GABA ratios in adult males [ratio]"
BXD_18044,"Central nervous system, neurochemistry: Midbrain 4,5-trihydroxyphenethylamine (Norepinephrine, noradrenaline) level in adult males [ng/mg protein]"
BXD_18045,"Central nervous system, neurochemistry: Midbrain 3,4-dihydroxyphenylacetic acid (DOPAC) level in adult males [ng/mg protein]"
BXD_18046,"Central nervous system, neurochemistry: Midbrain 3,4-dihydroxyphenethylamine (dopamine) level in adult males [ng/mg protein]"
BXD_18047,"Central nervous system, neurochemistry: Midbrain 3-methoxy-4-hydroxyphenyl acetic acid (Homovanillic acid, HVA) level in adult males [ng/mg protein]"
BXD_18048,"Central nervous system, neurochemistry: Midbrain 3-methoxy-4-hydroxyphenethylamine (3-MT) level in adult males [ng/mg protein]"
BXD_18049,"Central nervous system, protein expression: Midbrain dopamine transporter (DAT) expression level quantified by Western blotting in adult males [intensity score]"
BXD_18050,"Central nervous system, protein expression: Midbrain choline transporter (CHT) expression level quantified by Western blotting in adult males [intensity score]"
BXD_18051,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) freezing during training (Med Associates chamber,  2 sec 0.75 mA shock, 85 dB 3KHz tone, 4 tone-shock pairings) in singly-housed 3-4 month-old males (Figure 2A left)[%]"
BXD_18052,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) freezing during training (Med Associates chamber, 2 sec 0.75 mA shock,  85 dB 3KHz tone, 4 tone-shock pairings) in singly-housed 3-4 month-old males (Figure 2A middle)[%]"
BXD_18053,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups freezing during training (Med Associates chamber, 2 sec 0.75 mA shock,  85 dB 3KHz tone, 4 tone-shock pairings) in singly-housed 3-4 month-old males (Figure 2A right)[%]"
BXD_18054,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) locomoter distance in an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3A left)[m]"
BXD_18055,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) locomoter distance in an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3A middle)[m]"
BXD_18056,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups locomoter distance in an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3A right)[m]"
BXD_18057,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) freezing to tone after fear conditioning, nine exposures to a 85 dB 3KHz tones in singly-housed 3-4 month-old males (Figure 2C left)[sec]"
BXD_18058,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) freezing to tone after fear conditioning, nine exposures to a 85 dB 3KHz tones in singly-housed 3-4 month-old males (Figure 2C middle)[sec]"
BXD_18059,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups freezing to tone after fear conditioning, nine exposures to a 85 dB 3KHz tones in singly-housed 3-4 month-old males (Figure 2C right)[sec]"
BXD_18060,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) time in open arm of an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3C left)[sec]"
BXD_18061,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) time in open arm of an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3C middle)[sec]"
BXD_18062,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups time in open arm of an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3C right)[sec]"
BXD_18063,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) time in closed arm of an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3B left)[sec]"
BXD_18064,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) time in closed arm of an elevated plus (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3B middle)[sec]"
BXD_18065,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups time in closed arm of an elevated plus maze (measured for 5 minutes) in singly-housed 3-4 month-old males (Figure 3B right)[sec]"
BXD_18066,"Central nervous systems, behavior: Effects of chronic variable stress (unstressed control) freezing to context after fear conditioning (measured for 10 minutes) in singly-housed 3-4 month-old males (Figure 2B left)[sec]"
BXD_18067,"Central nervous systems, behavior: Effects of chronic variable stress (CVS for four weeks) freezing to context after fear conditioning (measured for 10 minutes) in singly-housed 3-4 month-old males (Figure 2B middle)[sec]"
BXD_18068,"Central nervous systems, behavior: Effects of chronic variable stress, difference between stress and control groups freezing to context after fear conditioning (measured for 10 minutes) in singly-housed 3-4 month-old males (Figure 2B right)[sec]"
BXD_18069,"Central nervous system, behavior, learning and memory: Fear conditioning acquisition, freezing response time following the final CS-US pairing during training in adult males (USC) and adult males and females (NIH) [%]."
BXD_18070,"Central nervous system, behavior, learning and memory: Fear conditioning expression, average freezing response time during the first three (USC) or one (NIH) CS presentation(s) in adult males (USC) and adult males and females (NIH) [%]."
BXD_18071,Polynomial_Slopes_of Medians 
BXD_18072,"Infectious disease, immune function: Cryptic GAS phenotype (Linear_Slopes_of Medians), contact Nourtan Abdeltawab, PhD Cairo University, nourtan@gmail.com"
BXD_18078,CMS-1
BXD_18079,CMS-2
BXD_18080,CMS-3
BXD_18081,CMS-4
BXD_18082,CMS-5
BXD_18083,CMS-6
BXD_18084,CMS-7
BXD_18085,CMS-8
BXD_18086,CMS-9
BXD_18087,CMS-10
BXD_18088,CMS-11
BXD_18089,CMS-12
BXD_18090,CMS-13
BXD_18091,CMS-14
BXD_18092,CMS-15
BXD_18093,CMS-16
BXD_18094,CMS-17
BXD_18095,CMS-18
BXD_18096,CMS-19
BXD_18097,CMS-20
BXD_18098,CMS-21
BXD_18099,CMS-22
BXD_18100,"Central nervous system, morphology: Brain weight of females after 11 weeks of alcohol consumption (20% v/v), using the drinking in the dark (DID) method (4 hr access on day 4 of DID) [g]"
BXD_18101,CMS-24
BXD_18102,CMS-25
BXD_18125,"Central nervous system, development, neurogenesis: Goldowitz Trait 
dang@cmmt.ubc.ca
etheberge94@gmail.com"
BXD_18126,"Central nervous system, development, neurogenesis: Goldowitz Trait dang@cmmt.ubc.ca etheberge94@gmail.com"
BXD_18127,"Central nervous system, development, neurogenesis: Goldowitz Trait 
dang@cmmt.ubc.ca
etheberge94@gmail.com"
BXD_18128,"Central nervous system, development, neurogenesis: Goldowitz Trait (dang@cmmt.ubc.ca or etheberge94@gmail.com)"
BXD_18180,Trait_51_bone_JH
BXD_18181,Trait_52_bone_JH
BXD_18182,Trait_53_bone_JH
BXD_18183,Trait_54_bone_JH
BXD_18184,Trait_55_bone_JH
BXD_18185,Trait_56_bone_JH
BXD_18186,Trait_57_bone_JH
BXD_18187,Trait_58_bone_JH
BXD_18188,Trait_59_bone_JH
BXD_18189,Trait_60_bone_JH
BXD_18190,Trait_61_bone_JH
BXD_18191,Trait_62_bone_JH
BXD_18192,Trait_63_bone_JH
BXD_18193,Trait_64_bone_JH
BXD_18194,Trait_65_bone_JH
BXD_18195,Trait_66_bone_JH
BXD_18196,Trait_67_bone_JH
BXD_18197,Trait_68_bone_JH
BXD_18198,Trait_69_bone_JH
BXD_18199,Trait_70_bone_JH
BXD_18200,Trait_71_bone_JH
BXD_18201,Trait_72_bone_JH
BXD_18202,Trait_73_bone_JH
BXD_18203,Trait_74_bone_JH
BXD_18204,Trait_75_bone_JH
BXD_18205,Trait_76_bone_JH
BXD_18206,Trait_77_bone_JH
BXD_18207,Trait_78_bone_JH
BXD_18208,Trait_79_bone_JH
BXD_18209,Trait_80_bone_JH
BXD_18210,Trait_81_bone_JH
BXD_18211,Trait_82_bone_JH
BXD_18212,Trait_83_bone_JH
BXD_18213,Trait_84_bone_JH
BXD_18214,Trait_85_bone_JH
BXD_18215,Trait_86_bone_JH
BXD_18216,Trait_87_bone_JH
BXD_18217,Trait_88_bone_JH
BXD_18218,Trait_89_bone_JH
BXD_18219,Trait_90_bone_JH
BXD_18220,Trait_91_bone_JH
BXD_18221,Trait_92_bone_JH
BXD_18222,Trait_93_bone_JH
BXD_18223,Trait_94_bone_JH
BXD_18224,Trait_95_bone_JH
BXD_18225,Trait_96_bone_JH
BXD_18226,Trait_97_bone_JH
BXD_18227,Trait_98_bone_JH
BXD_18228,Trait_99_bone_JH
BXD_18229,Trait_100_bone_JH
BXD_18230,Trait_101_bone_JH
BXD_18231,Trait_102_bone_JH
BXD_18232,Trait_103_bone_JH
BXD_18233,Trait_104_bone_JH
BXD_18234,Trait_105_bone_JH
BXD_18235,Trait_106_bone_JH
BXD_18236,Trait_107_bone_JH
BXD_18237,Trait_108_bone_JH
BXD_18238,Trait_109_bone_JH
BXD_18239,Trait_110_bone_JH
BXD_18240,Trait_111_bone_JH
BXD_18241,Trait_112_bone_JH
BXD_18242,Trait_113_bone_JH
BXD_18243,Trait_114_bone_JH
BXD_18244,Trait_115_bone_JH
BXD_18245,Trait_116_bone_JH
BXD_18246,Trait_117_bone_JH
BXD_18247,Trait_118_bone_JH
BXD_18248,Trait_119_bone_JH
BXD_18249,Trait_120_bone_JH
BXD_18250,Trait_121_bone_JH
BXD_18251,Trait_122_bone_JH
BXD_18252,Trait_123_bone_JH
BXD_18253,Trait_124_bone_JH
BXD_18254,Trait_125_bone_JH
BXD_18255,Trait_126_bone_JH
BXD_18256,Trait_127_bone_JH
BXD_18257,Trait_128_bone_JH
BXD_18258,Trait_129_bone_JH
BXD_18259,Trait_130_bone_JH
BXD_18260,Trait_131_bone_JH
BXD_18261,Trait_132_bone_JH
BXD_18262,Trait_133_bone_JH
BXD_18263,Trait_134_bone_JH
BXD_18264,Trait_135_bone_JH
BXD_18265,Trait_136_bone_JH
BXD_18266,Trait_137_bone_JH
BXD_18267,Trait_138_bone_JH
BXD_18268,Trait_139_bone_JH
BXD_18269,Trait_140_bone_JH
BXD_18270,Trait_141_bone_JH
BXD_18271,Trait_142_bone_JH
BXD_18272,Trait_143_bone_JH
BXD_18273,Trait_144_bone_JH
BXD_18274,Trait_145_bone_JH
BXD_18275,Trait_146_bone_JH
BXD_18276,Trait_147_bone_JH
BXD_18277,Trait_148_bone_JH
BXD_18278,Trait_149_bone_JH
BXD_18279,Trait_150_bone_JH
BXD_18280,PhenoTyper_001
BXD_18281,PhenoTyper_002
BXD_18282,PhenoTyper_003
BXD_18283,PhenoTyper_004
BXD_18284,PhenoTyper_005
BXD_18285,PhenoTyper_006
BXD_18286,PhenoTyper_007
BXD_18287,PhenoTyper_008
BXD_18288,PhenoTyper_009
BXD_18289,PhenoTyper_010
BXD_18290,PhenoTyper_011
BXD_18291,PhenoTyper_012
BXD_18292,PhenoTyper_013
BXD_18293,PhenoTyper_014
BXD_18294,PhenoTyper_015
BXD_18295,PhenoTyper_016
BXD_18296,PhenoTyper_017
BXD_18297,PhenoTyper_018
BXD_18298,PhenoTyper_019
BXD_18299,PhenoTyper_020
BXD_18300,PhenoTyper_021
BXD_18301,PhenoTyper_022
BXD_18302,PhenoTyper_023
BXD_18303,PhenoTyper_024
BXD_18304,PhenoTyper_025
BXD_18305,PhenoTyper_026
BXD_18306,PhenoTyper_027
BXD_18307,PhenoTyper_028
BXD_18308,PhenoTyper_029
BXD_18309,PhenoTyper_030
BXD_18310,PhenoTyper_031
BXD_18311,PhenoTyper_032
BXD_18312,PhenoTyper_033
BXD_18313,PhenoTyper_034
BXD_18314,PhenoTyper_035
BXD_18315,PhenoTyper_036
BXD_18316,PhenoTyper_037
BXD_18317,PhenoTyper_038
BXD_18318,PhenoTyper_039
BXD_18319,PhenoTyper_040
BXD_18320,PhenoTyper_041
BXD_18321,PhenoTyper_042
BXD_18322,PhenoTyper_043
BXD_18323,PhenoTyper_044
BXD_18324,PhenoTyper_045
BXD_18325,PhenoTyper_046
BXD_18326,PhenoTyper_047
BXD_18327,PhenoTyper_048
BXD_18328,PhenoTyper_049
BXD_18329,PhenoTyper_050
BXD_18330,PhenoTyper_051
BXD_18331,PhenoTyper_052
BXD_18332,PhenoTyper_053
BXD_18333,PhenoTyper_054
BXD_18334,PhenoTyper_055
BXD_18335,PhenoTyper_056
BXD_18336,PhenoTyper_057
BXD_18337,PhenoTyper_058
BXD_18338,PhenoTyper_059
BXD_18339,PhenoTyper_060
BXD_18340,PhenoTyper_061
BXD_18341,PhenoTyper_062
BXD_18342,PhenoTyper_063
BXD_18343,PhenoTyper_064
BXD_18344,PhenoTyper_065
BXD_18345,PhenoTyper_066
BXD_18346,PhenoTyper_067
BXD_18347,PhenoTyper_068
BXD_18348,PhenoTyper_069
BXD_18349,PhenoTyper_070
BXD_18350,PhenoTyper_071
BXD_18351,PhenoTyper_072
BXD_18352,PhenoTyper_073
BXD_18353,PhenoTyper_074
BXD_18354,PhenoTyper_075
BXD_18355,PhenoTyper_076
BXD_18356,PhenoTyper_077
BXD_18357,PhenoTyper_078
BXD_18358,PhenoTyper_079
BXD_18359,PhenoTyper_080
BXD_18360,PhenoTyper_081
BXD_18361,PhenoTyper_082
BXD_18362,PhenoTyper_083
BXD_18363,PhenoTyper_084
BXD_18364,PhenoTyper_085
BXD_18365,PhenoTyper_086
BXD_18366,PhenoTyper_087
BXD_18367,PhenoTyper_088
BXD_18368,PhenoTyper_089
BXD_18369,PhenoTyper_090
BXD_18370,PhenoTyper_091
BXD_18371,PhenoTyper_092
BXD_18372,PhenoTyper_093
BXD_18373,PhenoTyper_094
BXD_18374,PhenoTyper_095
BXD_18375,PhenoTyper_096
BXD_18376,PhenoTyper_097
BXD_18377,PhenoTyper_098
BXD_18378,PhenoTyper_099
BXD_18379,PhenoTyper_100
BXD_18380,PhenoTyper_101
BXD_18381,PhenoTyper_102
BXD_18382,PhenoTyper_103
BXD_18383,PhenoTyper_104
BXD_18384,PhenoTyper_105
BXD_18385,PhenoTyper_106
BXD_18386,PhenoTyper_107
BXD_18387,PhenoTyper_108
BXD_18388,PhenoTyper_109
BXD_18389,PhenoTyper_110
BXD_18390,PhenoTyper_111
BXD_18391,PhenoTyper_112
BXD_18392,PhenoTyper_113
BXD_18393,PhenoTyper_114
BXD_18394,PhenoTyper_115
BXD_18395,"Central nervous system, behavior, aging: Fear conditioning, freezing in response to context 24 h after training in males and females at about 15 months-of-age on normal chow diet (all Nash Annex cases) [percent]"
BXD_18396,"Immune system, infectious disease: Fitzpatrick trait DS1 (please contact efitzpat@uthsc.edu for details).  "
BXD_18398," Immune system, infectious disease: Fitzpatrick trait Cell 6 % subset (please contact efitzpat@uthsc.edu for details).  "
BXD_18400,"Immune system, infectious disease: Fitzpatrick trait Cell 2 %subset (please contact efitzpat@uthsc.edu for details).  "
BXD_18404,"Urogenital system, kidney, function: STZ ACR"
BXD_18405,"Urogenital system, kidney, morphology: Podocytes"
BXD_18406,"Urogenital system, kidney, morphology: non-podocytes"
BXD_18407,"Urogenital system, kidney, morphology: GSA"
BXD_18408,"Urogenital system, kidney, morphology: Cell density (total)"
BXD_18409,"Urogenital system, kidney, morphology: WT1 positive cells"
BXD_18410,"Urogenital system, kidney, morphology: WT1 negative cells"
BXD_18411,"Central nervous system, gene expression: Hp1bp3 gene expression in hippocampus based on average signal of SNP-free probes 10338180 (exon 2), 10344447 (exon 5), 10342675 (exon 9), and 10340971 (exon 12) using the BXD Aged Hippocampus Affy MoGene1.0 ST (May 15) RMA Gene Level dataset [log2 expression]"
BXD_18412,"Cardiovascular system, morphology: increment of systolic blood pressure (pressure at 4 wks minus pressure at baseline) in males after treatment with angiotensin II (1 mg/kg/day, minipump) for 4 weeks [mmhg]"
BXD_18416,Trait_151_bone_JH
BXD_18417,Trait_152_bone_JH
BXD_18418,"Trait_153_bone_JH
"
BXD_18419,Trait_154_bone_JH
BXD_18420,Trait_155_bone_JH
BXD_18421,Trait_156_bone_JH
BXD_18422,Trait_157_bone_JH
BXD_18423,Trait_158_bone_JH
BXD_18424,PC_1_bone_JH
BXD_18425,PC_2_bone_JH
BXD_18426,PC_3_bone_JH
BXD_18427,PC_4_bone_JH
BXD_18429,PC_6_bone_JH
BXD_18430,Phenotype:	Cardiovascular system: Ejection fraction by echocardiography of 17-week old females and males [%]
BXD_18431,Cardiovascular system: Shortening fraction by echocardiography of 17-week old females and males [%]
BXD_18432,Cardiovascular system: Ejection fraction by echocardiography of 17-week old paired females and males [%]
BXD_18433,Cardiovascular system: Shortening fraction by echocardiography of 17-week old paired females and males [%]
BXD_18434,Cormier trait 1 (contact dsiefker@uthsc.edu) 
BXD_18435,"Aging, metabolism: Lifespan, mean longevity of females at UTHSC on high fat diet (HFD, Envigo Teklad TD06414, 60.3% calories from fat (fatty acid profile comprises 37% saturated, 47% monounsaturated, 16% polyunsaturated fats), 18.4% from protein, 21.3% from carbohydrates caloric content of 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n = 809, B6D2F1 data excluded, 413 +/- 1.5 n=3) [days]"
BXD_18436,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell expression PCA eigengene generated using the DoD CDMRP Retina Affy MoGene 2.0 ST (May15) RMA Gene Level database (PC03, 8% of variance) and a set of 73 known and putative RGC signature genes (Ahcyl1, Amhr2, Apoe, Bcl2l11, Bex2, Cacna1a, Calb2, Cldn5, Coch, Csnk2a2, Epha2, Epha5, Ephb1, Ephb2, Fbxo2, Gap43, Gdf11, Gja7, Gja9, Gpnmb, Gpsn2, Grb7, Igf1, Igf1r, Igfbp7, Kcnc1, Kif3c, Klf4, Klf7, L1cam, Ldhd, Lsamp, Med1, Ndrg4, Nefl, Nefm, Nell1, Nptxr, Nras, Nrcam, Nrn1, Nrp1, Nupl1, Opn4, Pcp4, Plekha2, Pls3, Pouf4l, Rab3c, Rbfox3, Rbpms, Resp18, Ret, Rgn, Rgs4, Rnd1, Robo2, S100b, Sema6b, Sepp1, Sh3glb1, Slc12a5, Slit2, Snca, Sncg, Sox4, Stmn2, Thy1, Tubb3, Vamp1, Vsnl1, Xiap, Ywhah, Ywhaz) (BXD24 deleted)[PC score]"
BXD_18437,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell expression PCA eigengene generated using the DoD CDMRP Retina Affy MoGene 2.0 ST (May15) RMA Gene Level database (PC01, 50% of variance) and a set of 9  genes that covary well with Trait 10600 (C6orf106, Dlg1, Dlg2, Epb4.1l5, Hist3h2a, Meis1, Nebl, Nup155, Ppfia2) [PC score]"
BXD_18438,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell expression PCA eigengene generated using the Full HEI Retina Illumina RankInv database (PC01, 37% of variance) and a set of 7 genes that covary well with RGC Trait 10600 (Ablim2, Antxr2, Crhbp, Csmd2, Mknk1, Pdlim3, Rhno1) [PC score]"
BXD_18439,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell expression metatrait generated as the PC01 of  18438, 18437 and 18436 [PC score]"
BXD_18440,"Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = resistant, 1 = susceptible) [fraction of cohort that survives]"
BXD_18441,"Aging, metabolism: Lifespan, mean longevity of females on standard chow diet (Envigo Teklad LM-485 7912, 17% calories from fat (fatty acids comprise 0.8% saturated, 1.3% monounsaturated and 2.9% polyunsaturated fats), 25% from protein, 58% from carbohydrates, caloric content of 3.1 kcal/g) at UTHSC on a 12 hr light cycle in polypropylene cages (145 in2) with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding (updated Feb 2023 at n deaths = 913) [days]"
BXD_18442,"Central nervous system, metabolism: Iron (Fe) level in ventral midbrain (VMB) of young adults of both sexes (20 to 120 days of age) [ug/g wet weight]"
BXD_18443,"Central nervous system, metabolism: Copper (Cu) level in ventral midbrain (VMB) of young adult males (40 to 120 days of age) [ug/g wet weight]"
BXD_18444,"Central nervous system, metabolism: Zinc (Zn) level in ventral midbrain (VMB) of young adults of both sexes (40 to 120 days of age) [ug/g wet weight]"
BXD_18445,"Central nervous system, metabolism: Iron (Fe) level in hippocampus (HIP) of young adults of both sexes (40 to 120 days of age)   [ug/g wet weight]"
BXD_18446,"Central nervous system, metabolism: Copper (Cu) level in hippocampus (HIP) of young adults of both sexes (40 to 120 days of age)  [ug/g wet weight]"
BXD_18447,"Central nervous system, metabolism: Trait ZnHIP (contact BC Jones at bjone129@uthsc.edu)"
BXD_18448,"Central nervous system, metabolism: Iron (Fe) level in cortex (CTX) of young adults of both sexes (40 to 120 days of age) [ug/g wet weight]"
BXD_18449,"Central nervous system, metabolism: Copper (Cu) level in cortex (CTX) of young adults of both sexes (40 to 120 days of age) (DBA/2J winsorized from 9.33 to 6.0) [ug/g wet weight]"
BXD_18450,"Central nervous system, metabolism: Trait ZnCTX (contact BC Jones at bjone129@uthsc.edu)"
BXD_18452,"Immune system, infectious disease: Fitzpatrick trait Cell 1 % (please contact efitzpat@uthsc.edu for details).   "
BXD_18454,"Immune system, infectious disease: Fitzpatrick trait Cell 3 %subset (please contact efitzpat@uthsc.edu for details).  "
BXD_18455,"Immune system, infectious disease: Fitzpatrick trait Cell 4 %subset (please contact efitzpat@uthsc.edu for details).  "
BXD_18456,"Immune system, infectious disease: Fitzpatrick trait Cell 5 % subset (please contact efitzpat@uthsc.edu for details).  "
BXD_18459,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 20"
BXD_18460,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 21"
BXD_18461,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 22"
BXD_18462,"Central nervous system, behavior: inter-male aggression, attack latency of 3-4 month old males against a standard opponent (3 month old A/JOlaHsd male) on day 1 within a 10 min test on following 10 days of isolation [s]"
BXD_18463,"Central nervous system, behavior: inter-male aggression, attack latency by 3-4 month old males against a standard opponent (3 month old A/JOlaHsd male) on day 2 within a 10 min test following 10 days of isolation [s]"
BXD_18464,"Central nervous system, behavior: inter-male aggression, proportion of 3-4 month old males that attacked a standard opponent (3 month old A/JOlaHsd male) on day 1 within a 10 min test on following 10 days of isolation [attack proportion]"
BXD_18465,"Central nervous system, behavior: inter-male aggression, proportion of 3-4 month old males that attacked a standard opponent (3 month old A/JOlaHsd male) on day 2 within a 10 min test on following 10 days of isolation [attack proportion]"
BXD_18466,"Central nervous system, behavior: inter-male aggression, proportion of 3-4 month old males that attacked a standard opponent (3 month old A/JOlaHsd male) on days 1 and 2 within a 10 min test on following 10 days of isolation [attack proportion]"
BXD_18467,PC1_bone_development(GO:0060348)
BXD_18468,PC2_bone_development(GO:0060348)
BXD_18469,PC3_bone_development(GO:0060348)
BXD_18470,"Musculoskeletal system, morphology, gene expression: Principal component 1 for osteoblast differentiation(GO:0001649) accounting for 26% of variance using the UCLA GSE27483 BXD Bone Femur ILM Mouse WG-6 v1, v1.1 (Jan13) RSN database (gene list:Akt1, Asf1a, Bmp2, Bmp4, Bmp6, Bmp8a, Cbfb, Chrd, Cyr61, Dlx5, Epha2, Fgf9, Fignl1, Gabbr1, Gdf2, Gja1, Gli1, Gli2, H3f3a, H3f3b, Hira, Ift80, Ihh, Junb, Lef1, Lrrc17, Mef2c, Mef2d, Msx2, Nf1, Nog, Rspo2, Runx2, Shox2, Smad3, Smo, Sox2, Sox8, Sp7, Tmem119, Trp53inp2, Twist1, Twist2, Wnt11, Wnt3a, Wwox, Wwtr1) (PC score)"
BXD_18471,PC2_osteoblast_differentiation(GO:0001649)
BXD_18472,PC3_osteoblast_differentiation(GO:0001649)
BXD_18473,PC1_bone_mineralization(GO:0030282)
BXD_18474,PC2_bone_mineralization(GO:0030282)
BXD_18475,PC3_bone_mineralization(GO:0030282)
BXD_18476,PC1_ossification (GO:0001503)
BXD_18477,PC2_ossification (GO:0001503)
BXD_18478,PC3_ossification (GO:0001503)
BXD_18479,PC1_bone_trabecula_formation (GO:0060346)
BXD_18480,PC2_bone_trabecula_formation (GO:0060346)
BXD_18481,PC3_bone_trabecula_formation (GO:0060346)
BXD_18482,PC1_regulation_of_bone_remodeling (GO:0046850)
BXD_18483,PC2_regulation_of_bone_remodeling (GO:0046850)
BXD_18484,PC3_regulation_of_bone_remodeling (GO:0046850)
BXD_18485, PC1_response_to_vitamin D (GO:0033280)
BXD_18486,PC2_response_to_vitamin D (GO:0033280)
BXD_18487,PC3_response_to_vitamin D (GO:0033280)
BXD_18488,PC1_endochondral_ossification (GO:0001958)
BXD_18489,PC2_endochondral_ossification (GO:0001958)
BXD_18490,PC3_endochondral_ossification (GO:0001958)
BXD_18491,"Cardiovascular system, morphology, aging: Heart weight without statistical adjustment of older females at UTHSC (longevity cohort: 300 to 900 days of age using combined data for standard chow and high fat diets, CD: n=293, HFD: n=276) [mg]"
BXD_18492,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), sessions to meet acquisition criteria at a dose of 0.56 mg/kg/infusionÂ (see Fig 1a, Fig 3), in males and females at 12 to 14 weeks of age [sessions]
"
BXD_18493,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), principal component 1 that corresponds well to area under the dose-response curve and infusions on the descending limb of the dose-response curve (IDL trait), in males and females at 12 to 14 weeks of age  [PC score]

"
BXD_18494,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), principal component 2 that corresponds well to infusions on the ascending limb of the dose-response curve (IAL trait, see Fig 4), in males and females at 12 to 14 weeks of age  (this trait maps to Cyfip2 locus) [PC score] 
"
BXD_18495,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), consistency of cocaine intake across the ascending limb of the dose response curve, in males and females at 12 to 14 weeks of age (CAL trait, see Fig 5) (after publication: winsorized BXD77 from 1.598 to 1.325)  [coefficient of variation]

"
BXD_18496,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.032 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18497,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.056 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18498,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.1 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18499,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.18 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18500,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.32 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]
"
BXD_18501,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 0.56 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18502,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 1.0 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18503,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of infusions at a dose of 1.8 mg/kg/infusion (see Fig 1b),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]


"
BXD_18504,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.032 mg/kg/infusionÂ (see Fig 1d), in males and females at 12 to 14 weeks of ageÂ  [n/2 hr]

"
BXD_18505,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.056 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18506,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.1 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18507,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.18 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18508,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.32 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18509,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 0.56 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18510,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 1.0 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18511,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of active lever presses at a dose of 1.8 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18512,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.032 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18513,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.056 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18514,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.1 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]
"
BXD_18515,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.18 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18516,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.32 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18517,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 0.56 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18518,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 1.0 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18519,"Central nervous system, behavior, pharmacology: Intravenous cocaine self-administration (IVSA), number of inactive lever presses at a dose of 1.8 mg/kg/infusion (see Fig 1d),Â in males and females at 12 to 14 weeks of ageÂ [n/2 hr]

"
BXD_18520,"Blood chemistry: Gelsolin protein level in plasma from young adults, 1 sample with triplicate technical replicates [mg/l)"
BXD_18521,"Central nervous system, morphology: Brain weight of males, repeat measurement prior to dissection, statistically adjusted for variation in age, body weight, and dissection error [mg]"
BXD_18522,"Central nervous system, morphology: Brain weight in females, statistically adjusted for variation in age, body weight, and dissection error [mg]"
BXD_18523,"Central nervous system, morphology: Brain weight in males, statistically adjusted for variation in age, body weight, and dissection error [mg]"
BXD_18524,"Central nervous system, morphology: Brain weight average of both males and females, statistically adjusted for variation in age, body weight, and dissection error [mg]"
BXD_18525,Pre Publication Description 1
BXD_18526,"First principal component from expression of the three Hspb8 probes; 1456434_x_at, 1417013_at and 1417014_at in the Hippocampus Consortium M430v2 (Jun06) PDNN Database."
BXD_18528,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell neurofilament gene expression eigengene generated using the DoD CDMRP Retina Affy MoGene 2.0 ST (May15) RMA Gene Level database (PC01, 60% of variance) and all probe sets for Nflh, Nflm, and Nfhl [PC score]"
BXD_18529,"Genetics, variation: Coefficient of error (SE/mean) averaged across approximately 5000 valid phenotypes computed Aug 2016 (removal of cofactor phenotypes and a few traits with low N) [CE]"
BXD_18530,"Central nervous system, eye, visual system gene expression: Retinal ganglion cell gene expression eigengene generated using the DoD CDMRP Retina Affy MoGene 2.0 ST (May15) RMA Gene Level database (PC01, 50% of variance) and 39 probe sets from Macosko et al. (2015) set of unique retinal ganglion cell (RGC) signature genes (e.g., Ahnak2, Apbb2, Atl1, Cend1, Chl1, Chrnb3, Cplx1...)[PC score]"
BXD_18531,"Immune system, infectious disease: Fitzpatrick trait Cytokine 20 E (contact Liz Fitzpatrick for details efitzpat@uthsc.edu)"
BXD_18532,"Central nervous system, behavior: Offspring indirect genetic effect modifying maternal nestbuidling behavior, maternal nestbuilding behavior of C57BL/6J on postnatal day 6, mapped as a function of BXD pup genotype, per pup averaged across litters [n]
"
BXD_18533,"Immune system, infectious disease: Fitzpatrick trait DS4(please contact efitzpat@uthsc.edu for details).  "
BXD_18535,"Central nervous system, behavior: Offspring indirect genetic effect modifying maternal behavior, maternal behavior of C57BL/6J on postnatal day 14 mapped as a function of BXD pup genotype, per pup averaged across litters [n]"
BXD_18536,"Morphology, musculoskeletal system: Maternal indirect genetic effect modifying offspring growth, growth of C57BL/6J pups from day 6 to day 10 mapped as a function BXD mother genotype, per pup averaged across litters [g]"
BXD_18537,"Morphology, musculoskeletal system, metabolism: BXD pup short-term weight change on day 10, per pup averaged across litters [g]"
BXD_18538,"Central nervous system, behavior: BXD maternal provisioning on day 10, per pup averaged across litters, corrected for covariates [g]	"
BXD_18539,"Central nervous system, behavior: BXD offspring solicitation on day 14, per pup averaged across litters [n]"
BXD_18540,"Central nervous system, behavior: BXD maternal provisioning on day 14, per pup averaged across litters, corrected for covariates [g]"
BXD_18541,"Central nervous system, behavior: BXD offspring solicitation on day 10, per pup averaged across litters [n]"
BXD_18542,"Morphology, musculoskeletal system, metabolism: BXD pup weight on day 10, per pup averaged across litters [g]"
BXD_18544,"Morphology, musculoskeletal system, metabolism: Offspring weight on day 14, per pup averaged across litters [g]"
BXD_18547,Trait_body_weight_F_JH
BXD_18548,"Musculoskeletal system, morphology: Body weight of males, age-adjusted to 100 days (this data matches microCT bone traits GN18130 to GN18279) [g]"
BXD_18549,"Musculoskeletal system: Bone mineral density (BMD, BMC) of the femur of 16-week old males [g/cm2]"
BXD_18550,"Musculoskeletal system: Bone mineral density (BMD, BMC) of lumbar spine (L1-L6) of 16-week old males [g/cm2]"
BXD_18551,"Musculoskeletal system: Bone mineral density (BMD, BMC) of the total body minus skull of 16-week old males [g/cm2]"
BXD_18552,Musculoskeletal system: Bone mineral content (BMC) of the femur of 16-week old males [g]
BXD_18553,Musculoskeletal system: Bone mineral content (BMC) of lumbar spine (L1-L6) of 16-week old males [g]
BXD_18554,Musculoskeletal system: Bone mineral content (BMC) of the total body minus skull of 16-week old males [g]
BXD_18555,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in adult females [0 = none, 1 = urinates]"
BXD_18556,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in adult males [0 = none, 1 = urinates]"
BXD_18557,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in adults of both sexes [0 = none, 1 = urinates]"
BXD_18558,"Central nervous system, morphology: Striatum cholinergic neurons per section, eigentrait principal component 1 derived from all 6 levels (computed in GN1 by Rob Williams, Nov 2016) [PC score]"
BXD_18559,"Metabolism, morphology, aging: Body weight of females at UTHSC on a high fat diet (Harlan Teklad 06414, 60.3% calories from fat) approximately 1 year of age (mean 379 days), 12 hr light cycle and up to 10 animals/cage (updated October 2016) [g]"
BXD_18560,"Metabolism, morphology, aging: Body weight of females at UTHSC on a chow diet (Harlan Teklad 2918, 6% calories from fat) approximately 1 year of age (mean 379 days), 12 hr light cycle and up to 10 animals/cage (updated October 2016) [g]"
BXD_18561,"Central nervous system, development, neurogenesis: Goldowitz Trait dang@cmmt.ubc.ca "
BXD_18562,"Central nervous system, development, neurogenesis: Goldowitz Trait dang@cmmt.ubc.ca"
BXD_18563,"Central nervous system, development, neurogenesis: Goldowitz Trait dang@cmmt.ubc.ca etheberge94@gmail.com"
BXD_18564,"Metabolism, longevity, liver, proteomics: Methionine sulfoxide reductase A (MSRA) protein expression level in liver on standard chow diet in adult males (EPFL Cohort), eigengene computed using four MRSA peptides (EGQV..., HNFG..., NPDG..., and VISA...) [PC score]"
BXD_18565,"Immune system, infectious disease: Fitzpatrick trait DS2 (please contact efitzpat@uthsc.edu for details).  "
BXD_18570,"Central nervous system, pharmacology, behavior: Ethanol consumption (20% v/v ethanol in tap water), 3 h after lights out, difference scores 5th 4 hour exposure minus 1st 4 hour exposure (positive value indicates escalating consumption over 5 weeks) [g/kg] "
BXD_18571,Startle Male DIFF NO
BXD_18572,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean minus unstressed control group mean for males [force]"
BXD_18573,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males [%]"
BXD_18574,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18575,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males [%]"
BXD_18576,Startle Male Sum NO
BXD_18577,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males [%]"
BXD_18578,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18579,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males [%]"
BXD_18580,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18581,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18582,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean plus unstressed control group mean for males [force]"
BXD_18583,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for females [%]"
BXD_18584,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18585,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for females [%]"
BXD_18586,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18587,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean minus unstressed control group mean for females [force]"
BXD_18588,"Central nervous system, behavior: Startle Female Diff NO"
BXD_18589,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for females [%]"
BXD_18590,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18591,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for females [%]"
BXD_18592,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18593,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean plus unstressed control group mean for females [force]"
BXD_18594,"Startle Female Sum NO
"
BXD_18595,Trait_1_Jablonski
BXD_18596,Trait_2_Jablonski
BXD_18597,Trait_3_Jablonski
BXD_18598,Trait_4_Jablonski
BXD_18599,Trait_5_Jablonski
BXD_18600,Trait_6_Jablonski
BXD_18601,Trait_7_Jablonski
BXD_18602,Trait_8_Jablonski
BXD_18603,Trait_9_Jablonski
BXD_18604,Trait_10_Jablonski
BXD_18605,Trait_11_Jablonski
BXD_18606,Trait_12_Jablonski
BXD_18607,Trait_13_Jablonski
BXD_18608,Trait_14_Jablonski
BXD_18609,Trait_15_Jablonski
BXD_18610,Trait_16_Jablonski
BXD_18611,Trait_17_Jablonski
BXD_18612,Trait_18_Jablonski
BXD_18613,Trait_19_Jablonski
BXD_18614,"Central nervous system, morphology, eye, visual system: Necrotic axon number in the optic nerve in 13 to 30 month old males and females (BXD36, BXD71, BXD102, BXD56, and BXD29 were winsorized from 116, 276, 5825, 5552, and 4121, respectively) [necrotic sites/nerve]"
BXD_18615,Trait_21_Jablonski
BXD_18616,Trait_22_Jablonski
BXD_18617,Trait_23_Jablonski
BXD_18618,"Central nervous system, morphology, eye, visual system: Trait_24_Jablonski"
BXD_18619,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean minus unstressed control group mean for females [m/15 min]"
BXD_18620,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for females [m/15 min]"
BXD_18621,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for females [sec]"
BXD_18622,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) prenatal stress group mean plus unstressed control group mean for females [m/15 min]"
BXD_18623,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean plus unstressed control group mean for females  [m/15 min]"
BXD_18624,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for females [sec]"
BXD_18625,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for females [m/15 min]"
BXD_18626,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for females [m/15 min]"
BXD_18627,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for females [m/15 min]"
BXD_18628,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for females [m/15 min]"
BXD_18629,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for females [m/15 min]	"
BXD_18630,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for females [m/15 min]	"
BXD_18631,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for females [m/15 min]"
BXD_18632,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for females [m/15 min]"
BXD_18633,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean minus unstressed control group mean for females [g]"
BXD_18634,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean plus unstressed control group mean for females [g]"
BXD_18635,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) prenatal stress group mean minus unstressed control group mean for males [m/15 min]"
BXD_18636,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18637,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males [m/15 min]"
BXD_18638,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean plus unstressed control group mean for males [m/15 min]"
BXD_18639,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for males [sec]"
BXD_18640,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for males [sec]"
BXD_18641,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for males[m/15 min]"
BXD_18642,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for males [m/15 min]"
BXD_18643,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for males [m/15 min]"
BXD_18644,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for males [m/15 min]"
BXD_18645,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for males [m/15 min]	"
BXD_18646,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for males [m/15 min]"
BXD_18647,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males [m/15 min]"
BXD_18648,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for males [m/15 min]"
BXD_18649,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean minus unstressed control group mean for males [g]"
BXD_18650,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean plus unstressed control group mean for males [g]"
BXD_18651,Maternal Behavior All Diff
BXD_18652,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18653,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18654,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for males and females [sec]"
BXD_18655,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18656,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18657,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18658,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males and females [m/15 min]"
BXD_18659,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean minus unstressed control group mean for males and females [g]"
BXD_18660,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18661,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18662,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for males and females [sec]"
BXD_18663,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18664,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18665,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]	"
BXD_18666,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for males and females [m/15 min]"
BXD_18667,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, prenatal stress group mean plus unstressed control group mean for males and females [g]"
BXD_18668,"Central nervous system, development, neurogenesis: Cell death in brainstem following exposure to ethanol at day 9 of gestation (E9), TUNEL-positive apoptotic cells (subtracted control maltose-dextranes counts) (winsorized BXD 51 from 5488 to 4026 [cells/mm2]"
BXD_18669,"Central nervous system, development, neurogenesis: Cell death in forebrain following exposure to ethanol at day 9 of gestation (E9), TUNEL-positive apoptotic cells (subtracted control maltose-dextranes counts) [cells/mm2]). Strains included: C57BL/6J and DBA/2J parental strains, 9 most and 9 least susceptible recombinant BXD strains."
BXD_18670,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males and females [%]"
BXD_18671,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18672,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males and females [%]"
BXD_18673,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18674,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean minus unstressed control group mean for males and females [force]"
BXD_18675,Startle Both Difference no outlier
BXD_18676,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males and females [%]"
BXD_18677,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18678,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males and females [%]"
BXD_18679,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus), prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [%]"
BXD_18680,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), prenatal stress group mean plus unstressed control group mean for males and females [force]"
BXD_18681,Startle Both Sum no outlier
BXD_18682,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18683,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18684,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18685,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18686,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18687,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18688,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]	"
BXD_18689,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18690,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean sum unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18691,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18692,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18693,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18694,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18695,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18696,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18697,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18698,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18699,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18700,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18701,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18702,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18703,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18704,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean sum unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18705,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18706,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18707,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18708,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18709,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for males, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18710,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18711,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] "
BXD_18712,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18713,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18714,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18715,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex)  [m/15 min]"
BXD_18716,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean minus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18717,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip), prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18718,Acute Raw Loco Male Sum No Outlier
BXD_18719,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning, prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min] [sec]"
BXD_18720,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during post-test, prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18721,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), horizontal distance traveled during pre-test, prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18722,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18723,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection, prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18724,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled  after first cocaine injection minus horizontal distance traveled after saline injection (4 x 10 mL/kg ip) for females (unstressed controls) [m/15 min]"
BXD_18725,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after saline injection (4 x 10 mL/kg ip) for females (prenatal stress group) [m/15 min]"
BXD_18726,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled (m/15 min) after first cocaine injection minus horizontal distance traveled after saline injection (4 x 10 mL/kg ip) for males (unstressed controls) [m/15 min]"
BXD_18727,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after saline injection (4 x 10 mL/kg ip) for males (prenatal stress group) [m/15 min]"
BXD_18728,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (unstressed controls) [m/15 min]"
BXD_18729,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group) [m/15 min]"
BXD_18730,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for males (unstressed controls) [m/15 min]"
BXD_18731,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for males (prenatal stress group) [m/15 min]"
BXD_18732,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for females (unstressed controls) [sec]"
BXD_18733,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for females (prenatal stress group) [sec]"
BXD_18734,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for males (unstressed controls) [sec]"
BXD_18735,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for males (prenatal stress group) [sec]"
BXD_18736,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for females (unstressed controls) [m/15 min]"
BXD_18737,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for females (prenatal stress group) [m/15 min]"
BXD_18738,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for males (unstressed controls) [m/15 min]"
BXD_18739,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for males (prenatal stress group) [m/15 min]"
BXD_18740,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for males and females (unstressed controls) [g]"
BXD_18741,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for females (prenatal stress group) [g]"
BXD_18742,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for males (unstressed controls) [g]"
BXD_18743,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for males (prenatal stress group) [g]"
BXD_18744,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection minus horizontal distance traveled after first saline injection (4 x 10 mL/kg ip) for males and females (unstressed controls) [m/15 min]"
BXD_18745,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled  after first cocaine injection minus horizontal distance traveled after saline injection (4 x 10 mL/kg ip) for males and females (prenatal stress group) [m/15 min]"
BXD_18746,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for males and females (unstressed controls) [m/15 min]"
BXD_18747,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for males and females (prenatal stress group) [m/15 min]"
BXD_18748,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for males and females (unstressed controls) [sec]"
BXD_18749,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), conditioned place preference (CPP), time in cocaine-paired side after conditioning minus time in cocaine-paired side before conditioning for males and females (prenatal stress group) [sec]"
BXD_18750,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for males and females (unstressed controls) [m/15 min]"
BXD_18751,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for males and females (unstressed controls) [g]"
BXD_18752,"Central nervous system, development, neurogenesis: Cell death in brainstem following exposure to ethanol at day 9 of gestation (E9), TUNEL-positive apoptotic cells (subtracted control maltose-dextranes counts) (winsorized BXD51 from 5614 to 3585) [cells/mm2]"
BXD_18753,"Morphology, effects of prenatal stress: Body weight at eight weeks of age, for males and females (prenatal stress group) [g]"
BXD_18754,"Central nervous system, development, neurogenesis: Cell death in forebrain following exposure to ethanol at day 9 of gestation (E9), TUNEL-positive apoptotic cells (subtracted control maltose-dextranes counts) [cells/mm2], WINSORIZED: BXD 101 from -1205.540 to -267, BXD 2 from 2371.962 to 1598, C57BL/6J from 2596.029 to 1599, BXD 51 from 2948.987 to 1600, BXD 73 from 3382.251 to 1601."
BXD_18755,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) females (unstressed controls) [%]"
BXD_18756,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males (unstressed controls) [%]"
BXD_18757,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) females (prenatal stress group) [%]"
BXD_18758,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males (prenatal stress group) [%]"
BXD_18759,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) females (unstressed controls) [%]"
BXD_18760,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males (unstressed controls) [%]"
BXD_18761,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) females (prenatal stress group) [%]"
BXD_18762,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males (prenatal stress group) [%]"
BXD_18763,P3FC
BXD_18764,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), males (unstressed controls) [force]"
BXD_18765,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), females (prenatal stress group) [force]"
BXD_18766,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), males (prenatal stress group) [force]"
BXD_18767,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males and females (unstressed controls) [%]"
BXD_18768,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 74 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males and females (prenatal stress group) [%]"
BXD_18769,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males and females (unstressed controls) [%]"
BXD_18770,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, prepulse inhibition (PPI), change in startle response with 90 dB prepulse from response with no prepulse (70 dB background noise, Med Associates startle chamber, 100 msec interval, 110 dB startle stimulus) males and females (prenatal stress group) [%]"
BXD_18771,P3BC
BXD_18772,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), males and females (prenatal stress group) [force]"
BXD_18773,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), horizontal distance traveled after first cocaine injection for females (prenatal stress group), prenatal stress group mean plus unstressed control group mean for males and females, two standard deviation outliers excluded (calculated within strain/group/sex) [m/15 min]"
BXD_18774,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Cocaine response (4 x 10 mg/kg ip), sensitization, horizontal distance traveled after fourth cocaine injection minus horizontal distance traveled after first cocaine injection for males and females (prenatal stress group) [m/15 min]"
BXD_18775,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), males and females (unstressed controls) [force]"
BXD_18776,"Central nervous system, behavior, effects of prenatal stress: Acoustic startle response, 110 dB startle stimulus (70 dB background noise, Med Associates startle chamber), corrected for baseline activity (startle response divided by response in no stimulus trials), females (unstressed controls) [force]"
BXD_18777,"PCA Traits generated at February/17 09:36:59 from traits selected : PC01 based on all 30 mg/kg cocaine data (7 traits from Jones et al., 1999)"
BXD_18778,"Toxicology, liver, protein: CYP2E1 principal component 1 (EPFL/ETHZ BXD Liver, Chow Diet (Oct14) Light SWATH) based on 10 peptide fragment (37% of variance)"
BXD_18779,"Central nervous system, gene expression: Dopamine associated principal component 1 (80% variance) eigengene constructed from Slc6a3 (DAT, dopamine transporter), Slc18a2 (VMAT2), Ddc, and Foxa2 using VU BXD Midbrain expression data (high expression = positive values) [PC score]"
BXD_18780,Cormier trait 1
BXD_18781,"Central nervous system, behavior: BXD sibling solicitation on day 14, per pup averaged across litters, corrected for covariates  [n]"
BXD_18782,"Central nervous system, behavior: Indirect genetic effect (IGE) on C57BL/6J activity on postnatal day 6 caused by BXD foster sibling genotype [n litters]"
BXD_18783,"Central nervous system, behavior: BXD sibling indirect genetic effect modifying B6 foster-sibling behaviour, sucking of C57BL/6J on postnatal day 6 mapped as a function of BXD pup genotype, per pup averaged across litters, corrected for covariates [n]"
BXD_18784,"Central nervous system, behavior: BXD sibling activity on day 6, per pup averaged across litters [n]"
BXD_18785,"Central nervous system, behavior: BXD sibling sucking on day 6, per pup averaged across litters [n]"
BXD_18786,"Central nervous system, behavior: Offspring indirect genetic effect modifying maternal behavior, maternal suckling of C57BL/6J on postnatal day 6 mapped as a function of BXD pup genotype, averaged across litters [n]"
BXD_18787,"Central nervous system, behavior: Offspring indirect genetic effect modifying maternal behavior, maternal suckling of C57BL/6J on postnatal day 14 mapped as a function of BXD pup genotype, averaged across litters, corrected for covariates [n]"
BXD_18788,"Central nervous system, behavior: BXD sibling indirect genetic effect modifying B6 foster-sibling behaviour, sucking of C57BL/6J on postnatal day 14 mapped as a function of BXD pup genotype, per pup averaged across litters, corrected for covariates [n]"
BXD_18789,"Central nervous system, behavior: BXD offspring sucking on day 14, per pup averaged across litters [n]"
BXD_18790,"Central nervous system, behavior: Offspring indirect genetic effect modifying maternal behavior, maternal activity of C57BL/6J on postnatal day 14 mapped as a function of BXD pup genotype, averaged across litters, corrected for covariates [n]"
BXD_18791,"Cardiovascular system, morphology: Heart weight without statistical adjustment, males and females, age from 23 to 759 days, standard chow
"
BXD_18792,"Cardiovascular system, morphology: Heart weight adjusted by age, sex, and body weight, standard chow
"
BXD_18793,Cormier trait 1  BXD90 excluded until this strain can be repeated  BXD68 winsorized to 4.7
BXD_18794,"Central nervous system,  behavior: Activity and anxiety eigentrait computed from 40 behavioral traits with sample size of 56 strains or greater (Traits 11392, 11397, 11398, 11399, 11410, 11649, 11654, 11714, 11906, 11911, 11912, 11913, 12341, 12344, 12352, 12353, 12354, 12360, 12362, 12363, 12364, 12410, 12411, 12413, 12419, 12420, 12421, 12423, 12460, 12461, 12469, 12470, 12471, 12472, 12474, 12479, 12480, 12481, 12482, 12484) (BXD11 winsorised from 13.459 to 7.0)[PC value]"
BXD_18795,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details).  "
BXD_18796," Immune system, infectious disease: Fitzpatrick trait cytokine 6(please contact efitzpat@uthsc.edu for details)"
BXD_18797,"Immune system, infectious disease: Fitzpatrick trait cytokine 3 (please contact efitzpat@uthsc.edu for details).  "
BXD_18798,"Immune system, infectious disease: Fitzpatrick trait cytokine 4 (please contact efitzpat@uthsc.edu for details).  "
BXD_18799,"Immune system, infectious disease: Fitzpatrick trait cytokine 5(please contact efitzpat@uthsc.edu for details).  "
BXD_18800,"Immune system, infectious disease: Fitzpatrick trait cytokine 8(please contact efitzpat@uthsc.edu for details).  "
BXD_18801,"Immune system, infectious disease: Trait Cytokine 1 Contact Elizabeth Fitzpatrick for details (efitzpat@uthsc.edu)"
BXD_18802,"Immune system, infectious disease: Fitzpatrick trait cytokine 9 (please contact efitzpat@uthsc.edu for details).  "
BXD_18803,"Immune system, infectious disease: Fitzpatrick trait cytokine 10 (please contact efitzpat@uthsc.edu for details).  "
BXD_18804,"Immune system, infectious disease: Fitzpatrick trait cytokine 12 (please contact efitzpat@uthsc.edu for details).  "
BXD_18805,"Immune system, infectious disease: Fitzpatrick trait cytokine 13 (please contact efitzpat@uthsc.edu for details).  "
BXD_18806,"Immune system, infectious disease: Fitzpatrick trait cytokine 14 (please contact efitzpat@uthsc.edu for details).  "
BXD_18807,"Immune system, infectious disease: Fitzpatrick trait cytokine 11 (please contact efitzpat@uthsc.edu for details).  "
BXD_18808,"Immune system, infectious disease: Fitzpatrick trait cytokine 7(please contact efitzpat@uthsc.edu for details).  "
BXD_18810,"Immune system, infectious disease: Fitzpatrick Trait Cell 7 % subset (please contact Liz Fitzpatrick at efitzpat@uthsc.edu)"
BXD_18963,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 1 [s]"
BXD_18964,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 2 [s]"
BXD_18965,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 3 [s]"
BXD_18966,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 4 [s]"
BXD_18967,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 5 [s]"
BXD_18968,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 6 [s]"
BXD_18969,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 7 [s]"
BXD_18970,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 8 [s]"
BXD_18971,"Central nervous system, physiology, epilepsy: Myoclonic jerk threshold (MJT) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol), 28 days (untreated) after the last induction day (retested on day 37) [s]"
BXD_18972,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 1 [s]"
BXD_18973,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 2 [s]"
BXD_18974,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 3 [s]"
BXD_18975,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 4 [s]"
BXD_18976,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 5 [s]"
BXD_18977,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 6 [s]"
BXD_18978,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 7 [s]"
BXD_18979,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase on day 8 [s]"
BXD_18980,"Central nervous system, physiology, epilepsy: Generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol), 28 days (untreated) after the last induction day (retested on day 37) [s]"
BXD_18981,"Central nervous system, physiology, epilepsy: Kindling score measured as the slope of the reduction of the generalized seizure threshold (GST) latency in young adult males after inhalation of flurothyl (10% in 95% ethanol) during the induction phase (days 1 to 8) ) [GST/n seizure]"
BXD_18982,Jones_5.4
BXD_18983,Jones_1.4
BXD_18984,Jones_1.1
BXD_18985,Bone_trait_1_JH
BXD_18986,Bone_trait_2_JH
BXD_18987,Bone_trait_3_JH
BXD_18988,Bone_trait_4_JH
BXD_18989,Bone_trait_5_JH
BXD_18990,Bone_trait_6_JH
BXD_18991,Bone_trait_7_H
BXD_18992,Bone_trait_8_JH
BXD_18993,Bone_trait_9_JH
BXD_18994,Bone_trait_10_JH
BXD_18995,Bone_trait_11_JH
BXD_18996,Bone_trait_12_JH
BXD_18997,Bone_trait_13_JH
BXD_18998,Bone_trait_14_JH
BXD_18999,Bone_trait_15_JH
BXD_19000,Bone_trait_16_JH
BXD_19001,Bone_trait_17_H
BXD_19002,Bone_trait_18_JH
BXD_19003,Bone_trait_19_JH
BXD_19004,Bone_trait_20_JH
BXD_19005,Bone_trait_21_JH
BXD_19006,Bone_trait_22_JH
BXD_19007,Bone_trait_23_JH
BXD_19008,Bone_trait_24_JH
BXD_19009,Bone_trait_25_JH
BXD_19010,Bone_trait_26_JH
BXD_19011,Bone_trait_27_H
BXD_19012,Bone_trait_28_JH
BXD_19013,Bone_trait_29_JH
BXD_19014,Bone_trait_30_JH
BXD_19015,Bone_trait_31_JH
BXD_19016,Bone_trait_32_JH
BXD_19017,Bone_trait_33_JH
BXD_19018,Bone_trait_34_JH
BXD_19019,Bone_trait_35_JH
BXD_19020,Bone_trait_36_JH
BXD_19021,Bone_trait_37_H
BXD_19022,Bone_trait_38_JH
BXD_19023,Bone_trait_39_JH
BXD_19024,Bone_trait_40_JH
BXD_19025,Bone_trait_41_JH
BXD_19026,Bone_trait_42_JH
BXD_19027,Bone_trait_43_JH
BXD_19028,Bone_trait_44_JH
BXD_19029,Bone_trait_45_JH
BXD_19030,Bone_trait_46_JH
BXD_19031,Bone_trait_47_H
BXD_19032,Bone_trait_48_JH
BXD_19033,Bone_trait_49_JH
BXD_19034,Bone_trait_50_JH
BXD_19035,Bone_trait_51_JH
BXD_19036,Bone_trait_52_JH
BXD_19037,Bone_trait_53_JH
BXD_19038,Bone_trait_54_JH
BXD_19039,Bone_trait_55_JH
BXD_19040,Bone_trait_56_JH
BXD_19041,Bone_trait_57_H
BXD_19042,Bone_trait_58_JH
BXD_19043,Bone_trait_59_JH
BXD_19044,Bone_trait_60_JH
BXD_19045,Bone_trait_61_JH
BXD_19046,Bone_trait_62_JH
BXD_19047,Bone_trait_63_JH
BXD_19048,Bone_trait_64_JH
BXD_19049,Bone_trait_65_JH
BXD_19050,Bone_trait_66_JH
BXD_19051,Bone_trait_67_H
BXD_19052,Bone_trait_68_JH
BXD_19053,Bone_trait_69_JH
BXD_19054,Bone_trait_70_JH
BXD_19055,Bone_trait_71_JH
BXD_19056,Bone_trait_72_JH
BXD_19057,Bone_trait_73_JH
BXD_19058,Bone_trait_74_JH
BXD_19059,Bone_trait_75_JH
BXD_19060,Bone_trait_76_JH
BXD_19061,Bone_trait_77_H
BXD_19062,Bone_trait_78_JH
BXD_19063,Bone_trait_79_JH
BXD_19064,Bone_trait_80_JH
BXD_19065,Bone_trait_81_JH
BXD_19066,Bone_trait_82_JH
BXD_19067,Bone_trait_83_JH
BXD_19068,Bone_trait_84_JH
BXD_19069,Bone_trait_85_JH
BXD_19070,Bone_trait_86_JH
BXD_19071,Bone_trait_87_H
BXD_19072,Bone_trait_88_JH
BXD_19073,Bone_trait_89_JH
BXD_19074,Bone_trait_90_JH
BXD_19075,"Musculoskeletal system, morphology:  Tibia moment of inertia around the longer axis (65-116 days, males only) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_19076,Bone_trait_92_JH
BXD_19077,Bone_trait_93_JH
BXD_19078,Bone_trait_94_JH
BXD_19079,Bone_trait_95_JH
BXD_19080,Bone_trait_96_JH
BXD_19081,Bone_trait_97_H
BXD_19082,Bone_trait_98_JH
BXD_19083,Bone_trait_99_JH
BXD_19084,Bone_trait_100_JH
BXD_19085,Bone_trait_101_JH
BXD_19086,Bone_trait_102_JH
BXD_19087,Cormier trait 2.   BXD50 winsorized to 3.85.
BXD_19088,ymaze.distance.6mo
BXD_19089,weight.6mo
BXD_19090,ymaze.totalarms.6mo
BXD_19091,"ymaze.SA.6mo
"
BXD_19092,ymaze.AAR.6mo
BXD_19093,Narrow.beam.6mo
BXD_19094,Incline.screen.6mo
BXD_19095,Blood.glucose.6mo
BXD_19096,EPM.distance.6mo
BXD_19097,EPM.totalarms.6mo
BXD_19098,EPM.PercenOpenEntries.6mo
BXD_19099,EPM.PercenOpenTime.6mo 
BXD_19100,ymaze.distance.terminal
BXD_19101,ymaze.totalarms.terminal
BXD_19102,ymaze.SA.terminal
BXD_19103,ymaze.AAR.terminal
BXD_19104,weight.terminal
BXD_19105,FC.6mo.BL
BXD_19106,FC.6mo.PS1
BXD_19107,FC.6mo.PS2
BXD_19108,FC.6mo.PS3
BXD_19109,FC.6mo.PS4
BXD_19110,"Central nervous system, behavior: Conditioned fear memory (CFM), freezing in response to 10 min contextual fear memory test in wildtype non-transgenic B6-BXD F1 males and females at 6 months-of-age on normal chow diet (all Nash Annex cases) [percent]"
BXD_19111,FC.BL.terminal
BXD_19112,FC.PS1.terminal
BXD_19113,FC.PS2.terminal
BXD_19114,"FC.PS3.terminal
"
BXD_19115,FC.PS4.terminal
BXD_19116,"Central nervous system, behavior: Conditioned fear memory  (CFM), freezing in response to 10 min contextual fear memory test in wildtype non-transgenic B6-BXD F1 males and females at 14 months-of-age on normal chow diet (all Nash Annex cases) [percent]"
BXD_19117,Grip.strength.6mo
BXD_19118,Narrow.beam.terminal
BXD_19119,Grip.strength.terminal
BXD_19120,Incline.screen.terminal
BXD_19121,Blood.glucose.terminal
BXD_19122,EPM.distance.terminal
BXD_19123,EPM.totalarms.terminal
BXD_19124,EPM.PercenOpenEntries.terminal
BXD_19125,EPM.Percent.Open.Entries.terminal
BXD_19126,"Aging, metabolism, morphology: Body weight of female mice at 6 months of age at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat) for ~45-60 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n= 1139, including both natural death as well as harvested) [g]"
BXD_19127,EPM.PercentOpenTime.terminal
BXD_19128,Decline.Score.WM
BXD_19129,Decline.Slope.WM
BXD_19130,"Aging, metabolism, morphology: Body weight of females at 6 months of age at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) for ~45-60 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage,  updated Feb 2023, n=1090, including both natural death and harvested [g]"
BXD_19131,"Aging, metabolism, morphology: Body weight of females at 12 months of age at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat) for ~200 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023, n=876, includes natural death as well as harvested [g]"
BXD_19167,"Aging, metabolism, morphology: Body weight of females at 12 months of age at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) for ~250 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023, n=881, including both natural death as well as harvested [g]"
BXD_19168,"Aging, metabolism, morphology: Body weight of female mice at 18 months of age at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat) for ~400 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n=493, including both natural death as well as harvested) [g]"
BXD_19169,"Aging, metabolism, morphology: Body weight of females at 18 months of age at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) for ~400 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023, n=433, including natural death as well as harvested [g]"
BXD_19170,"Aging, metabolism, morphology: Body weight of female mice at 24 months of age at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat) for ~600 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n=179, including both natural death and harvested cases) [g]"
BXD_19171,"Aging, metabolism, morphology: Body weight of females at 24 months of age at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) for ~600 days, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023, n=87, including both natural death and harvested cases [g]"
BXD_19172,"Central nervous system, development, neurogenesis: Goldowitz Trait; contact kristina.balce@alumni.ubc.ca"
BXD_19173,"Central nervous system, metabolism: ZnHIP trait (combined from Jones et al. 2008 and 2016, contact BC Jones at bjone129@uthsc.edu)"
BXD_19174,"CNS, neurodegeneration: PCA Traits for SGN2017 Yellow Team (Microglial_Sig_14_Transcript)"
BXD_19175,un-named trait
BXD_19176,"Central nervous system, gene expression: PCA eigengene for microglial expression in hippocampus (Hippocampus Consortium PDNN data, all 99 strains) generated using 14 well known microglial markers (  ) [PC score]"
BXD_19212,"Cardiovascular system, heart: Mononuclear cardiomyocytes (stained using Abcam ab8295 TNNT2 antibody) in virgin females at 8-10 weeks of age (arcsin transformed)[%]"
BXD_19213,"Aging, metabolism, morphology: Body weight difference in females at 18 months of age at UTHSC on a high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) over ~400 day of high fat diet, 12 hr light cycle (145 sq-in polypropylene cages with up to 10 cases/cage, Harlan Teklad 7087 soft cob bedding), (updated Dec 2021) [g]"
BXD_19214,"Aging, metabolism, morphology: Body weight difference in females at 12 months of age at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) for  ~180 days, compared to regular chow diet; 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage; updated Dec 2021 [g]"
BXD_19215,Jones_dif
BXD_18130,"Musculoskeletal system, morphology: Femur length (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18131,"Musculoskeletal system, morphology: Femur mineralized volume  (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18132,"Musculoskeletal system, morphology: Femur material bone mineral density  (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18133,"Musculoskeletal system, morphology: Femur cortical envelop total volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18134,"Musculoskeletal system, morphology:  Femur cortical envelop mineralized volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18135,"Musculoskeletal system, morphology: Femur cortical envelop porosity (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [%]"
BXD_18136,"Musculoskeletal system, morphology: Femur cortical thickness (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm]"
BXD_18137,"Musculoskeletal system, morphology: Femur cortical material bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18138,"Musculoskeletal system, morphology: Femur cross-sectional volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18139,"Musculoskeletal system, morphology: Femur cortical volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18140,"Musculoskeletal system, morphology: Femur cortical marrow volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18141,"Musculoskeletal system, morphology: Femur polar moment of inertia (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18142,"Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18143,"Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18144,"Musculoskeletal system, morphology: Femur trabecular total volume (sex-averaged, age-adjusted )  measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18145,"Musculoskeletal system, morphology: Femur trabecular mineralized bone volume  (sex-averaged, age-adjusted )  measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18146,"Musculoskeletal system, morphology: Femur trabecular bone volume fraction (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [ratio]"
BXD_18147,"Musculoskeletal system, morphology: Femur trabecular bone connectivity density (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [1/mm3]"
BXD_18148,"Musculoskeletal system, morphology: Femur trabecular bone structural model index (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [ratio]"
BXD_18149,"Musculoskeletal system, morphology: Femur trabecular number (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [1/mm]"
BXD_18150,"Musculoskeletal system, morphology: Femur trabecular thickness (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18151,"Musculoskeletal system, morphology: Femur trabecular seperation (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18152,"Musculoskeletal system, morphology: Femur trabecular apparent bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18153,"Musculoskeletal system, morphology: Femur trabecular material bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18154,"Musculoskeletal system, morphology: Femur trabecular bone degree of anisotropy (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [ratio]"
BXD_18155,"Musculoskeletal system, morphology:  Tibia length (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18156,"Musculoskeletal system, morphology:  Tibia mineralized volume (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18157,"Musculoskeletal system, morphology:  Tibia material bone mineral density (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18158,"Musculoskeletal system, morphology:  Tibia cortical envelop total volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18159,"Musculoskeletal system, morphology:   Tibia cortical envelop mineralized volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18160,"Musculoskeletal system, morphology:  Tibia cortical envelop porosity (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [%]"
BXD_18161,"Musculoskeletal system, morphology:  Tibia cortical thickness (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm]"
BXD_18162,"Musculoskeletal system, morphology:  Tibia cortical material bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18163,"Musculoskeletal system, morphology:  Tibia cross-sectional volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18164,"Musculoskeletal system, morphology:  Tibia cortical volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18165,"Musculoskeletal system, morphology:  Tibia cortical marrow volume (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18166,"Musculoskeletal system, morphology:  Tibia polar moment of inertia (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18167,"Musculoskeletal system, morphology:  Tibia moment of inertia around the shorter axis (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18168,"Musculoskeletal system, morphology:  Tibia moment of inertia around the longer axis (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [g*mm2]"
BXD_18169,"Musculoskeletal system, morphology:  Tibia trabecular total volume (sex-averaged, age-adjusted )  measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18170,"Musculoskeletal system, morphology:  Tibia trabecular mineralized bone volume  (sex-averaged, age-adjusted )  measured by microcomputed tomography  (ÂµCT) [mm3]"
BXD_18171,"Musculoskeletal system, morphology:  Tibia trabecular bone volume fraction (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [ratio]"
BXD_18172,"Musculoskeletal system, morphology:  Tibia trabecular bone connectivity density (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [1/mm3]"
BXD_18173,"Musculoskeletal system, morphology:  Tibia trabecular bone structural model index (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [ratio]"
BXD_18174,"Musculoskeletal system, morphology:  Tibia trabecular number (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [1/mm]"
BXD_18175,"Musculoskeletal system, morphology:  Tibia trabecular thickness (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18176,"Musculoskeletal system, morphology:  Tibia trabecular seperation (sex-averaged, age-adjusted ) measured by microcomputed tomography  (ÂµCT) [mm]"
BXD_18177,"Musculoskeletal system, morphology:  Tibia trabecular apparent bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18178,"Musculoskeletal system, morphology:  Tibia trabecular material bone mineral density (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [mgHA/cm3]"
BXD_18179,"Musculoskeletal system, morphology:  Tibia trabecular bone degree of anisotropy (sex-averaged, age-adjusted ) measured at midshaft by microcomputed tomography  (ÂµCT) [ratio]"
BXD_19303,"Central nervous system, behavior, social interaction: Affiliative sniffing of an unfamiliar juvenile male partner during a 6-min direct social interaction session in adult males (non-winsorized values) [%]."
BXD_19304,"Central nervous system, behavior, social interaction: Ultrasonic vocalizations emitted during a 6-min direct social interaction session with an unfamiliar juvenile male partner in adult males (non-winsorized values) [number]."
BXD_19305,"Central nervous system, behavior, locomotor activity: Distance traveled during a 10-min habituation to a novel testing chamber prior to social interaction testing in adult males (non-winsorized values) [meters]."
BXD_19306,"Central nervous system, behavior, social interaction: Social approach preference assayed using 3-chamber paradigm, time spent in chamber containing an unfamiliar mouse minus time spent in chamber without a mouse (empty cup) (non-winsorized values) [difference score]."
BXD_19307,"Central nervous system, behavior, social interaction: Social approach preference assayed using 3-chamber paradigm, time spent sniffing a wire cup containing a stimulus mouse minus time spent sniffing an empty wire cup (non-winsorized values) [difference score]."
BXD_19308,"Central nervous system, behavior, social interaction: Social novelty preference assayed using 3-chamber paradigm, time spent in chamber containing a novel stimulus mouse minus time spent in chamber containing a familiar stimulus mouse (non-winsorized values) [difference score]."
BXD_19309,"Central nervous system, behavior, social interaction: Social novelty preference assayed using 3-chamber paradigm, time spent sniffing a wire cup containing a novel stimulus mouse minus time spent sniffing a wire cup containing a familiar stimulus mouse (non-winsorized values) [difference score]."
BXD_19310,"Central nervous system, behavior, locomotor activity, anxiety: Time spent in the center chamber during the 20-min habituation session in the 3-chamber social interaction task in adult males (non-winsorized values) [%]."
BXD_19311,"Central nervous system, behavior, locomotor activity, anxiety: Latency to leave the center chamber during the 20-min habituation session in the 3-chamber social interaction task in adult males (non-winsorized values) [sec]"
BXD_19312,"Central nervous system, behavior, locomotor activity: Side-chamber entries during the 20-min habituation session in the 3-chamber social interaction task in adult males (non-winsorized values) [number]."
BXD_19313,"Central nervous system, behavior, locomotor activity: Side-chamber entries during the 10-min social approach session in the 3-chamber social interaction task in adult males (non-winsorized values) [number]."
BXD_19314,"Central nervous system, behavior, locomotor activity: Side-chamber entries during the 10-min social novelty session in the 3-chamber social interaction task in adult males (non-winsorized values) [number]."
BXD_19315,"Central nervous system, inflammation, expression: CCL2 brain mRNA expression on normal chow diet [log2]"
BXD_19316,"Central nervous system, inflammation, expression: TNFalpha expression under normal chow diet [log2]"
BXD_19317,"Central nervous system, inflammation, expression: IL6 expression on normal chow diet [log2]"
BXD_19318,"Central nervous system, inflammation, expression: IL1beta mRNA expression on a normal chow diet [log2]"
BXD_19319,"Central nervous system, inflammation, expression: TGFbeta1 expression on normal chow diet [log2]"
BXD_19320,"Central nervous system, inflammation, expression: miR-15a expression on normal chow diet [log2]"
BXD_19321,"Central nervous system, inflammation, expression: miR-15b expression on normal chow diet [log2]"
BXD_19322,"Central nervous system, inflammation, expression: miR-21 expression on normal chow diet [log2]"
BXD_19323,"Central nervous system, inflammation, expression: miR-130 expression on a normal chow diet [log2]"
BXD_19324,"Central nervous system, inflammation, expression: miR-34a expression on a normal chow diet [log2]"
BXD_19325,"Central nervous system, inflammation, expression: miR-146a expression on a normal chow diet [log2]"
BXD_19326,"Central nervous system, inflammation, expression: miR-155 expression on a normal chow diet [log2]"
BXD_19327,"Central nervous system, inflammation, expression: Ccl2 expression on a high fat diet [log2]"
BXD_19328,"Central nervous system, inflammation, expression: TNFalpha expression on a high fat diet [log2]"
BXD_19329,"Central nervous system, inflammation, expression: IL6 mRNA expression on a high fat diet [log2]"
BXD_19330,"Central nervous system, inflammation, expression: IL1beta brain mRNA expression on a high fat diet [log2]"
BXD_19331,"Central nervous system, inflammation, expression: TGFbeta1 RNA expression on a high fat diet [log2]"
BXD_19332,"Central nervous system, inflammation, expression: miR-15a brain RNA expression on a high fat diet [log2]"
BXD_19333,"Central nervous system, inflammation, expression: miR-15b brain RNA expression on a high fat diet [log2]"
BXD_19334,brain_trait_20_LU
BXD_19335,brain_trait_21_LU
BXD_19336,brain_trait_22_LU
BXD_19337,brain_trait_23_LU
BXD_19338,brain_trait_24_LU
BXD_19339,brain_trait_25_LU
BXD_19340,brain_trait_26_LU
BXD_19341,brain_trait_27_LU
BXD_19342,brain_trait_28_LU
BXD_19343,brain_trait_29_LU
BXD_19344,brain_trait_30_LU
BXD_19345,"Central nervous system, inflammation, expression: miR-15b expression, combined normal and high fat diets [log2]"
BXD_19346,brain_trait_32_LU
BXD_19347,brain_trait_33_LU
BXD_19348,brain_trait_34_LU
BXD_19349,brain_trait_35_LU
BXD_19350,brain_trait_36_LU
BXD_19351,brain_trait_37_LU
BXD_19352,brain_trait_38_LU
BXD_19353,brain_trait_39_LU
BXD_19354,brain_trait_40_LU
BXD_19355,brain_trait_41_LU
BXD_19356,brain_trait_42_LU
BXD_19357,brain_trait_43_LU
BXD_19358,brain_trait_44_LU
BXD_19359,brain_trait_45_LU
BXD_19360,brain_trait_46_LU
BXD_19361,brain_trait_47_LU
BXD_19362,brain_trait_48_LU
BXD_19363,brain_trait_49_LU
BXD_19364,brain_trait_50_LU
BXD_19365,brain_trait_51_LU
BXD_19366,brain_trait_52_LU
BXD_19367,"Central nervous system, inflammation, expression: TGFbeta1 mRNA expression on a high fat diet, adjusted by age and sex [log2]"
BXD_19368,"Central nervous system, inflammation, expression: miR-15a brain RNA expression on a high fat diet, adjusted by age and sex [log2]"
BXD_19369,brain_trait_55_LU
BXD_19370,brain_trait_56_LU
BXD_19371,brain_trait_57_LU
BXD_19372,brain_trait_58_LU
BXD_19373,brain_trait_59_LU
BXD_19374,brain_trait_60_LU
BXD_19375,brain_trait_61_LU
BXD_19376,brain_trait_62_LU
BXD_19377,brain_trait_63_LU
BXD_19378,brain_trait_64_LU
BXD_19379,brain_trait_65_LU
BXD_19380,brain_trait_66_LU
BXD_19381,brain_trait_67_LU
BXD_19382,brain_trait_68_LU
BXD_19383,"Central nervous system, inflammation, expression: miR-130 brain RNA expression, combined chow and high fat diets, adjusted by age and sex [log2]"
BXD_19384,brain_trait_70_LU
BXD_19385,brain_trait_71_LU
BXD_19386,brain_trait_72_LU
BXD_19387,JBagley_Sucrose_trait1
BXD_19388,JBagley_Sucrose_trait2
BXD_19389,JBagley_Sucrose_trait3
BXD_19390,JBagley_Sucrose_trait4
BXD_19391,JBagley_Sucrose_trait5
BXD_19392,JBagley_Sucrose_trait6
BXD_19393,JBagley_Sucrose_trait7
BXD_19394,JBagley_Sucrose_trait8
BXD_19395,JBagley_Sucrose_trait9
BXD_19396,JBagley_Sucrose_trait10
BXD_19397,JBagley_Sucrose_trait11
BXD_19398,JBagley_Sucrose_trait12
BXD_19399,JBagley_Sucrose_trait13
BXD_19400,JBagley_Sucrose_trait14
BXD_19401,JBagley_Sucrose_trait15
BXD_19402,JBagley_Sucrose_trait16
BXD_19403,JBagley_Sucrose_trait17
BXD_19404,JBagley_Sucrose_trait18
BXD_19405,JBagley_Sucrose_trait19
BXD_19406,JBagley_Sucrose_trait20
BXD_19407,JBagley_Sucrose_trait21
BXD_19408,JBagley_Sucrose_trait22
BXD_19409,JBagley_Sucrose_trait23
BXD_19410,JBagley_Sucrose_trait24
BXD_19411,JBagley_Sucrose_trait25
BXD_19412,JBagley_Sucrose_trait26
BXD_19413,JBagley_Sucrose_trait27
BXD_19414,JBagley_Sucrose_trait28
BXD_19415,JBagley_Sucrose_trait29
BXD_19416,JBagley_Sucrose_trait30
BXD_19417,JBagley_Sucrose_trait31
BXD_19418,JBagley_Sucrose_trait32
BXD_19419,JBagley_Sucrose_trait33
BXD_19420,JBagley_Sucrose_trait34
BXD_19421,JBagley_Sucrose_trait35
BXD_19422,"Aging: Lifespan variability, longevity range of females within each strain at the Dana-Faber Cancer Institute (Redstone Animal Facility, Boston MA) from Jackson Laboratory between Nov 1982 and Mar 1983 on Purina chow (all data reinstated), computed by de Haan and colleagues (y-axis of Figure 1a) [days]"
BXD_19423,"Aging, metabolism: 75th quantile life span, longevity of females at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated August 2018 (n~620) [days]"
BXD_19424,"Aging, metabolism: 75th quantile life span, longevity of females at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated August 2018 (n ~ 665) [days]"
BXD_19425,"Immune system, infectious disease: Fitzpatrick trait Cell 1 no. (please contact efitzpat@uthsc.edu)"
BXD_19426,"Immune system, infectious disease: Fitzpatrick trait Cell 2 no.(please contact efitzpat@uthsc.edu)"
BXD_19427,"Immune system, infectious disease: Fitzpatrick trait Cell 3 no. (please contact efitzpat@uthsc.edu)"
BXD_19428,"Immune system, infectious disease: Fitzpatrick trait Cell 4 no. (please contact efitzpat@uthsc.edu)"
BXD_19429,"Immune system, infectious disease: Fitzpatrick trait Cell 5 no. (please contact efitzpat@uthsc.edu)"
BXD_19430,"Immune system, infectious disease: Fitzpatrick trait Cell 6 no.  (please contact efitzpat@uthsc.edu)"
BXD_19431,"Immune system, infectious disease: Fitzpatrick trait Cell 7 no. (please contact efitzpat@uthsc.edu)"
BXD_19432,Jones_3aM1
BXD_19433,Jones_3aM2
BXD_19434,Jones_3aM3
BXD_19435,Jones_3aM4
BXD_19436,Jones_3aM5
BXD_19437,Jones_3aM6
BXD_19438,Jones_3aM7
BXD_19439,Jones_3aM8
BXD_19440,Jones_3aM9
BXD_19441,"Central nervous system, behavior, development, communication: Infant vocalization, Roy 20"
BXD_19442,Jones_3aF1
BXD_19443,Jones_3aF2
BXD_19444,Jones_3aF3
BXD_19445,Jones_3aF4
BXD_19446,Jones_3aF5
BXD_19447,Jones_3aF6
BXD_19448,Jones_3aF7
BXD_19449,Jones_3aF8
BXD_19450,"Central nervous system, metabolism: Zinc (Zn) level in cortex (CTX) of young female adults (40 to 120 days of age) [ug/g wet weight] "
BXD_19451,"Aging, metabolism: Median life span, longevity of females at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n= 809) [days]"
BXD_19452,"Aging, metabolism: Median life span, longevity of females at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n= 857) (SE is actually median absolute difference MAD) [days]"
BXD_19453,MFL-1
BXD_19454,MFL-2
BXD_19455,MFL-3
BXD_19456,MFL-4
BXD_19457,MFL-5
BXD_19458,MFL-6
BXD_19459,MFL-7
BXD_19460,MFL-8
BXD_19461,"Central nervous system, pharmacology, behavior: Ethanol response, test 3 consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs. water) and 2-hour access after cycle 3 of control air (CTL) exposure, adult male (Dec 2014 Cohorts 1-5) [mg/kg]"
BXD_19462,MFL-10
BXD_19463,MFL-11
BXD_19464,MFL-12
BXD_19465,MFL-13
BXD_19466,MFL-14
BXD_19467,MFL-15
BXD_19468,MFL-16
BXD_19469,MFL-17
BXD_19470,"Central nervous system, pharmacology: Ethanol response, blood ethanol concentration during cycle 2 of chronic intermittent ethanol (CIE) exposure, adult male (Dec 2014 Cohorts 1-5) [mg/dl]"
BXD_19471,MFL-19
BXD_19472,MFL-20
BXD_19473,MFL-21
BXD_19474,MFL-22
BXD_19475,MFL-23
BXD_19476,MFL-24
BXD_19477,MFL-25
BXD_19478,MFL-26
BXD_19479,MFL-27
BXD_19480,MFL-28
BXD_19481,"Central nervous system, pharmacology, behavior: Ethanol response, final (week 6) baseline consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs. water) and 2-hour access before any ethanol vapor chamber treatments (CIE, ethanol exposed group), adult female (Dec 2014 Cohorts 1-5)[ml]"
BXD_19482,"Central nervous system, pharmacology: Ethanol response, blood ethanol concentration [mg/dl] during cycle 1 of chronic intermittent ethanol (CIE) exposure, adult female (Dec 2014 Cohorts 1-5)"
BXD_19483,MFL-31
BXD_19484,MFL-32
BXD_19485,MFL-33
BXD_19486,MFL-34
BXD_19487,MFL-35
BXD_19488,"Central nervous system, pharmacology: Ethanol response, blood ethanol concentration during cycle 3 of chronic intermittent ethanol (CIE) exposure, adult female (Dec 2014 Cohorts 1-5) [mg/dl] "
BXD_19489,MFL-37
BXD_19490,MFL-38
BXD_19491,MFL-39
BXD_19492,MFL-40
BXD_19493,MFL-41
BXD_19494,MFL-42
BXD_19495,MFL-43
BXD_19496,MFL-44
BXD_19497,MFL-45
BXD_19498,MFL-46
BXD_19499,"Central nervous system, pharmacology, behavior: Ethanol response, Test 2 consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs. water) and 2-hour access after cycle 2 of control air (CTL) exposure, adult female (Dec 2014 Cohorts 1-5)[ml]"
BXD_19500,MFL-48
BXD_19501,"Central nervous system, pharmacology, behavior: Ethanol response, test 3 consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs. water) and 2-hour access after Cycle 3 of control air (CTL) exposure, adult female (Dec 2014 Cohorts 1-5) [ml]"
BXD_19502,MFL-50
BXD_19503,MFL-51
BXD_19504,MFL-52
BXD_19505,MFL-53
BXD_19506,"Central nervous system, pharmacology, behavior: Ethanol response, week 6 of 6 baseline consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs. water) and 2-hour access before any ethanol vapor chamber treatments, adult female (Dec 2014 Cohorts 1-5)[ml]"
BXD_19507,"Central nervous system, behavior: inter-male aggression, attack latency of 3-4 month old males against a standard opponent (3 month old A/JOlaHsd male) on days 1 and 2 within a 10 min test on following 10 days of isolation [s]"
BXD_19508,"Endocrinology, effects of restraint stress. Change in plasma corticosterone (post stress minus baseline) in pregnant mice (E11 to 14) after one hour of restraint in a 50 mL conical tube. [ng/mL]"
BXD_19509,"Endocrinology, effects of restraint stress. Baseline plasma corticosterone (pre-stress) in pregnant mice (E11 to 14). [ng/mL]"
BXD_19510,Grip.strength.terminal.AD
BXD_19511,Grip.strength.6mo.AD
BXD_19512,"Central nervous system, behavior: Conditioned fear memory (CFM), difference in freezing in response to context 24 h after training in AD males and females minus their isogenic Ntg control means at about 14 months-of-age on normal chow diet (all Nash Annex cases) [percent]"
BXD_19513,"immune system, infectious disease: Fitzpatrick trait cell6%Tot (please contact efitzpat@uthsc.edu for details)."
BXD_19514,"Immune system, infectious disease: Fitzpatrick trait Cell 1%Tot (please contact efitzpat@uthsc.edu for details)"
BXD_19515,"Immune system, infectious disease: Fitzpatrick trait Cell 2%Tot (please contact efitzpat@uthsc.edu for details)."
BXD_19516,"Immune system, infectious disease: Fitzpatrick trait Cell 7%Tot (please contact efitzpat@uthsc.edu for details)."
BXD_19517,"Immune System, infectious disease: Fitzpatrick trait Cell 3%Tot (please contact efitzpat@uthsc.edu for details). "
BXD_19518,"Immune system, infectious disease: Fitzpatrick trait Cell 4%Tot (please contact efitzpat@uthsc.edu for details)"
BXD_19519,"Immune system, infectious disease: Fitzpatrick trait Cell 5%Tot (please contact efitzpat@uthsc.edu for details)."
BXD_19520,"Immune system, infectious disease: Fitzpatrick trait Cell 8 %LT"
BXD_19521,"Eye, visual system, physiology: Intraocular pressure (IOP) in strains with wildtype (B) alleles at Tyrp1 and Gpnmb, combined male and female averages (3 readings per eye ~6-8 cases/strain) under Avertin anesthesia at 6 and 12 months-of-age (measured between 9 and 11 AM using a tonometer, JAX mice raised at Emory University) [mmHg]"
BXD_19522,"Central nervous system, eye, visual system: Retinal ganglion cell axon regeneration two weeks after nerve crush at 60-60 days-of-age, numbers of labeled fibers detected 0.5 mm beyond crush in cases pretreated with an AAV Pten gene knockdown and post-treated with an intravitreal injection of zymosan plus CPT-cAMP (Figure 3A) [n]"
BXD_19523,"Central nervous system, eye, visual system: Retinal ganglion cell axon regeneration two weeks after nerve crush at 60-60 days-of-age, numbers of labeled fibers detected 0.5 mm beyond crush in cases pretreated with an AAV Pten gene knockdown and post-treated with an intravitreal injection of zymosan plus CPT-cAMP (Figure 3A) [n]"
BXD_19524,"Central nervous system, eye, visual system: Retinal ganglion cell axon regeneration two weeks after nerve crush at 60-60 days-of-age, numbers of labeled fibers detected 0.5 mm beyond crush in cases pretreated with an AAV Pten gene knockdown and post-treated with an intravitreal injection of zymosan plus CPT-cAMP (Figure 3A) [n]"
BXD_19525,"Central nervous system, eye, visual system gene expression: Corneal thickness measured by ocular coherence tomography (OCT) (note that data for BXD24 (106.1 +/- 1.1) and BXD11 (104+/-12) dropped from publication) [um]"
BXD_19526,"Central nervous system, eye, visual system: Retinal ganglion cell axon regeneration two weeks after nerve crush at 60-70 days-of-age, numbers of labeled fibers detected 0.5 mm beyond crush in cases pretreated with an AAV Pten gene knockdown and post-treated with an intravitreal injection of zymosan plus CPT-cAMP (Figure 3A) [n]"
BXD_19527,Mitochondria: DA MT estimations
BXD_19528,"Immune system, infectious disease: Fitzpatrick Trait DS3.  See E.A. Fitzpatrick (efitzpat@uthsc.edu) for details."
BXD_19529,"Immune system, infectious disease: Fitzpatrick trait DS5 (please contact efitzpat@uthsc.edu for details)"
BXD_19530,Jones_VMB_trait_1
BXD_19532,Jones_VMB_trait_3
BXD_19534,Jones_VMB_trait_5
BXD_19536,"Central nervous system, behavior, aging: Conditioned fear memory (CFM) in normal 15 month old BXD females raised on a high fat diet, freezing in response to context 24 h after training, (all Nash Annex cases) (data not in Neuner et al. 2019, but associated phenotypes generated at the same time, unpublished) percent]"
BXD_19537,Jones_VMBdif_trait_1
BXD_19538,Jones_VMBdif_trait_2
BXD_19539,Jones_VMBdif_trait_3
BXD_19540,"Central nervous system: Copper concentration in the ventral midbrain (VMB), hippocampus, and cortex of young adult males, first principal component (about 50% of variance, traits 19433, 19436, 19439) [PC score]"
BXD_19541,"Central nervous system: Iron concentration in the ventral midbrain (VMB), hippocampus, and cortex of young adult males, first principal component (about 60% explained variance in combined traits 19432, 19435, 19438) [PC score]"
BXD_19542,"Central nervous system: Zinc concentration in the ventral midbrain (VMB), hippocampus, and cortex of young adult males, first principal component (about 50% explained variance in combined traits 19434, 19437, 19440) [PC score]"
BXD_19543,"Immune system, infectious disease:Fitzpatrick trait DS6.  Please contact E. Fitzpatrick at efitzpat@uthsc.edu for details. "
BXD_19544,"Principal component derived from the principal components for iron, copper and zinc in ventral midbrain, hippocampus and cortex, BXDPublish ID 19540, 19541 and 19542"
BXD_19545,"PlasmaLipidomics: Myristic acid_CD having side chain FA composition [FA(14:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19546,"PlasmaLipidomics: Myristic acid_HFD having side chain FA composition [FA(14:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19547,"PlasmaLipidomics: Palmitic acid_CD having side chain FA composition [FA(16:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19548,"PlasmaLipidomics: Palmitic acid_HFD having side chain FA composition [FA(16:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19549,"PlasmaLipidomics: Palmitoleic acid_CD having side chain FA composition [FA(16:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19550,"PlasmaLipidomics: Palmitoleic acid_HFD having side chain FA composition [FA(16:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19551,"PlasmaLipidomics: Stearic acid_CD having side chain FA composition [FA(18:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19552,"PlasmaLipidomics: Stearic acid_HFD having side chain FA composition [FA(18:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19553,"PlasmaLipidomics: Oleic acid_CD having side chain FA composition [FA(18:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19554,"PlasmaLipidomics: Oleic acid_HFD having side chain FA composition [FA(18:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19555,"PlasmaLipidomics: Linoleic acid_CD having side chain FA composition [FA(18:2)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19556,"PlasmaLipidomics: Linoleic acid_HFD having side chain FA composition [FA(18:2)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19557,"PlasmaLipidomics: Linolenic acid_CD having side chain FA composition [FA(18:3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19558,"PlasmaLipidomics: Linolenic acid_HFD having side chain FA composition [FA(18:3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19559,"PlasmaLipidomics: Stearidonic acid_CD having side chain FA composition [FA(18:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19560,"PlasmaLipidomics: Stearidonic acid_HFD having side chain FA composition [FA(18:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19561,"PlasmaLipidomics: Eicosenoic acid_CD having side chain FA composition [FA(20:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19562,"PlasmaLipidomics: Eicosenoic acid_HFD having side chain FA composition [FA(20:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19563,"PlasmaLipidomics: DGLA(Dihomo-gamma-linolenic acid)_CD having side chain FA composition [FA(20:3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19564,"PlasmaLipidomics: DGLA(Dihomo-gamma-linolenic acid)_HFD having side chain FA composition [FA(20:3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19565,"PlasmaLipidomics: Arachidonic acid_CD having side chain FA composition [FA(20:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19566,"PlasmaLipidomics: Arachidonic acid_HFD having side chain FA composition [FA(20:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19567,"PlasmaLipidomics: Erucic acid_CD having side chain FA composition [FA(22:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19568,"PlasmaLipidomics: Erucic acid_HFD having side chain FA composition [FA(22:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19569,"PlasmaLipidomics: Adrenic acid_CD having side chain FA composition [FA(22:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19570,"PlasmaLipidomics: Adrenic acid_HFD having side chain FA composition [FA(22:4)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19571,"PlasmaLipidomics: DHA(Docosahexaenoic acid)_CD having side chain FA composition [FA(22:6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19572,"PlasmaLipidomics: DHA(Docosahexaenoic acid)_HFD having side chain FA composition [FA(22:6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19573,"PlasmaLipidomics: Nervonic acid_CD having side chain FA composition [FA(24:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19574,"PlasmaLipidomics: Nervonic acid_HFD having side chain FA composition [FA(24:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19575,"PlasmaLipidomics: Nisinic acid_CD having side chain FA composition [FA(24:6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19576,"PlasmaLipidomics: Nisinic acid_HFD having side chain FA composition [FA(24:6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19577,"PlasmaLipidomics: PI(16:0_18:2)_CD having side chain FA composition [PI(16:0_18:2)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19578,"PlasmaLipidomics: PI(16:0_18:2)_HFD having side chain FA composition [PI(16:0_18:2)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19579,"PlasmaLipidomics: PI(18:0_18:2)_CD having side chain FA composition [PI (mixture of 18:0_18:2 and 18:1_18:1)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19580,"PlasmaLipidomics: PI(18:0_18:2)_HFD having side chain FA composition [PI (mixture of 18:0_18:2 and 18:1_18:1)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19581,"PlasmaLipidomics: PI(Ao_P)_CD having side chain FA composition [PI(16:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19582,"PlasmaLipidomics: PI(Ao_P)_HFD having side chain FA composition [PI(16:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19583,"PlasmaLipidomics: PI(17:0_20:4)_CD having side chain FA composition [PI(17:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19584,"PlasmaLipidomics: PI(17:0_20:4)_HFD having side chain FA composition [PI(17:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19585,"PlasmaLipidomics: PI(Ao_S)_CD having side chain FA composition [PI(18:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19586,"PlasmaLipidomics: PI(Ao_S)_HFD having side chain FA composition [PI(18:0_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19587,"PlasmaLipidomics: PI(18:1_20:4)_CD having side chain FA composition [PI(18:1_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19588,"PlasmaLipidomics: PI(18:1_20:4)_HFD having side chain FA composition [PI(18:1_20:4)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19589,"PlasmaLipidomics: PI(Dha_S)_CD having side chain FA composition [PI(18:0_22:6)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19590,"PlasmaLipidomics: PI(Dha_S)_HFD having side chain FA composition [PI(18:0_22:6)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19591,"PlasmaLipidomics: PG(O_P)_CD having side chain FA composition [PG(16:0_18:1)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19592,"PlasmaLipidomics: PG(O_P)_HFD having side chain FA composition [PG(16:0_18:1)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19593,"PlasmaLipidomics: PG(L_P)_CD having side chain FA composition [PG(16:0_18:2)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19594,"PlasmaLipidomics: PG(L_P)_HFD having side chain FA composition [PG(16:0_18:2)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19595,"PlasmaLipidomics: PE(16:0_18:1)_CD having side chain FA composition [PE(16:0_18:1)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19596,"PlasmaLipidomics: PE(16:0_18:1)_HFD having side chain FA composition [PE(16:0_18:1)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19597,"PlasmaLipidomics: PE(16:0_18:2)_CD having side chain FA composition [PE(16:0_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19598,"PlasmaLipidomics: PE(16:0_18:2)_HFD having side chain FA composition [PE(16:0_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19599,"PlasmaLipidomics: PE(18:0e_18:1)_CD having side chain FA composition [PE(18:0e_18:1)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19600,"PlasmaLipidomics: PE(18:0e_18:1)_HFD having side chain FA composition [PE(18:0e_18:1)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19601,"PlasmaLipidomics: PE(18:0_18:2)_CD having side chain FA composition [PE (mixture of 18:1_18:1 as well)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19602,"PlasmaLipidomics: PE(18:0_18:2)_HFD having side chain FA composition [PE (mixture of 18:1_18:1 as well)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19603,"PlasmaLipidomics: PE(18:0e_18:2)_CD having side chain FA composition [PE(18:0e_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19604,"PlasmaLipidomics: PE(18:0e_18:2)_HFD having side chain FA composition [PE(18:0e_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19605,"PlasmaLipidomics: PE(18:1_18:2)_CD having side chain FA composition [PE(18:1_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19606,"PlasmaLipidomics: PE(18:1_18:2)_HFD having side chain FA composition [PE(18:1_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19607,"PlasmaLipidomics: PE(Ao_P)_CD having side chain FA composition [PE(16:0_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19608,"PlasmaLipidomics: PE(Ao_P)_HFD having side chain FA composition [PE(16:0_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19609,"PlasmaLipidomics: PE(20:0e_18:2)_CD having side chain FA composition [PE(20:0e_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19610,"PlasmaLipidomics: PE(20:0e_18:2)_HFD having side chain FA composition [PE(20:0e_18:2)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19611,"PlasmaLipidomics: PE(Ao_S)_CD having side chain FA composition [PE(18:0_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19612,"PlasmaLipidomics: PE(Ao_S)_HFD having side chain FA composition [PE(18:0_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19613,"PlasmaLipidomics: PE(18:0e_20:4)_CD having side chain FA composition [PE(18:0e_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19614,"PlasmaLipidomics: PE(18:0e_20:4)_HFD having side chain FA composition [PE(18:0e_20:4)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19615,"PlasmaLipidomics: PE(Dha_P)_CD having side chain FA composition [PE(16:0_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19616,"PlasmaLipidomics: PE(Dha_P)_HFD having side chain FA composition [PE(16:0_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19617,"PlasmaLipidomics: PE(16:0e_22:6)_CD having side chain FA composition [PE(16:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19618,"PlasmaLipidomics: PE(16:0e_22:6)_HFD having side chain FA composition [PE(16:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19619,"PlasmaLipidomics: PE(18:0e_22:6)_CD having side chain FA composition [PE(18:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19620,"PlasmaLipidomics: PE(18:0e_22:6)_HFD having side chain FA composition [PE(18:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19621,"PlasmaLipidomics: PE(20:0e_22:6)_CD having side chain FA composition [PE(20:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19622,"PlasmaLipidomics: PE(20:0e_22:6)_HFD having side chain FA composition [PE(20:0e_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19623,"PlasmaLipidomics: PE(20:2_22:6)_CD having side chain FA composition [PE(20:2_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19624,"PlasmaLipidomics: PE(20:2_22:6)_HFD having side chain FA composition [PE(20:2_22:6)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19625,"PlasmaLipidomics: PC(Dha_P)_CD having side chain FA composition [PC(16:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19626,"PlasmaLipidomics: PC(Dha_P)_HFD having side chain FA composition [PC(16:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19627,"PlasmaLipidomics: PC(18:2_20:4)_CD having side chain FA composition [PC(18:2_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19628,"PlasmaLipidomics: PC(18:2_20:4)_HFD having side chain FA composition [PC(18:2_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19629,"PlasmaLipidomics: PC(Ao_P)_CD having side chain FA composition [PC(16:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19630,"PlasmaLipidomics: PC(Ao_P)_HFD having side chain FA composition [PC(16:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19631,"PlasmaLipidomics: PC(18:2_18:2)_CD having side chain FA composition [PC(18:2_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19632,"PlasmaLipidomics: PC(18:2_18:2)_HFD having side chain FA composition [PC(18:2_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19633,"PlasmaLipidomics: PC(Dha_S)_CD having side chain FA composition [PC(18:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19634,"PlasmaLipidomics: PC(Dha_S)_HFD having side chain FA composition [PC(18:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19635,"PlasmaLipidomics: PC(Ao_S)_CD having side chain FA composition [PC(18:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19636,"PlasmaLipidomics: PC(Ao_S)_HFD having side chain FA composition [PC(18:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19637,"PlasmaLipidomics: PC(32:2)_CD having side chain FA composition [PC(mixture of 14:0_18:2 and 16:1_16:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19638,"PlasmaLipidomics: PC(32:2)_HFD having side chain FA composition [PC(mixture of 14:0_18:2 and 16:1_16:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19639,"PlasmaLipidomics: PC(33:1)_CD having side chain FA composition [PC(mixture of 17:1_16:0 and 15:0_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19640,"PlasmaLipidomics: PC(33:1)_HFD having side chain FA composition [PC(mixture of 17:1_16:0 and 15:0_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19641,"PlasmaLipidomics: PC(15:0_18:2)_CD having side chain FA composition [PC(15:0_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19642,"PlasmaLipidomics: PC(15:0_18:2)_HFD having side chain FA composition [PC(15:0_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19643,"PlasmaLipidomics: PC(18:0_16:0)_CD having side chain FA composition [PC(18:0_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19644,"PlasmaLipidomics: PC(18:0_16:0)_HFD having side chain FA composition [PC(18:0_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19645,"PlasmaLipidomics: PC(16:0_18:1)_CD having side chain FA composition [PC(16:0_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19646,"PlasmaLipidomics: PC(16:0_18:1)_HFD having side chain FA composition [PC(16:0_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19647,"PlasmaLipidomics: PC(34:2)_CD having side chain FA composition [PC(mixture of 16:0_18:2 and 16:1_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19648,"PlasmaLipidomics: PC(34:2)_HFD having side chain FA composition [PC(mixture of 16:0_18:2 and 16:1_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19649,"PlasmaLipidomics: PC(16:0e_18:2)_CD having side chain FA composition [PC(16:0e_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19650,"PlasmaLipidomics: PC(16:0e_18:2)_HFD having side chain FA composition [PC(16:0e_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19651,"PlasmaLipidomics: PC(17:1_18:2)_CD having side chain FA composition [PC(17:1_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19652,"PlasmaLipidomics: PC(17:1_18:2)_HFD having side chain FA composition [PC(17:1_18:2)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19653,"PlasmaLipidomics: PC(36:1)_CD having side chain FA composition [PC(mixture of 18:0_18:1 and 16:0_20:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19654,"PlasmaLipidomics: PC(36:1)_HFD having side chain FA composition [PC(mixture of 18:0_18:1 and 16:0_20:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19655,"PlasmaLipidomics: PC(36:2)_CD having side chain FA composition [PC(mixture of 18:0_18:2 and 18:1_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19656,"PlasmaLipidomics: PC(36:2)_HFD having side chain FA composition [PC(mixture of 18:0_18:2 and 18:1_18:1)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19657,"PlasmaLipidomics: PC(16:0e_20:4)_CD having side chain FA composition [PC(16:0e_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19658,"PlasmaLipidomics: PC(16:0e_20:4)_HFD having side chain FA composition [PC(16:0e_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19659,"PlasmaLipidomics: PC(38:2)_CD having side chain FA composition [PC(mixture of 18:0_20:2, 18:1_20:1 and 18:2_20:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19660,"PlasmaLipidomics: PC(38:2)_HFD having side chain FA composition [PC(mixture of 18:0_20:2, 18:1_20:1 and 18:2_20:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19661,"PlasmaLipidomics: PC(38:6)_CD having side chain FA composition [PC(mixture of 18:2_20:4 and 18:1_20:5)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19662,"PlasmaLipidomics: PC(38:6)_HFD having side chain FA composition [PC(mixture of 18:2_20:4 and 18:1_20:5)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19663,"PlasmaLipidomics: PC(20:0_20:4)_CD having side chain FA composition [PC(20:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19664,"PlasmaLipidomics: PC(20:0_20:4)_HFD having side chain FA composition [PC(20:0_20:4)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19665,"PlasmaLipidomics: PC(18:0_20:5)_CD having side chain FA composition [PC(18:0_20:5)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19666,"PlasmaLipidomics: PC(18:0_20:5)_HFD having side chain FA composition [PC(18:0_20:5)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19667,"PlasmaLipidomics: PC(18:0e_22:6)_CD having side chain FA composition [PC(18:0e_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19668,"PlasmaLipidomics: PC(18:0e_22:6)_HFD having side chain FA composition [PC(18:0e_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19669,"PlasmaLipidomics: PC(40:8)_CD having side chain FA composition [PC(mixture of 20:4_20:4 and 18:2_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19670,"PlasmaLipidomics: PC(40:8)_HFD having side chain FA composition [PC(mixture of 20:4_20:4 and 18:2_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19671,"PlasmaLipidomics: PC(19:0_22:6)_CD having side chain FA composition [PC(19:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19672,"PlasmaLipidomics: PC(19:0_22:6)_HFD having side chain FA composition [PC(19:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19673,"PlasmaLipidomics: PC(20:4_22:6)_CD having side chain FA composition [PC(20:4_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19674,"PlasmaLipidomics: PC(20:4_22:6)_HFD having side chain FA composition [PC(20:4_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19675,"PlasmaLipidomics: PC(20:0_22:6)_CD having side chain FA composition [PC(20:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19676,"PlasmaLipidomics: PC(20:0_22:6)_HFD having side chain FA composition [PC(20:0_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19677,"PlasmaLipidomics: PC(20:1_22:6)_CD having side chain FA composition [PC(20:1_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19678,"PlasmaLipidomics: PC(20:1_22:6)_HFD having side chain FA composition [PC(20:1_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19679,"PlasmaLipidomics: PC(20:2_22:6)_CD having side chain FA composition [PC(20:2_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19680,"PlasmaLipidomics: PC(20:2_22:6)_HFD having side chain FA composition [PC(20:2_22:6)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19681,"PlasmaLipidomics: Co(Q8)_CD having side chain FA composition [Co(Q8)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19682,"PlasmaLipidomics: Co(Q8)_HFD having side chain FA composition [Co(Q8)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19683,"PlasmaLipidomics: Co(Q9)_CD having side chain FA composition [Co(Q9)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19684,"PlasmaLipidomics: Co(Q9)_HFD having side chain FA composition [Co(Q9)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19685,"PlasmaLipidomics: DAG(L_P)_CD having side chain FA composition [DG(16:0_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19686,"PlasmaLipidomics: DAG(L_P)_HFD having side chain FA composition [DG(16:0_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19687,"PlasmaLipidomics: DAG(18:1_18:1)_CD having side chain FA composition [DAG(mixture of 18:1_18:1 and 18:0_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19688,"PlasmaLipidomics: DAG(18:1_18:1)_HFD having side chain FA composition [DAG(mixture of 18:1_18:1 and 18:0_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19689,"PlasmaLipidomics: DAG(18:1_18:2)_CD having side chain FA composition [DG(18:1_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19690,"PlasmaLipidomics: DAG(18:1_18:2)_HFD having side chain FA composition [DG(18:1_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19691,"PlasmaLipidomics: DAG(18:2_18:2)_CD having side chain FA composition [DG(18:2_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19692,"PlasmaLipidomics: DAG(18:2_18:2)_HFD having side chain FA composition [DG(18:2_18:2)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19693,"PlasmaLipidomics: DAG(Ao_P)_CD having side chain FA composition [DG(16:0_20:4)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19694,"Blood chemistry, plasma lipidomics: diacylglycerol (DAG Ao_P) levels with fatty acid (FA) side chain composition [DG(16:0_20:4)] belonging in males on a high fat diet from 8 weeks of age (HFD, 60% kCal/fat HarlanTD.06414) measured by MS [R.U.(AUC)], fasted overnight at 29 weeks (EPFL LISP3 Study) [unit]"
BXD_19695,"PlasmaLipidomics: DAG(18:1_20:4)_CD having side chain FA composition [DG(18:1_20:4)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19696,"PlasmaLipidomics: DAG(18:1_20:4)_HFD having side chain FA composition [DG(18:1_20:4)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19697,"PlasmaLipidomics: TAG(44:1)_CD having side chain FA composition [TG(10:0_16:0_18:1), TG(12:0_14:0_18:1), TG(12:0_16:0_16:1), TG(14:0_14:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19698,"PlasmaLipidomics: TAG(44:1)_HFD having side chain FA composition [TG(10:0_16:0_18:1), TG(12:0_14:0_18:1), TG(12:0_16:0_16:1), TG(14:0_14:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19699,"PlasmaLipidomics: TAG(46:1)_CD having side chain FA composition [TG(10:0_18:0_18:1), TG(12:0_16:0_18:1), TG(12:0_16:1_18:0), TG(14:0_14:0_18:1), TG(14:0_14:1_18:0), TG(14:0_16:0_16:1), TG(14:1_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19700,"PlasmaLipidomics: TAG(46:1)_HFD having side chain FA composition [TG(10:0_18:0_18:1), TG(12:0_16:0_18:1), TG(12:0_16:1_18:0), TG(14:0_14:0_18:1), TG(14:0_14:1_18:0), TG(14:0_16:0_16:1), TG(14:1_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19701,"PlasmaLipidomics: TAG(48:0)_CD having side chain FA composition [TG(14:0_16:0_18:0), TG(14:0_17:0_17:0), TG(15:0_15:0_18:0), TG(15:0_16:0_17:0), TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19702,"PlasmaLipidomics: TAG(48:0)_HFD having side chain FA composition [TG(14:0_16:0_18:0), TG(14:0_17:0_17:0), TG(15:0_15:0_18:0), TG(15:0_16:0_17:0), TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19703,"PlasmaLipidomics: TAG(48:1)_CD having side chain FA composition [TG(14:0_16:0_18:1), TG(16:0_16:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19704,"PlasmaLipidomics: TAG(48:1)_HFD having side chain FA composition [TG(14:0_16:0_18:1), TG(16:0_16:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19705,"PlasmaLipidomics: TAG(48:2)_CD having side chain FA composition [TG(12:0_18:1_18:1), TG(14:0_16:0_18:2), TG(14:0_16:1_18:1), TG(14:1_16:0_18:1), TG(16:0_16:0_16:2), TG(16:0_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19706,"PlasmaLipidomics: TAG(48:2)_HFD having side chain FA composition [TG(12:0_18:1_18:1), TG(14:0_16:0_18:2), TG(14:0_16:1_18:1), TG(14:1_16:0_18:1), TG(16:0_16:0_16:2), TG(16:0_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19707,"PlasmaLipidomics: TAG(48:3)_CD having side chain FA composition [TG(12:0_18:1_18:2), TG(14:0_16:0_18:3), TG(14:0_16:1_18:2), TG(14:0_16:2_18:1), TG(14:1_16:0_18:2), TG(14:1_16:1_18:1), TG(16:0_16:1_16:2), TG(16:1_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19708,"PlasmaLipidomics: TAG(48:3)_HFD having side chain FA composition [TG(12:0_18:1_18:2), TG(14:0_16:0_18:3), TG(14:0_16:1_18:2), TG(14:0_16:2_18:1), TG(14:1_16:0_18:2), TG(14:1_16:1_18:1), TG(16:0_16:1_16:2), TG(16:1_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19709,"PlasmaLipidomics: TAG(49:1)_CD having side chain FA composition [(15:0_16:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19710,"PlasmaLipidomics: TAG(49:1)_HFD having side chain FA composition [(15:0_16:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19711,"PlasmaLipidomics: TAG(49:2)_CD having side chain FA composition [TG(14:0_17:0_18:2), TG(14:0_17:1_18:1), TG(15:0_16:0_18:2), TG(15:0_16:1_18:1), TG(15:0_17:1_17:1), TG(15:1_16:0_18:1), TG(15:1_17:0_17:1), TG(15:2_17:0_17:0), TG(16:0_16:1_17:1), TG(16:1_16:1_17:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19712,"PlasmaLipidomics: TAG(49:2)_HFD having side chain FA composition [TG(14:0_17:0_18:2), TG(14:0_17:1_18:1), TG(15:0_16:0_18:2), TG(15:0_16:1_18:1), TG(15:0_17:1_17:1), TG(15:1_16:0_18:1), TG(15:1_17:0_17:1), TG(15:2_17:0_17:0), TG(16:0_16:1_17:1), TG(16:1_16:1_17:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19713,"PlasmaLipidomics: TAG(50:0)_CD having side chain FA composition [TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19714,"PlasmaLipidomics: TAG(50:0)_HFD having side chain FA composition [TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19715,"PlasmaLipidomics: TAG(50:1)_CD having side chain FA composition [TG(16:0_16:0_18:1), TG(16:0_16:1_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19716,"PlasmaLipidomics: TAG(50:1)_HFD having side chain FA composition [TG(16:0_16:0_18:1), TG(16:0_16:1_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19717,"PlasmaLipidomics: TAG(50:2)_CD having side chain FA composition [TG(14:0_18:1_18:1), TG(16:0_16:0_18:2), TG(16:0_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19718,"PlasmaLipidomics: TAG(50:2)_HFD having side chain FA composition [TG(14:0_18:1_18:1), TG(16:0_16:0_18:2), TG(16:0_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19719,"PlasmaLipidomics: TAG(50:3)_CD having side chain FA composition [TG(14:0_18:1_18:2), TG(16:0_16:0_18:3), TG(16:0_16:1_18:2), TG(16:0_16:2_18:1), TG(16:1_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19720,"PlasmaLipidomics: TAG(50:3)_HFD having side chain FA composition [TG(14:0_18:1_18:2), TG(16:0_16:0_18:3), TG(16:0_16:1_18:2), TG(16:0_16:2_18:1), TG(16:1_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19721,"PlasmaLipidomics: TAG(50:4)_CD having side chain FA composition [TG(14:0_18:1_18:3), TG(14:0_18:2_18:2), TG(14:1_18:1_18:2), TG(16:0_16:1_18:3), TG(16:0_16:2_18:2), TG(16:1_16:1_18:2), TG(16:1_16:2_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19722,"PlasmaLipidomics: TAG(50:4)_HFD having side chain FA composition [TG(14:0_18:1_18:3), TG(14:0_18:2_18:2), TG(14:1_18:1_18:2), TG(16:0_16:1_18:3), TG(16:0_16:2_18:2), TG(16:1_16:1_18:2), TG(16:1_16:2_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19723,"PlasmaLipidomics: TAG(51:1)_CD having side chain FA composition [TG(15:0_16:0_20:1), TG(15:0_17:0_19:1), TG(15:0_17:1_19:0), TG(15:0_18:0_18:1), TG(16:0_16:0_19:1), TG(16:0_17:0_18:1), TG(16:0_17:1_18:0), TG(17:0_17:0_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19724,"PlasmaLipidomics: TAG(51:1)_HFD having side chain FA composition [TG(15:0_16:0_20:1), TG(15:0_17:0_19:1), TG(15:0_17:1_19:0), TG(15:0_18:0_18:1), TG(16:0_16:0_19:1), TG(16:0_17:0_18:1), TG(16:0_17:1_18:0), TG(17:0_17:0_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19725,"PlasmaLipidomics: TAG(51:2)_CD having side chain FA composition [TG(15:0_18:0_18:2), TG(15:0_18:1_18:1), TG(16:0_17:0_18:2), TG(16:0_17:1_18:1), TG(17:0_17:1_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19726,"PlasmaLipidomics: TAG(51:2)_HFD having side chain FA composition [TG(15:0_18:0_18:2), TG(15:0_18:1_18:1), TG(16:0_17:0_18:2), TG(16:0_17:1_18:1), TG(17:0_17:1_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19727,"PlasmaLipidomics: TAG(51:3)_CD having side chain FA composition [TG(15:0_18:1_18:2), TG(15:1_18:1_18:1), TG(16:0_17:1_18:2), TG(16:1_17:0_18:2), TG(16:1_17:1_18:1), TG(17:1_17:1_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19728,"PlasmaLipidomics: TAG(51:3)_HFD having side chain FA composition [TG(15:0_18:1_18:2), TG(15:1_18:1_18:1), TG(16:0_17:1_18:2), TG(16:1_17:0_18:2), TG(16:1_17:1_18:1), TG(17:1_17:1_17:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19729,"PlasmaLipidomics: TAG(51:4)_CD having side chain FA composition [TG(15:0_18:1_18:3), TG(15:0_18:2_18:2), TG(15:1_18:1_18:2), TG(15:2_18:1_18:1), TG(16:0_17:1_18:3), TG(16:0_17:2_18:2), TG(16:1_17:1_18:2), TG(16:1_17:2_18:1), TG(17:1_17:1_17:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19730,"PlasmaLipidomics: TAG(51:4)_HFD having side chain FA composition [TG(15:0_18:1_18:3), TG(15:0_18:2_18:2), TG(15:1_18:1_18:2), TG(15:2_18:1_18:1), TG(16:0_17:1_18:3), TG(16:0_17:2_18:2), TG(16:1_17:1_18:2), TG(16:1_17:2_18:1), TG(17:1_17:1_17:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19731,"PlasmaLipidomics: TAG(52:1)_CD having side chain FA composition [TG(16:0_16:0_20:1), TG(16:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19732,"PlasmaLipidomics: TAG(52:1)_HFD having side chain FA composition [TG(16:0_16:0_20:1), TG(16:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19733,"PlasmaLipidomics: TAG(52:2)_CD having side chain FA composition [TG(16:0_16:1_20:1), TG(16:0_18:1_18:1), TG(16:1_16:1_20:0), TG(16:1_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19734,"PlasmaLipidomics: TAG(52:2)_HFD having side chain FA composition [TG(16:0_16:1_20:1), TG(16:0_18:1_18:1), TG(16:1_16:1_20:0), TG(16:1_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19735,"PlasmaLipidomics: TAG(52:3)_CD having side chain FA composition [TG(16:0_18:1_18:2), TG(16:1_18:0_18:2), TG(16:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19736,"PlasmaLipidomics: TAG(52:3)_HFD having side chain FA composition [TG(16:0_18:1_18:2), TG(16:1_18:0_18:2), TG(16:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19737,"PlasmaLipidomics: TAG(52:4)_CD having side chain FA composition [TG(16:0_18:1_18:3), TG(16:0_18:2_18:2), TG(16:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19738,"PlasmaLipidomics: TAG(52:4)_HFD having side chain FA composition [TG(16:0_18:1_18:3), TG(16:0_18:2_18:2), TG(16:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19739,"PlasmaLipidomics: TAG(52:5)_CD having side chain FA composition [TG(16:0_18:2_18:3), TG(16:1_18:1_18:3), TG(16:1_18:2_18:2), TG(16:2_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19740,"PlasmaLipidomics: TAG(52:5)_HFD having side chain FA composition [TG(16:0_18:2_18:3), TG(16:1_18:1_18:3), TG(16:1_18:2_18:2), TG(16:2_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19741,"PlasmaLipidomics: TAG(53:2)_CD having side chain FA composition [TG(15:0_18:1_20:1), TG(15:0_19:1_19:1), TG(16:0_18:1_19:1), TG(16:0_18:2_19:0), TG(17:0_18:0_18:2), TG(17:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19742,"PlasmaLipidomics: TAG(53:2)_HFD having side chain FA composition [TG(15:0_18:1_20:1), TG(15:0_19:1_19:1), TG(16:0_18:1_19:1), TG(16:0_18:2_19:0), TG(17:0_18:0_18:2), TG(17:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19743,"PlasmaLipidomics: TAG(53:3)_CD having side chain FA composition [TG(16:0_18:1_19:2), TG(16:0_18:2_19:1), TG(16:1_18:0_19:2), TG(16:1_18:1_19:1), TG(16:1_18:2_19:0), TG(17:0_17:1_19:2), TG(17:0_18:1_18:2), TG(17:1_17:1_19:1), TG(17:1_18:0_18:2), TG(17:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19744,"PlasmaLipidomics: TAG(53:3)_HFD having side chain FA composition [TG(16:0_18:1_19:2), TG(16:0_18:2_19:1), TG(16:1_18:0_19:2), TG(16:1_18:1_19:1), TG(16:1_18:2_19:0), TG(17:0_17:1_19:2), TG(17:0_18:1_18:2), TG(17:1_17:1_19:1), TG(17:1_18:0_18:2), TG(17:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19745,"PlasmaLipidomics: TAG(53:4)_CD having side chain FA composition [TG(17:0_18:2_18:2), TG(17:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19746,"PlasmaLipidomics: TAG(53:4)_HFD having side chain FA composition [TG(17:0_18:2_18:2), TG(17:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19747,"PlasmaLipidomics: TAG(54:1)_CD having side chain FA composition [TG(16:0_18:0_20:1), TG(16:0_18:1_20:0), TG(16:1_18:0_20:0), TG(18:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19748,"PlasmaLipidomics: TAG(54:1)_HFD having side chain FA composition [TG(16:0_18:0_20:1), TG(16:0_18:1_20:0), TG(16:1_18:0_20:0), TG(18:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19749,"PlasmaLipidomics: TAG(54:2)_CD having side chain FA composition [TG(16:0_18:1_20:1), TG(16:0_18:2_20:0), TG(18:0_18:0_18:2), TG(18:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19750,"PlasmaLipidomics: TAG(54:2)_HFD having side chain FA composition [TG(16:0_18:1_20:1), TG(16:0_18:2_20:0), TG(18:0_18:0_18:2), TG(18:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19751,"PlasmaLipidomics: TAG(54:3)_CD having side chain FA composition [TG(16:0_18:0_20:3), TG(16:0_18:1_20:2), TG(16:0_18:2_20:1), TG(16:0_18:3_20:0), TG(18:0_18:0_18:3), TG(18:0_18:1_18:2), TG(18:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19752,"PlasmaLipidomics: TAG(54:3)_HFD having side chain FA composition [TG(16:0_18:0_20:3), TG(16:0_18:1_20:2), TG(16:0_18:2_20:1), TG(16:0_18:3_20:0), TG(18:0_18:0_18:3), TG(18:0_18:1_18:2), TG(18:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19753,"PlasmaLipidomics: TAG(54:4)_CD having side chain FA composition [TG(16:0_18:1_20:3), TG(18:0_18:2_18:2), TG(18:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19754,"PlasmaLipidomics: TAG(54:4)_HFD having side chain FA composition [TG(16:0_18:1_20:3), TG(18:0_18:2_18:2), TG(18:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19755,"PlasmaLipidomics: TAG(54:5)_1_CD having side chain FA composition [TG(16:0_16:0_22:5), TG(16:0_18:2_20:3), TG(16:1_18:1_20:3), TG(18:1_18:1_18:3), TG(18:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19756,"PlasmaLipidomics: TAG(54:5)_1_HFD having side chain FA composition [TG(16:0_16:0_22:5), TG(16:0_18:2_20:3), TG(16:1_18:1_20:3), TG(18:1_18:1_18:3), TG(18:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19757,"PlasmaLipidomics: TAG(54:5)_2_CD having side chain FA composition [TG(16:0_18:1_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19758,"PlasmaLipidomics: TAG(54:5)_2_HFD having side chain FA composition [TG(16:0_18:1_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19759,"PlasmaLipidomics: TAG(54:6)_1_CD having side chain FA composition [TG(16:0_16:0_22:6), TG(16:0_16:1_22:5), TG(16:0_18:1_20:5), TG(16:0_18:2_20:4), TG(16:0_18:3_20:3), TG(16:1_16:1_22:4), TG(16:1_18:1_20:4), TG(16:1_18:2_20:3), TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19760,"PlasmaLipidomics: TAG(54:6)_1_HFD having side chain FA composition [TG(16:0_16:0_22:6), TG(16:0_16:1_22:5), TG(16:0_18:1_20:5), TG(16:0_18:2_20:4), TG(16:0_18:3_20:3), TG(16:1_16:1_22:4), TG(16:1_18:1_20:4), TG(16:1_18:2_20:3), TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19761,"PlasmaLipidomics: TAG(54:6)_2_CD having side chain FA composition [TG(16:1_18:1_20:4), TG(16:1_18:2_20:3), TG(18:1_18:2_18:3), TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19762,"PlasmaLipidomics: TAG(54:6)_2_HFD having side chain FA composition [TG(16:1_18:1_20:4), TG(16:1_18:2_20:3), TG(18:1_18:2_18:3), TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19763,"PlasmaLipidomics: TAG(54:7)_CD having side chain FA composition [TG(16:0_16:1_22:6), TG(16:0_18:1_20:6), TG(16:0_18:2_20:5), TG(16:0_18:3_20:4), TG(16:1_16:1_22:5), TG(16:1_18:1_20:5), TG(16:1_18:2_20:4), TG(18:1_18:2_18:4), TG(18:1_18:3_18:3), TG(18:2_18:2_18:3)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19764,"PlasmaLipidomics: TAG(54:7)_HFD having side chain FA composition [TG(16:0_16:1_22:6), TG(16:0_18:1_20:6), TG(16:0_18:2_20:5), TG(16:0_18:3_20:4), TG(16:1_16:1_22:5), TG(16:1_18:1_20:5), TG(16:1_18:2_20:4), TG(18:1_18:2_18:4), TG(18:1_18:3_18:3), TG(18:2_18:2_18:3)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19765,"PlasmaLipidomics: TAG(55:2)_CD having side chain FA composition [TG(16:0_18:1_21:1), TG(16:0_18:2_21:0), TG(16:0_19:1_20:1), TG(17:0_18:1_20:1), TG(17:0_18:2_20:0), TG(17:0_19:1_19:1), TG(18:0_18:1_19:1), TG(18:0_18:2_19:0), TG(18:1_18:1_19:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19766,"PlasmaLipidomics: TAG(55:2)_HFD having side chain FA composition [TG(16:0_18:1_21:1), TG(16:0_18:2_21:0), TG(16:0_19:1_20:1), TG(17:0_18:1_20:1), TG(17:0_18:2_20:0), TG(17:0_19:1_19:1), TG(18:0_18:1_19:1), TG(18:0_18:2_19:0), TG(18:1_18:1_19:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19767,"PlasmaLipidomics: TAG(55:3)_CD having side chain FA composition [TG(16:0_18:2_21:1), TG(16:0_19:1_20:2), TG(17:0_18:1_20:2), TG(17:0_18:2_20:1), TG(17:1_17:1_21:1), TG(17:1_18:0_20:2), TG(17:1_18:1_20:1), TG(17:1_19:1_19:1), TG(18:0_18:2_19:1), TG(18:1_18:1_19:1), TG(18:1_18:2_19:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19768,"PlasmaLipidomics: TAG(55:3)_HFD having side chain FA composition [TG(16:0_18:2_21:1), TG(16:0_19:1_20:2), TG(17:0_18:1_20:2), TG(17:0_18:2_20:1), TG(17:1_17:1_21:1), TG(17:1_18:0_20:2), TG(17:1_18:1_20:1), TG(17:1_19:1_19:1), TG(18:0_18:2_19:1), TG(18:1_18:1_19:1), TG(18:1_18:2_19:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19769,"PlasmaLipidomics: TAG(56:1)_CD having side chain FA composition [TG(16:0_16:0_24:1), TG(16:0_18:0_22:1), TG(16:0_18:1_22:0), TG(16:0_20:0_20:1), TG(18:0_18:0_20:1), TG(18:0_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19770,"PlasmaLipidomics: TAG(56:1)_HFD having side chain FA composition [TG(16:0_16:0_24:1), TG(16:0_18:0_22:1), TG(16:0_18:1_22:0), TG(16:0_20:0_20:1), TG(18:0_18:0_20:1), TG(18:0_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19771,"PlasmaLipidomics: TAG(56:2)_CD having side chain FA composition [TG(16:0_18:1_22:1), TG(16:0_20:1_20:1), TG(18:0_18:1_20:1), TG(18:1_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19772,"PlasmaLipidomics: TAG(56:2)_HFD having side chain FA composition [TG(16:0_18:1_22:1), TG(16:0_20:1_20:1), TG(18:0_18:1_20:1), TG(18:1_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19773,"PlasmaLipidomics: TAG(56:3)_CD having side chain FA composition [TG(16:0_18:1_22:2), TG(16:0_18:2_22:1), TG(16:0_18:3_22:0), TG(16:0_20:0_20:3), TG(16:0_20:1_20:2), TG(18:0_18:0_20:3), TG(18:0_18:1_20:2), TG(18:0_18:2_20:1), TG(18:0_18:3_20:0), TG(18:1_18:1_20:1), TG(18:1_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19774,"PlasmaLipidomics: TAG(56:3)_HFD having side chain FA composition [TG(16:0_18:1_22:2), TG(16:0_18:2_22:1), TG(16:0_18:3_22:0), TG(16:0_20:0_20:3), TG(16:0_20:1_20:2), TG(18:0_18:0_20:3), TG(18:0_18:1_20:2), TG(18:0_18:2_20:1), TG(18:0_18:3_20:0), TG(18:1_18:1_20:1), TG(18:1_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19775,"PlasmaLipidomics: TAG(56:4)_CD having side chain FA composition [TG(16:0_18:1_22:3), TG(16:0_20:1_20:3), TG(16:0_20:2_20:2), TG(18:0_18:1_20:3), TG(18:0_18:2_20:2), TG(18:1_18:1_20:2), TG(18:1_18:2_20:1), TG(18:2_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19776,"PlasmaLipidomics: TAG(56:4)_HFD having side chain FA composition [TG(16:0_18:1_22:3), TG(16:0_20:1_20:3), TG(16:0_20:2_20:2), TG(18:0_18:1_20:3), TG(18:0_18:2_20:2), TG(18:1_18:1_20:2), TG(18:1_18:2_20:1), TG(18:2_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19777,"PlasmaLipidomics: TAG(56:5)_CD having side chain FA composition [TG(16:0_18:1_22:4), TG(16:0_18:2_22:3), TG(16:0_20:2_20:3), TG(18:0_18:2_20:3), TG(18:1_18:1_20:3), TG(18:1_18:2_20:2), TG(18:2_18:2_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19778,"PlasmaLipidomics: TAG(56:5)_HFD having side chain FA composition [TG(16:0_18:1_22:4), TG(16:0_18:2_22:3), TG(16:0_20:2_20:3), TG(18:0_18:2_20:3), TG(18:1_18:1_20:3), TG(18:1_18:2_20:2), TG(18:2_18:2_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19779,"PlasmaLipidomics: TAG(56:7)_CD having side chain FA composition [TG(16:0_18:1_22:6), TG(16:0_18:2_22:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19780,"PlasmaLipidomics: TAG(56:7)_HFD having side chain FA composition [TG(16:0_18:1_22:6), TG(16:0_18:2_22:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19781,"PlasmaLipidomics: TAG(56:8)_CD having side chain FA composition [TG(16:0_18:1_22:7), TG(16:0_18:2_22:6), TG(16:0_20:4_20:4), TG(16:1_18:1_22:6), TG(18:2_18:2_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19782,"PlasmaLipidomics: TAG(56:8)_HFD having side chain FA composition [TG(16:0_18:1_22:7), TG(16:0_18:2_22:6), TG(16:0_20:4_20:4), TG(16:1_18:1_22:6), TG(18:2_18:2_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19783,"PlasmaLipidomics: TAG(58:10)_1_CD having side chain FA composition [TG(18:2_18:2_22:6), TG(18:2_20:3_20:5), TG(18:2_20:4_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19784,"PlasmaLipidomics: TAG(58:10)_1_HFD having side chain FA composition [TG(18:2_18:2_22:6), TG(18:2_20:3_20:5), TG(18:2_20:4_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19785,"PlasmaLipidomics: TAG(58:10)_2_CD having side chain FA composition [TG(16:0_20:4_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19786,"PlasmaLipidomics: TAG(58:10)_2_HFD having side chain FA composition [TG(16:0_20:4_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19787,"PlasmaLipidomics: TAG(58:2)_CD having side chain FA composition [TG(16:0_18:2_24:0), TG(18:0_18:2_22:0), TG(18:0_20:1_20:1), TG(18:1_18:1_22:0), TG(18:1_20:0_20:1), TG(18:2_20:0_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19788,"PlasmaLipidomics: TAG(58:2)_HFD having side chain FA composition [TG(16:0_18:2_24:0), TG(18:0_18:2_22:0), TG(18:0_20:1_20:1), TG(18:1_18:1_22:0), TG(18:1_20:0_20:1), TG(18:2_20:0_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19789,"PlasmaLipidomics: TAG(58:3)_CD having side chain FA composition [TG(16:0_18:2_24:1), TG(18:0_18:2_22:1), TG(18:1_18:1_22:1), TG(18:1_18:2_22:0), TG(18:1_20:1_20:1), TG(18:2_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19790,"PlasmaLipidomics: TAG(58:3)_HFD having side chain FA composition [TG(16:0_18:2_24:1), TG(18:0_18:2_22:1), TG(18:1_18:1_22:1), TG(18:1_18:2_22:0), TG(18:1_20:1_20:1), TG(18:2_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19791,"PlasmaLipidomics: TAG(58:4)_CD having side chain FA composition [TG(18:0_18:1_22:3), TG(18:0_18:2_22:2), TG(18:0_18:3_22:1), TG(18:0_20:1_20:3), TG(18:0_20:2_20:2), TG(18:1_18:1_22:2), TG(18:1_18:2_22:1), TG(18:1_18:3_22:0), TG(18:1_20:0_20:3), TG(18:1_20:1_20:2), TG(18:2_18:2_22:0), TG(18:2_20:0_20:2), TG(18:2_20:1_20:1), TG(18:3_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19792,"PlasmaLipidomics: TAG(58:4)_HFD having side chain FA composition [TG(18:0_18:1_22:3), TG(18:0_18:2_22:2), TG(18:0_18:3_22:1), TG(18:0_20:1_20:3), TG(18:0_20:2_20:2), TG(18:1_18:1_22:2), TG(18:1_18:2_22:1), TG(18:1_18:3_22:0), TG(18:1_20:0_20:3), TG(18:1_20:1_20:2), TG(18:2_18:2_22:0), TG(18:2_20:0_20:2), TG(18:2_20:1_20:1), TG(18:3_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19793,"PlasmaLipidomics: TAG(58:9)_CD having side chain FA composition [TG(16:0_20:3_22:6), TG(16:0_20:4_22:5), TG(18:1_18:1_22:7), TG(18:1_18:2_22:6), TG(18:1_20:3_20:5), TG(18:1_20:4_20:4), TG(18:2_18:2_22:5), TG(18:2_20:3_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19794,"PlasmaLipidomics: TAG(58:9)_HFD having side chain FA composition [TG(16:0_20:3_22:6), TG(16:0_20:4_22:5), TG(18:1_18:1_22:7), TG(18:1_18:2_22:6), TG(18:1_20:3_20:5), TG(18:1_20:4_20:4), TG(18:2_18:2_22:5), TG(18:2_20:3_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19795,"PlasmaLipidomics: TAG(60:12)_CD having side chain FA composition [TG(16:0_22:6_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19796,"PlasmaLipidomics: TAG(60:12)_HFD having side chain FA composition [TG(16:0_22:6_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19797,"PlasmaLipidomics: TAG(60:13)_CD having side chain FA composition [TG(18:2_20:5_22:6), TG(20:4_20:4_20:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19798,"PlasmaLipidomics: TAG(60:13)_HFD having side chain FA composition [TG(18:2_20:5_22:6), TG(20:4_20:4_20:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19799,"PlasmaLipidomics: TAG(62:14)_CD having side chain FA composition [TG(18:2_22:6_22:6), TG(20:4_20:4_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19800,"PlasmaLipidomics: TAG(62:14)_HFD having side chain FA composition [TG(18:2_22:6_22:6), TG(20:4_20:4_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19801,"PlasmaLipidomics: TAG(64:16)_CD having side chain FA composition [TG(20:4_22:6_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19802,"PlasmaLipidomics: TAG(64:16)_HFD having side chain FA composition [TG(20:4_22:6_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19803,"LiverLipidomics: DHA(Docosahexaenoic acid)_CD having side chain FA composition [FA(22:6n3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on chow diet (6% kCal/fat Harlan.2918) from 8 weeks of age. This phenotype is part of the EPFL LISP3 Study."
BXD_19804,"LiverLipidomics: DHA(Docosahexaenoic acid)_HFD having side chain FA composition [FA(22:6n3)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Mice were on high fat diet (60% kCal/fat HarlanTD.06414) from 8 weeks of age.This phenotype is part of the EPFL LISP3 Study."
BXD_19805,"LiverLipidomics: Arachidonic acid_CD having side chain FA composition [FA(20:4n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19806,"LiverLipidomics: Arachidonic acid_HFD having side chain FA composition [FA(20:4n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19807,"LiverLipidomics: Palmitoleic acid_CD having side chain FA composition [FA(16:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19808,"LiverLipidomics: Palmitoleic acid_HFD having side chain FA composition [FA(16:1)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19809,"LiverLipidomics: Linoleic acid_CD having side chain FA composition [FA(18:2n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19810,"LiverLipidomics: Linoleic acid_HFD having side chain FA composition [FA(18:2n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19811,"LiverLipidomics: DGLA(Dihomo_gamma_linolenic acid)_CD having side chain FA composition [FA(20:3n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19812,"LiverLipidomics: DGLA(Dihomo_gamma_linolenic acid)_HFD having side chain FA composition [FA(20:3n6)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19813,"LiverLipidomics: Palmitic acid_CD having side chain FA composition [FA(16:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19814,"LiverLipidomics: Palmitic acid_HFD having side chain FA composition [FA(16:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19815,"LiverLipidomics: Oleic acid_CD having side chain FA composition [FA(18:1n9)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19816,"LiverLipidomics: Oleic acid_HFD having side chain FA composition [FA(18:1n9)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19817,"LiverLipidomics: Stearic acid_CD having side chain FA composition [FA(18:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19818,"LiverLipidomics: Stearic acid_HFD having side chain FA composition [FA(18:0)] belonging to the lipid class fatty acid (FA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19819,"LiverLipidomics: PI(Dha_S)_1_CD having side chain FA composition [PI(22:6_18:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19820,"LiverLipidomics: PI(Dha_S)_1_HFD having side chain FA composition [PI(22:6_18:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19821,"LiverLipidomics: PS(Dha_P)_CD having side chain FA composition [PS(22:6_16:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19822,"LiverLipidomics: PS(Dha_P)_HFD having side chain FA composition [PS(22:6_16:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19823,"LiverLipidomics: PI(Ao_P)_CD having side chain FA composition [PI(20:4_16:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19824,"LiverLipidomics: PI(Ao_P)_HFD having side chain FA composition [PI(20:4_16:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19825,"LiverLipidomics: PS(Ao_P)_CD having side chain FA composition [PS(20:4_16:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19826,"LiverLipidomics: PS(Ao_P)_HFD having side chain FA composition [PS(20:4_16:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19827,"LiverLipidomics: PG(L_P)_CD having side chain FA composition [PG(18:2_16:0)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19828,"LiverLipidomics: PG(L_P)_HFD having side chain FA composition [PG(18:2_16:0)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19829,"LiverLipidomics: PI(Dha_S)_2_CD having side chain FA composition [PI(22:6_18:0)_2] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19830,"LiverLipidomics: PI(Dha_S)_2_HFD having side chain FA composition [PI(22:6_18:0)_2] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19831,"LiverLipidomics: PE(Dha_S)_CD having side chain FA composition [PE(22:6_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19832,"LiverLipidomics: PE(Dha_S)_HFD having side chain FA composition [PE(22:6_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19833,"LiverLipidomics: PI(Ao_S)_CD having side chain FA composition [PI(20:4_18:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19834,"LiverLipidomics: PI(Ao_S)_HFD having side chain FA composition [PI(20:4_18:0)] belonging to the lipid class phosphatidylinositol (PI), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19835,"LiverLipidomics: PG(O_P)_CD having side chain FA composition [PG(18:1_16:0)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19836,"LiverLipidomics: PG(O_P)_HFD having side chain FA composition [PG(18:1_16:0)] belonging to the lipid class phosphatidylglycerol (PG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19837,"LiverLipidomics: PS(Ao_S)_CD having side chain FA composition [PS(20:4_18:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19838,"LiverLipidomics: PS(Ao_S)_HFD having side chain FA composition [PS(20:4_18:0)] belonging to the lipid class phosphatidylserine (PS), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19839,"LiverLipidomics: PA(L_P)_CD having side chain FA composition [PA(18:2_16:0)] belonging to the lipid class phosphatidic acid (PA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19840,"LiverLipidomics: PA(L_P)_HFD having side chain FA composition [PA(18:2_16:0)] belonging to the lipid class phosphatidic acid (PA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19841,"LiverLipidomics: PE(Dha_P)_CD having side chain FA composition [PE(22:6_16:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19842,"LiverLipidomics: PE(Dha_P)_HFD having side chain FA composition [PE(22:6_16:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19843,"LiverLipidomics: PC(Dha_P)_CD having side chain FA composition [PC(22:6_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19844,"LiverLipidomics: PC(Dha_P)_HFD having side chain FA composition [PC(22:6_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19845,"LiverLipidomics: PC(Ao_P)_CD having side chain FA composition [PC(20:4_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19846,"LiverLipidomics: PC(Ao_P)_HFD having side chain FA composition [PC(20:4_16:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19847,"LiverLipidomics: PE(Ao_P)_CD having side chain FA composition [PE(20:4_16:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19848,"LiverLipidomics: PE(Ao_P)_HFD having side chain FA composition [PE(20:4_16:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19849,"LiverLipidomics: PA(O_P)_CD having side chain FA composition [PA(18:1_16:0)] belonging to the lipid class phosphatidic acid (PA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19850,"LiverLipidomics: PA(O_P)_HFD having side chain FA composition [PA(18:1_16:0)] belonging to the lipid class phosphatidic acid (PA), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19851,"LiverLipidomics: PE(Dha_S)_CD having side chain FA composition [PE(22:6_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19852,"LiverLipidomics: PE(Dha_S)_HFD having side chain FA composition [PE(22:6_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19853,"LiverLipidomics: MLCL(LLL)_CD having side chain FA composition [MLCL(18:2_18:2_18:2)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19854,"LiverLipidomics: MLCL(LLL)_HFD having side chain FA composition [MLCL(18:2_18:2_18:2)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19855,"LiverLipidomics: PC(Dha_S)_CD having side chain FA composition [PC(22:6_18:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19856,"LiverLipidomics: PC(Dha_S)_HFD having side chain FA composition [PC(22:6_18:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19857,"LiverLipidomics: PE(Ao_S)_CD having side chain FA composition [PE(20:4_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19858,"LiverLipidomics: PE(Ao_S)_HFD having side chain FA composition [PE(20:4_18:0)] belonging to the lipid class phosphatidylethanolamine (PE), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19859,"LiverLipidomics: DAG(Dha_P)_CD having side chain FA composition [DAG(22:6_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19860,"LiverLipidomics: DAG(Dha_P)_HFD having side chain FA composition [DAG(22:6_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19861,"LiverLipidomics: PC(Ao_S)_CD having side chain FA composition [PC(20:4_18:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19862,"LiverLipidomics: PC(Ao_S)_HFD having side chain FA composition [PC(20:4_18:0)] belonging to the lipid class phosphatidylcholine (PC), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19863,"LiverLipidomics: MLCL(LLO)_CD having side chain FA composition [MLCL(18:2_18:2_18:1)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19864,"LiverLipidomics: MLCL(LLO)_HFD having side chain FA composition [MLCL(18:2_18:2_18:1)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19865,"LiverLipidomics: DAG(Ao_P)_CD having side chain FA composition [DAG(20:4_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19866,"LiverLipidomics: DAG(Ao_P)_HFD having side chain FA composition [DAG(20:4_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19867,"LiverLipidomics: DAG(L_P)_CD having side chain FA composition [DAG(18:2_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19868,"LiverLipidomics: DAG(L_P)_HFD having side chain FA composition [DAG(18:2_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19869,"LiverLipidomics: MLCL(LOO)_CD having side chain FA composition [MLCL(18:2_18:1_18:1)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19870,"LiverLipidomics: MLCL(LOO)_HFD having side chain FA composition [MLCL(18:2_18:1_18:1)] belonging to the lipid class monolysocardiolipin (MLCL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19871,"LiverLipidomics: DAG(Dha_S)_CD having side chain FA composition [DAG(22:6_18:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19872,"LiverLipidomics: DAG(Dha_S)_HFD having side chain FA composition [DAG(22:6_18:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19873,"LiverLipidomics: DAG(Ao_S)_CD having side chain FA composition [DAG(20:4_18:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19874,"LiverLipidomics: DAG(Ao_S)_HFD having side chain FA composition [DAG(20:4_18:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19875,"LiverLipidomics: DAG(O_P)_CD having side chain FA composition [DAG(18:1_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19876,"LiverLipidomics: DAG(O_P)_HFD having side chain FA composition [DAG(18:1_16:0)] belonging to the lipid class diacylglycerol (DAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19877,"LiverLipidomics: CL(LLPoPo)_CD having side chain FA composition [CL(18:2_18:2_16:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19878,"LiverLipidomics: CL(LLPoPo)_HFD having side chain FA composition [CL(18:2_18:2_16:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19879,"LiverLipidomics: CL(LLLPo)_CD having side chain FA composition [CL(18:2_18:2_18:2_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19880,"LiverLipidomics: CL(LLLPo)_HFD having side chain FA composition [CL(18:2_18:2_18:2_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19881,"LiverLipidomics: CL(LLLL)_CD having side chain FA composition [CL(18:2_18:2_18:2_18:2)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19882,"LiverLipidomics: CL(LLLL)_HFD having side chain FA composition [CL(18:2_18:2_18:2_18:2)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19883,"LiverLipidomics: Co(Q9)_CD having side chain FA composition [Co(Q9)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19884,"LiverLipidomics: Co(Q9)_HFD having side chain FA composition [Co(Q9)] belonging to the lipid class coenzyme Q, measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19885,"LiverLipidomics: CL(LOPoPo)_CD having side chain FA composition [CL(18:2_18:1_16:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19886,"LiverLipidomics: CL(LOPoPo)_HFD having side chain FA composition [CL(18:2_18:1_16:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19887,"LiverLipidomics: CL(LLOPo)_1_CD having side chain FA composition [CL(18:2_18:2_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19888,"LiverLipidomics: CL(LLOPo)_1_HFD having side chain FA composition [CL(18:2_18:2_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19889,"LiverLipidomics: CL(LLLO)_CD having side chain FA composition [CL(18:2_18:2_18:2_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19890,"LiverLipidomics: CL(LLLO)_HFD having side chain FA composition [CL(18:2_18:2_18:2_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19891,"LiverLipidomics: CL(LLPoP)_CD having side chain FA composition [CL(18:2_18:2_16:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19892,"LiverLipidomics: CL(LLPoP)_HFD having side chain FA composition [CL(18:2_18:2_16:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19893,"LiverLipidomics: CL(LLLP)_CD having side chain FA composition [CL(18:2_18:2_18:2_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19894,"LiverLipidomics: CL(LLLP)_HFD having side chain FA composition [CL(18:2_18:2_18:2_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19895,"LiverLipidomics: CL(LOOPo)_CD having side chain FA composition [CL(18:2_18:1_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19896,"LiverLipidomics: CL(LOOPo)_HFD having side chain FA composition [CL(18:2_18:1_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19897,"LiverLipidomics: CL(LLOO)_CD having side chain FA composition [CL(18:2_18:2_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19898,"LiverLipidomics: CL(LLOO)_HFD having side chain FA composition [CL(18:2_18:2_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19899,"LiverLipidomics: CL(LLOP)_CD having side chain FA composition [CL(18:2_18:2_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19900,"LiverLipidomics: CL(LLOP)_HFD having side chain FA composition [CL(18:2_18:2_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19901,"LiverLipidomics: CL(LOPPo)_CD having side chain FA composition [CL(18:2_18:1_16:0_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19902,"LiverLipidomics: CL(LOPPo)_HFD having side chain FA composition [CL(18:2_18:1_16:0_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19903,"LiverLipidomics: CL(LOOO)_CD having side chain FA composition [CL(18:2_18:1_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19904,"LiverLipidomics: CL(LOOO)_HFD having side chain FA composition [CL(18:2_18:1_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19905,"LiverLipidomics: CL(OOOPo)_CD having side chain FA composition [CL(18:1_18:1_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19906,"LiverLipidomics: CL(OOOPo)_HFD having side chain FA composition [CL(18:1_18:1_18:1_16:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19907,"LiverLipidomics: CL(LLPoP)_2_CD having side chain FA composition [CL(18:2_18:2_16:1_16:0)-2] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19908,"LiverLipidomics: CL(LLPoP)_2_HFD having side chain FA composition [CL(18:2_18:2_16:1_16:0)-2] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19909,"LiverLipidomics: CL(LOOP)_CD having side chain FA composition [CL(18:2_18:1_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19910,"LiverLipidomics: CL(LOOP)_HFD having side chain FA composition [CL(18:2_18:1_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19911,"LiverLipidomics: CL(LOPP)_CD having side chain FA composition [CL(18:2_18:1_16:0_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19912,"LiverLipidomics: CL(LOPP)_HFD having side chain FA composition [CL(18:2_18:1_16:0_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19913,"LiverLipidomics: CL(OOOO)_CD having side chain FA composition [CL(18:1_18:1_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19914,"LiverLipidomics: CL(OOOO)_HFD having side chain FA composition [CL(18:1_18:1_18:1_18:1)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19915,"LiverLipidomics: CL(OOPP)_CD having side chain FA composition [CL(18:1_18:1_16:0_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19916,"LiverLipidomics: CL(OOPP)_HFD having side chain FA composition [CL(18:1_18:1_16:0_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19917,"LiverLipidomics: CL(OOOP)_CD having side chain FA composition [CL(18:1_18:1_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19918,"LiverLipidomics: CL(OOOP)_HFD having side chain FA composition [CL(18:1_18:1_18:1_16:0)] belonging to the lipid class cardiolipin (CL), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19919,"LiverLipidomics: TAG(48:0)_CD having side chain FA composition [TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19920,"LiverLipidomics: TAG(48:0)_HFD having side chain FA composition [TG(16:0_16:0_16:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19921,"LiverLipidomics: TAG(48:1)_CD having side chain FA composition [TG(14:0_16:0_18:1),TG(16:0_16:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19922,"LiverLipidomics: TAG(48:1)_HFD having side chain FA composition [TG(14:0_16:0_18:1),TG(16:0_16:0_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19923,"LiverLipidomics: TAG(48:2)_CD having side chain FA composition [TG(14:0_16:0_18:2),TG(12:0_18:1_18:1),TG(14:0_16:1_18:1),TG(14:1_16:0_18:1),TG(16:0_16:0_16:2),TG(16:0_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19924,"LiverLipidomics: TAG(48:2)_HFD having side chain FA composition [TG(14:0_16:0_18:2),TG(12:0_18:1_18:1),TG(14:0_16:1_18:1),TG(14:1_16:0_18:1),TG(16:0_16:0_16:2),TG(16:0_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19925,"LiverLipidomics: TAG(48:3)_CD having side chain FA composition [TG(12:0_18:1_18:2),TG(14:0_16:0_18:3),TG(14:0_16:1_18:2),TG(14:0_16:2_18:1),TG(14:1_16:0_18:2),TG(14:1_16:1_18:1),TG(16:0_16:1_16:2),TG(16:1_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19926,"LiverLipidomics: TAG(48:3)_HFD having side chain FA composition [TG(12:0_18:1_18:2),TG(14:0_16:0_18:3),TG(14:0_16:1_18:2),TG(14:0_16:2_18:1),TG(14:1_16:0_18:2),TG(14:1_16:1_18:1),TG(16:0_16:1_16:2),TG(16:1_16:1_16:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19927,"LiverLipidomics: TAG(50:0)_CD having side chain FA composition [TG(16:0_16:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19928,"LiverLipidomics: TAG(50:0)_HFD having side chain FA composition [TG(16:0_16:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19929,"LiverLipidomics: TAG(50:1)_CD having side chain FA composition [TG(16:0_16:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19930,"LiverLipidomics: TAG(50:1)_HFD having side chain FA composition [TG(16:0_16:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19931,"LiverLipidomics: TAG(50:2)_CD having side chain FA composition [TG(14:0_18:1_18:1),TG(16:0_16:0_18:2),TG(16:0_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19932,"LiverLipidomics: TAG(50:2)_HFD having side chain FA composition [TG(14:0_18:1_18:1),TG(16:0_16:0_18:2),TG(16:0_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19933,"LiverLipidomics: TAG(50:3)_CD having side chain FA composition [TG(14:0_18:1_18:2),TG(16:0_16:0_18:3),TG(16:0_16:1_18:2),TG(16:0_16:2_18:1),TG(16:1_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19934,"LiverLipidomics: TAG(50:3)_HFD having side chain FA composition [TG(14:0_18:1_18:2),TG(16:0_16:0_18:3),TG(16:0_16:1_18:2),TG(16:0_16:2_18:1),TG(16:1_16:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19935,"LiverLipidomics: TAG(50:4)_CD having side chain FA composition [TG(14:0_18:1_18:3),TG(14:0_18:2_18:2),TG(14:1_18:1_18:2),TG(16:0_16:1_18:3),TG(16:0_16:2_18:2),TG(16:1_16:1_18:2),TG(16:1_16:2_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19936,"LiverLipidomics: TAG(50:4)_HFD having side chain FA composition [TG(14:0_18:1_18:3),TG(14:0_18:2_18:2),TG(14:1_18:1_18:2),TG(16:0_16:1_18:3),TG(16:0_16:2_18:2),TG(16:1_16:1_18:2),TG(16:1_16:2_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19937,"LiverLipidomics: TAG(52:0)_CD having side chain FA composition [TG(16:0_16:0_20:0),TG(16:0_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19938,"LiverLipidomics: TAG(52:0)_HFD having side chain FA composition [TG(16:0_16:0_20:0),TG(16:0_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19939,"LiverLipidomics: TAG(52:1)_CD having side chain FA composition [TG(16:0_16:0_20:1),TG(16:0_16:1_20:0),TG(16:0_18:0_18:1),TG(16:1_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19940,"LiverLipidomics: TAG(52:1)_HFD having side chain FA composition [TG(16:0_16:0_20:1),TG(16:0_16:1_20:0),TG(16:0_18:0_18:1),TG(16:1_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19941,"LiverLipidomics: TAG(52:2)_CD having side chain FA composition [TG(16:0_18:0_18:2),TG(16:0_18:1_18:1),TG(16:1_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19942,"LiverLipidomics: TAG(52:2)_HFD having side chain FA composition [TG(16:0_18:0_18:2),TG(16:0_18:1_18:1),TG(16:1_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19943,"LiverLipidomics: TAG(52:3)_CD having side chain FA composition [TG(16:0_18:1_18:2),TG(16:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19944,"LiverLipidomics: TAG(52:3)_HFD having side chain FA composition [TG(16:0_18:1_18:2),TG(16:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19945,"LiverLipidomics: TAG(52:4)_CD having side chain FA composition [TG(16:0_16:0_20:4),TG(16:0_18:1_18:3),TG(16:0_18:2_18:2),TG(16:1_18:1_18:2),TG(16:2_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19946,"LiverLipidomics: TAG(52:4)_HFD having side chain FA composition [TG(16:0_16:0_20:4),TG(16:0_18:1_18:3),TG(16:0_18:2_18:2),TG(16:1_18:1_18:2),TG(16:2_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19947,"LiverLipidomics: TAG(52:5)_CD having side chain FA composition [TG(16:0_18:2_18:3),TG(16:1_18:1_18:3),TG(16:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19948,"LiverLipidomics: TAG(52:5)_HFD having side chain FA composition [TG(16:0_18:2_18:3),TG(16:1_18:1_18:3),TG(16:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19949,"LiverLipidomics: TAG(54:0)_CD having side chain FA composition [TG(18:0_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19950,"LiverLipidomics: TAG(54:0)_HFD having side chain FA composition [TG(18:0_18:0_18:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19951,"LiverLipidomics: TAG(54:1)_CD having side chain FA composition [TG(16:0_16:0_22:1),TG(16:0_18:0_20:1),TG(16:0_18:1_20:0),TG(16:1_18:0_20:0),TG(18:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19952,"LiverLipidomics: TAG(54:1)_HFD having side chain FA composition [TG(16:0_16:0_22:1),TG(16:0_18:0_20:1),TG(16:0_18:1_20:0),TG(16:1_18:0_20:0),TG(18:0_18:0_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19953,"LiverLipidomics: TAG(54:2)_CD having side chain FA composition [TG(16:0_18:0_20:2),TG(16:0_18:1_20:1),TG(16:0_18:2_20:0),TG(16:1_18:0_20:1),TG(16:1_18:1_20:0),TG(18:0_18:0_18:2),TG(18:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19954,"LiverLipidomics: TAG(54:2)_HFD having side chain FA composition [TG(16:0_18:0_20:2),TG(16:0_18:1_20:1),TG(16:0_18:2_20:0),TG(16:1_18:0_20:1),TG(16:1_18:1_20:0),TG(18:0_18:0_18:2),TG(18:0_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19955,"LiverLipidomics: TAG(54:3)_CD having side chain FA composition [TG(16:0_18:0_20:3),TG(16:0_18:1_20:2),TG(16:0_18:2_20:1),TG(16:1_18:0_20:2),TG(16:1_18:1_20:1),TG(18:0_18:1_18:2),TG(18:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19956,"LiverLipidomics: TAG(54:3)_HFD having side chain FA composition [TG(16:0_18:0_20:3),TG(16:0_18:1_20:2),TG(16:0_18:2_20:1),TG(16:1_18:0_20:2),TG(16:1_18:1_20:1),TG(18:0_18:1_18:2),TG(18:1_18:1_18:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19957,"LiverLipidomics: TAG(54:4)_CD having side chain FA composition [TG(16:0_16:0_22:4),TG(16:0_18:0_20:4),TG(16:0_18:1_20:3),TG(16:0_18:2_20:2),TG(18:0_18:2_18:2),TG(18:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19958,"LiverLipidomics: TAG(54:4)_HFD having side chain FA composition [TG(16:0_16:0_22:4),TG(16:0_18:0_20:4),TG(16:0_18:1_20:3),TG(16:0_18:2_20:2),TG(18:0_18:2_18:2),TG(18:1_18:1_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19959,"LiverLipidomics: TAG(54:5)_1_CD having side chain FA composition [TG(16:0_16:0_22:5),TG(16:0_18:2_20:3),TG(16:1_18:1_20:3),TG(18:1_18:1_18:3),TG(18:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19960,"LiverLipidomics: TAG(54:5)_1_HFD having side chain FA composition [TG(16:0_16:0_22:5),TG(16:0_18:2_20:3),TG(16:1_18:1_20:3),TG(18:1_18:1_18:3),TG(18:1_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19961,"LiverLipidomics: TAG(54:5)_2_CD having side chain FA composition [TG(16:0_18:1_20:4),TG(16:0_18:1_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19962,"LiverLipidomics: TAG(54:5)_2_HFD having side chain FA composition [TG(16:0_18:1_20:4),TG(16:0_18:1_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19963,"LiverLipidomics: TAG(54:6)_1_CD having side chain FA composition [TG(16:0_16:1_22:5),TG(16:0_18:1_20:5),TG(16:0_18:2_20:4),TG(16:0_18:3_20:3),TG(16:1_18:1_20:4),TG(16:1_18:2_20:3),TG(18:1_18:2_18:3),TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19964,"LiverLipidomics: TAG(54:6)_1_HFD having side chain FA composition [TG(16:0_16:1_22:5),TG(16:0_18:1_20:5),TG(16:0_18:2_20:4),TG(16:0_18:3_20:3),TG(16:1_18:1_20:4),TG(16:1_18:2_20:3),TG(18:1_18:2_18:3),TG(18:2_18:2_18:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19965,"LiverLipidomics: TAG(54:6)_2_CD having side chain FA composition [TG(16:0_16:0_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19966,"LiverLipidomics: TAG(54:6)_2_HFD having side chain FA composition [TG(16:0_16:0_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19967,"LiverLipidomics: TAG(56:0)_CD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19968,"LiverLipidomics: TAG(56:0)_HFD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19969,"LiverLipidomics: TAG(56:1)_CD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19970,"LiverLipidomics: TAG(56:1)_HFD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19971,"LiverLipidomics: TAG(56:2)_CD having side chain FA composition [TG(16:0_18:1_22:1),TG(16:0_18:2_22:0),TG(16:0_20:1_20:1),TG(18:0_18:1_20:1),TG(18:0_18:2_20:0),TG(18:1_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19972,"LiverLipidomics: TAG(56:2)_HFD having side chain FA composition [TG(16:0_18:1_22:1),TG(16:0_18:2_22:0),TG(16:0_20:1_20:1),TG(18:0_18:1_20:1),TG(18:0_18:2_20:0),TG(18:1_18:1_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19973,"LiverLipidomics: TAG(56:3)_CD having side chain FA composition [TG(16:0_18:1_22:2),TG(16:0_18:2_22:1),TG(16:0_20:0_20:3),TG(16:0_20:1_20:2),TG(18:0_18:0_20:3),TG(18:0_18:1_20:2),TG(18:0_18:2_20:1),TG(18:1_18:1_20:1),TG(18:1_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19974,"LiverLipidomics: TAG(56:3)_HFD having side chain FA composition [TG(16:0_18:1_22:2),TG(16:0_18:2_22:1),TG(16:0_20:0_20:3),TG(16:0_20:1_20:2),TG(18:0_18:0_20:3),TG(18:0_18:1_20:2),TG(18:0_18:2_20:1),TG(18:1_18:1_20:1),TG(18:1_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19975,"LiverLipidomics: TAG(56:4)_CD having side chain FA composition [TG(16:0_18:0_22:4),TG(16:0_18:1_22:3),TG(16:0_20:1_20:3),TG(16:0_20:2_20:2),TG(18:0_18:1_20:3),TG(18:0_18:2_20:2),TG(18:1_18:1_20:2),TG(18:1_18:2_20:1),TG(18:2_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19976,"LiverLipidomics: TAG(56:4)_HFD having side chain FA composition [TG(16:0_18:0_22:4),TG(16:0_18:1_22:3),TG(16:0_20:1_20:3),TG(16:0_20:2_20:2),TG(18:0_18:1_20:3),TG(18:0_18:2_20:2),TG(18:1_18:1_20:2),TG(18:1_18:2_20:1),TG(18:2_18:2_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19977,"LiverLipidomics: TAG(56:5)_CD having side chain FA composition [TG(16:0_18:1_22:4),TG(16:0_20:2_20:3),TG(16:1_18:0_22:4),TG(16:1_20:2_20:2),TG(18:0_18:1_20:4),TG(18:0_18:2_20:3),TG(18:1_18:1_20:3),TG(18:1_18:2_20:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19978,"LiverLipidomics: TAG(56:5)_HFD having side chain FA composition [TG(16:0_18:1_22:4),TG(16:0_20:2_20:3),TG(16:1_18:0_22:4),TG(16:1_20:2_20:2),TG(18:0_18:1_20:4),TG(18:0_18:2_20:3),TG(18:1_18:1_20:3),TG(18:1_18:2_20:2)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19979,"LiverLipidomics: TAG(56:7)_1_CD having side chain FA composition [TG(16:0_18:2_22:5),TG(16:0_20:3_20:4),TG(16:1_18:1_22:5),TG(16:1_18:2_22:4),TG(16:1_20:3_20:3),TG(18:1_18:2_20:4),TG(18:2_18:2_20:3)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19980,"LiverLipidomics: TAG(56:7)_1_HFD having side chain FA composition [TG(16:0_18:2_22:5),TG(16:0_20:3_20:4),TG(16:1_18:1_22:5),TG(16:1_18:2_22:4),TG(16:1_20:3_20:3),TG(18:1_18:2_20:4),TG(18:2_18:2_20:3)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19981,"LiverLipidomics: TAG(56:7)_2_CD having side chain FA composition [TG(16:0_18:1_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19982,"LiverLipidomics: TAG(56:7)_2_HFD having side chain FA composition [TG(16:0_18:1_22:6)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19983,"LiverLipidomics: TAG(56:8)_CD having side chain FA composition [TG(16:0_18:1_22:7),TG(16:0_18:2_22:6),TG(16:0_20:4_20:4),TG(18:1_18:2_20:5),TG(18:2_18:2_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19984,"LiverLipidomics: TAG(56:8)_HFD having side chain FA composition [TG(16:0_18:1_22:7),TG(16:0_18:2_22:6),TG(16:0_20:4_20:4),TG(18:1_18:2_20:5),TG(18:2_18:2_20:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19985,"LiverLipidomics: TAG(58:1)_CD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19986,"LiverLipidomics: TAG(58:1)_HFD having side chain FA composition [] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19987,"LiverLipidomics: TAG(58:2)_CD having side chain FA composition [TG(16:0_18:1_24:1),TG(16:0_18:2_24:0),TG(16:0_20:1_22:1),TG(18:0_18:1_22:1),TG(18:0_18:2_22:0),TG(18:0_20:1_20:1),TG(18:1_18:1_22:0),TG(18:1_20:0_20:1),TG(18:2_20:0_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19988,"LiverLipidomics: TAG(58:2)_HFD having side chain FA composition [TG(16:0_18:1_24:1),TG(16:0_18:2_24:0),TG(16:0_20:1_22:1),TG(18:0_18:1_22:1),TG(18:0_18:2_22:0),TG(18:0_20:1_20:1),TG(18:1_18:1_22:0),TG(18:1_20:0_20:1),TG(18:2_20:0_20:0)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19989,"LiverLipidomics: TAG(58:3)_CD having side chain FA composition [TG(18:0_18:2_22:1),TG(18:1_18:1_22:1),TG(18:1_18:2_22:0),TG(18:1_20:1_20:1),TG(18:2_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19990,"LiverLipidomics: TAG(58:3)_HFD having side chain FA composition [TG(18:0_18:2_22:1),TG(18:1_18:1_22:1),TG(18:1_18:2_22:0),TG(18:1_20:1_20:1),TG(18:2_20:0_20:1)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19991,"LiverLipidomics: TAG(58:8)_CD having side chain FA composition [TG(18:1_18:1_22:6),TG(18:1_18:2_22:5),TG(18:2_18:2_22:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19992,"LiverLipidomics: TAG(58:8)_HFD having side chain FA composition [TG(18:1_18:1_22:6),TG(18:1_18:2_22:5),TG(18:2_18:2_22:4)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19993,"LiverLipidomics: TAG(58:9)_CD having side chain FA composition [TG(18:1_18:2_22:6),TG(18:2_18:2_22:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. Chow diet (6% kCal/fat Harlan.2918). This phenotype is part of the EPFL LISP3 Study."
BXD_19994,"LiverLipidomics: TAG(58:9)_HFD having side chain FA composition [TG(18:1_18:2_22:6),TG(18:2_18:2_22:5)] belonging to the lipid class triacylglycerol (TAG), measured by MS [R.U.(AUC)] in overnight fasted male mice at 29 weeks of age. High fat diet (60% kCal/fat HarlanTD.06414).This phenotype is part of the EPFL LISP3 Study."
BXD_19995,Mitochondria: Estimate of mtDNA copy number
BXD_19996,VMB Fe M 40ppm PQ1
BXD_19998,Jones_VMB_P_trait_3
BXD_20000,Jones_VMB_P_trait_5
BXD_20002,Jones_VMB_P2_trait_1
BXD_20004,Jones_VMB_P2_trait_3
BXD_20006,Jones_VMB_P2_trait_5
BXD_20009,"Principal component for Fe, Cu, Zn in male BXD mice fed 240ppm [Fe] diet"
BXD_20010,BaseW1D4
BXD_20011,BaseW2D4
BXD_20012,BaseW3D4
BXD_20013,BaseW4D4
BXD_20014,BaseW5D4
BXD_20015,Jones_VMB_P3_trait_1
BXD_20017,Jones_VMB_P3_trait_3
BXD_20019,Jones_VMB_P3_trait_5
BXD_20021,Jones_Eva_VMB_trait_1
BXD_20022,Jones_Eva_VMB_trait_2
BXD_20023,Jones_Eva_VMB_trait_3
BXD_20024,Jones_Eva_VMB_trait_4
BXD_20025,Jones_Eva_VMB_trait_5
BXD_20026,Jones_Eva_VMB_trait_6
BXD_20027,Jones_EA_VMB_trait_1
BXD_20028,Jones_EA_VMB_trait_2
BXD_20029,Jones_EA_VMB_trait_3
BXD_20030,Jones_EA_VMB_trait_4
BXD_20031,Jones_EA_VMB_trait_5
BXD_20032,Jones_EA_VMB_trait_6
BXD_20033,"Central nervous system, metabolism, nutrition: Iron (Fe) level  difference in ventral midbrain (VMB) of adult males fed either 6 months 40 ppm iron diet treated with or without Paraquat or without once a week for 3 weeks (10 mg/kg i. p.) [Âµg/g]"
BXD_20034,Jones_Adamova_VMB_trait_2
BXD_20035,Jones_Adamova_VMB_trait_3
BXD_20036,Jones_Adamova_VMB_trait_4
BXD_20037,Jones_Adamova_VMB_trait_5
BXD_20038,Jones_Adamova_VMB_trait_6
BXD_20077,Base2HW1
BXD_20078,Base2HW2
BXD_20079,Base2HW3
BXD_20080,Base2HW4
BXD_20081,Base2HW5
BXD_20082,Slope2Hweek
BXD_20083,"Immune system, infectious disease: Fitzpatrick trait DS6T (please contact efitzpat@uthsc.edu for details)."
BXD_20084,"Immune system, infectious disease: Fitzpatrick trait DS4T (please contact efitzpat@uthsc.edu for details)."
BXD_20085,"Immune system, infectious disease: Fitzpatrick Trait Cell 8 No. (please contact efitzpat@uthsc.edu for details). "
BXD_20086,"Central nervous system, behavior: Motor planning, proprioception and coordination performance in day 1 time, the mice spent on the rotating rod between days 60-81 in males and females [sec]"
BXD_20087,"Musculoskeletal system, aging, metabolism: Gastrocnemius muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=319) [g]"
BXD_20088,"Musculoskeletal system, aging, metabolism: Gastrocnemius muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=298) [g]"
BXD_20089,"Musculoskeletal system, aging, metabolism: Soleus muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=319) [g]"
BXD_20090,"Musculoskeletal system, aging, metabolism: Soleus muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=298) [g]"
BXD_20091,"Musculoskeletal system, aging, metabolism: Quadriceps muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=319) [g]"
BXD_20092,"Musculoskeletal system, aging, metabolism: Quadriceps muscle mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, May 2018 (n=298) [g]"
BXD_20093,"Central nervous System, development, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca "
BXD_20094,"Central nervous system, behavior: Motor planning, proprioception, coordination improvements in day 3 time, the mice spent on the rotating rod between days 60-81 in males and females (BXD75 winsorized from 94.758 to 102.222) [sec]
"
BXD_20095,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_20096,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca
"
BXD_20097,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_20098,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females in future chronic mild stress (CMS) group (week 1 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20099,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females in future chronic mild stress (CMS) group (week 2 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20100,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females in future chronic mild stress (CMS) group (week 3 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20101,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females in future chronic mild stress (CMS) group (week 4 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20102,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females in future chronic mild stress (CMS) group (week 5 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20103,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 1 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20104,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 2 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20105,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 3 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20106,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 4 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20107,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 5 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20108,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 6 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20109,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) protocl  (week 7 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20110,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females in post the chronic mild stress (CMS) Period  (week 1 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20111,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females in post the chronic mild stress (CMS) Period  (week 2 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20112,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females in post the chronic mild stress (CMS) Period  (week 3 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20113,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females in post the chronic mild stress (CMS) Period  (week 4 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20114,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in future chronic mild stress (CMS) and DID group (week 1 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20115,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in future chronic mild stress (CMS) and DID group (week 2 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20116,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in future chronic mild stress (CMS) and DID group (week 3 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20117,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in future chronic mild stress (CMS) and DID group (week 4 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20118,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in future chronic mild stress (CMS) and DID group (week 5 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20119,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 1 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20120,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 2 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20121,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 3 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20122,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 4 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20123,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 5 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20124,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 6 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20125,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the chronic mild stress (CMS) and DID protocl  (week 7 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20126,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 1 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20127,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 2 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20128,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 3 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20129,"Endocrinology, physiology: Fecal corticosterone in 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 4 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20130,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol  (week 1 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20131,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol  (week 2 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20132,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol  (week 3 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20133,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol  (week 4 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20134,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol  (week 5 of period 1, P1, baseline) [ng/g dry weight]"
BXD_20135,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 1 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20136,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 2 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20137,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 3 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20138,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 4 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20139,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 5 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20140,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 6 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20141,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the drinking in the dark (DID) protocol in the chronic mild stress (CMS) period  (week 7 of period 2, P2, CMS) [ng/g dry weight]"
BXD_20142,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 1 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20143,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 2 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20144,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 3 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20145,"Endocrinology, physiology: Fecal corticosterone in normally housed 4-6 month old females during the DID protocl in post the chronic mild stress (CMS) Period  (week 4 of period 3, P3, post CMS) [ng/g dry weight]"
BXD_20146,"Central nervous system, aging, metabolism: Brain weight of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=117) [mg]"
BXD_20147,"Central nervous system, aging, metabolism: Brain weight of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=86) [mg]"
BXD_20148,"Urogenital system, morphology, aging, metabolism: Kidney mass of females between 6 and 25 months of age (bilateral, not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 2018 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=311) [g]	"
BXD_20149,"Urogenital system, morphology, aging, metabolism: Kidney mass of females between 6 and 25 months of age (bilateral, not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=300) [g]	"
BXD_20150,"Urogenital system, morphology, aging, metabolism: Kidney mass of females between 6 and 25 months of age (bilateral, as percentage of body weight, not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=311) [%]	"
BXD_20151,"Urogenital system, morphology, aging, metabolism: Kidney mass of females between 6 and 25 months of age (bilateral, as percentage of body weight, not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=300) (BXD28 value of 2.18 winsorized to 1.39) [%]"
BXD_20152,"Urogenital system, morphology, aging, metabolism: Left kidney mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=311) [g]"
BXD_20153,"Urogenital system, morphology, aging, metabolism: Left kidney mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=300) [g]	"
BXD_20154,"Urogenital system, morphology, aging, metabolism: Right kidney mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=311) [g]"
BXD_20155,"Urogenital system, morphology, aging, metabolism: Right kidney mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=300) [g]	"
BXD_20156,"Gastrointestinal system, morphology, aging, metabolism: Liver mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=308) [g]	"
BXD_20157,"Gastrointestinal system, morphology, aging, metabolism: Liver mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=289) [g]	"
BXD_20158,"Gastrointestinal system, morphology, aging, metabolism: Liver mass of females between 6 and 25 months of age (as percentage of body weight, not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=308) [%]	"
BXD_20159,"Gastrointestinal system, morphology, aging, metabolism: Liver mass of females between 6 and 25 months of age (as percentage of body weight, not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2018 (n=289) [%]	"
BXD_20160,"Immune system, infectious disease: Fitzpatrick trait cytokine 4LH (please contact efitzpat@uthsc.edu for details). "
BXD_20161,"Immune system, infectious disease: Fitzpatrick trait cytokine 5LH (please contact efitzpat@uthsc.edu for details)."
BXD_20162,"Immune system, infectious disease: Fitzpatrick trait Cytokine 5LH (please email fitzpat@uthsc.edu for details)."
BXD_20163,"Central nervous system, pharmacology, behavior: Body weight of week 1 of period 1 (P1, baseline),  in normally housed control for CMS 4-6 month old females [g]"
BXD_20164,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20165,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20166,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20167,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20168,"Central nervous system, pharmacology, behavior: Body weight of week 2 of period 1 (P1, baseline),  in normally housed control for CMS 4-6 month old females [g]"
BXD_20169,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 2 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20170,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 2 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20171,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 2 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20172,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 2 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20173,"Central nervous system, pharmacology, behavior: Body weight of week 3 of period 1 (P1, baseline),  in normally housed control for CMS 4-6 month old females [g]"
BXD_20174,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20175,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20176,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20177,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20178,"Central nervous system, pharmacology, behavior: Body weight of week 4 of period 1 (P1, baseline),  in normally housed control for CMS 4-6 month old females [g]"
BXD_20179,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20180,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20181,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20182,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20183,"Central nervous system, pharmacology, behavior: Body weight of week 5 of period 1 (P1, baseline),  in normally housed control for CMS 4-6 month old females [g]"
BXD_20184,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 5 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20185,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 5 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20186,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 5 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20187,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 5 of period 1 (P1, baseline), in normally housed control for CMS females [g/kg]"
BXD_20188,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 1 (P1, baseline), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20189,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 1 (P1, baseline), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20190,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 1 (P1, baseline), in  normally housed control for CMS 4-6 month old females  [Î” g/kg]"
BXD_20191,"Central nervous system, pharmacology, behavior: Body weight of week 1 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20192,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20193,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20194,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20195,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20196,"Central nervous system, pharmacology, behavior: Body weight of week 2 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20197,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 2 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20198,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 2 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20199,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 2 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20200,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 2 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20201,"Central nervous system, pharmacology, behavior: Body weight of week 3 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20202,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20203,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20204,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20205,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20206,"Central nervous system, pharmacology, behavior: Body weight of week 4 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20207,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20208,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20209,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20210,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20211,"Central nervous system, pharmacology, behavior: Body weight of week 5 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20212,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 5 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20213,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 5 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20214,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 5 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20215,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 5 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20216,"Central nervous system, pharmacology, behavior: Body weight of week 6 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20217,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 Week 6 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20218,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 Week 6 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20219,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 Week 6 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20220,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 Week 6 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20221,"Central nervous system, pharmacology, behavior: Body weight of week 7 of period 2 (P2, chronic mild stress period),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20222,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 7 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20223,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 7 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20224,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 7 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20225,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 7 of period 2  (P2, chronic mild stress period), in normally housed control for CMS 4-6 month old females"
BXD_20226,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 2 (P2, chronic mild stress (CMS) period), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20227,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 2 (P2, chronic mild stress (CMS) period), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20228,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 2 (P2, chronic mild stress (CMS) period), in  normally housed control for CMS 4-6 month old females  [Î” g/kg]"
BXD_20229,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 2 (P2, 2 CMS) and average of all in period 1 (P1, baseline), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20230,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 2 (P2, CMS) and average of all in period 1 (P1, baseline), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20231,"Central nervous system, pharmacology, behavior: Body weight of week 1 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20232,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20233,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20234,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20235,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20236,"Central nervous system, pharmacology, behavior: Body weight of week 2 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20237,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 Week 2 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20238,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 Week 2 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20239,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 Week 2 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20240,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 Week 2 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20241,"Central nervous system, pharmacology, behavior: Body weight of week 3 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20242,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20243,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20244,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20245,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20246,"Central nervous system, pharmacology, behavior: Body weight of week 4 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females  [g]"
BXD_20247,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20248,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20249,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20250,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of perod 3 (P3, post chronic mild stress),  in normally housed control for CMS 4-6 month old females [g/kg]"
BXD_20251,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 2 (P2, chronic mild stress (CMS) period), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20252,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 3 (P3, post chronic mild stress (CMS) period), in normally housed control for CMS 4-6 month old females  [g/kg]"
BXD_20253,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 3 (P3, post chronic mild stress (CMS) period), in  normally housed control for CMS 4-6 month old females  [Î” g/kg]"
BXD_20254,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 3 (P3, post CMS) and average of all in period 2 (P2, chronic mild stress (CMS)), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20255,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 3 (P3, post CMS) and average of all in period 2 (P2, chronic mild stress (CMS)), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20256,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 3 (P3, post CMS) and average of all in period 1 (P1, baseline), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20257,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 3 (P3, post CMS) and average of all in period 1 (P1, baseline), in normally housed control for chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20258,"Central nervous system, pharmacology, behavior: Body weight of week 1 of period 1 (P1, baseline),  in chronic mild stress 4-6 month old females [g]"
BXD_20259,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20260,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20261,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20262,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20263,"Central nervous system, pharmacology, behavior: Body weight of week 2 of period 1 (P1, baseline),  in chronic mild stress 4-6 month old females [g]"
BXD_20264,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 2 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20265,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 2 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20266,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 2 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20267,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 2 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20268,"Central nervous system, pharmacology, behavior: Body weight of week 3 of period 1 (P1, baseline),  in chronic mild stress 4-6 month old females [g]"
BXD_20269,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20270,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20271,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20272,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20273,"Central nervous system, pharmacology, behavior: Body weight of week 4 of period 1 (P1, baseline),  in chronic mild stress 4-6 month old females [g]"
BXD_20274,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20275,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20276,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20277,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20278,"Central nervous system, pharmacology, behavior: Body weight of week 5 of period 1 (P1, baseline),  in chronic mild stress 4-6 month old females [g]"
BXD_20279,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 5 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20280,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 5 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20281,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 5 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20282,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 5 of period 1 (P1, baseline), in chronic mild stress females [g/kg]"
BXD_20283,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20284,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20285,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 1 (P1, baseline), in  chronic mild stress 4-6 month old females  [Î” g/kg]"
BXD_20286,"Central nervous system, pharmacology, behavior: Body weight of week 1 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20287,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20288,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20289,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20290,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20291,"Central nervous system, pharmacology, behavior: Body weight of week 2 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20292,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 2 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20293,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 2 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20294,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 2 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20295,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 2 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20296,"Central nervous system, pharmacology, behavior: Body weight of week 3 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20297,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20298,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20299,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20300,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20301,"Central nervous system, pharmacology, behavior: Body weight of week 4 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20302,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20303,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20304,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20305,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20306,"Central nervous system, pharmacology, behavior: Body weight of week 5 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20307,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 5 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20308,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 5 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20309,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 5 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20310,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 5 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20311,"Central nervous system, pharmacology, behavior: Body weight of week 6 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20312,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 Week 6 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20313,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 Week 6 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20314,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 Week 6 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20315,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 Week 6 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20316,"Central nervous system, pharmacology, behavior: Body weight of week 7 of period 2 (P2, chronic mild stress period),  in chronic mild stress 4-6 month old females  [g]"
BXD_20317,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 7 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20318,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 7 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20319,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 7 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20320,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 7 of period 2  (P2, chronic mild stress period), in chronic mild stress 4-6 month old females"
BXD_20321,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 2 (P2, chronic mild stress (CMS) period), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20322,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 2 (P2, chronic mild stress (CMS) period), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20323,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 2 (P2, chronic mild stress (CMS) period), in  chronic mild stress 4-6 month old females  [Î” g/kg]"
BXD_20324,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 2 (P2, 2 CMS) and average of all in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20325,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 2 (P2, CMS) and average of all in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20326,"Central nervous system, pharmacology, behavior: Body weight of week 1 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females  [g]"
BXD_20327,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 1 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20328,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 1 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20329,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 1 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20330,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 1 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20331,"Central nervous system, pharmacology, behavior: Body weight of week 2 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females  [g]"
BXD_20332,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 Week 2 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20333,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 Week 2 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20334,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 Week 2 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20335,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 Week 2 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20336,"Central nervous system, pharmacology, behavior: Body weight of week 3 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females  [g]"
BXD_20337,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 3 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20338,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 3 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20339,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 3 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20340,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 3 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20341,"Central nervous system, pharmacology, behavior: Body weight of week 4 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females  [g]"
BXD_20342,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 1 week 4 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20343,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 2 week 4 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20344,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 2 h access on day 3 week 4 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20345,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, 4 h access on day 4 week 4 of perod 3 (P3, post chronic mild stress),  in chronic mild stress 4-6 month old females [g/kg]"
BXD_20346,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 2h in period 3 (P3, post stress period), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20347,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period 3 (P3, post chronic mild stress (CMS) period), in chronic mild stress 4-6 month old females  [g/kg]"
BXD_20348,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between  the EtOH cosumptions of  last 4h and 1st 4h in period 3 (P3, post chronic mild stress (CMS) period), in  chronic mild stress 4-6 month old females  [Î” g/kg]"
BXD_20349,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 3 (P3, post CMS) and average of all in period 2 (P2, chronic mild stress (CMS)), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20350,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 3 (P3, post CMS) and average of all in period 2 (P2, chronic mild stress (CMS)), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20351,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 2h in period 3 (P3, post CMS) and average of all in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20352,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference between average EtOH cosumption for all 4h in period 3 (P3, post CMS) and average of all in period 1 (P1, baseline), in chronic mild stress 4-6 month old females  [Î”g/kg]"
BXD_20353,"Cardiovascular system, aging, metabolism: Heart mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 2018 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, August 2018 (n=302) [g]"
BXD_20354,"Cardiovascular system, aging, metabolism: Heart mass of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, August 2018 (n=284) [g]"
BXD_20355,"Cardiovascular system, aging, metabolism: Heart mass of females between 6 and 25 months of age (as percentage of body weight, not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, August 2018 (n=302) [%]"
BXD_20356,"Cardiovascular system, aging, metabolism: Heart mass of females between 6 and 25 months of age (as percentage of body weight, not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, August 2018 (n=284) [%]"
BXD_20357,"Central nervous system, behavior: Sensorimotor reflex performance of negative geotaxis (_) between days 1-15 in males and females [sec]"
BXD_20358,"Central nervous system, behavior: Sensorimotor reflex performance of cliff aversion (_) between days 1-15 in males and females (BXD32 winsorized from 7.305 to 5.464 and C57BL/6J winsorized from 8.529 to 5.465 by JRS) [sec]"
BXD_20359,"Central nervous system, behavior: Sensorimotor reflex performance of surface righting (_) between days 1-15 in males and females [sec] "
BXD_20360,"Central nervous system, behavior: Sensorimotor reflex performance of forelimb grasp (_) between days 1-15 in males and females [sec]"
BXD_20361,x
BXD_20362,"Central nervous system, behavior: Locomotion activity, motor coordination performance of distance travelled on open-field between days 60-81 in males and females [cm]"
BXD_20363,"Central nervous system, behavior: Locomotion activity, motor coordination performance of time spent in periphery on open-field between days 60-81 in males and females [sec]"
BXD_20364,none
BXD_20365,"Central nervous system, behavior: Locomotion activity, motor coordination performance of time spent in centre on open-field between days 60-81 in males and females [sec]"
BXD_20366,X
BXD_20367,"Central nervous system, behavior: Locomotion activity, motor coordination performance of time spent moving on open-field between days 60-81 in males and females [sec]"
BXD_20368,x
BXD_20369,"Central nervous system, behavior: Locomotion activity, motor coordination performance of time spent not moving on open-field  between days 60-81 in males and females [sec]"
BXD_20370,X
BXD_20371,"Central nervous system, behavior: Locomotion activity, motor coordination performance of velocity on open-field between days 60-81 in males and females (BXD32 winsorized from 21.296 to 12.448) [sec]"
BXD_20372,X
BXD_20373,63_S_C-NREM
BXD_20374,64_S_C-REM
BXD_20375,65_S_C-WAKE
BXD_20376,"Central nervous system, metabolism, nutrition:  Iron level in ventral midbrain of 20-120-day-old males and females fed 240 ppm Fe diet [ug/g]"
BXD_20377,Metal_cons_070918_trait_2
BXD_20378,Metal_cons_070918_trait_3
BXD_20379,Metal_cons_070918_trait_4
BXD_20380,Metal_cons_070918_trait_5
BXD_20381,Metal_cons_070918_trait_6
BXD_20382,Metal_cons_070918_trait_7
BXD_20383,Metal_cons_070918_trait_8
BXD_20384,Metal_cons_070918_trait_9
BXD_20385,"Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 121-240-day-old males and females fed 240 ppm Fe diet [ug/g]"
BXD_20386,Metal_cons_070918_trait_11
BXD_20387,Metal_cons_070918_trait_12
BXD_20388,Metal_cons_070918_trait_13
BXD_20389,Metal_cons_070918_trait_14
BXD_20390,Metal_cons_070918_trait_15
BXD_20391,Metal_cons_070918_trait_16
BXD_20392,Metal_cons_070918_trait_17
BXD_20393,Metal_cons_070918_trait_18
BXD_20394,Metal_cons_070918_trait_19
BXD_20395,Metal_cons_070918_trait_20
BXD_20396,Metal_cons_070918_trait_21
BXD_20397,Metal_cons_070918_trait_22
BXD_20398,Metal_cons_070918_trait_23
BXD_20399,Metal_cons_070918_trait_24
BXD_20400,Metal_cons_070918_trait_25
BXD_20401,Metal_cons_070918_trait_26
BXD_20402,Metal_cons_070918_trait_27
BXD_20403,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference of the average EtOH consumption for all 2h in period P2 (P2 Chronic Mild Stress (CMS)) versus the average of all in period 1 (P1, baseline) between chronic mild stress and normal handle 4-6 month old females mice [delta g/kg]"
BXD_20404,Mean_4h_CD-D_P2-P1
BXD_20405,Mean_2h_CD-D_P3-P2
BXD_20406,Mean_4h_CD-D_P3-P2
BXD_20407,Mean_2h_CD-D_P3-P1
BXD_20408,Mean_4h_CD-D_P3-P1
BXD_20409,"Eigenvariable derived from differences in DID etc. Winsorized from original values, NB DBA -4.156, BXD48 -2.616, BXD49 -2.199; BXD90 1.85, BXD78 3.117, BXD73 5.412"
BXD_20410,"Immune system, infectious disease: Fitzpatrick trait cytokine 5LHPCR please contact efitzpat@uthsc.edu for details"
BXD_20411,"Immune System, infectious disease: Fitzpatrick trait CG1 (please contact efitzpat@uthsc.edu for details). "
BXD_20412,"Immune system, infectious disease: S. Rectivirgula response (100ug, three times/week for two weeks, one time in third week, farmers lung disease), sacrificed 20hrs after last exposure. The expression of Cdh2 in the lung lobe by PCR."
BXD_20413,"Immune system, infectious disease: S. Rectivirgula response (100ug, three times/week for two weeks, one time in third week, farmers lung disease), sacrificed 20hrs after last exposure. The expression of Cdh2 in the lung lobe by PCR."
BXD_20414,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_20415,"Auditory system: Click test (80 dB) at about 15 cm above cage, behavior response (sudden movement or pinna reflex) where 0 is no visible response, 1 is pinna movement only, 2 whole body movement (jump) [ordinary]"
BXD_20416,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, difference of scores of average EtOH consumption for all 2h in period P2 (P2 Chronic Mild Stress (CMS)) versus in period 1 (P1, baseline) between chronic mild stress and normal handle 4-6 month old females mice [delta g/kg]"
BXD_20417,CMSDID_DID for P2_P1_4hr
BXD_20418,CMSDID_DID for P3_P2_2hr
BXD_20419,CMSDID_DID for P3_P2_4hr
BXD_20420,CMSDID_DID for P3_P1_2hr
BXD_20421,CMSDID_DID for P3_P1_4hr
BXD_20422,"Eye, morphology, visual system: Eye weight corrected for log of age, sex, and body (100-day-old male-female average) of new BXD cohort only (BXD43 and higher) [mg]"
BXD_20423,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during pre-test (no cocaine or saline injection), control group females [m/15 min]"
BXD_20424,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during pre-test (no cocaine or saline injection), prenatal stress group females [m/15 min]"
BXD_20425,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during pre-test (no cocaine or saline injection), control group males [m/15 min]"
BXD_20426,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during pre-test (no cocaine or saline injection), prenatal stress group males [m/15 min]"
BXD_20427,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during post-test (no cocaine or saline injection), control group females [m/15 min]"
BXD_20428,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during post-test (no cocaine or saline injection), prenatal stress group females [m/15 min]"
BXD_20429,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during post-test (no cocaine or saline injection), control group males [m/15 min]"
BXD_20430,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), horizontal distance traveled during post-test (no cocaine or saline injection), prenatal stress group males [m/15 min]"
BXD_20431,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), locomotor habituation, change in horizontal distance traveled from pre-test to post-test (no cocaine or saline injection), control group females [m/15 min]"
BXD_20432,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), locomotor habituation, change in horizontal distance traveled from pre-test to post-test (no cocaine or saline injection), prenatal stress group females [m/15 min]"
BXD_20433,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), locomotor habituation, change in horizontal distance traveled from pre-test to post-test (no cocaine or saline injection), control group males [m/15 min]"
BXD_20434,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Conditioned place preference (CPP), locomotor habituation, change in horizontal distance traveled from pre-test to post-test (no cocaine or saline injection), prenatal stress group males [m/15 min]"
BXD_20435,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group females [m/15 min]"
BXD_20436,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group females [m/15 min]"
BXD_20437,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, control group males [m/15 min]"
BXD_20438,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, prenatal stress group males [m/15 min]"
BXD_20439,"Central nervous system, pharmacology, behavior, effects of prenatal stress: Saline response (4 x 10 mL/kg ip), conditioned place preference (CPP), horizontal distance traveled during first saline conditioning session, control group females [m/15 min]"
BXD_20456,"Eye, morphology, visual system: Eye weight minus lens weight corrected for age, sex, body and brain weight [mg]"
BXD_20457,"Eye, morphology, visual system: Eye weight (unilateral, freshly dissected), corrected by regression for sex, log age, and body weight to 75 days (weight high due to inclusion of extraocular muscles) [mg]"
BXD_20458,Metal_conc_112818_trait_1
BXD_20459,Metal_conc_112818_trait_2
BXD_20460,Metal_conc_112818_trait_3
BXD_20461,Metal_conc_112818_trait_4
BXD_20462,Metal_conc_112818_trait_5
BXD_20463,Metal_conc_112818_trait_6
BXD_20464,Metal_conc_112818_trait_7
BXD_20465,Metal_conc_112818_trait_8
BXD_20466,Metal_conc_112818_trait_9
BXD_20467,Metal_conc_112818_trait_10
BXD_20468,Metal_conc_112818_trait_11
BXD_20469,Metal_conc_112818_trait_12
BXD_20470,Metal_conc_112818_trait_13
BXD_20471,Metal_conc_112818_trait_14
BXD_20472,Metal_conc_112818_trait_15
BXD_20473,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficit defined as first age at which performance dropped to chance (50%), male and females average of AD-BXD cases positive for 5XFAD transgene [months]"
BXD_20474,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD cases as quantified by ELISA in 6-month-old in male and female cases that are 5XFD-positive AD-BXDF1 [ng AB1-42/mg total protein]"
BXD_20475,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD cases as quantified by ELISA in 14-month-old in male and female cases that are 5XFD-positive AD-BXDF1 [ng AB1-42/mg total protein]"
BXD_20476,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20477,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20478,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20479,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20480,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20481,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20482,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20483,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20484,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20485,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20486,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20487,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20488,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20489,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20490,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20491,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20492,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 8-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20493,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20494,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20495,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20496,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20497,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20498,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20499,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20500,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20501,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20502,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20503,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 12-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20504,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20505,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20506,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20507,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20508,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20509,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20510,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20511,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20512,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20513,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20514,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20515,"Metabolism, morphology: Body weight (g) measured in 16-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20516,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20517,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20518,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20519,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20520,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20521,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20522,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20523,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20524,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20525,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20526,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20527,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20528,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20529,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20530,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20531,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20532,Metabolism: Blood glucose (mg/dL) measured in 6-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [mg/dL]
BXD_20533,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across males and females from the AD-BXD population positive for 5XFAD transgene [mg/dL]
BXD_20534,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20535,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20536,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20537,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20538,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20539,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20540,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20541,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20542,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20543,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20544,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20545,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20546,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20547,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20548,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20549,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20550,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20551,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20552,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20553,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20554,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20555,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 14-month-old males and females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20556,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficits; individual mice defined as ""impaired"" when chance performance dropped below chance (50%). This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [months]"
BXD_20557,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20558,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20559,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20560,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20561,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20562,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20563,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20564,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20565,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20566,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20567,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20568,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20569,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20570,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20571,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20572,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20573,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 8-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20574,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20575,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20576,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20577,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20578,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20579,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20580,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20581,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20582,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20583,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20584,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 12-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20585,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20586,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20587,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20588,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20589,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20590,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20591,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20592,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20593,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20594,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20595,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20596,"Metabolism, morphology: Body weight (g) measured in 16-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20597,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20598,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20599,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%] [%]"
BXD_20600,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20601,"Central nervous system, behavior, activity: Distance traveled in  elevated plus maze by 14-month-old male and female non-transgenic littermates of AD-BXD cases (Ntg) [m]"
BXD_20602,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20603,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%] [%]"
BXD_20604,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20605,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20606,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20607,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20608,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20609,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20610,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20611,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20612,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20613,Metabolism: Blood glucose (mg/dL) measured in 6-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20614,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20615,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20616,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20617,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20618,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20619,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20620,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20621,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20622,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20623,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20624,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20625,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20626,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20627,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20628,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20629,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20630,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20631,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20632,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20633,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20634,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20635,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20636,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 14-month-old male and female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20637,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficits; individual mice defined as ""impaired"" when chance performance dropped below chance (50%). This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [months]"
BXD_20638,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD strains as quantified by ELISA assay. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene. [ng AB1-42/mg total protein]"
BXD_20639,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD strains as quantified by ELISA assay. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene. [ng AB1-42/mg total protein]"
BXD_20640,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20641,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20642,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20643,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20644,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20645,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20646,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20647,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20648,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20649,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20650,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20651,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20652,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20653,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20654,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20655,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20656,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 8-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20657,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20658,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20659,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20660,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20661,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20662,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20663,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20664,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20665,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20666,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20667,"Central nervous system, behavior: Activity level in a Y-maze test, number of arm entered by 12-month-old female positive for the 5XFAD Alzheimer's transgene [N]"
BXD_20668,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20669,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20670,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20671,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20672,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20673,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20674,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20675,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20676,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20677,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20678,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20679,"Metabolism, morphology: Body weight (g) measured in 16-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20680,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20681,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20682,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20683,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20684,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20685,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20686,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20687,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20688,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20689,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20690,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20691,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20692,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20693,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20694,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20695,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20696,Metabolism: Blood glucose level in 6-month-old AD-BXD F1 females carrying human Alzheimer's disease transgenes (5XFAD) [mg/dL]
BXD_20697,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across females from the AD-BXD population positive for 5XFAD transgene [mg/dL]
BXD_20698,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20699,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20700,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20701,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20702,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20703,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20704,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20705,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20706,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20707,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20708,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20709,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20710,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20711,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20712,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20713,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20714,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20715,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20716,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20717,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20718,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20719,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 14-month-old females from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20720,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficits; individual mice defined as ""impaired"" when chance performance dropped below chance (50%). This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [months]"
BXD_20721,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD strains as quantified by ELISA assay. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene. [ng AB1-42/mg total protein]"
BXD_20722,"Central nervous system, pathology: Human beta-amyloid 1-42 levels in cortex of AD-BXD strains as quantified by ELISA assay. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene. [ng AB1-42/mg total protein]"
BXD_20723,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20724,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20725,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20726,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20727,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20728,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20729,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20730,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20731,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20732,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20733,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20734,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20735,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20736,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20737,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20738,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20739,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 8-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20740,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20741,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20742,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20743,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20744,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20745,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20746,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20747,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20748,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20749,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20750,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 12-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20751,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20752,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20753,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20754,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20755,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20756,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20757,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20758,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20759,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20760,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20761,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20762,"Metabolism, morphology: Body weight (g) measured in 16-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [g]"
BXD_20763,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20764,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20765,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20766,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20767,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [m]"
BXD_20768,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [entries]"
BXD_20769,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%] [%]"
BXD_20770,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20771,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20772,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20773,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20774,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20775,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20776,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [s] [s]"
BXD_20777,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [N] [N]"
BXD_20778,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [N] [Z]"
BXD_20779,Metabolism: Blood glucose (mg/dL) measured in 6-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [mg/dL]
BXD_20780,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across males from the AD-BXD population positive for 5XFAD transgene [mg/dL]
BXD_20781,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20782,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20783,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20784,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20785,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20786,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20787,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20788,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20789,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20790,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20791,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20792,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20793,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20794,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20795,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20796,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20797,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20798,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20799,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20800,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20801,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old males from the AD-BXD population positive for 5XFAD transgene [%]"
BXD_20802,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time freezing during contextual fear memory test (a measure of overall contextual fear memory) in  14-month-old males from the AD-BXD cases positive for 5XFAD transgene [%]"
BXD_20803,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficits; individual mice defined as ""impaired"" when chance performance dropped below chance (50%). This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [months]"
BXD_20804,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20805,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20806,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20807,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20808,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20809,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20810,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20811,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20812,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20813,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20814,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20815,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20816,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20817,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20818,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20819,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20820,"Central nervous system, behavior, activity: Distance traveled in the y-maze in 8-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20821,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20822,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20823,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20824,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20825,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20826,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20827,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20828,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20829,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20830,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20831,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 12-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20832,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20833,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20834,"Central nervous system, behavior, learning and memory: Performance on the Y-maze as measured by percentage ofl arm entries that were successful spontaneous alternations by 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20835,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20836,"Central nervous system, behavior: Activity level in a y-maze, number of arms entered for 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N]"
BXD_20837,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20838,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20839,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20840,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20841,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20842,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20843,"Metabolism, morphology: Body weight at 16-months of female non-transgenic controls (Ntg) for the 5XFAD [g]"
BXD_20844,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20845,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20846,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%] [%]"
BXD_20847,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20848,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20849,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20850,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze in 14-month-old female non-transgenic controls for the AD-BXDs (Ntg-BXDs) [%]"
BXD_20851,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20852,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20853,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20854,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20855,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20856,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20857,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20858,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20859,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20860,Metabolism: Blood glucose (mg/dL) measured in 6-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20861,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20862,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20863,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20864,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20865,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20866,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20867,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20868,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20869,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20870,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20871,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20872,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20873,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20874,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20875,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20876,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20877,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20878,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20879,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20880,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20881,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20882,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20883,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 14-month-old female non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20884,"Central nervous system, behavior, learning and memory: Age at onset of working memory deficits; individual mice defined as ""impaired"" when chance performance dropped below chance (50%). This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [months]"
BXD_20885,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 2-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20886,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 2-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20887,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 2-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20888,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 2-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20889,"Metabolism, morphology: Body weight (g) measured in 2-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20890,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 4-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20891,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 4-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20892,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 4-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20893,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 4-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20894,"Metabolism, morphology: Body weight (g) measured in 4-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20895,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20896,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20897,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20898,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20899,"Metabolism, morphology: Body weight (g) measured in 6-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20900,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 8-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20901,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 8-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20902,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 8-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20903,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 8-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20904,"Metabolism, morphology: Body weight (g) measured in 8-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20905,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 10-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20906,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 10-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20907,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 10-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20908,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 10-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20909,"Metabolism, morphology: Body weight (g) measured in 10-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20910,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 12-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20911,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 12-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20912,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 12-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20913,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 12-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20914,"Metabolism, morphology: Body weight (g) measured in 12-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20915,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20916,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20917,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20918,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20919,"Metabolism, morphology: Body weight (g) measured in 14-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20920,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were successful spontaneous alternations. This data is strain averaged across 16-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20921,"Central nervous system, behavior, activity: Distance traveled in the y-maze. This data is strain averaged across 16-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20922,"Central nervous system, behavior, activity: Total arms entered in the y-maze. This data is strain averaged across 16-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20923,"Central nervous system, behavior, learning and memory: Performance on the y-maze as measured by % of total arm entries that were unsuccessful spontaneous alternations; known as alternating arm returns (also can be used as an error index). This data is strain averaged across 16-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20924,"Metabolism, morphology: Body weight (g) measured in 16-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [g]"
BXD_20925,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20926,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20927,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%] [%]"
BXD_20928,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20929,"Central nervous system, behavior, activity: Distance traveled in the elevated plus maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [m]"
BXD_20930,"Central nervous system, behavior, activity: Total arms entered in the elevated plus maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [entries]"
BXD_20931,"Central nervous system, behavior, activity: Anxiety assay, percentage time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%] [%]"
BXD_20932,"Central nervous system, behavior, activity: Anxiety assay, time spent in open arms of an elevated plus maze. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20933,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20934,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20935,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20936,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 6-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20937,"Central nervous system, behavior, sensorimotor function: Time reach a safety platform on either side of a narrow (0.5"") beam in seconds. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20938,"Central nervous system, behavior, sensorimotor function, negative geotaxis: Time taken in seconds for mouse to right itself after being place face-down on an wire mesh screen inclined at a 45 degree angle. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [s] [s]"
BXD_20939,"Central nervous system, behavior: Peak grip strength in Newtons. A more negative grip strength equals better performance on the task. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [N]"
BXD_20940,"Central nervous system, behavior, sensorimotor: Composite sensorimotor score derived from individual performance on a sensorimotor battery including 3 tasks: 1) time to cross a narrow beam, 2) time to right oneself on an incline screen (negative geotaxis), and 3) grip strength. Z-scores for each task were derived based on 14-moth-old population performance and summed to create a single composite score. The lower composite score, the better overall sensorimotor performance. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [N] [Z]"
BXD_20941,Metabolism: Blood glucose (mg/dL) measured in 6-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20942,Metabolism: Blood glucose (mg/dL) measured in 14-month-old mice. This data is strain averaged across male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [mg/dL]
BXD_20943,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20944,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20945,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20946,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20947,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20948,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20949,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20950,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20951,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20952,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20953,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 6-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20954,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, baseline freezing - the percentage of the 180s baseline period (prior to any shock onset) spent freezing. Can be used as estimate of baseline anxiety. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20955,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 1 freezing - the percentage of time during the 40s period following the offset of shock #1 spent freezing. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20956,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 2 freezing - the percentage of time during the 40s period following the offset of shock #2 spent freezing. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20957,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 3 freezing - the percentage of time during the 40s period following the offset of shock #3 spent freezing. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20958,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, post-shock 4 freezing - the percentage of time during the 40s period following the offset of shock #4 spent freezing. Can be used as a measured of final contextual fear acquisition. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20959,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 0-2 of contextual fear memory test. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20960,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 2-4 of contextual fear memory test. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20961,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 4-6 of contextual fear memory test. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20962,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 6-8 of contextual fear memory test. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20963,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during minutes 8-10 of contextual fear memory test. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20964,"Central nervous system, behavior, learning and memory: Contextual fear conditioning, percentage of time spent freezing during entire contextual fear memory test. Can be used as a measure of overall contextual fear memory. This data is strain averaged across 14-month-old male non-transgenic littermates from the AD-BXD population (Ntg-BXDs) [%]"
BXD_20965,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_20966,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_20967,"Central nervous system, behavior: Gait performance, motor coordination performance of duty factor (_) between days 60-81 in males and females (BXD15 winsorized from 0.682 to 0.647 by JRS) [unitless]"
BXD_20968,x
BXD_20969,"Central nervous system, behavior: Gait performance, motor coordination performance of body speed (_) between days 60-81 in males and females (BXD15 winsorized from 107.915 to 147.554 by JRS) [mm/s]"
BXD_20970,"	Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_20971,"Central nervous system, behavior: Gait performance, motor coordination performance of stance duration (_) between days 60-81 in males and females (BXD15 winsorized from 0.693 to 0.456 by JRS) [sec]"
BXD_20972,"Central nervous system, behavior: Gait performance, motor coordination performance of swing duration (_) between days 60-81 in males and females (BXD15 winsorized from 0.305 to 0.271 by JRS) [sec]"
BXD_20973,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_20974,N/A
BXD_20975,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_20976,"Cofactor, outlier detection: B6D2F1 as outlier, where B6D2F1 phenotype = 2, all others = 1 [indicator]"
BXD_20977,"Cofactor, outlier detection: D2B6F1 as outlier, where D2B6F1 phenotype = 2, all others = 1 [indicator]"
BXD_20978,"Cofactor, outlier detection: C57BL/6J as outlier, where C57BL/6J phenotype = 2, all others = 1 [indicator]"
BXD_20979,"Cofactor, outlier detection: DBA/2J as outlier, where DBA/2J phenotype = 2, all others = 1 [indicator]"
BXD_20980,"Cofactor, outlier detection: BXD1 as outlier, where BXD1 phenotype = 2, all others = 1 [indicator]"
BXD_20981,"Cofactor, outlier detection: BXD2 as outlier, where BXD2 phenotype = 2, all others = 1 [indicator]"
BXD_20982,"Cofactor, outlier detection: BXD5 as outlier, where BXD5 phenotype = 2, all others = 1 [indicator]"
BXD_20983,"Cofactor, outlier detection: BXD6 as outlier, where BXD6 phenotype = 2, all others = 1 [indicator]"
BXD_20984,"Cofactor, outlier detection: BXD8 as outlier, where BXD8 phenotype = 2, all others = 1 [indicator]"
BXD_20985,"Cofactor, outlier detection: BXD9 as outlier, where BXD9 phenotype = 2, all others = 1 [indicator]"
BXD_20986,"Cofactor, outlier detection: BXD11 as outlier, where BXD11 phenotype = 2, all others = 1 [indicator]"
BXD_20987,"Cofactor, outlier detection: BXD12 as outlier, where BXD12 phenotype = 2, all others = 1 [indicator]"
BXD_20988,"Cofactor, outlier detection: BXD13 as outlier, where BXD13 phenotype = 2, all others = 1 [indicator]"
BXD_20989,"Cofactor, outlier detection: BXD14 as outlier, where BXD14 phenotype = 2, all others = 1 [indicator]"
BXD_20990,"Cofactor, outlier detection: BXD15 as outlier, where BXD15 phenotype = 2, all others = 1 [indicator]"
BXD_20991,"Cofactor, outlier detection: BXD16 as outlier, where BXD16 phenotype = 2, all others = 1 [indicator]"
BXD_20992,"Cofactor, outlier detection: BXD18 as outlier, where BXD18 phenotype = 2, all others = 1 [indicator]"
BXD_20993,"Cofactor, outlier detection: BXD19 as outlier, where BXD19 phenotype = 2, all others = 1 [indicator]"
BXD_20994,"Cofactor, outlier detection: BXD20 as outlier, where BXD20 phenotype = 2, all others = 1 [indicator]"
BXD_20995,"Cofactor, outlier detection: BXD21 as outlier, where BXD21 phenotype = 2, all others = 1 [indicator]"
BXD_20996,"Cofactor, outlier detection: BXD22 as outlier, where BXD22 phenotype = 2, all others = 1 [indicator]"
BXD_20997,"Cofactor, outlier detection: BXD23 as outlier, where BXD23 phenotype = 2, all others = 1 [indicator]"
BXD_20998,"Cofactor, outlier detection: BXD24 as outlier, where BXD24 phenotype = 2, all others = 1 [indicator]"
BXD_20999,"Cofactor, outlier detection: BXD24a as outlier, where BXD24a phenotype = 2, all others = 1 [indicator]"
BXD_21000,"Cofactor, outlier detection: BXD25 as outlier, where BXD25 phenotype = 2, all others = 1 [indicator]"
BXD_21001,"Cofactor, outlier detection: BXD27 as outlier, where BXD27 phenotype = 2, all others = 1 [indicator]"
BXD_21002,"Cofactor, outlier detection: BXD28 as outlier, where BXD28 phenotype = 2, all others = 1 [indicator]"
BXD_21003,"Cofactor, outlier detection: BXD29 as outlier, where BXD29 phenotype = 2, all others = 1 [indicator]"
BXD_21004,"Cofactor, outlier detection: BXD30 as outlier, where BXD30 phenotype = 2, all others = 1 [indicator]"
BXD_21005,"Cofactor, outlier detection: BXD31 as outlier, where BXD31 phenotype = 2, all others = 1 [indicator]"
BXD_21006,"Cofactor, outlier detection: BXD32 as outlier, where BXD32 phenotype = 2, all others = 1 [indicator]"
BXD_21007,"Cofactor, outlier detection: BXD33 as outlier, where BXD33 phenotype = 2, all others = 1 [indicator]"
BXD_21008,"Cofactor, outlier detection: BXD34 as outlier, where BXD34 phenotype = 2, all others = 1 [indicator]"
BXD_21009,"Cofactor, outlier detection: BXD35 as outlier, where BXD35 phenotype = 2, all others = 1 [indicator]"
BXD_21010,"Cofactor, outlier detection: BXD36 as outlier, where BXD36 phenotype = 2, all others = 1 [indicator]"
BXD_21011,"Cofactor, outlier detection: BXD37 as outlier, where BXD37 phenotype = 2, all others = 1 [indicator]"
BXD_21012,"Cofactor, outlier detection: BXD38 as outlier, where BXD38 phenotype = 2, all others = 1 [indicator]"
BXD_21013,"Cofactor, outlier detection: BXD39 as outlier, where BXD39 phenotype = 2, all others = 1 [indicator]"
BXD_21014,"Cofactor, outlier detection: BXD40 as outlier, where BXD40 phenotype = 2, all others = 1 [indicator]"
BXD_21015,"Cofactor, outlier detection: BXD41 as outlier, where BXD41 phenotype = 2, all others = 1 [indicator]"
BXD_21016,"Cofactor, outlier detection: BXD42 as outlier, where BXD42 phenotype = 2, all others = 1 [indicator]"
BXD_21017,"Cofactor, outlier detection: BXD43 as outlier, where BXD43 phenotype = 2, all others = 1 [indicator]"
BXD_21018,"Cofactor, outlier detection: BXD44 as outlier, where BXD44 phenotype = 2, all others = 1 [indicator]"
BXD_21019,"Cofactor, outlier detection: BXD45 as outlier, where BXD45 phenotype = 2, all others = 1 [indicator]"
BXD_21020,"Cofactor, outlier detection: BXD48 as outlier, where BXD48 phenotype = 2, all others = 1 [indicator]"
BXD_21021,"Cofactor, outlier detection: BXD48a as outlier, where BXD48a phenotype = 2, all others = 1 [indicator]"
BXD_21022,"Cofactor, outlier detection: BXD49 as outlier, where BXD49 phenotype = 2, all others = 1 [indicator]"
BXD_21023,"Cofactor, outlier detection: BXD50 as outlier, where BXD50 phenotype = 2, all others = 1 [indicator]"
BXD_21024,"Cofactor, outlier detection: BXD51 as outlier, where BXD51 phenotype = 2, all others = 1 [indicator]"
BXD_21025,"Cofactor, outlier detection: BXD52 as outlier, where BXD52 phenotype = 2, all others = 1 [indicator]"
BXD_21026,"Cofactor, outlier detection: BXD53 as outlier, where BXD53 phenotype = 2, all others = 1 [indicator]"
BXD_21027,"Cofactor, outlier detection: BXD54 as outlier, where BXD54 phenotype = 2, all others = 1 [indicator]"
BXD_21028,"Cofactor, outlier detection: BXD55 as outlier, where BXD55 phenotype = 2, all others = 1 [indicator]"
BXD_21029,"Cofactor, outlier detection: BXD56 as outlier, where BXD56 phenotype = 2, all others = 1 [indicator]"
BXD_21030,"Cofactor, outlier detection: BXD59 as outlier, where BXD59 phenotype = 2, all others = 1 [indicator]"
BXD_21031,"Cofactor, outlier detection: BXD60 as outlier, where BXD60 phenotype = 2, all others = 1 [indicator]"
BXD_21032,"Cofactor, outlier detection: BXD61 as outlier, where BXD61 phenotype = 2, all others = 1 [indicator]"
BXD_21033,"Cofactor, outlier detection: BXD62 as outlier, where BXD62 phenotype = 2, all others = 1 [indicator]"
BXD_21034,"Cofactor, outlier detection: BXD63 as outlier, where BXD63 phenotype = 2, all others = 1 [indicator]"
BXD_21035,"Cofactor, outlier detection: BXD64 as outlier, where BXD64 phenotype = 2, all others = 1 [indicator]"
BXD_21036,"Cofactor, outlier detection: BXD65 as outlier, where BXD65 phenotype = 2, all others = 1 [indicator]"
BXD_21037,"Cofactor, outlier detection: BXD65a as outlier, where BXD65a phenotype = 2, all others = 1 [indicator]"
BXD_21038,"Cofactor, outlier detection: BXD65b as outlier, where BXD65b phenotype = 2, all others = 1 [indicator]"
BXD_21039,"Cofactor, outlier detection: BXD66 as outlier, where BXD66 phenotype = 2, all others = 1 [indicator]"
BXD_21040,"Cofactor, outlier detection: BXD67 as outlier, where BXD67 phenotype = 2, all others = 1 [indicator]"
BXD_21041,"Cofactor, outlier detection: BXD68 as outlier, where BXD68 phenotype = 2, all others = 1 [indicator]"
BXD_21042,"Cofactor, outlier detection: BXD69 as outlier, where BXD69 phenotype = 2, all others = 1 [indicator]"
BXD_21043,"Cofactor, outlier detection: BXD70 as outlier, where BXD70 phenotype = 2, all others = 1 [indicator]"
BXD_21044,"Cofactor, outlier detection: BXD71 as outlier, where BXD71 phenotype = 2, all others = 1 [indicator]"
BXD_21045,"Cofactor, outlier detection: BXD72 as outlier, where BXD72 phenotype = 2, all others = 1 [indicator]"
BXD_21046,"Cofactor, outlier detection: BXD73 as outlier, where BXD73 phenotype = 2, all others = 1 [indicator]"
BXD_21047,"Cofactor, outlier detection: BXD73a as outlier, where BXD73a phenotype = 2, all others = 1 [indicator]"
BXD_21048,"Cofactor, outlier detection: BXD73b as outlier, where BXD73b phenotype = 2, all others = 1 [indicator]"
BXD_21049,"Cofactor, outlier detection: BXD74 as outlier, where BXD74 phenotype = 2, all others = 1 [indicator]"
BXD_21050,"Cofactor, outlier detection: BXD75 as outlier, where BXD75 phenotype = 2, all others = 1 [indicator]"
BXD_21051,"Cofactor, outlier detection: BXD76 as outlier, where BXD76 phenotype = 2, all others = 1 [indicator]"
BXD_21052,"Cofactor, outlier detection: BXD77 as outlier, where BXD77 phenotype = 2, all others = 1 [indicator]"
BXD_21053,"Cofactor, outlier detection: BXD78 as outlier, where BXD78 phenotype = 2, all others = 1 [indicator]"
BXD_21054,"Cofactor, outlier detection: BXD79 as outlier, where BXD79 phenotype = 2, all others = 1 [indicator]"
BXD_21055,"Cofactor, outlier detection: BXD81 as outlier, where BXD81 phenotype = 2, all others = 1 [indicator]"
BXD_21056,"Cofactor, outlier detection: BXD83 as outlier, where BXD83 phenotype = 2, all others = 1 [indicator]"
BXD_21057,"Cofactor, outlier detection: BXD84 as outlier, where BXD84 phenotype = 2, all others = 1 [indicator]"
BXD_21058,"Cofactor, outlier detection: BXD85 as outlier, where BXD85 phenotype = 2, all others = 1 [indicator]"
BXD_21059,"Cofactor, outlier detection: BXD86 as outlier, where BXD86 phenotype = 2, all others = 1 [indicator]"
BXD_21060,"Cofactor, outlier detection: BXD87 as outlier, where BXD87 phenotype = 2, all others = 1 [indicator]"
BXD_21061,"Cofactor, outlier detection: BXD88 as outlier, where BXD88 phenotype = 2, all others = 1 [indicator]"
BXD_21062,"Cofactor, outlier detection: BXD89 as outlier, where BXD89 phenotype = 2, all others = 1 [indicator]"
BXD_21063,"Cofactor, outlier detection: BXD90 as outlier, where BXD90 phenotype = 2, all others = 1 [indicator]"
BXD_21064,"Cofactor, outlier detection: BXD91 as outlier, where BXD91 phenotype = 2, all others = 1 [indicator]"
BXD_21065,"Cofactor, outlier detection: BXD93 as outlier, where BXD93 phenotype = 2, all others = 1 [indicator]"
BXD_21066,"Cofactor, outlier detection: BXD94 as outlier, where BXD94 phenotype = 2, all others = 1 [indicator]"
BXD_21067,"Cofactor, outlier detection: BXD95 as outlier, where BXD95 phenotype = 2, all others = 1 [indicator]"
BXD_21068,"Cofactor, outlier detection: BXD98 as outlier, where BXD98 phenotype = 2, all others = 1 [indicator]"
BXD_21069,"Cofactor, outlier detection: BXD99 as outlier, where BXD99 phenotype = 2, all others = 1 [indicator]"
BXD_21070,"Cofactor, outlier detection: BXD100 as outlier, where BXD100 phenotype = 2, all others = 1 [indicator]"
BXD_21071,"Cofactor, outlier detection: BXD101 as outlier, where BXD101 phenotype = 2, all others = 1 [indicator]"
BXD_21072,"Cofactor, outlier detection: BXD102 as outlier, where BXD102 phenotype = 2, all others = 1 [indicator]"
BXD_21073,"Cofactor, outlier detection: BXD104 as outlier, where BXD104 phenotype = 2, all others = 1 [indicator]"
BXD_21074,"Cofactor, outlier detection: BXD105 as outlier, where BXD105 phenotype = 2, all others = 1 [indicator]"
BXD_21075,"Cofactor, outlier detection: BXD106 as outlier, where BXD106 phenotype = 2, all others = 1 [indicator]"
BXD_21076,"Cofactor, outlier detection: BXD107 as outlier, where BXD107 phenotype = 2, all others = 1 [indicator]"
BXD_21077,"Cofactor, outlier detection: BXD108 as outlier, where BXD108 phenotype = 2, all others = 1 [indicator]"
BXD_21078,"Cofactor, outlier detection: BXD109 as outlier, where BXD109 phenotype = 2, all others = 1 [indicator]"
BXD_21079,"Cofactor, outlier detection: BXD110 as outlier, where BXD110 phenotype = 2, all others = 1 [indicator]"
BXD_21080,"Cofactor, outlier detection: BXD111 as outlier, where BXD111 phenotype = 2, all others = 1 [indicator]"
BXD_21081,"Cofactor, outlier detection: BXD112 as outlier, where BXD112 phenotype = 2, all others = 1 [indicator]"
BXD_21082,"Cofactor, outlier detection: BXD113 as outlier, where BXD113 phenotype = 2, all others = 1 [indicator]"
BXD_21083,"Cofactor, outlier detection: BXD114 as outlier, where BXD114 phenotype = 2, all others = 1 [indicator]"
BXD_21084,"Cofactor, outlier detection: BXD115 as outlier, where BXD115 phenotype = 2, all others = 1 [indicator]"
BXD_21085,"Cofactor, outlier detection: BXD116 as outlier, where BXD116 phenotype = 2, all others = 1 [indicator]"
BXD_21086,"Cofactor, outlier detection: BXD117 as outlier, where BXD117 phenotype = 2, all others = 1 [indicator]"
BXD_21087,"Cofactor, outlier detection: BXD119 as outlier, where BXD119 phenotype = 2, all others = 1 [indicator]"
BXD_21088,"Cofactor, outlier detection: BXD120 as outlier, where BXD120 phenotype = 2, all others = 1 [indicator]"
BXD_21089,"Cofactor, outlier detection: BXD121 as outlier, where BXD121 phenotype = 2, all others = 1 [indicator]"
BXD_21090,"Cofactor, outlier detection: BXD122 as outlier, where BXD122 phenotype = 2, all others = 1 [indicator]"
BXD_21091,"Cofactor, outlier detection: BXD123 as outlier, where BXD123 phenotype = 2, all others = 1 [indicator]"
BXD_21092,"Cofactor, outlier detection: BXD124 as outlier, where BXD124 phenotype = 2, all others = 1 [indicator]"
BXD_21093,"Cofactor, outlier detection: BXD125 as outlier, where BXD125 phenotype = 2, all others = 1 [indicator]"
BXD_21094,"Cofactor, outlier detection: BXD126 as outlier, where BXD126 phenotype = 2, all others = 1 [indicator]"
BXD_21095,"Cofactor, outlier detection: BXD127 as outlier, where BXD127 phenotype = 2, all others = 1 [indicator]"
BXD_21096,"Cofactor, outlier detection: BXD128 as outlier, where BXD128 phenotype = 2, all others = 1 [indicator]"
BXD_21097,"Cofactor, outlier detection: BXD128a as outlier, where BXD128a phenotype = 2, all others = 1 [indicator]"
BXD_21098,"Cofactor, outlier detection: BXD130 as outlier, where BXD130 phenotype = 2, all others = 1 [indicator]"
BXD_21099,"Cofactor, outlier detection: BXD131 as outlier, where BXD131 phenotype = 2, all others = 1 [indicator]"
BXD_21100,"Cofactor, outlier detection: BXD132 as outlier, where BXD132 phenotype = 2, all others = 1 [indicator]"
BXD_21101,"Cofactor, outlier detection: BXD133 as outlier, where BXD133 phenotype = 2, all others = 1 [indicator]"
BXD_21102,"Cofactor, outlier detection: BXD134 as outlier, where BXD134 phenotype = 2, all others = 1 [indicator]"
BXD_21103,"Cofactor, outlier detection: BXD135 as outlier, where BXD135 phenotype = 2, all others = 1 [indicator]"
BXD_21104,"Cofactor, outlier detection: BXD136 as outlier, where BXD136 phenotype = 2, all others = 1 [indicator]"
BXD_21105,"Cofactor, outlier detection: BXD137 as outlier, where BXD137 phenotype = 2, all others = 1 [indicator]"
BXD_21106,"Cofactor, outlier detection: BXD138 as outlier, where BXD138 phenotype = 2, all others = 1 [indicator]"
BXD_21107,"Cofactor, outlier detection: BXD139 as outlier, where BXD139 phenotype = 2, all others = 1 [indicator]"
BXD_21108,"Cofactor, outlier detection: BXD141 as outlier, where BXD141 phenotype = 2, all others = 1 [indicator]"
BXD_21109,"Cofactor, outlier detection: BXD142 as outlier, where BXD142 phenotype = 2, all others = 1 [indicator]"
BXD_21110,"Cofactor, outlier detection: BXD144 as outlier, where BXD144 phenotype = 2, all others = 1 [indicator]"
BXD_21111,"Cofactor, outlier detection: BXD145 as outlier, where BXD145 phenotype = 2, all others = 1 [indicator]"
BXD_21112,"Cofactor, outlier detection: BXD146 as outlier, where BXD146 phenotype = 2, all others = 1 [indicator]"
BXD_21113,"Cofactor, outlier detection: BXD147 as outlier, where BXD147 phenotype = 2, all others = 1 [indicator]"
BXD_21114,"Cofactor, outlier detection: BXD148 as outlier, where BXD148 phenotype = 2, all others = 1 [indicator]"
BXD_21115,"Cofactor, outlier detection: BXD149 as outlier, where BXD149 phenotype = 2, all others = 1 [indicator]"
BXD_21116,"Cofactor, outlier detection: BXD150 as outlier, where BXD150 phenotype = 2, all others = 1 [indicator]"
BXD_21117,"Cofactor, outlier detection: BXD151 as outlier, where BXD151 phenotype = 2, all others = 1 [indicator]"
BXD_21118,"Cofactor, outlier detection: BXD152 as outlier, where BXD152 phenotype = 2, all others = 1 [indicator]"
BXD_21119,"Cofactor, outlier detection: BXD153 as outlier, where BXD153 phenotype = 2, all others = 1 [indicator]"
BXD_21120,"Cofactor, outlier detection: BXD154 as outlier, where BXD154 phenotype = 2, all others = 1 [indicator]"
BXD_21121,"Cofactor, outlier detection: BXD155 as outlier, where BXD155 phenotype = 2, all others = 1 [indicator]"
BXD_21122,"Cofactor, outlier detection: BXD156 as outlier, where BXD156 phenotype = 2, all others = 1 [indicator]"
BXD_21123,"Cofactor, outlier detection: BXD157 as outlier, where BXD157 phenotype = 2, all others = 1 [indicator]"
BXD_21124,"Cofactor, outlier detection: BXD160 as outlier, where BXD160 phenotype = 2, all others = 1 [indicator]"
BXD_21125,"Cofactor, outlier detection: BXD161 as outlier, where BXD161 phenotype = 2, all others = 1 [indicator]"
BXD_21126,"Cofactor, outlier detection: BXD162 as outlier, where BXD162 phenotype = 2, all others = 1 [indicator]"
BXD_21127,"Cofactor, outlier detection: BXD165 as outlier, where BXD165 phenotype = 2, all others = 1 [indicator]"
BXD_21128,"Cofactor, outlier detection: BXD168 as outlier, where BXD168 phenotype = 2, all others = 1 [indicator]"
BXD_21129,"Cofactor, outlier detection: BXD169 as outlier, where BXD169 phenotype = 2, all others = 1 [indicator]"
BXD_21130,"Cofactor, outlier detection: BXD170 as outlier, where BXD170 phenotype = 2, all others = 1 [indicator]"
BXD_21131,"Cofactor, outlier detection: BXD171 as outlier, where BXD171 phenotype = 2, all others = 1 [indicator]"
BXD_21132,"Cofactor, outlier detection: BXD172 as outlier, where BXD172 phenotype = 2, all others = 1 [indicator]"
BXD_21133,"Cofactor, outlier detection: BXD173 as outlier, where BXD173 phenotype = 2, all others = 1 [indicator]"
BXD_21134,"Cofactor, outlier detection: BXD174 as outlier, where BXD174 phenotype = 2, all others = 1 [indicator]"
BXD_21135,"Cofactor, outlier detection: BXD175 as outlier, where BXD175 phenotype = 2, all others = 1 [indicator]"
BXD_21136,"Cofactor, outlier detection: BXD176 as outlier, where BXD176 phenotype = 2, all others = 1 [indicator]"
BXD_21137,"Cofactor, outlier detection: BXD177 as outlier, where BXD177 phenotype = 2, all others = 1 [indicator]"
BXD_21138,"Cofactor, outlier detection: BXD178 as outlier, where BXD178 phenotype = 2, all others = 1 [indicator]"
BXD_21139,"Cofactor, outlier detection: BXD180 as outlier, where BXD180 phenotype = 2, all others = 1 [indicator]"
BXD_21140,"Cofactor, outlier detection: BXD181 as outlier, where BXD181 phenotype = 2, all others = 1 [indicator]"
BXD_21141,"Cofactor, outlier detection: BXD183 as outlier, where BXD183 phenotype = 2, all others = 1 [indicator]"
BXD_21142,"Cofactor, outlier detection: BXD184 as outlier, where BXD184 phenotype = 2, all others = 1 [indicator]"
BXD_21143,"Cofactor, outlier detection: BXD186 as outlier, where BXD186 phenotype = 2, all others = 1 [indicator]"
BXD_21144,"Cofactor, outlier detection: BXD187 as outlier, where BXD187 phenotype = 2, all others = 1 [indicator]"
BXD_21145,"Cofactor, outlier detection: BXD188 as outlier, where BXD188 phenotype = 2, all others = 1 [indicator]"
BXD_21146,"Cofactor, outlier detection: BXD189 as outlier, where BXD189 phenotype = 2, all others = 1 [indicator]"
BXD_21147,"Cofactor, outlier detection: BXD190 as outlier, where BXD190 phenotype = 2, all others = 1 [indicator]"
BXD_21148,"Cofactor, outlier detection: BXD191 as outlier, where BXD191 phenotype = 2, all others = 1 [indicator]"
BXD_21149,"Cofactor, outlier detection: BXD192 as outlier, where BXD192 phenotype = 2, all others = 1 [indicator]"
BXD_21150,"Cofactor, outlier detection: BXD193 as outlier, where BXD193 phenotype = 2, all others = 1 [indicator]"
BXD_21151,"Cofactor, outlier detection: BXD194 as outlier, where BXD194 phenotype = 2, all others = 1 [indicator]"
BXD_21152,"Cofactor, outlier detection: BXD195 as outlier, where BXD195 phenotype = 2, all others = 1 [indicator]"
BXD_21153,"Cofactor, outlier detection: BXD196 as outlier, where BXD196 phenotype = 2, all others = 1 [indicator]"
BXD_21154,"Cofactor, outlier detection: BXD197 as outlier, where BXD197 phenotype = 2, all others = 1 [indicator]"
BXD_21155,"Cofactor, outlier detection: BXD198 as outlier, where BXD198 phenotype = 2, all others = 1 [indicator]"
BXD_21156,"Cofactor, outlier detection: BXD199 as outlier, where BXD199 phenotype = 2, all others = 1 [indicator]"
BXD_21157,"Cofactor, outlier detection: BXD200 as outlier, where BXD200 phenotype = 2, all others = 1 [indicator]"
BXD_21158,"Cofactor, outlier detection: BXD201 as outlier, where BXD201 phenotype = 2, all others = 1 [indicator]"
BXD_21159,"Cofactor, outlier detection: BXD202 as outlier, where BXD202 phenotype = 2, all others = 1 [indicator]"
BXD_21160,"Cofactor, outlier detection: BXD203 as outlier, where BXD203 phenotype = 2, all others = 1 [indicator]"
BXD_21161,"Cofactor, outlier detection: BXD204 as outlier, where BXD204 phenotype = 2, all others = 1 [indicator]"
BXD_21162,"Cofactor, outlier detection: BXD205 as outlier, where BXD205 phenotype = 2, all others = 1 [indicator]"
BXD_21163,"Cofactor, outlier detection: BXD206 as outlier, where BXD206 phenotype = 2, all others = 1 [indicator]"
BXD_21164,"Cofactor, outlier detection: BXD207 as outlier, where BXD207 phenotype = 2, all others = 1 [indicator]"
BXD_21165,"Cofactor, outlier detection: BXD208 as outlier, where BXD208 phenotype = 2, all others = 1 [indicator]"
BXD_21166,"Cofactor, outlier detection: BXD209 as outlier, where BXD209 phenotype = 2, all others = 1 [indicator]"
BXD_21167,"Cofactor, outlier detection: BXD210 as outlier, where BXD210 phenotype = 2, all others = 1 [indicator]"
BXD_21168,"Cofactor, outlier detection: BXD211 as outlier, where BXD211 phenotype = 2, all others = 1 [indicator]"
BXD_21169,"Cofactor, outlier detection: BXD212 as outlier, where BXD212 phenotype = 2, all others = 1 [indicator]"
BXD_21170,"Cofactor, outlier detection: BXD213 as outlier, where BXD213 phenotype = 2, all others = 1 [indicator]"
BXD_21171,"Cofactor, outlier detection: BXD214 as outlier, where BXD214 phenotype = 2, all others = 1 [indicator]"
BXD_21172,"Cofactor, outlier detection: BXD215 as outlier, where BXD215 phenotype = 2, all others = 1 [indicator]"
BXD_21173,"Cofactor, outlier detection: BXD216 as outlier, where BXD216 phenotype = 2, all others = 1 [indicator]"
BXD_21174,"Cofactor, outlier detection: BXD217 as outlier, where BXD217 phenotype = 2, all others = 1 [indicator]"
BXD_21175,"Cofactor, outlier detection: BXD218 as outlier, where BXD218 phenotype = 2, all others = 1 [indicator]"
BXD_21176,"Cofactor, outlier detection: BXD219 as outlier, where BXD219 phenotype = 2, all others = 1 [indicator]"
BXD_21177,"Cofactor, outlier detection: BXD220 as outlier, where BXD220 phenotype = 2, all others = 1 [indicator]"
BXD_21178,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21179,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21180,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21181,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression in control (tap water, CTL) young (2-4 months) females, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21182,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21183,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21184,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21185,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21186,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) females, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21187,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression in control (tap water, CTL) young (2-4 months) males, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21188,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21189,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21190,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (200mg%) in drinking water (Cort+DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21191,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21192,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21193,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21194,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21195,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 concentration]"
BXD_21196,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21197,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) females, after Natural Logarithm (ln) transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21198,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21199,"Central nervous system, pharmacology, endocrinology: Interleukin 1 beta expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21200,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 concentration]"
BXD_21201,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21202,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 1 beta gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21203,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression in control (tap water, CTL) young (2-4 months) females, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21204,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21205,"Central nervous system, pharmacology, endocrinology: Interleukin 6 expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21206,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21207,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21208,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) females, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21209,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression in control (tap water, CTL) young (2-4 months) males, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21210,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21211,"Central nervous system, pharmacology, endocrinology: Interleukin 6 expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21212,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21213,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21214,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21215,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21216,"Central nervous system, pharmacology, endocrinology: Interleukin 6 expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21217,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21218,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21219,"Central nervous system, pharmacology, endocrinology: Fold change of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone in drinking water (20mg%, Cort+DFP)) in  (2-4 month) females, after LOG2 transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21220,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21221,"Central nervous system, pharmacology, endocrinology: Interleukin 6 expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21222,"Central nervous system, pharmacology, endocrinology: Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21223,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21224,"Central nervous system, pharmacology, endocrinology: Fold changes of Interleukin 6 gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21225,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression in control (tap water, CTL) young (2-4 months) females, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21226,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21227,"Central nervous system, pharmacology, endocrinology: TNF-alpha expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21228,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) females, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21229,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21230,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) females, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21231,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression in control (tap water, CTL) young (2-4 months) males, measured by qrtPCR [Î”CT (VS CT of GAPDH)]"
BXD_21232,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21233,"Central nervous system, pharmacology, endocrinology: TNF-alpha expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21234,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%) in drinking water (Cort+DFP) in young (2-4 months) males, fold change [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21235,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, fold change ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21236,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, fold change ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21237,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21238,"Central nervous system, pharmacology, endocrinology: TNF-alpha expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) females, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21239,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor Necrosis Factor alpha (TNFa) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP) treatment (4 mg/kg i.p.) and 7 days of corticosterone (20 mg%) in drinking water (Cort+DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 concentration]"
BXD_21240,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) females, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21241,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) females, after Natural Logarithm (ln) transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21242,"Central nervous system, pharmacology, endocrinology: TNF-alpha gene expression following corticosterone treatment (20 mg% in drinking water for 7 days, Cort) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21243,"Central nervous system, pharmacology, endocrinology: TNF-alpha expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p., DFP) in young (2-4 months) males, fold change after Natural Logarithm (ln) transformation [VS CTL calculated on Î”Î”CT], measured by qrtPCR"
BXD_21244,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor alpha (TNF a) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 concentration]"
BXD_21245,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of corticosterone treatment (20 mg% in drinking water for 7 days, Cort)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS Cort calculated on Î”Î”CT), measured by qrtPCR"
BXD_21246,"Central nervous system, pharmacology, endocrinology: Fold changes of TNF-alpha gene expression 6h following diisopropylflurophosphate treatment (4 mg/kg i.p.) and 7 days of corticosterone (20mg%, Cort+DFP)) vs the expression of diisopropylflurophosphate treatment (4 mg/kg i.p., DFP)in young (2-4 months) males, after Natural Logarithm (ln) transformation ((Cort+DFP) VS DFP calculated on Î”Î”CT), measured by qrtPCR"
BXD_21247,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21248,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca
"
BXD_21249,none
BXD_21265,F_Mean_mg_kg
BXD_21266,F_mg_kg1_1
BXD_21267,F_mg_kg1_2
BXD_21268,F_mg_kg1_3
BXD_21269,F_mg_kg1_4
BXD_21270,F_mg_kg1_5
BXD_21271,F_mg_kg1_6
BXD_21272,F_mg_kg1_7
BXD_21273,M_Mean_mg_kg
BXD_21274,M_mg_kg1_1
BXD_21275,M_mg_kg1_2
BXD_21276,M_mg_kg1_3
BXD_21277,M_mg_kg1_4
BXD_21278,M_mg_kg1_5
BXD_21279,M_mg_kg1_6
BXD_21280,M_mg_kg1_7
BXD_21281,CMS_BW_at_sac
BXD_21282,NH_BW_at_sac
BXD_21283,CMS_Adrenal_W
BXD_21284,CMS_Prefrontal_Cortex_W
BXD_21285,CMS_Hippocampus_W
BXD_21286,CMS_Hypothalamus_W
BXD_21287,CMS_Pituitary_glandtary_W
BXD_21288,CMS_Thymus_W
BXD_21289,CMS_Heart_W
BXD_21290,NH_Heart_W
BXD_21291,CMS_HW_BW
BXD_21292,NH_HW_BW
BXD_21293,CMS_Adrenal_W_1000_BW
BXD_21294,CMS_Prefrontal_Cortex_W_1000_BW
BXD_21295,CMS_Hippocampus_W_1000_BW
BXD_21296,CMS_Hypotalamus_W_1000_BW
BXD_21297,CMS_Pituitary_gland_W_1000_BW
BXD_21298,CMS_Thymus_W_1000_BW
BXD_21299,CMS_Plasma_Corticosterone
BXD_21300,CMS_Sacrifie_Age
BXD_21301,NH_Sacrifie_Age
BXD_21302,"Aging, metabolism: Median life span difference, longevity of females at UTHSC on normal low fat chow diet minus unhealthy high fat diet (see parent traits 19452 and 19451, updated August 2020) [days]"
BXD_21303,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21304,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21305,"Central nervous system, auditory system, hearing: Hearing loss evaluated by auditory brainstem response threshold at 16 kHz (Fig 2A, ahl8 locus) [dB SPL]"
BXD_21307,Contrast1.Stress.Dif.2H
BXD_21308,Contrast1.Control.Dif.2H
BXD_21309,Contrast1.Stress.Dif.4H
BXD_21310,Contrast1.Control.Dif.4H
BXD_21311,Contrast2.Stress.Dif.2H
BXD_21312,Contrast2.Stress.Dif.4H
BXD_21313,Contrast2.Control.Dif.2H
BXD_21314,Contrast2.Control.Dif.4H
BXD_21315,Comparison1.2H
BXD_21316,Comparison1.4H
BXD_21317,Comparison2.2H
BXD_21318,Comparison2.4H
BXD_21319,BW_Female_all_age
BXD_21320,HW_BW_Female_all_age
BXD_21321,HW_Raw_Female_all_age
BXD_21322,HW_Adjusted_Female_all_age
BXD_21323,BW_Male_all_age
BXD_21324,HW_BW_Male_all_age
BXD_21325,HW_Raw_Male_all_age
BXD_21326,HW_Adjusted_Male_all_age
BXD_21327,BW_Female_Male_all_age
BXD_21328,HW_BW_Female_Male_all_age
BXD_21329,HW_Raw_Female_Male_all_age
BXD_21330,HW_Adjusted_Female_Male_all_age
BXD_21331,BW_Female_less_than_2_months
BXD_21332,HW_BW_Female_less_than_2_months
BXD_21333,Cardiovascular system: HW Raw Female less than 2 months
BXD_21334,HW_Adjusted_Female_less_than_2_months
BXD_21335,BW_Male_less_than_2_months
BXD_21336,HW_BW_Male_less_than_2_months
BXD_21337,HW_Raw_Male_less_than_2_months
BXD_21338,HW_Adjusted_Male_less_than_2_months
BXD_21339,BW_Female_Male_less_than_2_months
BXD_21340,HW_BW_Female_Male_less_than_2_months
BXD_21341,HW_Raw_Female_Male_less_than_2_months
BXD_21342,HW_Adjusted_Female_Male_less_than_2_months
BXD_21343,BW_Female_2_3_months
BXD_21344,HW_BW_Female_2_3_months
BXD_21345,HW_Raw_Female_2_3_months
BXD_21346,HW_Adjusted_Female_2_3_months
BXD_21347,BW_Male_2_3_months
BXD_21348,HW_BW_Male_2_3_months
BXD_21349,HW_Raw_Male_2_3_months
BXD_21350,HW_Adjusted_Male_2_3_months
BXD_21351,BW_Female_Male_2_3_months
BXD_21352,HW_BW_Female_Male_2_3_months
BXD_21353,HW_Raw_Female_Male_2_3_months
BXD_21354,HW_Adjusted_Female_Male_2_3_months
BXD_21355,BW_Female_3_8_months
BXD_21356,HW_BW_Female_3_8_months
BXD_21357,HW_Raw_Female_3_8_months
BXD_21358,HW_Adjusted_Female_3_8_months
BXD_21359,BW_Male_3_8_months
BXD_21360,HW_BW_Male_3_8_months
BXD_21361,HW_Raw_Male_3_8_months
BXD_21362,HW_Adjusted_Male_3_8_months
BXD_21363,BW_Female_Male_3_8_months
BXD_21364,HW_BW_Female_Male_3_8_months
BXD_21365,"Cardiovascular system: Heart mass (female and male combined) at  3 to 8 months of age (not adjusted for age or body weight) at UTHSC on standard chow diet (Harlan Teklad 2018 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), January 2019 [g]"
BXD_21366,"Cardiovascular system: Heart mass (female and male combined) from 3 to 8 months of age adjusted for age and body weight at UTHSC on standard chow diet (Harlan Teklad 2018 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), January 2019 [g]"
BXD_21367,BW_Female_6_16_months
BXD_21368,HW_BW_Female_6_16_months
BXD_21369,HW_Raw_Female_6_16_months
BXD_21370,HW_Adjusted_Female_6_16_months
BXD_21371,BW_Male_6_16_months
BXD_21372,HW_BW_Male_6_16_months
BXD_21373,HW_Raw_Male_6_16_months
BXD_21374,HW_Adjusted_Male_6_16_months
BXD_21375,BW_Female_Male_6_16_months
BXD_21376,HW_BW_Female_Male_6_16_months
BXD_21377,HW_Raw_Female_Male_6_16_months
BXD_21378,HW_Adjusted_Female_Male_6_16_months
BXD_21379,BW_Female_16_months_and_older
BXD_21380,HW_BW_Female_16_months_and_older
BXD_21381,HW_Raw_Female_16_months_and_older
BXD_21382,HW_Adjusted_Female_16_months_and_older
BXD_21383,BW_Male_16_months_and_older
BXD_21384,HW_BW_Male_16_months_and_older
BXD_21385,HW_Raw_Male_16_months_and_older
BXD_21386,HW_Adjusted_Male_16_months_and_older
BXD_21387,BW_Female_Male_16_months_and_older
BXD_21388,HW_BW_Female_Male_16_months_and_older
BXD_21389,HW_Raw_Female_Male_16_months_and_older
BXD_21390,HW_Adjusted_Female_Male_16_months_and_older
BXD_21391,"Cardiovascular system, nutrition, toxicology: Iron level in heart of males and females (all ages, uncorrected from 20 to 650-days) fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively (data updated 17Jun2020) [ug/g]"
BXD_21392,"Cardiovascular system, nutrition, toxicology: Copper level in heart of 20 to 650-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively (Updated) [ug/g]"
BXD_21393,"Cardiovascular system, nutrition, toxicology: Zinc level in heart of 20 to 650-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively (Updated) [ug/g]"
BXD_21394,"Cardiovascular system, nutrition, toxicology: Iron level in heart of 20 to 650-day-old males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21395,"Cardiovascular system, nutrition, toxicology: Copper level in heart of 20 to 650-day-old males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21396,"Cardiovascular system, nutrition, toxicology: Zinc level in heart of 20 to 650-day-old males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21397,"Cardiovascular system, nutrition, toxicology: Iron level in heart of 20 to 650-day-old females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively (Updated) [ug/g]"
BXD_21398,"Cardiovascular system, nutrition, toxicology: Copper level in heart of 20 to 650-day-old females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated)  [ug/g]"
BXD_21399,"Cardiovascular system, nutrition, toxicology: Zinc level in heart of 20 to 650-day-old females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21400,"Cardiovascular system, nutrition, toxicology: Iron concentration in heart of 20 to 240-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively [ug/g]"
BXD_21401,"Cardiovascular system, nutrition, toxicology: Copper concentration in heart of 20 to 240-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively (Updated) [ug/g]"
BXD_21402,"Cardiovascular system, nutrition, toxicology: Zinc concentration in heart of 20 to 240 to day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21403,"Cardiovascular system, nutrition, toxicology: Iron concentration in heart of ï¼žï¼240-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21404,"Cardiovascular system, nutrition, toxicology: Copper concentration in heart of ï¼žï¼240-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21405,"Cardiovascular system, nutrition, toxicology: Zinc concentration in heart of ï¼žï¼240-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively (Updated) [ug/g]"
BXD_21406,"Cofactor, genetics, reproduction: Generation number (filial generations) per year over 20 to 40 years of breeding history at the Jackson Laboratory or University of Tennessee Health Science Center (BXD1 to BXD32 averaged over 40 y, BXD24 only used the Cep190 mutant substrain, BXD33 to BXD42 over 20 y, BXD43 to BXD103 over 15 y) [F/year]"
BXD_21407,x
BXD_21408,"Central nervous system, behavior: Gait performance, motor coordination performance of leg combination (_) between days 60-81 in males and females [%]"
BXD_21409,"Eye, morphology, visual system: Eye weight minus lens weight, corrected for variance associated with sex and age (normalized to values of 75-day-old 22 gm female mouse, data for subset of 122 cases and 28 strains) [mg]"
BXD_21410,"Central nervous system, behavior: Gait performance, motor coordination performance of posterior extreme position (_) between days 60-81 in males and females (BXD15 winsorized from 0.054 to 0.037 by JRS) [body units]"
BXD_21411,"Infectious disease, immune system: Respiratory syncytial virus (RSV) log transformed qPCR expression level 4 days after intranasal infection at 5 days of age with 2x10^5 TCID50/g in both sexes [log(2) viral NS1 expression]"
BXD_21412,Iron concentration in VMB difference between PQ (10 mg/kg) treated mice and control mice [Âµg/g]   
BXD_21413,Iron concentration in VMB difference between PQ (5 mg/kg) treated mice and control mice [Âµg/g]   
BXD_21414,Copper concentration in VMB difference between PQ (1 mg/kg) treated mice and control mice [Âµg/g]   
BXD_21415,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21416,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21417,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21418,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21419,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21420,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21421,"Central nervous System, behavior; Goldowitz lab Traits; Contact -jeffyrajans@cmmt.ubc.ca"
BXD_21422,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21423,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21424,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21425,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21426,x
BXD_21427,"Central nervous system, behavior: Gait performance, motor coordination performance of step cycle (duration of heel strike of one paw and continues until the heel strike of the same paw in preparation for the next step) between days 60-81 in males and females (BXD15 winsorized from 1.014 to 0.716 by JRS) [sec]"
BXD_21428,x
BXD_21429,x
BXD_21430,Iron (Fe) level in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1 mg/kg i. p.) and control mice [Âµg/g]
BXD_21431,Copper concentration in VMB difference between PQ (5 mg/kg) treated mice and control mice [Âµg/g]
BXD_21432,Copper concentration in VMB difference between PQ (10 mg/kg) treated mice and control mice [Âµg/g]
BXD_21433,Zinc concentration in VMB difference between PQ (1 mg/kg) treated mice and control mice [Âµg/g]
BXD_21434,Zinc concentration in VMB difference between PQ (5 mg/kg) treated mice and control mice [Âµg/g]
BXD_21435,Zinc concentration in VMB difference between PQ (10 mg/kg) treated mice and control mice [Âµg/g]
BXD_21436,"Central nervous system, morphology, eye, visual system: Live axon average density in the optic nerve in 13 to 30 month old males and females [Avg Density Live/10micron^2]"
BXD_21437,"Central nervous system, morphology, eye, visual system: Necrotic axon average density in the optic nerve in 13 to 30 month old males and females [Avg Density Necrotic/10micron^2]"
BXD_21438,"Central nervous system, metabolism, toxicity: Iron (Fe) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with saline i. p. (Paraquat 0 mg/kg) once a week for 3 weeks [Âµg/g]"
BXD_21439,Mean_FeVMB_PQ1
BXD_21440,Mean_FeVMB_PQ5
BXD_21441,Mean_FeVMB_PQ10
BXD_21442,"Central nervous system, metabolism, toxicity: Copper (Cu) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with saline i. p. (Paraquat 0 mg/kg) once a week for 3 weeks [Âµg/g]"
BXD_21443,"Central nervous system, metabolism, toxicity: Copper (Cu) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat i. p. (Paraquat 1 mg/kg) once a week for 3 weeks [Âµg/g]"
BXD_21444,"Central nervous system, metabolism, toxicity: Copper (Cu) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (5 mg/kg i. p.) once a week for 3 weeks [Âµg/g]"
BXD_21445,"Central nervous system, metabolism, toxicity: Copper (Cu) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (10 mg/kg i. p.) once a week for 3 weeks [Âµg/g]"
BXD_21446,Zinc (Zn) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with saline i. p. (Paraquat 0 mg/kg) once a week for 3 weeks [Âµg/g]
BXD_21447,Mean_ZnVMB_PQ1
BXD_21448,Mean_ZnVMB_PQ5
BXD_21449,Mean_ZnVMB_PQ10
BXD_21450,"Aging, metabolism: Mean life span, longevity of females, combined data both diets, on either a standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat) or on a high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g) at UTHSC on a 12 hr light cycle in polypropylene cages (145 in2) with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding (unweighted average, updated Feb 2023 [days] "
BXD_21451,"Central nervous system, metabolism, toxicity: Iron (Fe) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat 5 mg/kg once a week for 3 weeks [Âµg/g]"
BXD_21452,"Immune system, infectious disease: Fitzpatrick trait     (please contact efitzpat@uthsc.edu)"
BXD_21453,"Immune system, infectious disease: Fitzpatrick trait cytokine"
BXD_21454,"Behavior, effects of restraint stress, maternal behavior. Percent of in contact observations of dam-pup interaction in the first 10 postnatal days, in the control group [%]"
BXD_21455,"Behavior, effects of restraint stress, maternal behavior. Percent of in contact observations of dam-pup interaction in the first 10 postnatal days, in the control prenatal stress group [%]"
BXD_21456,"Immune system, infectious disease: Fitzpatrick trait     (please contact efitzpat@uthsc.edu)"
BXD_21457,"Gene expression, learning and memory: MAGUK mRNA eigengene based on first PCA that accounts for 48% of variance in Hippocampus PDNN M430 array data using probe sets 1427692_a_at for Cask, 1450768_at for DLG1, 1421199_at for DLG2, 1419581_at for DLG4, and 1424198_at for DLG5 (polarity is corrected so that high PCA values correspond generally to higher MAGUK expression)[z score]"
BXD_21458,"Central nervous system, metabolism, toxicity: Paraquat concentration in cerebellum of adult males treated with Paraquat (1 mg/kg i.p.) once a week for 3 weeks [Âµg/g]"
BXD_21459,"Central nervous system, metabolism, toxicity: Paraquat concentration in cerebellum of adult males treated with Paraquat (5 mg/kg i.p.) once a week for 3 weeks [Âµg/g]"
BXD_21460,"Central nervous system, metabolism, toxicity: Paraquat concentration in cerebellum of adult males treated with Paraquat (10 mg/kg i.p.) once a week for 3 weeks [Âµg/g]"
BXD_21461,"Immune system, infectious disease: Fitzpatrick trait 10LBMM20k (please contact efitzpat@uthsc.edu)"
BXD_21462,"Immune system, infectious disease: Fitzpatrick trait 10LBMM40k (please contact efitzpat@uthsc.edu)"
BXD_21463,Immune system infectious disease: Fitzpatrick trait 06LBMM20k
BXD_21464,"Immune system, infectious disease: Fitzpatrick trait 06LBMM40k (please contact efitzpat@uthsc.edu)"
BXD_21465,"Principal Component Analysis of Paraquat concentration in cerebellum [ug/g] of adult males treated with Paraquat (1, 5, 10 mg/kg i.p.) once a week for 3 weeks. "
BXD_21466,"PCA of Iron (Fe) level in ventral midbrain (VMB) of adult males treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1, 5, 10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21467,"PCA of Zinc (Zn) level in ventral midbrain (VMB) of adult males treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1, 5, 10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21468,"Immune system, infectious disease: S. Rectivirgula response (100ug, three times/week for two weeks, one time in third week, farmers lung disease), sacrificed 20hrs after last exposure. The expression of T-bet in the lung lobe by PCR."
BXD_21469,"Immune system, infectious disease: Fitzpatrick xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_21470,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_21471,"PCA of Copper (Cu) level in ventral midbrain (VMB) of adult males treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1, 5, 10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21472,"PCA2 of Copper (Cu) level in ventral midbrain (VMB) of adult males treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1, 5, 10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21473,"Aging, metabolism, morphology: Baseline body weight of female mice at entry into aging colony at UTHSC, adjusted for age at entry into colony, 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n= 2295) [g]"
BXD_21474,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21475,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21476,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21477,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21478,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21479,"Central nervous system, behavior: Brain weight (contact jeffyrajans@cmmt.ubc.ca) [mg]"
BXD_21480,"Central nervous system, behavior, pharmacology: Initial sensitivity to the ataxic effects of THC measured as time mobile in the open field 30 min post-injection, difference between baseline day 0 (vehicle) and day 1 (vehicle) in the control group [s]"
BXD_21481,"Central nervous system, behavior, pharmacology: Initial sensitivity to the ataxic effects of THC measured as time mobile in the open field 30 min post-injection, difference between baseline day 0 (vehicle) and day 1 (THC, 10 mg/kg) in the THC group [s]"
BXD_21482,"Central nervous system, behavior, pharmacology: Initial sensitivity to the antinociceptive effects of THC measured as tail withdrawal latency (52áµ’C), difference between baseline day 0 (vehicle) and day 1 (vehicle) in the control group [s]"
BXD_21483,"Central nervous system, behavior, pharmacology: Initial sensitivity to the antinociceptive effects of THC measured as tail withdrawal latency (52áµ’C), difference between baseline day 0 (vehicle) and day 1 (THC, 10 mg/kg) in the THC group [s]"
BXD_21484,"Central nervous system, behavior, pharmacology: Initial sensitivity to the hypothermic effects of THC measured as rectal body temperature, difference between baseline day 0 (vehicle) and day 1 (vehicle) in males of the control group [áµ’C]"
BXD_21485,"Central nervous system, behavior, pharmacology: Initial sensitivity to the hypothermic effects of THC measured as rectal body temperature, difference between baseline day 0 (vehicle) and day 1 (THC, 10 mg/kg) in males of the THC group [áµ’C]"
BXD_21486,"Central nervous system, behavior, pharmacology: Initial sensitivity to the hypothermic effects of THC measured as rectal body temperature, difference between baseline day 0 (vehicle) and day 1 (vehicle) in females of the control group [áµ’C]"
BXD_21487,"Central nervous system, behavior, pharmacology: Initial sensitivity to the hypothermic effects of THC measured as rectal body temperature, difference between baseline day 0 (vehicle) and day 1 (THC, 10 mg/kg) in females of the THC group [áµ’C]"
BXD_21488,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21489,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.c"
BXD_21490,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21491,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21492,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21493,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21494,"Central nervous System, behavior; Goldowitz lab Traits; Contact jeffyrajans@cmmt.ubc.ca"
BXD_21495,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_21496,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_21497,"astrocytes, diff, dashbrook@UTHSC.edu"
BXD_21498,"Neurons, diff, dashbrook@UTHSC.edu
"
BXD_21499,"OPC, diff, dashbrook@UTHSC.edu
"
BXD_21500,"MO, diff, dashbrook@UTHSC.edu
"
BXD_21501,"Microglia, diff, dashbrook@UTHSC.edu
"
BXD_21502,"Endothelial cells, diff, dashbrook@UTHSC.edu
"
BXD_21503,"Eigentrait, diff, dashbrook@UTHSC.edu
"
BXD_21504,"astrocytes, control, dashbrook@UTHSC.edu
"
BXD_21505,"Neurons, control, dashbrook@UTHSC.edu
"
BXD_21506,"OPCs, control, dashbrook@UTHSC.edu
"
BXD_21507,"MOs, control, dashbrook@UTHSC.edu
"
BXD_21508,"Microglia, control, dashbrook@UTHSC.edu
"
BXD_21509,"Endothelial cells, control, dashbrook@UTHSC.edu
"
BXD_21510,"Eigentrait, control, dashbrook@UTHSC.edu
"
BXD_21511,"astrocytes, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21512,"Neurons, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21513,"OPC, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21514,"MOs, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21515,"Microglia, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21516,"Endothelial cells, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21517,"Eigentrait, CORT+DFP, dashbrook@UTHSC.edu
"
BXD_21518,"Cardiovascular system, nutrition: Iron concentration in heart of 20-650-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively [ug/g]"
BXD_21519,"Cardiovascular system, nutrition: Zinc concentration in heart of 20-650-day-old males and females fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu and Zn, respectively [ug/g]"
BXD_21520,"Musculoskeletal system, metabolism, gastrointestinal system: Calcium absorption in small intestine, 3 month old males (AIN93G diet with 0.25% calcium), oral gavage test with serum measurement of 45calcium [% dose delivered]"
BXD_21521,"Aging, metabolism, life span: MeanAccResidyearsCD [years]"
BXD_21522,"Aging, metabolism, life span: MeanAccResiddaysCD [days]"
BXD_21523,"Aging, metabolism, life span: MeanAccResidyearsHFD [years]"
BXD_21524,"Aging, metabolism, life span: MeanAccResiddaysHFD [days]"
BXD_21525,"Central nervous system, visual system: Volume-normalized compliance (phi-normalized) of eye, step response compliance using increasing pressure steps only with reference at 13 mmHg [pressure change]"
BXD_21526,Cancer: Makowski 000001 (liza.makowski@uthsc.edu)
BXD_21527,Cancer: Makowski 000002 (liza.makowski@uthsc.edu)
BXD_21528,Cancer: Makowski 000003 (liza.makowski@uthsc.edu)
BXD_21529,Cancer: Makowski 000004 (liza.makowski@uthsc.edu)
BXD_21530,Cancer: Makowski 000005 (liza.makowski@uthsc.edu)
BXD_21531,Cancer: Makowski 000006 (liza.makowski@uthsc.edu)
BXD_21532,Cancer: Makowski 000007 (liza.makowski@uthsc.edu)
BXD_21533,"Aging, metabolism: Coefficient of variation (CoV) of strain average longevity of females at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat) at UTHSC on a 12 hr light cycle in polypropylene cages (145 in2) with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding [CoV%]"
BXD_21534,"Aging, metabolism: Coefficient of variation (CoV) of strain average longevity of females at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [CoV%]"
BXD_21535,"Aging: Life span variability, longevity coefficient of variation (CoV_ of females within each strain at the Dana-Faber Cancer Institute (Redstone Animal Facility, Boston MA) from Jackson Laboratory between Nov 1982 and Mar 1983 on Purina chow (all data reinstated), computed by Williams and colleagues from original Gelman data (entered Dec 2019) [CoV]"
BXD_21536,PCA of PQ in CB 01/06/2020
BXD_21537,Cancer: Makowski 000008 (liza.makowski@uthsc.edu)
BXD_21538,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21539,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21540,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21541,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21542,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21543,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males,  qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21544,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21545,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21546,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21547,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21548,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21549,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21550,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21551,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21552,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old females, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21553,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex after 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21554,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa)  gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21555,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21556,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21557,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21558,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21559,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex  after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21560,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 Fold Change]"
BXD_21561,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 6 (IL6) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21562,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex after 7 days of corticosterone (Cort, 20 mg%) treatment in drinking water (Cort) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]
"
BXD_21563,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21564,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Tumor necrosis factor a (TNFa) gene expression in prefrontal cortex 6h after diisopropylfluorophosphate (DFP, 4 mg/kg i.p.) treatment (DFP) in 2-4 month old males and females combined, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21565,"Central nervous system, pharmacology, endocrinology, immunology, toxicology: Interleukin 1 beta (IL1B) expression principal component 1 in prefrontal cortex 6h after diisopropylflurophosphate (DFP, 4 mg/kg i.p.) and 7 days of corticosterone (Cort, 20 mg%) treatments in drinking water (Cort+DFP) in 2-4 month old males and females, PCA from Traits BXD_21200, 21196, and 21557, qrtPCR assay calculated as delta-delta cycle threshold versus control [PCA score]"
BXD_21566,"Central nervous system, metabolism, immunology, toxicology: Interleukin 1 beta (IL1B) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (1 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21567,"Central nervous system, metabolism, immunology, toxicology: Interleukin 1 beta (IL1B) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (1 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21568,"Central nervous system, metabolism, immunology, toxicology: Interleukin 1 beta (IL1B) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (5 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21569,"Central nervous system, metabolism, immunology, toxicology: Interleukin 1 beta (IL1B) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (10 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21570,"Central nervous system, metabolism, immunology, toxicology: Leukemia inhibitory factor (Lif) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (1 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21571,"Central nervous system, metabolism, immunology, toxicology: Leukemia inhibitory factor (Lif) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (5 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21572,"Central nervous system, metabolism, immunology, toxicology: Leukemia inhibitory factor (Lif) expression in cerebellum of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat (10 mg/kg i.p.) once a week for 3 weeks, qrtPCR assay calculated as delta-delta cycle threshold versus control [log2 fold change]"
BXD_21573,"Central nervous system, metabolism, toxicity: Iron (Fe) concentration in ventral midbrain (VMB) of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat 1 mg/kg once a week for 3 weeks [Âµg/g]"
BXD_21574,"Infectious disease, immune function, gene expression: Ace2 covariate eigengene (64% of variance) following H1N1 (PR8) influenza A virus (2x10E3 FFU) infection of 9-14 week-old females (Ace2, Akap14, Ccdc17, Cdkl4, Cyp4f15, Fgg, Lrrc46, Muc5ac, Reg3g, Rng128, Ttc39a) [PC Score]"
BXD_21575,"Infectious disease, immune function: Body weight change  TWO days post infection (2 dpi) with H1N1 (PR8) influenza A virus (2x10E3 FFU) in 9-14 week old females (same cases used in BXD Lung RNAseq data set: HZI Lung Flu Infected BXD (Nov16), GN807) [%]"
BXD_21576,"Infectious disease, immune function: Body weight change ONE days post infection (1 dpi) with H1N1 (PR8) influenza A virus (2x10E3 FFU) in 9-14 week old females (cases used in BXD Lung RNAseq data set: HZI Lung Flu Infected BXD (Nov16), GN807) [%]"
BXD_21577,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 1, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21578,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 2, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21579,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 3, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21580,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 4, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21581,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 5, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21582,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 6, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21583,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 7, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21584,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 8, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21585,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 9, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21586,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 10, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21587,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 11, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21588,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 12, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21589,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 13, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21590,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 14, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21591,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 15, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21592,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 16, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21593,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 17 (mainly MHC  region), raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21594,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 18, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21595,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome 19, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]"
BXD_21596,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome X, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21597,"Cofactor, genetics, genomics: Structural variants (SVs) on chromosome Y, raw, uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21598,"Cofactor, genetics, genomics: Structural variants (SVs) on all chromosomes, raw uncorrected sum of calls using LongRanger on linked-read sequencing data [n]
"
BXD_21599,"Cofactor, genetics, genomics: Structural variants (SVs) on all chromosome, corrected weighted sum of calls (Z score normalized per chromosome) using LongRanger on linked-read sequencing data [z score x 100 Â± z score x 10]"
BXD_21600,"Cofactor, genetic: Genotype on chromosome Y. 0 = B6, 1 = D2"
BXD_21601,"Morphology, toxicity: Body weight of adult males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively per 6 months, and treated with saline i.p once a week for 3 weeks; paraquat control mice [g]"
BXD_21602,"Morphology, toxicity: Body weight of adult males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively per 6 months, and treated with Paraquat (1 mg/kg i. p.) once a week for 3 weeks [g]"
BXD_21603,"Morphology, toxicity: Body weight of adult males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively per 6 months, and treated with Paraquat (5 mg/kg i. p.) once a week for 3 weeks [g]"
BXD_21604,"Morphology, toxicity: Body weight of adult males fed Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively per 6 months, and treated with Paraquat (10 mg/kg i. p.) once a week for 3 weeks [g]"
BXD_21605,Genomics: Recombinations estimated per genome
BXD_21606,"Other, cofactor: F2 or AI derived BXD strain. "
BXD_21607,"Aging, metabolism: Serum fasting glucose of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=255) [mmol/L]"
BXD_21608,"Aging, metabolism: Serum fasting glucose of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=254) [mmol/L]"
BXD_21609,"Aging, metabolism: Serum total cholesterol of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=255) [mmol/L]"
BXD_21610,"Aging, metabolism: Serum total cholesterol of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted fovernight before sacrifice, June 2020 (n=254) [mmol/L]"
BXD_21611,Purkinje Cells at P30
BXD_21612,"Aging, metabolism: Adiposity of females between 6 and 25 months of age (calculated from harvested adipose tissue weights as a percentage of body weight) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2020 (n= 309) [%]"
BXD_21613,"Aging, metabolism: Adiposity of females between 6 and 25 months of age (calculated from harvested adipose tissue weights as a percentage of body weight) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, June 2020 (n=292) [%]"
BXD_21614,Whole Cerebellum Volume at P30
BXD_21615,EGL Cell Count at E15
BXD_21616,"Central nervous system, auditory system, hearing: Hearing sensitivity evaluated by auditory brainstem response thresholds at 8 kHz in both sexes from 12 to 32 month of age (lower values associated with better hearing; Fig 4a, ahp locus) [dB SPL]"
BXD_21617,"Central nervous system, auditory system, hearing: Hearing sensitivity evaluated by auditory brainstem response thresholds at 16 kHz in both sexes from 12 to 32 month of age (lower values associated with better hearing; Fig 2a and Fig 4b, ahp locus) [dB SPL]"
BXD_21618,"Central nervous system, auditory system, hearing: Hearing sensitivity evaluated by auditory brainstem response thresholds at 32 kHz in both sexes from 12 to 32 month of age (lower values associated with better hearing; Fig 4c, ahp locus) [dB SPL]"
BXD_21619,Average Volume of Molecular Layer Cells at P30
BXD_21620,Average ML cell count at P30
BXD_21621,IGL Density (2500 um2 at P30)
BXD_21622,Average CB Cell Number at E15
BXD_21623,Whole CB Volume at E15
BXD_21624,Rhombic Lip at E15
BXD_21625,Whole CB Volume at E18
BXD_21626,Average Rhombic Lip Density at E15
BXD_21627,Whole CB Volume E12
BXD_21628,"Liver, metabolism, toxicity: Iron (Fe) level in liver of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21629,"Liver, metabolism, toxicity: Iron (Fe) level in liver of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (5 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21630,"Liver, metabolism, toxicity: Iron (Fe) level in liver of adult males fed 240 ppm iron diet per 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21631,"Liver, metabolism, toxicity: Copper (Cu) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21632,"Liver, metabolism, toxicity: Copper (Cu) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (5 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21633,"Liver, metabolism, toxicity: Copper (Cu) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21634,"Liver, metabolism, toxicity: Zinc (Zn) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (1 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21635,"Lliver, metabolism, toxicity: Zinc (Zn) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (5 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21636,"Liver, metabolism, toxicity: Zinc (Zn) level in liver of adult males fed Envigo diet 7912 containing 240 ppm Fe, 93 ppm Cu, and 63 ppm Zn, for 6 months and treated with Paraquat once a week for 3 weeks; difference between Paraquat treated mice (10 mg/kg i. p.) and control mice [Âµg/g]"
BXD_21637,"Metagenome, microbiota, gastrointestinal system, metabolism: Acidovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21638,"Metagenome, microbiota, gastrointestinal system, metabolism: Acinetobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21639,"Metagenome, microbiota, gastrointestinal system, metabolism: Akkermansia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21640,"Metagenome, microbiota, gastrointestinal system, metabolism: Alistipes (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21641,"Metagenome, microbiota, gastrointestinal system, metabolism: Alloprevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21642,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerotruncus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21643,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21644,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21645,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21646,"Metagenome, microbiota, gastrointestinal system, metabolism: Barnesiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21647,"Metagenome, microbiota, gastrointestinal system, metabolism: Bifidobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21648,"Metagenome, microbiota, gastrointestinal system, metabolism: Bilophila (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21649,"Metagenome, microbiota, gastrointestinal system, metabolism: Blautia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21650,"Metagenome, microbiota, gastrointestinal system, metabolism: Brevundimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21651,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricicoccus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21652,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21653,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium IV (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21654,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium sensu stricto (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21655,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XI (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21656,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XlVb (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21657,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XVIII (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21658,"Metagenome, microbiota, gastrointestinal system, metabolism: Comamonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21659,"Metagenome, microbiota, gastrointestinal system, metabolism: Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21660,"Metagenome, microbiota, gastrointestinal system, metabolism: Curtobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21661,"Metagenome, microbiota, gastrointestinal system, metabolism: Desulfovibrio (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21662,"Metagenome, microbiota, gastrointestinal system, metabolism: Enhydrobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21663,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21664,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterorhabdus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21665,"Metagenome, microbiota, gastrointestinal system, metabolism: Escherichia/Shigella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21666,"Metagenome, microbiota, gastrointestinal system, metabolism: Eubacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21667,"Metagenome, microbiota, gastrointestinal system, metabolism: Faecalibacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21668,"Metagenome, microbiota, gastrointestinal system, metabolism: Flavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21669,"Metagenome, microbiota, gastrointestinal system, metabolism: Granulicatella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21670,"Metagenome, microbiota, gastrointestinal system, metabolism: Helicobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21671,"Metagenome, microbiota, gastrointestinal system, metabolism: Klebsiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21672,"Metagenome, microbiota, gastrointestinal system, metabolism: Lachnospiracea incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21673,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21674,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21675,"Metagenome, microbiota, gastrointestinal system, metabolism: Leuconostoc (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21676,"Metagenome, microbiota, gastrointestinal system, metabolism: Mucispirillum (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21677,"Metagenome, microbiota, gastrointestinal system, metabolism: Odoribacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21678,"Metagenome, microbiota, gastrointestinal system, metabolism: Oscillibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21679,"Metagenome, microbiota, gastrointestinal system, metabolism: Parabacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21680,"Metagenome, microbiota, gastrointestinal system, metabolism: Parasutterella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21681,"Metagenome, microbiota, gastrointestinal system, metabolism: Pasteurella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21682,"Metagenome, microbiota, gastrointestinal system, metabolism: Pedobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21683,"Metagenome, microbiota, gastrointestinal system, metabolism: Peptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21684,"Metagenome, microbiota, gastrointestinal system, metabolism: Prevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21685,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21686,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudoflavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21687,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21688,"Metagenome, microbiota, gastrointestinal system, metabolism: Ralstonia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21689,"Metagenome, microbiota, gastrointestinal system, metabolism: Raoultella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21690,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhizobium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21691,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhodobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21692,"Metagenome, microbiota, gastrointestinal system, metabolism: Rikenella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21693,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21694,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus2 (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21695,"Metagenome, microbiota, gastrointestinal system, metabolism: Saccharibacteria genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21696,"Metagenome, microbiota, gastrointestinal system, metabolism: Sphingobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21697,"Metagenome, microbiota, gastrointestinal system, metabolism: Sporobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21698,"Metagenome, microbiota, gastrointestinal system, metabolism: Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21699,"Metagenome, microbiota, gastrointestinal system, metabolism: Stenotrophomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21700,"Metagenome, microbiota, gastrointestinal system, metabolism: Streptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21701,"Metagenome, microbiota, gastrointestinal system, metabolism: Turicibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21702,"Metagenome, microbiota, gastrointestinal system, metabolism: Ureaplasma (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21703,"Metagenome, microbiota, gastrointestinal system, metabolism: Veillonella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21704,"Metagenome, microbiota, gastrointestinal system, metabolism: Weissella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21705,"Metagenome, microbiota, gastrointestinal system, metabolism: Actinobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21706,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroidetes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21707,"Metagenome, microbiota, gastrointestinal system, metabolism: Candidatus Saccharibacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21708,"Metagenome, microbiota, gastrointestinal system, metabolism: Deferribacteres (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21709,"Metagenome, microbiota, gastrointestinal system, metabolism: Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21710,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21711,"Metagenome, microbiota, gastrointestinal system, metabolism: Tenericutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21712,"Metagenome, microbiota, gastrointestinal system, metabolism: Verrucomicrobia (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21713,"Metagenome, microbiota, gastrointestinal system, metabolism: Acidovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21714,"Metagenome, microbiota, gastrointestinal system, metabolism: Acinetobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21715,"Metagenome, microbiota, gastrointestinal system, metabolism: Akkermansia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21716,"Metagenome, microbiota, gastrointestinal system, metabolism: Alistipes (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21717,"Metagenome, microbiota, gastrointestinal system, metabolism: Alloprevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21718,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerotruncus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21719,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21720,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21721,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21722,"Metagenome, microbiota, gastrointestinal system, metabolism: Barnesiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21723,"Metagenome, microbiota, gastrointestinal system, metabolism: Bifidobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21724,"Metagenome, microbiota, gastrointestinal system, metabolism: Bilophila (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21725,"Metagenome, microbiota, gastrointestinal system, metabolism: Blautia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21726,"Metagenome, microbiota, gastrointestinal system, metabolism: Brevundimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21727,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricicoccus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21728,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21729,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium IV (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21730,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium sensu stricto (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21731,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XI (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21732,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XlVb (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21733,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XVIII (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21734,"Metagenome, microbiota, gastrointestinal system, metabolism: Comamonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21735,"Metagenome, microbiota, gastrointestinal system, metabolism: Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21736,"Metagenome, microbiota, gastrointestinal system, metabolism: Curtobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21737,"Metagenome, microbiota, gastrointestinal system, metabolism: Desulfovibrio (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21738,"Metagenome, microbiota, gastrointestinal system, metabolism: Enhydrobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21739,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21740,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterorhabdus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21741,"Metagenome, microbiota, gastrointestinal system, metabolism: Escherichia/Shigella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21742,"Metagenome, microbiota, gastrointestinal system, metabolism: Eubacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21743,"Metagenome, microbiota, gastrointestinal system, metabolism: Faecalibacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21744,"Metagenome, microbiota, gastrointestinal system, metabolism: Flavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21745,"Metagenome, microbiota, gastrointestinal system, metabolism: Granulicatella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21746,"Metagenome, microbiota, gastrointestinal system, metabolism: Helicobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21747,"Metagenome, microbiota, gastrointestinal system, metabolism: Klebsiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21748,"Metagenome, microbiota, gastrointestinal system, metabolism: Lachnospiracea incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21749,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21750,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21751,"Metagenome, microbiota, gastrointestinal system, metabolism: Leuconostoc (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21752,"Metagenome, microbiota, gastrointestinal system, metabolism: Mucispirillum (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21753,"Metagenome, microbiota, gastrointestinal system, metabolism: Odoribacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21754,"Metagenome, microbiota, gastrointestinal system, metabolism: Oscillibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21755,"Metagenome, microbiota, gastrointestinal system, metabolism: Parabacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21756,"Metagenome, microbiota, gastrointestinal system, metabolism: Parasutterella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21757,"Metagenome, microbiota, gastrointestinal system, metabolism: Pasteurella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21758,"Metagenome, microbiota, gastrointestinal system, metabolism: Pedobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21759,"Metagenome, microbiota, gastrointestinal system, metabolism: Peptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21760,"Metagenome, microbiota, gastrointestinal system, metabolism: Prevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21761,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21762,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudoflavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21763,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21764,"Metagenome, microbiota, gastrointestinal system, metabolism: Ralstonia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21765,"Metagenome, microbiota, gastrointestinal system, metabolism: Raoultella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21766,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhizobium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21767,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhodobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21768,"Metagenome, microbiota, gastrointestinal system, metabolism: Rikenella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21769,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21770,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus2 (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21771,"Metagenome, microbiota, gastrointestinal system, metabolism: Saccharibacteria genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21772,"Metagenome, microbiota, gastrointestinal system, metabolism: Sphingobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21773,"Metagenome, microbiota, gastrointestinal system, metabolism: Sporobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21774,"Metagenome, microbiota, gastrointestinal system, metabolism: Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21775,"Metagenome, microbiota, gastrointestinal system, metabolism: Stenotrophomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21776,"Metagenome, microbiota, gastrointestinal system, metabolism: Streptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21777,"Metagenome, microbiota, gastrointestinal system, metabolism: Turicibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21778,"Metagenome, microbiota, gastrointestinal system, metabolism: Ureaplasma (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21779,"Metagenome, microbiota, gastrointestinal system, metabolism: Veillonella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21780,"Metagenome, microbiota, gastrointestinal system, metabolism: Weissella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21781,"Metagenome, microbiota, gastrointestinal system, metabolism: Actinobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21782,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroidetes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21783,"Metagenome, microbiota, gastrointestinal system, metabolism: Candidatus Saccharibacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21784,"Metagenome, microbiota, gastrointestinal system, metabolism: Deferribacteres (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21785,"Metagenome, microbiota, gastrointestinal system, metabolism: Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21786,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21787,"Metagenome, microbiota, gastrointestinal system, metabolism: Tenericutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21788,"Metagenome, microbiota, gastrointestinal system, metabolism: Verrucomicrobia (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21789,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU_1 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus ) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21790,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU10 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21791,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU100 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21792,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU101 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21793,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU102 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21794,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU103 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21795,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU104 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21796,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU105 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21797,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU106 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21798,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU107 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21799,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU108 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21800,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU109 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21801,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU11 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21802,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU110 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21803,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU111 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21804,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU112 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21805,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU113 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21806,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU114 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21807,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU115 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21808,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU116 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21809,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU117 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21810,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU118 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21811,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU119 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21812,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU12 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21813,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU120 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21814,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU121 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21815,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU122 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21816,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU123 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21817,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU124 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21818,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU125 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21819,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU126 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21820,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU127 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21821,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU128 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21822,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU129 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21823,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU13 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21824,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU130 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21825,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU131 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21826,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU132 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21827,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU133 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21828,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU134 (Bacteroidetes;Bacteroidales;Rikenellaceae;AF12) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21829,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU135 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21830,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU136 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21831,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU137 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21832,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU138 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21833,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU139 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21834,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU14 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21835,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU140 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21836,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU141 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21837,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU142 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21838,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU143 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21839,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU144 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21840,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU145 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21841,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU146 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21842,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU147 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21843,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU148 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21844,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU149 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21845,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU15 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21846,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU150 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21847,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU151 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21848,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU152 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21849,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU153 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21850,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU154 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21851,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU155 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21852,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU156 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21853,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU157 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21854,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU158 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21855,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU159 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21856,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU16 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21857,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU160 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21858,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU161 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21859,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU162 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21860,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU163 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21861,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU164 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21862,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU165 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21863,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU166 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21864,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU167 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21865,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU168 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21866,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU169 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21867,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU17 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21868,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU170 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21869,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU171 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21870,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU172 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21871,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU173 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21872,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU174 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21873,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU175 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21874,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU176 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21875,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU177 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21876,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU178 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21877,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU179 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21878,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU18 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21879,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU180 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21880,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU181 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21881,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU182 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21882,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU183 (Firmicutes;Clostridiales;Lachnospiraceae;Anaerostipes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21883,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU184 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21884,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU185 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21885,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU186 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21886,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU187 (Firmicutes;Clostridiales;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21887,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU188 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21888,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU189 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21889,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU19 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21890,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU190 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21891,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU191 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21892,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU192 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21893,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU193 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21894,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU194 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21895,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU195 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21896,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU196 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21897,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU197 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21898,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU198 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21899,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU199 (Firmicutes;Clostridiales;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21900,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU2 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21901,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU20 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21902,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU200 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21903,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU201 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21904,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU202 (Firmicutes;Clostridiales;Peptococcaceae;rc4-4) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21905,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU203 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21906,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU204 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21907,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU205 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21908,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU206 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21909,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU207 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21910,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU208 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21911,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU209 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21912,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU21 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21913,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU210 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21914,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU211 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcusgarvieae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21915,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU212 (Firmicutes;Clostridiales;Lachnospiraceae;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21916,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU213 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21917,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU214 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21918,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU215 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21919,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU216 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostoc) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21920,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU217 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21921,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU218 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21922,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU219 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21923,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU22 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21924,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU220 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21925,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU221 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21926,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU222 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21927,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU223 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21928,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU224 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21929,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU225 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21930,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU226 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21931,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU227 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21932,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU228 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21933,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU229 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21934,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU23 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21935,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU230 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21936,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU231 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroidesdistasonis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21937,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU232 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21938,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU233 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21939,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU234 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21940,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU235 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21941,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU236 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21942,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU237 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21943,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU238 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21944,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU239 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21945,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU24 (Firmicutes;Turicibacterales;Turicibacteraceae;Turicibacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21946,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU240 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21947,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU241 (Firmicutes;Clostridiales;Lachnospiraceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21948,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU242 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21949,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU243 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21950,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU244 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21951,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU245 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21952,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU246 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21953,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU247 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21954,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU248 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21955,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU249 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21956,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU25 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21957,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU250 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21958,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU251 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21959,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU252 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21960,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU253 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21961,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU254 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21962,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU255 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21963,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU256 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21964,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU258 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21965,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU259 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21966,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU26 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21967,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU260 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21968,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU261 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21969,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU262 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21970,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU263 (Firmicutes;Clostridiales;Lachnospiraceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21971,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU264 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21972,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU265 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21973,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU266 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21974,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU267 (Firmicutes;Clostridiales;Clostridiaceae;Candidatus Arthromitus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21975,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU268 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21976,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU269 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21977,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU27 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21978,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU270 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21979,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU271 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21980,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU272 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21981,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU273 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21982,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU274 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21983,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU275 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21984,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU276 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21985,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU277 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21986,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU278 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21987,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU279 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21988,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU28 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21989,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU280 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21990,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU281 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21991,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU282 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21992,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU283 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21993,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU284 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21994,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU285 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21995,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU286 (Firmicutes;Clostridiales;Lachnospiraceae;0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21996,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU287 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21997,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU288 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21998,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU289 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_21999,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU29 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22000,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU290 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22001,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU291 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22002,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU292 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22003,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU293 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22004,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU294 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22005,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU295 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22006,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU296 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22007,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU297 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22008,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU298 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22009,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU299 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22010,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU3 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22011,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU30 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22012,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU300 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22013,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU301 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22014,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU302 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22015,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU303 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22016,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU304 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22017,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU305 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22018,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU306 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22019,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU307 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22020,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU308 (Firmicutes;Clostridiales;Lachnospiraceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22021,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU309 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22022,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU31 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22023,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU310 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22024,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU311 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22025,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU312 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22026,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU313 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22027,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU314 (Firmicutes;Clostridiales;Lachnospiraceae;Ruminococcusgauvreauii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22028,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU315 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22029,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU316 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22030,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU317 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22031,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU318 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22032,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU319 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22033,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU32 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22034,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU320 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22035,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU321 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22036,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU322 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22037,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU323 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22038,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU324 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22039,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU325 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22040,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU326 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22041,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU327 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22042,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU328 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22043,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU329 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22044,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU33 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22045,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU330 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22046,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU331 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22047,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU332 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22048,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU333 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22049,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU334 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22050,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU335 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22051,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU336 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22052,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU337 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22053,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU338 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22054,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU339 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22055,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU34 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22056,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU340 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22057,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU341 (Firmicutes;Clostridiales;Lachnospiraceae;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22058,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU342 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22059,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU343 (Firmicutes;Clostridiales;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22060,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU344 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22061,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU345 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22062,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU346 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22063,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU347 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22064,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU348 (Firmicutes;Clostridiales;Ruminococcaceae;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22065,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU349 (Firmicutes;Clostridiales;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22066,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU35 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22067,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU350 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22068,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU351 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22069,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU352 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22070,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU353 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22071,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU354 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22072,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU355 (Firmicutes;Clostridiales;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22073,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU356 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22074,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU357 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22075,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU358 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22076,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU359 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22077,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU36 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22078,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU360 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22079,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU361 (Firmicutes;Clostridiales;Ruminococcaceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22080,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU362 (Firmicutes;Clostridiales;Ruminococcaceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22081,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU363 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22082,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU364 (Firmicutes;Clostridiales;Ruminococcaceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22083,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU365 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22084,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU366 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacterhepaticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22085,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU367 (Tenericutes;Mycoplasmatales;Mycoplasmataceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22086,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU368 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22087,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU369 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridiumpiliforme) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22088,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU37 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22089,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU370 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22090,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU371 (Firmicutes;Clostridiales;Ruminococcaceae;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22091,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU372 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22092,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU373 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.78) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22093,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU374 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacterium0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22094,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU375 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22095,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU376 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22096,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU377 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22097,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU378 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22098,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU379 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22099,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU38 (Firmicutes;Bacillales;Staphylococcaceae;Staphylococcusaureus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22100,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU380 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22101,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU381 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22102,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU382 (Firmicutes;Clostridiales;Lachnospiraceae;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22103,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU383 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22104,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU384 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22105,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU385 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22106,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU386 (Firmicutes;Lactobacillales;Leuconostocaceae;Weissellaconfusa) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22107,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU387 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22108,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU388 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22109,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU389 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22110,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU39 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22111,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU390 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22112,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU391 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22113,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU392 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22114,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU393 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22115,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU394 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22116,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU395 (Firmicutes;Clostridiales;Ruminococcaceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22117,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU396 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22118,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU397 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22119,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU398 (Firmicutes;Clostridiales;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22120,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU399 (Firmicutes;Clostridiales;Lachnospiraceae;0.77) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22121,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU4 (Actinobacteria;Bifidobacteriales;Bifidobacteriaceae;Bifidobacteriumpseudolongum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22122,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU40 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22123,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU400 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22124,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU401 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22125,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU402 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22126,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU403 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22127,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU404 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22128,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU405 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22129,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU406 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22130,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU407 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumcelatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22131,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU408 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22132,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU409 (Firmicutes;Clostridiales;Lachnospiraceae;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22133,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU41 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22134,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU410 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22135,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU411 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22136,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU412 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22137,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU413 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22138,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU414 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22139,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU415 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Proteus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22140,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU416 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22141,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU417 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22142,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU418 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Slackia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22143,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU419 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22144,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU42 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22145,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU420 (Firmicutes;Clostridiales;Ruminococcaceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22146,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU421 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22147,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU422 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22148,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU423 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22149,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU424 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22150,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU425 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22151,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU426 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22152,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU427 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22153,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU428 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22154,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU429 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22155,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU43 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22156,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU430 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22157,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU431 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22158,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU432 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Klebsiella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22159,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU433 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22160,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU434 (Firmicutes;Clostridiales;Christensenellaceae;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22161,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU435 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22162,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU436 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22163,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU437 (Proteobacteria;Caulobacterales;Caulobacteraceae;Mycoplana) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22164,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU438 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22165,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU439 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroidesacidifaciens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22166,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU44 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22167,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU440 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22168,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU441 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22169,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU442 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22170,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU443 (Firmicutes;Clostridiales;0.64) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22171,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU444 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22172,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU445 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22173,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU446 (Firmicutes;Clostridiales;Lachnospiraceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22174,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU447 (Proteobacteria;Rhizobiales;Rhizobiaceae;Agrobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22175,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU448 (Proteobacteria;Xanthomonadales;Xanthomonadaceae;Stenotrophomonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22176,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU449 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22177,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU45 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22178,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU450 (Firmicutes;Clostridiales;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22179,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU451 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22180,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU452 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22181,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU453 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22182,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU454 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22183,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU455 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22184,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU456 (Firmicutes;Clostridiales;Ruminococcaceae;0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22185,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU457 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacteriummastitidis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22186,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU458 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22187,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU459 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22188,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU46 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22189,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU460 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22190,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU461 (Firmicutes;Clostridiales;Lachnospiraceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22191,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU462 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22192,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU463 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22193,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU464 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Oxalobacterformigenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22194,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU465 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22195,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU466 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22196,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU467 (Firmicutes;Clostridiales;Lachnospiraceae;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22197,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU468 (Proteobacteria;Pasteurellales;Pasteurellaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22198,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU469 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22199,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU47 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22200,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU470 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22201,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU471 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22202,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU472 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22203,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU473 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22204,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU474 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22205,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU475 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22206,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU476 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22207,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU477 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22208,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU478 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22209,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU479 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22210,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU48 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22211,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU480 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22212,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU481 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22213,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU482 (Firmicutes;Clostridiales;Ruminococcaceae;Faecalibacteriumprausnitzii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22214,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU483 (Proteobacteria;Pseudomonadales;Moraxellaceae;Acinetobacter1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22215,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU484 (Bacteroidetes;Bacteroidales;[Paraprevotellaceae];[Prevotella]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22216,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU485 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22217,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU486 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22218,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU487 (Firmicutes;Clostridiales;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22219,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU488 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22220,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU489 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22221,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU49 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22222,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU490 (Firmicutes;Clostridiales;Veillonellaceae;Veillonelladispar) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22223,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU491 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;Clostridiumcocleatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22224,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU492 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22225,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU493 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22226,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU494 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22227,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU495 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22228,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU496 (Firmicutes;Clostridiales;Ruminococcaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22229,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU497 (Firmicutes;Clostridiales;Dehalobacteriaceae;Dehalobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22230,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU498 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22231,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU499 (Actinobacteria;Actinomycetales;Microbacteriaceae;Curtobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22232,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU5 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22233,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU50 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22234,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU500 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22235,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU501 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22236,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU502 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22237,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU503 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22238,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU504 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22239,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU505 (Firmicutes;Clostridiales;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22240,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU506 (Firmicutes;Clostridiales;Lachnospiraceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22241,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU507 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22242,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU508 (Firmicutes;Clostridiales;Ruminococcaceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22243,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU509 (Firmicutes;Clostridiales;Lachnospiraceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22244,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU51 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22245,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU510 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Collinsella0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22246,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU511 (Proteobacteria;Pseudomonadales;Pseudomonadaceae;Pseudomonasveronii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22247,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU512 (Firmicutes;Clostridiales;Clostridiaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22248,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU513 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22249,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU514 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22250,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU515 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22251,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU516 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22252,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU517 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22253,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU518 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22254,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU519 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22255,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU52 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22256,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU520 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22257,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU521 (Firmicutes;Clostridiales;Lachnospiraceae;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22258,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU522 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22259,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU523 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostocfallax) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22260,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU524 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22261,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU525 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22262,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU526 (Firmicutes;Clostridiales;Ruminococcaceae;0.59) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22263,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU527 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Ralstonia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22264,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU528 (0.9;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22265,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU529 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22266,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU53 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22267,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU530 (Proteobacteria;Campylobacterales;Helicobacteraceae;Flexispira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22268,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU531 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Sphingobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22269,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU532 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22270,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU533 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22271,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU534 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22272,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU535 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22273,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU536 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22274,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU537 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22275,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU538 (Firmicutes;Clostridiales;Ruminococcaceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22276,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU539 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22277,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU54 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22278,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU540 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22279,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU541 (Firmicutes;Clostridiales;0.83) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22280,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU542 (Firmicutes;Clostridiales;Ruminococcaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22281,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU543 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22282,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU544 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22283,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU545 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22284,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU546 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22285,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU547 (0.91;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22286,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU548 (Firmicutes;Clostridiales;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22287,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU549 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22288,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU55 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22289,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU550 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22290,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU551 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22291,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU552 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22292,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU553 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22293,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU554 (Firmicutes;Bacillales;Bacillaceae;Bacillusflexus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22294,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU555 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22295,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU556 (Firmicutes;Clostridiales;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22296,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU557 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22297,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU558 (Proteobacteria;Pasteurellales;Pasteurellaceae;Actinobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22298,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU559 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22299,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU56 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22300,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU560 (Firmicutes;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22301,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU561 (Firmicutes;Clostridiales;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22302,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU562 (Firmicutes;Clostridiales;Lachnospiraceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22303,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU563 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22304,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU564 (Actinobacteria;Actinomycetales;Microbacteriaceae;Agromyces) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22305,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU565 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22306,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU566 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22307,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU567 (Firmicutes;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22308,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU568 (Firmicutes;Clostridiales;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22309,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU569 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22310,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU57 (Verrucomicrobia;Verrucomicrobiales;Verrucomicrobiaceae;Akkermansiamuciniphila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22311,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU570 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22312,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU571 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22313,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU572 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22314,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU573 (Proteobacteria;Burkholderiales;Comamonadaceae;Comamonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22315,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU574 (Bacteroidetes;Bacteroidales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22316,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU575 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22317,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU576 (Firmicutes;Clostridiales;Ruminococcaceae;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22318,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU577 (Actinobacteria;Actinomycetales;Actinomycetaceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22319,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU578 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22320,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU579 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22321,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU58 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22322,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU580 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22323,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU581 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22324,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU582 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22325,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU583 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22326,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU584 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22327,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU585 (Firmicutes;Lactobacillales;Lactobacillaceae;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22328,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU586 (Proteobacteria;Rhodobacterales;Rhodobacteraceae;Rhodobacter0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22329,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU587 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22330,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU588 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22331,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU589 (Firmicutes;Clostridiales;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22332,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU59 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22333,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU590 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22334,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU591 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22335,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU592 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22336,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU593 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22337,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU594 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22338,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU595 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22339,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU596 (Proteobacteria;Burkholderiales;Comamonadaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22340,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU597 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22341,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU598 (Proteobacteria;Pseudomonadales;Moraxellaceae;Enhydrobacter0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22342,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU599 (0.96;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22343,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU6 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22344,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU60 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22345,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU600 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22346,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU601 (Firmicutes;Clostridiales;Lachnospiraceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22347,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU602 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22348,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU603 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22349,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU604 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22350,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU605 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22351,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU606 (OD1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22352,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU607 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumbutyricum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22353,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU608 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22354,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU609 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Pedobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22355,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU61 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22356,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU62 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22357,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU63 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22358,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU64 (Firmicutes;Clostridiales;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22359,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU65 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22360,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU66 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22361,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU67 (Firmicutes;Clostridiales;Lachnospiraceae;Roseburia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22362,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU68 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Desulfovibrio) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22363,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU69 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22364,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU7 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillusreuteri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22365,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU70 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Bilophila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22366,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU71 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22367,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU72 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22368,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU73 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22369,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU74 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22370,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU75 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22371,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU76 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22372,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU77 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22373,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU78 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22374,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU79 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22375,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU8 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22376,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU80 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22377,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU81 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22378,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU82 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22379,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU83 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22380,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU84 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22381,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU85 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcusalactolyticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22382,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU86 (Firmicutes;Lactobacillales;Enterococcaceae;Enterococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22383,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU87 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22384,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU88 (Deferribacteres;Deferribacterales;Deferribacteraceae;Mucispirillumschaedleri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22385,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU89 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22386,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU9 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;DesulfovibrioC21) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22387,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU90 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22388,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU91 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22389,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU92 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22390,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU93 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22391,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU94 (Firmicutes;Clostridiales;Lachnospiraceae;0.72) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22392,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU95 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22393,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU96 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22394,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU97 (Firmicutes;Clostridiales;Peptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22395,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU98 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22396,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU99 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22397,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU_1 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus ) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22398,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU10 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22399,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU100 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22400,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU101 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22401,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU102 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22402,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU103 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22403,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU104 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22404,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU105 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22405,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU106 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22406,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU107 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22407,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU108 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22408,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU109 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22409,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU11 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22410,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU110 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22411,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU111 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22412,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU112 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22413,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU113 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22414,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU114 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22415,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU115 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22416,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU116 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22417,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU117 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22418,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU118 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22419,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU119 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22420,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU12 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22421,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU120 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22422,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU121 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22423,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU122 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22424,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU123 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22425,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU124 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22426,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU125 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22427,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU126 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22428,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU127 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22429,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU128 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22430,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU129 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22431,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU13 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22432,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU130 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22433,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU131 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22434,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU132 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22435,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU133 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22436,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU134 (Bacteroidetes;Bacteroidales;Rikenellaceae;AF12) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22437,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU135 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22438,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU136 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22439,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU137 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22440,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU138 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22441,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU139 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22442,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU14 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22443,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU140 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22444,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU141 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22445,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU142 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22446,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU143 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22447,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU144 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22448,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU145 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22449,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU146 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22450,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU147 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22451,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU148 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22452,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU149 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22453,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU15 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22454,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU150 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22455,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU151 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22456,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU152 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22457,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU153 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22458,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU154 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22459,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU155 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22460,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU156 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22461,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU157 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22462,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU158 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22463,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU159 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22464,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU16 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22465,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU160 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22466,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU161 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22467,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU162 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22468,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU163 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22469,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU164 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22470,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU165 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22471,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU166 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22472,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU167 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22473,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU168 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22474,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU169 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22475,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU17 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22476,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU170 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22477,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU171 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22478,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU172 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22479,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU173 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22480,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU174 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22481,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU175 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22482,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU176 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22483,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU177 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22484,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU178 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22485,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU179 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22486,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU18 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22487,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU180 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22488,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU181 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22489,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU182 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22490,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU183 (Firmicutes;Clostridiales;Lachnospiraceae;Anaerostipes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22491,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU184 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22492,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU185 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22493,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU186 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22494,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU187 (Firmicutes;Clostridiales;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22495,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU188 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22496,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU189 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22497,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU19 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22498,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU190 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22499,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU191 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22500,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU192 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22501,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU193 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22502,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU194 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22503,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU195 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22504,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU196 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22505,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU197 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22506,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU198 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22507,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU199 (Firmicutes;Clostridiales;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22508,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU2 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22509,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU20 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22510,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU200 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22511,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU201 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22512,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU202 (Firmicutes;Clostridiales;Peptococcaceae;rc4-4) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22513,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU203 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22514,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU204 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22515,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU205 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22516,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU206 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22517,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU207 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22518,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU208 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22519,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU209 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22520,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU21 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22521,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU210 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22522,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU211 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcusgarvieae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22523,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU212 (Firmicutes;Clostridiales;Lachnospiraceae;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22524,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU213 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22525,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU214 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22526,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU215 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22527,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU216 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostoc) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22528,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU217 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22529,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU218 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22530,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU219 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22531,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU22 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22532,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU220 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22533,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU221 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22534,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU222 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22535,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU223 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22536,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU224 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22537,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU225 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22538,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU226 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22539,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU227 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22540,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU228 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22541,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU229 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22542,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU23 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22543,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU230 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22544,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU231 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroidesdistasonis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22545,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU232 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22546,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU233 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22547,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU234 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22548,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU235 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22549,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU236 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22550,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU237 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22551,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU238 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22552,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU239 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22553,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU24 (Firmicutes;Turicibacterales;Turicibacteraceae;Turicibacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22554,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU240 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22555,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU241 (Firmicutes;Clostridiales;Lachnospiraceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22556,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU242 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22557,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU243 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22558,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU244 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22559,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU245 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22560,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU246 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22561,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU247 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22562,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU248 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22563,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU249 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22564,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU25 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22565,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU250 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22566,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU251 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22567,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU252 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22568,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU253 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22569,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU254 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22570,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU255 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22571,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU256 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22572,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU258 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22573,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU259 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22574,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU26 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22575,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU260 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22576,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU261 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22577,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU262 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22578,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU263 (Firmicutes;Clostridiales;Lachnospiraceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22579,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU264 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22580,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU265 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22581,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU266 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22582,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU267 (Firmicutes;Clostridiales;Clostridiaceae;Candidatus Arthromitus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22583,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU268 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22584,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU269 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22585,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU27 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22586,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU270 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22587,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU271 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22588,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU272 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22589,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU273 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22590,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU274 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22591,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU275 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22592,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU276 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22593,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU277 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22594,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU278 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22595,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU279 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22596,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU28 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22597,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU280 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22598,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU281 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22599,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU282 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22600,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU283 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22601,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU284 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22602,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU285 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22603,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU286 (Firmicutes;Clostridiales;Lachnospiraceae;0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22604,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU287 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22605,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU288 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22606,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU289 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22607,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU29 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22608,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU290 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22609,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU291 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22610,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU292 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22611,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU293 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22612,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU294 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22613,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU295 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22614,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU296 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22615,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU297 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22616,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU298 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22617,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU299 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22618,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU3 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22619,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU30 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22620,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU300 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22621,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU301 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22622,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU302 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22623,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU303 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22624,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU304 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22625,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU305 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22626,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU306 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22627,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU307 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22628,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU308 (Firmicutes;Clostridiales;Lachnospiraceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22629,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU309 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22630,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU31 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22631,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU310 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22632,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU311 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22633,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU312 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22634,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU313 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22635,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU314 (Firmicutes;Clostridiales;Lachnospiraceae;Ruminococcusgauvreauii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22636,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU315 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22637,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU316 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22638,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU317 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22639,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU318 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22640,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU319 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22641,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU32 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22642,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU320 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22643,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU321 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22644,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU322 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22645,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU323 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22646,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU324 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22647,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU325 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22648,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU326 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22649,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU327 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22650,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU328 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22651,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU329 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22652,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU33 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22653,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU330 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22654,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU331 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22655,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU332 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22656,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU333 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22657,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU334 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22658,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU335 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22659,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU336 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22660,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU337 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22661,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU338 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22662,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU339 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22663,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU34 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22664,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU340 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22665,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU341 (Firmicutes;Clostridiales;Lachnospiraceae;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22666,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU342 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22667,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU343 (Firmicutes;Clostridiales;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22668,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU344 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22669,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU345 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22670,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU346 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22671,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU347 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22672,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU348 (Firmicutes;Clostridiales;Ruminococcaceae;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22673,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU349 (Firmicutes;Clostridiales;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22674,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU35 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22675,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU350 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22676,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU351 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22677,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU352 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22678,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU353 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22679,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU354 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22680,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU355 (Firmicutes;Clostridiales;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22681,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU356 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22682,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU357 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22683,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU358 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22684,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU359 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22685,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU36 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22686,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU360 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22687,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU361 (Firmicutes;Clostridiales;Ruminococcaceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22688,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU362 (Firmicutes;Clostridiales;Ruminococcaceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22689,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU363 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22690,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU364 (Firmicutes;Clostridiales;Ruminococcaceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22691,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU365 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22692,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU366 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacterhepaticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22693,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU367 (Tenericutes;Mycoplasmatales;Mycoplasmataceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22694,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU368 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22695,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU369 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridiumpiliforme) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22696,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU37 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22697,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU370 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22698,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU371 (Firmicutes;Clostridiales;Ruminococcaceae;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22699,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU372 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22700,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU373 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.78) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22701,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU374 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacterium0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22702,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU375 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22703,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU376 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22704,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU377 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22705,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU378 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22706,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU379 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22707,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU38 (Firmicutes;Bacillales;Staphylococcaceae;Staphylococcusaureus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22708,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU380 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22709,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU381 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22710,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU382 (Firmicutes;Clostridiales;Lachnospiraceae;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22711,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU383 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22712,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU384 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22713,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU385 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22714,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU386 (Firmicutes;Lactobacillales;Leuconostocaceae;Weissellaconfusa) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22715,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU387 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22716,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU388 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22717,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU389 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22718,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU39 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22719,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU390 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22720,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU391 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22721,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU392 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22722,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU393 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22723,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU394 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22724,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU395 (Firmicutes;Clostridiales;Ruminococcaceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22725,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU396 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22726,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU397 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22727,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU398 (Firmicutes;Clostridiales;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22728,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU399 (Firmicutes;Clostridiales;Lachnospiraceae;0.77) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22729,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU4 (Actinobacteria;Bifidobacteriales;Bifidobacteriaceae;Bifidobacteriumpseudolongum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22730,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU40 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22731,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU400 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22732,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU401 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22733,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU402 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22734,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU403 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22735,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU404 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22736,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU405 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22737,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU406 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22738,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU407 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumcelatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22739,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU408 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22740,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU409 (Firmicutes;Clostridiales;Lachnospiraceae;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22741,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU41 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22742,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU410 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22743,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU411 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22744,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU412 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22745,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU413 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22746,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU414 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22747,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU415 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Proteus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22748,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU416 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22749,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU417 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22750,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU418 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Slackia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22751,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU419 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22752,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU42 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22753,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU420 (Firmicutes;Clostridiales;Ruminococcaceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22754,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU421 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22755,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU422 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22756,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU423 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22757,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU424 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22758,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU425 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22759,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU426 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22760,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU427 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22761,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU428 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22762,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU429 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22763,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU43 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22764,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU430 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22765,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU431 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22766,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU432 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Klebsiella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22767,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU433 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22768,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU434 (Firmicutes;Clostridiales;Christensenellaceae;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22769,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU435 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22770,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU436 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22771,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU437 (Proteobacteria;Caulobacterales;Caulobacteraceae;Mycoplana) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22772,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU438 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22773,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU439 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroidesacidifaciens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22774,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU44 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22775,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU440 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22776,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU441 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22777,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU442 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22778,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU443 (Firmicutes;Clostridiales;0.64) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22779,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU444 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22780,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU445 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22781,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU446 (Firmicutes;Clostridiales;Lachnospiraceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22782,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU447 (Proteobacteria;Rhizobiales;Rhizobiaceae;Agrobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22783,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU448 (Proteobacteria;Xanthomonadales;Xanthomonadaceae;Stenotrophomonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22784,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU449 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22785,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU45 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22786,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU450 (Firmicutes;Clostridiales;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22787,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU451 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22788,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU452 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22789,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU453 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22790,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU454 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22791,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU455 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22792,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU456 (Firmicutes;Clostridiales;Ruminococcaceae;0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22793,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU457 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacteriummastitidis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22794,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU458 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22795,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU459 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22796,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU46 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22797,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU460 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22798,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU461 (Firmicutes;Clostridiales;Lachnospiraceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22799,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU462 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22800,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU463 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22801,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU464 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Oxalobacterformigenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22802,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU465 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22803,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU466 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22804,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU467 (Firmicutes;Clostridiales;Lachnospiraceae;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22805,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU468 (Proteobacteria;Pasteurellales;Pasteurellaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22806,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU469 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22807,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU47 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22808,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU470 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22809,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU471 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22810,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU472 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22811,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU473 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22812,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU474 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22813,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU475 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22814,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU476 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22815,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU477 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22816,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU478 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22817,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU479 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22818,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU48 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22819,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU480 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22820,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU481 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22821,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU482 (Firmicutes;Clostridiales;Ruminococcaceae;Faecalibacteriumprausnitzii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22822,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU483 (Proteobacteria;Pseudomonadales;Moraxellaceae;Acinetobacter1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22823,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU484 (Bacteroidetes;Bacteroidales;[Paraprevotellaceae];[Prevotella]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22824,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU485 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22825,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU486 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22826,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU487 (Firmicutes;Clostridiales;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22827,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU488 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22828,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU489 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22829,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU49 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22830,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU490 (Firmicutes;Clostridiales;Veillonellaceae;Veillonelladispar) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22831,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU491 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;Clostridiumcocleatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22832,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU492 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22833,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU493 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22834,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU494 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22835,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU495 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22836,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU496 (Firmicutes;Clostridiales;Ruminococcaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22837,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU497 (Firmicutes;Clostridiales;Dehalobacteriaceae;Dehalobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22838,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU498 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22839,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU499 (Actinobacteria;Actinomycetales;Microbacteriaceae;Curtobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22840,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU5 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22841,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU50 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22842,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU500 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22843,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU501 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22844,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU502 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22845,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU503 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22846,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU504 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22847,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU505 (Firmicutes;Clostridiales;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22848,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU506 (Firmicutes;Clostridiales;Lachnospiraceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22849,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU507 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22850,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU508 (Firmicutes;Clostridiales;Ruminococcaceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22851,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU509 (Firmicutes;Clostridiales;Lachnospiraceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22852,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU51 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22853,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU510 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Collinsella0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22854,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU511 (Proteobacteria;Pseudomonadales;Pseudomonadaceae;Pseudomonasveronii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22855,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU512 (Firmicutes;Clostridiales;Clostridiaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22856,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU513 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22857,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU514 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22858,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU515 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22859,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU516 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22860,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU517 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22861,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU518 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22862,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU519 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22863,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU52 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22864,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU520 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22865,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU521 (Firmicutes;Clostridiales;Lachnospiraceae;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22866,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU522 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22867,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU523 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostocfallax) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22868,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU524 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22869,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU525 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22870,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU526 (Firmicutes;Clostridiales;Ruminococcaceae;0.59) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22871,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU527 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Ralstonia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22872,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU528 (0.9;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22873,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU529 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22874,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU53 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22875,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU530 (Proteobacteria;Campylobacterales;Helicobacteraceae;Flexispira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22876,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU531 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Sphingobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22877,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU532 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22878,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU533 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22879,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU534 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22880,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU535 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22881,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU536 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22882,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU537 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22883,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU538 (Firmicutes;Clostridiales;Ruminococcaceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22884,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU539 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22885,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU54 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22886,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU540 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22887,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU541 (Firmicutes;Clostridiales;0.83) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22888,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU542 (Firmicutes;Clostridiales;Ruminococcaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22889,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU543 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22890,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU544 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22891,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU545 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22892,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU546 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22893,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU547 (0.91;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22894,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU548 (Firmicutes;Clostridiales;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22895,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU549 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22896,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU55 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22897,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU550 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22898,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU551 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22899,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU552 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22900,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU553 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22901,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU554 (Firmicutes;Bacillales;Bacillaceae;Bacillusflexus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22902,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU555 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22903,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU556 (Firmicutes;Clostridiales;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22904,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU557 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22905,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU558 (Proteobacteria;Pasteurellales;Pasteurellaceae;Actinobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22906,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU559 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22907,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU56 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22908,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU560 (Firmicutes;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22909,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU561 (Firmicutes;Clostridiales;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22910,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU562 (Firmicutes;Clostridiales;Lachnospiraceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22911,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU563 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22912,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU564 (Actinobacteria;Actinomycetales;Microbacteriaceae;Agromyces) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22913,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU565 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22914,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU566 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22915,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU567 (Firmicutes;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22916,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU568 (Firmicutes;Clostridiales;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22917,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU569 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22918,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU57 (Verrucomicrobia;Verrucomicrobiales;Verrucomicrobiaceae;Akkermansiamuciniphila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22919,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU570 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22920,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU571 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22921,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU572 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22922,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU573 (Proteobacteria;Burkholderiales;Comamonadaceae;Comamonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22923,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU574 (Bacteroidetes;Bacteroidales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22924,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU575 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22925,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU576 (Firmicutes;Clostridiales;Ruminococcaceae;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22926,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU577 (Actinobacteria;Actinomycetales;Actinomycetaceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22927,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU578 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22928,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU579 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22929,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU58 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22930,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU580 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22931,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU581 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22932,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU582 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22933,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU583 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22934,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU584 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22935,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU585 (Firmicutes;Lactobacillales;Lactobacillaceae;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22936,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU586 (Proteobacteria;Rhodobacterales;Rhodobacteraceae;Rhodobacter0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22937,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU587 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22938,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU588 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22939,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU589 (Firmicutes;Clostridiales;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22940,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU59 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22941,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU590 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22942,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU591 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22943,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU592 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22944,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU593 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22945,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU594 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22946,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU595 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22947,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU596 (Proteobacteria;Burkholderiales;Comamonadaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22948,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU597 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22949,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU598 (Proteobacteria;Pseudomonadales;Moraxellaceae;Enhydrobacter0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22950,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU599 (0.96;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22951,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU6 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22952,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU60 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22953,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU600 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22954,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU601 (Firmicutes;Clostridiales;Lachnospiraceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22955,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU602 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22956,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU603 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22957,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU604 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22958,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU605 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22959,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU606 (OD1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22960,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU607 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumbutyricum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22961,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU608 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22962,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU609 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Pedobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22963,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU61 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22964,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU62 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22965,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU63 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22966,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU64 (Firmicutes;Clostridiales;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22967,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU65 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22968,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU66 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22969,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU67 (Firmicutes;Clostridiales;Lachnospiraceae;Roseburia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22970,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU68 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Desulfovibrio) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22971,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU69 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22972,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU7 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillusreuteri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22973,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU70 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Bilophila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22974,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU71 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22975,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU72 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22976,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU73 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22977,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU74 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22978,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU75 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22979,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU76 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22980,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU77 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22981,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU78 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22982,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU79 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22983,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU8 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22984,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU80 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22985,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU81 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22986,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU82 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22987,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU83 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22988,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU84 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22989,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU85 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcusalactolyticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22990,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU86 (Firmicutes;Lactobacillales;Enterococcaceae;Enterococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22991,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU87 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22992,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU88 (Deferribacteres;Deferribacterales;Deferribacteraceae;Mucispirillumschaedleri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22993,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU89 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22994,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU9 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;DesulfovibrioC21) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22995,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU90 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22996,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU91 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22997,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU92 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22998,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU93 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_22999,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU94 (Firmicutes;Clostridiales;Lachnospiraceae;0.72) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23000,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU95 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23001,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU96 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23002,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU97 (Firmicutes;Clostridiales;Peptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23003,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU98 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23004,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU99 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a high fat diet (HFD, EPFL LISP3 Cohort, 2014-2018) [log fraction]"
BXD_23005,"Metagenome, microbiota, gastrointestinal system, metabolism: Acidovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23006,"Metagenome, microbiota, gastrointestinal system, metabolism: Acinetobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23007,"Metagenome, microbiota, gastrointestinal system, metabolism: Akkermansia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23008,"Metagenome, microbiota, gastrointestinal system, metabolism: Alistipes (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23009,"Metagenome, microbiota, gastrointestinal system, metabolism: Alloprevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23010,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerotruncus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23011,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23012,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23013,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23014,"Metagenome, microbiota, gastrointestinal system, metabolism: Barnesiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23015,"Metagenome, microbiota, gastrointestinal system, metabolism: Bifidobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23016,"Metagenome, microbiota, gastrointestinal system, metabolism: Bilophila (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23017,"Metagenome, microbiota, gastrointestinal system, metabolism: Blautia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23018,"Metagenome, microbiota, gastrointestinal system, metabolism: Brevundimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23019,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricicoccus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23020,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23021,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium IV (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23022,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium sensu stricto (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23023,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XI (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23024,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XlVb (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23025,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XVIII (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23026,"Metagenome, microbiota, gastrointestinal system, metabolism: Comamonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23027,"Metagenome, microbiota, gastrointestinal system, metabolism: Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23028,"Metagenome, microbiota, gastrointestinal system, metabolism: Curtobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23029,"Metagenome, microbiota, gastrointestinal system, metabolism: Desulfovibrio (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23030,"Metagenome, microbiota, gastrointestinal system, metabolism: Enhydrobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23031,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23032,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterorhabdus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23033,"Metagenome, microbiota, gastrointestinal system, metabolism: Escherichia/Shigella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23034,"Metagenome, microbiota, gastrointestinal system, metabolism: Eubacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23035,"Metagenome, microbiota, gastrointestinal system, metabolism: Faecalibacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23036,"Metagenome, microbiota, gastrointestinal system, metabolism: Flavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23037,"Metagenome, microbiota, gastrointestinal system, metabolism: Granulicatella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23038,"Metagenome, microbiota, gastrointestinal system, metabolism: Helicobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23039,"Metagenome, microbiota, gastrointestinal system, metabolism: Klebsiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23040,"Metagenome, microbiota, gastrointestinal system, metabolism: Lachnospiracea incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23041,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23042,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23043,"Metagenome, microbiota, gastrointestinal system, metabolism: Leuconostoc (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23044,"Metagenome, microbiota, gastrointestinal system, metabolism: Mucispirillum (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23045,"Metagenome, microbiota, gastrointestinal system, metabolism: Odoribacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23046,"Metagenome, microbiota, gastrointestinal system, metabolism: Oscillibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23047,"Metagenome, microbiota, gastrointestinal system, metabolism: Parabacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23048,"Metagenome, microbiota, gastrointestinal system, metabolism: Parasutterella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23049,"Metagenome, microbiota, gastrointestinal system, metabolism: Pasteurella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23050,"Metagenome, microbiota, gastrointestinal system, metabolism: Pedobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23051,"Metagenome, microbiota, gastrointestinal system, metabolism: Peptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23052,"Metagenome, microbiota, gastrointestinal system, metabolism: Prevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23053,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23054,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudoflavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23055,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23056,"Metagenome, microbiota, gastrointestinal system, metabolism: Ralstonia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23057,"Metagenome, microbiota, gastrointestinal system, metabolism: Raoultella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23058,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhizobium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23059,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhodobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23060,"Metagenome, microbiota, gastrointestinal system, metabolism: Rikenella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23061,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23062,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus2 (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23063,"Metagenome, microbiota, gastrointestinal system, metabolism: Saccharibacteria genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23064,"Metagenome, microbiota, gastrointestinal system, metabolism: Sphingobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23065,"Metagenome, microbiota, gastrointestinal system, metabolism: Sporobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23066,"Metagenome, microbiota, gastrointestinal system, metabolism: Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23067,"Metagenome, microbiota, gastrointestinal system, metabolism: Stenotrophomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23068,"Metagenome, microbiota, gastrointestinal system, metabolism: Streptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23069,"Metagenome, microbiota, gastrointestinal system, metabolism: Turicibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23070,"Metagenome, microbiota, gastrointestinal system, metabolism: Ureaplasma (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23071,"Metagenome, microbiota, gastrointestinal system, metabolism: Veillonella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23072,"Metagenome, microbiota, gastrointestinal system, metabolism: Weissella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23073,"Metagenome, microbiota, gastrointestinal system, metabolism: Actinobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23074,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroidetes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23075,"Metagenome, microbiota, gastrointestinal system, metabolism: Candidatus Saccharibacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23076,"Metagenome, microbiota, gastrointestinal system, metabolism: Deferribacteres (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23077,"Metagenome, microbiota, gastrointestinal system, metabolism: Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23078,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23079,"Metagenome, microbiota, gastrointestinal system, metabolism: Tenericutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23080,"Metagenome, microbiota, gastrointestinal system, metabolism: Verrucomicrobia (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23081,"Metagenome, microbiota, gastrointestinal system, metabolism: Acidovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23082,"Metagenome, microbiota, gastrointestinal system, metabolism: Acinetobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23083,"Metagenome, microbiota, gastrointestinal system, metabolism: Akkermansia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23084,"Metagenome, microbiota, gastrointestinal system, metabolism: Alistipes (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23085,"Metagenome, microbiota, gastrointestinal system, metabolism: Alloprevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23086,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerotruncus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23087,"Metagenome, microbiota, gastrointestinal system, metabolism: Anaerovorax (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23088,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23089,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23090,"Metagenome, microbiota, gastrointestinal system, metabolism: Barnesiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23091,"Metagenome, microbiota, gastrointestinal system, metabolism: Bifidobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23092,"Metagenome, microbiota, gastrointestinal system, metabolism: Bilophila (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23093,"Metagenome, microbiota, gastrointestinal system, metabolism: Blautia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23094,"Metagenome, microbiota, gastrointestinal system, metabolism: Brevundimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23095,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricicoccus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23096,"Metagenome, microbiota, gastrointestinal system, metabolism: Butyricimonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23097,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium IV (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23098,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium sensu stricto (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23099,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XI (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23100,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XlVb (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23101,"Metagenome, microbiota, gastrointestinal system, metabolism: Clostridium XVIII (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23102,"Metagenome, microbiota, gastrointestinal system, metabolism: Comamonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23103,"Metagenome, microbiota, gastrointestinal system, metabolism: Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23104,"Metagenome, microbiota, gastrointestinal system, metabolism: Curtobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23105,"Metagenome, microbiota, gastrointestinal system, metabolism: Desulfovibrio (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23106,"Metagenome, microbiota, gastrointestinal system, metabolism: Enhydrobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23107,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23108,"Metagenome, microbiota, gastrointestinal system, metabolism: Enterorhabdus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23109,"Metagenome, microbiota, gastrointestinal system, metabolism: Escherichia/Shigella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23110,"Metagenome, microbiota, gastrointestinal system, metabolism: Eubacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23111,"Metagenome, microbiota, gastrointestinal system, metabolism: Faecalibacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23112,"Metagenome, microbiota, gastrointestinal system, metabolism: Flavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23113,"Metagenome, microbiota, gastrointestinal system, metabolism: Granulicatella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23114,"Metagenome, microbiota, gastrointestinal system, metabolism: Helicobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23115,"Metagenome, microbiota, gastrointestinal system, metabolism: Klebsiella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23116,"Metagenome, microbiota, gastrointestinal system, metabolism: Lachnospiracea incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23117,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23118,"Metagenome, microbiota, gastrointestinal system, metabolism: Lactococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23119,"Metagenome, microbiota, gastrointestinal system, metabolism: Leuconostoc (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23120,"Metagenome, microbiota, gastrointestinal system, metabolism: Mucispirillum (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23121,"Metagenome, microbiota, gastrointestinal system, metabolism: Odoribacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23122,"Metagenome, microbiota, gastrointestinal system, metabolism: Oscillibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23123,"Metagenome, microbiota, gastrointestinal system, metabolism: Parabacteroides (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23124,"Metagenome, microbiota, gastrointestinal system, metabolism: Parasutterella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23125,"Metagenome, microbiota, gastrointestinal system, metabolism: Pasteurella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23126,"Metagenome, microbiota, gastrointestinal system, metabolism: Pedobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23127,"Metagenome, microbiota, gastrointestinal system, metabolism: Peptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23128,"Metagenome, microbiota, gastrointestinal system, metabolism: Prevotella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23129,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23130,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudoflavonifractor (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23131,"Metagenome, microbiota, gastrointestinal system, metabolism: Pseudomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23132,"Metagenome, microbiota, gastrointestinal system, metabolism: Ralstonia (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23133,"Metagenome, microbiota, gastrointestinal system, metabolism: Raoultella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23134,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhizobium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23135,"Metagenome, microbiota, gastrointestinal system, metabolism: Rhodobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23136,"Metagenome, microbiota, gastrointestinal system, metabolism: Rikenella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23137,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23138,"Metagenome, microbiota, gastrointestinal system, metabolism: Ruminococcus2 (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23139,"Metagenome, microbiota, gastrointestinal system, metabolism: Saccharibacteria genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23140,"Metagenome, microbiota, gastrointestinal system, metabolism: Sphingobacterium (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23141,"Metagenome, microbiota, gastrointestinal system, metabolism: Sporobacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23142,"Metagenome, microbiota, gastrointestinal system, metabolism: Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23143,"Metagenome, microbiota, gastrointestinal system, metabolism: Stenotrophomonas (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23144,"Metagenome, microbiota, gastrointestinal system, metabolism: Streptococcus (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23145,"Metagenome, microbiota, gastrointestinal system, metabolism: Turicibacter (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23146,"Metagenome, microbiota, gastrointestinal system, metabolism: Ureaplasma (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23147,"Metagenome, microbiota, gastrointestinal system, metabolism: Veillonella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23148,"Metagenome, microbiota, gastrointestinal system, metabolism: Weissella (genus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23149,"Metagenome, microbiota, gastrointestinal system, metabolism: Actinobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23150,"Metagenome, microbiota, gastrointestinal system, metabolism: Bacteroidetes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23151,"Metagenome, microbiota, gastrointestinal system, metabolism: Candidatus Saccharibacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23152,"Metagenome, microbiota, gastrointestinal system, metabolism: Deferribacteres (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23153,"Metagenome, microbiota, gastrointestinal system, metabolism: Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23154,"Metagenome, microbiota, gastrointestinal system, metabolism: Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23155,"Metagenome, microbiota, gastrointestinal system, metabolism: Tenericutes (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23156,"Metagenome, microbiota, gastrointestinal system, metabolism: Verrucomicrobia (phylum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23157,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU_1 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus ) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23158,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU10 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23159,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU100 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23160,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU101 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23161,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU102 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23162,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU103 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23163,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU104 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23164,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU105 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23165,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU106 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23166,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU107 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23167,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU108 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23168,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU109 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23169,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU11 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23170,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU110 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23171,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU111 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23172,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU112 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23173,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU113 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23174,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU114 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23175,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU115 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23176,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU116 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23177,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU117 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23178,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU118 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23179,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU119 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23180,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU12 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23181,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU120 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23182,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU121 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23183,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU122 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23184,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU123 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23185,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU124 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23186,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU125 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23187,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU126 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23188,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU127 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23189,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU128 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23190,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU129 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23191,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU13 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23192,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU130 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23193,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU131 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23194,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU132 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23195,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU133 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23196,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU134 (Bacteroidetes;Bacteroidales;Rikenellaceae;AF12) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23197,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU135 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23198,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU136 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23199,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU137 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23200,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU138 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23201,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU139 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23202,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU14 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23203,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU140 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23204,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU141 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23205,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU142 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23206,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU143 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23207,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU144 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23208,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU145 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23209,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU146 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23210,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU147 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23211,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU148 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23212,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU149 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23213,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU15 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23214,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU150 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23215,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU151 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23216,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU152 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23217,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU153 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23218,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU154 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23219,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU155 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23220,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU156 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23221,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU157 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23222,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU158 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23223,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU159 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23224,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU16 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23225,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU160 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23226,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU161 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23227,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU162 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23228,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU163 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23229,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU164 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23230,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU165 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23231,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU166 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23232,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU167 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23233,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU168 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23234,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU169 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23235,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU17 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23236,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU170 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23237,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU171 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23238,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU172 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23239,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU173 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23240,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU174 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23241,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU175 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23242,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU176 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23243,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU177 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23244,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU178 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23245,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU179 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23246,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU18 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23247,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU180 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23248,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU181 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23249,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU182 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23250,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU183 (Firmicutes;Clostridiales;Lachnospiraceae;Anaerostipes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23251,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU184 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23252,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU185 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23253,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU186 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23254,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU187 (Firmicutes;Clostridiales;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23255,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU188 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23256,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU189 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23257,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU19 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23258,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU190 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23259,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU191 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23260,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU192 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23261,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU193 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23262,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU194 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23263,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU195 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23264,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU196 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23265,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU197 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23266,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU198 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23267,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU199 (Firmicutes;Clostridiales;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23268,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU2 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23269,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU20 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23270,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU200 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23271,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU201 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23272,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU202 (Firmicutes;Clostridiales;Peptococcaceae;rc4-4) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23273,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU203 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23274,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU204 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23275,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU205 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23276,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU206 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23277,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU207 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23278,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU208 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23279,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU209 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23280,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU21 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23281,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU210 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23282,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU211 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcusgarvieae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23283,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU212 (Firmicutes;Clostridiales;Lachnospiraceae;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23284,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU213 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23285,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU214 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23286,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU215 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23287,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU216 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostoc) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23288,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU217 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23289,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU218 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23290,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU219 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23291,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU22 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23292,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU220 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23293,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU221 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23294,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU222 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23295,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU223 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23296,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU224 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23297,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU225 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23298,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU226 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23299,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU227 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23300,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU228 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23301,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU229 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23302,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU23 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23303,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU230 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23304,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU231 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroidesdistasonis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23305,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU232 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23306,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU233 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23307,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU234 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23308,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU235 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23309,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU236 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23310,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU237 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23311,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU238 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23312,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU239 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23313,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU24 (Firmicutes;Turicibacterales;Turicibacteraceae;Turicibacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23314,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU240 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23315,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU241 (Firmicutes;Clostridiales;Lachnospiraceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23316,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU242 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23317,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU243 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23318,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU244 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23319,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU245 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23320,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU246 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23321,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU247 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23322,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU248 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23323,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU249 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23324,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU25 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23325,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU250 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23326,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU251 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23327,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU252 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23328,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU253 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23329,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU254 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23330,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU255 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23331,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU256 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23332,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU258 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23333,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU259 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23334,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU26 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23335,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU260 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23336,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU261 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23337,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU262 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23338,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU263 (Firmicutes;Clostridiales;Lachnospiraceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23339,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU264 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23340,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU265 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23341,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU266 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23342,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU267 (Firmicutes;Clostridiales;Clostridiaceae;Candidatus Arthromitus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23343,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU268 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23344,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU269 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23345,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU27 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23346,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU270 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23347,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU271 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23348,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU272 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23349,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU273 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23350,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU274 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23351,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU275 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23352,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU276 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23353,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU277 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23354,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU278 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23355,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU279 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23356,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU28 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23357,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU280 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23358,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU281 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23359,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU282 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23360,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU283 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23361,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU284 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23362,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU285 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23363,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU286 (Firmicutes;Clostridiales;Lachnospiraceae;0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23364,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU287 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23365,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU288 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23366,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU289 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23367,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU29 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23368,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU290 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23369,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU291 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23370,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU292 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23371,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU293 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23372,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU294 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23373,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU295 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23374,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU296 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23375,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU297 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23376,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU298 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23377,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU299 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23378,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU3 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23379,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU30 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23380,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU300 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23381,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU301 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23382,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU302 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23383,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU303 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23384,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU304 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23385,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU305 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23386,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU306 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23387,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU307 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23388,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU308 (Firmicutes;Clostridiales;Lachnospiraceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23389,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU309 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23390,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU31 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23391,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU310 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23392,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU311 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23393,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU312 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23394,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU313 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23395,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU314 (Firmicutes;Clostridiales;Lachnospiraceae;Ruminococcusgauvreauii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23396,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU315 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23397,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU316 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23398,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU317 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23399,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU318 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23400,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU319 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23401,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU32 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23402,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU320 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23403,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU321 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23404,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU322 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23405,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU323 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23406,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU324 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23407,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU325 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23408,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU326 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23409,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU327 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23410,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU328 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23411,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU329 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23412,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU33 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23413,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU330 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23414,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU331 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23415,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU332 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23416,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU333 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23417,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU334 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23418,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU335 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23419,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU336 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23420,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU337 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23421,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU338 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23422,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU339 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23423,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU34 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23424,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU340 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23425,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU341 (Firmicutes;Clostridiales;Lachnospiraceae;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23426,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU342 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23427,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU343 (Firmicutes;Clostridiales;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23428,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU344 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23429,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU345 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23430,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU346 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23431,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU347 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23432,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU348 (Firmicutes;Clostridiales;Ruminococcaceae;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23433,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU349 (Firmicutes;Clostridiales;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23434,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU35 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23435,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU350 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23436,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU351 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23437,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU352 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23438,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU353 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23439,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU354 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23440,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU355 (Firmicutes;Clostridiales;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23441,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU356 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23442,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU357 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23443,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU358 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23444,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU359 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23445,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU36 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23446,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU360 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23447,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU361 (Firmicutes;Clostridiales;Ruminococcaceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23448,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU362 (Firmicutes;Clostridiales;Ruminococcaceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23449,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU363 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23450,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU364 (Firmicutes;Clostridiales;Ruminococcaceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23451,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU365 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23452,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU366 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacterhepaticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23453,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU367 (Tenericutes;Mycoplasmatales;Mycoplasmataceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23454,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU368 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23455,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU369 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridiumpiliforme) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23456,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU37 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23457,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU370 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23458,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU371 (Firmicutes;Clostridiales;Ruminococcaceae;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23459,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU372 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23460,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU373 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.78) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23461,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU374 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacterium0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23462,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU375 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23463,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU376 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23464,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU377 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23465,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU378 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23466,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU379 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23467,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU38 (Firmicutes;Bacillales;Staphylococcaceae;Staphylococcusaureus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23468,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU380 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23469,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU381 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23470,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU382 (Firmicutes;Clostridiales;Lachnospiraceae;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23471,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU383 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23472,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU384 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23473,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU385 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23474,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU386 (Firmicutes;Lactobacillales;Leuconostocaceae;Weissellaconfusa) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23475,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU387 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23476,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU388 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23477,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU389 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23478,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU39 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23479,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU390 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23480,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU391 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23481,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU392 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23482,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU393 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23483,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU394 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23484,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU395 (Firmicutes;Clostridiales;Ruminococcaceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23485,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU396 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23486,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU397 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23487,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU398 (Firmicutes;Clostridiales;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23488,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU399 (Firmicutes;Clostridiales;Lachnospiraceae;0.77) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23489,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU4 (Actinobacteria;Bifidobacteriales;Bifidobacteriaceae;Bifidobacteriumpseudolongum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23490,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU40 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23491,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU400 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23492,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU401 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23493,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU402 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23494,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU403 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23495,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU404 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23496,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU405 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23497,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU406 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23498,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU407 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumcelatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23499,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU408 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23500,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU409 (Firmicutes;Clostridiales;Lachnospiraceae;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23501,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU41 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23502,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU410 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23503,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU411 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23504,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU412 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23505,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU413 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23506,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU414 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23507,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU415 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Proteus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23508,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU416 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23509,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU417 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23510,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU418 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Slackia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23511,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU419 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23512,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU42 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23513,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU420 (Firmicutes;Clostridiales;Ruminococcaceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23514,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU421 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23515,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU422 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23516,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU423 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23517,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU424 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23518,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU425 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23519,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU426 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23520,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU427 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23521,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU428 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23522,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU429 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23523,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU43 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23524,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU430 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23525,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU431 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23526,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU432 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Klebsiella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23527,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU433 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23528,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU434 (Firmicutes;Clostridiales;Christensenellaceae;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23529,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU435 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23530,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU436 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23531,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU437 (Proteobacteria;Caulobacterales;Caulobacteraceae;Mycoplana) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23532,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU438 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23533,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU439 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroidesacidifaciens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23534,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU44 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23535,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU440 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23536,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU441 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23537,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU442 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23538,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU443 (Firmicutes;Clostridiales;0.64) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23539,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU444 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23540,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU445 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23541,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU446 (Firmicutes;Clostridiales;Lachnospiraceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23542,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU447 (Proteobacteria;Rhizobiales;Rhizobiaceae;Agrobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23543,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU448 (Proteobacteria;Xanthomonadales;Xanthomonadaceae;Stenotrophomonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23544,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU449 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23545,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU45 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23546,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU450 (Firmicutes;Clostridiales;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23547,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU451 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23548,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU452 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23549,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU453 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23550,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU454 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23551,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU455 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23552,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU456 (Firmicutes;Clostridiales;Ruminococcaceae;0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23553,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU457 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacteriummastitidis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23554,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU458 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23555,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU459 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23556,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU46 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23557,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU460 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23558,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU461 (Firmicutes;Clostridiales;Lachnospiraceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23559,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU462 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23560,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU463 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23561,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU464 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Oxalobacterformigenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23562,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU465 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23563,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU466 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23564,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU467 (Firmicutes;Clostridiales;Lachnospiraceae;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23565,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU468 (Proteobacteria;Pasteurellales;Pasteurellaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23566,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU469 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23567,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU47 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23568,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU470 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23569,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU471 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23570,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU472 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23571,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU473 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23572,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU474 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23573,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU475 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23574,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU476 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23575,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU477 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23576,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU478 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23577,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU479 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23578,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU48 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23579,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU480 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23580,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU481 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23581,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU482 (Firmicutes;Clostridiales;Ruminococcaceae;Faecalibacteriumprausnitzii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23582,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU483 (Proteobacteria;Pseudomonadales;Moraxellaceae;Acinetobacter1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23583,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU484 (Bacteroidetes;Bacteroidales;[Paraprevotellaceae];[Prevotella]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23584,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU485 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23585,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU486 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23586,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU487 (Firmicutes;Clostridiales;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23587,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU488 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23588,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU489 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23589,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU49 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23590,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU490 (Firmicutes;Clostridiales;Veillonellaceae;Veillonelladispar) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23591,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU491 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;Clostridiumcocleatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23592,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU492 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23593,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU493 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23594,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU494 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23595,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU495 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23596,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU496 (Firmicutes;Clostridiales;Ruminococcaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23597,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU497 (Firmicutes;Clostridiales;Dehalobacteriaceae;Dehalobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23598,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU498 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23599,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU499 (Actinobacteria;Actinomycetales;Microbacteriaceae;Curtobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23600,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU5 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23601,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU50 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23602,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU500 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23603,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU501 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23604,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU502 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23605,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU503 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23606,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU504 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23607,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU505 (Firmicutes;Clostridiales;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23608,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU506 (Firmicutes;Clostridiales;Lachnospiraceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23609,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU507 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23610,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU508 (Firmicutes;Clostridiales;Ruminococcaceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23611,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU509 (Firmicutes;Clostridiales;Lachnospiraceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23612,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU51 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23613,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU510 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Collinsella0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23614,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU511 (Proteobacteria;Pseudomonadales;Pseudomonadaceae;Pseudomonasveronii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23615,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU512 (Firmicutes;Clostridiales;Clostridiaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23616,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU513 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23617,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU514 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23618,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU515 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23619,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU516 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23620,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU517 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23621,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU518 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23622,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU519 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23623,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU52 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23624,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU520 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23625,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU521 (Firmicutes;Clostridiales;Lachnospiraceae;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23626,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU522 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23627,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU523 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostocfallax) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23628,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU524 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23629,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU525 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23630,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU526 (Firmicutes;Clostridiales;Ruminococcaceae;0.59) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23631,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU527 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Ralstonia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23632,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU528 (0.9;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23633,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU529 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23634,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU53 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23635,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU530 (Proteobacteria;Campylobacterales;Helicobacteraceae;Flexispira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23636,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU531 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Sphingobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23637,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU532 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23638,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU533 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23639,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU534 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23640,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU535 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23641,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU536 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23642,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU537 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23643,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU538 (Firmicutes;Clostridiales;Ruminococcaceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23644,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU539 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23645,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU54 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23646,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU540 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23647,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU541 (Firmicutes;Clostridiales;0.83) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23648,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU542 (Firmicutes;Clostridiales;Ruminococcaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23649,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU543 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23650,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU544 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23651,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU545 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23652,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU546 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23653,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU547 (0.91;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23654,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU548 (Firmicutes;Clostridiales;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23655,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU549 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23656,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU55 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23657,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU550 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23658,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU551 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23659,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU552 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23660,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU553 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23661,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU554 (Firmicutes;Bacillales;Bacillaceae;Bacillusflexus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23662,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU555 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23663,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU556 (Firmicutes;Clostridiales;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23664,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU557 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23665,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU558 (Proteobacteria;Pasteurellales;Pasteurellaceae;Actinobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23666,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU559 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23667,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU56 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23668,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU560 (Firmicutes;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23669,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU561 (Firmicutes;Clostridiales;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23670,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU562 (Firmicutes;Clostridiales;Lachnospiraceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23671,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU563 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23672,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU564 (Actinobacteria;Actinomycetales;Microbacteriaceae;Agromyces) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23673,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU565 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23674,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU566 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23675,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU567 (Firmicutes;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23676,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU568 (Firmicutes;Clostridiales;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23677,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU569 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23678,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU57 (Verrucomicrobia;Verrucomicrobiales;Verrucomicrobiaceae;Akkermansiamuciniphila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23679,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU570 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23680,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU571 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23681,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU572 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23682,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU573 (Proteobacteria;Burkholderiales;Comamonadaceae;Comamonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23683,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU574 (Bacteroidetes;Bacteroidales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23684,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU575 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23685,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU576 (Firmicutes;Clostridiales;Ruminococcaceae;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23686,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU577 (Actinobacteria;Actinomycetales;Actinomycetaceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23687,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU578 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23688,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU579 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23689,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU58 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23690,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU580 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23691,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU581 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23692,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU582 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23693,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU583 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23694,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU584 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23695,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU585 (Firmicutes;Lactobacillales;Lactobacillaceae;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23696,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU586 (Proteobacteria;Rhodobacterales;Rhodobacteraceae;Rhodobacter0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23697,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU587 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23698,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU588 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23699,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU589 (Firmicutes;Clostridiales;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23700,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU59 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23701,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU590 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23702,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU591 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23703,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU592 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23704,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU593 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23705,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU594 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23706,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU595 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23707,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU596 (Proteobacteria;Burkholderiales;Comamonadaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23708,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU597 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23709,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU598 (Proteobacteria;Pseudomonadales;Moraxellaceae;Enhydrobacter0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23710,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU599 (0.96;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23711,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU6 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23712,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU60 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23713,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU600 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23714,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU601 (Firmicutes;Clostridiales;Lachnospiraceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23715,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU602 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23716,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU603 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23717,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU604 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23718,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU605 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23719,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU606 (OD1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23720,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU607 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumbutyricum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23721,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU608 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23722,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU609 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Pedobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23723,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU61 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23724,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU62 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23725,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU63 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23726,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU64 (Firmicutes;Clostridiales;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23727,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU65 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23728,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU66 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23729,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU67 (Firmicutes;Clostridiales;Lachnospiraceae;Roseburia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23730,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU68 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Desulfovibrio) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23731,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU69 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23732,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU7 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillusreuteri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23733,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU70 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Bilophila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23734,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU71 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23735,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU72 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23736,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU73 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23737,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU74 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23738,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU75 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23739,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU76 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23740,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU77 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23741,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU78 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23742,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU79 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23743,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU8 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23744,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU80 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23745,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU81 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23746,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU82 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23747,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU83 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23748,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU84 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23749,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU85 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcusalactolyticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23750,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU86 (Firmicutes;Lactobacillales;Enterococcaceae;Enterococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23751,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU87 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23752,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU88 (Deferribacteres;Deferribacterales;Deferribacteraceae;Mucispirillumschaedleri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23753,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU89 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23754,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU9 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;DesulfovibrioC21) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23755,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU90 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23756,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU91 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23757,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU92 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23758,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU93 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23759,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU94 (Firmicutes;Clostridiales;Lachnospiraceae;0.72) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23760,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU95 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23761,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU96 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23762,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU97 (Firmicutes;Clostridiales;Peptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23763,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU98 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23764,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU99 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23765,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU_1 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus ) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23766,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU10 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23767,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU100 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23768,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU101 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23769,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU102 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23770,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU103 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23771,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU104 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23772,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU105 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23773,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU106 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23774,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU107 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23775,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU108 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23776,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU109 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23777,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU11 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23778,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU110 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23779,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU111 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23780,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU112 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23781,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU113 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23782,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU114 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23783,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU115 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23784,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU116 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23785,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU117 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23786,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU118 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23787,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU119 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23788,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU12 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23789,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU120 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23790,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU121 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23791,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU122 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23792,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU123 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23793,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU124 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23794,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU125 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23795,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU126 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23796,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU127 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23797,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU128 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23798,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU129 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23799,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU13 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23800,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU130 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23801,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU131 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23802,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU132 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23803,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU133 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23804,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU134 (Bacteroidetes;Bacteroidales;Rikenellaceae;AF12) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23805,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU135 (Firmicutes;Clostridiales;Lachnospiraceae;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23806,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU136 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23807,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU137 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23808,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU138 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23809,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU139 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23810,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU14 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23811,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU140 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23812,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU141 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23813,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU142 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23814,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU143 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23815,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU144 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23816,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU145 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23817,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU146 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23818,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU147 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23819,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU148 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23820,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU149 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23821,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU15 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23822,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU150 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23823,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU151 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23824,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU152 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23825,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU153 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23826,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU154 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23827,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU155 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23828,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU156 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23829,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU157 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23830,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU158 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23831,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU159 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23832,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU16 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23833,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU160 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23834,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU161 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23835,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU162 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23836,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU163 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23837,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU164 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23838,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU165 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23839,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU166 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23840,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU167 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23841,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU168 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23842,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU169 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23843,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU17 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23844,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU170 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23845,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU171 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23846,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU172 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23847,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU173 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23848,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU174 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23849,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU175 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23850,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU176 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23851,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU177 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23852,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU178 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23853,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU179 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23854,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU18 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23855,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU180 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23856,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU181 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23857,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU182 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23858,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU183 (Firmicutes;Clostridiales;Lachnospiraceae;Anaerostipes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23859,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU184 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23860,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU185 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23861,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU186 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23862,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU187 (Firmicutes;Clostridiales;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23863,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU188 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23864,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU189 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23865,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU19 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23866,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU190 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23867,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU191 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23868,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU192 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23869,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU193 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23870,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU194 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23871,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU195 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23872,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU196 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23873,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU197 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23874,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU198 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23875,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU199 (Firmicutes;Clostridiales;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23876,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU2 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23877,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU20 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23878,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU200 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23879,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU201 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23880,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU202 (Firmicutes;Clostridiales;Peptococcaceae;rc4-4) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23881,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU203 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23882,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU204 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23883,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU205 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23884,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU206 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23885,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU207 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23886,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU208 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23887,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU209 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23888,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU21 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23889,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU210 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23890,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU211 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcusgarvieae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23891,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU212 (Firmicutes;Clostridiales;Lachnospiraceae;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23892,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU213 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23893,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU214 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23894,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU215 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23895,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU216 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostoc) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23896,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU217 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23897,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU218 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23898,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU219 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23899,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU22 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23900,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU220 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23901,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU221 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23902,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU222 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23903,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU223 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23904,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU224 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23905,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU225 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23906,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU226 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23907,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU227 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23908,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU228 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23909,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU229 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23910,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU23 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23911,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU230 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23912,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU231 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroidesdistasonis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23913,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU232 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23914,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU233 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23915,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU234 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23916,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU235 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23917,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU236 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23918,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU237 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23919,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU238 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23920,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU239 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23921,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU24 (Firmicutes;Turicibacterales;Turicibacteraceae;Turicibacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23922,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU240 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23923,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU241 (Firmicutes;Clostridiales;Lachnospiraceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23924,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU242 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23925,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU243 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23926,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU244 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23927,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU245 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23928,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU246 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23929,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU247 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23930,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU248 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23931,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU249 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23932,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU25 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23933,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU250 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23934,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU251 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23935,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU252 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23936,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU253 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23937,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU254 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23938,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU255 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23939,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU256 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23940,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU258 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23941,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU259 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23942,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU26 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23943,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU260 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23944,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU261 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23945,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU262 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23946,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU263 (Firmicutes;Clostridiales;Lachnospiraceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23947,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU264 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23948,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU265 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23949,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU266 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23950,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU267 (Firmicutes;Clostridiales;Clostridiaceae;Candidatus Arthromitus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23951,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU268 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23952,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU269 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23953,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU27 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23954,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU270 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23955,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU271 (Bacteroidetes;Bacteroidales;Prevotellaceae;Prevotella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23956,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU272 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23957,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU273 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23958,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU274 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23959,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU275 (Firmicutes;Clostridiales;Ruminococcaceae;Clostridiumthermosuccinogenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23960,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU276 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23961,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU277 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23962,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU278 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23963,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU279 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23964,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU28 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23965,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU280 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23966,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU281 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23967,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU282 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23968,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU283 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23969,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU284 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23970,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU285 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23971,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU286 (Firmicutes;Clostridiales;Lachnospiraceae;0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23972,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU287 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23973,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU288 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23974,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU289 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23975,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU29 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23976,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU290 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23977,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU291 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23978,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU292 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23979,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU293 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23980,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU294 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23981,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU295 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23982,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU296 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23983,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU297 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23984,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU298 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23985,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU299 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23986,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU3 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23987,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU30 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23988,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU300 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23989,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU301 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23990,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU302 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23991,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU303 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23992,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU304 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23993,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU305 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23994,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU306 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23995,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU307 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.86) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23996,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU308 (Firmicutes;Clostridiales;Lachnospiraceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23997,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU309 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23998,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU31 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_23999,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU310 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24000,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU311 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24001,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU312 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24002,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU313 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24003,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU314 (Firmicutes;Clostridiales;Lachnospiraceae;Ruminococcusgauvreauii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24004,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU315 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24005,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU316 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24006,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU317 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24007,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU318 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24008,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU319 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24009,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU32 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24010,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU320 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24011,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU321 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24012,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU322 (TM7;CW040;F16) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24013,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU323 (Firmicutes;Clostridiales;Ruminococcaceae;0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24014,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU324 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24015,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU325 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24016,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU326 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24017,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU327 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24018,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU328 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24019,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU329 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24020,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU33 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24021,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU330 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24022,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU331 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24023,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU332 (Firmicutes;Clostridiales;Christensenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24024,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU333 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24025,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU334 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24026,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU335 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24027,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU336 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24028,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU337 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24029,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU338 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24030,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU339 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24031,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU34 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24032,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU340 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24033,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU341 (Firmicutes;Clostridiales;Lachnospiraceae;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24034,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU342 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24035,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU343 (Firmicutes;Clostridiales;0.82) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24036,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU344 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24037,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU345 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24038,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU346 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24039,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU347 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24040,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU348 (Firmicutes;Clostridiales;Ruminococcaceae;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24041,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU349 (Firmicutes;Clostridiales;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24042,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU35 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24043,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU350 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24044,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU351 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24045,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU352 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24046,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU353 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24047,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU354 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24048,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU355 (Firmicutes;Clostridiales;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24049,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU356 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24050,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU357 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24051,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU358 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24052,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU359 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24053,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU36 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24054,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU360 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24055,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU361 (Firmicutes;Clostridiales;Ruminococcaceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24056,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU362 (Firmicutes;Clostridiales;Ruminococcaceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24057,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU363 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24058,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU364 (Firmicutes;Clostridiales;Ruminococcaceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24059,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU365 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24060,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU366 (Proteobacteria;Campylobacterales;Helicobacteraceae;Helicobacterhepaticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24061,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU367 (Tenericutes;Mycoplasmatales;Mycoplasmataceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24062,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU368 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24063,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU369 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridiumpiliforme) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24064,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU37 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24065,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU370 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24066,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU371 (Firmicutes;Clostridiales;Ruminococcaceae;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24067,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU372 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24068,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU373 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.78) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24069,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU374 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacterium0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24070,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU375 (Firmicutes;Lactobacillales;Streptococcaceae;Lactococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24071,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU376 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24072,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU377 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24073,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU378 (Firmicutes;Clostridiales;Lachnospiraceae;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24074,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU379 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24075,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU38 (Firmicutes;Bacillales;Staphylococcaceae;Staphylococcusaureus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24076,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU380 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24077,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU381 (Firmicutes;Clostridiales;Lachnospiraceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24078,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU382 (Firmicutes;Clostridiales;Lachnospiraceae;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24079,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU383 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24080,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU384 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24081,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU385 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24082,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU386 (Firmicutes;Lactobacillales;Leuconostocaceae;Weissellaconfusa) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24083,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU387 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24084,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU388 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24085,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU389 (Firmicutes;Clostridiales;Peptostreptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24086,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU39 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24087,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU390 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24088,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU391 (Firmicutes;Clostridiales;Lachnospiraceae;Clostridium0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24089,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU392 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24090,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU393 (Firmicutes;Clostridiales;Ruminococcaceae;Butyricicoccuspullicaecorum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24091,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU394 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24092,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU395 (Firmicutes;Clostridiales;Ruminococcaceae;0.8) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24093,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU396 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24094,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU397 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24095,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU398 (Firmicutes;Clostridiales;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24096,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU399 (Firmicutes;Clostridiales;Lachnospiraceae;0.77) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24097,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU4 (Actinobacteria;Bifidobacteriales;Bifidobacteriaceae;Bifidobacteriumpseudolongum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24098,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU40 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24099,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU400 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24100,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU401 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24101,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU402 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24102,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU403 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24103,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU404 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24104,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU405 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24105,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU406 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24106,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU407 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumcelatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24107,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU408 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24108,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU409 (Firmicutes;Clostridiales;Lachnospiraceae;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24109,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU41 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24110,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU410 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24111,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU411 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24112,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU412 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24113,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU413 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24114,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU414 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24115,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU415 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Proteus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24116,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU416 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24117,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU417 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24118,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU418 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Slackia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24119,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU419 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24120,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU42 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24121,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU420 (Firmicutes;Clostridiales;Ruminococcaceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24122,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU421 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24123,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU422 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24124,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU423 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24125,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU424 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24126,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU425 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24127,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU426 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24128,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU427 (Firmicutes;Clostridiales;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24129,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU428 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24130,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU429 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24131,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU43 (Firmicutes;Clostridiales;0.95) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24132,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU430 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24133,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU431 (Firmicutes;Clostridiales;0.91) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24134,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU432 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;Klebsiella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24135,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU433 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24136,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU434 (Firmicutes;Clostridiales;Christensenellaceae;0.6) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24137,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU435 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24138,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU436 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24139,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU437 (Proteobacteria;Caulobacterales;Caulobacteraceae;Mycoplana) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24140,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU438 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24141,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU439 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroidesacidifaciens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24142,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU44 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24143,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU440 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24144,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU441 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24145,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU442 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24146,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU443 (Firmicutes;Clostridiales;0.64) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24147,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU444 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24148,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU445 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24149,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU446 (Firmicutes;Clostridiales;Lachnospiraceae;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24150,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU447 (Proteobacteria;Rhizobiales;Rhizobiaceae;Agrobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24151,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU448 (Proteobacteria;Xanthomonadales;Xanthomonadaceae;Stenotrophomonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24152,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU449 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24153,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU45 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24154,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU450 (Firmicutes;Clostridiales;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24155,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU451 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24156,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU452 (Firmicutes;Clostridiales;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24157,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU453 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24158,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU454 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24159,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU455 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24160,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU456 (Firmicutes;Clostridiales;Ruminococcaceae;0.58) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24161,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU457 (Actinobacteria;Actinomycetales;Corynebacteriaceae;Corynebacteriummastitidis) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24162,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU458 (Cyanobacteria;YS2) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24163,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU459 (Firmicutes;Clostridiales;0.9) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24164,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU46 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24165,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU460 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24166,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU461 (Firmicutes;Clostridiales;Lachnospiraceae;0.69) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24167,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU462 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24168,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU463 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24169,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU464 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Oxalobacterformigenes) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24170,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU465 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24171,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU466 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24172,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU467 (Firmicutes;Clostridiales;Lachnospiraceae;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24173,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU468 (Proteobacteria;Pasteurellales;Pasteurellaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24174,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU469 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24175,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU47 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24176,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU470 (Proteobacteria;Enterobacteriales;Enterobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24177,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU471 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24178,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU472 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24179,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU473 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24180,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU474 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24181,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU475 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24182,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU476 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24183,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU477 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24184,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU478 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24185,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU479 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24186,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU48 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24187,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU480 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24188,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU481 (Bacteroidetes;Bacteroidales;Rikenellaceae;Rikenella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24189,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU482 (Firmicutes;Clostridiales;Ruminococcaceae;Faecalibacteriumprausnitzii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24190,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU483 (Proteobacteria;Pseudomonadales;Moraxellaceae;Acinetobacter1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24191,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU484 (Bacteroidetes;Bacteroidales;[Paraprevotellaceae];[Prevotella]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24192,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU485 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24193,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU486 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24194,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU487 (Firmicutes;Clostridiales;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24195,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU488 (Firmicutes;Clostridiales;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24196,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU489 (Firmicutes;Clostridiales;0.66) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24197,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU49 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24198,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU490 (Firmicutes;Clostridiales;Veillonellaceae;Veillonelladispar) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24199,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU491 (Firmicutes;Erysipelotrichales;Erysipelotrichaceae;Clostridiumcocleatum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24200,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU492 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24201,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU493 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24202,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU494 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24203,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU495 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24204,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU496 (Firmicutes;Clostridiales;Ruminococcaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24205,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU497 (Firmicutes;Clostridiales;Dehalobacteriaceae;Dehalobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24206,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU498 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24207,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU499 (Actinobacteria;Actinomycetales;Microbacteriaceae;Curtobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24208,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU5 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24209,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU50 (Firmicutes;Clostridiales;Lachnospiraceae;Blautiaproducta) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24210,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU500 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24211,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU501 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24212,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU502 (Firmicutes;Clostridiales;[Mogibacteriaceae]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24213,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU503 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24214,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU504 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24215,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU505 (Firmicutes;Clostridiales;0.85) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24216,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU506 (Firmicutes;Clostridiales;Lachnospiraceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24217,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU507 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24218,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU508 (Firmicutes;Clostridiales;Ruminococcaceae;0.94) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24219,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU509 (Firmicutes;Clostridiales;Lachnospiraceae;0.88) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24220,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU51 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24221,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU510 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Collinsella0.54) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24222,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU511 (Proteobacteria;Pseudomonadales;Pseudomonadaceae;Pseudomonasveronii) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24223,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU512 (Firmicutes;Clostridiales;Clostridiaceae;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24224,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU513 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24225,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU514 (Proteobacteria;Burkholderiales;Alcaligenaceae;Sutterella) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24226,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU515 (Firmicutes;Clostridiales;Ruminococcaceae;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24227,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU516 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24228,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU517 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24229,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU518 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24230,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU519 (Firmicutes;Clostridiales;Lachnospiraceae;0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24231,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU52 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24232,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU520 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24233,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU521 (Firmicutes;Clostridiales;Lachnospiraceae;0.84) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24234,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU522 (Firmicutes;Clostridiales;Clostridiaceae;Clostridium0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24235,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU523 (Firmicutes;Lactobacillales;Leuconostocaceae;Leuconostocfallax) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24236,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU524 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24237,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU525 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24238,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU526 (Firmicutes;Clostridiales;Ruminococcaceae;0.59) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24239,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU527 (Proteobacteria;Burkholderiales;Oxalobacteraceae;Ralstonia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24240,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU528 (0.9;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24241,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU529 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24242,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU53 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24243,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU530 (Proteobacteria;Campylobacterales;Helicobacteraceae;Flexispira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24244,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU531 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Sphingobacterium) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24245,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU532 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24246,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU533 (Firmicutes;Clostridiales;Ruminococcaceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24247,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU534 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24248,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU535 (Firmicutes;Clostridiales;0.89) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24249,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU536 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24250,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU537 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24251,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU538 (Firmicutes;Clostridiales;Ruminococcaceae;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24252,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU539 (Firmicutes;Clostridiales;Ruminococcaceae;0.53) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24253,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU54 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24254,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU540 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24255,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU541 (Firmicutes;Clostridiales;0.83) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24256,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU542 (Firmicutes;Clostridiales;Ruminococcaceae;0.68) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24257,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU543 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24258,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU544 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24259,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU545 (Firmicutes;Clostridiales;0.61) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24260,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU546 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24261,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU547 (0.91;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24262,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU548 (Firmicutes;Clostridiales;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24263,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU549 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24264,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU55 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24265,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU550 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24266,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU551 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24267,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU552 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24268,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU553 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24269,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU554 (Firmicutes;Bacillales;Bacillaceae;Bacillusflexus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24270,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU555 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24271,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU556 (Firmicutes;Clostridiales;0.74) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24272,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU557 (Firmicutes;Clostridiales;Ruminococcaceae;0.51) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24273,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU558 (Proteobacteria;Pasteurellales;Pasteurellaceae;Actinobacillus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24274,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU559 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24275,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU56 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24276,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU560 (Firmicutes;0.56) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24277,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU561 (Firmicutes;Clostridiales;0.76) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24278,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU562 (Firmicutes;Clostridiales;Lachnospiraceae;0.96) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24279,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU563 (Firmicutes;Clostridiales;Lachnospiraceae;0.52) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24280,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU564 (Actinobacteria;Actinomycetales;Microbacteriaceae;Agromyces) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24281,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU565 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24282,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU566 (Tenericutes;RF39) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24283,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU567 (Firmicutes;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24284,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU568 (Firmicutes;Clostridiales;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24285,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU569 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24286,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU57 (Verrucomicrobia;Verrucomicrobiales;Verrucomicrobiaceae;Akkermansiamuciniphila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24287,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU570 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24288,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU571 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24289,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU572 (Firmicutes;Clostridiales;Lachnospiraceae;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24290,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU573 (Proteobacteria;Burkholderiales;Comamonadaceae;Comamonas) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24291,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU574 (Bacteroidetes;Bacteroidales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24292,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU575 (Firmicutes;Clostridiales;0.93) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24293,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU576 (Firmicutes;Clostridiales;Ruminococcaceae;0.55) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24294,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU577 (Actinobacteria;Actinomycetales;Actinomycetaceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24295,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU578 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24296,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU579 (Firmicutes;Clostridiales;Lachnospiraceae;Dorea) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24297,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU58 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24298,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU580 (1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24299,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU581 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24300,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU582 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillus0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24301,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU583 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24302,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU584 (Firmicutes;Clostridiales;0.97) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24303,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU585 (Firmicutes;Lactobacillales;Lactobacillaceae;0.81) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24304,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU586 (Proteobacteria;Rhodobacterales;Rhodobacteraceae;Rhodobacter0.73) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24305,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU587 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumperfringens) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24306,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU588 (Actinobacteria;Coriobacteriales;Coriobacteriaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24307,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU589 (Firmicutes;Clostridiales;0.65) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24308,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU59 (Firmicutes;Clostridiales;Ruminococcaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24309,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU590 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24310,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU591 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24311,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU592 (Firmicutes;Clostridiales;0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24312,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU593 (Firmicutes;Clostridiales;0.98) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24313,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU594 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24314,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU595 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24315,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU596 (Proteobacteria;Burkholderiales;Comamonadaceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24316,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU597 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24317,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU598 (Proteobacteria;Pseudomonadales;Moraxellaceae;Enhydrobacter0.99) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24318,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU599 (0.96;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24319,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU6 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24320,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU60 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24321,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU600 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24322,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU601 (Firmicutes;Clostridiales;Lachnospiraceae;0.75) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24323,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU602 (Bacteroidetes;Bacteroidales;Porphyromonadaceae;Parabacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24324,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU603 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24325,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU604 (Firmicutes;Clostridiales;Ruminococcaceae;Ruminococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24326,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU605 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24327,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU606 (OD1;) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24328,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU607 (Firmicutes;Clostridiales;Clostridiaceae;Clostridiumbutyricum) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24329,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU608 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24330,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU609 (Bacteroidetes;Sphingobacteriales;Sphingobacteriaceae;Pedobacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24331,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU61 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24332,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU62 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24333,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU63 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24334,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU64 (Firmicutes;Clostridiales;0.92) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24335,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU65 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24336,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU66 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24337,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU67 (Firmicutes;Clostridiales;Lachnospiraceae;Roseburia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24338,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU68 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Desulfovibrio) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24339,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU69 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24340,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU7 (Firmicutes;Lactobacillales;Lactobacillaceae;Lactobacillusreuteri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24341,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU70 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;Bilophila) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24342,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU71 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24343,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU72 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24344,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU73 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24345,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU74 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24346,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU75 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24347,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU76 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24348,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU77 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24349,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU78 (Firmicutes;Clostridiales) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24350,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU79 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24351,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU8 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24352,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU80 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24353,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU81 (Bacteroidetes;Bacteroidales;Rikenellaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24354,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU82 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24355,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU83 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24356,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU84 (Firmicutes;Clostridiales;Lachnospiraceae;Coprococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24357,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU85 (Firmicutes;Lactobacillales;Streptococcaceae;Streptococcusalactolyticus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24358,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU86 (Firmicutes;Lactobacillales;Enterococcaceae;Enterococcus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24359,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU87 (Actinobacteria;Coriobacteriales;Coriobacteriaceae;Adlercreutzia) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24360,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU88 (Deferribacteres;Deferribacterales;Deferribacteraceae;Mucispirillumschaedleri) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24361,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU89 (Firmicutes;Clostridiales;Lachnospiraceae;[Ruminococcus]gnavus) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24362,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU9 (Proteobacteria;Desulfovibrionales;Desulfovibrionaceae;DesulfovibrioC21) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24363,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU90 (Bacteroidetes;Bacteroidales;Bacteroidaceae;Bacteroides) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24364,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU91 (Firmicutes;Clostridiales;Lachnospiraceae;1) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24365,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU92 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24366,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU93 (Bacteroidetes;Bacteroidales;[Odoribacteraceae];Odoribacter) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24367,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU94 (Firmicutes;Clostridiales;Lachnospiraceae;0.72) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24368,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU95 (Firmicutes;Clostridiales;Ruminococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24369,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU96 (Firmicutes;Clostridiales;Lachnospiraceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24370,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU97 (Firmicutes;Clostridiales;Peptococcaceae) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24371,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU98 (Firmicutes;Clostridiales;Ruminococcaceae;Oscillospira) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24372,"Metagenome, microbiota, gastrointestinal system, metabolism: OTU99 (Bacteroidetes;Bacteroidales;S24-7) proportion assessed by 16S rRNA sequencing of cecum content from young adult males (3-6 months) on a standard chow diet (CD, EPFL LISP3 Cohort, 2014-2018) [normalised log fraction]"
BXD_24373,"Aging, metabolism: Serum fasting glucose of females between 6 and 12 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 2018 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice,  July 2020 [mmol/L]"
BXD_24374,"Aging, metabolism: Serum fasting glucose of females between 18 and 24 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, July 2020 [mmol/L]"
BXD_24375,"Aging, metabolism: Serum fasting glucose of females between 6 and 12 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, July 2020 [mmol/L]"
BXD_24376,"Aging, metabolism: Serum fasting glucose of females between 18 and 24 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, July 2020 [mmol/L]"
BXD_24377,"Aging, metabolism: Serum triglycerides of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=255) [mmol/L]"
BXD_24378,"Aging, metabolism: Serum triglycerides of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=254) [mmol/L]"
BXD_24379,"Aging, metabolism: Serum free fatty acids of females between 6 and 25 months of age (not adjusted for age) at UTHSC on standard chow diet (Harlan Teklad 7912 chow diet, 6.2% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=255) [mmol/L]"
BXD_24380,"Aging, metabolism: Serum free fatty acids of females between 6 and 25 months of age (not adjusted for age) at UTHSC on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, fasted overnight before sacrifice, June 2020 (n=254) [mmol/L]"
BXD_24381,EGL Cell Density E15
BXD_24382,EGL Volume E15
BXD_24383,"Central nervous system, immunology, toxicology: sum of genotypes at max LRS positions from eQTL of Paraquat phenotypes in brain"
BXD_24384,Mitochondria: mtDNA copy number estimate in liver of 4 to 8 months of age female mice on chow diet (n)
BXD_24385,Mitochondria: mtDNA copy number estimate in liver of 10 to 14 months of age female mice on chow diet (n)
BXD_24386,Mitochondria: mtDNA copy number estimate in liver of 16 to 20 months of age female mice on chow diet (n)
BXD_24387,Mitochondria: mtDNA copy number estimate in liver of 22 to 26 months of age female mice on chow diet (n)
BXD_24388,PCA1 PQ metals in liver
BXD_24389,PCA2 PQ metals in liver
BXD_24390,PCA3 PQ metals in liver
BXD_24391,PCA1 PQ metals in liver
BXD_24392,PCA2 PQ metals in liver
BXD_24393,PCA3 PQ metals in liver
BXD_24394,Mitochondria: mtDNA copy number estimate in liver of 16 to 20 months of age female mice on high fat (n)
BXD_24395,Mitochondria: mtDNA copy number estimate in liver of 4 to 8 months of age female mice on high fat (n)
BXD_24396,"Mitochondria: mtDNA copy number estimate in liver of 22 to 26 months of age female mice, difference between chow-diet and high fat diet (n)"
BXD_24397,"Mitochondria: mtDNA copy number estimate in spleen of 30 to 60 day old male mice on chow diet, from sequencing (n)"
BXD_24398,Cancer: Makowski 000009 (liza.makowski@uthsc.edu)
BXD_24399,Mitochondria: mtDNA copy number estimate in liver of 10 to 14 months of age female mice on high fat (n)
BXD_24400,Mitochondria: mtDNA copy number estimate in liver of 22 to 26 months of age female mice on high fat (n)
BXD_24401,Cancer: Makowski 000010 (liza.makowski@uthsc.edu)	
BXD_24402,Cancer: Makowski 000011 (liza.makowski@uthsc.edu)
BXD_24403,Cancer: Makowski 000012 (liza.makowski@uthsc.edu)
BXD_24404,Cancer: Makowski 000013 (liza.makowski@uthsc.edu)
BXD_24405,Cancer: Makowski 000014 (liza.makowski@uthsc.edu)
BXD_24406,Cancer: Makowski 000015 (liza.makowski@uthsc.edu)
BXD_24407,Cancer: Makowski 000016 (liza.makowski@uthsc.edu)
BXD_24408,Cancer: Makowski 000017 (liza.makowski@uthsc.edu)
BXD_24409,"Central nervous system, morphology: Cerebellar volume at P30"
BXD_24410,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)"
BXD_24411,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)"
BXD_24412,Cancer: Makowski 000018 (liza.makowski@uthsc.edu)
BXD_24413,Genomics: Harris_Sasani_002(harriske@uw.edu)rate_per_bp_1000000000
BXD_24414,Genomics: Harris_Sasani_003(harriske@uw.edu)
BXD_24415,"Genetics, statistics, cofactors: BXD F2 derived [-1 = epochs 1,2,4 and 6] or advanced intercross derived (AI) [1 = epochs 3 and 5]"
BXD_24416,"Data from 
J Neurosc. 1998 Dec 1;18(23):9948-53.
doi: 10.1523/JNEUROSCI.18-23-09948.1998.
Cell production and cell death in the generation of variation in neuron number. R C Strom, R W Williams
"
BXD_24417,"Reproduction, development, morphology: Litter size, postnatal day 21 (Hager Lab, 2009-20014, University of Manchester) [n]"
BXD_24418,"Reproduction, development, morphology: Females per litter, postnatal day 21 (Hager Lab, 2009-20014, University of Manchester) [n]"
BXD_24419,"Reproduction, development, morphology: Males per litter, postnatal day 21 (Hager Lab, 2009-20014, University of Manchester) [n]"
BXD_24420,"Development, morphology- Mean body weight of BXDF1 females at day 21 [g]"
BXD_24421,"Development, morphology- Mean body weight of BXDF1 males at day 21 [g]"
BXD_24422,"Development, morphology- Mean body weight of BXDF1 (males and females) at day 21 [g]"
BXD_24423,"Development, morphology- Mean tail length of BXDF1 females at day 21 [mm]"
BXD_24424,"Development, morphology- Mean tail length of BXDF1 males at day 21 [mm]"
BXD_24425,"Development, morphology- Mean tail length of BXDF1 (males and females) at day 21 [mm]"
BXD_24426,"Central nervous system, development, morphology- Mean brain weight of BXDF1 females at day 21 [mg]"
BXD_24427,"Central nervous system, development, morphology- Mean brain weight of BXDF1 males at day 21 [mg]"
BXD_24428,"Central nervous system, development, morphology- Mean brain weight of BXDF1 (males and females) at day 21 [mg]"
BXD_24429,"Immune system, infectious disease: Fitzpatrick trait xxxx (please contact efitzpat@uthsc.edu for details)."
BXD_24430,"Genetics, variation: Autosomal germline C>A mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24431,"Genetics, variation: Autosomal germline C>T mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24432,"Genetics, variation: Autosomal germline C>G mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24433,"Genetics, variation: Autosomal germline A>C mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24434,"Genetics, variation: Autosomal germline A>T mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24435,"Genetics, variation: Autosomal germline A>G mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24436,"Genetics, variation: Autosomal germline CpG>TpG mutations, measured by whole genome sequencing at approximately 40X coverage [fraction]"
BXD_24437,"Genetics, variation: Autosomal germline C>A mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24438,"Genetics, variation: Autosomal germline C>T mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24439,"Genetics, variation: Autosomal germline C>G mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24440,"Genetics, variation: Autosomal germline A>C mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24441,"Genetics, variation: Autosomal germline A>T mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24442,"Genetics, variation: Autosomal germline A>G mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24443,"Genetics, variation: Autosomal germline CpG>TpG mutation rate, expressed per base pair per generation, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24444,"Genetics, variation: Overall autosomal germline mutation rate, measured by whole genome sequencing at approximately 40X coverage [per base pair, per generation]"
BXD_24445,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, Copper (Cu) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively after using the drinking in the dark (DID) method for 16 weeks [Âµg/g]"
BXD_24446,"Central nervous system, pharmacology, metabolism, behavior: Copper (Cu) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively under normal husbandary  [Âµg/g]"
BXD_24447,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, Iron (Fe) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively after using the drinking in the dark (DID) method for 16 weeks [Âµg/g]"
BXD_24448,"Central nervous system, pharmacology, metabolism, behavior: Iron (Fe) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively under nomral husbandary  [Âµg/g]"
BXD_24449,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, Zinc (Zn) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively after using the drinking in the dark (DID) method for 16 weeks [Âµg/g]"
BXD_24450,"Central nervous system, pharmacology, metabolism, behavior: Zinc (Zn) concentration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively under normal husbandary  [Âµg/g]"
BXD_24451,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, Ratio of Cuppor/Zinc (Cu/Zn) concertration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively after using the drinking in the dark (DID) method for 16 weeks [(µg/g)/(µg/g)]"
BXD_24452,"Central nervous system, pharmacology, metabolism, behavior: Ratio of Cuppor/Zinc (Cu/Zn) concertration in hippocampus of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively under normal husbandary [(Âµg/g)/(Âµg/g)]"
BXD_24453,"Central nervous system, pharmacology, behavior: Ethanol response, consumption of 20% v/v EtOH using the drinking in the dark (DID) method, average EtOH cosumption for all 4h in period  of 16 weeks  of 93 to 311- day-old females [g/kg]"
BXD_24454,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, hippocampus weight of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectively after using the drinking in the dark (DID) method for 16 weeks [g]"
BXD_24455,"Central nervous system, pharmacology, metabolism, behavior: Ethanol response, hippocampus weight of 144 to 311- day-old females fed with Envigo diet 7912 containing 240, 93, and 63 ppm Fe, Cu, and Zn, respectivelyunder normal husbandary[g]"
BXD_24458,"Central nervous system, stereology, toxicology: Saline response, control for paraquat, tyrosine hydroxylase staining in substantia nigra pars compacta in 7â€“8-month-old males treated with saline once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24459,"Central nervous system, stereology, toxicology: Paraquat response, tyrosine hydroxylase staining in substantia nigra pars compacta in 7â€“8-month-old males treated with 5 mg/kg paraquat once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24460,"Central nervous system, stereology, toxicology: Saline response, control for paraquat, NeuN staining in substantia nigra pars compacta in 7â€“8-month-old males treated with saline once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24461,"Central nervous system, stereology, toxicology: Paraquat response, NeuN staining in substantia nigra pars compacta in 7â€“8-month-old males treated with 5 mg/kg paraquat once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24462,"Central nervous system, stereology, toxicology: Saline response, control for paraquat, Nuclei (DAPI) staining in substantia nigra pars compacta in 7â€“8-month-old males treated with saline once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24463,"Central nervous system, stereology, toxicology: Paraquat response, Nuclei (DAPI) staining in substantia nigra pars compacta in 7â€“8-month-old males treated with 5 mg/kg paraquat once a week for 3 weeks, 24h after last injection (ip) [counts]"
BXD_24464,"Aging, metabolism: Standard deviation (SD) of lifespan of females at UTHSC on standard chow diet (Teklad 7912 chow diet, 6.2% fat) at UTHSC on a 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding). Updated Feb 2023 [days]"
BXD_24465,"Aging, metabolism: Standard deviation (SD) of lifespan of females at UTHSC on a high fat diet (Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage on Teklad 7087 soft cob bedding. Updated Feb 2023 [days]"
BXD_24466,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in younger animals based on a generalized linear model accounting for sex where value of 1 is rapid urination when handled (UTHSC/CITG Colony) [residual n]"
BXD_24467,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress when scruffed) in older animals based on a generalized linear model accounting for sex where value of 1 is rapid urination when handled (UTHSC Aging Colony) [residual n]"
BXD_24468,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in all animals (young and old) based on a generalized linear model accounting for sex where value of 1 is rapid urination when handled (UTHSC both colonies) [residual n]"
BXD_24469,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in all females (young and old) based on a generalized linear model accounting for specific colony where value of 1 is rapid urination when handled (UTHSC both colonies) [residual n]"
BXD_24470,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in all males (young and old) based on a generalized linear model accounting for specific colony where value of 1 is rapid urination when handled (UTHSC both colonies) [residual n]"
BXD_24471,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in younger females where value of 1 is rapid urination when handled (UTHSC CITG Colony) [0=no micturition, 1=micturition]"
BXD_24472,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in younger males where value of 1 is rapid urination when handled (UTHSC CITG Colony) [0=no micturition, 1=micturition]"
BXD_24473,"Central nervous system, peripheral nervous system, behavior: Micturition, urination induced by handling (mild stress) in older females where value of 1 is rapid urination when handled (UTHSC Aging Colony) [0=no micturition, 1=micturition]"
BXD_24474,Cancer: Makowski_TIMER_000001 (liza.makowski@uthsc.edu)
BXD_24475,Cancer: Makowski_TIMER_000002 (liza.makowski@uthsc.edu)
BXD_24476,Cancer: Makowski_TIMER_000003 (liza.makowski@uthsc.edu)
BXD_24477,Cancer: Makowski_TIMER_000004 (liza.makowski@uthsc.edu)
BXD_24478,Cancer: Makowski_TIMER_000005 (liza.makowski@uthsc.edu)
BXD_24479,Cancer: Makowski_TIMER_000006 (liza.makowski@uthsc.edu)
BXD_24480,Cancer: Makowski_TIMER_000007 (liza.makowski@uthsc.edu)
BXD_24481,Cancer: Makowski_TIMER_000008 (liza.makowski@uthsc.edu)
BXD_24482,Cancer: Makowski_TIMER_000009 (liza.makowski@uthsc.edu)
BXD_24483,Cancer: Makowski_TIMER_000010 (liza.makowski@uthsc.edu)
BXD_24484,Cancer: Makowski_TIMER_000011 (liza.makowski@uthsc.edu)
BXD_24485,Cancer: Makowski_TIMER_000012 (liza.makowski@uthsc.edu)
BXD_24486,Cancer: Makowski_TIMER_000013 (liza.makowski@uthsc.edu)
BXD_24487,Cancer: Makowski_TIMER_000014 (liza.makowski@uthsc.edu)
BXD_24488,Cancer: Makowski_TIMER_000015 (liza.makowski@uthsc.edu)
BXD_24489,Cancer: Makowski_TIMER_000016 (liza.makowski@uthsc.edu)
BXD_24490,Cancer: Makowski_TIMER_000017 (liza.makowski@uthsc.edu)
BXD_24491,Cancer: Makowski_TIMER_000018 (liza.makowski@uthsc.edu)
BXD_24492,Cancer: Makowski_TIMER_000019 (liza.makowski@uthsc.edu)
BXD_24493,Cancer: Makowski_TIMER_000020 (liza.makowski@uthsc.edu)
BXD_24494,Cancer: Makowski_TIMER_000021 (liza.makowski@uthsc.edu)
BXD_24495,Cancer: Makowski_TIMER_000022 (liza.makowski@uthsc.edu)
BXD_24496,Cancer: Makowski_TIMER_000023 (liza.makowski@uthsc.edu)
BXD_24497,Cancer: Makowski_TIMER_000024 (liza.makowski@uthsc.edu)
BXD_24498,Cancer: Makowski_TIMER_000025 (liza.makowski@uthsc.edu)
BXD_24499,Cancer: Makowski_TIMER_000026 (liza.makowski@uthsc.edu)
BXD_24500,Cancer: Makowski_TIMER_000027 (liza.makowski@uthsc.edu)
BXD_24501,Cancer: Makowski_TIMER_000028 (liza.makowski@uthsc.edu)
BXD_24502,Cancer: Makowski_TIMER_000029 (liza.makowski@uthsc.edu)
BXD_24503,Cancer: Makowski_TIMER_000030 (liza.makowski@uthsc.edu)
BXD_24504,Cancer: Makowski_TIMER_000031 (liza.makowski@uthsc.edu)
BXD_24505,Cancer: Makowski_TIMER_000032 (liza.makowski@uthsc.edu)
BXD_24506,Cancer: Makowski_TIMER_000033 (liza.makowski@uthsc.edu)
BXD_24507,Cancer: Makowski_TIMER_000034 (liza.makowski@uthsc.edu)
BXD_24508,Cancer: Makowski_TIMER_000035 (liza.makowski@uthsc.edu)
BXD_24509,Cancer: Makowski_TIMER_000036 (liza.makowski@uthsc.edu)
BXD_24510,Cancer: Makowski_TIMER_000037 (liza.makowski@uthsc.edu)
BXD_24511,Cancer: Makowski_TIMER_000038 (liza.makowski@uthsc.edu)
BXD_24512,Cancer: Makowski_TIMER_000039 (liza.makowski@uthsc.edu)
BXD_24513,Cancer: Makowski_TIMER_000040 (liza.makowski@uthsc.edu)
BXD_24514,Cancer: Makowski_TIMER_000041 (liza.makowski@uthsc.edu)
BXD_24515,Cancer: Makowski_TIMER_000042 (liza.makowski@uthsc.edu)
BXD_24516,Cancer: Makowski_TIMER_000043 (liza.makowski@uthsc.edu)
BXD_24517,Cancer: Makowski_TIMER_000044 (liza.makowski@uthsc.edu)
BXD_24518,Cancer: Makowski_TIMER_000045 (liza.makowski@uthsc.edu)
BXD_24519,Cancer: Makowski_TIMER_000046 (liza.makowski@uthsc.edu)
BXD_24520,Cancer: Makowski_TIMER_000047 (liza.makowski@uthsc.edu)
BXD_24521,Cancer: Makowski_TIMER_000048 (liza.makowski@uthsc.edu)
BXD_24522,Cancer: Makowski_TIMER_000049 (liza.makowski@uthsc.edu)
BXD_24523,Cancer: Makowski_TIMER_000050 (liza.makowski@uthsc.edu)
BXD_24524,Cancer: Makowski_TIMER_000051 (liza.makowski@uthsc.edu)
BXD_24525,Cancer: Makowski_TIMER_000052 (liza.makowski@uthsc.edu)
BXD_24526,Cancer: Makowski_TIMER_000053 (liza.makowski@uthsc.edu)
BXD_24527,Cancer: Makowski_TIMER_000054 (liza.makowski@uthsc.edu)
BXD_24528,Cancer: Makowski_TIMER_000055 (liza.makowski@uthsc.edu)
BXD_24529,Cancer: Makowski_TIMER_000056 (liza.makowski@uthsc.edu)
BXD_24530,Cancer: Makowski_TIMER_000057 (liza.makowski@uthsc.edu)
BXD_24531,Cancer: Makowski_TIMER_000058 (liza.makowski@uthsc.edu)
BXD_24532,Cancer: Makowski_TIMER_000059 (liza.makowski@uthsc.edu)
BXD_24533,Cancer: Makowski_TIMER_000060 (liza.makowski@uthsc.edu)
BXD_24534,Cancer: Makowski_TIMER_000061 (liza.makowski@uthsc.edu)
BXD_24535,Cancer: Makowski_TIMER_000062 (liza.makowski@uthsc.edu)
BXD_24536,Cancer: Makowski_TIMER_000063 (liza.makowski@uthsc.edu)
BXD_24537,Cancer: Makowski_TIMER_000064 (liza.makowski@uthsc.edu)
BXD_24538,Cancer: Makowski_TIMER_000065 (liza.makowski@uthsc.edu)
BXD_24539,Cancer: Makowski_TIMER_000066 (liza.makowski@uthsc.edu)
BXD_24540,Cancer: Makowski_TIMER_000067 (liza.makowski@uthsc.edu)
BXD_24541,Cancer: Makowski_TIMER_000068 (liza.makowski@uthsc.edu)
BXD_24542,Cancer: Makowski_TIMER_000069 (liza.makowski@uthsc.edu)
BXD_24543,Cancer: Makowski_TIMER_000070 (liza.makowski@uthsc.edu)
BXD_24544,Cancer: Makowski_TIMER_000071 (liza.makowski@uthsc.edu)
BXD_24545,Cancer: Makowski_TIMER_000072 (liza.makowski@uthsc.edu)
BXD_24546,Cancer: Makowski_TIMER_000073 (liza.makowski@uthsc.edu)
BXD_24547,Cancer: Makowski_TIMER_000074 (liza.makowski@uthsc.edu)
BXD_24548,Cancer: Makowski_TIMER_000075 (liza.makowski@uthsc.edu)
BXD_24549,Cancer: Makowski_TIMER_000076 (liza.makowski@uthsc.edu)
BXD_24550,Cancer: Makowski_TIMER_000077 (liza.makowski@uthsc.edu)
BXD_24551,Cancer: Makowski_TIMER_000078 (liza.makowski@uthsc.edu)
BXD_24552,Cancer: Makowski_TIMER_000079 (liza.makowski@uthsc.edu)
BXD_24553,Cancer: Makowski_TIMER_000080 (liza.makowski@uthsc.edu)
BXD_24554,Cancer: Makowski_TIMER_000081 (liza.makowski@uthsc.edu)
BXD_24555,Cancer: Makowski_TIMER_000082 (liza.makowski@uthsc.edu)
BXD_24556,Cancer: Makowski_TIMER_000083 (liza.makowski@uthsc.edu)
BXD_24557,Cancer: Makowski_TIMER_000084 (liza.makowski@uthsc.edu)
BXD_24558,Cancer: Makowski_TIMER_000085 (liza.makowski@uthsc.edu)
BXD_24559,Cancer: Makowski_TIMER_000086 (liza.makowski@uthsc.edu)
BXD_24560,Cancer: Makowski_TIMER_000087 (liza.makowski@uthsc.edu)
BXD_24561,Cancer: Makowski_TIMER_000088 (liza.makowski@uthsc.edu)
BXD_24562,Cancer: Makowski_TIMER_000089 (liza.makowski@uthsc.edu)
BXD_24563,Cancer: Makowski_TIMER_000090 (liza.makowski@uthsc.edu)
BXD_24564,Cancer: Makowski_TIMER_000091 (liza.makowski@uthsc.edu)
BXD_24565,Cancer: Makowski_TIMER_000092 (liza.makowski@uthsc.edu)
BXD_24566,Cancer: Makowski_TIMER_000093 (liza.makowski@uthsc.edu)
BXD_24567,Cancer: Makowski_TIMER_000094 (liza.makowski@uthsc.edu)
BXD_24568,Cancer: Makowski_TIMER_000095 (liza.makowski@uthsc.edu)
BXD_24569,Cancer: Makowski_TIMER_000096 (liza.makowski@uthsc.edu)
BXD_24570,Cancer: Makowski_TIMER_000097 (liza.makowski@uthsc.edu)
BXD_24571,Cancer: Makowski_TIMER_000098 (liza.makowski@uthsc.edu)
BXD_24572,Cancer: Makowski_TIMER_000099 (liza.makowski@uthsc.edu)
BXD_24573,Cancer: Makowski_TIMER_000100 (liza.makowski@uthsc.edu)
BXD_24574,Cancer: Makowski_TIMER_000101 (liza.makowski@uthsc.edu)
BXD_24575,Cancer: Makowski_TIMER_000102 (liza.makowski@uthsc.edu)
BXD_24576,Cancer: Makowski_TIMER_000103 (liza.makowski@uthsc.edu)
BXD_24577,Cancer: Makowski_TIMER_000104 (liza.makowski@uthsc.edu)
BXD_24578,Cancer: Makowski_TIMER_000105 (liza.makowski@uthsc.edu)
BXD_24579,Cancer: Makowski_TIMER_000106 (liza.makowski@uthsc.edu)
BXD_24580,Cancer: Makowski_TIMER_000107 (liza.makowski@uthsc.edu)
BXD_24581,Cancer: Makowski_TIMER_000108 (liza.makowski@uthsc.edu)
BXD_24582,Cancer: Makowski_TIMER_000109 (liza.makowski@uthsc.edu)
BXD_24583,Cancer: Makowski_TIMER_000110 (liza.makowski@uthsc.edu)
BXD_24584,Cancer: Makowski_TIMER_000111 (liza.makowski@uthsc.edu)
BXD_24585,Cancer: Makowski_TIMER_000112 (liza.makowski@uthsc.edu)
BXD_24586,Cancer: Makowski_TIMER_000113 (liza.makowski@uthsc.edu)
BXD_24587,Cancer: Makowski_TIMER_000114 (liza.makowski@uthsc.edu)
BXD_24588,Cancer: Makowski_TIMER_000115 (liza.makowski@uthsc.edu)
BXD_24589,Cancer: Makowski_TIMER_000116 (liza.makowski@uthsc.edu)
BXD_24590,Cancer: Makowski_TIMER_000117 (liza.makowski@uthsc.edu)
BXD_24591,Cancer: Makowski_TIMER_000118 (liza.makowski@uthsc.edu)
BXD_24592,Cancer: Makowski_TIMER_000119 (liza.makowski@uthsc.edu)
BXD_24593,Cancer: Makowski_TIMER_000120 (liza.makowski@uthsc.edu)
BXD_24594,Cancer: Makowski_TIMER_000121 (liza.makowski@uthsc.edu)
BXD_24595,Cancer: Makowski_TIMER_000122 (liza.makowski@uthsc.edu)
BXD_24596,Cancer: Makowski_TIMER_000123 (liza.makowski@uthsc.edu)
BXD_24597,Cancer: Makowski_TIMER_000124 (liza.makowski@uthsc.edu)
BXD_24598,Cancer: Makowski_TIMER_100001 (liza.makowski@uthsc.edu)
BXD_24599,Cancer: Makowski_TIMER_100002 (liza.makowski@uthsc.edu)
BXD_24600,Cancer: Makowski_TIMER_100003 (liza.makowski@uthsc.edu)
BXD_24601,Cancer: Makowski_TIMER_100004 (liza.makowski@uthsc.edu)
BXD_24602,Cancer: Makowski_TIMER_100005 (liza.makowski@uthsc.edu)
BXD_24603,Cancer: Makowski_TIMER_100006 (liza.makowski@uthsc.edu)
BXD_24604,Cancer: Makowski_TIMER_100007 (liza.makowski@uthsc.edu)
BXD_24605,Cancer: Makowski_TIMER_100008 (liza.makowski@uthsc.edu)
BXD_24606,Cancer: Makowski_TIMER_100009 (liza.makowski@uthsc.edu)
BXD_24607,Cancer: Makowski_TIMER_100010 (liza.makowski@uthsc.edu)
BXD_24608,Cancer: Makowski_TIMER_100011 (liza.makowski@uthsc.edu)
BXD_24609,Cancer: Makowski_TIMER_100012 (liza.makowski@uthsc.edu)
BXD_24610,Cancer: Makowski_TIMER_100013 (liza.makowski@uthsc.edu)
BXD_24611,Cancer: Makowski_TIMER_100014 (liza.makowski@uthsc.edu)
BXD_24612,Cancer: Makowski_TIMER_100015 (liza.makowski@uthsc.edu)
BXD_24613,Cancer: Makowski_TIMER_100016 (liza.makowski@uthsc.edu)
BXD_24614,Cancer: Makowski_TIMER_100017 (liza.makowski@uthsc.edu)
BXD_24615,Cancer: Makowski_TIMER_100018 (liza.makowski@uthsc.edu)
BXD_24616,Cancer: Makowski_TIMER_100019 (liza.makowski@uthsc.edu)
BXD_24617,Cancer: Makowski_TIMER_100020 (liza.makowski@uthsc.edu)
BXD_24618,Cancer: Makowski_TIMER_100021 (liza.makowski@uthsc.edu)
BXD_24619,Cancer: Makowski_TIMER_100022 (liza.makowski@uthsc.edu)
BXD_24620,Cancer: Makowski_TIMER_100023 (liza.makowski@uthsc.edu)
BXD_24621,Cancer: Makowski_TIMER_100024 (liza.makowski@uthsc.edu)
BXD_24622,Cancer: Makowski_TIMER_100025 (liza.makowski@uthsc.edu)
BXD_24623,Cancer: Makowski_TIMER_100026 (liza.makowski@uthsc.edu)
BXD_24624,Cancer: Makowski_TIMER_100027 (liza.makowski@uthsc.edu)
BXD_24625,Cancer: Makowski_TIMER_100028 (liza.makowski@uthsc.edu)
BXD_24626,Cancer: Makowski_TIMER_100029 (liza.makowski@uthsc.edu)
BXD_24627,Cancer: Makowski_TIMER_100030 (liza.makowski@uthsc.edu)
BXD_24628,Cancer: Makowski_TIMER_100031 (liza.makowski@uthsc.edu)
BXD_24629,Cancer: Makowski_TIMER_100032 (liza.makowski@uthsc.edu)
BXD_24630,Cancer: Makowski_TIMER_100033 (liza.makowski@uthsc.edu)
BXD_24631,Cancer: Makowski_TIMER_100034 (liza.makowski@uthsc.edu)
BXD_24632,Cancer: Makowski_TIMER_100035 (liza.makowski@uthsc.edu)
BXD_24633,Cancer: Makowski_TIMER_100036 (liza.makowski@uthsc.edu)
BXD_24634,Cancer: Makowski_TIMER_100037 (liza.makowski@uthsc.edu)
BXD_24635,Cancer: Makowski_TIMER_100038 (liza.makowski@uthsc.edu)
BXD_24636,Cancer: Makowski_TIMER_100039 (liza.makowski@uthsc.edu)
BXD_24637,Cancer: Makowski_TIMER_100040 (liza.makowski@uthsc.edu)
BXD_24638,Cancer: Makowski_TIMER_100041 (liza.makowski@uthsc.edu)
BXD_24639,Cancer: Makowski_TIMER_100042 (liza.makowski@uthsc.edu)
BXD_24640,Cancer: Makowski_TIMER_100043 (liza.makowski@uthsc.edu)
BXD_24641,Cancer: Makowski_TIMER_100044 (liza.makowski@uthsc.edu)
BXD_24642,Cancer: Makowski_TIMER_100045 (liza.makowski@uthsc.edu)
BXD_24643,Cancer: Makowski_TIMER_100046 (liza.makowski@uthsc.edu)
BXD_24644,Cancer: Makowski_TIMER_100047 (liza.makowski@uthsc.edu)
BXD_24645,Cancer: Makowski_TIMER_100048 (liza.makowski@uthsc.edu)
BXD_24646,Cancer: Makowski_TIMER_100049 (liza.makowski@uthsc.edu)
BXD_24647,Cancer: Makowski_TIMER_100050 (liza.makowski@uthsc.edu)
BXD_24648,Cancer: Makowski_TIMER_100051 (liza.makowski@uthsc.edu)
BXD_24649,Cancer: Makowski_TIMER_100052 (liza.makowski@uthsc.edu)
BXD_24650,Cancer: Makowski_TIMER_100053 (liza.makowski@uthsc.edu)
BXD_24651,Cancer: Makowski_TIMER_100054 (liza.makowski@uthsc.edu)
BXD_24652,Cancer: Makowski_TIMER_100055 (liza.makowski@uthsc.edu)
BXD_24653,Cancer: Makowski_TIMER_100056 (liza.makowski@uthsc.edu)
BXD_24654,Cancer: Makowski_TIMER_100057 (liza.makowski@uthsc.edu)
BXD_24655,Cancer: Makowski_TIMER_100058 (liza.makowski@uthsc.edu)
BXD_24656,Cancer: Makowski_TIMER_100059 (liza.makowski@uthsc.edu)
BXD_24657,Cancer: Makowski_TIMER_100060 (liza.makowski@uthsc.edu)
BXD_24658,Cancer: Makowski_TIMER_100061 (liza.makowski@uthsc.edu)
BXD_24659,Cancer: Makowski_TIMER_100062 (liza.makowski@uthsc.edu)
BXD_24660,Cancer: Makowski_TIMER_100063 (liza.makowski@uthsc.edu)
BXD_24661,Cancer: Makowski_TIMER_100064 (liza.makowski@uthsc.edu)
BXD_24662,Cancer: Makowski_TIMER_100065 (liza.makowski@uthsc.edu)
BXD_24663,Cancer: Makowski_TIMER_100066 (liza.makowski@uthsc.edu)
BXD_24664,Cancer: Makowski_TIMER_100067 (liza.makowski@uthsc.edu)
BXD_24665,Cancer: Makowski_TIMER_100068 (liza.makowski@uthsc.edu)
BXD_24666,Cancer: Makowski_TIMER_100069 (liza.makowski@uthsc.edu)
BXD_24667,Cancer: Makowski_TIMER_100070 (liza.makowski@uthsc.edu)
BXD_24668,Cancer: Makowski_TIMER_100071 (liza.makowski@uthsc.edu)
BXD_24669,Cancer: Makowski_TIMER_100072 (liza.makowski@uthsc.edu)
BXD_24670,Cancer: Makowski_TIMER_100073 (liza.makowski@uthsc.edu)
BXD_24671,Cancer: Makowski_TIMER_100074 (liza.makowski@uthsc.edu)
BXD_24672,Cancer: Makowski_TIMER_100075 (liza.makowski@uthsc.edu)
BXD_24673,Cancer: Makowski_TIMER_100076 (liza.makowski@uthsc.edu)
BXD_24674,Cancer: Makowski_TIMER_100077 (liza.makowski@uthsc.edu)
BXD_24675,Cancer: Makowski_TIMER_100078 (liza.makowski@uthsc.edu)
BXD_24676,Cancer: Makowski_TIMER_100079 (liza.makowski@uthsc.edu)
BXD_24677,Cancer: Makowski_TIMER_100080 (liza.makowski@uthsc.edu)
BXD_24678,Cancer: Makowski_TIMER_100081 (liza.makowski@uthsc.edu)
BXD_24679,Cancer: Makowski_TIMER_100082 (liza.makowski@uthsc.edu)
BXD_24680,Cancer: Makowski_TIMER_100083 (liza.makowski@uthsc.edu)
BXD_24681,Cancer: Makowski_TIMER_100084 (liza.makowski@uthsc.edu)
BXD_24682,Cancer: Makowski_TIMER_100085 (liza.makowski@uthsc.edu)
BXD_24683,Cancer: Makowski_TIMER_100086 (liza.makowski@uthsc.edu)
BXD_24684,Cancer: Makowski_TIMER_100087 (liza.makowski@uthsc.edu)
BXD_24685,Cancer: Makowski_TIMER_100088 (liza.makowski@uthsc.edu)
BXD_24686,Cancer: Makowski_TIMER_100089 (liza.makowski@uthsc.edu)
BXD_24687,Cancer: Makowski_TIMER_100090 (liza.makowski@uthsc.edu)
BXD_24688,Cancer: Makowski_TIMER_100091 (liza.makowski@uthsc.edu)
BXD_24689,Cancer: Makowski_TIMER_100092 (liza.makowski@uthsc.edu)
BXD_24690,Cancer: Makowski_TIMER_100093 (liza.makowski@uthsc.edu)
BXD_24691,Cancer: Makowski_TIMER_100094 (liza.makowski@uthsc.edu)
BXD_24692,Cancer: Makowski_TIMER_100095 (liza.makowski@uthsc.edu)
BXD_24693,Cancer: Makowski_TIMER_100096 (liza.makowski@uthsc.edu)
BXD_24694,Cancer: Makowski_TIMER_100097 (liza.makowski@uthsc.edu)
BXD_24695,Cancer: Makowski_TIMER_100098 (liza.makowski@uthsc.edu)
BXD_24696,Cancer: Makowski_TIMER_100099 (liza.makowski@uthsc.edu)
BXD_24697,Cancer: Makowski_TIMER_100100 (liza.makowski@uthsc.edu)
BXD_24698,Cancer: Makowski_TIMER_100101 (liza.makowski@uthsc.edu)
BXD_24699,Cancer: Makowski_TIMER_100102 (liza.makowski@uthsc.edu)
BXD_24700,Cancer: Makowski_TIMER_100103 (liza.makowski@uthsc.edu)
BXD_24701,Cancer: Makowski_TIMER_100104 (liza.makowski@uthsc.edu)
BXD_24702,Cancer: Makowski_TIMER_100105 (liza.makowski@uthsc.edu)
BXD_24703,Cancer: Makowski_TIMER_100106 (liza.makowski@uthsc.edu)
BXD_24704,Cancer: Makowski_TIMER_100107 (liza.makowski@uthsc.edu)
BXD_24705,Cancer: Makowski_TIMER_100108 (liza.makowski@uthsc.edu)
BXD_24706,Cancer: Makowski_TIMER_100109 (liza.makowski@uthsc.edu)
BXD_24707,Cancer: Makowski_TIMER_100110 (liza.makowski@uthsc.edu)
BXD_24708,Cancer: Makowski_TIMER_100111 (liza.makowski@uthsc.edu)
BXD_24709,Cancer: Makowski_TIMER_100112 (liza.makowski@uthsc.edu)
BXD_24710,Cancer: Makowski_TIMER_100113 (liza.makowski@uthsc.edu)
BXD_24711,Cancer: Makowski_TIMER_100114 (liza.makowski@uthsc.edu)
BXD_24712,Cancer: Makowski_TIMER_100115 (liza.makowski@uthsc.edu)
BXD_24713,Cancer: Makowski_TIMER_100116 (liza.makowski@uthsc.edu)
BXD_24714,Cancer: Makowski_TIMER_100117 (liza.makowski@uthsc.edu)
BXD_24715,Cancer: Makowski_TIMER_100118 (liza.makowski@uthsc.edu)
BXD_24716,Cancer: Makowski_TIMER_100119 (liza.makowski@uthsc.edu)
BXD_24717,Cancer: Makowski_TIMER_100120 (liza.makowski@uthsc.edu)
BXD_24718,Cancer: Makowski_TIMER_100121 (liza.makowski@uthsc.edu)
BXD_24719,Cancer: Makowski_TIMER_100122 (liza.makowski@uthsc.edu)
BXD_24720,Cancer: Makowski_TIMER_100123 (liza.makowski@uthsc.edu)
BXD_24721,"Central nervous system, behavior, motor learning: motor performance improvements was calculated on rotarod at constant acceleration (4 to 40 rpm) over 2 minutes where day 3 was subtracted from the performance on day 1 (mean of day 3- mean of day 1) at the postnatal ages (P)90-P120"
BXD_24722,"Central nervous system, behavior, motor learning: The difference in time [sec] on rotarod at constant acceleration (4 to 40 rpm) over 2 minutes between day 3 and day 1 performance at the postnatal ages (P)90-P120"
BXD_24723,"Central nervous system, behaviour, Fore- & Hind limb placement accuracy: The performance of accurate limb placement on horizontal ladder walking task containing irregular walking pattern at the postnatal ages (P)90-P120 (BXD 40 winsorized from 0.051 to 0.046 & BXD 69 winsorized from 0.051 to 0.046 by JRS)"
BXD_24724,"Central nervous system, behaviour, Fore- & Hind limb placement: The rate of missteps on horizontal ladder walking task containing irregular walking pattern at the postnatal ages (P)90-P120 "
BXD_24725,"Central nervous system, behaviour, fore- & hind limb placement: The rate of correction in limb placement on horizontal ladder walking task containing irregular walking pattern at the postnatal ages (P)90-P120 (BXD32 winsorized from -0.030 to -0.016 by JRS)"
BXD_24726,"Central nervous system, behavior, skilled motor learning: Percentage of success in which the food pellet is obtained on the first advance of the forelimb towards the food over 10 days of performance on skilled motor reaching task at the postnatal ages (P)90-P120"
BXD_24727,"Central nervous System, behavior, skilled motor learning: Percentage of Non first advance of the forelimb towards the food over 10 days of performance on skilled motor reaching task at the postnatal ages (P)90-P120"
BXD_24728,"Central nervous system, behavior, skilled motor learning: Difference between the average performance on the first 2 days and the last 2 days, divided by the number of inter-trial intervals."
BXD_24729,"Central nervous system, behavior, motor learning: motor performance improvements was calculated on complex wheel where day 3 was subtracted from the performance on day 1 (mean of day 3- mean of day 1) at the postnatal ages (P)90-P120"
BXD_24730,"Central nervous System, Behavior, Motor learning: The difference between intratrial day 1 performance of time [sec] on complex wheel task containing irregular walking pattern at the postnatal ages (P)90-P120"
BXD_24731,"Genetics, genomics: SINEs detected in sequencing of each BXD strain, counts of high quality hits in BLAST (e-score <1E-10, length > 149 nucleotides, identify > 75%) [n]"
BXD_24732,"Aging, metabolism, morphology: Body weight change from baseline to 6 months of age on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g]"
BXD_24733,"Aging, metabolism, morphology: Body weight change from 6 to 12 months of age on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g]"
BXD_24734,"Aging, metabolism, morphology: Body weight change from 12 to 18 months of age on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g]"
BXD_24735,"Aging, metabolism, morphology: Body weight change from 18 to 24 months of age on standard chow diet (Harlan Teklad 7912 chow diet, 18% fat), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g]"
BXD_24736,"Aging, metabolism, morphology: Body weight change from baseline to 6 months of age on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g); 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g] "
BXD_24737,"Aging, metabolism, morphology: Body weight change from 6 to 12 months of age on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g); 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g] "
BXD_24738,"Aging, metabolism, morphology: Body weight change from 12 to 18 months of age on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g); 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g]"
BXD_24739,"Aging, metabolism, morphology: Body weight change from 18 to 24 months of age on high fat diet (Harlan Teklad 06414, 18.4% protein, 60.3% calories from fat, 5.1 kcal/g); 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage [g] "
BXD_24740,"Immune system, autoimmune disease: MOG35-55 EAE model, incidence rate in females"
BXD_24741,"Immune system, autoimmune disease: MOG35-55 EAE model, peak clinical score in females"
BXD_24742,"Immune system, autoimmune disease: MOG35-55 EAE model, day of symptom development in females with disease"
BXD_24743,"Immune system, autoimmune disease: MOG35-55 EAE model, length of acute disease in symptomatic females"
BXD_24744,"Immune system, autoimmune disease: MOG35-55 EAE model, clinical score in females at study termination (day 30 post-immunization)"
BXD_24745,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 1 in females at 11 to 13 weeks of age [sec]"
BXD_24746,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 2 in females at 11 to 13 weeks of age [sec]"
BXD_24747,"Central nervous system, behavior: Habituation to a novel environment, arm visit time during an 8-arm radial maze test, measured as the difference between days 1 and 2 in females at 11 to 13 weeks of age [sec]"
BXD_24748,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 1 in females and males at 11 to 13 weeks of age [sec]"
BXD_24749,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 2 in females and males at 11 to 13 weeks of age [sec]"
BXD_24750,"Central nervous system, behavior: Habituation to a novel environment, arm visit time during an 8-arm radial maze test, measured as the difference between days 1 and 2 in females and males at 11 to 13 weeks of age [sec]"
BXD_24751,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 1 in males at 11 to 13 weeks of age [sec]"
BXD_24752,"Central nervous system, behavior: Activity in a novel environment, arm visit time during an 8-arm radial maze test on day 2 in males at 11 to 13 weeks of age [sec]"
BXD_24753,"Central nervous system, behavior: Habituation to a novel environment, arm visit time during an 8-arm radial maze test, measured as the difference between days 1 and 2 in males at 11 to 13 weeks of age [sec]"
BXD_24754,"Aging, metabolism: Lifespan, mean longevity of females at UTHSC on high fat diet (HFD) supplemented with 1% nicotinamide (NAM, aka vitamin B3; Teklad custom diet TD.180921 with 1% (10g/kg) added to HFD, 60% kcal from fat (TD.06414)), 12 hr light cycle in polypropylene cages (145 sq-in with up to 10 animals/cage, Harlan Teklad 7087 soft cob bedding), 12 hr light cycle with up to 10 animals/cage, updated Feb 2023 (n = 98) [days]"
BXD_24755,mean_LD1
BXD_24756,var_LD1
BXD_24757,mean_centroid
BXD_24758,var_centroid
BXD_24759,mean_mesh_volume
BXD_24760,mean_surface_area
BXD_24761,mean_ben_sizes
BXD_24762,median_mesh_volume
BXD_24763,median_surface_area
BXD_24764,median_ben_sizes
BXD_24765,mean_PC1
BXD_24766,mean_PC2
BXD_24767,mean_PC3
BXD_24768,median_PC1
BXD_24769,median_PC2
BXD_24770,median_PC3
BXD_24781,"winsorized strains include
BXD102
BXD56
BXD29 
BXD99
BXD9
BXD71"
BXD_24782,Description unavailable
BXD_24793,Unpublished data
BXD_24794,Cardiovascular system: Body weight during echocardiography of 4-5 month old females [g]
BXD_24795,Cardiovascular system: Pulmonary valve peak velosity by echocardiography of 4-5 month old females [mm/s]
BXD_24796,Cardiovascular system: Pulmonary valve peak pressure by echocardiography of 4-5 month old females [mmHg]
BXD_24797,Cardiovascular system: Septum thickness by echocardiography of 4-5 month old females [mm]
BXD_24798,Cardiovascular system: Septum thickness by echocardiography of 4-5 month old females [mm]
BXD_24799,Cardiovascular system: End-diastolic diameter by echocardiography of 4-5 month old females [mm]
BXD_24800,Cardiovascular system: End-systolic diameter by echocardiography of 4-5 month old females [mm]
BXD_24801,Cardiovascular system: Posterior wall thickness by echocardiography of 4-5 month old females [mm]
BXD_24802,Cardiovascular system: Posterior wall thickness by echocardiography of 4-5 month old females [mm]
BXD_24803,Cardiovascular system: Ejection fraction by echocardiography of 4-5 month old females [%]
BXD_24804,Cardiovascular system: Shortening fraction by echocardiography of 4-5 month old females [%]
BXD_24805,Cardiovascular system: Left ventricular mass by echocardiography of 4-5 month old females [mg]
BXD_24806,Cardiovascular system: Left ventricular volumn by echocardiography of 4-5 monthold females [mg]
BXD_24807,Cardiovascular system: Left ventricular volumn by echocardiography of 4-5 monthold females [mg]
BXD_24808,"Cardiovascular system, physiology: Heart rate during echocardiography of 4-5 monthold females [beat/min]"
BXD_24809,Cardiovascular system: Cardiac output  by echoc by echocardiography of 4-5 month old females [ml/min]
BXD_24810,Cardiovascular system: End-diastolic diameter by echocardiography of 4-5 month old females [mm]
BXD_24811,Cardiovascular system: Body weight during echocardiography of 4-5 month old males [g]
BXD_24812,Cardiovascular system: Pulmonary valve peak velosity by echocardiography of 4-5 month old males [mm/s]
BXD_24813,Cardiovascular system: Pulmonary valve peak pressure by echocardiography of 4-5 month old males [mmHg]
BXD_24814,Cardiovascular system: Septum thickness by echocardiography of 4-5 month old males [mm]
BXD_24815,Cardiovascular system: Septum thickness by echocardiography of 4-5 month old males [mm]
BXD_24816,Cardiovascular system: End-diastolic diameter by echocardiography of 4-5 month old males [mm]
BXD_24817,Cardiovascular system: End-systolic diameter by echocardiography of 4-5 month old males [mm]
BXD_24818,Cardiovascular system: Posterior wall thickness by echocardiography of 4-5 month old males [mm]
BXD_24819,Cardiovascular system: Posterior wall thickness by echocardiography of 4-5 month old males [mm]
BXD_24820,Cardiovascular system: Ejection fraction by echocardiography of 4-5 month old males [%]
BXD_24821,Cardiovascular system: Shortening fraction by echocardiography of 4-5 month old males [%]
BXD_24822,Cardiovascular system: Left ventricular mass by echocardiography of 4-5 month old males [mg]
BXD_24823,Cardiovascular system: Left ventricular volumn by echocardiography of 4-5 monthold males [mg]
BXD_24824,Cardiovascular system: Left ventricular volumn by echocardiography of 4-5 monthold males [mg]
BXD_24825,"Cardiovascular system, physiology: Heart rate during echocardiography of 4-5 monthold males [beat/min]"
BXD_24826,Cardiovascular system: Cardiac output  by echoc by echocardiography of 4-5 month old males [ml/min]
BXD_24827,Cardiovascular system: End-diastolic diameter by echocardiography of 4-5 month old males [mm]
BXD_24828,"Cofactor, genetics: Inbreeding coefficient of isogenic BXD family members where 1 = fully inbred strains (BXD1 to BXD223), 0.5 = F1 hybrid of BXD parental strains, and 0 = B2D2F1 and D2B6F1 "
BXD_24829,"Infectious disease, immunology, meta-genomics: M. tuberculosis colony forming units in lung at 4 weeks post-infection [log10 CFU]"
BXD_24830,"Infectious disease, immunology, meta-genomics: M. tuberculosis colony forming units in spleen at 4 weeks post-infection [log10 CFU]"
BXD_24831,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0003 (recF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24832,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0007 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24833,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0009 (ppiA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24834,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0010c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24835,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0012 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24836,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0016c (pbpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24837,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0017c (rodA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24838,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0018c (ppp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24839,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0019c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24840,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0020c (TB39.8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24841,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0021c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24842,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0022c (whiB5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24843,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0024 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24844,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0025 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24845,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0026 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24846,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0027 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24847,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0028 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24848,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0029 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24849,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0034 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24850,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0035 (fadD34) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24851,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0037c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24852,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0038 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24853,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0039c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24854,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0040c (mtc28) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24855,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0042c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24856,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0043c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24857,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0044c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24858,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0045c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24859,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0047c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24860,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0048c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24861,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0049 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24862,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0050 (ponA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24863,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0051 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24864,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0052 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24865,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0056 (rplI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24866,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0057 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24867,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0061 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24868,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0062 (celA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24869,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0063 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24870,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0065 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24871,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0066c (icd2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24872,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0067c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24873,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0068 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24874,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0069c (sdaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24875,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0070c (glyA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24876,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0071 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24877,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0074 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24878,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0075 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24879,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0076c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24880,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0077c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24881,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0078 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24882,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0078A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24883,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0079 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24884,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0081 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24885,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0082 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24886,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0083 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24887,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0084 (hycD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24888,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0085 (hycP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24889,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0086 (hycQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24890,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0087 (hycE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24891,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0088 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24892,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0089 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24893,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0090 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24894,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0092 (ctpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24895,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0093c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24896,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0094c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24897,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0095c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24898,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0096 (PPE1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24899,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0097 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24900,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0098 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24901,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0099 (fadD10) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24902,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0101 (nrp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24903,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0103c (ctpB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24904,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0106 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24905,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0109 (PE_PGRS1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24906,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0110 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24907,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0111 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24908,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0112 (gca) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24909,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0113 (gmhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24910,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0114 (gmhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24911,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0115 (hddA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24912,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0116c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24913,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0117 (oxyS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24914,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0118c (oxcA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24915,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0120c (fusA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24916,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0121c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24917,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0122 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24918,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0124 (PE_PGRS2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24919,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0125 (pepA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24920,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0126 (treS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24921,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0127 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24922,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0129c (fbpC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24923,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0130 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24924,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0131c (fadE1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24925,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0132c (fgd2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24926,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0133 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24927,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0134 (ephF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24928,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0135c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24929,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0137c (msrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24930,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0138 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24931,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0139 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24932,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0140 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24933,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0141c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24934,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0142 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24935,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0145 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24936,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0153c (ptbB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24937,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0154c (fadE2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24938,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0155 (pntAa) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24939,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0157 (pntB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24940,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0158 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24941,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0161 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24942,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0162c (adhE1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24943,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0163 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24944,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0165c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24945,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0167 (yrbE1A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24946,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0168 (yrbE1B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24947,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0169 (mce1A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24948,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0170 (mce1B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24949,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0171 (mce1C) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24950,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0172 (mce1D) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24951,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0173 (lprK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24952,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0174 (mce1F) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24953,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0175 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24954,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0176 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24955,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0177 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24956,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0178 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24957,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0179c (lprO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24958,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0181c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24959,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0182c (sigG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24960,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0183 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24961,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0184 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24962,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0185 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24963,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0186 (bglS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24964,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0187 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24965,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0188 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24966,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0191 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24967,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0195 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24968,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0196 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24969,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0197 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24970,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0198c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24971,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0199 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24972,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0200 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24973,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0201c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24974,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0202c (mmpL11) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24975,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0204c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24976,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0205 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24977,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0206c (mmpL3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24978,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0207c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24979,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0208c (trmB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24980,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0209 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24981,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0210 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24982,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0211 (pckA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24983,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0212c (nadR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24984,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0215c (fadE3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24985,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0216 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24986,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0217c (lipW) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24987,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0218 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24988,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0219 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24989,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0220 (lipC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24990,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0221 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24991,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0222 (echA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24992,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0223c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24993,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0229c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24994,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0231 (fadE4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24995,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0232 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24996,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0233 (nrdB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24997,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0234c (gabD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24998,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0235c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_24999,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0237 (lpqI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25000,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0238 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25001,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0240 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25002,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0241c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25003,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0242c (fabG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25004,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0243 (fadA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25005,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0244c (fadE5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25006,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0247c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25007,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0248c (sdhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25008,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0249c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25009,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0251c (hsp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25010,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0253 (nirD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25011,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0254c (cobU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25012,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0255c (cobQ1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25013,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0256c (PPE2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25014,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0259c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25015,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0260c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25016,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0261c (narK3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25017,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0262c (aac) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25018,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0263c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25019,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0264c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25020,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0265c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25021,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0266c (oplA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25022,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0269c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25023,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0270 (fadD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25024,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0271c (fadE6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25025,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0272c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25026,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0273c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25027,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0274 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25028,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0275c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25029,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0277c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25030,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0278c (PE_PGRS3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25031,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0279c (PE_PGRS4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25032,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0280 (PPE3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25033,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0281 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25034,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0293c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25035,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0294 (tam) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25036,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0295c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25037,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0296c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25038,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0297 (PE_PGRS5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25039,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0298 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25040,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0300 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25041,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0302 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25042,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0303 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25043,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0306 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25044,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0307c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25045,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0308 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25046,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0309 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25047,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0310c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25048,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0311 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25049,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0312 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25050,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0313 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25051,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0314c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25052,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0315 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25053,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0316 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25054,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0317c (glpQ2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25055,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0318c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25056,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0319 (pcp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25057,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0320 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25058,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0321 (dcd) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25059,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0322 (udgA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25060,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0323c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25061,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0324 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25062,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0325 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25063,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0326 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25064,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0327c (cyp135A1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25065,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0328 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25066,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0329c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25067,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0331 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25068,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0332 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25069,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0333 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25070,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0339c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25071,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0341 (iniB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25072,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0343 (iniC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25073,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0344c (lpqJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25074,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0345 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25075,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0347 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25076,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0348 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25077,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0353 (hspR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25078,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0354c (PPE7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25079,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0356c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25080,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0359 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25081,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0360c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25082,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0362 (mgtE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25083,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0364 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25084,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0365c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25085,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0366c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25086,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0368c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25087,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0369c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25088,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0370c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25089,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0371c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25090,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0373c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25091,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0376c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25092,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0377 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25093,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0380c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25094,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0381c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25095,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0385 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25096,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0386 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25097,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0387c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25098,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0388c (PPE9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25099,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0389 (purT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25100,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0390 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25101,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0391 (metZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25102,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0392c (ndhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25103,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0393 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25104,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0394c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25105,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0395 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25106,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0398c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25107,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0399c (lpqK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25108,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0400c (fadE7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25109,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0403c (mmpS1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25110,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0405 (pks6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25111,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0406c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25112,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0407 (fgd1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25113,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0408 (pta) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25114,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0409 (ackA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25115,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0413 (mutT3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25116,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0418 (lpqL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25117,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0420c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25118,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0421c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25119,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0424c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25120,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0425c (ctpH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25121,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0427c (xthA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25122,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0428c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25123,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0431 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25124,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0432 (sodC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25125,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0433 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25126,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0434 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25127,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0436c (pssA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25128,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0437c (psd) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25129,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0438c (moeA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25130,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0439c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25131,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0441c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25132,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0443 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25133,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0444c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25134,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0445c (sigK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25135,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0446c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25136,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0447c (ufaA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25137,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0448c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25138,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0449c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25139,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0450c (mmpL4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25140,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0451c (mmpS4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25141,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0452 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25142,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0453 (PPE11) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25143,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0454 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25144,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0456c (echA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25145,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0457c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25146,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0458 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25147,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0459 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25148,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0461 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25149,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0464c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25150,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0465c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25151,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0466 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25152,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0468 (fadB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25153,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0469 (umaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25154,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0470A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25155,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0470c (pcaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25156,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0471c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25157,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0472c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25158,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0473 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25159,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0474 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25160,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0475 (hbhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25161,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0476 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25162,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0477 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25163,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0478 (deoC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25164,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0480c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25165,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0481c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25166,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0484c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25167,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0485 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25168,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0487 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25169,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0488 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25170,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0490 (senX3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25171,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0491 (regX3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25172,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0492A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25173,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0492c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25174,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0493c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25175,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0494 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25176,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0495c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25177,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0496 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25178,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0497 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25179,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0498 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25180,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0499 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25181,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0501 (galE2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25182,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0502 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25183,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0503c (cmaA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25184,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0504c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25185,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0505c (serB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25186,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0506 (mmpS2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25187,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0508 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25188,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0513 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25189,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0516c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25190,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0518 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25191,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0519c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25192,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0520 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25193,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0521 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25194,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0522 (gabP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25195,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0523c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25196,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0532 (PE_PGRS6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25197,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0533c (fabH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25198,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0535 (pnp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25199,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0536 (galE3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25200,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0537c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25201,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0538 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25202,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0539 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25203,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0540 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25204,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0544c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25205,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0545c (pitA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25206,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0546c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25207,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0547c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25208,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0549c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25209,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0552 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25210,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0554 (bpoC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25211,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0557 (pimB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25212,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0559c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25213,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0560c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25214,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0561c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25215,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0563 (htpX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25216,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0564c (gpsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25217,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0566c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25218,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0567 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25219,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0568 (cyp135B1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25220,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0570 (nrdZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25221,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0571c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25222,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0572c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25223,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0573c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25224,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0574c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25225,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0575c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25226,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0576 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25227,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0577 (TB27.3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25228,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0578c (PE_PGRS7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25229,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0579 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25230,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0580c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25231,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0581 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25232,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0582 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25233,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0583c (lpqN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25234,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0585c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25235,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0586 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25236,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0587 (yrbE2A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25237,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0588 (yrbE2B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25238,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0589 (mce2A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25239,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0590 (mce2B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25240,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0590A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25241,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0591 (mce2C) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25242,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0592 (mce2D) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25243,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0593 (lprL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25244,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0595c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25245,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0597c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25246,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0598c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25247,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0599c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25248,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0600c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25249,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0602c (tcrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25250,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0604 (lpqO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25251,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0605 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25252,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0606 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25253,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0609 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25254,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0610c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25255,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0611c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25256,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0612 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25257,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0613c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25258,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0614 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25259,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0616c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25260,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0618 (galTa) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25261,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0619 (galTb) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25262,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0620 (galK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25263,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0621 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25264,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0622 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25265,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0624 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25266,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0625c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25267,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0629c (recD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25268,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0630c (recB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25269,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0631c (recC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25270,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0632c (echA3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25271,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0633c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25272,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0634A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25273,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0634c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25274,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0642c (mmaA4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25275,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0643c (mmaA3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25276,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0644c (mmaA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25277,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0645c (mmaA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25278,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0646c (lipG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25279,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0650 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25280,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0653c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25281,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0654 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25282,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0655 (mkl) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25283,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0656c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25284,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0658c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25285,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0659c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25286,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0661c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25287,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0662c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25288,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0663 (atsD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25289,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0665 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25290,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0668 (rpoC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25291,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0670 (end) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25292,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0671 (lpqP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25293,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0672 (fadE8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25294,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0673 (echA4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25295,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0677c (mmpS5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25296,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0678 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25297,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0679c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25298,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0681 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25299,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0686 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25300,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0687 (fabG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25301,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0688 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25302,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0690c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25303,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0691c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25304,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0692 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25305,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0693 (pqqE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25306,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0694 (lldD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25307,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0695 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25308,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0696 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25309,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0697 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25310,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0698 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25311,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0712 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25312,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0713 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25313,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0724A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25314,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0725c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25315,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0726c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25316,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0727c (fucA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25317,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0728c (serA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25318,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0729 (xylB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25319,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0731c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25320,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0734 (mapA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25321,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0735 (sigL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25322,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0737 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25323,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0739 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25324,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0740 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25325,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0742 (PE_PGRS8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25326,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0744c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25327,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0745 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25328,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0746 (PE_PGRS9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25329,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0747 (PE_PGRS10) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25330,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0749 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25331,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0750 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25332,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0751c (mmsB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25333,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0752c (fadE9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25334,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0753c (mmsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25335,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0755c (PPE12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25336,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0756c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25337,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0757 (phoP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25338,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0758 (phoR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25339,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0760c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25340,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0761c (adhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25341,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0762c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25342,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0764c (cyp51) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25343,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0765c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25344,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0766c (cyp123) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25345,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0767c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25346,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0768 (aldA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25347,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0769 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25348,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0770 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25349,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0771 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25350,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0773c (ggtA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25351,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0774c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25352,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0775 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25353,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0776c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25354,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0778 (cyp126) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25355,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0779c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25356,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0781 (ptrBa) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25357,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0782 (ptrBb) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25358,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0783c (emrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25359,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0784 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25360,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0785 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25361,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0786c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25362,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0787 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25363,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0789c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25364,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0791c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25365,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0792c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25366,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0793 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25367,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0794c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25368,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0795 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25369,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0796 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25370,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0798c (cfp29) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25371,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0799c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25372,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0800 (pepC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25373,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0802c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25374,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0804 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25375,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0805 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25376,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0806c (cpsY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25377,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0813c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25378,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0815c (cysA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25379,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0818 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25380,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0820 (phoT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25381,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0821c (phoY2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25382,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0822c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25383,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0823c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25384,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0825c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25385,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0827c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25386,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0829 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25387,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0831c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25388,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0833 (PE_PGRS13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25389,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0834c (PE_PGRS14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25390,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0835 (lpqQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25391,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0836c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25392,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0837c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25393,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0838 (lpqR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25394,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0839 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25395,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0840c (pip) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25396,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0842 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25397,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0843 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25398,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0844c (narL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25399,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0845 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25400,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0846c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25401,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0847 (lpqS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25402,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0848 (cysK2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25403,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0849 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25404,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0850 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25405,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0851c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25406,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0852 (fadD16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25407,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0856 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25408,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0857 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25409,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0858c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25410,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0859 (fadA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25411,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0860 (fadB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25412,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0861c (ercc3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25413,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0862c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25414,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0863 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25415,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0864 (moaC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25416,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0865 (mog) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25417,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0867c (rpfA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25418,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0868c (moaD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25419,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0869c (moaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25420,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0870c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25421,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0872c (PE_PGRS15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25422,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0874c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25423,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0876c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25424,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0877 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25425,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0878c (PPE13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25426,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0881 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25427,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0885 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25428,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0886 (fprB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25429,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0887c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25430,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0889c (citA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25431,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0891c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25432,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0892 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25433,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0893c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25434,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0894 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25435,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0895 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25436,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0897c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25437,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0899 (ompA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25438,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0901 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25439,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0904c (accD3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25440,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0905 (echA6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25441,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0906 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25442,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0907 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25443,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0908 (ctpE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25444,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0910 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25445,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0911 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25446,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0913c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25447,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0914c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25448,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0915c (PPE14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25449,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0916c (PE7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25450,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0917 (betP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25451,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0918 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25452,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0919 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25453,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0920c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25454,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0921 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25455,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0923c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25456,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0924c (mntH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25457,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0925c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25458,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0926c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25459,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0927c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25460,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0928 (pstS3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25461,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0929 (pstC2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25462,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0930 (pstA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25463,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0933 (pstB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25464,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0935 (pstC1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25465,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0936 (pstA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25466,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0937c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25467,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0938 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25468,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0939 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25469,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0940c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25470,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0941c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25471,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0942 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25472,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0943c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25473,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0944 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25474,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0945 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25475,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0949 (uvrD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25476,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0950c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25477,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0953c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25478,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0954 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25479,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0955 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25480,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0958 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25481,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0959 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25482,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0960 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25483,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0961 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25484,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0962c (lprP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25485,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0963c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25486,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0964c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25487,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0965c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25488,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0966c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25489,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0968 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25490,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0969 (ctpV) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25491,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0970 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25492,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0971c (echA7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25493,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0972c (fadE12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25494,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0973c (accA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25495,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0974c (accD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25496,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0975c (fadE13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25497,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0976c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25498,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0981 (mprA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25499,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0983 (pepD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25500,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0985c (mscL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25501,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0986 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25502,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0987 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25503,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0988 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25504,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0989c (grcC2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25505,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0990c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25506,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0992c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25507,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0994 (moeA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25508,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0995 (rimJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25509,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0996 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25510,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0997 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25511,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0998 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25512,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv0999 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25513,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1000c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25514,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1001 (arcA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25515,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1003 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25516,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1004c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25517,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1006 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25518,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1008 (tatD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25519,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1009 (rpfB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25520,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1010 (ksgA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25521,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1012 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25522,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1013 (pks16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25523,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1016c (lpqT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25524,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1019 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25525,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1020 (mfd) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25526,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1021 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25527,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1022 (lpqU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25528,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1026 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25529,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1027c (kdpE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25530,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1028c (kdpD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25531,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1030 (kdpB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25532,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1031 (kdpC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25533,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1032c (trcS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25534,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1033c (trcR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25535,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1037c (esxI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25536,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1039c (PPE15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25537,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1040c (PE8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25538,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1042c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25539,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1043c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25540,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1045 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25541,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1046c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25542,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1047 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25543,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1048c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25544,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1049 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25545,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1050 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25546,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1051c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25547,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1052 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25548,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1053c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25549,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1056 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25550,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1058 (fadD14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25551,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1059 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25552,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1060 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25553,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1061 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25554,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1062 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25555,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1063c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25556,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1064c (lpqV) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25557,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1065 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25558,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1067c (PE_PGRS19) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25559,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1068c (PE_PGRS20) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25560,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1069c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25561,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1070c (echA8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25562,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1071c (echA9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25563,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1072 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25564,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1075c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25565,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1076 (lipU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25566,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1077 (cbs) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25567,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1078 (pra) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25568,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1079 (metB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25569,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1080c (greA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25570,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1082 (mca) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25571,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1084 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25572,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1085c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25573,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1086 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25574,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1087 (PE_PGRS21) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25575,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1087A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25576,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1088 (PE9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25577,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1090 (celA2b) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25578,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1091 (PE_PGRS22) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25579,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1095 (phoH2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25580,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1096 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25581,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1097c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25582,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1099c (glpX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25583,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1100 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25584,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1102c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25585,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1103c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25586,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1104 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25587,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1105 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25588,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1106c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25589,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1108c (xseA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25590,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1109c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25591,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1111c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25592,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1112 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25593,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1115 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25594,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1116A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25595,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1118c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25596,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1121 (zwf1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25597,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1123c (bpoB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25598,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1124 (ephC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25599,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1125 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25600,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1126c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25601,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1127c (ppdK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25602,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1128c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25603,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1129c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25604,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1130 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25605,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1131 (gltA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25606,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1132 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25607,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1134 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25608,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1135A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25609,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1135c (PPE16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25610,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1138c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25611,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1139c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25612,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1140 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25613,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1141c (echA11) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25614,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1142c (echA10) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25615,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1144 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25616,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1145 (mmpL13a) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25617,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1147 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25618,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1148c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25619,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1149 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25620,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1151c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25621,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1152 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25622,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1153c (omt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25623,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1155 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25624,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1156 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25625,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1158c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25626,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1159 (pimE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25627,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1159A (phhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25628,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1160 (mutT2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25629,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1161 (narG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25630,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1162 (narH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25631,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1163 (narJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25632,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1164 (narI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25633,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1165 (typA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25634,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1167c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25635,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1171 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25636,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1172c (PE12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25637,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1173 (fbiC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25638,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1174c (TB8.4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25639,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1175c (fadH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25640,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1176c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25641,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1178 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25642,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1180 (pks3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25643,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1181 (pks4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25644,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1182 (papA3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25645,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1183 (mmpL10) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25646,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1184c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25647,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1185c (fadD21) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25648,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1186c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25649,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1187 (rocA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25650,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1188 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25651,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1189 (sigI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25652,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1190 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25653,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1191 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25654,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1192 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25655,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1193 (fadD36) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25656,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1194c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25657,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1195 (PE13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25658,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1196 (PPE18) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25659,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1199c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25660,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1203c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25661,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1204c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25662,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1205 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25663,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1206 (fadD6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25664,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1207 (folP2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25665,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1209 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25666,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1210 (tagA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25667,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1212c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25668,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1213 (glgC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25669,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1214c (PE14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25670,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1215c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25671,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1216c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25672,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1217c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25673,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1218c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25674,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1219c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25675,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1220c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25676,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1221 (sigE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25677,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1225c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25678,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1226c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25679,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1227c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25680,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1230c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25681,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1231c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25682,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1233c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25683,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1234 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25684,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1235 (lpqY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25685,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1236 (sugA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25686,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1237 (sugB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25687,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1238 (sugC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25688,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1239c (corA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25689,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1242 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25690,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1243c (PE_PGRS23) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25691,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1244 (lpqZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25692,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1245c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25693,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1246c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25694,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1247c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25695,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1250 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25696,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1251c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25697,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1252c (lprE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25698,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1253 (deaD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25699,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1255c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25700,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1256c (cyp130) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25701,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1257c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25702,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1259 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25703,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1260 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25704,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1261c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25705,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1262c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25706,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1263 (amiB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25707,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1264 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25708,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1267c (embR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25709,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1269c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25710,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1270c (lprA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25711,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1271c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25712,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1272c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25713,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1273c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25714,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1276c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25715,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1277 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25716,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1278 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25717,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1279 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25718,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1280c (oppA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25719,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1281c (oppD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25720,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1282c (oppC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25721,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1283c (oppB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25722,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1284 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25723,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1286 (cysN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25724,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1287 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25725,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1288 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25726,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1289 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25727,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1290A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25728,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1314c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25729,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1316c (ogt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25730,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1317c (alkA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25731,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1321 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25732,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1322 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25733,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1322A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25734,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1323 (fadA4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25735,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1325c (PE_PGRS24) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25736,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1328 (glgP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25737,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1329c (dinG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25738,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1330c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25739,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1331 (clpS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25740,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1332 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25741,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1333 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25742,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1334 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25743,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1335 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25744,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1336 (cysM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25745,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1337 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25746,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1339 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25747,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1340 (rph) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25748,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1341 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25749,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1344 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25750,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1345 (fadD33) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25751,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1346 (fadE14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25752,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1348 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25753,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1349 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25754,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1350 (fabG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25755,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1351 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25756,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1352 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25757,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1353c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25758,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1354c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25759,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1355c (moeY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25760,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1356c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25761,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1357c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25762,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1359 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25763,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1361c (PPE19) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25764,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1362c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25765,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1363c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25766,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1364c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25767,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1365c (rsfA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25768,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1366 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25769,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1367c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25770,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1368 (lprF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25771,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1369c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25772,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1370c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25773,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1371 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25774,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1372 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25775,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1373 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25776,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1374c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25777,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1376 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25778,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1377c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25779,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1378c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25780,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1386 (PE15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25781,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1387 (PPE20) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25782,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1393c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25783,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1395 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25784,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1396c (PE_PGRS25) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25785,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1397c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25786,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1399c (lipH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25787,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1400c (lipI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25788,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1401 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25789,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1403c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25790,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1404 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25791,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1405c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25792,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1407 (fmu) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25793,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1410c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25794,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1411c (lprG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25795,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1413 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25796,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1414 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25797,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1418 (lprH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25798,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1420 (uvrC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25799,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1421 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25800,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1422 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25801,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1424c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25802,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1426c (lipO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25803,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1427c (fadD12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25804,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1429 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25805,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1430 (PE16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25806,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1431 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25807,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1432 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25808,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1433 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25809,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1435c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25810,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1439c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25811,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1441c (PE_PGRS26) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25812,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1445c (devB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25813,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1446c (opcA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25814,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1447c (zwf2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25815,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1448c (tal) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25816,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1450c (PE_PGRS27) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25817,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1452c (PE_PGRS28) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25818,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1455 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25819,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1459c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25820,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1460 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25821,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1467c (fadE15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25822,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1468c (PE_PGRS29) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25823,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1469 (ctpD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25824,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1470 (trxA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25825,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1472 (echA12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25826,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1473 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25827,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1474c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25828,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1478 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25829,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1486c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25830,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1488 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25831,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1489A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25832,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1490 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25833,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1492 (mutA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25834,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1493 (mutB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25835,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1494 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25836,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1495 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25837,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1496 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25838,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1498c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25839,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1499 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25840,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1501 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25841,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1502 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25842,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1503c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25843,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1504c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25844,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1505c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25845,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1506c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25846,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1507A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25847,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1507c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25848,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1508A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25849,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1509 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25850,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1511 (gmdA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25851,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1512 (epiA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25852,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1513 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25853,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1514c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25854,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1515c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25855,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1516c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25856,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1517 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25857,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1518 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25858,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1521 (fadD25) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25859,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1523 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25860,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1524 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25861,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1525 (wbbL2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25862,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1526c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25863,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1528c (papA4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25864,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1529 (fadD24) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25865,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1530 (adh) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25866,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1531 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25867,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1532c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25868,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1533 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25869,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1534 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25870,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1535 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25871,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1537 (dinX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25872,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1538c (ansA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25873,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1541c (lprI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25874,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1542c (glbN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25875,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1543 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25876,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1544 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25877,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1546 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25878,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1549 (fadD11.1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25879,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1551 (plsB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25880,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1552 (frdA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25881,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1553 (frdB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25882,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1554 (frdC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25883,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1556 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25884,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1557 (mmpL6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25885,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1558 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25886,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1561 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25887,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1562c (treZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25888,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1563c (treY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25889,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1565c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25890,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1566c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25891,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1568 (bioA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25892,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1569 (bioF1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25893,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1575 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25894,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1579c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25895,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1580c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25896,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1581c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25897,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1582c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25898,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1585c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25899,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1586c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25900,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1587c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25901,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1588c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25902,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1589 (bioB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25903,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1591 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25904,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1592c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25905,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1593c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25906,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1597 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25907,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1598c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25908,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1604 (impA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25909,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1607 (chaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25910,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1608c (bcpB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25911,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1615 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25912,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1616 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25913,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1618 (tesB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25914,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1619 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25915,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1620c (cydC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25916,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1621c (cydD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25917,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1622c (cydB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25918,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1623c (cydA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25919,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1624c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25920,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1626 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25921,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1627c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25922,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1628c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25923,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1629 (polA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25924,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1632c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25925,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1633 (uvrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25926,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1634 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25927,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1635c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25928,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1637c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25929,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1638 (uvrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25930,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1639c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25931,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1640c (lysS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25932,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1644 (tsnR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25933,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1646 (PE17) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25934,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1647 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25935,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1648 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25936,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1651c (PE_PGRS30) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25937,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1660 (pks10) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25938,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1662 (pks8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25939,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1663 (pks17) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25940,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1664 (pks9) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25941,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1665 (pks11) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25942,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1666c (cyp139) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25943,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1667c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25944,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1668c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25945,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1669 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25946,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1670 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25947,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1671 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25948,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1672c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25949,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1673c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25950,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1674c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25951,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1675c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25952,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1676 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25953,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1677 (dsbF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25954,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1678 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25955,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1679 (fadE16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25956,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1680 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25957,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1681 (moeX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25958,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1682 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25959,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1683 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25960,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1686c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25961,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1687c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25962,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1688 (mpg) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25963,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1690 (lprJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25964,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1691 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25965,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1692 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25966,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1694 (tlyA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25967,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1696 (recN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25968,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1698 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25969,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1700 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25970,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1701 (xerD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25971,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1702c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25972,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1703c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25973,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1704c (cycA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25974,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1705c (PPE22) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25975,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1709 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25976,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1710 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25977,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1714 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25978,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1715 (fadB3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25979,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1716 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25980,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1717 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25981,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1718 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25982,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1719 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25983,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1720c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25984,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1724c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25985,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1725c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25986,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1726 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25987,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1727 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25988,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1728c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25989,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1729c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25990,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1730c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25991,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1732c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25992,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1733c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25993,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1735c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25994,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1736c (narX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25995,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1737c (narK2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25996,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1739c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25997,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1741 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25998,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1742 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_25999,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1744c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26000,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1745c (idi) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26001,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1746 (pknF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26002,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1747 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26003,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1748 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26004,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1749c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26005,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1750c (fadD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26006,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1751 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26007,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1752 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26008,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1753c (PPE24) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26009,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1754c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26010,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1755c (plcD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26011,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1756c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26012,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1757c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26013,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1758 (cut1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26014,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1759c (wag22) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26015,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1761c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26016,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1762c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26017,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1763 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26018,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1764 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26019,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1765A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26020,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1765c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26021,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1767 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26022,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1768 (PE_PGRS31) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26023,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1769 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26024,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1771 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26025,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1773c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26026,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1774 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26027,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1775 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26028,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1776c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26029,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1777 (cyp144) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26030,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1778c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26031,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1779c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26032,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1780 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26033,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1785c (cyp143) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26034,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1789 (PPE26) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26035,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1790 (PPE27) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26036,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1791 (PE19) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26037,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1793 (esxN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26038,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1798 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26039,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1800 (PPE28) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26040,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1802 (PPE30) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26041,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1803c (PE_PGRS32) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26042,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1804c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26043,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1805c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26044,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1807 (PPE31) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26045,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1808 (PPE32) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26046,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1810 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26047,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1813c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26048,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1815 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26049,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1816 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26050,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1818c (PE_PGRS33) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26051,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1819c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26052,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1820 (ilvG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26053,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1821 (secA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26054,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1823 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26055,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1824 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26056,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1825 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26057,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1829 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26058,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1831 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26059,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1833c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26060,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1834 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26061,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1836c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26062,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1838c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26063,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1840c (PE_PGRS34) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26064,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1841c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26065,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1842c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26066,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1843c (guaB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26067,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1847 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26068,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1850 (ureC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26069,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1855c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26070,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1857 (modA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26071,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1859 (modC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26072,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1860 (apa) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26073,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1861 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26074,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1862 (adhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26075,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1863c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26076,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1864c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26077,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1865c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26078,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1866 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26079,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1867 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26080,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1868 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26081,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1869c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26082,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1870c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26083,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1871c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26084,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1872c (lldD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26085,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1874 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26086,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1875 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26087,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1876 (bfrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26088,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1878 (glnA3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26089,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1879 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26090,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1880c (cyp140) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26091,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1881c (lppE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26092,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1883c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26093,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1884c (rpfC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26094,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1885c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26095,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1886c (fbpB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26096,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1890c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26097,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1891 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26098,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1892 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26099,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1894c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26100,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1895 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26101,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1896c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26102,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1897c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26103,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1899c (lppD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26104,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1900c (lipJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26105,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1901 (cinA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26106,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1903 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26107,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1904 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26108,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1906c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26109,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1907c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26110,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1908c (katG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26111,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1909c (furA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26112,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1910c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26113,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1911c (lppC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26114,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1912c (fadB5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26115,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1913 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26116,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1914c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26117,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1915 (aceAa) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26118,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1916 (aceAb) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26119,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1919c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26120,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1920 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26121,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1922 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26122,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1923 (lipD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26123,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1924c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26124,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1925 (fadD31) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26125,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1926c (mpt63) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26126,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1927 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26127,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1929c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26128,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1932 (tpx) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26129,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1933c (fadE18) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26130,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1934c (fadE17) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26131,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1935c (echA13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26132,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1936 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26133,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1937 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26134,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1938 (ephB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26135,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1940 (ribA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26136,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1943c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26137,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1944c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26138,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1945 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26139,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1946c (lppG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26140,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1947 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26141,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1948c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26142,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1949c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26143,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1950c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26144,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1951c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26145,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1953 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26146,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1954c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26147,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1955 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26148,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1956 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26149,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1957 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26150,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1958c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26151,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1959c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26152,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1961 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26153,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1962c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26154,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1963c (mce3R) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26155,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1965 (yrbE3B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26156,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1967 (mce3B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26157,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1968 (mce3C) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26158,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1969 (mce3D) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26159,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1970 (lprM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26160,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1971 (mce3F) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26161,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1972 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26162,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1974 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26163,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1976c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26164,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1978 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26165,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1980c (mpt64) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26166,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1982c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26167,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1984c (cfp21) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26168,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1985c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26169,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1986 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26170,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1988 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26171,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1989c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26172,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1990A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26173,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1991c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26174,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1992c (ctpG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26175,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1993c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26176,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1994c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26177,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1995 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26178,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1996 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26179,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1997 (ctpF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26180,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1998c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26181,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv1999c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26182,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2001 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26183,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2002 (fabG3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26184,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2003c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26185,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2004c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26186,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2005c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26187,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2006 (otsB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26188,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2007c (fdxA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26189,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2008c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26190,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2010 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26191,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2011c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26192,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2012 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26193,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2014 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26194,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2015c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26195,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2016 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26196,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2018 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26197,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2019 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26198,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2020c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26199,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2021c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26200,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2025c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26201,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2026c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26202,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2027c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26203,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2028c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26204,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2029c (pfkB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26205,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2030c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26206,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2031c (hspX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26207,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2032 (acg) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26208,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2033c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26209,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2035 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26210,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2036 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26211,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2037c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26212,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2038c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26213,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2039c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26214,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2040c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26215,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2041c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26216,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2042c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26217,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2043c (pncA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26218,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2044c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26219,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2045c (lipT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26220,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2046 (lppI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26221,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2047c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26222,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2048c (pks12) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26223,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2051c (ppm1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26224,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2052c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26225,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2053c (fxsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26226,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2054 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26227,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2059 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26228,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2061c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26229,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2062c (cobN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26230,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2065 (cobH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26231,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2066 (cobI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26232,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2067c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26233,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2069 (sigC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26234,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2070c (cobK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26235,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2071c (cobM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26236,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2072c (cobL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26237,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2073c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26238,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2074 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26239,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2075c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26240,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2076c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26241,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2077A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26242,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2078 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26243,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2079 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26244,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2080 (lppJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26245,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2081c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26246,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2083 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26247,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2084 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26248,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2086 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26249,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2088 (pknJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26250,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2089c (pepE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26251,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2090 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26252,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2091c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26253,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2092c (helY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26254,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2095c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26255,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2096c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26256,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2097c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26257,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2100 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26258,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2101 (helZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26259,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2102 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26260,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2105 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26261,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2106 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26262,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2107 (PE22) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26263,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2108 (PPE36) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26264,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2112c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26265,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2114 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26266,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2115c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26267,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2116 (lppK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26268,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2118c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26269,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2119 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26270,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2120c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26271,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2123 (PPE37) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26272,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2125 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26273,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2126c (PE_PGRS37) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26274,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2127 (ansP1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26275,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2128 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26276,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2129c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26277,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2131c (cysQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26278,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2133c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26279,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2134c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26280,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2136c (uppP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26281,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2137c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26282,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2140c (TB18.6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26283,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2141c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26284,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2142c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26285,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2143 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26286,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2148c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26287,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2149c (yfiH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26288,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2159c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26289,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2160A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26290,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2161c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26291,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2162c (PE_PGRS38) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26292,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2167c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26293,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2168c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26294,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2170 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26295,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2171 (lppM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26296,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2173 (idsA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26297,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2175c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26298,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2176 (pknL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26299,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2177c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26300,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2179c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26301,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2180c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26302,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2181 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26303,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2183c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26304,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2184c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26305,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2185c (TB16.3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26306,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2187 (fadD15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26307,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2189c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26308,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2190c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26309,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2197c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26310,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2200c (ctaC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26311,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2203 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26312,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2205c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26313,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2206 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26314,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2207 (cobT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26315,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2208 (cobS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26316,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2209 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26317,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2212 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26318,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2213 (pepB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26319,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2214c (ephD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26320,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2216 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26321,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2217 (lipB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26322,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2222c (glnA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26323,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2224c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26324,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2226 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26325,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2227 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26326,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2230c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26327,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2231c (cobC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26328,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2232 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26329,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2234 (ptpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26330,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2236c (cobD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26331,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2237 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26332,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2240c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26333,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2241 (aceE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26334,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2248 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26335,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2249c (glpD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26336,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2250c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26337,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2251 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26338,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2252 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26339,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2253 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26340,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2254c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26341,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2257c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26342,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2258c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26343,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2260 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26344,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2261c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26345,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2262c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26346,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2263 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26347,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2264c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26348,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2265 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26349,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2266 (cyp124) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26350,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2267c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26351,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2268c (cyp128) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26352,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2269c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26353,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2270 (lppN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26354,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2271 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26355,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2272 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26356,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2273 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26357,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2274c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26358,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2275 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26359,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2276 (cyp121) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26360,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2277c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26361,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2278 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26362,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2279 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26363,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2280 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26364,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2281 (pitB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26365,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2282c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26366,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2284 (lipM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26367,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2285 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26368,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2286c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26369,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2287 (yjcE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26370,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2288 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26371,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2289 (cdh) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26372,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2290 (lppO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26373,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2291 (sseB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26374,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2293c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26375,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2295 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26376,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2296 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26377,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2297 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26378,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2298 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26379,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2300c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26380,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2301 (cut2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26381,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2302 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26382,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2303c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26383,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2305 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26384,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2306A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26385,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2306B transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26386,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2307B transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26387,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2307D transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26388,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2307c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26389,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2308 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26390,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2309A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26391,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2309c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26392,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2311 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26393,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2312 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26394,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2313c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26395,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2314c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26396,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2315c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26397,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2316 (uspA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26398,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2317 (uspB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26399,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2318 (uspC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26400,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2319c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26401,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2320c (rocE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26402,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2321c (rocD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26403,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2322c (rocD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26404,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2323c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26405,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2325c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26406,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2326c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26407,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2328 (PE23) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26408,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2329c (narK1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26409,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2330c (lppP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26410,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2331 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26411,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2331A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26412,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2332 (mez) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26413,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2334 (cysK1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26414,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2335 (cysE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26415,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2336 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26416,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2337c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26417,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2338c (moeW) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26418,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2340c (PE_PGRS39) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26419,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2341 (lppQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26420,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2344c (dgt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26421,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2347c (esxP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26422,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2353c (PPE39) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26423,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2354 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26424,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2355 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26425,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2356c (PPE40) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26426,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2360c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26427,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2362c (recO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26428,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2363 (amiA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26429,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2366c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26430,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2367c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26431,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2368c (phoH1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26432,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2370c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26433,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2372c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26434,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2374c (hrcA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26435,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2375 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26436,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2378c (mbtG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26437,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2379c (mbtF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26438,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2380c (mbtE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26439,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2381c (mbtD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26440,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2383c (mbtB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26441,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2384 (mbtA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26442,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2385 (mbtJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26443,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2386c (mbtI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26444,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2387 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26445,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2388c (hemN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26446,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2390c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26447,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2394 (ggtB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26448,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2403c (lppR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26449,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2404c (lepA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26450,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2405 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26451,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2406c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26452,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2407 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26453,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2408 (PE24) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26454,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2409c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26455,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2410c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26456,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2414c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26457,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2415c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26458,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2416c (eis) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26459,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2417c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26460,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2419c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26461,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2422 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26462,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2423 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26463,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2424c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26464,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2426c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26465,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2427c (proA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26466,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2428 (ahpC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26467,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2429 (ahpD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26468,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2430c (PPE41) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26469,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2431c (PE25) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26470,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2432c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26471,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2433c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26472,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2434c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26473,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2435c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26474,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2436 (rbsK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26475,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2437 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26476,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2443 (dctA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26477,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2444c (rne) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26478,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2446c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26479,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2449c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26480,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2450c (rpfE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26481,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2451 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26482,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2452c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26483,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2453c (mobA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26484,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2458 (mmuM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26485,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2459 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26486,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2462c (tig) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26487,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2463 (lipP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26488,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2464c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26489,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2466c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26490,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2467 (pepN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26491,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2468c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26492,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2469c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26493,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2472 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26494,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2473 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26495,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2474c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26496,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2475c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26497,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2476c (gdh) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26498,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2478c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26499,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2479c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26500,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2480c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26501,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2481c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26502,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2482c (plsB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26503,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2483c (plsC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26504,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2484c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26505,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2485c (lipQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26506,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2486 (echA14) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26507,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2487c (PE_PGRS42) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26508,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2488c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26509,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2489c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26510,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2490c (PE_PGRS43) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26511,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2491 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26512,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2492 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26513,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2494 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26514,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2495c (pdhC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26515,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2496c (pdhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26516,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2497c (pdhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26517,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2498c (citE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26518,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2499c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26519,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2500c (fadE19) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26520,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2501c (accA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26521,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2502c (accD1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26522,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2504c (scoA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26523,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2505c (fadD35) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26524,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2506 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26525,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2510c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26526,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2513 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26527,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2514c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26528,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2515c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26529,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2517c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26530,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2521 (bcp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26531,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2522c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26532,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2525c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26533,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2527 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26534,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2528c (mrr) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26535,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2529 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26536,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2531c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26537,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2532c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26538,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2535c (pepQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26539,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2536 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26540,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2542 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26541,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2543 (lppA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26542,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2544 (lppB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26543,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2545 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26544,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2546 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26545,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2549c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26546,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2553c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26547,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2556c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26548,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2557 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26549,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2558 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26550,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2559c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26551,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2562 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26552,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2563 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26553,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2564 (glnQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26554,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2565 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26555,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2566 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26556,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2567 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26557,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2568c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26558,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2569c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26559,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2570 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26560,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2571c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26561,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2573 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26562,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2574 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26563,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2575 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26564,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2576c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26565,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2577 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26566,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2578c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26567,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2583c (relA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26568,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2584c (apt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26569,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2589 (gabT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26570,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2591 (PE_PGRS44) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26571,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2597 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26572,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2598 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26573,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2599 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26574,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2600 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26575,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2601 (speE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26576,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2602 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26577,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2605c (tesB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26578,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2606c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26579,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2607 (pdxH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26580,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2609c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26581,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2614A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26582,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2615c (PE_PGRS45) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26583,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2616 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26584,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2618 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26585,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2620c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26586,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2622 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26587,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2623 (TB31.7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26588,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2624c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26589,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2625c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26590,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2626c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26591,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2627c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26592,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2628 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26593,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2629 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26594,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2630 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26595,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2631 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26596,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2633c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26597,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2635 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26598,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2636 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26599,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2637 (dedA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26600,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2638 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26601,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2639c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26602,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2641 (cadI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26603,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2642 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26604,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2643 (arsC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26605,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2644c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26606,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2645 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26607,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2646 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26608,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2648 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26609,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2649 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26610,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2651c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26611,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2655c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26612,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2656c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26613,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2657c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26614,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2658c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26615,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2663 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26616,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2665 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26617,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2666 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26618,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2667 (clpC2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26619,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2668 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26620,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2669 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26621,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2670c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26622,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2671 (ribD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26623,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2672 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26624,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2674 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26625,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2679 (echA15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26626,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2680 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26627,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2681 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26628,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2683 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26629,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2684 (arsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26630,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2685 (arsB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26631,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2686c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26632,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2687c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26633,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2688c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26634,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2689c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26635,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2691 (ceoB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26636,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2693c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26637,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2694c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26638,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2695 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26639,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2696c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26640,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2701c (suhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26641,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2702 (ppgK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26642,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2704 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26643,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2705c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26644,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2707 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26645,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2708c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26646,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2709 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26647,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2710 (sigB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26648,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2712c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26649,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2714 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26650,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2715 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26651,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2716 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26652,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2717c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26653,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2718c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26654,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2721c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26655,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2722 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26656,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2723 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26657,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2727c (miaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26658,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2728c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26659,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2729c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26660,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2730 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26661,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2731 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26662,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2732c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26663,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2733c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26664,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2734 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26665,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2735c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26666,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2736c (recX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26667,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2737c (recA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26668,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2740 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26669,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2741 (PE_PGRS47) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26670,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2742c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26671,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2743c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26672,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2744c (35kd_ag) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26673,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2748c (ftsK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26674,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2750 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26675,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2751 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26676,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2752c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26677,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2755c (hsdS.1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26678,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2756c (hsdM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26679,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2757c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26680,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2759c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26681,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2761c (hsdS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26682,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2765 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26683,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2766c (fabG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26684,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2767c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26685,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2771c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26686,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2772c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26687,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2774c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26688,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2775 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26689,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2776c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26690,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2778c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26691,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2780 (ald) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26692,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2781c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26693,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2782c (pepR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26694,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2784c (lppU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26695,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2788 (sirR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26696,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2789c (fadE21) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26697,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2790c (ltp1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26698,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2791c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26699,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2792c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26700,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2793c (truB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26701,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2795c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26702,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2799 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26703,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2800 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26704,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2801c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26705,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2802c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26706,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2803 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26707,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2804c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26708,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2806 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26709,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2807 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26710,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2808 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26711,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2809 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26712,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2810c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26713,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2812 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26714,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2813 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26715,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2814c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26716,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2815c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26717,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2816c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26718,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2817c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26719,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2818c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26720,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2819c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26721,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2820c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26722,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2821c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26723,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2822c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26724,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2823c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26725,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2824c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26726,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2826c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26727,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2829c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26728,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2831 (echA16) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26729,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2832c (ugpC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26730,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2833c (ugpB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26731,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2834c (ugpE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26732,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2835c (ugpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26733,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2836c (dinF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26734,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2840c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26735,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2848c (cobB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26736,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2849c (cobO) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26737,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2850c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26738,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2851c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26739,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2854 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26740,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2855 (mtr) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26741,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2856 (nicT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26742,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2857c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26743,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2858c (aldC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26744,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2859c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26745,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2860c (glnA4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26746,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2861c (mapB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26747,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2862c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26748,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2863 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26749,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2864c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26750,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2865 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26751,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2867c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26752,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2869c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26753,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2871 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26754,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2872 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26755,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2873 (mpt83) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26756,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2874 (dipZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26757,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2877c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26758,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2878c (mpt53) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26759,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2879c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26760,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2880c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26761,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2884 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26762,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2885c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26763,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2886c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26764,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2887 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26765,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2891 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26766,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2893 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26767,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2894c (xerC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26768,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2895c (viuB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26769,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2896c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26770,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2897c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26771,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2899c (fdhD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26772,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2900c (fdhF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26773,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2901c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26774,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2902c (rnhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26775,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2905 (lppW) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26776,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2910c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26777,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2911 (dacB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26778,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2912c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26779,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2913c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26780,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2914c (pknI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26781,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2915c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26782,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2917 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26783,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2918c (glnD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26784,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2919c (glnB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26785,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2920c (amt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26786,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2922c (smc) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26787,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2923c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26788,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2924c (fpg) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26789,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2926c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26790,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2928 (tesA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26791,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2929 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26792,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2930 (fadD26) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26793,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2931 (ppsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26794,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2932 (ppsB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26795,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2933 (ppsC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26796,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2934 (ppsD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26797,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2935 (ppsE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26798,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2936 (drrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26799,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2937 (drrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26800,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2938 (drrC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26801,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2939 (papA5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26802,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2940c (mas) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26803,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2941 (fadD28) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26804,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2942 (mmpL7) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26805,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2943 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26806,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2944 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26807,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2945c (lppX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26808,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2947c (pks15) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26809,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2949c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26810,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2950c (fadD29) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26811,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2951c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26812,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2952 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26813,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2954c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26814,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2955c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26815,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2956 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26816,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2957 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26817,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2959c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26818,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2960c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26819,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2961 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26820,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2962c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26821,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2963 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26822,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2964 (purU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26823,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2966c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26824,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2967c (pca) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26825,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2970A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26826,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2970c (lipN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26827,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2972c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26828,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2973c (recG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26829,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2974c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26830,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2976c (ung) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26831,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2978c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26832,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2979c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26833,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2982c (gpsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26834,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2985 (mutT1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26835,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2989 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26836,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2991 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26837,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2993c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26838,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2997 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26839,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2998 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26840,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv2999 (lppY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26841,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3000 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26842,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3005c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26843,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3007c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26844,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3008 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26845,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3010c (pfkA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26846,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3013 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26847,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3015c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26848,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3016 (lpqA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26849,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3017c (esxQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26850,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3019c (esxR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26851,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3020c (esxS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26852,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3021c (PPE47) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26853,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3022A (PE29) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26854,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3022c (PPE48) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26855,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3023c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26856,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3024c (trmU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26857,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3026c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26858,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3036c (TB22.2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26859,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3037c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26860,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3040c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26861,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3041c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26862,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3045 (adhC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26863,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3047c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26864,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3050c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26865,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3054c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26866,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3055 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26867,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3057c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26868,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3058c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26869,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3059 (cyp136) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26870,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3060c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26871,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3061c (fadE22) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26872,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3062 (ligB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26873,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3063 (cstA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26874,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3064c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26875,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3065 (mmr) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26876,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3066 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26877,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3067 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26878,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3068c (pgmA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26879,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3069 (ccrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26880,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3070 (ccrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26881,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3071 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26882,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3072c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26883,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3073c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26884,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3074 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26885,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3075c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26886,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3076 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26887,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3079c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26888,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3080c (pknK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26889,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3081 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26890,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3082c (virS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26891,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3083 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26892,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3084 (lipR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26893,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3085 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26894,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3086 (adhD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26895,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3087 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26896,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3088 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26897,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3089 (fadD13) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26898,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3090 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26899,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3091 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26900,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3092c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26901,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3093c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26902,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3094c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26903,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3095 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26904,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3096 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26905,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3098c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26906,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3099c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26907,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3101c (ftsX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26908,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3102c (ftsE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26909,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3103c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26910,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3104c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26911,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3107c (agpS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26912,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3109 (moaA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26913,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3111 (moaC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26914,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3113 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26915,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3114 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26916,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3116 (moeB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26917,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3117 (cysA3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26918,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3119 (moaE1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26919,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3120 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26920,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3122 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26921,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3123 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26922,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3124 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26923,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3125c (PPE49) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26924,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3127 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26925,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3130c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26926,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3131 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26927,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3132c (devS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26928,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3133c (devR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26929,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3134c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26930,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3135 (PPE50) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26931,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3136 (PPE51) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26932,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3138 (pflA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26933,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3139 (fadE24) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26934,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3140 (fadE23) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26935,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3141 (fadB4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26936,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3142c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26937,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3143 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26938,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3144c (PPE52) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26939,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3145 (nuoA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26940,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3146 (nuoB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26941,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3147 (nuoC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26942,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3148 (nuoD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26943,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3149 (nuoE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26944,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3150 (nuoF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26945,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3151 (nuoG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26946,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3152 (nuoH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26947,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3154 (nuoJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26948,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3155 (nuoK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26949,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3156 (nuoL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26950,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3157 (nuoM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26951,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3160c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26952,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3161c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26953,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3162c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26954,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3163c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26955,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3164c (moxR3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26956,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3165c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26957,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3166c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26958,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3167c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26959,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3168 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26960,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3169 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26961,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3170 (aofH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26962,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3171c (hpx) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26963,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3172c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26964,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3173c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26965,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3174 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26966,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3175 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26967,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3176c (mesT) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26968,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3177 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26969,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3178 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26970,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3179 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26971,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3180c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26972,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3181c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26973,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3184 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26974,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3185 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26975,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3186 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26976,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3187 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26977,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3188 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26978,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3189 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26979,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3192 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26980,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3194c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26981,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3195 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26982,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3196 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26983,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3197 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26984,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3198A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26985,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3198c (uvrD2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26986,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3199c (nudC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26987,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3200c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26988,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3201c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26989,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3202c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26990,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3203 (lipV) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26991,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3204 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26992,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3205c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26993,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3207c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26994,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3208A (TB9.4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26995,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3209 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26996,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3210c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26997,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3213c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26998,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3214 (gpm2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_26999,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3216 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27000,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3218 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27001,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3220c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27002,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3223c (sigH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27003,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3224 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27004,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3224B transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27005,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3225c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27006,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3226c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27007,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3229c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27008,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3230c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27009,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3231c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27010,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3235 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27011,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3236c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27012,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3237c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27013,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3240c (secA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27014,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3241c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27015,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3243c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27016,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3249c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27017,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3250c (rubB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27018,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3253c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27019,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3254 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27020,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3256c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27021,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3261 (fbiA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27022,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3263 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27023,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3267 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27024,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3268 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27025,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3270 (ctpC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27026,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3271c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27027,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3273 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27028,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3278c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27029,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3282 (maf) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27030,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3283 (sseA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27031,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3284 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27032,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3286c (sigF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27033,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3288c (usfY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27034,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3289c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27035,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3290c (lat) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27036,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3291c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27037,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3292 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27038,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3293 (pcd) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27039,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3294c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27040,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3295 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27041,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3296 (lhr) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27042,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3297 (nei) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27043,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3298c (lpqC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27044,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3299c (atsB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27045,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3300c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27046,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3301c (phoY1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27047,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3303c (lpdA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27048,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3304 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27049,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3305c (amiA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27050,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3306c (amiB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27051,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3307 (deoD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27052,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3308 (pmmB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27053,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3309c (upp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27054,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3310 (sapM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27055,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3311 (satS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27056,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3312A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27057,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3312c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27058,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3313c (add) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27059,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3314c (deoA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27060,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3316 (sdhC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27061,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3318 (sdhA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27062,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3319 (sdhB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27063,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3323c (moaX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27064,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3324c (moaC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27065,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3325 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27066,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3326 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27067,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3327 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27068,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3328c (sigJ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27069,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3329 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27070,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3330 (dacB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27071,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3331 (sugI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27072,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3332 (nagA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27073,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3333c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27074,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3334 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27075,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3335c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27076,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3336c (trpS) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27077,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3337 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27078,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3338 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27079,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3339c (icd1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27080,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3340 (metC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27081,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3342 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27082,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3344c (PE_PGRS49) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27083,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3345c (PE_PGRS50) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27084,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3346c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27085,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3348 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27086,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3349c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27087,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3353c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27088,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3354 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27089,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3355c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27090,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3358 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27091,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3360 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27092,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3361c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27093,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3364c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27094,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3365c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27095,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3366 (spoU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27096,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3367 (PE_PGRS51) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27097,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3368c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27098,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3369 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27099,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3370c (dnaE2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27100,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3373 (echA18) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27101,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3375 (amiD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27102,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3376 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27103,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3377c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27104,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3378c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27105,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3379c (dxs2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27106,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3380c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27107,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3381c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27108,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3382c (lytB1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27109,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3383c (idsB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27110,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3384c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27111,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3386 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27112,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3387 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27113,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3388 (PE_PGRS52) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27114,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3389c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27115,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3392c (cmaA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27116,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3393 (iunH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27117,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3394c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27118,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3395A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27119,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3395c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27120,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3396c (guaA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27121,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3397c (phyA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27122,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3398c (idsA1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27123,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3399 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27124,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3400 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27125,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3401 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27126,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3403c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27127,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3405c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27128,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3406 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27129,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3407 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27130,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3408 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27131,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3409c (choD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27132,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3410c (guaB3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27133,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3412 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27134,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3413c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27135,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3414c (sigD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27136,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3415c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27137,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3416 (whiB3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27138,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3417c (groEL) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27139,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3419c (gcp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27140,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3420c (rimI) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27141,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3421c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27142,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3422c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27143,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3424c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27144,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3426 (PPE58) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27145,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3427c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27146,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3428c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27147,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3429 (PPE59) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27148,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3431c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27149,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3432c (gadB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27150,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3433c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27151,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3434c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27152,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3437 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27153,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3438 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27154,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3439c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27155,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3440c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27156,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3441c (mrsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27157,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3445c (esxU) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27158,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3446c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27159,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3447c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27160,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3448 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27161,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3449 (mycP4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27162,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3450c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27163,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3451 (cut3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27164,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3452 (cut4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27165,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3453 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27166,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3454 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27167,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3458c (rpsD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27168,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3463 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27169,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3467 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27170,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3468c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27171,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3469c (mhpE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27172,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3470c (ilvB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27173,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3471c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27174,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3472 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27175,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3473c (bpoA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27176,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3475 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27177,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3476c (kgtP) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27178,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3477 (PE31) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27179,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3481c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27180,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3482c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27181,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3483c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27182,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3484 (cpsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27183,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3485c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27184,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3487c (lipF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27185,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3488 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27186,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3490 (otsA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27187,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3491 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27188,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3492c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27189,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3493c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27190,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3494c (mce4F) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27191,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3495c (lprN) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27192,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3496c (mce4D) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27193,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3497c (mce4C) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27194,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3498c (mce4B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27195,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3499c (mce4A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27196,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3500c (yrbE4B) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27197,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3501c (yrbE4A) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27198,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3502c (fabG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27199,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3503c (fdxD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27200,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3504 (fadE26) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27201,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3505 (fadE27) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27202,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3506 (fadD17) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27203,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3507 (PE_PGRS53) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27204,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3509c (ilvX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27205,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3510c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27206,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3511 (PE_PGRS55) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27207,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3512 (PE_PGRS56) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27208,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3513c (fadD18) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27209,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3514 (PE_PGRS57) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27210,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3516 (echA19) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27211,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3517 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27212,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3518c (cyp142) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27213,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3519 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27214,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3522 (ltp4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27215,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3525c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27216,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3526 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27217,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3527 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27218,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3528c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27219,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3529c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27220,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3530c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27221,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3531c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27222,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3532 (PPE61) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27223,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3533c (PPE62) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27224,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3534c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27225,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3535c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27226,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3536c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27227,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3537 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27228,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3538 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27229,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3539 (PPE63) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27230,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3540c (ltp2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27231,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3542c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27232,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3543c (fadE29) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27233,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3544c (fadE28) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27234,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3545c (cyp125) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27235,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3546 (fadA5) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27236,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3547 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27237,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3548c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27238,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3549c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27239,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3551 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27240,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3552 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27241,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3553 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27242,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3554 (fdxB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27243,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3555c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27244,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3556c (fadA6) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27245,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3557c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27246,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3558 (PPE64) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27247,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3559c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27248,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3560c (fadE30) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27249,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3561 (fadD3) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27250,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3562 (fadE31) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27251,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3563 (fadE32) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27252,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3564 (fadE33) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27253,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3565 (aspB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27254,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3566A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27255,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3566c (nat) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27256,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3567c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27257,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3568c (bphC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27258,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3569c (bphD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27259,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3570c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27260,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3571 (hmp) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27261,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3572 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27262,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3573c (fadE34) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27263,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3574 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27264,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3575c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27265,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3576 (lppH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27266,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3577 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27267,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3578 (arsB2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27268,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3584 (lpqE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27269,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3585 (radA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27270,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3586 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27271,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3589 (mutY) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27272,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3590c (PE_PGRS58) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27273,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3591c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27274,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3592 (TB11.2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27275,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3593 (lpqF) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27276,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3594 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27277,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3595c (PE_PGRS59) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27278,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3596c (clpC1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27279,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3600c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27280,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3604c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27281,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3605c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27282,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3606c (folK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27283,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3610c (ftsH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27284,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3614c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27285,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3615c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27286,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3616c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27287,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3618 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27288,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3619c (esxV) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27289,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3621c (PPE65) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27290,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3622c (PE32) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27291,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3623 (lpqG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27292,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3624c (hpt) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27293,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3626c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27294,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3630 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27295,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3631 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27296,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3632 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27297,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3633 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27298,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3636 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27299,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3637 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27300,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3638 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27301,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3639c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27302,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3640c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27303,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3641c (fic) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27304,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3645 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27305,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3647c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27306,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3648c (cspA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27307,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3649 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27308,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3650 (PE33) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27309,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3651 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27310,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3653 (PE_PGRS61) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27311,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3654c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27312,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3656c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27313,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3657c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27314,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3659c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27315,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3660c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27316,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3661 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27317,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3663c (dppD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27318,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3664c (dppC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27319,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3665c (dppB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27320,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3666c (dppA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27321,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3667 (acs) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27322,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3668c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27323,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3672c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27324,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3674c (nth) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27325,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3675 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27326,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3676 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27327,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3677c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27328,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3678A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27329,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3679 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27330,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3680 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27331,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3681c (whiB4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27332,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3682 (ponA2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27333,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3683 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27334,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3684 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27335,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3686c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27336,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3687c (rsfB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27337,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3688c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27338,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3689 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27339,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3690 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27340,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3691 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27341,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3692 (moxR2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27342,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3693 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27343,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3694c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27344,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3695 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27345,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3696c (glpK) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27346,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3697c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27347,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3698 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27348,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3699 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27349,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3700c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27350,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3702c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27351,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3703c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27352,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3704c (gshA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27353,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3705A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27354,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3705c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27355,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3707c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27356,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3711c (dnaQ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27357,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3715c (recR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27358,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3716c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27359,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3717 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27360,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3719 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27361,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3720 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27362,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3723 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27363,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3724B (cut5b) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27364,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3725 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27365,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3726 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27366,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3728 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27367,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3730c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27368,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3731 (ligC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27369,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3732 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27370,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3733c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27371,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3735 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27372,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3737 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27373,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3739c (PPE67) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27374,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3740c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27375,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3741c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27376,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3742c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27377,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3744 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27378,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3745c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27379,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3746c (PE34) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27380,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3747 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27381,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3748 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27382,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3749c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27383,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3750c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27384,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3751 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27385,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3752c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27386,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3754 (tyrA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27387,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3755c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27388,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3756c (proZ) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27389,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3757c (proW) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27390,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3758c (proV) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27391,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3759c (proX) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27392,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3760 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27393,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3761c (fadE36) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27394,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3762c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27395,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3763 (lpqH) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27396,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3764c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27397,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3765c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27398,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3766 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27399,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3767c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27400,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3768 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27401,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3769 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27402,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3770A transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27403,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3770c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27404,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3771c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27405,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3773c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27406,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3774 (echA21) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27407,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3775 (lipE) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27408,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3776 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27409,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3777 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27410,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3779 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27411,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3780 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27412,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3786c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27413,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3787c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27414,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3788 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27415,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3789 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27416,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3793 (embC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27417,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3794 (embA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27418,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3796 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27419,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3797 (fadE35) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27420,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3799c (accD4) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27421,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3802c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27422,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3803c (fbpD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27423,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3804c (fbpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27424,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3805c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27425,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3810 (pirG) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27426,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3811 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27427,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3812 (PE_PGRS62) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27428,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3813c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27429,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3814c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27430,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3815c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27431,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3816c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27432,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3817 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27433,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3818 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27434,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3819 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27435,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3821 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27436,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3822 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27437,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3823c (mmpL8) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27438,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3826 (fadD23) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27439,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3827c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27440,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3828c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27441,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3829c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27442,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3830c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27443,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3831 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27444,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3832c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27445,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3833 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27446,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3835 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27447,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3836 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27448,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3837c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27449,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3840 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27450,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3841 (bfrB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27451,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3842c (glpQ1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27452,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3843c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27453,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3844 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27454,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3845 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27455,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3846 (sodA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27456,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3847 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27457,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3848 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27458,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3849 (espR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27459,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3850 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27460,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3852 (hns) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27461,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3854c (ethA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27462,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3855 (ethR) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27463,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3856c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27464,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3857c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27465,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3858c (gltD) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27466,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3860 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27467,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3863 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27468,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3864 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27469,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3865 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27470,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3866 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27471,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3867 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27472,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3868 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27473,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3869 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27474,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3870 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27475,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3871 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27476,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3872 (PE35) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27477,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3873 (PPE68) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27478,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3874 (esxB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27479,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3875 (esxA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27480,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3876 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27481,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3877 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27482,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3880c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27483,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3881c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27484,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3882c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27485,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3883c (mycP1) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27486,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3884c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27487,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3885c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27488,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3886c (mycP2) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27489,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3887c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27490,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3888c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27491,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3889c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27492,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3890c (esxC) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27493,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3892c (PPE69) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27494,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3893c (PE36) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27495,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3894c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27496,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3895c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27497,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3896c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27498,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3897c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27499,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3898c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27500,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3899c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27501,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3900c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27502,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3906c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27503,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3908 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27504,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3910 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27505,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3911 (sigM) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27506,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3912 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27507,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3915 transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27508,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3916c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27509,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3917c (parB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27510,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3919c (gidB) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27511,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3920c transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27512,"Infectious disease, immunology, meta-genomics: M. tuberculosis TnSeq Rv3923c (rnpA) transposon mutant abundance in vivo vs in vitro at 4 weeks post-infection [log2 fold change]"
BXD_27513,Cancer: Makowski 000019 (liza.makowski@uthsc.edu)
BXD_27514,Cancer: Makowski 000020 (liza.makowski@uthsc.edu)
BXD_27515,Cancer: Makowski 000021 (liza.makowski@uthsc.edu)
BXD_27516,Cancer: Makowski 000022 (liza.makowski@uthsc.edu)
BXD_27517,Cancer: Makowski 000023 (liza.makowski@uthsc.edu)
BXD_27518,Description unavailable
BXD_27519,Description unavailable
BXD_27520,Description unavailable
BXD_27521,Description unavailable
BXD_27522,Description unavailable
BXD_27523,Description unavailable
BXD_27524,Description unavailable
BXD_27525,Description unavailable
BXD_27526,Description unavailable
BXD_27527,Description unavailable
